
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-14101-14400*
  '(".1-puro" "67phox" "A-351G" "A-EGFP" "A-PXA" "A-PXAs" "A-allele" "A-dead"
    "A-loop" "A-type" "A1" "A1-OSU" "A1-R479" "A1-ST3" "A1-Wa" "A10" "A12"
    "A13" "A14" "A16" "A161S" "A2780-shFANCD2" "A278P" "A4" "A5" "A502Y503"
    "A6" "A7" "A8" "A9" "AAM10" "AAM15" "AAV" "AAVs" "ABPs" "ABSTRACT"
    "ABSciex" "ABT-199+GS-1101" "ABT-199+NVP-BEZ235" "ABT-199-R" "ABT-199R"
    "ABT-737-resistance" "ABT-99-R" "ABT199-NVP+BEZ235" "ABT199-R" "AC07"
    "ACGT" "ADAMTS" "ADP+Pi" "ADP-Pi" "AE" "AGAACAnnnTGTTCT" "AGRPPPPPYPGPPL"
    "AHNMD" "AICR" "AIM2-like" "AJCC" "AKT-dependence" "AKT-dependent"
    "AKT-interaction-defective" "AKT-mediated" "ALRs" "AMOT–YAP"
    "AMPK-competent" "AMPK-dependent" "AMPKwhich" "ANC" "ANTGTAACANT" "AOA"
    "AP-2a" "APO-BrdU" "APP-related" "APP-tg" "APP-transgenic" "AQD" "AQDA"
    "AQL" "AR-regulated-promoter" "AR-treatment" "ARBS" "ARBS#1" "ARBSs" "ARIC"
    "AS-ODNs" "AS605240" "ASCO" "ASO-qPCR-assays" "ASPP2-rAd"
    "ASPP2-rAd-infected" "ASPP2-rAd-injected" "ASPP2-rAd-treated" "AT4"
    "ATF-like" "ATF6b" "ATFs" "ATG2B" "ATM-S1981" "ATMi" "ATP-synthase"
    "ATP–actin" "ATR-dependent" "ATTG" "AUGUSTIN" "AUGs" "AUTS2" "AXand" "AZ"
    "AZA-Deoxy-Cytidine" "Abbott" "Abcam" "Abnet" "Abp" "Abstract" "Abubaker"
    "Ac-H3" "Ac-Lys49" "Ac-Phe-Phos" "Ac-p53" "Acaca" "Ace-K120-p53"
    "Acetyl-Lysine" "Acetyl-methyllysine" "Acetylation-defective" "Achilles"
    "Acuto" "Ad-ZBP-89" "Ad-ZBP-89-infected" "Ad-p53-PTM" "Ad-p53-PTM-treated"
    "AdDNStat5" "AdNull" "AdStat5aY694F" "AdWTStat5" "Addgene" "Affymetrix"
    "Africa" "African" "African-American" "African-Americans" "Africans" "Ag"
    "Ags" "Aim" "Aims" "Akhand" "Akt-S473" "Akt-dependent" "Akt-pS473"
    "Akt-pT308" "Akt-survival" "Akti-1" "Albany" "Aldefluor-positive"
    "Alekseev" "Aleskandarany" "Alexa" "Alexa-488" "Allendale" "Allostery"
    "Alon" "Altan" "Altan-Bonnet" "AlthoughFancd2" "Altmae" "Alu-PCR" "AluI"
    "AluSg" "AluSx" "AluY" "Alvarez" "Alzheimer" "Alzheimer's" "Alzheimer’s"
    "Amanda" "America" "American" "Americans" "Amersham" "Amgen" "Amicon"
    "Amit" "Amphiphysin" "Amplex" "Anagnoston" "Anagnostou" "Anders" "Anderson"
    "Andre" "Andrianantoandro" "Andrianantoandro’s" "Androgen-deprivation"
    "AngII" "AngII-infusion" "AngIII" "AngIV" "Angiomotin-Like-1" "Angulo"
    "Annexin-V-FITC" "Annexin-V-FITC-positive" "Annexin-V-FITC-staining"
    "AntagomiR-500" "Antifade" "Antonescu" "ApaI" "ApcMin" "Appratus" "Apt-GNP"
    "Apt-GNP-treated" "Apt-GNPs" "Aptamer-NP" "Arg-I" "Arg-II" "Arg-II-induced"
    "Arg-II-p38" "Arg-to-His" "Arg787X" "Ariani" "Ariotti" "Armstrong"
    "Aroeira" "Arteaga" "Arthur" "Asangani" "Ashkenazi" "Ashman" "Asian"
    "Asians" "Asp316" "Atg12-Atg5-Atg16" "Atlasi" "Aug" "Austin" "Australia"
    "AviTag" "Ayaz" "Ayrshire" "Ayvaz" "Aβ" "Aβ-pathologies" "A " "A–E" "A–S1E"
    "A–S4C" "A→G" "B*2705" "B*5701" "B-C" "B-DNA" "B-LCL" "B-LCL-phenotype"
    "B-LCL-type" "B-LCLs" "B-RAGC" "B-boxes" "B-cell-like" "B-lymphoblastoid"
    "B1" "B104-1-1" "B1–loop" "B3" "B3BD" "B3BDs" "B4" "B6" "B6BAFL" "B7"
    "BAC16-RTAstop" "BAC16-based" "BACH1-pathway" "BAD2SA" "BALB" "BALF5"
    "BAPTA-AM" "BAXβ" "BC021736" "BCL-2-like" "BCL2-like" "BCLL" "BCP-ALL"
    "BCR-ABL-negativity" "BCR-ABL1" "BCRP-substrate" "BCSC" "BCSCs" "BCSS"
    "BCT" "BD-Pharmingen" "BD-p53K381ac" "BEDtools" "BGJ398" "BH3-only" "BIMAS"
    "BIOGNOSYS" "BJ" "BL-like" "BMCC1s" "BMCC1ΔC" "BMEL" "BMMNCs" "BNF" "BNHL"
    "BOLERO-2" "BOROWA" "BOROWA-MAZGAJ" "BPTES" "BR1" "BR1-loop" "BR1–loop"
    "BRAFV600E-mutation-positive" "BRAFi" "BRAFi+MEKi" "BRAFi+MEKi+ERKi"
    "BRAFultra" "BRAT" "BRCA-DEGs" "BRCA1-2" "BRCA1-A" "BRCA1-IRIS-dependent"
    "BRCA1-IRIS-expressing" "BRCA1-IRIS-induced" "BRCA1-IRIS-overexpressing"
    "BRCA1-IRIS-overexpression" "BRCA1-IRIS-overexpression-induced"
    "BRCA1-IRIS-silenced" "BRCA1-IRIS-specific" "BRCA1-competent"
    "BRCA1-deficent" "BRCA1-proficient" "BRCAness" "BRCAx" "BRD"
    "BRD4-occupancy" "BRLF1" "BT-459" "BT-H1" "BTG" "BTG3-mHW" "BTG4" "BTN3A2"
    "BUN" "BWL" "BZLF1" "Baba" "Baccelli" "Background" "Bader" "Baldwin"
    "Bannayan-Riley-Ruvalcaba" "Bannayan–Riley–Ruvalcaba" "Barnes" "Barrett"
    "Barrios-Rodiles" "Bartek" "Bartolo" "Basal-type" "Basile" "Bayarsaihan"
    "Bcl" "Bcl-2" "Bcl-2-family" "Bcl-xl" "Bcrp1" "Beckman" "Begg" "Begg's"
    "Behrends" "Bekker" "Bekker-Jensen" "Ben-Men" "Ben-Men1-LucB" "Benayoun"
    "Benjamini" "Bennett" "Berkowitz" "Berlin" "Bert" "Bethesda" "Beum"
    "Bi-allelic" "Biase" "Binet" "Binstadt" "Bio" "Bio-Rad" "BioGPS" "BioGrid"
    "Biobank" "Bioo" "Bioresources" "Biosystems" "Biotechnonlgy" "Birbeck"
    "Birnbaum" "Bis" "Bis-I" "Bisson" "Bl6" "BlaM" "Blackburn" "Blackwood"
    "Blais" "Blanchet1146" "BmtI" "Bonferroni" "Borge" "Bothmer" "Bottinger"
    "Botuyan" "Boudjenah" "Boutet" "Bouwmeester" "Box-1" "Box1" "Box1 " "Box2"
    "Boyden" "Bozozok" "BrCSC" "BrCSCs" "BrCa" "Braak" "Braak's" "Brazil"
    "Brazilians" "Brca1-deficent" "Brca1F" "BrdU-treatment" "Brenton" "Breslow"
    "Breyer" "Brezinski" "Broad" "Brockman" "Brockmeyer" "Broers" "Brouxhon"
    "Brown-Forsythe" "Browser" "Brunet" "Brusewold" "Bruton" "Bruton's"
    "Bruton’s" "BstUI" "BuGZ" "BubR" "BubR1-D432-484" "Burgermeister" "Burkitt"
    "Burkitt's" "Burlingame" "Busino" "BxPC-3cells" "Byeon" "B–C" "C#16"
    "C-1305-induced" "C-160A" "C-Cdh1" "C-Mad2" "C-NHEJ" "C-dependent"
    "C-group" "C-mediated" "C-null" "C-rich" "C-subunit" "C-subunits"
    "C-terminally" "C-transactivation" "C-type" "C1" "C125A" "C128A" "C18"
    "C1b" "C1b-GFP" "C1–C5" "C2" "C3" "C30C31" "C5" "C5-C" "C5-N" "C5-derived"
    "C57" "C6" "C9orf80" "CA+AA" "CAAT" "CAAX" "CAAX-box" "CACGTG" "CAF-like"
    "CAGNTG" "CAL-101" "CAMA" "CAMA-eveR" "CAMK1" "CAMKII" "CAMP" "CANNTG"
    "CANT" "CARMA" "CARMA-BCL10-MALT1" "CAS882268–69–1" "CAV-SCC" "CAV-TME"
    "CAV-total" "CAV1-TME" "CAV1and" "CAY10576" "CB660" "CB660+c-Myc"
    "CBM-complex" "CBMDISC" "CCAAT" "CCCGAGGTGCTGGAGGACA" "CCGGAA" "CCGGAG"
    "CCN5" "CCSP-rtTA" "CCTGAGGTGCTGGAGGACA" "CCs" "CC " "CD-tagged"
    "CD-tagging" "CD154+T-cytotoxic" "CD154+TcM" "CD178" "CD28-coated"
    "CD28-stimulated" "CD3+T-cells" "CD4+T" "CD4-cre-mediated" "CD44V6"
    "CD44V6-c" "CD44hiCD62Llo" "CD44loCD62Lhi" "CD532" "CD8αα" "CD95-Fc"
    "CD95-Fc-treated" "CD95L-T4" "CDBF" "CDBP" "CDC25-like" "CDs" "CDt" "CEP17"
    "CEP7" "CFL1-siRNA2" "CFL1-small" "CFPAC-1and" "CGC" "CGG" "CGGAAGT" "CGGT"
    "CGP53353" "CH106" "CH167" "CH198" "CH293" "CHEN" "CHIP" "CHIR99061"
    "CHOP-regimen" "CICs" "CID755673" "CIMP" "CKD6" "CLIA" "CLIC6" "CLT"
    "CLTCALK" "CMGC" "CMRA" "CMV2-Cav1" "CNGA1antibody" "CNKI" "CNVs" "COAD"
    "COPASI" "CP-724714" "CPTH2" "CRAC" "CRAMP" "CRAPome" "CRCT2"
    "CRD42014013145" "CREB5" "CREBP" "CRISPR" "CRL-1623" "CRL-1831" "CRL1623"
    "CRPCs" "CSDSDGLAPPQHLIR" "CSNK1A" "CSRP2" "CT990201" "CTEP" "CTG"
    "CTL+AngII" "CUG" "CXCR5-dependent" "CYT387" "CaCl" "CaMD" "CaMKKII"
    "CaMKKβ" "CaMKKβ-mediated" "Caesarean" "Calbiochem" "Callejas"
    "Calorimetry" "Cambride" "Cambridge" "Campo" "Canada" "Candiolo" "Cano"
    "Cap-independent" "Caraci" "Cardiac-specific" "Carlsbad" "Carlsson"
    "Carragher" "Case-control" "Castellone" "Castro" "Caucasian" "Caucasians"
    "Cav-1-dependent" "Cdc13p" "Cdc20" "Cell-SELEX" "CellTracker"
    "Cercopithecus" "Ceroid" "ChIP-ed" "ChIP-qPCR" "ChIP-quantitative"
    "ChIP-sequencing" "ChIP-sequencings" "ChIP–reChIP" "Champaign" "Chan"
    "Chang" "Changsha" "Chappell" "Charles" "Chatsworth" "Chatterjee" "Chaulk"
    "Cheng-rong" "Cheng-shan" "Chesselet" "Chicago" "Chidlow" "Child-Pugh"
    "Childs-Pugh" "Chk1-2" "Choi" "Chong" "Chop" "Choueiri" "Choy" "Chrom"
    "ChromHMM" "ChromHMM15" "ChromHMM7" "Chu" "Chung" "Ciccia" "Cinti" "Cip"
    "Cip1" "Circos" "Cl13" "ClaI" "Clara" "Clark" "CldU" "Cleveland"
    "Climate-associated" "ClinicalTrials" "Clinico-pathological" "Clontech"
    "CoIP" "CoRNR" "Cochrane" "Collins" "Collisson" "Colon-26" "Combadiere"
    "CompPASS" "Compd" "Complement" "Con" "Concentration-response"
    "Connecticut" "Coomassie" "Corso" "Costa" "Couet" "Coulter" "Covance"
    "Cowden" "Cowden-associated" "Cox-regression" "Cre" "Cre-ER-inducible"
    "Cre-loxP" "CreERT2" "Crgf" "Crohn" "Crohn's" "Crohn’s" "Cross-reactivity"
    "Cruz" "CsH" "Ct" "Cu-o-phenanthroline" "Cui" "Cuningham" "Currie" "Cycin"
    "Cys-259s" "Cys113-Serl" "Cys326Cy" "Cytoscan" "Czech" "Cα" "Cα-Cα"
    "CβF-wildtype" "CβS" "Cδ" "C→T" "D-HPLC" "D-MMEJ" "D-dark" "D-derived"
    "D-domain" "D-domain-based" "D-loop" "D-loops" "D-type" "D10" "D11Q"
    "D149N–dsDNA" "D1–D3" "D2" "D3" "D3-hydroxyls" "D3-phosphoinositides"
    "D3-phosphorylated" "D316" "D319N" "D4" "D4-D4" "D425Med" "D4D5" "D5"
    "D5-D5" "D5F3" "D69C12" "D6A4" "D7" "D816V" "DAA" "DAAs" "DAF-2DA" "DAMI"
    "DAVID" "DBS" "DC-LAMP" "DDR4" "DDR4-like" "DDR5" "DDR5-like"
    "DDR5-private" "DE3" "DEFG" "DENND1A" "DETA" "DETA-NONOate" "DETANONOate"
    "DFI" "DG" "DHB" "DHMEQ" "DHS-seq" "DHT" "DIANA" "DKO" "DLAT-lipoyl" "DLD1"
    "DMet" "DN-ETS1" "DNA-PKcs-proficient" "DNA-damage-induced"
    "DNA-damage-inducible" "DNA-damage-inducing" "DNA-damage-repair"
    "DNA-demethylating-agent" "DNA-end-resection" "DNA–p53" "DNA–protein" "DNS"
    "DNase-hypersensitive" "DNase-seq" "DNaseI" "DNaseI-Seq" "DO" "DO-1" "DOI"
    "DPPC" "DPs" "DR-GFP" "DRAM1-pcDNA4" "DRβ" "DSBs" "DSGIS" "DSGxxS" "DSGΦS"
    "DSGΦxS" "DSR" "DSS-C57" "DSS-induced" "DTBA" "DTIC" "DUAN" "DUF3454"
    "DUSP2-mediated" "DZNep" "Dako" "Dallas" "Damier" "Dana" "Dana–Farber"
    "Danbury" "Daniels" "Danish" "Danvers" "Daugherty" "Davis" "De-repression"
    "Dead" "Delta-like" "Denmark" "Dephoure" "Diaz" "Diego" "Diehl" "Dimitrova"
    "Dobbles" "Dogterom" "Dollé" "Dominant-negative" "Domingo" "Dominguez"
    "Dong" "Dose–response" "Double-Drug" "Dox" "Dox-or" "Drevytska" "Du"
    "Duchenne" "Dulbecco" "Dulbecco's" "Dunn" "Duolink" "DupA502" "Dutch"
    "D–S3F" "E-GBM" "E-GBMs" "E-box" "E-box1" "E-box3" "E-box4" "E-box5"
    "E-boxes" "E-cadherin-1" "E-selection" "E12" "E154" "E154A" "E155" "E155A"
    "E17K" "E1B" "E1b" "E1α" "E2-like" "E2-transfection" "E2F-dependent"
    "E2F-independent" "E2F1-3" "E2FA" "E2FB" "E4" "E409K+E413K" "E47" "E5"
    "E6E7" "EAp53" "EBNA" "EBP-α" "EBSCO" "EC-monocyte" "EC50" "ECACC" "ECMs"
    "ECNM" "ECX" "EDTA-Blood" "EE" "EGBs" "EGF-like" "EGFR-CT" "EGFR-ErbB2"
    "EGFR-family" "EGFR-p845" "EGFR-positive" "EGFRKD" "EGFRwt" "EGJ" "EGL-10"
    "EK505" "EKR1" "EKR2" "ELESPPPPYSRYPM" "ELISArrays" "ELT" "ELT3-T3"
    "ELT3-V3" "EMD-2648" "EMP-33" "EMT-like" "EOCs" "EORTC" "EPBB41L3" "ER+"
    "ER+ " "ER-dependence" "ER-endosome" "ERCC" "ERCP" "EREs" "ERK-Snail-1"
    "ERK-mediated-NF-κB" "ERK2-L73P" "ERK2-R65S" "ERKi" "ERRC6" "ERα-negative"
    "ERα-positive" "ESCRT" "ESCRT-0" "ESE" "ESEfinder" "ESHRE" "ESI-MRM"
    "ETS-family" "EU" "EUS" "EYDLELSDΦE" "EZH1" "Early-stage" "Easwaran"
    "Eckert" "EcoRV" "EcoRV-site" "Egger" "Egger's" "Egger’s" "Egorova"
    "Eif4ebp2" "Eighty-nine" "Eindhoven" "Eisenman" "Eisenmann" "Elena" "Elisa"
    "Elizur" "Elk-1ΔC" "Elledge" "Elmer" "Embryology" "Empore" "EnCa" "EndMT"
    "Engelman" "English" "Ensembl" "Epithelial-mesenchymal"
    "Epithelial–mesenchymal" "Eppendorf" "Erb4" "ErbB" "ErbB2-ErbB3"
    "ErbB2-driven" "ErbB2-expressing" "ErbB2-induced" "ErbB2-mediated"
    "ErbB2-positive" "ErbB2-positve" "ErbB2-transformed" "ErbB3"
    "Erbb2-induced" "Erben" "Eriksson" "Erlotinib" "Escribano" "Escribano-Diaz"
    "Espinosa" "Ess1" "Europe" "European" "European-American" "Europeans"
    "Evren" "Ewa" "ExoELISA" "Exocrine" "Exocrine-like-PDA" "Exoquick"
    "Exposure-response" "Exposure-safety" "Exposure-survival" "E–S6G" "F-BAR"
    "F-FDG" "F-FDG-PET" "F-SNP" "F-labeled" "F0" "F1" "F12-medium" "F2" "F4"
    "F7" "F9" "FA+PDTC" "FACSAria" "FAIRE" "FAIRE-seq" "FAK-Y397" "FBXO42"
    "FBXW1" "FBXs" "FDCP-1" "FDR=0.05" "FEC100" "FERM" "FFPE" "FFpSPR-Pin1"
    "FFpSPR-WW" "FHRE" "FISH" "FITC-CD14" "FKBPs" "FKWBC" "FL8" "FLAG"
    "FLAG-coated" "FLAG-immunoprecipitates" "FLAG-tag" "FLAG-β-TrCP-288C"
    "FLAG-β-TrCP-R510A" "FLB6-67" "FLT3-ITD" "FLT3-ITD-expressing" "FM4-64"
    "FMS-like" "FNAB" "FNAC" "FNIII" "FOX" "FOX-like"
    "FOXA1-immunoprecipitates" "FOXD" "FOXM" "FOXN2" "FOXP" "FOXP1potentiation"
    "FOXP1w" "FOXP3+T" "FRAX1036" "FS" "FTYP" "FXFP" "Fabi" "Fan-di" "Farber"
    "FasR" "Faslg" "FastPure" "Fawcett" "FcγR2A-131" "Fcγreceptor" "Fe" "Feng"
    "Fenton" "Ferrell" "Fersht" "Feuerstein" "Ficoll" "Fifty-one" "Fifty-seven"
    "Fifty-three" "Figeys" "Figueiredo" "Figueiredo-Pereira" "Fine-tuning"
    "Finegan" "Finland" "Finnish" "Five-year" "Flag" "Flag-4xSUMO-2"
    "Flag-HeLa" "Flag-INMAP" "Fms-like" "Follow-up" "Forkhead" "Forsea"
    "Forsythe" "Forty-eight" "Forty-four" "Forty-one" "Forty-three" "Foulstone"
    "Fourier" "FoxO1-ΔDB" "FoxO1protein" "FoxO3a-3A" "Foxp1-ES" "Foxp1b"
    "Fradet" "Fradet-Turcotte" "France" "Franco" "Frankel" "Fraumeni" "Frax"
    "Frax-597" "Frax1036" "Frax716" "Frederick" "Free-energy" "Freed-Pastor"
    "Freg" "French" "French-Canadian" "Frev" "Fu" "Fund" "Fwd" "Förster" "F–6H"
    "F–S1H" "F–S3H" "G*Power" "G-allele" "G-overhang" "G-overhangs"
    "G-quadruplex" "G-quartets" "G-rich" "G-strand" "G0" "G1" "G1-to-S"
    "G1082A" "G12D" "G12V" "G151D" "G151D–DNA" "G151D–dsDNA" "G161V"
    "G161V-AKT2" "G17V" "G2" "G2-type" "G2M" "G380E" "G6P" "GA" "GA+AA"
    "GAACGG" "GAB" "GAB1+GAB2" "GAB2-containing" "GAL4-CARMA2" "GAP1" "GC-MS"
    "GCNs" "GDM" "GENCODE" "GES" "GFAP-immunoreactive" "GFP-CL1" "GFP-MIIA"
    "GFP-PTM" "GFP-PTM-transfected" "GFP-S1916A-MIIA-HC" "GFP-empty"
    "GFP-fusion" "GFP-hairpin" "GFP-lamin" "GFP-lentiviral" "GFP-only"
    "GFP-rAd" "GFP-rAd-infected" "GFP-rAd-treated" "GFPu-1" "GFR-MDRD" "GG"
    "GG+GT" "GGCAAGGTGATCCTGGTGA" "GGC→GAC" "GGGAAGGTGATTCTGGTGA"
    "GGGGCTGGGCCGGGGACCCGGG" "GGOH" "GGT→GAT" "GGs" "GI" "GI50" "GICs" "GKT"
    "GLEBS" "GMBH" "GNC2" "GPPWWPP" "GProX" "GRB2-N-SH3" "GRO-α"
    "GS-1101+ABT-199" "GS-1101+ABT199" "GSE12093" "GSE13937" "GSE15471"
    "GSE2034" "GSE20347" "GSE22220" "GSE2603" "GSE28996" "GSE3494" "GSE40689"
    "GSE47404" "GSE4922" "GSE58462" "GSE59973" "GSE6532" "GSE7390" "GSEAs"
    "GSKα" "GSKβ" "GST-4xSUMO-2" "GST-53BP1-Cterm"
    "GST-53BP1-Cterm-S1609D-S1618D" "GST-53BP1-Cterm-S1618D" "GST-SUMO-2-2KA"
    "GST-SUMO-2-GA" "GST-TRCT" "GST-TRCT-7A" "GST-TRCT-NLS" "GST-mutp53R175H"
    "GST-only" "GT+TT" "GTC" "GTG" "GTGGGAA" "GTML" "GTPases" "GU356538.1"
    "GVGD" "GWASs" "Gai" "Gain-of-function" "Gaithersburg" "Gajiwala" "Ganci"
    "Gantt" "Garrido" "Garrido-Gill" "Gascoigne" "Gavin" "Gdańsk" "GdmCl"
    "GenBank" "Gender-specific" "Gene-environment" "GeneCopoeia" "Genentech"
    "Genetically-engineered" "Geneva" "Genkyotex" "Genomatix" "Genome-Wide"
    "Genome-wide" "GenomeEUtwin" "Genomes" "Genzyme" "Georges" "Georgiou"
    "Germain" "German" "Germany" "Ghosh" "Giannoni" "Gibbs" "Giemsa" "Gieson"
    "Gilford" "Ginnan" "Giordano" "Giorguieff" "Giorguieff-Chesselet"
    "Giovanni" "Gjorloff" "Gjorloff-Wingren" "Glazer" "GlcNAc" "Gleason"
    "Gleixner" "Glostrup" "Glu313X" "Gnmt" "Goetz" "Gofuku" "Goldman" "Gomes"
    "Gonzalez" "Gonzalez-Angulo" "Gonzalez-Suarez" "Goodarzi" "Graff" "Grande"
    "GraphPad" "Grassmann" "Greipp" "Gria1-4" "Grotegut" "Ground-state"
    "Group3" "Group4" "Gry" "Gu" "Guglielmo" "Gvaramia" "GxxG" "Gy" "GΦx"
    "Gαi-GPCRs" "Gαq-coupled" "Gβγ" "G–1I" "G→A" "H&E" "H-1975" "H-1975-A2"
    "H-bond" "H-score" "H-scores" "H-score " "H1" "H176E" "H1975-A2" "H1993"
    "H2AK119ub" "H2AX-139m" "H2AX-siRNA-transfected" "H2T" "H3" "H3K14Ac"
    "H3K27" "H3K9" "H3K9ac" "H4" "H4K20" "HA-SLX4" "HA-Tag"
    "HA-immunoprecipitations" "HA-mutp53D281G" "HA-tag" "HACE" "HADDOCK" "HBSS"
    "HCAP18" "HCC-1187" "HCC-1500" "HCC-38" "HCC-group" "HCC-like"
    "HCC-patients" "HCIP" "HCIPs" "HCQ" "HCT" "HCT116-DKO"
    "HCV-NS5A-expressing" "HCVcc" "HCXXGXXR" "HDAC1-10" "HDFs" "HEK293Tcells"
    "HER2-enrich" "HER2-trastuzumab" "HER2-trogocytosed" "HER2-trogocytosis"
    "HER2.2" "HER2Δ16" "HER2Δ16H" "HER2Δ16M1" "HERITAGE" "HERmark" "HFD"
    "HFD-fed" "HGGs" "HGMD" "HGSOCs" "HIAC" "HIF-1-mediated" "HIF-1promotes"
    "HIF-1αlpha" "HIF-α" "HIF-α–dependent" "HIN" "HIN-A" "HIN-B" "HIV-1B"
    "HIV-Tat" "HIV-peptide-pulsed" "HKL" "HLA-A*0201-restricted" "HLA-A2"
    "HLA-B*2705" "HLA-B*2705-restricted" "HLA-DM" "HLA-DO" "HLA-DR4" "HLA-I"
    "HM450K" "HME" "HMGA2-miR-200" "HMLE" "HNOKs" "HNSCCCC" "HNSCCs" "HOP-92"
    "HPASMCs" "HPECs" "HPJ" "HPMC" "HPMCs" "HPRD" "HPV-associated"
    "HPV-positive" "HPVE6" "HR-HPV" "HR-defective" "HR-deficient" "HR-pathway"
    "HR-proficient" "HR50" "HR=0.15" "HR=0.19" "HR=1.85" "HR=2.17" "HR=2.30"
    "HR=3.19" "HR=3.31" "HR=3.38" "HR=6.9" "HSC-3-CaDEC12" "HSC-3-GF" "HSP8A"
    "HSV-1" "HSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRR" "HT1080" "HTC-116" "HTTs"
    "HVS" "Hadia" "Hairy" "Hakai1" "Hakai1-mediated" "Hamdan" "Hancock"
    "Hansen" "Hanson" "HapMap" "HapMap-CEU" "HaploReg" "Haploview" "Haraguchi"
    "Hardy-Weinberg" "Harrison" "Hawaii" "Hawaiians" "Hayden" "HealthABC"
    "Heeschen" "Heist" "Heliocobacter" "Hematoxylin-eosin" "Hensch" "Her-1"
    "HercepTest" "Hercules" "Hes1" "Hetero-zygous" "Hey1L" "Hf5205"
    "High-grade" "High-level" "High-resolution" "Hilden" "Himedia" "HindIII"
    "Hippo-SHH" "Hippo-YAP" "Hippo–LATS" "Hippo–TAZ" "Hippo–YAP" "Hiraoka"
    "His-SLX4-8" "His-TGFBRI" "His-Wip1" "His-rich" "His-tag" "Hispanic"
    "Hochberg" "Hodgkin" "Hodgkins" "Hodgkin’s" "Hoechst" "Hoefer" "Hoermann"
    "Hofmann" "Hollestelle" "Holliday" "Hong" "Honjo" "Hoogsteen" "Hopkins"
    "Hough" "Houston" "Hpy188I" "Hsia" "Hu" "HuH-7-FoxM1-shRNA" "HuMECs"
    "Huang" "Humar" "Huntington" "Huntington's" "Huntington’s" "Hurtado"
    "Hutchinson" "Hutchinson–Gilford" "Hutchison" "Hwang" "Hybond" "Hybond-N"
    "Hybrid-A" "Hybrid-B" "Hypoxia" "H–S6J" "I-CB660+c-Myc" "I-II" "I-III"
    "I-TASSER" "I-enhancing" "I-up-regulating" "IARC" "IC50" "IC50s" "IC50 "
    "IC75" "IC75s" "ICGEB" "ICU" "IDT" "IE" "IFI16-NLS" "IFV" "IGF-1-treated"
    "IGF-IRβ" "IGF-axis" "IGFPB" "IGFPB2-negative" "IGVH" "II-2" "II-III"
    "II-IV" "IIA" "III+IV" "III-2" "III-IV" "III-like" "IIIA" "IIIB" "III–IV"
    "IIa " "IIc" "IIc " "II–III" "IKK-ε" "IKKs" "IL-15-DC-primed" "IL-2Rβ"
    "IL6β" "ILIB" "IMC" "IMC-A12" "IMQLMPFGV" "INFα" "INFγ" "IP-MS" "IPed"
    "IQR" "IR-A" "IR-B" "IRB" "IRES" "IRIFs" "IRY1328" "ISGs" "ISR1" "ISS"
    "IST5-002" "ITAM" "ITC" "ITD-mediated" "ITE" "ITIM-like" "ITIMs" "ITx-13"
    "IU" "IVAN" "IVIS" "IVIS-Caliper" "IVS" "Ib" "Iba1-immunoreactive"
    "Ig-like" "IgA" "IgG-gold" "Igarashi" "Igκ" "Ikbkap" "Ikbkb" "Ile126Asnfs"
    "Ile28-Ala31" "Illumina" "ImageQuant" "Imagestream" "Immuno-histological"
    "ImmunoResearch" "Immunotherapy" "In-Vitro" "In-depth" "In-vitro" "InVivo2"
    "InWeb" "Inc" "Inhba" "Innes" "Innovex" "Insl" "Insr" "Instituto"
    "Inter-Domain" "Inuzuka" "Invitrogen" "Ioannidis" "Iorio" "Iowa" "Ipswich"
    "Iran" "Isogai" "Iwona" "IĸBs" "Iα" "IκBand" "I–II" "I–III" "JAK2+14"
    "JAK2V617F" "JAK2s" "JAK2Δ14" "JCRB" "JE" "JFH" "JFH1" "JFH1-based" "JMD"
    "JNK-II" "JNK-dependent" "JNK-independent" "JPM50.6" "JQ1" "JUN" "JUNB"
    "Jackson" "Jak2-829" "Jan" "Jang" "Japanese" "Jasin" "Jeggo" "Jegher"
    "Jeromin" "Jewish" "Jez" "Jharkhand" "Ji" "Ji-chao" "Jiao" "Jill" "Johns"
    "Johnson" "Jolla" "Jolma" "Jonckheere" "Jonckheere–Terpstra" "Ju" "Ju-mei"
    "Juhasz" "K-RBP" "K-Rta" "K-bZIP" "K13" "K13A" "K14cre" "K15" "K179M"
    "K179M-AKT1" "K323" "K323R" "K33A" "K372K373" "K381K382" "K381ac" "K417R"
    "K48-only" "K59del" "K601L" "K63-only" "K8" "K8.1" "K9" "KB1P-3"
    "KB1P-3.12" "KB1PR-3.12" "KF11" "KFL2" "KG" "KK10" "KKDQ" "KKDQ-Vpus"
    "KKKTI" "KKR" "KMTs" "KO22" "KT21-MG1-Luc5D" "KTN1-AS1" "KW-2449" "KZ"
    "Kadoorie" "Kaestner" "Kai" "Kakugawa" "Kalinsky" "Kalluri" "Kang" "Kanto"
    "Kaplan" "Kaplan-Meier" "Kaplan–Meier" "Kaposi" "Kaposi’s" "Katayama"
    "Kathleen" "Katkoori" "Kazakhstan" "Keitoku" "Kennedy" "Kevan" "Ki-67"
    "Kim" "Kinase-I" "Kip" "Kirsten" "Kit-8" "Klinefelter" "Knock-down"
    "Knudson" "Knudson’s" "Kodera" "Koelsche" "Kokudo" "Kolmogorov"
    "Kolmogorov-Smirnov" "Konda" "Kong" "Koo" "Korea" "Korean" "Kothari"
    "Krammer" "Kress" "Kruppel-like" "Kruskal-Wallis" "Ku" "Kuala" "Kufor"
    "Kufor-Rakeb" "Kulke" "Kuriyan" "Kyoto" "L-DOPA" "L-Myc" "L-OHP"
    "L-OHP-induced" "L-OHP-treated" "L-dopa" "L-light" "L-type" "L1"
    "L11-miR-130a" "L2" "L2-associated" "L2-like" "L2049fs" "L2a" "L4A" "L73P"
    "L858R+T790M" "LABM1" "LAML" "LAMTOR" "LAP2α" "LAPTM" "LARP1-interactome"
    "LAST1" "LATS1-a" "LATS1-b" "LATS1b" "LBD" "LC-MS-MS" "LC3-I" "LC3-PE"
    "LC3B-I" "LC3B-II" "LC3II" "LCK-pY394" "LCL" "LCL-like" "LCL-phenotype"
    "LCLs" "LDH1~LDH5" "LFA" "LFCQLAK" "LGD-4665" "LIHC" "LINE1" "LIU" "LLΦS"
    "LMFS" "LNM" "LNMs" "LOF" "LOVD" "LPS" "LREA" "LROS" "LSAMP" "LSM410"
    "LST-G" "LST-NG" "LTAD" "LTD" "LTED" "LTED-eveR" "LTQSPLL" "LTR" "LTR10B"
    "LTR10B1" "LTRs" "LTx-20" "LUO" "LUX-Lung" "LXXLL" "LY-6" "LY5.1FL" "LZs"
    "Lac" "LacO" "Laemmli" "Lafayette" "Lai" "Laminopathies" "Langerhans"
    "Langosch" "Langosch's" "Langridge-Smith" "Lareau" "Large-scale" "Laron"
    "Late-onset" "Late-stage" "Laurén" "Lbc" "LeR" "Leask" "Leber" "Lef"
    "Lef-miniP" "Lehmann" "Lehtinen" "Lenardo" "Lenti" "Lenti-miR-21-i"
    "Lenti-scr" "Leonid" "Leonova" "Leopold" "Lesourne" "Let-7a"
    "Let-7a-STAT3-miR-21" "Lettre" "Lewy" "Li" "Li-Fraumeni" "Liao"
    "Lieberkühn" "Lifesciences" "LightCycler" "Ling-qiang" "Lipofectamine"
    "Litovchick" "Live" "Live-cell" "Lo" "Locascio" "Lodish" "Lodish's"
    "Log-rank" "Lohmann" "London" "Long-range" "Lonza" "Lopez" "Lorenz"
    "Loss-of-function" "Louis" "Loureiro" "Lu" "Luc-reporter" "Lumpur"
    "Lyapina" "Lyashenko" "Lymphocryptovirus" "Lys→Arg" "M-phases" "M13mp18"
    "M249AR4" "M249R4" "MALDI-TOF" "MALS" "MAPK-ERK2-dependent"
    "MAPK-redundant" "MAPKi" "MAVER" "MAZGAJ" "MBA" "MBA-231" "MBCD"
    "MC-lineage" "MCC-APC" "MCF-7-hPit-1-luc" "MCF-7-hPit-1-luc-shControl"
    "MCF-7-hPit-1-luc-shMMP-1" "MCF-7-hPit-1-luc-shMMP-13" "MCF10"
    "MCF10-ERBB2" "MCF10-Er-Src" "MCF10A-Er-Src" "MCF10A-ErbB2"
    "MCF7-LTED-eveR" "MCF7-eveR" "MCF7-parental" "MCM2–7" "MCM3AP-AS1" "MCMs"
    "MDA-231-1833" "MDA-231-1833-BTR" "MDA-MB361" "MDA-MD-231" "MDM2-intact"
    "MDSCC" "MEB-MED-8A" "MEB-Med8a" "MEK-ERK1" "MEK-induced" "MEK1-2" "MEK1CA"
    "MEK2DD" "MEKi" "MEKi " "MELT1" "MEM" "MEME" "MENG" "MESG" "MET-driven"
    "METpm" "MErT" "MFC-7" "MGA" "MGB" "MGC" "MGC-83" "MGEMQLSSVTDS" "MGH"
    "MHC" "MHC-I" "MHCC" "MHCC-97L" "MHV" "MHV-68" "MIIB" "MIIs" "MIR-93"
    "MIR-REPORT" "MIR31HG" "MIR93" "MIical1" "MJG11" "MK2206" "MKK3E" "MKK6E"
    "MLC-dependent" "MLN4924-treatment" "MLT1H" "MMECs" "MMP-1-1633" "MMP-1a"
    "MMTV-ErbB2" "MMTV-NeuNDL" "MMTV-NeuNDL2-5" "MMTV-PyMT" "MMTV-PyMT-derived"
    "MN328" "MN525" "MNC" "MNCs" "MNase-on-ChIP" "MNase-seq" "MQLMPFGCL"
    "MQLMPFGCLL" "MRC5SV" "MS" "MS-PCR" "MS-bioinformatics" "MSKMEL173" "MTOB"
    "MTS-2-MTS" "MUS312-MEI9" "MUTZ" "MUTZ-LCs" "MV-4-11" "MV-4–11" "MYPT"
    "MYST-family" "MacDonald" "Mahlapuu" "Mailand" "Malanchi" "Malay" "Malays"
    "Malaysia" "Malovannaya" "Manassas" "Mannheim" "Margetts" "Markov" "Marson"
    "Martinez" "Maryland" "Mas" "Masker" "Massachusetts" "Massague" "Masson"
    "Masson's" "Mastercycler" "Mastermind-like" "Material" "Mathematica"
    "Matsuda" "Matsuoka" "Matsushima" "Matthews" "Matys" "Mbp" "McCoy"
    "McCoy’s" "McHugh" "MeAIB" "Medici" "Medina-Franco" "Meier" "Melbourne"
    "Mellacheruvu" "Meloche" "Menten" "Mer61" "Met-1" "MetaCore" "MetaboChip"
    "Method" "Methods" "Methyl-β-cyclodexrin" "Mexican" "Mfold" "MiR-100"
    "MiR-141" "MiR-329" "MiR-500" "MiR-93" "MiR-93-5P" "MiRanda" "Michaelis"
    "Michaelis–Menten" "Michealis" "Michealis–Menten" "Micheli" "Michigan"
    "MicroRNA-34a" "Millipore" "Ming-yuan" "Mingueneau" "Minoo" "Miotti"
    "Misteli" "MitoTracker" "Miyahara" "Mizuno" "Mn" "Mn28" "Mn44" "Mnt"
    "Mock-treated" "Mohua" "Mondo-Mlx" "Morris" "Morrison" "Moundhri"
    "Mps1-phosphorylation-dependent" "Mt" "Mukawa" "Mukhina" "Mulla"
    "Multi-scale" "Multianalyte" "Munster" "Murata" "Mustafi" "Mxd"
    "MyBioSource" "Myc-BUB1-WT" "Myc-like" "Myc-network" "Myc-tag" "MycER"
    "Müllerian" "MβCD" "MβCD-injection" "N+160" "N+240" "N+80" "N-CC"
    "N-Myc-OFF" "N-SH2" "N-SH3" "N-SH3-GST" "N-SH3-mediated" "N-acetyl"
    "N-formyl" "N-glycosylation" "N-labeled" "N-nitrosation" "N-stage" "N-ter"
    "N-transactivation" "N0" "N171-82Q" "N2b" "N4" "N=114" "N=17" "N=22" "N=30"
    "N=35" "N=45" "N=76" "N=9" "NA7" "NCBI" "NCDV" "NCI" "NCI-60" "NCID"
    "NCSLC" "NCT00662636" "NCTs" "NDL2-5" "NF-kB1" "NF-κ" "NF-κB1"
    "NF-κB1-binding" "NF-κΒ" "NF2-null" "NFAT-90" "NFTs" "NGEC-1" "NGP" "NH"
    "NHGRI" "NHKOs" "NICD-like" "NIU" "NKF" "NL4-3" "NLS2" "NLS3" "NLSs" "NNG"
    "NNSC" "NNSCs" "NO-ULK1-SIRT1" "NOSE" "NOTCH" "NPV" "NQO1-null" "NQQ"
    "NQQ1-expressing" "NRAS-driven" "NRF2-β" "NRFA2" "NSTEMI" "NT-proBNP" "NV9"
    "NVP" "NVP-BEZ235+ABT199" "NVP-BEZ235-only" "NVP-BGJ398" "NaNO" "Naeher"
    "Nakamura" "Nakanishi" "Nanomedicine" "Narita" "Nascimento"
    "Nascimento-Silva" "NcoI" "NecroX" "NecroX-5" "Nelson" "NeoALTTO"
    "Netherlands" "NetworKIN" "Neu" "NeuNDL-Postn" "Neuroid" "Newcastle"
    "Newcastle-Ottawa" "Newschaffer" "Nexalign" "Ngo" "Nguyen" "Ni"
    "Ni-affinity" "Nichols" "Niessner" "Nika" "Niki" "Nikon" "Nili"
    "Ninety-eight" "Ninety-six" "Nishino" "NoLS1" "NoLS2" "Nobusawa" "Nolen"
    "Norambuena" "Nordisk" "Notch" "Notch-Hes1" "Notch-Hes5" "Notch-dependent"
    "Notch-mediated" "Notch-regulated" "Nothern" "Nottingham" "Nov" "Novo"
    "Nox" "Nox-mediated" "Nox4" "Nox4-superoxide" "Nox4-transgenic" "Nsp" "Nu"
    "Nuclear" "N = 1" "N = 13" "O-GlcNAcylation" "O-Mad2" "O-linked"
    "O-linked-GlcNAc" "O1" "O2" "O3" "O4" "OB-fold" "OCL-LY-19" "OCT4A" "OCT4B"
    "OCT4B1" "ODNs" "OGG1and" "OGG1expression" "OGTT" "OH" "OLT" "OMIM"
    "OPTIMA" "OR=1.22" "OR=1.24" "OR=1.47" "OR=1.70" "OR=2.41" "OR=2.71"
    "ORFeome" "ORIEL" "ORR" "ORRs" "ORs" "OSU" "OSU-AA" "OSU-C42A" "OSU-DD"
    "OSU-EE" "OSU-TT" "OSU-like" "OSU-ΔC13" "OT-I" "OTFs" "OVA257-264" "OXP"
    "Oc4" "Oct-1" "Oct1" "Oct4#1" "Oct4#2" "Oct4-pT235" "Oct4A" "Oct4B"
    "Oct4B-164" "Oct4B-190" "Oct4B-265" "Oct4B1" "Ogino" "Ohashi" "Okazaki"
    "Okuzumi" "Oligomycin-A" "Olsen" "Olympus" "Omani" "OncoMap" "Oncoimmune"
    "Oncology" "Oncomine" "One-STrEP-Tag" "Oosawa" "Opti" "Opti-MEM" "Osaka"
    "Ossovskaya" "Otsu" "Ottawa" "Oudoff" "Oulu" "Overlack" "Ovid" "Oxford"
    "P1" "P13K" "P190RhoGAP-B" "P2" "P3C1" "P53-MYC-associated" "P7" "P72R"
    "P=0.002" "P=0.003" "P=0.006" "P=0.007" "P=0.008" "P=0.009" "P=0.01"
    "P=0.012" "P=0.016" "P=0.017" "P=0.0184" "P=0.019" "P=0.02" "P=0.021"
    "P=0.029" "P=0.03" "P=0.032" "P=0.0342" "P=0.037" "P=0.04" "P=0.0416"
    "P=0.0469" "P=0.07" "PA-Rac1DN" "PAN" "PANC" "PANC-03.27" "PANC-1and"
    "PANG" "PAR1nc" "PARP1c" "PARP1c " "PARP1nc" "PARP1nc " "PARPi" "PARPis"
    "PASMC" "PAXR" "PAXR1-PAXR6" "PBI" "PBI-05204" "PBLs" "PBS–EDTA"
    "PC3-ovBTG3-mHW" "PCA" "PD-fluid-exposed" "PD-fluid-treated"
    "PD-patient-derived" "PD98059" "PDA" "PDAC-CSCs" "PDE4B1" "PDGEN"
    "PDH-E1rα" "PDK" "PDSCC" "PELIKANT" "PERK-eIF2" "PERL" "PEST" "PFK"
    "PFT+Nut" "PFT-α" "PGAGGY" "PGC1-α" "PGC1-α-regulated" "PH-in" "PHTSs"
    "PI-4-5-P" "PI-4-P" "PI-pure" "PI3K-C2α" "PI3K-and" "PI3K-pathway"
    "PI3K-pathway-related" "PI3KCA" "PIAS1-shared" "PIAS1-shared-binding"
    "PIDRGG" "PIK3C" "PIKK" "PIKKs" "PIM1+ERK" "PIP-null" "PK-K" "PKCα" "PKCβI"
    "PKCβII-CA" "PKCβII-DN" "PKCβII-GFP" "PKD1-C1a" "PKD1-C1b" "PKD2–cyan"
    "PKH-26" "PLCβ" "PLINK" "PMID" "PMR" "PNET3" "PPIase-WW" "PPIs" "PPRE"
    "PPROM" "PR-negative" "PROMACTA" "PROSPERO" "PRP4K" "PRi " "PR + " "PSQ"
    "PTCH1-PPxY" "PTCH1-YAP" "PTCH1-a" "PTDC" "PTEN-1" "PTEN-2" "PTEN-L"
    "PTEN-null" "PTEN-proficient" "PTEN-status" "PTEN-α" "PTENP1" "PTEN–L"
    "PTMCs" "PTPα" "PTPγ" "PTX" "PTide" "PUMA-expressers" "PY1" "PY1*&2" "PY2"
    "PYHIN" "Paget" "Pak" "Pakistan" "Paks" "Palumbo" "PanD24" "PanD3"
    "Pandolfi" "Paneth" "Parasassi" "Pardanani" "Parkinson" "Parkinson’s"
    "Parmigiani" "Parton" "Passos" "Paster" "Path1" "Path2" "Patrick" "PaxDb"
    "Paz-Elizur" "Pba" "Pcat" "Pck1" "Pearson" "Pearson's" "Peinado" "Peng"
    "Pennsylvania" "PepA" "PeproTech" "Peptidyl-prolyl" "Pereira" "Perez"
    "Perez-Rivas" "Perkin" "Permi" "Peschiaroli" "Peutz" "Peutz-Jegher" "Pfas"
    "Ph-like" "Pharmingen" "Philadelphia" "Philippines" "Phillips" "PhyloP"
    "Pin1" "Pin1-knocked-out" "Pin1-recognition" "Pinoles" "Pittsburgh"
    "Pittsburgh's" "Pl" "PlexinA" "Plk1impairs" "Poger" "Poisson" "PolyPhen"
    "Polyphen-2" "Polyploids" "Polyposis" "Polζ" "Polη" "Polι" "Polκ"
    "Post-Mortem" "Post-mortem" "Postn-null" "Pot1a" "Pozo" "Prasad" "Premix"
    "Primorac" "Princeton" "Prismatomeris" "Pritchard" "Pro-caspase-8"
    "Pro-inflammatory" "Probst" "Probst-Hensch" "Project" "Promega"
    "Promigratory" "Prx5" "Pu" "Pugh" "Pull-down" "Purkinje" "Putrajaya" "PvuI"
    "PvuII" "Pvul" "Pvull" "PxRPxK" "PxRPxK-motif" "PxxP" "Py-MT-expressing"
    "Pyr" "Pyro" "Pyrococcus" "P→PI" "P≤0.001" "Q1" "Q2" "Q2+Q4" "Q2404X" "Q3"
    "Q377E" "Q4" "Q4R7" "Q7" "QARS" "QD" "QFS" "QIU" "QTL" "QTLs" "QTRAP" "Qi"
    "Qi-fei" "Qiagen" "Qu" "Quantikine" "Quasimesenchymal-PDA" "Quemesa"
    "QuikChange" "R-CHOP" "R-SMAD" "R-squared" "R0" "R1" "R150Q–DNA"
    "R150Q–dsDNA" "R2" "R3" "R368C" "R4" "R5" "R509H" "R5P" "R6" "R63S" "R65S"
    "R662L" "R86A" "R9" "RA3331" "RAD001+ABT-199" "RAD51–DNA" "RAD51–ssDNA"
    "RAE49-51AAA" "RAGB" "RAGC" "RAMBA" "RAS-G12V-expressing" "RASSFA1" "RB20"
    "RB23" "RB25" "RB27" "RB42" "RB46" "RB55" "RBP-Jk-null" "RCPHHER" "RDW"
    "RFI" "RFLP" "RING" "RING-RING" "RIP-Chip" "RIPA-buffer" "RMSDs" "RMSF"
    "RMSFs" "RNA" "RNA-DNA" "RNA-based" "RNA22" "RNALancerII" "RNAPs"
    "RNAhybrid" "RNAi" "RNaseP" "ROS-clearance" "RPL" "RPLs" "RPMI1640" "RPMS"
    "RPS6-S235" "RPS6-S240" "RR-HEp-2" "RR-U251" "RRE" "RREs" "RRMI"
    "RRRCWWGYYY" "RS-4-11" "RSV" "RT-PCR+RFLP" "RUNX-CBFβ"
    "RUNX1-transcriptional" "RVA" "RVAs" "RVS" "RVSP" "RX-0201" "RXR-α"
    "RXRXXS" "RXXS" "RYSPPPPYSSHS" "Rabdocoetsin" "Rac1" "Rac1during" "RacN17"
    "RacV12" "Rad3-related" "Rad51" "Rad59" "Radiation-activated" "Ragulator"
    "Rakeb" "Ramalingam" "Ramaswamy" "Ras-anchorage" "Ras-like" "Rassf1C"
    "Razani" "Rb-E2F" "Re-ChIP" "Re-expressed" "Re-expression" "Re-induction"
    "Re-infection" "Re-introduction" "RecA-like" "RefSeq" "Regina" "Rel-like"
    "Rensselaer" "Responder" "Retinamides" "Rett" "Rettori" "RevMan" "Rex"
    "Rhadinovirus" "Rhes-mHTT" "RhesS33N" "RhesmHTT" "RhoA–ROCK"
    "Ribonucleosidediphosphate" "Ribose-5-Phosphate" "Richter" "Richter's"
    "Right-handed" "Roberto" "Robo" "Robol" "Roche" "Rockford" "Rockout"
    "Rockville" "Rod-like" "Rodiles" "Rodriguez" "Roncagalli" "Rosengren"
    "RosettaLigand" "Rosner" "Roswell" "Rotterdam" "Roux" "Rpr" "Rptor" "RsaI"
    "Rta-L3P" "RtaΔSTAD" "Rubiaceae" "Rushlow" "Ruskinn" "RyR-mediated" "S-CDK"
    "S-acetyldihydrolipoyl-lysine" "S-farnesylthiosalicylic" "S-peptide"
    "S-phase-type" "S1" "S100P" "S12A" "S151D" "S151D-induced" "S151D-mediated"
    "S16H" "S1893A" "S1981" "S1C" "S1E" "S1L-O" "S1–S3" "S2-S6" "S218E" "S222D"
    "S2A" "S2A-B" "S2B" "S2B–D" "S2C" "S3" "S31-201" "S33" "S33N" "S33Y" "S362"
    "S37" "S3D" "S3J" "S4A" "S4B" "S4D–F" "S4E" "S4F" "S515" "S564" "S5A" "S5C"
    "S5–S8" "S6" "S6-kinase" "S680" "S681-3A" "S6A" "S6A-B" "S6A-D" "S6C"
    "S6C-D" "S6F" "S7" "S715" "S718-2A" "S7A" "S7B" "S7C" "S8" "S8A" "S8B" "S9"
    "S9A" "SA11-30-19" "SA11-4F-like" "SABiosciences" "SAC-relevant" "SAINT"
    "SANKOWSKA" "SAXS" "SB216367-treated" "SB2167632-treated" "SB21763" "SBE4"
    "SBE4-Luc" "SC-like" "SCC23" "SCID-Beige" "SCneo" "SDF-1α-CXCR4" "SDF1α"
    "SDS-polyacrylamide" "SDs" "SENP1-3" "SENPs" "SFM" "SGEC"
    "SH2-domain-containing" "SHCTPPPPYHADPS" "SHH-independence" "SHH-pathway"
    "SHH-subgroup" "SHINE" "SHP-mediated" "SIFT" "SIM" "SIM3" "SIMs" "SINE"
    "SIRPA" "SIRT" "SIRT1-3" "SIRT1-7" "SIRTs" "SIRTs1-3" "SIRTs3-5" "SIRTs4-5"
    "SISH" "SIVagm" "SIVcpz" "SIVden" "SIVgsn" "SIVmon" "SIVmus" "SIVolc"
    "SIVrcm" "SIVsmm" "SK-H1" "SK-MEL23" "SKI" "SKKs" "SKN" "SKQQRIK"
    "SKWARSKA" "SL9" "SLC32" "SLC36" "SLC38" "SLNs" "SLX4-9" "SM-AHNMD"
    "SM22-5HTT" "SMAD1-5" "SMAD1-5-8" "SMAD2-3" "SMAD2-deficieny" "SMARC"
    "SMMC" "SMMC-7402" "SN50" "SNF-related" "SNHG15" "SNHG16" "SNON" "SNORA26"
    "SNP" "SNP309T" "SNP6.0" "SNPnexus" "SNPs" "SNVs" "SNaPshotTM" "SPO17"
    "SPO2" "SPO28" "SPSS" "SQ-29548" "SRIT1" "SRp55-PTC+b" "SSHs" "STAMP"
    "STAT3-regulatory" "STATA" "STE20-like" "STUbL" "SU-DHL-16" "SUEN-1"
    "SUM1316MO2" "SUM131MO2" "SUNE-1" "SUVmax" "SVTCTYSPALNK" "SVneo" "SWOG"
    "SYBR" "Sabo" "Sadasivam" "Saharan" "Saksela" "Salek" "Salem" "Sanger"
    "Sankarshanan" "Sapitnib" "Sarasqueta" "Sarcoplasmic" "Sato" "Scaffidi"
    "Scd" "SceI" "Schekman" "Schellman" "Schildhause" "Schizosaccharomyces"
    "Schlosser" "Schmit" "Schubert" "Schwann" "Schwartz" "ScienCell" "SeAP"
    "Sean" "Sebolt" "Sebolt-Leopold" "Segain" "Seguin" "Selleck"
    "Semi-quantitative" "Sendai" "Sensimix" "Seok" "Sep15i" "Sequence-based"
    "Ser-to-Ala" "Ser-to-Glu" "Ser15" "Ser16-phospholamban" "Ser19" "Ser1981"
    "Ser326Se" "Ser473-p-AKT" "Ser634" "Ser634X" "Ser9" "Serfaty" "Serhan"
    "Serl" "Sertoli" "Sessa" "Set2-CYTR" "Set2-INCBR" "Seubert" "Seventy-two"
    "ShC1" "ShC2" "ShC3" "ShCon" "ShSlug" "ShSlug2" "Shaanxi" "Shapiro"
    "Shapiro-Wilk" "Sharrocks" "Shc2" "Shen" "Shigaki" "Shokat" "Short-term"
    "Shui" "Sichuan" "Side-chain" "Sigma-Aldrich" "Sigma–Aldrich" "Silva"
    "Silvia" "Simonnet" "Single-Drug" "Sini" "Sirt6-deficent" "Sixty-five"
    "Skp-Cullin-F-box" "Skurk" "Sl" "Slit" "Slovak" "Slug-negative"
    "Slug-positive" "Slx4p" "Smad1" "Smad1-5-8" "Smad2" "Smad2-3" "Smads"
    "Smirnov" "Snail" "Soerensen" "Solanas" "Sonenshein" "Sorensen"
    "Sorrentino" "Sowa" "Spain" "Spanish" "Spearman" "Spearman's" "Spearman’s"
    "SpectraMax" "Sphere-forming" "Sporn" "SqCC" "SqCCs" "Src530" "SrcY527F"
    "Staerk" "Stat5a-C-ter" "Stat5a-NTCCD" "Steady-state" "Stefanova" "Stephen"
    "Stephens" "Stepwise" "Straza" "Straza's" "Streptactin"
    "Streptavidin-binding-peptide" "Stress-induced" "StressMarq" "StressMarq "
    "Strippoli" "Study" "Suarez" "Substrate-WW" "Suehiro" "Sugimoto"
    "Sundarranjan" "SupD1" "Super-picture" "SuperFop" "SuperScript" "SuperTop"
    "Superarray" "Surfact" "Surfact-Amps" "Swedish" "Switzerland" "Sykes"
    "Syrkin" "Sytox" "Szostak" "T-10" "T-397C" "T-CB660+c-Myc" "T-REx-HeLa"
    "T-cell" "T-cell-conditional" "T-cell-lines" "T-cytotoxic" "T-helper"
    "T-stage" "T1" "T1-T2" "T1-weighted" "T1897A" "T1987" "T2" "T2-weighted"
    "T202" "T2DM" "T3" "T325" "T4" "T41" "T679" "T790M-A" "T790M-B" "T790M-C"
    "T790M-D" "T790M-E" "TA65" "TAA" "TAG-3" "TAGGGT" "TALEN"
    "TALEN-technology" "TALENs" "TAMR" "TASSER" "TATA" "TATA-box"
    "TATA-proximal" "TATGT" "TAZ–TEAD-dependent" "TAp73" "TAp73KO" "TAp73β"
    "TAp73βisoform" "TB#2952" "TBE" "TBM" "TCAD" "TCEP-Neutral"
    "TCPVQLWVDSTPPPGTR" "TCR-ITAM" "TEAD-binding" "TEFb" "TESK" "TESKs" "TEY"
    "TGF-β1-treated" "TGFBR" "TGFBRI-II" "TGFBRI-TGFBRII" "TGFRBII" "TGFΒRI"
    "TGR-1" "TGTTCT" "TH-immunoreactive" "THEMIS" "THEMIS-Strep" "THEMIS-dPRR1"
    "THhr308" "TIAM1-Halo" "TIC" "TIC-like" "TKI-naïve"
    "TKI-resistance-generated" "TL" "TMD-231" "TME-like" "TMEM75" "TMN" "TNBCs"
    "TNF-α-induced-vascular" "TNFSF10A" "TNFα-treated" "TOCR1" "TOCR2"
    "TOP-FLASH" "TOPO1ccs" "TOPO2" "TOV1112D" "TP53-null" "TRCN0000015549"
    "TRCN0000015552" "TRCN0000179552" "TRCN0000219794" "TRCT-NLS"
    "TRIM33-repressive" "TRIPZ" "TSC2-RG" "TSC2-null" "TSC2-ΔRG" "TSP1ang"
    "TT-3" "TTAGGG" "TTCCAGGAT" "TTCCTGGGA" "TTDp" "TTDp53K381acK382me2" "TTLM"
    "TTT" "TVAG" "TVG261" "TXNIP-promoter" "TaKaRa" "TagDust" "Tagger"
    "Taglialatela" "Taiwan" "Taiwanese" "Tanigaki" "Taniguchi" "Taq" "Taqman"
    "TargetScan" "Tat-induced" "Tax-containing" "Tax-p300" "Tc" "TcM" "Tcrb"
    "Tcsubsets" "Tds" "Tecnai" "Teff" "Telomerase-expressing" "Tengs"
    "Terpstra" "Tert" "Tet-On" "Texas" "Tg" "Tg+AngII"
    "Th1-differentiation-specific" "Th17" "Th2" "Th2-drift" "Th2-specifc"
    "Th2-thrift" "Th2-tyope" "Thailand" "Thermo" "Theseeks" "Thiel" "Thiery"
    "Thirty-nine" "Thl7" "Thomas" "Thr-Pro-motifs" "Thr-rich" "Thr-to-Ala"
    "Thr17-phospholamban" "Thr18" "Thr180" "Thr183" "Thr202" "Thr726Asnfs"
    "Three-Module" "Three-dimensional" "Thy-1" "Tian" "Tian-hui" "Time-lapse"
    "Tip60pT158" "TissueScan" "Todaro" "Tof" "Tof-II" "Toll-like" "Transport-0"
    "Transwells" "Treatment-emergent" "Trichomonas" "Tricia" "Triple-Negative"
    "Tris-HCl" "TrkB-FL" "TrkB-T1" "Trunc" "Try527" "Tucson" "Tuerk"
    "Tumour-specific" "Tumourâ" "Tunisia" "Turcotte" "Turkish" "Tuteja"
    "Twelve-month-old" "Twenty-eight" "Twenty-four" "Twenty-nine" "Twenty-one"
    "Twenty-six" "Two-hybrid" "Tx" "Type-2" "Tyr-X-X-Met"
    "Tyr-phosphorylation-independent" "Tyr182" "Tyr185" "Tyr204" "Tyr216"
    "Tyr321X" "Tyr419Src" "Tyr527" "Tyr536" "Tyr542" "Tyr564" "Tyr580" "TβR"
    "TβRs" "T→C" "U-266" "U-shape" "U-shaped" "U1" "U251" "U73122" "U87MGvIII"
    "UAS" "UBZs" "UCSC" "UCSF" "UCSFwhich" "UDP-glucuronyltransferases" "UDR"
    "UGA" "UICC" "UICC-TNM" "UK-like" "UKM" "UKMMC" "ULK" "ULK1-siRNA-treated"
    "UMHS" "UO126-treatment" "URL" "USA" "USP2-AS1" "USP2a" "UTR-F1" "UTR-FL"
    "UTRs" "UV-C" "UVA" "UVB" "UVC" "Ulk1" "Uniprot" "UvsX" "V191S_fs*11"
    "V2THS" "V3.71" "V3THS" "V5-ASPP2-transfected" "V5-tag" "V600D" "V600E"
    "VA0D1" "VAD" "VCAM" "VE-cadherin–Dendra2" "VE1" "VEFGR2" "VENTANA" "VGLL"
    "VGLL4-mimicking" "VGLL4–TEAD4" "VGP" "VIC" "VILO" "VM" "VM-47" "VM15"
    "VNLG" "VNLG-145" "VNLG-146" "VNLG-147" "VNLG-152" "VNLG-152's"
    "VPS9D1-AS1" "VSV-G" "VSV-G-pseudotyped" "VX" "VX-11E" "Val-DMet"
    "Val-to-Phe" "Valastyan" "Valencia" "VarCall" "Varnagy" "Vaughan" "Vauthey"
    "Vav1CA" "Vav1DN" "Velikova" "Veprintsev" "VeraTag" "Vertebral-Cancer"
    "Vim-269" "Vim-411" "Vinciguerra" "Virgilio" "Vitale" "Vivanco" "Vleugel"
    "Vogelstein" "Vordemark" "Vα2" "W2A" "W4A" "WB" "WC" "WEHI" "WEHI-539"
    "WERYSZKO" "WHI-SHARe" "WI" "WI61" "WITO" "WKYMVm" "WM" "WNT" "WRW4" "WST"
    "WST-8" "WSxWS" "WT-GFP-MIIA" "WT-GFP-MIIA-HC" "WT-PAK1" "WT-like"
    "WT-β-arrestin-1" "WT-β-arrestin-1-RFP" "WT-β-arrestin1-RFP" "WTGFP"
    "WTGFP-IIA" "WT–DNA" "WU" "WW2" "Waals" "Waf1" "Wageningen" "Wako"
    "Walker-B" "Wallis" "Walz" "WanFang" "Warburg" "Washington" "Weid" "Weigel"
    "Weinberg" "Whipple" "Whiteman" "Whitney" "Whole-cell" "Whole-mount"
    "Wickline" "Wilcoxon" "Wilcoxon-Mann-Whitney" "Wilk" "William" "Wilmanns"
    "Wilmott" "Wingless-Int" "Wingren" "Wnt-off" "Wnt-on" "X-axis" "X-ray"
    "X-rays" "X174" "XF24" "XIV" "XbaI" "Xbal" "Xenarios" "Xia" "Xiangya"
    "Xiao" "Xiao-qian" "Xin-li" "Xin-pin" "Xin-yao" "Xiong" "Xiu" "Xiu-Freg"
    "Xq28" "Xu" "Y-axis" "Y-family" "Y204" "Y259X" "Y261N" "Y576" "YAP-E2F-Rb"
    "YAP-WW1-WW2" "YAP–TP73-mediated" "YB-1-TOPO1" "YBF30" "YDSGΦSDΦE" "YGeFS"
    "YM" "YRI" "YXXM" "Ya" "Ya-qiong" "Yamada" "Yamagishi" "Yamamoto"
    "Yamamura" "Yancovitz" "Yanez" "Yanez-Mo" "Yap1–1gamma" "Yap1–2" "Yasuda"
    "Yes-associated" "Yeung" "Yi" "Yilmaz" "Yorkie" "Yu" "Yue" "Yue-lin" "Yuji"
    "Yun" "Z-VAD" "Z-stack" "ZFN-1" "ZFN-2" "ZFNs" "ZR75" "ZR75-LTED-eveR"
    "ZR75-eveR" "ZVAD" "Zavadil" "Zeisberg" "Zeiss" "Zhang" "Zhao" "Zheng"
    "Zhou" "Ziemann" "Ziess" "Zimmermann" "Zona" "Zta" "a-actinin" "a3ß3" "aac"
    "aare" "ab50581" "aberrancies" "aberrantly-expressed" "above-discussed"
    "absorbance" "absorbances" "ac-p53" "accurateness" "acetyl-group"
    "acetyl-lysine" "acetyl-methyllysine" "acetyl-residues"
    "acetylation-defective" "acetylation-methylation" "acetylcholine"
    "acid-induced" "acid-mediated" "acids" "acinar-like" "acinus-like" "acral"
    "actin-regulatory" "actinin-rod" "activation-loop" "activator-1"
    "activators" "active-site" "activin-like" "acyl-histone" "acyl-lysine"
    "adapters" "adducts" "adeno" "adenocarcimomas" "adenoid"
    "adenoma-adenocarcinoma" "adenoma-cancer" "adenoma-carcinoma"
    "adenoviral-mediated" "advanced-T" "advanced-stage" "adventitia"
    "afatininb" "agag" "agar" "age-accelerated" "age-associated"
    "age-dependent" "agomir-141" "agomir-141-HGC27" "agomir-NC"
    "agomir-NC-HGC27" "agonism" "alarmin" "algorithm" "algorithms" "alkyl"
    "alkylant" "alkylants" "allantoin" "allele-knockout" "allels"
    "allo-antigen-specific" "alloactivation-induced" "alloantigen"
    "allogeneic-type" "alloresponse" "allosterism" "allostimulation-induced"
    "alone-treatment" "alpha-beta" "alpha-keto" "alpha-negative"
    "alpha-subfamily" "already-accessible" "alt-NHEJ" "alterspu" "alveoli"
    "amalexanox" "amines" "amino-acid" "amino-bisphosphonates" "amino-terminal"
    "amino-terminus" "aminoacid" "aminoacids" "aminobisphosphonate"
    "aminooxyacetate" "ammonium" "amoeba-like" "amoeboid" "amphisomes"
    "amplicon" "amplicons" "analoges" "ancestry-specific"
    "anchorage-independence" "and-2CT" "and-histochemical" "and50.6"
    "andCDKN2A" "andDAXX" "andMlx" "andPolq" "andTrp53" "andUlk2" "andare"
    "andk" "androgen-dependence" "androgen-dependency" "androgen-shared"
    "aneuploidy" "angiography" "angioplasty-associated" "anhydroglucose"
    "animal-like" "anions" "anisotropy" "anorexia" "anoxia"
    "anoxia-reoxygenation" "antagomiR-500" "antagomir" "anterior-posterior"
    "anthracyclin" "anthraquinone" "antiandrogen-liganded" "antigen"
    "antigenemia" "antigens" "antimycin-inhibitable" "antiparallel"
    "antiplatelet" "antitumour" "apical–basolateral" "apocrine" "apocrine-like"
    "app" "appose" "aptamer-GNP" "aptene" "arabinofuranosyl" "arachidonate"
    "arachnoid" "arboxyl" "arboxyl-terminal" "arginase-II" "arisen"
    "as-yet-unknown" "aspirin-treated" "assembly-1" "assessingmalignancy"
    "associ" "associ-ation" "asym" "atand" "ath-miR-5661" "ation" "autism-like"
    "autistic-like" "auto-activating" "auto-activation" "auto-antigen"
    "auto-inhibited" "auto-regulatory" "autophagosome-membrane-associated"
    "autophagosomes" "autoradiography" "autoregulates" "autosampler"
    "autosomal-dominant" "average-risk" "avian-like" "avidin-biotin" "avß3"
    "axilla" "axis-mediated" "axon" "aza-dC" "azaCdR" "azoxymethane" "a–d"
    "b-AR" "b-ions" "bHLHLZ" "bHLHZ" "bHLHZip" "back-to-back"
    "backward–forward" "bacmid" "bafilomycin" "balances-relationship"
    "band-pass" "barbed-end" "basal-associated" "basal-like" "basal-type"
    "basaloid" "base-stack" "beforre" "begun" "benzimidazoles-1" "beta-a"
    "beta-binding" "beta-trefoil" "better-known" "between-study"
    "between-subgroup" "betweenDAXX" "bi" "bi-allelic" "bi-cistronic"
    "bi-directionally" "bi-nucleate" "bi-orientation" "bicalutamide-goserelin"
    "bilayer" "bilayers" "bilirubinemia" "binding-defective" "binding-sequence"
    "bio-availability" "bio-conjugate" "bio-conjugates" "biomass" "biosensors"
    "biospecimens" "biotin-16-dUTP" "biotin-maleimide" "biotinyl-lysine"
    "biphosphate" "biquitin" "birthweight" "bisphosphate" "blocker" "blockers"
    "blood-brain" "blood–brain" "bodies" "bone-marrow" "bothMlxip" "bothNF2"
    "botulinum" "box-O" "box-O3a" "bp" "bp+141" "bp+209" "brac" "bradykinesia"
    "brainstem" "branched-chain" "break-apart" "break-induced" "breakpoint"
    "breakpoints" "break–inducing" "briefer" "brighter" "brite" "broad-complex"
    "broad-spectrum" "broader" "broadly-applicable" "buffy" "build-up"
    "by-product" "by-products" "by-stander" "byrATG" "by~40%"
    "c-MYC-positivity" "c-Met-positivity" "c-Myc-OFF" "c-NHEJ"
    "c-NHEJ-proficient" "c-SRC" "c-hNox4" "c-hNox4Tg" "c1" "cDNA" "cHiPLC"
    "cIAPs" "caRheb" "cabon" "cadmium-mediated" "cadmium-stimulated"
    "calbindin-poor" "calcein-AM" "caliper" "calvaria" "camptopthecin"
    "cancer-relevant" "cancer-stem-cell" "cap-dependent" "cap-independent"
    "capillary-like" "capsid" "carbon-5" "carbonyl" "carbonyl-amide"
    "carboxy-tail" "carboxyethyl" "carboxyfluorescein" "carboxyl"
    "carboxyl-terminal" "carboxyl-terminus" "carboxylases" "cardia"
    "cardiac-specific" "cardiotropin-1" "cardless" "cargos" "carotid"
    "carriers" "carryover" "case-control" "case–control" "caspase-9-specific"
    "caspsase-3" "castration-resistance" "catc" "cation-π" "caudate"
    "cause-and-effect" "caveolar-mediated" "caveolin-1-positive" "caveolin-1α"
    "cavernosum" "ccRCC" "ccr" "ccr7-ccL19" "ceRNA" "cell-autonomous"
    "cell-cycle-dependent" "cell-cycle-related" "cell-environment"
    "cell-in-cell" "cell-intrinsic" "cell-permeable" "cell-proliferative"
    "cell-to-cell" "cell-tracker" "cell-type-specific" "cellcept" "cells"
    "cellulo" "cell–autologous" "cence" "center-stage" "centromere" "cerebella"
    "cerebellum" "cerevisiae" "cg" "chao" "cheaper" "checkpoint-activating"
    "checkpoint-effector" "checkpoint-regulatory" "chemically-enhanced"
    "chemically-synthesized" "chemo" "chemo-immune" "chemo-potentiators"
    "chemoattractant" "chemoimmunotherapy" "chemoprotectants"
    "chemoradiotherapy" "chemoresistance" "chemoresistant" "chemoresponse"
    "chi-square" "chi-squared" "child-birth" "cholesterol-depleting"
    "cholesterol-rich" "chosen" "chr7" "chromagen" "chromagene" "chromatid"
    "chromatids" "chromatin-accessibility" "chromatin-immunoprecipitaion"
    "chromatin-immunoprecipitation" "chromatin-immunoprecipitations"
    "chromatograms" "chromophobe" "chromosome-microtubule" "chromosome-spindle"
    "chromosome-type" "chronic-obstructive" "chronic-stress"
    "chronologically-aged" "cip1" "circuitries" "circuitry"
    "cis-diamine-dichloroplatinum" "cis-regulatory" "cisternae" "cistrome"
    "cistromes" "cl" "clade" "clades" "classical-NHEJ" "classifier"
    "classifiers" "clearer" "cleaved-caspase-3" "cline" "clinical-trials-based"
    "clinicians" "clinico" "clinico-genomic" "clinico-histological"
    "clinico-pathological" "closed-angle" "closely-packed" "coagulant"
    "codominant" "codon" "codon-specificity" "codons" "cofators" "coil-like"
    "coiled-coil" "coiled-coil-deleted" "colectomy" "coli" "colitis-associated"
    "collagen-mimic" "collagens" "colonoscopy" "colony-enhancing"
    "colony-formation" "colony-forming" "colposcopy" "combination-treated"
    "comorbid" "compacta" "compartment-associated" "complexomes"
    "computer-generated" "concentration-dependently" "concentration-response"
    "concentration–response" "conduce" "confetti-like" "conformers"
    "confounder" "confounders" "conjunctiva" "consecutives"
    "constitutively-activated" "contact-inhibited" "contextwe" "continuum"
    "control+2" "control-rAd-infected" "control-rAd-treated"
    "control-siRNA-treated" "conv" "cooperativety" "coprecipitate"
    "coprecipitates" "coptidis" "copy-number" "copy–template" "core-binding"
    "core-biopsy" "core-motif" "correlatedwith" "corroborations"
    "corticosteroids" "cost-effective" "costimulators" "counter-acted"
    "counter-regulation" "counter-selective" "counter-therapeutic"
    "counterion-release" "covariate" "covariates" "coworkers"
    "creatine-phosphate" "crebinostat" "crescent-shaped" "cross-activation"
    "cross-contamination" "cross-linkers" "cross-phosphorylation"
    "cross-platform" "cross-reactivity" "cross-regulation" "cross-resistance"
    "cross-sample" "cross-sectional" "cross-sections" "cross-species"
    "cross-study" "cross-validation" "crossedCCSP" "crossedCCSP-rtTA"
    "crosslinkers" "crossover" "crossovers" "cryo" "csSAM" "ctive"
    "cullin-RING" "cut-off" "cut-point" "cyan" "cyc" "cycler" "cyclinDs"
    "cyclohexamide" "cyclohexmide" "cylinD2" "cysteine-to-serine" "cyto"
    "cytokeratin-positive" "cytologically-uniform" "cytometer" "cytophagy"
    "cytoplasma" "d6-d30" "dDP" "dE2f1" "dGFP" "dabrafenib+trametinib"
    "damage-associated" "damage-dependent" "damage-induced" "damage-inducing"
    "damage-initiated" "damage-mediated" "damage-repair" "damaged-signal"
    "dark-adapted" "dark-brown" "dark-colored" "dataset" "datasets" "dbSNP"
    "de-activated" "de-amination" "de-condensation" "de-lipidated"
    "de-regulate" "de-regulated" "de-regulation" "de-repressed"
    "de-ubiquitylating" "deacetlyases" "deadenylases" "deazaneplanocin"
    "decamer" "decamers" "decan" "decarboxylases" "decidua" "decile" "deciles"
    "decreasedK" "deep-sequenced" "deeper" "deficieny" "degron" "degrons"
    "dehydrogenases" "del11q" "del17p" "del5395" "delocalizes" "demalonylates"
    "denaturant" "dendrite" "denileukindiftitox" "density-induced"
    "deoxycitydine" "deoxynucleotidyltransferase-mediated" "deoxyuridine"
    "deprivation-induced" "der" "describd" "destabilise" "desuccinylates"
    "detachment-induced" "deubiquitylate" "di-oligomers" "di-phosphorylation"
    "diamide" "diaminobenzidine" "diaphanous-related" "diathesis-stress"
    "dichroism" "diet-containing" "diet-control" "diet-controlled"
    "diet-induced" "diffraction-limited" "diffuse-type" "digoxigenin-dUTP"
    "dihidrotestosterone" "dihydrolipoyllysine" "dimethylammonium"
    "dimethyllysine" "dinucleotides" "diphosphate" "diploid" "direct-repeat"
    "discoid" "discrepant" "discriminant" "disease-like" "disease-wide"
    "disintegrins" "dismutates" "dissemination-factor-positive"
    "distinct-morphology" "dithio-carbamate" "dithiocarbamate" "dithiolane"
    "dmKG" "dnMAML1" "dnTCF7L2" "doi" "domain-3" "domain-BRC4" "domain–BRC4"
    "dominant-negative" "donor-derived" "donor-reactive" "donor-specific"
    "dormancy" "dose-depended" "dose-dependency" "dose-dependently"
    "dose-dependent–response" "dose-dependent–survival" "dose-escalation"
    "dose-groups" "dose-limiting" "dose-proportional" "dose-ranging"
    "dose-response" "dose-survival" "dose–MET–survival" "dose–response"
    "dose–survival" "double-blind" "double-drug" "double-minute" "double-stain"
    "double-strand" "double-strand-break" "double-tyrosine" "doublecortin-like"
    "doublings" "doubly-spliced" "down-expression" "down-modulate"
    "down-modulating" "down-modulation" "down-regulatory" "down-stream"
    "down-tuning" "downmodulate" "downmodulates" "drawn" "drug-immune"
    "drug-modifier" "drug-sensitivity" "drug-tolerance" "ds" "dsDNA" "dsDNAs"
    "dual-ChIP" "dual-ChIPs" "dual-chromatin-immunoprecipitations"
    "dual-colour" "duplexes" "dura" "durotaxis" "dyf" "dyskinesia"
    "dyskinesias" "dysphagia" "dysplasia" "eLife" "eQTL" "eQTLs" "early-life"
    "early-onset" "early-passage" "early-stage" "easy-to-interpret"
    "easy-to-use" "eccrine" "ectoderm" "ectodomain" "ectodomains" "ed" "edema"
    "edgeR" "effiux" "efflux-enabling" "eight-times" "eighty-eight"
    "eighty-six" "ekspert" "el" "electroblotter" "electron-dense"
    "element-binding" "eltrombopag" "empty-vector" "encapsidates" "end-organ"
    "end-protection" "end-resection" "end-stage" "end-to-end" "endocardium"
    "endocytic-MVB-exosomal" "endocytocis" "endometrioid" "endometrium"
    "endoperoxide" "endoplasm" "endoscopists" "endoscopy" "endothelial-cell"
    "endothelial-specific" "endothelial-targeted" "endothelium-denudation"
    "endotoxemia" "endpoint" "endpoints" "engraftedPtch1" "enhancer"
    "enhancer-binding" "enhancer-like" "enolase-like" "enroute"
    "enteroendocrine" "enthalpy" "entropy" "enzyme-substrate" "eosin"
    "eosinophil" "eosinophils" "ep" "epidermis-like" "epidermoid" "epige"
    "epige-netic" "epigenetically-regulated" "epihelioid" "epileptiform"
    "episome" "episomes" "epithelia" "epithelial-derived" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-to-mesenchymal"
    "epithelial–mesenchymal" "epithelial–stromal" "epithelium" "epitheloid"
    "equationsin" "erythema" "erythroplakia" "esiRNAs" "eslin" "esophagectomy"
    "estimations" "et" "ethiology" "ethnic-specific" "et " "evaluators"
    "eventuates" "ex" "ex-vivo" "exercise-associated" "exercise-induced"
    "exodomain" "exome" "exon-14" "exon-intron" "exon-plot" "exon18-24"
    "exon19" "exons" "exosome" "experimentally-induced" "exposure-MET-survival"
    "exposure-biomarker-response" "exposure-biomarker-survival"
    "exposure-response" "exposure-safety" "exposure-specific"
    "exposure-survival" "exposure–AE" "exposure–MET–survival"
    "exposure–response" "exposure–safety" "exposure–survival" "expressers"
    "extra-abdominal" "extra-thyroidal" "extrathyroid" "face-to-face"
    "factor-A" "factor-κB1" "false-discovery" "families---have"
    "family-association" "far-reaching" "far-superior"
    "farnesiltransferase-inhibitors" "farnesyl" "farther" "fast-evolving"
    "fast-growing" "fast-migrating" "favorable-risk" "fecal" "feed-back"
    "feedforward" "fei" "female-to-male" "fiIaments" "fibrillin-3"
    "fibroblast-like" "fibroblast-to-CAF" "fibroblast-to-cancer-associated"
    "fibroblastoid" "fibroblasts" "fibronectin-Luc" "fibroscopy" "filler"
    "findPeaks" "fine-mapped" "fine-needle" "fine-tune" "fine-tuned"
    "fine-tuning" "first-affected" "first-degree" "first-generation"
    "first-in-class" "first-in-human" "first-line" "five-residue" "five-week"
    "five-year" "fivefold-change" "flavanoid" "flavonoid" "flavonoids" "flmice"
    "flow-induced" "flow-mediated" "floxmice" "fluoresce"
    "fluorescence-microscopy" "fluorescently-labeled" "fluorophore"
    "fluorophores" "fluoroscopy" "flurouracil" "fluvastatin" "fms-like"
    "foci-formation" "foci-number" "folic" "follicle" "follicles" "follow-up"
    "forBcl-2" "forklike" "formyl" "forty-four" "forty-one" "forty-three"
    "fossae" "four-nucleotide" "four-stranded" "fourth-most" "foxhead" "foxp1b"
    "fragans" "frame-shift" "frames" "frameshift" "free-energy" "free-survival"
    "frequently-mutated" "fresh-cut" "freshly-cut" "fromCCSP" "fromCCSP-rtTA"
    "fromFancd2" "fromUlk1" "front-back" "front-line" "front-to-back"
    "furiosus" "fusiform" "fusiong" "gDNA" "gac" "gadolinium"
    "gain-of-function" "galactopyranoside" "gallbladder" "gandotinib"
    "gastrectomy" "gastrocnemius" "gastroscopy" "gat" "gatekeeper" "geal "
    "gefitinib-induced" "gel-filtration" "gender-specific" "gene-disease"
    "gene-environment" "gene-environmental" "gene-gene" "genes"
    "genetically-engineered" "genic" "genioglossus" "genome" "genome-wide"
    "genotype" "genotype-phenotype" "genotypes" "genotypesTrp53" "geographies"
    "geranyl" "geranyl-geranyl" "geranyl-pyrophosphate" "geranylgeraniol"
    "geranylgeranyl" "germ-line" "germline" "ggt" "gingiva" "glia" "globulin"
    "glomeruli" "glomeruloid" "glucose-6-phospate" "glucose-addiction"
    "glutamax" "glutamine-addiction" "glutaminolysis-dependent"
    "glycerophospholipids" "glycolysis-supportive" "goes" "gonio"
    "gonio-scopically" "good-risk" "gossypol" "grade-dependent"
    "gradient–induced" "gradings" "granulosa" "granulose" "grayscale" "greater"
    "greater-than-additive" "greatest" "green-labeled" "group-I" "group-wise"
    "growth-arrest" "growth-regulatory" "guanine-DNA" "guanine-adenine"
    "guanine-cytosine" "guanine-quadruplex" "guanine-thymine" "guanylate"
    "h-h-p53" "hBora" "hESC" "hESCs" "hGH" "hHGF" "hIL7" "hKFC" "hL7"
    "hMDM2-hMDMX" "hMDMXFL" "hMOB1" "hNox4" "hSSB" "hTNFα" "hYAP" "hYAP1"
    "half-life" "half-lives" "half-maximal" "half-site" "half-sites"
    "half-time" "hand-foot" "haplo" "haplo-insufficiency" "haplotype"
    "haplotypes" "harakiri" "hard-wired" "head-and-neck" "head-group"
    "headgroup" "heavy-chain" "helicase-defective" "helices" "helix"
    "helix-loop-helix" "hematocrit" "hematuria" "hemithyroidectomy"
    "hemoperitoneum" "heparin-affinity" "hepatectomy" "heptapeptide"
    "herpesvirinae" "herpesvirus-8" "hetero-dimer" "hetero-dimers"
    "hetero-geneous" "hetero-oligomeric" "hetero-oligomers" "heteroduplex"
    "heterozygote" "hexamer" "hg18" "hg19" "hidden" "high-VO" "high-affinity"
    "high-avidity" "high-confidence" "high-density" "high-dose" "high-exposure"
    "high-expressing" "high-expression" "high-fidelity" "high-frequency"
    "high-grade" "high-impact" "high-intensity" "high-level" "high-mobility"
    "high-motility" "high-resolution" "high-risk" "high-salt" "high-turnover"
    "higher-grade" "higher-level" "higher-order" "higher-than-normal"
    "highervalues" "highest-risk" "highly-conserved" "highly-induced"
    "highly-inducible" "highly-related" "highly-sensitive" "histidine-rich"
    "histologies" "histology" "histone-lysine" "histopathology" "histoscore"
    "histotype" "hmdm2" "hmdmxΔ1–6" "hmdmxΔ2–7" "hoc" "homeodomain" "homo-FRET"
    "homo-dimers" "homo-zygotes" "homogenates" "homolog" "homologs"
    "homology-Bin" "homozygote" "homozygotes" "host-cell-specific"
    "host-parasite" "hot-spots" "hotspot" "hotspots" "hr" "hsa-miR-146a"
    "hsa-miR-148a" "hsa-miR-150" "hsa-miR-34b" "hsa-miR-545" "hui" "human-like"
    "humanEGFR" "hydroxy" "hydroxybutyrate" "hydroxyethyl" "hydroxyl"
    "hydroxyphenyl" "hyper" "hyper-androgenemic" "hyper-bilirubinemia"
    "hyper-dependence" "hyper-proliferative" "hyper-sensitivity"
    "hyperandrogenism" "hyperandrogensim" "hyperbilirubinemia"
    "hyperinsulinemia" "hyperploidy" "hyperresponse" "hypo-androgenemic"
    "hypo-methylated" "hypo-methylatedPtch1" "hypo-methylation"
    "hypo-methylation-dependent" "hypo-phosphorylation"
    "hypothalamic-pituitary-adrenal" "hypoxia-mimicker" "hypoxia–pretreatment"
    "hypoxic-exposed" "hypoxic-mediated" "hypoxic-reductions" "iFISH" "iRT"
    "iSLK" "iSelect" "ice-cold" "ice-water" "ick1" "identifier" "identiﬁes"
    "ii" "iii" "ike" "ill-defined" "imDC" "imDCs" "imIL" "imIL-15" "imIL-15DC"
    "imIL-15DCs" "imIL-4" "imIL-4DC" "imidazoacridinone" "imide"
    "immediate-early" "immune-modulatory" "immune-precipitates"
    "immune-precipitation" "immune-stimulatory" "immune-surveillance"
    "immune-tolerance" "immuno" "immuno-electron" "immuno-fluorescence"
    "immuno-precipitation" "immuno-transmission" "immunoEM" "immunoassay"
    "immunoassays" "immunoblank" "immunochemistry" "immunocytochemistry"
    "immunodeplete" "immunodominance" "immunodominant"
    "immunofluorescence-microscopy" "immunoglobulin" "immunoglobulin-like"
    "immunohistochemistry" "immunohistology" "immunopathology"
    "immunoprecipates" "immunoprecipitation-PCR" "immunoprecipitation-qPCR"
    "immunoreactants" "immunostainings" "immunosurveillance" "immunotolerance"
    "impactful" "impoartant" "imtermediate" "in-depth" "in-frame" "in-hospital"
    "in-house" "in-silico" "in-situ" "in-turn" "in-vitro" "in-viv" "in3"
    "inHuh7.5.1" "inNF2" "inUlk1" "inactivators" "inase" "incompleteness"
    "indel" "independentDAXX" "independently-correlated" "indicats" "indictors"
    "individual-level" "individuals" "induced-apoptosis" "infection-associated"
    "infections" "inflammation-driven" "inflammation-induced"
    "inflammation-triggered" "infoldings" "inhibitior-induced"
    "inhibitor-transfected" "initio" "injection-dose" "injection-duration"
    "injection-frequency" "inline" "inositol-trisphosphate" "inpkd1"
    "insect-derived" "inside-out" "insightful" "insulin-axis"
    "insulin-dependent" "insulin-induced" "insulin-producing"
    "insulin-sensitive" "insulin-stimulated" "integrin-αv" "integrin-β3"
    "intention-to-treat" "inter-cellular" "inter-center" "inter-connectivity"
    "inter-domain" "inter-endothelial" "inter-individual" "inter-membrane"
    "inter-module" "inter-origin" "inter-patient" "inter-quadruplex"
    "inter-receptor" "inter-relationship" "inter-tumor" "interaction-like"
    "interchromatin" "interconverts" "interdomain" "interferon-regulatory"
    "intermediate–strong" "interquartile" "interstitium" "interstrand"
    "intertumour" "intestinal-type" "intima" "intra" "intra-chromosomal"
    "intra-dermal" "intra-dermally" "intra-module" "intra-molecularly"
    "intra-observer" "intra-operative" "intra-tumour" "intra-vesicular"
    "intracardiac" "intracrine" "intrastrand" "intravasate" "intron1" "intron7"
    "intronless" "invaginations" "invariant" "invasion-suppressing"
    "invasivenes" "invasivenes-sand" "inverted-stage" "investigator-initiated"
    "iodoacetamide" "ionic" "irradiation-induced" "irregularly-shaped"
    "ischemia-reperfusion" "isi04" "islands" "iso17q" "isoenzyme" "isoenzymes"
    "isoforms" "isograft" "isopeptide" "isoprenyl" "isosteres" "isotype" "iv"
    "junction-associated" "juxamembrane" "kConFab" "kJ" "kJ·mol" "kaposin"
    "kappa-B" "kappa-light-chain-enhancer" "karyotypes" "kbp" "kcal" "kd"
    "kelch-like" "kg" "ki-67" "kilobases" "kinase-2" "kinase-3β" "kinase-II"
    "kinase-defective" "kinome" "knock-down" "knock-in" "knock-on"
    "knocked-down" "knockin" "knocking-down" "krupple-like" "kyurenine"
    "lambda" "lambdas" "lamella" "lamellae" "lamina" "language-based"
    "lanosterol" "lapaitinib" "lapatinib-treatment" "laptinib" "laptinib's"
    "large-cell" "large-scale" "large-size" "largest-ever" "laser-capture"
    "laser-induced" "late-onset" "late-stage" "latency-associated"
    "latency-lytic" "latency-maintenance" "latent-lytic" "latently-infected"
    "later-firing" "later-life" "lavage" "leading-edge" "learnt"
    "leave-one-out" "left-handed" "left–right" "leiden" "lenti-miR-34c"
    "lenti-vector" "lentivirus-small" "lesion-induced" "less-strongly" "let-7a"
    "let-7b" "let-7c" "let-7d" "let-7f" "let7-b" "leucine-zipper" "leukocoria"
    "leukocyte-vessel" "levels" "levelsare" "levesl" "life-expectancy"
    "life-long" "lifecycle" "lifespan" "lifespans" "ligand-dependency"
    "light-adaption" "light-brown" "lineage-specific" "lipoate"
    "lipopolysaccharide" "lipopolysaccharides" "lipoproteins" "liposome"
    "lipoyl-lysine" "liquid-ordered" "literature-data" "lithium-mediated"
    "littermate" "littermates" "live-cell" "lobules" "local-regional"
    "location-based" "location-function" "location-specific" "locus-specific"
    "log-dilutions" "long-chain" "long-durability" "long-lasting" "long-lived"
    "long-pass" "long-range" "long-ranged" "long-terminal" "long-time" "longum"
    "lookup" "loop-swap" "loss-of" "loss-of-function" "low-abundance"
    "low-affinity" "low-allele" "low-avidity" "low-copy" "low-cost"
    "low-density" "low-dose" "low-expression" "low-grade" "low-level"
    "low-penetration" "low-profile" "low-resolution" "low-risk" "low-salt"
    "lower-stress" "loxP" "lpr" "luc-mut" "lumens" "luminal-like" "ly0.1"
    "lymph-node" "lymph-node-negative" "lymphadenopathy" "lymphoblastoid"
    "lymphoma2" "lymphoscintigraphy" "lysis" "lysosomal-thiol" "l¡ate"
    "m-Apple" "mAKT" "mAKT1-K179M" "mApple-paxillin" "mApple-paxillin-labeled"
    "mCRCs" "mFoxp1" "mGluRs" "mHMDMX" "mHTT-laden" "mIL-15" "mIL-4" "mMPT"
    "mR-21" "mRNA-like" "mSsb1" "mSsb2" "mTOCR1" "mTOR-S2448"
    "mTOR-immunoreactive" "mTOR-p70S6K" "mYAP" "macroglobulin"
    "macrophage-like" "macrosomia" "macules" "mahua" "main-effects"
    "malignances" "mammaries" "mammary-specific" "mammosphere"
    "mammosphere-like" "mammospheres" "mannosyl" "mantle-cell" "marker-based"
    "marker-by-marker" "mass-spec" "matrice" "mean±SD" "medaka"
    "mediator-induced" "medulla" "mel-624" "melanin" "mellitus"
    "membrane-permeable" "membrane-resident" "membraneOur" "memory-like"
    "meninges" "mesenchymal-like" "mesenchymal-to-epithelial" "mesenchyme"
    "mesenchyme-like" "mesenchymocytes" "meshwork" "mesoderm" "mesylate"
    "meta-genes" "meta-phase" "meta-regression" "metabolically-generated"
    "metabolically-targeted" "metagene" "metallo" "metastazise" "methacrylate"
    "methoxy" "methoxy-polyethylene" "methoxyestradiol" "methyl-containing"
    "methyl-o-guanine-methyl-transferase" "methyl-specific"
    "methyl-β-cyclodextrin" "methyladenine" "methylation-specific-PCR"
    "methylcytosine" "methylene" "methyllysine" "methylumbelliferone"
    "mevalonate–RHO" "miR-100" "miR-106b-25" "miR-107" "miR-122"
    "miR-122a-Bcl-w" "miR-130a-3p" "miR-130b" "miR-130bi" "miR-141"
    "miR-141-suppressed" "miR-143" "miR-144" "miR-145" "miR-155" "miR-15a"
    "miR-17" "miR-17-92" "miR-182" "miR-182-mediated" "miR-185" "miR-191"
    "miR-200" "miR-200b" "miR-202" "miR-203" "miR-205" "miR-206"
    "miR-206-transfected" "miR-208a" "miR-21-mediated" "miR-218" "miR-21and"
    "miR-21functions" "miR-22" "miR-224" "miR-224-residing" "miR-23b" "miR-24"
    "miR-24-mediated" "miR-25" "miR-26a" "miR-29a" "miR-301" "miR-30a" "miR-31"
    "miR-329" "miR-329-mediated" "miR-329-transfected" "miR-335" "miR-34"
    "miR-342" "miR-342-3p" "miR-376a-P85α" "miR-423-5p" "miR-4449" "miR-451"
    "miR-500" "miR-500-mut" "miR-500–inhibited" "miR-500–mediated"
    "miR-500–overexpressing" "miR-500–silenced" "miR-500–transduced" "miR-608"
    "miR-7KD" "miR-9" "miR-93" "miR-93's" "miR-93-5P" "miR-93’s" "miR-98"
    "miR-99a" "miR-99b" "miR-NS" "miR-Scr" "miR17-92" "miR29" "miR34a" "miRDB"
    "miRISC" "miRNA-155" "miRNA-199a" "miRNA-21" "miRNA-DEGs" "miRNA27a"
    "miRNAs-stably" "miRNP" "miScript" "mical" "micro-carcinoma"
    "micro-dissected" "micro-environment" "micro-environmental"
    "micro-irradiation" "microM" "microRNA-200" "microRNA-206" "microRNA-21"
    "microRNA-21-mediated" "microT" "microbeads" "microbiota" "microclusters"
    "microdomains" "micrographs" "microhomologies" "microhomology"
    "micrometastases" "micron-thick" "microplate" "microribonucleoprotein"
    "microsatellite" "microsatellites" "microtiter" "microvasculature"
    "microvessels" "mid-lytic" "midbrain" "middle-down" "midpoint"
    "migration-regulatory" "milk-producing" "millisecond" "mimic-miR-93"
    "mind-body" "mini-chromosome" "mini-fiIaments" "mini-helix" "mini-review"
    "miniP" "minichromosome" "minimise" "minss" "minute-2" "mirVana"
    "mis-expression" "mis-localisation" "mis-localization" "misbalance"
    "missense" "mitochondria-resident" "mitochondria-to-AMPK"
    "mitochondrial-dependent" "mitochondrial-encoded" "mitochondrial-membrane"
    "mitochondrial-potential" "mitomycin" "mitoses" "mock-depleted"
    "mock-treated" "moderate-intensity" "moderate-strength" "modern-day"
    "modules" "mon" "mono-allelic" "mono-cistrionic" "mono-cultured"
    "mono-cultures" "mono-methylation" "mono-phosphorylated" "mono-therapy"
    "monoacyglycerol" "monoamine" "monocyte-derived" "monolayer"
    "monomer–junction" "mononucleosomes" "monophosphate" "monosomy"
    "monotherapies" "monotherapy" "mons" "morbidities" "morphometry" "mortem"
    "most-to-least" "motheaten" "motif-containing" "motifs" "motile" "mtH"
    "mucoepidermoid" "mucosa" "multi-acinar" "multi-center" "multi-component"
    "multi-domain" "multi-ethnic" "multi-focal" "multi-functional" "multi-gene"
    "multi-institutional" "multi-minute" "multi-protein" "multi-step"
    "multi-variable" "multiangle" "multibiomarker" "multicenter" "multicentre"
    "multidomain" "multifold" "multiforme" "multilocus" "multimers"
    "multinucleate" "multiorgan" "multiple-testing" "multiprotein" "multiscale"
    "multisubunit" "multivariate" "mut-Htt-induced" "mutantcyclin" "mutants"
    "mutation-detection" "mutp" "mutp53-ErbB2" "mutp53A193T" "mutp53R172H"
    "mutp53R273H" "my-Akt1-K179M" "myoII" "myocardium" "myofibroblast-like"
    "myofibroblasts" "myr-AKT-expressing" "myrFAK" "myrPI3K" "myristate"
    "mΔpro" "n=1" "n=10" "n=101" "n=12" "n=13" "n=15" "n=150" "n=16" "n=18"
    "n=2" "n=20" "n=22" "n=23" "n=25" "n=28" "n=3" "n=30" "n=33" "n=4" "n=47"
    "n=5" "n=6" "n=67" "n=7" "n=76" "n=8" "n=9" "nAChR" "nAChRs" "nESI" "nL"
    "nM–2" "nN" "nano-vesicles" "nanoLC" "nanoLC-MS" "nanoLC400" "nanovesicles"
    "naphthoflavone" "nasopharyn" "nasopharyn-geal" "nasopharynx" "nativeAg"
    "ncomms7074" "near-complete" "near-normal" "near-physiological"
    "near-total" "nearest" "necropsy" "necrostatin" "neddylatio"
    "negative-regulating" "negatively-mutated" "neo-adjuvant" "neoadjuvant"
    "neocortices" "nephrectomy" "nephropathy" "netic" "network-based"
    "network-level" "neurite" "neurite-like" "neuro" "neuro-pathogenesis"
    "neuro-pathy" "neuroendocrine" "neurofibromatosis-2" "neurogulin"
    "neuropathologically-confirmed" "neuropathology" "neuropil" "neurosphere"
    "neurospheres" "neutral-buffered" "neutropenia" "neutrophil-like"
    "never-smokers" "nevoid" "newer" "newly-accrued" "newly-diagnosed"
    "newly-evolved" "next-generation" "nick-end" "nicked-circular" "nidulans"
    "nigrosome" "nigrosomes" "niquel" "no-recurrence" "node-negative"
    "node-positive" "nodes" "nonTE" "nonaminobisphosphonates" "noncancer"
    "noncarriers" "nonhistone" "nonhomologous-end-joining" "nonhuman"
    "nonmalignant" "nonmutant" "nononcogene" "nonpolypoid" "nonrandom"
    "nonsense-mediated" "normal-cell" "normal-like" "nr" "nsRNA" "nt" "nts"
    "nuclear-receptor-mediated" "nuclear-to-cytoplasm" "nuclear-to-cytoplasmic"
    "nucleases" "nucleate" "nucleo" "nucleo-cytoskeletal" "nucleosome-devoid"
    "nucleotide-1562" "nucleotide-1607" "nucleus-like" "null-like" "n = 15"
    "n = 2" "n = 3" "n = 4" "n = 6" "n = 6 " "n = 1" "n = 2" "n = 6"
    "occludens" "occludin-1" "oestrogen" "of42" "ofCCSP" "ofCCSP-rtTA" "ofNF2"
    "off-set" "off-target" "off-targets" "old-aged" "older-cut" "oligo"
    "oligo-anovulation" "oligodendroblasts" "oligodeoxynucleotides"
    "oligomycin" "oligomycin-A" "oligomycin-A-mediated" "oligopyrimidine"
    "oligos" "oligosaccharide-oligonucleotide" "omain" "omentum" "omic" "omics"
    "omni" "on-bead" "on-going" "on-target" "on-the-fly" "oncogenic-like"
    "oncokinases" "oncomiR" "oncomiRs" "oncoretrovirus" "oncospheres" "oncovin"
    "one-compartment" "one-dimensional" "one-directional" "one-half" "one-log"
    "one-third" "one-way" "onlineS1A" "onlineS2" "onlineS3A" "onlineS3B"
    "onlines" "only-infected" "oocytes" "open-angle" "open-label" "open-source"
    "orEGFR" "orange-red" "orchiectomy" "order-of-magnitude" "organelle"
    "organelles" "oriLyts" "oropharynx" "ortholog" "orthologues" "osteoblasts"
    "otif" "ought" "ourPtch1" "out-of-frame" "outs" "ovBTG3" "ovariectomy"
    "over-activated" "over-activation" "over-activity" "over-all"
    "over-compensation" "over-phosphorylation" "over-proliferation"
    "over-replication" "over-simplification" "overabundance" "overview"
    "oxCaMKII" "oxcarbazepine" "oxidases" "oxidative-stress" "oxoGua" "oxodGuo"
    "oxodeoxyguanosine" "oxoglutarate" "oxyPin1" "p-Tyr" "p190RhoGAP-A"
    "p21WAF1" "p21waf1" "p27-haploinsufficient" "p27shRNA" "p27ΔNLS" "p38-KM"
    "p38-MAPK" "p38-Thr180" "p38KM" "p38MAPK" "p38αD179A" "p38αshRNA" "p38β"
    "p38βD179A" "p4EBP1" "p53-PTM" "p53-PTM-B" "p53-PTM-E8-11"
    "p53-PTM-transduced" "p53-defective" "p53-depedent" "p53-immunopositive"
    "p53-null" "p53-pathway" "p53-rAd" "p53-wild" "p53ER" "p53F" "p53H"
    "p53K382ac" "p53RE" "p53REs" "p53wt" "p53β" "p95HER2"
    "p=0.011-Mann-Whithey" "p=0.022" "p=0.029" "p=0.04" "pAKT1" "pAKT2"
    "pARE2-TATA-LUC" "pAkt" "pBAD" "pBabe" "pBcl-2" "pBcl-2levels" "pCDNA3"
    "pCMV" "pCMV–E2" "pCR" "pEJ" "pEJ2-GFP" "pET32a-GP63" "pETS1" "pFoxo3a"
    "pGFPPTM" "pGL-3" "pGL2-B-MMP-13-145" "pGL2-Basic" "pGL2-promoter"
    "pGL3-promoter" "pGL3B-MMP-1-1633" "pGL3B-MMP-13-1548" "pGSK-3β" "pGSK3α"
    "pGSK3β" "pH" "pHDAC3" "pHDAC4" "pHMM" "pH " "pIL" "pIL-18" "pIRS-1" "pIκB"
    "pKAP-1" "pLKO" "pLNCX" "pLNCX-HA-AKT1" "pLNCX-HA-AKT1-K179M"
    "pLNCX-HA-AKT1-W80A" "pLNCX-HA-mAKT1-K179M" "pLNCX1" "pLNCX1-HA-AKT2"
    "pLNCX1-HA-mAKT1" "pLPCX" "pLPCX-HA-AKT2" "pMET" "pMLC" "pN0" "pOct"
    "pOct-T235" "pPHW1" "pPRAS40" "pRB" "pRC" "pRKIP" "pRPS6-S240"
    "pRSV-hPit-1-overexpressed" "pRc" "pReceiver" "pReceiver-M02"
    "pReceiver-M02-MET" "pS" "pS-P" "pS10-histone" "pS1618" "pS1618–53BP1"
    "pS1916" "pS235" "pSI-CHECK2" "pSTAT3" "pSTAT5" "pSTAT6" "pSV-Renilla"
    "pSer-Pro" "pSmad2" "pT" "pT202" "pT231-Pro" "pT231-tau" "pT2–4" "pT3"
    "pTNM" "pTRE2-hPit-1-Luc-shMMP-13" "pTyr419Src" "pTyr530Src" "pUC19"
    "pUL97" "pY1234" "pY1334" "pY204-Erk" "pack-year" "pack-years"
    "paclitaxel-intrinsic" "paclitaxel-resistance-promoting" "pair-long"
    "pair-wise" "paired-end" "pairwise" "pan-Pak" "pan-cellular"
    "pan-inhibitor" "pan-mutation" "pan-nuclear" "panH3ac"
    "pancreaticoduodenectomy" "pancreatitis" "panel-c5" "papilliferum"
    "para-cancerous" "paracrine" "paracrystals" "paralogues" "parametersof"
    "parenchyma" "parentals" "parity-induced" "parkinsonism" "parrallel"
    "participations" "partum" "parvulins" "pathobiology" "pathogen-associated"
    "pathology-associated" "pathophysiology" "pathway-centric" "pathways"
    "pathy" "patient-level" "patternless" "pc-JFH-1-core" "pc-JFH1-core"
    "pcDNA" "pcDNA-p38KM" "pcDNA3-β-arrestin-1" "pcDNA3.1-CFL1" "pcMV6"
    "pcMV6-TXNIP" "pcMV6-TXNIP-expressing" "pcMV6-TXNIP-transfection" "peIF4E"
    "peg-IFN" "peginterferon" "penetrance" "pentaene" "pentose-phosphate"
    "peptidases" "peptide-18" "peptide-receptive" "peptides" "perhaps"
    "peri-neural" "peri-tumor" "peri-tumoral" "perindopril" "periosteum"
    "peritoneum" "phagophore" "phagophores" "pharmacotherapy" "phase-contrast"
    "phellodendri" "phenethyl" "phenylarsine" "phenylethyl" "phiphilux"
    "phiphilux+T-cell" "phiphilux+T-cytotoxic" "phiphilux+TcM" "phiphilux+Th"
    "phophatidylethylnolamine" "phorbol-12-myrisate-13-acetate-induced"
    "phospha-tidylethanolamine-binding" "phosphate-binding"
    "phosphatidyl-inositol-3" "phosphatidylethanolamines"
    "phosphatidylinositide" "phosphatidylinositides" "phosphatiylcholines"
    "phosphine" "phospho-PKC" "phosphoSer" "phosphodegron" "phosphodegron-like"
    "phosphodegrons" "phosphoflow" "phosphofructokinases" "phosphoglycogen"
    "phosphoinositides" "phosphoinostitide" "phospholipids" "phosphonetworks"
    "phosphopeptide" "phosphopeptides" "phosphoproteome" "phosphor-Ser715"
    "phosphor-specific" "phosphoribosyl" "phosphorylation-competent"
    "phosphoserines" "phosphosite" "phosphosites" "phosphotidylethanolamine"
    "phosphotidylinositide" "phosphotidylinositol"
    "phosphotidylinositol-3-kinase" "photo-release" "photo-released"
    "photomicrograph" "photomicrographs" "photooxidant" "phsophoinositide"
    "phylogeny" "physically-interacting" "physiologically-achievable"
    "physiologically-relevant" "pifithrin-α" "pilomyxoid" "pilot-sample"
    "placebo-controlled" "placeholder" "plasma-like" "plate-bound" "plate-wise"
    "platinium" "platinum-combination" "platinum-taxane" "platinum–DNA"
    "pleckstrin" "pleiotropy" "pleomorphism" "plexiform" "ploidy" "plusC4D"
    "point-wise" "pointed-end" "poli-lysine" "poly-A" "poly-A-binding"
    "poly-A-enriched" "poly-ADP-ribose" "poly-l-lysine" "polyA" "polyadenine"
    "polycomb-repressive" "polylinker" "polymerase-1" "polymerase1"
    "polymorphism" "polymorphisms" "polyphatidylinositol" "polypid" "polyploid"
    "polypoid" "polypyrimidine" "polysomy" "polyubiqutinate" "pombe"
    "poor-prognosis" "poorer" "poorest" "population-wide" "porcine-derived"
    "porcine-like" "porocarcinomas" "poroid" "positive-regulatory" "positron"
    "post-PD" "post-amsacrine" "post-apoptotic"
    "post-atmospheric-oxygen-exposure" "post-cataract" "post-chemotherapy"
    "post-diagnosis" "post-doctoral" "post-entry" "post-hoc"
    "post-implantation" "post-induction" "post-infection" "post-injection"
    "post-irradiation" "post-knockdown" "post-lactational" "post-menopausal"
    "post-menopause" "post-mortem" "post-natal" "post-operational"
    "post-operative" "post-partum" "post-receptor" "post-relapse"
    "post-replicative" "post-sampling" "post-stimulation" "post-synaptic"
    "post-transcription" "post-transcriptional" "post-transcriptionally"
    "post-transfection" "post-translational" "post-translationally"
    "post-transplant" "post-transplantation" "post-treatment"
    "post-ubiquitination" "posteriorizes" "postmortem" "postrelapse"
    "potentiators" "pre-contracted" "prePD" "prePD " "pregravid" "prelamin"
    "preorganizes" "preproinsulin" "preterm" "pri" "pri-mi" "prior-to-therapy"
    "priori" "pro-LL-37" "pro-angiogenesis" "pro-angiogenic" "pro-apoptosis"
    "pro-arrest" "pro-atherosclerotic" "pro-autophagic" "pro-caspase-3"
    "pro-coagulatory" "pro-death" "pro-differentiative" "pro-fibrotic"
    "pro-growth" "pro-inflammatory" "pro-invasion" "pro-metastasis"
    "pro-metastatic" "pro-migratory" "pro-myeloid" "pro-peptide"
    "pro-proliferative" "pro-renin" "pro-survival" "pro-tumoral"
    "pro-tumorigenic" "pro-viral" "proband" "probands" "procarcinogen"
    "procoagulant" "procollagen" "product-activating" "product-binding"
    "progenies" "progenitor-like" "progenitors" "progeny" "progerin"
    "progeroid" "progesteron" "prognosticators" "proliferator-activated"
    "prolin" "proline-containing" "prolyl-hydroxylase" "promyeloid"
    "proof-of-concept" "proof-of-principle" "prostaglandins" "prostasomes"
    "protease3" "protein-10" "protein-DNA" "protein-coding" "proteins"
    "proteins---including" "proteolipid" "proteoliposomes" "proteome"
    "proteomes" "proteosome" "proto-oncoproteins" "protomer" "protomers"
    "proton-donor" "protooncogene" "proven" "proxidant" "ps-ns"
    "pseudo-adaptor" "pseudo-kinase" "pseudo-symmetric" "pseudo-wild-type"
    "pseudogene" "pseudogenes" "psiCHECK2" "psycho" "psycho-social" "pubis"
    "pull-down" "pull-downs" "pulldown" "pulldowns" "pulse-chase" "punctae"
    "putamen" "pylori" "p " "p = 0.002" "q-q" "q-value" "q12–q24" "qChIP"
    "qChIP-PCR" "qMSP" "qPCR-ChIP" "qRT" "qian" "qiang" "qiong" "quadri"
    "quadri-radials" "quadruplex-duplex" "quantile-quantile" "quantitative-PCR"
    "quantitative-reverse-transcription-PCR" "quantum-dot" "quasi"
    "quasi-continuum" "r=-0.334" "r=-0.422" "r=0.52" "rATG" "rFSH" "rIL-2"
    "radiation-activated" "radiation-induced" "radiation-treated"
    "radio-metabolic" "radio-potentiators" "radio-resistance"
    "radio-sensitivity" "radioresistance" "radioresistant" "random-effect"
    "random-effects" "rapacmycin" "rapalogs" "rationally-designed" "rbf"
    "re-ChIP" "re-acquisition" "re-adhesion" "re-analyzed" "re-balancing"
    "re-compute" "re-confirmed" "re-distribution" "re-emergence" "re-emphasize"
    "re-enforced" "re-engaging" "re-engineering" "re-entered" "re-entry"
    "re-established" "re-establishes" "re-establishment" "re-evaluate"
    "re-examined" "re-excision" "re-expressed" "re-expressing" "re-expression"
    "re-gained" "re-growth" "re-immunoprecipitated" "re-induced" "re-induction"
    "re-infection" "re-initiation" "re-interrogated" "re-introduced"
    "re-introducing" "re-introduction" "re-isolated" "re-joining" "re-ligation"
    "re-localization" "re-occurrence" "re-organised" "re-oxygenation"
    "re-plated" "re-plating" "re-proliferate" "re-reviewed" "re-seeded"
    "re-sensitization" "re-sensitize" "re-sensitized" "re-suspended"
    "re-testing" "re-treated" "re-vascularization" "re-verified" "reChIP"
    "reaction–single-strand" "read-outs" "read-pairs" "readout" "realplex"
    "rebalance" "receptor-1" "receptor-level" "receptor-ligand"
    "receptor-receptor" "receptor-χ" "receptors-interactions"
    "receptor–receptor" "recombination-dependent" "recombination-mediated"
    "reconfirm" "recouples" "red-shifted" "redirects" "redox-dependence"
    "reduced-length" "refractometer" "reg" "regeneration-competent" "region-1"
    "region-wide" "regrow" "regrowth" "regulatioh" "regulators" "reinitiate"
    "rejectors" "relatively-demarcated" "relaxant" "remodeler" "reno"
    "reno-protective" "repairosome" "replication-fork" "replication-initiating"
    "repopulate" "reporter-based" "representativeness" "repressors"
    "reproductive-age" "reprogramme" "resection-dependent" "reserpine"
    "resource-intensive" "responder-stimulator" "responders" "reticulum"
    "retinamide" "retinoids-ATRA" "retrovirally-infected" "retrovirus"
    "reverse-phase" "reverse-transcribed" "rex" "rhNodal-treated" "rhabdoid"
    "ribonuleoprotien" "ribose" "right-handed" "rilotumumab±epirubicin"
    "ring-type" "risk-HPVs" "risk-haplotype" "risk-haplotype-tagging"
    "risk-modifying" "roGFP" "rod-like" "rong" "root-mean-square-deviations"
    "root-mean-square-fluctuation" "rotarod" "round-shaped" "rpm" "rs1005819"
    "rs10118930" "rs10119004" "rs1042522" "rs1059234" "rs107251" "rs10758669"
    "rs10758677" "rs10815148" "rs10815162" "rs10974944" "rs10974947"
    "rs11020802" "rs11999802" "rs12340895" "rs12342421" "rs12343065"
    "rs12343867" "rs1256049" "rs12740374" "rs1277930" "rs13042395" "rs140693"
    "rs1536798" "rs1598856" "rs16260" "rs1729786" "rs1799793" "rs1799817"
    "rs1801270" "rs189037" "rs1965328" "rs2029807" "rs2039806" "rs2059806"
    "rs2059807" "rs2070583" "rs2149555" "rs2149556" "rs2234693" "rs2252673"
    "rs2274223" "rs2294008" "rs2294008T" "rs230498" "rs230521" "rs230528"
    "rs230530" "rs230531" "rs230539" "rs2536512" "rs25487" "rs28362491"
    "rs2841505" "rs2976392" "rs3753753" "rs3774932" "rs3774956" "rs3774964"
    "rs3774968" "rs3780378" "rs3803304" "rs3808850" "rs3824432" "rs3902354"
    "rs4072037" "rs4495487" "rs4645948" "rs4648055" "rs4648068" "rs4648408"
    "rs4712047" "rs4758633" "rs4946935" "rs4970836" "rs4970837" "rs4986938"
    "rs511744" "rs5742933" "rs583104" "rs599839" "rs602633" "rs61764370"
    "rs7847294" "rs7849191" "rs7857730" "rs89037" "rs9340799" "run-on"
    "s-hydroxy" "s12863-014-0147-y" "s12885-015-1031-5" "s12885-015-1035-1"
    "s12885-015-1041-3" "s12943-015-0293-5" "s12964-015-0085-y"
    "s12967-015-0382-7" "s12977-014-0123-7" "s13046-014-0109-2"
    "s13058-014-0503-x" "s13058-014-0505-8" "s13058-014-0513-8"
    "s13059-014-0526-8" "s13059-014-0536-6" "s253-FOXO3a" "s253-FoxO3a"
    "s315-FOXO3a" "s315-FoxO3a" "s40478-014-0174-y" "sE-cad" "sICAM-1"
    "sVCAM-1" "saline-exposed" "saline-injected" "saline-treated"
    "salt-dependence" "salt-inducible-kinase-1" "salt-sensitivity"
    "sandwich-type" "sc-30141" "scatterplot" "screen-result" "screenings"
    "second-generation" "second-hit" "second-line" "second-most"
    "secondary-passage" "secondary-structure" "secretases" "secretome" "seeQTL"
    "selenocysteine" "selenoproteins" "self-antigen" "self-antigens"
    "self-apoptosis" "self-associate" "self-contained" "self-degradation"
    "self-differentiation" "self-identification" "self-identifications"
    "self-identified" "self-induced" "self-interact" "self-ligands"
    "self-limiting" "self-renew" "self-renewal" "self-reported" "self-reports"
    "self-tissues" "self-ubiquitination" "self-ubiquitylated" "semaphorine"
    "semi" "semi-expert" "semi-permeable" "semi-quantitative"
    "semi-quantitatively" "semidry" "senes" "senes-cence" "senescence-like"
    "sensitises" "sensitizer" "sensor-HyPer" "septae" "seq"
    "sequence-selectively" "sequence-specific" "sequencings" "serine-protein"
    "serum-deprivation" "sessile" "seven-gene" "seven-nt" "seven-pass"
    "seven-residue" "sevenmaker" "sex-independent" "sex-strata" "sexuals"
    "sh-BRG1#1" "sh-BRG1#2" "sh-NS#1" "sh-NS#2" "sh-TERT#1" "sh-TERT#2" "sh1α"
    "sh1α1" "sh1α2" "sh2α" "sh5" "shAR" "shCOX-2" "shCTRL" "shControl" "shFN"
    "shGFP" "shIRIS" "shMMP" "shMMP-1" "shMMP-13" "shMonA" "shMyc" "shNQO1"
    "shPak" "shPak1" "shPak1-bearing" "shPak2" "shRNAi" "shSI1-1" "shSI1-2"
    "shSIRT4" "shSep15" "shSep15+Dox" "shStat5a" "shT1" "shT2" "shTHEMIS"
    "shTRIM33" "shTip60-1506" "shTip60-887" "shYAP" "shagreen" "shan"
    "shcontrol-luc" "sheet-like" "sheletrin" "short-interfering"
    "short-survival" "short-term" "shp38α-756" "shp38α-758" "shp38β-652"
    "shp38β-751" "shp53" "shut-down" "shutoff" "shβ-arrestin-1" "shβ-arrestin1"
    "shβarr1-luc" "si-Con" "si-E2F4" "si-E2F4-SKBr3" "si-PPARγ" "siBRCA"
    "siBRCA1" "siBRCA1-SKBr3" "siBUBR1" "siControl" "siCtrl" "siEZH"
    "siEZH2-mediated" "siGFP" "siH1" "siIRIS" "siLuc" "siMET" "siMical1"
    "siMonA" "siNON" "siPAK1" "siPIAS1" "siPKCδ" "siPOLQ" "siPPARγ" "siREV1"
    "siRNA#2" "siRNA1" "siRNA3" "siRUNX1" "siSIRT" "siSIRT-8" "siSIRT1"
    "siSIRT1–9" "siScr" "siSema6A" "siYAP" "siYAP#1" "siYAP#2" "sicyclin"
    "side-chain" "side-chains" "side-effects" "sidechain" "sidechains"
    "signal-to-noise" "signal-transducer" "signature-expressing" "signficant"
    "signiﬁcant" "silico" "simpler" "simplest" "simplex" "single-base"
    "single-cell" "single-copy" "single-drug" "single-gene" "single-marker"
    "single-molecule" "single-nucleotide" "single-span" "single-stage"
    "single-stand" "single-strand" "single-use" "sinus-lining" "siomycin"
    "sip53" "sirtuin" "sitealter" "situ" "six-well" "size-control"
    "size-exclusion" "skin-permeable" "skin-specific" "sliding-widow"
    "sliding-window" "slow-growing" "slow-migrating" "slow-moving"
    "slow-twitch" "slower-migrating" "slowing-down" "small-cell"
    "small-interfering" "small-molecule" "small-scale" "smaller-sized"
    "smokers" "smooth-muscle-actin" "snap-frozen" "sodium-binding" "soft-agar"
    "soft-tissue" "solid-phase" "solute" "spacer" "spacers" "specialists"
    "specifc" "specks-positive" "sphere-forming" "spheroid-forming"
    "spherosome" "sphigomyelins" "sphingomyelines" "sphingosine-1"
    "spindle-like" "spindlelike" "spleen-to-liver" "squamous-cell" "ss" "ssy1p"
    "stably-expressing" "stably-transduced" "stage-A" "stage-B,12" "stage-C"
    "stage-specificity" "stagetip" "stand-alone" "standard-methods"
    "standard-of-care" "stander" "statin-drug" "statin-sensitivity"
    "steady-state" "stellate" "stellates" "stem-cell" "stem-cell-derived"
    "stem-like" "stem-loop" "stemness" "stent" "step-wise" "steroid-responsive"
    "steroid-thyroid-retinoid" "strain-specific" "strand-exchange"
    "strand-swap" "streptavidin-S-FLAG" "stress-activated" "stress-diathesis"
    "stress-induced" "stress-inducing" "stress-mediated" "stressful"
    "stressors" "striata" "striatal-enriched" "stromal-specific"
    "structurally-related" "structure-dependent" "structure-specific"
    "structure–function" "study-wide" "sub-G0" "sub-G1" "sub-Saharan"
    "sub-analysis" "sub-cellular" "sub-clone" "sub-clones" "sub-complex"
    "sub-confluent" "sub-domain" "sub-endothelial" "sub-fragments"
    "sub-functionalization" "sub-functionalize" "sub-line" "sub-lines"
    "sub-localization" "sub-mesothelial" "sub-nano" "sub-nanomolar" "sub-ns"
    "sub-nuclear" "sub-optimal" "sub-pathway" "sub-population"
    "sub-populations" "sub-set" "sub-structure" "sub-tumoral" "sub-type"
    "sub-unit" "subQ" "subcategories" "subclass" "subclasses" "subcompartments"
    "subcomplex" "subfamilies" "subfragment-1" "subgroup-directed"
    "subgroup-specific" "subject-environment" "sublines" "submembrane"
    "subproteome" "subset" "subsets" "substeps" "substrate-WW"
    "substrate–velocity" "subthreshold" "subtype" "subvariant" "succinate"
    "succinimidyl" "succinyl" "succinyl-CoA" "sugar-phosphate" "suggestes"
    "sulfide" "sulfur-containing" "sulfur–sulfur" "sulphate-polyacrylamide"
    "superSeries" "superclasses" "superfamilies" "supernatant" "supernatants"
    "supernates" "superoxides" "superpathway" "supershift" "suppl"
    "suppressor-like" "supra-physiologic" "supra-physiological"
    "supra-physiologically" "supress" "supresses" "survivingFancd2"
    "switch-like" "switched-off" "symptomatology" "syn-decan" "synapse"
    "synapses" "syndrome-associated" "synergism" "tBax" "tacrolimus" "tagSNPs"
    "target-gene" "targeted-therapy" "targetome" "tau-transgenic" "taxan"
    "taxane-based" "telaprevir" "telomerase-deficient" "telomerase-independent"
    "telomerase-positive" "telomere-13" "telomere-like" "temozomolide"
    "template–copy" "temporal-spatial" "ten-eleven" "tentacle-like" "tertile"
    "tertiles" "tet-off" "tetracycline-repressible" "tetrad" "tetradecanoyl"
    "tetratrico" "tetrazolium" "thatVav1" "theApc" "theNkx" "theNkx2.1-Cre"
    "thePtch1" "theTip60" "theUlk1" "theand" "theca" "therapy-induced"
    "therapy-insensitive" "therapy-mediated" "thevalues" "thewrn" "thiamine"
    "thio" "thiol-reductase" "third-generation" "third-line" "thirty-five"
    "thirty-seven" "thirty-two" "three-dimensional" "three-dimensionally"
    "three-item" "three-layered" "three-quadruplex" "three-quartet"
    "three-stacked" "three-stage" "three-state" "three-stranded" "three-week"
    "three-year" "threonine-rich" "threonine-specific" "thrombocythaemia"
    "thrombocythemia" "thromboxanes" "thymidine-phosphorylase–negative"
    "thyroidectomy" "tibialis" "tightly-coordinated" "time-course"
    "time-cumulative" "time-dependently" "time-exposures" "time-lag"
    "time-lapse" "time-point" "time-points" "time-to-lung"
    "time-to-progression" "timeframe" "timelapse" "titre" "titres" "to-80"
    "toATP" "top-down" "topiramate" "topoisomerases" "topology" "tramtrack"
    "trans-autophoshorylation" "trans-dimerization" "trans-homodimerization"
    "trans-interaction" "trans-membrane" "trans-sexuals" "trans-splicer"
    "trans-splicing" "trans-splicing-generated" "trans-splicing-mediated"
    "trans-vessel" "trans-vivo" "trans-well" "transactivation-competent"
    "transcatheter" "transceptor-type" "transcript-specific"
    "transcription-PCR" "transcription-quantitative"
    "transcriptionally-activated" "transcriptome" "transcriptomes"
    "transdominant" "transducer" "transfections" "transmembrane-containing"
    "transposon" "transposons" "transrepress" "transrepresses" "transwell"
    "traptamers" "treastuzumab" "treated-Hep3b" "treated-SiHa" "treated-mice"
    "treatment-naïve" "tri-and" "tri-leucine" "triacylglycerols"
    "triazoloacridinone" "trichrome" "trifluridine" "trihydroxystilbene"
    "trim-and-fill" "trimester" "trimethylates" "trinucleotide" "triphosphate"
    "triple-alanine" "triple-immunostained" "triple-negative" "trisomy"
    "trogocytosed-HER2" "trysosine" "ts-miR-mediated" "tubal" "tubastatin"
    "tuberinis" "tubule" "tubules" "tubulo" "tubulo-interstitial" "tug-of-war"
    "tumor-adjacent" "tumor-initiating" "tumor-reactive" "tumor-sphere"
    "tumor-spheres" "tumor-suppressive" "tumors" "tumors-granular"
    "tumorsphere" "tumorspheres" "tumour-cell-specific" "tumour-derived"
    "tumour-initiating" "tumour-promoting" "tumour-specific"
    "tumour-suppressing" "tunable-combinatorial" "tunica" "turning-off"
    "twenty-six" "twenty-two" "twice-weekly" "two-cell" "two-color"
    "two-compartment" "two-dimension" "two-hit" "two-hybrid" "two-log"
    "two-pool" "two-prong" "two-pronged" "two-serine" "two-signal" "two-stage"
    "two-state" "two-states" "two-step" "two-tailed" "two-tetrad" "two-thirds"
    "two-way" "tyope" "type-1" "type-III" "type-V" "tyrosine-kinase–inhibitor"
    "tyrosine-protein" "ubiquitin-proteasome-mediated"
    "ubiquitination-proteasome" "ultra-amplification" "ultra-deep-NGS"
    "ultra-high-risk" "ultra-low" "uman" "un" "unc" "unc-51" "unc-51-like"
    "uncorrect" "under-expressed" "undergoes" "undergone" "underpinnings"
    "undertaken" "ungula" "units" "univariate" "unresponsiveness" "untangle"
    "up-expressed" "up-expression" "upto" "uranyl" "urea" "ureters"
    "uroepithelium" "utero" "utero-placental" "uvea" "uveal" "v-Kit" "v-ets"
    "vCCL1" "vIII" "vIL" "vSOX" "vTK" "vacuo" "vacuole" "vaginalis"
    "value=0.03" "variable-sized" "variant–DNA" "variates" "vascular-invasive"
    "vasculopathy" "vasospasm" "vector-only" "vehicle-treated" "velvety-smooth"
    "vemurafenib+cobimetinib" "vemurafenib+selumetinib" "venules" "vera"
    "vestigial-like" "viableFancd2" "videomicroscopy" "villi" "villus"
    "vimentin-Luc" "virally-derived" "virally-infected" "virally-reactivated"
    "virally-transformed" "viremia" "vitro" "viv" "viz" "water-membrane"
    "weak-to-intermediate" "weakest" "web-based" "webpage" "website"
    "weightlifters" "well-annotated" "well-characterised" "well-conserved"
    "well-defined" "well-designed" "well-differentiated" "well-documented"
    "well-positioned" "well-recognized" "well-studied" "well-tolerated"
    "whole-brain" "whole-cell" "whole-cohort" "whole-exome" "whole-genome"
    "whole-mount" "wich" "wide-range" "widely-utilized" "wild-typed" "wilde"
    "wildtype" "withARF" "withEGFR" "withNkx" "withNkx2.1-Cre" "withdrawn" "wk"
    "wnt8" "work-up" "workers" "workflow" "written" "wt-p53"
    "wt-p53-expressing" "wtp53" "x-axis" "x-radiation" "xY"
    "xanthoastrocytomas" "xestospongin" "xl" "yao" "yeast-based"
    "yeast-two-hybrid" "yes-associated" "young-aged" "yr" "zeste" "zeylanica"
    "zinc-dependent" "zipper-like" "zymogens" "zymography" "×
10"
    "×10" "×3" "×6" "×80" "×Tcf" "× 10" "× 10 " "× 10" "ĸB" "Δ1" "Δ1-565"
    "Δ122p53" "Δ133p53" "Δ133p53alpha" "Δ133p53α" "Δ14" "Δ16" "Δ2" "Δ271–409"
    "Δ3" "Δ418,419" "Δ432-484" "Δ432–484" "Δ559,560" "Δ566-919" "Δ609-919"
    "Δ671-919" "Δ747-752" "ΔBS1" "ΔC" "ΔC13" "ΔCTNNB1" "ΔCq" "ΔD418,419" "ΔE1A"
    "ΔFosB" "ΔG" "ΔHAT" "ΔMFI" "ΔN3" "ΔNLS" "ΔPH" "ΔPH-Myr-AKT1-K179M" "ΔPol1"
    "ΔPol2" "ΔRAD51" "ΔSTAD" "ΔTA" "ΔUBA" "ΔV559" "Δint11" "Δpercentage" "Δpro"
    "Δtail" "ΔΨ" "ΔΨm" "ΕDN1" "α-KG" "α-enolase" "α-helical" "α-helix"
    "α-isoform" "α-primase" "α-receptor" "α-tubulins" "α1-PPIase" "α1-core"
    "α1-α2" "α3" "α3β3" "α4" "α4-β6" "α7nAChR" "αKG" "αSMA-positively"
    "αSMA + " "β-AR" "β-TrCP-288C-R510A" "β-TrCP1reversed" "β-adrenergic"
    "β-barrel" "β-barrels" "β-caryophyllene" "β-hydroxybutyrate" "β-mediated"
    "β-naphthoflavone" "β-oxidation" "β-propeller" "β-scaffold" "β-sheet"
    "β-strand" "β-strands" "β-transducin" "β-turn" "β1-PPIase" "β1-β2" "β2-β3"
    "β3" "β4" "β4-α1" "β5-α4" "β6" "β6-β7" "β7" "β=0.04" "β=0.07" "β=0.08"
    "β=0.09" "β=0.10" "β=0.18" "β=0.32" "βIII-Tubulin" "βMHC" "βTRCP2"
    "βTRCP2-binding" "βTRCP2-interacting" "βTrCP2" "βc" "γ-CD" "γ-H2AXand"
    "γ-chain" "γ-herpesvirinae" "γ-herpesvirus" "γ-irradiated" "γ-irradiation"
    "γ-isoform" "γ-radiation" "γ-radiation-induced" "γ-radiation-treated"
    "γ-subunit" "γ-subunits" "γ1" "γ1-herpesviruses" "γ2" "γ2A" "γ3" "εAde"
    "εCyt" "εdA" "εdC" "ζ-ITAM" "κB" "λ-phosphatase" "μL" "μg" "μg " "μg " "μl"
    "μmol" "π-stacked" "χ2" "‘hotspot’" "‘metagene’" " 000" "∆TD" "∽15%"
    "≪0.001"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-14101-14400*
  '("alterspu" "hMDMXFL" "mHMDMX" "the 7th AUG initiation codon" "hmdm2" "coIP"
    "the bicistronic hmdmx" "CGC" "AUGs" "hmdmx" "p53β" "+384"
    "the 7th AUG codon" "AUG" "hMDMX" "co-association" "deubiquitylate" "DHB"
    "andDAXX" "betweenDAXX" "independentDAXX" "TALEN" "in 1:1" "S1981"
    "p21 WAF1/Cip1" "Intron 1" "subsequent Sanger" "oligos" "chr7:55111526"
    "unique EGFRvIII breakpoints" "only one breakpoint" "intron7/exon"
    "intron 1" "EGFRwt" "2–7" "~90%" "buffy" "Dallas" "colposcopy"
    "gastroscopy" "IIIA" "cytophagy" "different ovarian cancer subtypes"
    "other ovarian cancer subtypes" "81/86" "78/86" "LFA" "CD44V6" "16/19"
    "Baccelli" "other ovarian epithelial cancer subtypes" "OCCC" "19/" "16/22"
    "= 0.019" "Bayarsaihan" "comorbid" "=0.81" "=0.21" "=-0.01" "β=0.10"
    "=-0.05" "β=0.04" "=-0.04" "=-0.02" "=0.154" "=0.083" "R-squared" "=0.34"
    "=114" "everyday stressors" "psycho" "ILIB" "=0.08" "=0.18" "=0.32"
    "intestinal and diffuse subtype"
    "covering all promising GWAS-indentified SNPs" "Cardia" "rs13042395"
    "rs2294008 T" "pack-year" "co-variates" "III+IV" "only 0–1 risk genotypes"
    "= 1.03–1.64" "AG/GG" "AG/AA" "= 1.03–1.63" "non-cardia" "Insl"
    "polyphatidylinositol" "gastrointestinal epithelia" "1q22" "rs4072037"
    "rs2976392" "rs2294008" "re-evaluate" "= 0.155" "0–1" "non-denatured"
    "intense non-specific" "hYAP1" "BMEL" "hYAP" "∆TD" "mYAP" "Oudoff"
    "non-specifically" "10X" "Matsuda" "levesl" "1 x" "miR17-92"
    "mesenchymal cells/fibroblasts" "p38 MAPK-" "gene/protein"
    "thickened alveolar septae" "interstitium" "septae"
    "fibroblasts/myofibroblasts" "microdomains" "deficieny" "p38KM"
    "number/Coulter" "pRC/CMV2" "CMV2" "Superarray" "IPF" "∼ 80%" "BRAT"
    "PIKKs" "PIKK" "BRCA1-associated ATM activator-1" "activator-1" "H2AK119ub"
    "CCLE" "remodeler" "re-sensitization" "genes/pathways" "∼ 20%" "= 2.3" "−9"
    "H1993" "traptamers" "PROMACTA" "eltrombopag" "γ2A" "promyeloid" "Staerk"
    "Seubert" "Matthews" "…which" "gandotinib" "Shan" "FERM" "SAXS" "HADDOCK"
    "appose" "Lodish's" "Lodish" "Poger" "GxxG" "DPPC" "bilayers"
    "crosslinkers" "Laron" "Box1 " "SKQQRIK" "KKR" "submembrane" "parrallel"
    "Box1" "Langosch's" "Langosch" "hGH" "co-patching" "agonism" "Helix"
    "the associated JAK2s" "JAK2s" "Genentech" "βc"
    "a signalling competent hexamer" "cardiotropin-1" "ligand/hormone" "YGeFS"
    "WSxWS" "FNIII" "two membrane proximal receptor-associated JAK2s" "or 2+"
    "whose tumor HER2 immunohistochemistry" "serum/plasma" "Beum" "Kyoto"
    "anthracyclin" "forward/side" "and 2:1" "E:T" "non-HER2-trogocytosed"
    "E:T cell" "Fcγreceptor" "= 0.023" "N = 13" "N = 1" "= 10" "SISH"
    "/College" "CEP17" "Z-stack" "polyploid" "2/12" "4/15" "11/32" "and 2/6"
    "the IHC 3+" "the IHC 2+" "the IHC 1+" "TCAD" "Nsp" "HER2 /CEP17" "IHC 3+"
    "IHC 2+" "IHC 1+" "IHC/FISH" "epidermal growth factor receptor-2" "HER2 /"
    "SNP 6.0 " "SNP 6.0" "HER 2+" "In 3" "GES" "MGC-83" "MGC" "multiforme"
    "14q" "Notch/Hes1" "A denomatous polyposis coli (APC)" "Yilmaz"
    "mouse intestinal epithelium" "NCID" "ΔRG" "enteroendocrine" "Lieberkühn"
    "The intestinal epithelium undergoes" "DBZ" "Paneth" "pS235" "HNSCCCC"
    "Rettori" "nonhuman" "qMSP" "Thailand" "uroepithelium" "13q12.3-q13"
    "conduce" "AICR" "Washington" "STATA" "n = 12" "n = 20" "n = 13" "n = 9"
    "chemoresistant" "ovarian cancer chemoresistance" "P=0.01" "IVAN" "MBA"
    "NOSE" "n=9" "n=20" "n=30" "P=0.04" "PCA" "chemoresponse" "n=76"
    "clinico-genomic datasets" "P=0.02" "=23" "n=12" "n=28" "=67" "* p" "n=22"
    "E-box4" "E-box5" "E-box3" "five possible E-boxes" "Kit-8" "Achilles"
    "MDA-MB-231/ShCon" "MDA-MB-231/ShSlug2" "MDA/ShCon" "Stemness" "CAGNTG"
    "CANNTG" "ShSlug" "IDC" "sample/spot" "invasivenes" "TAMR"
    "Epithelial-to-mesenchymal" "E-Boxes" "anti-hormonal" "7-week-old"
    "Non-migratory" "/oxCaMKII/AMPK" "MnSOD/mtH" "AMPKwhich" "MCF10A-Er-Src"
    "oxCaMKII" "describd" "toATP" "levelsare" "flurouracil" "PFK"
    "phosphofructokinases" "MCF10-Er-Src" "dismutates" "Mn28" "roGFP" "Mn44"
    "aggressive cancer subtypes" "correlatedwith" "anions"
    "aggressive breast cancer subtypes" "in 1X" "U-shape" "TTDp" "methyllysine"
    "~14-fold" "N-labeled" "hydroxyl" "dimethyllysine" "dimethylammonium"
    "p53K382ac" "~52,000" "publically available datasets" "p53K381ac" "K381ac"
    "considerably 0.5 h" "U-shaped" "K381K382" "KMTs" "KAT" "~3%" "misbalance"
    "regulatioh" "ECAR" "succinyl" "22:6n-3" "Kennedy"
    "phosphatidylethanolamines (PE)" "phosphatidylethanolamines"
    "sphigomyelins (SM)" "sphigomyelins" "Gnmt" "neddylatio" "ONCOMINE"
    "oncokinases" "sphingomyelines (SM)" "phosphatiylcholines"
    "triacylglycerols" "sphingomyelines" "n=13" "=34" "16:0/18:1" "6-months"
    "8 p" "de-regulation" "Katkoori" "FS" "HNSCCs" "Ganci" "siBRCA" "siGFP-"
    "sip53/siBRCA1" "ApaI" "mutp53D281G" "mutp53/E2F4" "si-E2F4" "the Glazer's"
    "Glazer" "wich" "re-gained" "di-oligomers" "pUC19" "HindIII" "mutp53R175H"
    "mutp53R273H" "siGFP" "mutp53R172H" "multipolar mitoses" "mitoses"
    "Polo-like kinase2" "anti-tumoural" "re-chIP" "#7" "P-values"
    "three Burkitt’s" "~10%" "AviTag" "CDt/MS" "CD-tagging" "Hydroxy"
    "a physical co-localization" "co-complexes" "FOXP1potentiation" "FOXP1w"
    "Bozozok" "×Tcf" "miniP" "Lef" "FoxP1b" "Foxp1b" "posteriorizes" "CT990201"
    "cheaper" "BFP+/GFP+" "CDBP" "CDBF" "endocardium" "casein kinase 1α"
    "co-complexed" "Gleixner" "Ashman" "#63" "#76" "#184" "#1665" "#1671"
    "in fact KIT D816V+" "D816V+" "Erben" "Hoermann" "#1659" "#12"
    "polymorphism (RFLP)" "RNA/cDNA" "MNCs" "MNC" "#903" "a special subvariant"
    "subvariant" "JMD" "4q12" "ECNM" "PTD" "catc" "agag" "AHNMD"
    "a robust diagnostic algorithm" "n=25" "=28" "n=16" "=63" "n=1" "n=5"
    "BCR-ABL1" "/MPN" "miR-106b-25" "ovarian carcinoma cell genotype"
    "SKOV3/DDP" "pathological subtype" "I/II" "MIR93" "P70S6 kinase"
    "miR-93-5P" "MiR-93-5P" "FIGO" "MIR-93" "omentum" "targetome" "P–mediated"
    "using Spearman’s" "Chicago" "Bioo" "RNALancerII" "Maryland" "Lifesciences"
    "Fwd" "Chatsworth" "chromagene" "-diaminobenzidine" "diaminobenzidine"
    "anti-miR-21 and/or" "non-sense" "Written" "Changsha" "Xiangya" "Manassas"
    "Rockville" "GeneCopoeia" "Biotechnonlgy" "which equals 1 mg/kg" "BC021736"
    "MiR-34b" "miR-21 and/or" "Spearman’s" "BCT" "miR-21and/or" "Iorio"
    "miR-34b/c" "miR-34b" "Newschaffer" "Fersht" "Veprintsev" "only 2 °C"
    "liposomes" "nearly 10 °C" "Ficoll" "°C/min" "PHTSs" "CTG"
    "Phosphoinositides" "Bannayan–Riley–Ruvalcaba" "Niessner" "Carragher"
    "Forsea" "VM-15" "VM" "Videomicroscopy" "Dunn" "mutant/PTEN-null" "ZA"
    "nonaminobisphosphonates" "aminobisphosphonate" "CAAX-box" "CAAX"
    "isoprenyl" "spleen-to-liver" "DTIC" "videomicroscopy" "48hs" "72hs" "24hs"
    "three-year" "the transformed oral mucosa" "pGSK3α/β" "Mucoepidermoid"
    "WCE" "4/6" "6/6" "3/5" "WDSCC" "PDSCC" "MDSCC" "OTSCC" "the buccal mucosa"
    "OTFs" "CMGC" "Hadia" "mahua" "Mohua" "Jharkhand" "α/β" "= 28" "= 0.001"
    "1/6" "43/43" "= 0.0005" "2/7" "n = 2" "7/10" "1/5" "= 0.0002" "= 0.006"
    "= 0.0006" "= 39" "Mas" "AngIV" "AngIII" "evaluators" "Nikon"
    "quantitative nuclear morphometry" "the largest organelle" "nucleo" "MPTP-"
    "MPTP" "perindopril" "dyskinesias" "the rostral ventrolateral medulla"
    "↔dopamine" "L-dopa" "reserpine" "AngII/AT1/Nox4" "Ginnan" "interchromatin"
    "StressMarq " "the more affected nigrosome" "TH+" "OH" "prePD "
    "neurologically intact individuals/AMC" "almost non-existent" "StressMarq"
    "Damier" "nigrosomes" "putamen" "Barnes" "Garrido"
    "1-methyl-4-phenylpyridinium" "midbrain" "Chesselet" "Giorguieff"
    "Simonnet" "AngII/AT1" "BBB" "the first-affected calbindin-poor nigrosome"
    "prePD" "nigrosome" "n = 3" "p = 0.002" "≤ 0.05" "n = 15" "Hutchison"
    "− / −MEFs" "pKAP-1" "A-type" "∽15%" "Jeggo" "Y259X" "ATMi" "Zimmermann"
    "Diaz" "Escribano" "Virgilio" "LAP2α" "Botuyan" "Suarez" "Misteli"
    "Scaffidi" "Goldman" "The most severe laminopathies" "Eriksson" "progerin"
    "prelamin" "Gilford" "Hutchinson" "progeroid" "laminopathies" "Broers"
    "Laminopathies" "Dimitrova" "Bothmer" "Turcotte" "Fradet" "Passos" "Bartek"
    "Elledge" "Ciccia" "Mailand" "Bekker" "HDF" "× 10 " "μg " "H4K20" "Varnagy"
    "Ziemann" "Eisenmann" "co-incubation" "neonatal mouse calvaria" "calvaria"
    "osteoblasts" "Alvarez" "Gry" "Rodiles" "Blais" "Callejas" "Seok" "Fenton"
    "Pereira" "Figueiredo" "Miyahara" "= 0.05" "= 0.046" "= 0.027" "= 0.012"
    "DAA" "SVR" "telaprevir" "DAAs" "Serfaty" "peginterferon" "Vinciguerra"
    "Campo" "JFH1" "Yuji" "HCVcc" "JFH" "expression/activity" "IRS-1/2"
    "insulin receptor substrate 1/2" "T2DM" "in 1–3" "pIRS-1" "pc-JFH1-core"
    "Ib/II" "Ds" "sicyclin" "IC75s" "MEKi " "PRi " "Compd" "Amgen" "PRi"
    "IC50s" "# 11" "3 + " "= 6" "IC50 " "LROS" "co-operatively" "Ras-like"
    "mean ±  SD" "on/ off" "Valastyan" "GSE13937" "GSE47404"
    "various publicly available datasets" "GSE20347" "subsequent miR-31" "EZH1"
    "OLIGO" "Asangani" "DZNep" "deazaneplanocin" "mature miR-31"
    "the benign Barrett’s" "the benign Barrett"
    "miR-31 in ESCC, EAC and Barrett’s" "Yamagishi" "trimethylates" "miR-31"
    "re-suspended" "A/G" "= 0.042" "= 0.008" "easy-to-use" "LOVD" "webpage"
    "PERL" "lookup" "VarCall" "non-pathogenic" "Circos" "VUS" "pylori"
    "Heliocobacter" "C-mediated" "122p53" "photomicrographs" "mΔpro" "p53+"
    "Δ 122p53" "Δ133p53α" "Δpro" "Δ 133p53α" "Δ122p53" "Scr" "andPolq"
    "platinium" "ΔRAD51" "A-dead" "ΔPol2" "ΔPol1" "siPOLQ" "D-loops"
    "non-enzymatic" "J/m 2" "D-loop" "fluorophores" "Andrianantoandro’s"
    "re-examined" "P-ends" "actinin" "severing models/results" "models/results"
    "Andrianantoandro" "ADP+Pi" "Thomas" "Dominguez" "Roberto" "Nolen"
    "Kuriyan" "D11Q" "substeps" "one-half" "frames/s" "rod-like"
    "a half helical pitch ∼25%" "subfragment-1" "Hanson" "paracrystals"
    "bilayer" "anisotropy" "Oosawa" "ABPs" "amoeboid" "Kodera" "Ngo" "N=22"
    "n = 8" "n = 18" "∼25%" "Baba" "Shigaki" "Kalinsky" "Kothari" "Domingo"
    "/leucovorin (LV)" "Roswell" "Ogino" "Liao" "Sarasqueta" "Abubaker" "CCs"
    "a significantly higher RFI" "RFI" "CIMP" "hyperploidy"
    "three major mutational hotspots" "= 0.027" "= 0.11" "= 0.44" "= 3"
    "= 0.49" "= 0.052" "= 0.23" "= 0.58" "= 0.014" "P  = 0.032" "= 0.033"
    "PI3KCA" "= 0.36" "= 0.67" "≤ 0.05" "= 0.04" "n  = 47" "MAZGAJ" "BOROWA"
    "SANKOWSKA" "PELIKANT" "Iwona" "WERYSZKO" "SKWARSKA" "AUGUSTIN" "Ewa" "h"
    "approximately 3 μmol/L" "active caspsase-3" "∼19%"
    "approximately 1 μmol/L" "imidazoacridinone" "polymerase1"
    "5-Dimethylaminopropyloamino-8-hydroxytriazoloacridinone" "Gdańsk" "TKD"
    "triazoloacridinone" "∼80%" "∼7%" "ΔΨ m" "cells /well" "FMS-like"
    "glucose-6-phospate" "Acaca" "LAML" "LIHC" "geranylgeraniol (GGOH)" "GGOH"
    "geranylgeraniol" "Scd" "dmKG" "aminooxyacetate (AOA)" "AOA"
    "aminooxyacetate" "αKG" "Pyr" "Ribose" "MSEA" "tBax" "CB660" "Pfas"
    "both Burkitt’s" "oncomine" "shMonA" "shCtrl" "siCtrl"
    "ovarian cancer cell line TOV1112D" "TOV1112D" "siMonA" "andMlx"
    "bothMlxip" "P3C1" "dox" "Mondo" "Mxd" "bHLHZ" "co-regulated" "GC-MS" "2DG"
    "co-regulation" "E-Box" "20th-day" "BWL" "esiRNAs" "ets" "co-glycolic"
    "Aptamer" "noncancer" "Albany" "Rensselaer" "Mfold" "Aptamers" "Tuerk"
    "Szostak" "aptamers" "SELEX" "aptamer" "Nanomedicine" "is/are" "PKCα/β"
    "Bis" "S715/S718-2A" "S718-2A" "S681-3A" "active protein kinase Cδ"
    "C125A/C128A" "the constitutively active β-catenin S33Y" "4SA" "vIII"
    "B-boxes" "multidomain" "Cδ" "anti- FLAG" "non-phosphorylated" "T-cell"
    "domain/motifs" "mono-phosphorylated" "REST/Elk-1ΔC" "D-domain/common"
    "H176E/L4A" "D316/9A" "FXFP" "D-domain" "Neurite-like" "MEK1CA"
    "auto-activating" "R65S/D319N" "L73P/S151D" "neurite-like" "sevenmaker"
    "auto-activation" "the constitutively active MEK1-ΔN3/S218E/S222D"
    "ΔN3/S218E/S222D" "TEY" "Anti-proliferative" "non-G" "non-CpG"
    "mono-allelic" "ß-value" "COAD" "HM450K" "GAC" "G→A" "amines" "TGFRBII"
    "normal colonic mucosa" "non-significant" "2.2 × 10" "= 0.009" "= 0.035"
    "p = 0.022" "p = 0.002" "= 0.0006" "C→T" "non-hereditary"
    "different pathologic gradings" "gradings" "absorbances" "miR-130bi"
    "miRDB" "quantitative real-time PCR" "MiR-130b" "northeastern Iran"
    "Kazakhstan" "miR-130b" "miR-221/222" "Non-migrating" "≥ 50" "n  = 3"
    "SCC23" "MCF10A/5SAΔTA" "MCF10A/5SA" "5SAΔTA" "ΔTA" "monoacyglycerol"
    "MCF10" "5SA" "overabundance" "MCM2–7" "5 d" "reinitiate" "minichromosome"
    "siYAP #1" "BrdU+" "re-initiation" "siYAP" "FSC" "siYAP#2" "siYAP#1"
    "foxhead" "Rb/E2F" "Mizuno" "Zhao" "–152" "–7" "re-entered" "Pulldown"
    "Appratus" "CoIP" "IIF" "INMAP" "= 0.044" "siSIRT" "BJ/TERT" "MRC-5/TERT"
    "secretome (SMS)" "–9" "cavernosum" "isoenzyme" "p38mapk" "recouples"
    "expression/secretion" "≤ 0.05" "2 – 3" "procoagulant"
    "clinically relevant covariates" "age/10" "NSTEMI" "MDRD" "exodomain" "RDW"
    "coronary angiography" "angiography" "MMP-1 as" "Zheng" "-9"
    "the cell-permeable fluorogenic substrate PhiPhiLux" "caspase-3/-7"
    "phellodendri" "coptidis" "erythroplakia" "oropharynx" "co-stimulated"
    "mitochondrial-dependent anti-apoptotic" "FasR" "non-treated" "-7"
    "PhiPhiLux" "HNOKs" "NHKOs" "Hwang" "Anti-apoptotic"
    "activation/inactivation" "syringocystadenoma/syringocystadenocarcinoma"
    "pubis" "axilla" "mons" "Eccrine" "poroma/porocarcinomas"
    "10 extramammary Paget" "Paget" "papilliferum" "eccrine" "2/6" "1/1"
    "learnt" "rbf" "rpr" "RB/E2F" "G1-to-S" "Parkinson’s" "Parkinson"
    "gastrocnemius" "Duchenne" "E2F/DP" "PDK"
    "Drosophila mitochondria-associated dE2F/dDP" "degree/level" "Rpr"
    "simplest" "dE2f2" "dE2f1" "-to-S" "effiux" "BRCAness" "multicentre"
    "PARPis" "camptopthecin" "netic" "epige" "multisubunit" "intrastrand"
    "the high-grade serous EOCs" "EOCs" "high-grade serous histology" "ERCC"
    "=0.048" "significantly more motile" "A161S" "pBabe" "=0.059" "Anderson"
    "‘hotspot’" "EAp53" "p =0.002" "=0.030" "n=33" "monoclonal immunoglobulin"
    "ISS" "grayscale" "mimic/inhibitor" "lipofectamine" "1:5,000" "~2%" "siMet"
    "p=0.002" "non-HCC" "=22" "=25" "n=47" "suggestes" "microT" "DIANA"
    "Anti-miR-93" "=47" "biphosphate" "Pugh" "in 1x" "± 0.11" "± 0.01" "RNA22"
    "n=8" "=16" "=13" "=33" "Eckert" "deadly breast cancer subtypes" "n =4"
    "4 μg " "Anti-mouse" "BAXβ" "in 3NP-induced" "pcDNA4" "3NP-" "3NP" "*** P"
    "** P" "P- value" "N -acetyl" "ccRCC" "the axillary fossae" "fossae"
    "agomir" "siRNA#2" "-UTRs" "pGL-3" "≤0.05" "The quantitative real-time PCR"
    "transcriptomes" "12p13" "Gastrectomy" "the more aggressive subtype"
    "Straza's" "Straza" "MTOB" "sulfide (BPTES)" "BPTES" "sulfide"
    "p21 waf1/cip1" "p21 waf1" "the vesicular organelles" "prostasomes" "Goetz"
    "−CAF-like" "αSMA + " "nanovesicles" "Exosomes"
    "the triple immunostainings" "immunostainings" "αSMA+" "TME-like"
    "immunoreactants" "Munster" "GMBH" "Olympus" "Quemesa" "Eindhoven" "Tecnai"
    "uranyl" "FEI" "Wageningen" "ImmunoEM" "MyBioSource" "Elmer" "Perkin"
    "microplate" "ExoELISA" "Exoquick" "immunoEM" "exosomes" "exosome"
    "islands/clusters" "CAV1and" "gingiva" "alpha-smooth muscle" "Frederick"
    "Berlin" "Pinoles" "Innovex" "1%O" "mono-cultured" "CAV1 and"
    "HSC-3 organotypic mono-cultures" "Denmark" "Glostrup" "Dako" "Cambride"
    "Laemmli" "Brusewold" "Ruskinn" "1% O" "Ayrshire" "mono-cultures" "3-mm"
    "Oulu" "Co-cultures" "Clinico" "nano" "CAF-like" "CAV1+" "CaDEC12"
    "mimicker" "TME" "P  = 0.003" "8-mm" "= 54" "= 49" "n  = 15" "= 0.01"
    "BxPC-3 cells" "PANC-1 and" "occludin-1" "Zona" "p21 Waf1/Cip1" "72-hour"
    "48-hour" "12-hour" "8-hour" "4-hour" "factor/visfatin" "Cip/Kip"
    "occludens" "CDK2/cyclin" "WM" "-AMP-dependent" "zeylanica" "CDK2/"
    "and 50.6" "p21 Waf1" "mannosyl" "Borge" "fostamatinib/ibrutinib" "IGVH"
    "Bruton’s" "matrices" "receptor-1" "venules" "α 4" "timelapse" "Sertoli"
    "co-segregation" "GVGD" "1/423" "breast/and" "Polyphen-2" "in 1/516" "SIFT"
    "≤45" "0/90" "a neutral polymorphism" "granulosa" "progesteron" "0.9–1.3%"
    "Slovak" "Czech" "IVS2 +" "Finnish" "del5395" "IVS" "Malaysia" "Pakistan"
    "Philippines" "Spain" "Nothern" "Dutch" "Canada" "Finland" "Netherlands"
    "Jewish" "Ashkenazi" "France" "French" "2/180" "2/526" "Malay" "1/90"
    "2/172" "Malays" "Putrajaya (HPJ)" "Lumpur (HKL)" "HPJ" "Putrajaya" "HKL"
    "Lumpur" "Kuala" "UKMMC" "UKM" "non- BRCA1 /2" "accurateness" "atand"
    "HGMD" "Sini" "12/245" "72 hrs" "TMD-231" "non-CSC"
    "cumulative population doublings" "Cumulative population doublings"
    "first measured cumulative population doublings" "doublings" "thio"
    "Neoadjuvant" "CD44 +" "glia" "trkB" "upstream/downstream"
    "lateral temporal neocortices" "neocortices" "Rett" "***p " "βIII-Tubulin"
    "TrkB" "**p " "p70S6K/eIF4B" "Fusiform" "cortical circuitry" "synapse"
    "monoamine" "Purkinje" "autistic-like" "autism-like" "neuropathology"
    "symptomatology" "fusiform" "n = 4" "= 0.004" "= 0.1" "= 0.09" "= 0.009"
    "1 + " "de-regulated" "= 0.6" "= 0.02" "= 0.002" "= 0.003" "= 0.03" "*p "
    "4 μg" "polyubiqutinate" "a longer spacer" "GΦx" "NCDV" "YDSGΦSDΦE" "LLΦS"
    "DNS" "SA11-4F-like" "-Φ-" "D/E" "Phosphodegrons" "motif:WD40" "EE" "YM"
    "porcine OSU" "KU" "OSU-like" "ΔC13" "OSU-ΔC13" "RVAs" "animal-like"
    "DSGIS" "DSGΦxS" "UK-like" "A6/A10" "A13/A14" "A4/A16" "phosphodegron-like"
    "VACV" "OSU" "RVA" "DSGΦS" "The icosahedral RV particle encapsidates"
    "encapsidates" "phosphodegron" "-13" "2P" "7/9" "BNF" "naphthoflavone"
    "ITE" "vehicle-treated neurospheres" "Akti-1/2-treated U87 neurospheres"
    "Akt-pS473" "pOct" "anti-Oct4-pT235" "OCT4B1" "OCT4B" "Atlasi" "Jez"
    "Breyer" "Oct4B1" "Oct4B" "Oct4B-265" "OCT4A" "Oct4A" "Oct4-pT235"
    "anti-Oct4A" "pseudogenes" "6p21" "Akti-1/2" "Vitro" "NFT" "Mortem" "PDGEN"
    "OPTIMA" "ECACC" "dbSNP" "Ensembl" "Late-onset Alzheimer’s"
    "late-onset Alzheimer’s" "–13" "= 0.1" "= 0.007" "= 0.025" "p = 0.029"
    "= 0.016" "= 0.017" "= 0.022" "= 0.030" "pCMV6" "hMOB1" "±0.11" "shYAP"
    "photomicrograph" "±0.03" "=0.016" "PCT" "MHCC" "HIF-1αlpha" "umol/L"
    "Vordemark" "ODNs" "Normal cervical stratified epithelia"
    "oligodeoxynucleotides" "tetrazolium" "levels/activity" "p65/50" "pIκB"
    "pHDAC3" "CAY10576" "SN50" "FEM" "Oxford" "PROSPERO" "Ioannidis"
    "hyperinsulinemia" "Exons" "Goodarzi" "Iran" "representativeness"
    "hyperandrogensim" "Rotterdam" "Brazil" "English" "allelic polymorphism"
    "Insr" "DENND1A" "fibrillin-3" "hyperandrogenism" "rs2059807" "rs2059806"
    "rs1799817" "GA + AA" "= 0.38" "= 0.19" "plexiform" "stereotactic biopsy"
    "1p" "19q" "1p/19q" "non-methylation" "SDs" "PSQ" "co-deletion" "1p36"
    "= 0.49" "= 0.008" "= 0.014" "non-methylated" "= 0.037" "= 0.047"
    "transcript/cell" "re-compute" "Forsythe" "Wilk" "Shapiro" "Charles"
    "impactful" "hoc" "Farber" "Dana" "Parmigiani" "Giovanni" "G* Power"
    "two-tailed Wilcoxon" "G*Power" "*Power" "Wallis" "Schlosser" "Sabo" "Walz"
    "Morrison" "Sean" "in 3T9" "UV/VIS" "re-induction" "theand" "Burkitt's"
    "levels/cell" "and 3F" "Theseeks" "& 4" "24
hr"
    "SS/AA" "ISG" "CH167" "YBF30" "Sendai" "SupD1" "~4-fold" "EK505" "KKDQ"
    "WITO" "CH106" "DSGxxS" "transdominant" "E154A/E155A" "PxxP" "~2-fold"
    "IRES" "the former enhanced LTR promoter activity ~3-" "~3-" "mon" "SIVrcm"
    "SIVagm" "SIVden" "SIVolc" "SIVsmm" "~2-" "SIVmon" "SIVmus" "SIVgsn"
    "SIVcpz" "downmodulates" "NL4-3" "Cercopithecus" "RNAPII" "downmodulate"
    "ISGs" "primate lentiviral genomes" "~95%" "n = 7" "l¡ate" "beforre"
    "signficant" "zymography" "erbB" "fragans" "Prismatomeris" "Rubiaceae"
    "24 h" "Foulstone" "Hensch" "Probst" "IGFPB" "race/ethnicity" "race/ethnic"
    "Poorer" "mort  " "Covariates" "Hawaiians" "Hawaii" "= 0.01" "P  = 0.02"
    "P  = 0.03" "P  = 0.002" "= 0.0002" "P  = 0.009" "= 0.47" "= 0.15" "≥50 "
    "Racial/ethnic" "= 5" "= 35" "= 10" "racial/ethnic" "NIU" "hui" "LUO"
    "DONG" "qiong" "Ya" "XU" "shan" "Cheng-rong" "DUAN" "LU" "rong" "UVA"
    "Mustafi" "-trihydroxystilbene" "trihydroxystilbene" "QIU" "yao" "CHEN"
    "qian" "Xiao" "YU" "Ju" "XIONG" "non-leukemic" "#1–#9" "pro-caspase-3"
    "PL-treated primary BMMNCs" "PL 20+NAC" "PL-treated BMMNCs"
    "the PL-treated BMMNCs" "ie" "longum" "edema" "BMMNCs" "and 3C" "#6" "#11"
    "#5" "co-stained" "mmol/L" "dsDNAs" "NcoI" "≤0.01" "SW480/SN" "SCneo"
    "Jasin" "mitomycin C-" "mitomycin" "UvsX" "Heteroduplex" "crossover" "ss"
    "heteroduplex" "HDHB" "Co-transfection" "SRp55-PTC+b" "Lareau" "DAMI"
    "a premature termination codon (PTC)" "codon (PTC)" "TATGT" "matrice"
    "ESEfinder" "ESE" "interquartile" "essential thrombocythemia"
    "thrombocythemia" "NCBI" "JAK2+14" "JAK2Δ14" "Δ14" "= 0.076" "ng/ μ L"
    "specific mutational genotypes" "a unique subset" "mutational genotypes"
    "the specific mutational genotype" "Nelson" "most institutional datasets"
    "pancreatobiliary epithelial subtype" "Whipple" "pancreaticoduodenectomy"
    "AJCC" "EUS" "ERCP" "anorexia" "Massachusetts" "non-G12D"
    "the most common mutational genotype" "χ 2" "orchiectomy" "Ohashi" "CRCT2"
    "– EGF" "pGL4/1285Mut" "+362" "non-silenced" "SFM" "+EGF" "non-EGF" "-FTC"
    "pGL4/1285" "bps" "E1b/c" "phosphotidylinositol-3-kinase" "E1B" "Bcrp1"
    "BCRP/Bcrp1" "phosphotidylinositol" "8Br-cAMP" "to 14-3-3" "=0.037" "20/20"
    "Polζ" "DSR" "Co-IP" "SENPs" "peptidases"
    "Starvation simultaneously causes p53 phosphorylation/acetylation"
    "phosphorylation/acetylation" "anti-SUMO2/3" "N-acetyl" "~30%" "the Begg's"
    "GA/AA" "GG/GA" "GBC" "Rs2274223" "cardia" "Abnet" "rs2274223" "= 0.586"
    "14–1" "= 1.27" "OR = 1.22" "cg" "lpr" "PAC" "deoxyuridine" "Fc" "exocrine"
    "CD44+" "CD24+" "PanD24" "PanD3" "Exocrine" "PDA" "Collisson" "GSE15471"
    "America" "≥1" "6-month" "sheet-like" "HIV-1B" "CGG" "CREBP" "SKN-" "SKN"
    "cofators" "LTD" "scatterplot" "Clade" "mGluRs" "excitatory synapses"
    "synapses" "dendrite" "clade" "clades" "n = 15" "n = 10" "= 21" "= 28"
    "units/ ml" "vasospasm" "DMet" "WKYMVm" "relaxant" "Keitoku" "adventitia"
    "formyl" "arachidonate" "Serhan" "SQ-29548" "Tx" "Thr18/Ser19" "pMLC"
    "nmol/L" "CsH" "Feuerstein" "Weid" "antiplatelet" "stent" "PTCA"
    "Brezinski" "Silva" "Nascimento" "eosinophil" "formyl peptide receptor-2"
    "ectoderm" "primarily underwent non-apoptotic" "progenitor-like" "ureters"
    "necrostatin" "bafilomycin" "PepA" "VAD" "myrPI3K" "myrFAK" "methacrylate"
    "hydroxyethyl" "Tert" "DICD" "60 min" "# 2" "# 1" "Non-apoptotic"
    "luminal-like" "stem/progenitors" "pReceiver" "siMET" "Mt" "lenti" "SUNE-1"
    "miR-34c/MET" "μ l" "MiR-34c" "miR-26a" "NGP" "BMCC1ΔC" "ΔC" "Ser1981"
    "Lbc" "BNIPXL" "box-O3a" "arboxyl" "otif-" "otif" "10 min" "4  μ g"
    "Non-phosphorylated" "Δ432-484" "#3" "Dogterom" "MELT 1" "Vleugel" "C/D"
    "BubR1-D432-484" "BubR" "mutation/deletion" "co-localisation"
    "screen/paper" "Harrison" "Stephen" "Schekman" "placeholder" "conformers"
    "BuGZ" "B3BD/GLEBS" "Δ432–484" "E409K+E413K" "E409K+" "pombe"
    "Schizosaccharomyces" "LacO" "Lac" "ought" "tetratrico" "BR1" "MELT1"
    "B3BD" "B3BDs" "cerevisiae" "GLEBS" "APC/C" "co-recruitment" "centromeres"
    "complex/cyclosome" "Primorac" "Overlack" "A12" "siBUBR1" "Chop/CHOP"
    "siH1" "preproinsulin" "CAAT" "48 hrs" "μ L" "μ g/mL" "Seguin" "Oct4#2"
    "invasion/migration" "Oct4#1" "Re-ChIP" "HDAC1/2" "PTEN-2" "PTEN-1" "qChIP"
    "STAMP" "MEME" "mono-methylation" "oncogenic-like" "suppressor-like" "PCR"
    "SIRPA" "RefSeq" "TIC-like" "deacetlyases" "Oct4-driven lung TICs" "TICs"
    "Oc4" "=0.0002" "re-enforced" "S2C" "S5A" "anti-Rabbit" "Chung" "Finegan"
    "Suehiro" "Sato" "ATF1/2" "ORFeome" "Arthur" "McHugh" "Figeys"
    "Bouwmeester" "soluble complexomes" "Sonenshein" "Honjo" "Tanigaki" "AP/MS"
    "ATFs" "Inuzuka" "Busino" "Roux" "Meloche" "Peschiaroli" "Lyapina" "βTRCP2"
    "Gajiwala" "FOXN2" "ligases/F-box" "Olsen" "Dephoure" "QARS" "Schmit"
    "Litovchick" "Sadasivam" "FBXs" "Sowa" "CompPASS" "written" "outs" "FBXO42"
    "HCIP" "Mellacheruvu" "CRAPome" "Prasad" "HPRD" "Xenarios" "Bader"
    "BioGrid" "HCIPs" "RPL" "MGA" "co-regulators" "RPLs" "Poisson" "Choi"
    "Matys" "superclasses"
    "location-specific (i.e. chromatin-associated and chromatin-free) complexomes"
    "complexomes" "superfamilies" "non-FOX" "these location-specific PPIs"
    "Liu" "TAP/MS" "Matsuoka" "Behrends" "Malovannaya" "Gavin" "Koo" "Brunet"
    "Innes" "Sykes" "Kress" "Anders" "Lehtinen" "Hamdan" "Ariani" "Lehmann"
    "Mahlapuu" "Carlsson" "Tuteja" "Benayoun" "Hurtado" "Georges" "Jolma"
    "sequencings" "FOXM" "FOXD" "FOX-like" "Kaestner" "Weigel" "forklike"
    "PPIs" "Eisenman" "Blackwood" "Baldwin" "Ghosh" "Hayden" "Massague"
    "MacDonald" "Sharrocks" "C-terminally" "16 h" "co-regulate" "= 0.037" "= 7"
    "= 6" "= 4" "T/C" "Abbott" "Amanda" "Locascio" "Tricia" "Syrkin" "Leonid"
    "Berkowitz" "Jill" "KZ" "cytotoxic T lymphocyte-associated antigen"
    "meninges" "lymphoscintigraphy" "7/17" "10/17" "Antonescu" "positron"
    "F-labeled" "acral" "PMR" "EORTC" "SUVmax" "2-fluoro-2-deoxy-D-glucose"
    "= 0.04" "p-value = 0.03" "= 0.04" "= 0.33" "multibiomarker"
    "genomic/transcriptomic" "Nottingham" "non-practical"
    "the ovarian carcinoma genome" "Brenton" "biospecimens" "ΕDN1"
    "non-overlapping" "titres" "TTS" "approximately 3 kbp/min" "kbp/min"
    "RNAPs" "genic" "‘metagene’" "AluSg" "AluSx" "AluY" "findPeaks"
    "intragenic enhancer" "hg18" "PTENP1" "pseudogene" "ceRNA" "csSAM" "≪0.001"
    "=49" "HGSOCs" "Terpstra" "Jonckheere" "classifiers" "HGSOC" "DO-1"
    "anti-rabbit" "N =4" "N =9" "P =0.006" "P→PI" "→PI" "phosphotidylinositide"
    "DTBA" "NaNO" "Cl" "MESG" "Michaelis" "Pandolfi" "K13A"
    "dramatic allosterism" "allosterism"
    "the nonnatural purine nucleobase 7-methyl-6-thioguanine"
    "7-methyl-6-thioguanine" "liposome" "CUG" "HCXXGXXR" "phospholipase C1"
    "10q23" "-bisphosphate" "= 1.03" "miR-101/STMN1" "Frankel"
    "autophagy-associated protein LC3II" "LC3II" "miRanda" "5-8F" "nasopharynx"
    "miR-101" "Radioresistance" "supress" "K13/K15"
    "the centromeric mononucleosomes" "mononucleosomes" "pS1618" "supresses"
    "IRIFs" "IRIF" "GST-53BP1-Cterm" "prolin" "pS10-histone" "autoradiography"
    "UDR" "hBora" "Plk1 impairs" "Polo-like kinase 1" "Angiomotin-Like-1"
    "kJ·mol" "calorimetry" "SHCTPPPPYHADPS" "AGRPPPPPYPGPPL" "EYPPYPPPPYPSG"
    "MRYQHPPEYGAARP" "ELESPPPPYSRYPM" "xY" "kJ" "·mol" "enthalpy" "Gibbs"
    "YQGPPPPYPKHL" "Isothermal Titration Calorimetry (ITC)" "Calorimetry (ITC)"
    "ITC" "AQDA" "QD" "PY2" "*&2" "PY1" "RYSPPPPYSSHS" "ºC" "Calorimetry (DSC)"
    "Calorimetry" "WW2" "Uniprot" "PPxY" "of 42" "&2" "10.1038/ncomms7074"
    "doi" "amalexanox" "a human brain microvascular endothelial monolayer"
    "IgA" "memory-like" "proteolipid" "Tcrb/d" "bronchoalveolar lavage"
    "lavage" "CMRA" "CellTracker" "the atypical IKKs" "IKKs" "24 h" "48 h"
    "n =5" "1 +" "early onset Leber’s" "Leber" "homozygote" "Daugherty"
    "Turkish" "associ" "Saharan" "Northern Europeans" "Europeans"
    "the control group revealed 25 (38.5%) Arg homozygotes" "Hetero" "geal "
    "nasopharyn" "gonio" "pathy" "neuro" "BstUI" "POAG" "= 0.13" "Spearman's"
    "S31-201" "xl" "Bcl" "Greipp" "longer TTT" "7544-7545delCT" "geographies"
    "Jeromin" "17p13" "+12" "≥20%" "≥30%" "briefer" "mutated IGHV"
    "un-mutated IGHV" "Binet" "P -values" "=0.005" "P =0.007" "11q22.3"
    "P =0.008" "=45" "N=15" "N=4" "N=3" "N=10" "male/female" "11q" "TissueScan"
    "epidermoid" "proteosome" "Tengs" "COGS" "hHGF" "viv"
    "an uncommon germline single nucleotide polymorphism (SNP)" "P- values"
    "BRCA 1/2" "28-day" "3/7" "= 0.18" "n = 5" "Non-synonymous" "identiﬁes"
    "Graff" "anti-migratory" "anti-invasive" "Ramalingam" "MNK1/2"
    "our proprietary novel retinamides" "MDM2/ CHIP" "AR/MNK" "co-treated"
    "siSCR" "VNLG-152's" "VNLG-152" "-152" "ZVAD" "VN/14-1" "peIF4E"
    "signiﬁcant" "VN/66-1" "14-1" "66-1" "VNLG-145" "VNLG" "retinamides"
    "retinamide" "hydroxyphenyl" "RAMBA" "Retinamides" "n = 3" "4 μg" "GI 50"
    "12-month-old" "Hakai1" "HTC-116" "C57BL/6J" "-Tg" "Robol"
    "a strong co-localization" "Min/+" "U/mL" "HER2/" "non-tumorous"
    "non-cancerous" "pcMV6" "pcMV" "n=101" "n=150" "=101" "=150" "=-0.422"
    "=-0.334" "NCTs" "Her-1/2" "* P" "cells/ well" "G 0 /G 1" "P =0.012"
    "networks-KLF4-p21-Cyclin D1" "MST1/2" "Inhba" "Crgf" "Faslg"
    "nuclear-to-cytoplasmic" "MOB kinase activator 1A/B" "48h" "/B" "LATS1/2"
    "STE20-like" "insulin/IGF" "IMC" "EC50" "respective EC50" "24–31" "BHK"
    "pY1334" "insulin/IGF1" "non-insulin" "alpha-beta" "2p" "CLIA" "Pyro"
    "OncoMap" "non-V600E" "forty-one"
    "the aforementioned adjacent benign renal parenchyma"
    "benign renal parenchyma" "chromophobe" "indel" "GTG"
    "the adjacent benign renal parenchyma" "weak cytoplasmic BRAF V600E IHC"
    "strong cytoplasmic BRAF V600E IHC" "nephrectomy" "UMHS" "Choueiri"
    "glomeruloid" "= 45" "= 20" "histologies" "HER2 positive recurrent EnCa"
    "0-3+" "as 2+" "HERmark" "Herceptest" "histologic subtype" "recurrent EnCa"
    "RF/mm 2" "H2T" "USC" "VeraTag" "HercepTest" "p95HER2" "BrCa" "EnCa"
    "Subsets" "= 16" "= 0.02" "= 0.07" "≥ 2" "0.27–1.01" "immunohistology"
    "PAXR" "the recently identified prognostic marker BTF4/BTN3A2"
    "BTF4/BTN3A2" "amplification/overexpression" "PRP4K" "72 h" "24 h" "V2THS"
    "60 min" "= 0.05" "48 h" "= 0.03" "Tunisia" "Rushlow" "MYCNA" "Lohmann"
    "the bioinformatic tool PolyPhen" "PolyPhen" "Choy"
    "a premature stop codon" "RB42" "RB20" "*24" "*6" "3/50" "Bi" "Knudson’s"
    "13q14.2" "Knudson" "leukocoria" "OMIM" "impoartant" "shβarr1-luc" "IVIS"
    "Caliper" "Genomatix" "α7nAChR" "Shβ-arrestin1" "Shcontrol" "shβ-arrestin1"
    "nAChR" "nAChRs" "=0.52" "SWOG" "omni-" "omni" "non-genetic" "face-to-face"
    "SNVs" "CNVs" "withdrawn" "n=15" "anti- growth/survival"
    "anti-growth/survival" "V600E/R662L" "activation/dependency" "V600E/R509H"
    "phylogeny" "likely additional genetic underpinnings" "underpinnings"
    "growth/survival" "the clonogenic (i.e., long-term) growth/survival"
    "BRAFi+MEKi+ERKi" "MAPKi" "CNV" "amplicons" "mutant/variant"
    "sub-optimal ERKi" "ERKi" "DDR5" "DDR4" "vemurafenib+selumetinib" "#9"
    "DPs" "LOF" "the most pertinent exons" "upfront BRAFi+MEKi" "priori"
    "BRAFi+MEKi" "MEKi" "BRAFultra" "BRAFi" "A/C" "re-sensitize" "mutant/"
    "=15" "Africans" "hematologic oncology" "the qualitative Begg’s"
    "the qualitative Begg" "SNP309T" "Pl" "Egger’s" "OR=1.24" "=0.07" "OR=1.22"
    "GG+GT" "P=0.008" "OR=1.47" "GT+TT" "double-minute" "RevMan" "WanFang"
    "CBMDISC" "CNKI" "EBSCO" "Ovid" "=0.10" "Material/Methods" "parentals"
    "doublecortin-like" "NetworKIN" "phosphosite" "Phosphopeptides"
    "phosphonetworks" "Phosphopeptide" "succinate" "GProX" "Codon"
    "3971 unique phosphopeptides" "phosphopeptides" "phosphopeptide"
    "phosphosites" "phosphoproteome" "≥1.5" "= 30" "LC – MS/MS" "- 13" "ng/μL"
    "∼16%" "Chu" "Humar" "the Egger's" "Begg's" "Egger's" "Begg" "HWE" "Corso"
    "Omani" "Moundhri" "Mexican" "Franco" "16q22.1" "95% CIs" "P = 0.007"
    "= 0.004" "= 0.011" "= 0.06" "phosphorylation/conformation"
    "proteins/lipids" "inflammatory fatty acids/phospholipids" "lipoproteins"
    "15 LO1" "Type-2" "15HETE" "eosinophils" "15LO1" "activated/phosphorylated"
    "15-lipoxygenase-1" "auto-regulatory" "diabetic nephropathy"
    "mellitus (DM)" "healthy SGEC" "SGEC" "phosphotidylethanolamine"
    "15 HETE-PE" "15HETE-PE" "co-transfection" "FMN" "interconverts" "NH"
    "HSQC" "ΔG" "xref  Alzheimer’s" "redirects" "subthreshold" "BPMS" "RPMS"
    "methylcytosine" "decan" "Yun" "Rosner" "NF-κB/Snail/YY1/RKIP" "a3ß3" "ß3"
    "Dobbles" "avß3" "CICs" "Pba" "NF-κB/Snail/" "BNHL" "DHMEQ"
    "immunosurveillance" "DETANONOate" "pRKIP" "OXP" "Mulla" "Yeung"
    "Chatterjee" "phophatidylethylnolamine" "nononcogene" "Brockman"
    "Castellone" "Isogai" "HCAP18/LL-37" "anti-CRAMP" "Anti-CRAMP"
    "azoxymethane (AOM)" "azoxymethane" "procarcinogen" "hCAP18/LL-37"
    "noncancerous colonic mucosa" "mucosa" "60/68" "protease3" "CAMP"
    "de-activated" "48 h" "Schwann" "Yi" "basolateral = 1 × 10 −6 cm/s" "cm/s"
    "app" "the group II Pak" "Frax716" "Frax1036" "inNF2" "bothNF2"
    "benign meningioma cells MN328" "MN525" "MN328" "Ben-Men" "Frax" "shPak2"
    "shPak" "arachnoid" "Paks" "~0.5" "60-mm" "= 0.042" "P = 0.003" "= 0.005"
    "G0/G1" "acinar-like" "MTS" "P -value" "= 0.15" "-caspase-3" "EGFR/ERBB2"
    "Erbb" "regrow" "theApc" "theNkx" "flox/floxmice" "withNkx"
    "co-precipitate" "families---have" "co-precipitates" "immunoprecipates"
    "YXXM" "fl/flmice" "orEGFR" "withEGFR" "Δ747-752" "necropsy" "ofCCSP"
    "transgenes" "crossedCCSP" "+ mice" "humanEGFR" "+mice" "fromCCSP" "clara"
    "rtTA" "L858R+T790M" "LREA" "hetero-" "4-week" "fl/fl" "Ph+" "co-coltured"
    "hIL7" "haplo" "PAX5/AUTS2" "FLB6-67" "B6BAFL" "LY5.1FL" "1.06–1.40"
    "1.10–3.02" "1.42–2.48" "approximately 2–3" "aberrancies" "units/mL"
    "n = 4" "= 0.08" "= 5" "= 6" "n = 1" "n = 2" "= 4" "= 15" "AntagomiR"
    "gastric cancer chemoresistance" "publicly available algorithms" "miRNP"
    "microribonucleoprotein" "antagomiR" "IĸBs" "cIAPs" "sensitises" "ĸB"
    "Nuclear/cytoplasmic" "24 h" "= 0.006" "= 0.023" "BCL2-like" "= 0.012"
    "= 0.018" "non-tumour" "microvessels" "shFN" "shCOX-2"
    "lipopolysaccharides" "thromboxanes" "prostaglandins" "endoperoxide"
    "HNSCC" "α-enolase 1-like" "non-immunogenic"
    "both exogenous and endogenous Ags" "nativeAg" "non-classical"
    "exogenous Ags" "+EBV" "TB#2952" "C#16" "#16" "#2952" "URL" "BL-like"
    "on/off" "HLA-DR4" "24h" "64-76K" "Igκ" "Frev" "enolase-like" "invariant"
    "Ii" "CD8+" "non-Hodgkin’s" "tumors/cells" "Ags/peptides" "m / z" "CD4+ T"
    "non-Hodgkins" "CD8+ T cells" "amphisomes" "Transport-0" "HCQ" "ESCRT"
    "LAPTM" "autophosphorylation/activation" "subcomplex" "SKKs"
    "CAS882268–69–1" "Martinez" "Taglialatela" "pGSK-3β"
    "epithelial-to-mesenchymal" "Bovine lens epithelium" "Bcl-2/pBcl-2" "Ziess"
    "Bcl-2/pBcl-2 levels" "Bcl-2/pBcl-2levels"
    "adenomatous polyposis coli (APC)" "VEGF/pBcl-2"
    "post-atmospheric-oxygen-exposure" "kinase-3β" "phosphoglycogen" "GS"
    "Tian" "Huang" "Caraci" "Easwaran" "Skurk" "glycogen synthase kinase-3β"
    "Chong" "PCO" "pBcl-2" "mMPT" "-3β" "3-days" "Biase" "Vitale"
    "near-total thyroidectomy" "preoperative LNM" "hemithyroidectomy" "LNM"
    "1.04–1.82" "FNAC" "BRAFV600E-mutation-positive PTMCs" "re-confirmed"
    "LNMs" "extrathyroid" "PTMCs" "SEER" "biopsy (FNAB)" "FNAB" "US"
    "BRAFV600E-mutation-positive PTMC" "Cochrane" "PTMC" "=77" "=30"
    "S362/374A" "FTYP" "kinase-2" "sh5" "subfamilies" "kyurenine"
    "Huntington’s" "LIVE/DEAD" "Live/Dead" "Yorkie" "geranylgeranyl"
    "Sorrentino" "Jiao" "VGLL4" "VGLL" "Adenomatous polyposis coli (APC)"
    "coli (APC)" "Feng" "Yu" "cancer-associated Gα" "uveal" "rapacmycin"
    "glomeruli" "Chaulk" "o" "feedforward" "paralogues" "orthologues"
    "BCL-2-like" "Gα s" "tumorspheres" "Malanchi" "Py-MT+" "subQ" "Abp" "AR+"
    "dnMAML1" "Mastermind-like" "the primary or secondary tumorsphere"
    "tumorsphere" "Met-1" "isograft" "lobules" "C57/Bl6" "FVB/N" "NeuNDL"
    "apocrine" "PyMT" "periosteum" "mesenchyme" "HER4/ErbB4" "apocrine-like"
    "the mammary epithelium" "8/16" "= 5" "β 4" "P=0.0342" "Peritoneum" "sm"
    "P=0.0469" "P=0.0184" "P=0.0416" "Niki" "Taniguchi" "=0.0342" "=0.0469"
    "≤50" "=0.0184" "=0.0416" "ly0.1" "INFα/β" "INFγ" "infiltration/metastasis"
    "Nakamura" "pg/ml" "cyclin-dependent kinase 4/6" "pIL" "CRL1623" "ccr"
    "genioglossus" "Giemsa" "TSCC" "IC50" "Lopez" "Kulke" "hyperbilirubinemia"
    "a significantly higher ORR" "bilirubinemia" "ECOG"
    "significantly higher ORRs" "ORRs" "ORR" "non-progression" "Identifier"
    "OPRT" "phosphoribosyl" "Newer" "≥2" "21-day" "n = 1" "n = 2" "= 0.042"
    "= 0.033" "= 0.008" "= 0.005" "1-year" "PR + " "= 0.05" "≥50" "H&E"
    "non–small-cell" "n  = 7" "= 17" "= 30" "mg/day" "≥ 65" "NVP-BEZ235+ABT199"
    "gossypol" "GS-1101+ABT-199" "ABT-199+NVP-BEZ235" "p-70S6 kinase"
    "ABT-737-resistance" "germinal center B-cell-like" "B-cell-like"
    "non-Hodgkin" "μ g" "45 min" "72 h" "Akti-1" "HT1080" "-phenylethyl"
    "phenylethyl" "phenylarsine" "retroviruses" "P-proficient" "PERK"
    "P-deficient" "Nox4/Nox1" "physiology/pathology"
    "cardiac hypertrophy/dysfunction" "Matsushima" "GKT" "Switzerland" "Geneva"
    "Genkyotex" "Tg+ AngII" "interstitial mesenchymocytes/myofibroblasts"
    "HyPer" "Burlingame" "CTL+AngII" "Tg+AngII" "•-" "homologs/isoforms" "Nox"
    "eventuates" "myocardium" "hNox4" "AngII" "c-hNox4Tg" "c-hNox4 Tg" "24 hrs"
    "H & E" "similar placental pathophysiology" "non-preeclamptic" "partum"
    "HTR-8/SVneo" "both the chorionic villi" "chorionic villi" "N=17" "=35"
    "non-immune" "EGFR/ERBB1" "trimester" "trysosine" "the chorionic villi"
    "villi" "SGA" "P=0.029" "N=7" "= 34" "=20" "n= 6" "n= 10" "= 13" "=39"
    "n=7" "=17" "hypoxia/reoxygenation" "EGFR/ERBB" "EGF-like" "=76"
    "repairosome" "Blackburn" "quadri" "S/G2" "interstitial DNA DSBs" "TAG-3"
    "TAGGGT" "end-to-end" "G-overhang" "non-preference" "AATCCC" "C-rich"
    "telomere-like" "hSSB" "coli" "polyadenine" "polypyrimidine" "co-recruited"
    "mSSB1" "Pot1a" "mSsb1" "G-overhangs" "Gu" "ribonuleoprotien" "sheletrin"
    "G-strand" "chromosomal G-overhangs" "G-rich" "-to-" "Freg" "Xiu"
    "gallbladder" "kelch-like" "gastrointestinal fibroscopy" "fibroscopy"
    "fluoroscopy" "gastrectomy" "10 min" "232d" "577d" "258d" "422d" "d" "333d"
    "H-score " "H-score" "Nov" "Gastrointestinal Oncology" "= 0.076" "95% CI "
    "= 1" "= 0.005" "P  = 0.007" "= 0.011" "viral replication ab initio"
    "initio" "viral episomes" "simpler"
    "The cellular polyadenylation-binding protein C1" "deadenylases" "polyA"
    "carryover" "Ser634/636" "TEFb" "hypoxia inducible factor 1α" "co-opts"
    "late gene K8.1" "SeAP" "Gantt" "iSLK" "pulldown" "BALF5" "Narita"
    "viral kinase pUL97" "pUL97" "lamina" "phosphoserines" "Peptidyl"
    "peptidyl" "nidulans" "phosphatase 2A" "parvulins" "FKBPs" "millisecond"
    "L3P" "herpesvirinae" "LZs" "LR" "multimers" "supershift" "RtaΔSTAD"
    "GPPWWPP" "antigen (EBNA)" "EBNA" "a broadly-applicable RRE" "RRE" "CANT"
    "ANTGTAACANT" "16-nt palindromic RREs" "RBP-Jk/VP16" "ΔSTAD" "GTGGGAA"
    "vTK" "C/EBP" "ACGT" "-1α" "hKFC"
    "cellular transcription intermediary factor 1β" "oriLyts" "vSOX" "shutoff"
    "vIL" "kaposin" "NNG" "ISRE" "trinucleotide" "TTCCTGGGA" "TTCCAGGAT" "RREs"
    "true late protein K8.1" "NLSs" "heptapeptide" "Zta" "bacmid"
    "-tetradecanoyl" "tetradecanoyl" "K8.1" "IE" "lifecycle" "‑unique"
    "linear viral genome" "capsid" "Africa" "Lymphocryptovirus"
    "rhadinovirus (RRV)" "‑herpesvirus" "rhadinovirus" "HVS" "MHV"
    "Rhadinovirus" "ds" "Kaposi’s" "~70%" "γ1" "γ2" "Andre" "lapaitinib"
    "P27ΔNLS" "p27ΔNLS" "ΔNLS" "laptinib's" "laptinib"
    "starvation/restimulation" "co-immunostaining" "re-distribution"
    "ErbB2/Neu" "multiorgan" "non-tumorigenic" "chemoprotectants" "BCLL" "n=10"
    "=18" "microM" "aminoacid" "non-synonymous" "aminoacids" "TTT"
    "non-genotoxic" "editing/maturation" "SNHG15" "mRNA-like" "1/2" "SNHG16"
    "DANCR" "classifier" "Public ChIP-seq and RNA-seq datasets" "Gencode"
    "Burkitt" "Enhancer" "bHLHLZ" "NRO" "Wilcoxon" "Costa" "IRB" "oncospheres"
    "Trunc" "covering most MYB exons" "=0.05"
    "a particularly aggressive subtype" "Jegher" "Peutz" "mucoepidermoid"
    "adenoid" "non-metastatic" "de-repressed" "shSI1-2" "shT2"
    "secondary mammospheres" "shT1" "firefly:Renilla" "pGL2/" "GAACGG"
    "shSI1-1" "sh2α" "sh1α" "EV" "non-hypoxic" "metagene"
    "tumor-initiating BCSCs" "dehydrogenases" "BCSC" "BCSCs" "GSE7390"
    "GSE6532" "GSE4922" "GSE3494" ".1-puro" "2 /5" "TSC1/2" "cADPR/RyR"
    "/cADPR" "CD38/NAD +" "NQQ" "blockers" "CRAC" "xestospongin" "CAMKII"
    "MDA-MB-231+" "CaMKKII" "RKO/shNQO1" "NAD(P)H:quinone oxidoreductase"
    "45 min" "10 min" "≤0.02" "tagSNPs" "confounders"
    "previously reported SNP's" "previously reported SNP" "Connecticut"
    "Danbury" "Ribonucleosidediphosphate" "RRMI" "The most significant SNPs"
    "= 0.0002" "CIPN" "co-morbidities" "=0.0004" "resection/HR"
    "deletion/resection" "secondary DSBs" "resection/deletion" "pPHW1" "≤418"
    "only 2 bp" "DBS" "extensive resection/deletion" "pEJ" "cyto" "BmtI"
    "EcoRV" "associated yet mutually exclusive chromatin subcompartments"
    "subcompartments" "microhomologies" "Ku" "classical non-homologous" "MMEJ"
    "microhomology" "16B12" "/G1" "assessingmalignancy" "ac" "MicroRNA-34a"
    "10min" "U/ml" "Byeon" "Giannoni" "Src530" "Parasassi" "Pu" "Akhand"
    "by~40%" "501C/A" "pTyr419 Src" "277C/A" "248C/A" "oxidases (NOX)"
    "oxidases" "10 min" "Amplex" "pTyr530 Src" "pTyr530Src" "pTyr419Src"
    "activation/deactivation" "490C/A" "~40%" "ANTI-FLAG" "45min" "H-bond"
    "+0.9" "AQL-" "HSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRR" "AQD" "AQL"
    "mass/charge" "unfavorable mass/charge" "RCPHHER" "CSDSDGLAPPQHLIR"
    "TCPVQLWVDSTPPPGTR" "LFCQLAK" "SVTCTYSPALNK"
    "both respective iodoacetamide" "nL/min" "inline" "Chrom" "cHiPLC"
    "autosampler" "nanoLC" "ekspert" "ABSciex" "BIOGNOSYS" "iRT" "vacuo"
    "stagetip" "Empore" "μg/μL" "CaCl" "WAKO" "rpm" "-iodoacetamide"
    "Calbiochem" "phosphine" "carboxyethyl" " 000" "Amicon" "GdmCl" "UVB/UVC"
    "Iodoacetamide" "ORIEL" "TL" "ImageQuant" "electroblotter" "semidry"
    "Hybond" "TBE" "Surfact" "IDT" "TT-3" "GTC" "photooxidant" "anthraquinone"
    "QTRAP" "nESI" "Fourier" "-iodoacetamide-labeled" "iodoacetamide" "⩾3"
    "clearer" "AEs" "AE" "ANC" "co-administration"
    "the only significant covariate" "rilotumumab systemic CL" "kg" "CL"
    "minss" "ECX" "covariates" "rilotumumab±epirubicin/cisplatin/capecitabine"
    "=0.25" "=0.17" "=0.23" "=81" "discriminant" "temozomolide" "=0.026"
    "HR=0.19" "=0.29" "HR=6.9" "HR=0.15" "=0.047" "=0.14" "=0.15"
    "immunochemistry" "Neuroendocrine" "alkylant" "alkylants" "P =0.017"
    "=0.19" "P =0.003" "P =0.002" "repopulate" "caliper" "8-week-old" "tertile"
    "Semi" "transwells" "much smaller mammospheres" "Mammospheres" "non-round"
    "shIRIS" "shcontrol" "cell/nuclear" "intronless" "EGFR/" "K/AKT" "Sapitnib"
    "/T" "siIRIS" "siLuc" "HME/IRIS" "established preclinical TNBCs"
    "invasive TNBCs" "HOSE" "HME" "poorest"
    "an aggressive breast cancer subtype" "Forkhead box O3a"
    "expression/activation" "neurogulin" "class O3a" "n = 6 " "= 12" "n = 6"
    "2 + " "+ 2" "Nu/Nu" "T202/Y204" "associated canonical EREs" "EREs" "LXXLL"
    "CoRNR" "co-repressor" "transrepresses" "co-repressors" "transrepress"
    "ER+/HER2+" "PR+" "co-activators" "/HER2+" "PBI" "Cinti" "Nakanishi"
    "Egger" "Yamamoto" "Aleskandarany" "1.13–1.45" "1.29–1.78" "Ottawa"
    "Newcastle" "anti-pAkt" "Fabi" "Xia" "P = 0.009" "P = 0.002" "= 54" "13–1"
    "trimerizes" "pSTAT5" "imIL-15DCs" "costimulators" "=0.04" "=10"
    "Δpercentage" "ΔMFI" "extracellular signal-regulated kinase 1/2"
    "succinimidyl" "carboxyfluorescein" "Teff"
    "memory CD4 and CD8 T-cell subsets" "anti-CMV" "PBLs" "imIL-15DC" "imDC"
    "imIL" "phosphoflow" "Ags" "imDCs" "Ag" "pT202" "μg " "fibroblast-like"
    "=0.0005" "=12" "=0.06" "=5" "=0.09" "=0.008" "n =6" "=9" "n =8" "n =7"
    "CD8 + T cells" "NKF" "focal epitheloid" "a pediatric brainstem GG"
    "2 pediatric anaplastic supratentorial GGs" "pilomyxoid" "epitheloid"
    "immunopositive/Sanger" "equivocal/ weak IHC" "background/" "IDH1/2"
    "a predictive algorithm" "discordant IHC" "equivocal IHC"
    "immunopositive BRAF VE1" "Koelsche" "2/5" "3q13.31" "LSAMP" "Nobusawa"
    "non-epithelioid" "7/13" "heavy background/" "SNapshotTM" "concordant IHC"
    "mutation/IHC+" "IHC/mutational" "IHC+" "SNaPshotTM" "immunoblank" "dura"
    "chromagen" "parenchyma" "gadolinium"
    "our original anaplastic pleomorphic xanthoastrocytomas" "Inc" "AZ"
    "Tucson" "Ventana" "rhabdoid" "pleomorphic xanthoastrocytomas" "EGBs"
    "neuropil" "patternless" "GGs" "anaplastic pleomorphic xanthoastrocytomas"
    "xanthoastrocytomas" "non-tumoral" "5/6" "mutation/" "endometrioid"
    "Rodriguez" "clinico" "yr" "-alkyl" "alkyl" "dinucleotides" "EOC" "ick1"
    "let-7d" "≥500" "p27/" "Cycin" "us" "MRC5SV" "180BRM"
    "Camptothecin (CPT)-induced DSBs" "∼1%" "S6C" "S6A" "let-7b" "S1E"
    "Anti-Mouse" "2 Gy" "HCT116 p53-/-"
    "HCT116 control cells underwent apoptosis 20 hrs"
    "stabilization/activation" "activation/stabilization"
    "stabilization/up-regulation" "omain" "ike" "biquitin-" "biquitin" "u"
    "USP2a" "HPRT" "VCMS" "tunica" "eosin" "MCP-1/JE" "78/24" "Fe" "flavonoid"
    "flavonoids" "CIMT" "carotid" "adhesion molecule-1" "Gieson" "intima"
    "Histology" "C57BL/6" "IKKß" "flavanoid" "Segain" "supernatants" "DLD1"
    "IEC" "cells/wells" "p38 MAPK" "PlexinA" "metastazise" "Hoechst"
    "a commercially available siMical1" "siMical1" "≤0.001" "soft agar"
    "siScr/cells" "2/21" "siScr" "24-36h" "2/56"
    "a third specific commercially available siSema6A" "siSema6A" "and 2/59"
    "665/2" "Elena" "Regina" "intracardiac" "mical" "semaphorine" "caspase 3/7"
    "with/without" "uncorrect" "chromatids" "Smirnov" "Kolmogorov" "SceI"
    "Okazaki" "subclass" "long-time" "polyploids" "Polyploids" "pearson"
    "two available datasets" "re-introduction" "PARPi" "potentiators"
    "antitumour" "non-targeted" "Caspase 3/7" "= 2" "p53-PTM-E8-11" "AdNull"
    "pGFPPTM" "n=6" "units/ml" "G1/S" "co-positivity" "co-targeting"
    "unresponsiveness" "SHINE" "GEJ" "identifier" "polysomy" "NVP" "1+" "mg/mL"
    "Thr202/Tyr204" "non-linear" "non-amplified" "neurites"
    "15-His59-His157-Thr152" "Serl" "carbonyl" "co-purifies" "tg"
    "hypoxia-inducible transcription factor-1" "pT231-tau" "pT" "cyclohexmide"
    "diamide" "oxyPin1" "pTide" "PTide" "Aβ" "NFTs" "Alzheimer’s" "g/Ml"
    "non-covalent" "anti-agent" "botulinum" "approximately 80 mg/kg/day"
    "mg/kg/day" "fillers" "filler" "I-enhancing" "around 30-years-of-age"
    "anti-aging" "n=3" "n= 3" "MBCD" "Masson's" "Masson" "n=4" "HDFs"
    "18-months-of-age" "=4" "RT-PCR/real-time" "anhydroglucose" "CDs"
    "Methyl-β-cyclodexrin" "TβRs" "dermal collagens" "MβCD" "non-human" "= 3"
    "TIC" "Serial mammosphere re-plating" "re-plating" "tet-inducible shp53"
    "tetracycline inducible shp53" "shp53" "+++" "parous p53H/+" "alveoli"
    "larger mammospheres" "mammaries" "H/+" "mammosphere" "`also" "wk" "mutp"
    "p53 homozygous genotypes" "Homozygous p53H/H" "p53-/+" "p53H/+" "p53H/H"
    "H/H" "p53 -/-" "p53-/-" "heterozygous p53H/+" "homozygous p53H/H" "p53H"
    "Tg" "hotspot" "progenies" "wtp53" "mutp53" "uman" "3+" "=0.011" "= 0.01"
    "cylinD2" "HGGS" "cyclinDs" "the target-predicting database Targetscan"
    "Targetscan" "HGGs" "P=0.012" "episomes" "Basile" "Cip1/Waf1" "∼10-fold"
    "∼2-fold" "∼0.5-fold" "pCMV" "GraphPad" "/G 1" "Beckman" "cytometer"
    "Abcam" "cells/well" "μl" "mg/ml" "methylumbelliferone" "fluorophore"
    "fluoresce" "-galactopyranoside" "galactopyranoside" "pH " "Amersham"
    "RIPA" "ep realplex 4 thermal cycler" "Sensimix" "Eppendorf" "cycler"
    "realplex" "ep" "SpectraMax" "Renilla" "Himedia" "PeproTech"
    "ImmunoResearch" "Jackson" "pCMV–E2" "–NF-κB–Luc" "Promega" "ICGEB"
    "Dulbecco's" "Dulbecco" "episome" "re-infection" "cyc" "non-histone" "∼0.5"
    "45 min" "Re-expression" "the intestinal epithelium" "Wnt/β-catenin"
    "p38MAPK" "Crohn's" "intestinal epithelium" "UC" "2b" "n = 6" "= 9" "= 12"
    "Leonova" "newly-evolved TE-associated p53REs" "transposons" "co-opted"
    "non-repeat" "these TE-associated p53REs" "Cui" "many strong p53REs"
    "co-locate" "Gomes" "Espinosa" "2664/2932" "four L2-associated p53REs"
    "all TE-associated p53REs" "TE-associated p53REs" "MLT1H" "LTR10B" "Masker"
    "relatively weak p53REs" "more highly conserved p53REs" "20nts" "nts"
    "DXR-treated LCLs" "weakest" "decile" "larger spacers" "the weak p53REs"
    "spacers" "decamer" "DAVID" "18hrs" "ChromHMM15" "∼15%" "deciles"
    "distal enhancer" "ChromHMM7" "FAIRE" "DNaseI" "Seq" "LCLs" "LCL" "seq"
    "context/state" "ChromHMM" "Hidden" "p53 RE" "Nili" "SINE" "LTRs"
    "RRRCWWGYYY" "decamers" "transposon" "displaying highly negative PhyloP"
    "PhyloP" "nonTE-associated p53REs" "nonTE" "p53REs" "DHS" "p53RE"
    "lymphoblastoid" "hg19" "2 +" "= 3" "=  0.06" "∼95%" "Michigan" "TASSER"
    "spectrometric/proteomic" "multinucleate" "viral antigens" "oncovin"
    "Pharmingen" "CβS" "anti-Acetyl-Lysine" "MJG11" "Millipore"
    "nucleus/nucleolus" "ΔE1A" "thewrn" "methylene" "K323R/K417R" "Lys→Arg"
    "re-immunoprecipitated" "ed" "Zeiss" "Q377E/G380E" "-GFP-dependent" "nsRNA"
    "mutantcyclin" "bHLHZip" "rex" "NLS2" "NLS3" "NoLS1" "NoLS2"
    "two putative nucleolar localization/retention" "Tof" "LTR"
    "at least seven regulatory/nonstructural" "regulatory/nonstructural" "Rex"
    "Kaposi" "leukemia/lymphoma (ATLL)" "oncoretrovirus" "type-1" "DNA/Protein"
    "RPMI 1640" "Non-specific" "/human" "utero" "pT308" "invasive stellates"
    "stellates" "incompletely developed lumens" "lumens" "ovBTG3"
    "nonmalignant" "mHW" "BTG" "interdomain" "Wu" "Wnt/" "gene/transducer"
    "H -scores" "β 1" "pcDNA3" "μ g/ml" "P =0.02" "P =0.03" "MGB" "VIC"
    "Hercules" "Cruz" "Rockford" "anti-FLAG" "Louis" "supernatant" "Lysis"
    "Nexalign" "edgeR" "a global pre-library overview" "BEDtools" "GENCODE"
    "pHMM" "Markov" "hidden" "TagDust" "Biotin" "WI" "Ipswich" "μL" "Diego"
    "barcode" "Mannheim" "Roche" "LightCycler" "Austin" "mirVana" "sh-TERT#1"
    "sh-TERT#2" "sh-BRG1#1" "sh-BRG1#2" "Germany" "Hilden" "miScript" "Taq"
    "Premix" "SYBR" "TAKARA" "VILO" "SuperScript" "Ex" "Otsu" "TaKaRa"
    "FastPure" "Lipofectamine" "MEM" "Opti" "Osaka" "Wako" "RPMI1640"
    "miR-208a" "miR-29a" "pri-" "pri" "anoxia" "Drevytska"
    "transposable element LINE1" "LINE1" "protooncogene" "myristate" "Marson"
    "TATA" "co-transcriptionally" "approximately eight-times" "Hochberg"
    "Benjamini" "RMRP" "16 h" "E-boxes" "14‑3‑3" "TESK" "PLCβ"
    "Chemoattractant" "β3" "‑γ2" "‑e" "‑β3" "phosphatidylinositide" "‑δ"
    "anti–phospho-PKC" "GPCR/Gαi" "U73122" "Gβγ" "C1b" "C1b-GFP" "PKD1-C1b"
    "Gα" "cyan" "Chemoattractants" "CID755673" "inpkd1" "SDF1α" "shRNAi" "Gö"
    "Gαi" "PLCβ2/3" "phosphorylation/dephosphorylation"
    "dephosphorylation/activation" "SSHs" "‑3" "TESKs" "meshwork"
    "chemoattractants" "chemoattractant" "Gai" "phosphorylation/activation"
    "re-entry" "nucleate" "bi" "Atg12-Atg5-Atg16" "phagophores" "phagophore"
    "re-growth" "analoges" "621-101" "ELT" "HBSS" "≥ 1.5" "90 min" "×
10"
    "1-3 " "2  +" "1  +" "SNON" "SKI" "chromatid" "inase" "2OH-BNPP" "SBE4"
    "spindle-like" "TGFΒRI" "kbp" "2OH-BNPP1" "TGFBR" "kinome" "TGFBRII" "1X"
    "CO-IP" "= 1" "3 +" "72h" "8/9" "= 0.046" "Non-canonical" "SMAD2/3"
    "induced biological endpoints" "endpoints" "isoenzymes" "hematuria" "HPECs"
    "HPEC" "Klinefelter" "VEGF/kinase" "robust re-vascularization"
    "injury/damage" "HAEC" "dihidrotestosterone (DHT)" "dihidrotestosterone"
    "bilateral ovariectomy" "ovariectomy" "sexuals" "the proband's" "ungula"
    "3576_3577insA" "tuberinis" "carboxyl" "CaMD" "leiden" "_3577insA"
    "focal and generalized epileptiform" "epileptiform" "topiramate"
    "oxcarbazepine" "EEG" "shagreen" "macules" "Sichuan" "RAGB" "nmol/mg/min"
    "nmol/mg" "MeAIB" "proteoliposomes" "VA0D1" "RAGC" "SLC36" "RAGA"
    "Ragulator/RAG" "helices" "SLC38" "anti-His" "DE3" "Non-targeting" "-101"
    "LC–MS/MS" "oligodendroblasts" "medulla" "tubules" "corroborations"
    "tubule" "contextwe" "enroute" "proxidant" "TIN" "TD" "FA+PDTC" "mg/dl"
    "Folic" "PTDC" "24 hr" "vacuole" "Cisternae" "cisternae" "infoldings"
    "further and peaked 12 hrs" "BUN" "hetero" "reno" "viz" "tubulo" "ICU"
    "CRRT" "CKD" "ammonium (PDTC)" "ammonium" "folic" "AKI"
    "kappa-light-chain-enhancer" "= 2" "& E" "W2A/W4A" "Rockout" "nN/molecule"
    "MLCII" "Förster" "COPASI" "andare" "aare" "andk" "j" "equationsin"
    "PA-Rac1DN" "458-nm" "the photoswitchable fluorescent protein Dendra2"
    "Dendra2" "anti–mouse" "72 h" "2 B" "acetylcholine" "physical stressors"
    "Phillips" "weightlifters" "FMD" "IARC" "noncarriers" "tibialis" "PCr"
    "Fraumeni" "mL/min" "G-allele" "A-allele" "The most significant SNP" "HR50"
    "heterozygotes" "2q33.3-q34" "member 5B" "QTL" "10p11" "and 2q33.3–q34"
    "QTLs" "MZ" "2Max" "HERITAGE" "integrated personal omics" "nonrandom"
    "Athletic personal omics" "Biobank" "Kadoorie" "covariate" "multiscale"
    "omic" "Integrated personal omics" "related personal omics" "omics" "GWASs"
    "=1" "CldU" "immunodeplete" "NPE" "LTQSPLL" "eslin" "lambda" "and 3X-FLAG"
    "MCMs" "TRCT" "miRNA27a" "RVH" "normoxic HPASMC" "Pcat" "phenethyl"
    "HPASMCs" "PASMC" "PPRE" "HPASMC" "phospho-ERK 1/2" "72 hrs" "sitealter"
    "Alk4/7" "ALK 4/7" "paracrine" "re-expressed" "ALK4/7" "activin-like"
    "stellate" "pancreatitis" "Heeschen" "mesoderm" "hESCs" "hESC" "= 0.0004"
    "Smad2/3" "LIU" "WU" "fei" "Qi" "Yue" "PANG" "ZHANG" "qiang" "QU" "Kai"
    "MENG" "chao" "Ji" "multicenter" "siomycin" "approximately 6 μmol/L" "FHRE"
    "tyrosine kinase-3" "systemic pharmacotherapy" "OLT" "nearly 6 μmol/L"
    "G 1 /S" "RhesmHTT" "rebalance" "neurite" "R6/2" "S33N" "RhesS33N"
    "rotarod" "6-week-old" "co-injection" "AAV"
    "Impaired striatal dopamine circuitry" "Ikbkap" "Ikbkb"
    "hemispheres showed enriched electron-dense cytoplasmic organelles"
    "endoplasm" "14α-demethylase" "lanosterol" "coactivator 1α" "N171-82Q"
    "caRheb" "ctive" "AAVs" "adeno" "striata" "caudate" "R6/1" "dyskinesia"
    "axon" "mHTT" "HTTs" "Huntington's" "Huntington" "·3" "·7" "Aug"
    "pathological lymphadenopathy" "=2" "·5" "bulky lymphadenopathy"
    "Richter's" "Richter" "·4" "·0" "·9-27" "IGHV" "Bruton's" "Bruton"
    "Chemoimmunotherapy" "Nordisk" "Novo" "Danish" "neutropenia" "IQR"
    "17p13.1" "Jan" "ClinicalTrials" "endpoint" "Bethesda" "chemoimmunotherapy"
    "anti-senescence" "TAp73β" "monophosphate" "TAp73 KO" "allantoin" "TAp73KO"
    "16h" "TAp73β isoform" "TAp73βisoform" "ribose" "Du" "cence" "senes"
    "TAp73" "216a/217" "Perhaps" "Cleveland" "probands" "V191S_fs*11"
    "Patient III-2’s" "Patient II-2’s" "thyroid cancer and Patient III-2’s"
    "II-2" "_fs" "The proband’s" "lifelong non-smokers"
    "likewise underwent esophagectomy" "underwent subtotal colectomy"
    "colectomy" "AVM" "III-2" "the proband’s"
    "underwent palliative chemoradiotherapy" "chemoradiotherapy"
    "progressive dysphagia" "colonoscopy" "underwent total thyroidectomy"
    "thyroidectomy" "underwent esophagectomy" "dysphagia" "proband"
    "extensive polyposis/ganglioneuromatosis" "situ" "*11" "_569insC" "Exome"
    "++" "TMN" "P=0.002" "=0.032" "P=0.03" "P=0.007" "Multivariate" "=0.003"
    "=0.009" "=0.02" "=0.017" "Forty-one" "=0.03" "a predominant Th17-"
    "stander" "indicats" "CLT" "denileukindiftitox" "re-occurrence" "el"
    "Currie" "Yamamura" "Thl7" "the external antigens" "CD4 + T" "CD4+T"
    "predominant Th17-" "1x" "X-axis" "Y-axis" "Ct" "tyope" "Th17/Treg"
    "dendritic cell (DC)-based immunotherapy" "Th17-" "Th1/Th2" "Th17"
    "specifc" "VS" "C-group" "FOXP" "anti-tumors" "co-occurred" "homeodomain"
    "± 50" "GO/G1 phase" "Hoefer" "siNON-" "siPIAS1" "S100P" "≥93%"
    "Co-immunoprecipitation" "SUMO2/3" "cistrome"
    "two other active enhancer/promoter" "cistromes" "co-occupancy" "CSRP2"
    "superpathway" "∼10%" "siNON" "x" "hexamer" "TGTTCT" "AGAACAnnnTGTTCT"
    "LBD" "Transcriptome" "∼30%" "∼50%" "S2B" "S1C" "degrons" "phosphodegrons"
    "cyclohexamide" "lentiviral shStat5a/b" "timeframe" "shAR" "shStat5a/b"
    "Δ1-565" "-N-ter" "N-ter" "C-ter" "NTCCD" "antigen (PSA)" "IST5-002"
    "phosphorylation-competent Stat5a/b" "AdDNStat5" "AdStat5aY694F" "CRPCs"
    "5a/b" "intracrine" "active Stat5a/b" "Antigen" "Active Stat5a/b"
    "Stat5a/b" "60 min" "this special subset" "the more advanced histology"
    "Konda" "endoscopists" "sessile" "microsatellite" "Mukawa" "Hiraoka"
    "Sugimoto" "polypid" "5/36" "5/34" "13/36" "dysplasia" "IIc " "IIc" "IIa "
    "non-polypoid" "subcategories" "fecal" "Polypoid" "endoscopy" "IIa"
    "nonpolypoid" "LSTs" "LST-NG" "LST" "polypoid" "non-invasive" "sublines"
    "insightful" "Δ PH" "Okuzumi" "UCSF" "PMID" "Kevan Shokat’s" "UCSFwhich"
    "Shokat" "Kevan" "membraneOur" "Stephens" "GGGAAGGTGATTCTGGTGA"
    "CCTGAGGTGCTGGAGGACA" "GGCAAGGTGATCCTGGTGA" "CCCGAGGTGCTGGAGGACA" "AKT1/2"
    "allels" "mAKT" "William" "Clontech" "pLPCX" "#15990" "pLNCX1" "pLNCX"
    "Clara" "QuikChange" "pLNCX1-HA-mAKT1" "Addgene" "Birnbaum" "Morris"
    "_358718" "V3THS" "Lafayette" "Thermo" "TRIPZ" "DMEM" "Allendale" "Lonza"
    "McCoy’s" "McCoy" "ScienCell" "ATCC" "Hopkins" "Johns" "Vogelstein" "Bert"
    "Candiolo" "Instituto" "Giordano" "Silvia" "JCRB" "Bioresources"
    "anti-mouse" "Antifade" "Alexa" "Princeton" "Covance" "Aldrich" "pPRAS40"
    "pAKT1" "pAKT2" "pGSK3β" "pFoxo3a" "Danvers" "pBAD" "Houston" "Selleck"
    "G161V-AKT2" "TPA" "DKO" "HCT" "MET -amplified H1993" "DOI" "Vivanco"
    "eLife" "re-introducing" "non-catalytic" "non-transformed" "non-small-cell"
    "endocytocis" "BlaM" "lamellae" "MUTZ" "cholesterol-rich invaginations"
    "CLR" "C-type" "Birbeck" "Langerhans" "co-localizes" "Toll-like"
    "non-stem cells" "anti-CSC" "Int" "HER2 +" "nonmutant" "RV/left" "TUNEL-"
    "·d −1" "RVSP" "TTAGGG" "5HTT" "TA65" "SM22-" "SM" "μmoL/L" "Solanas"
    "Barrett" "bio" "Thiel" "nephropathy" "allograft" "Chappell" "oncology"
    "solute" "Lai" "EMT-like" "the visceral and parietal peritoneum" "Nishino"
    "Hough" "polylinker" "Guglielmo" "Grotegut" "Engelman" "Boutet" "Whiteman"
    "Haraguchi" "Miotti" "Salem" "Ariotti" "microclusters" "Burgermeister"
    "Schwartz" "Norambuena" "Collins" "Couet" "microvasculature" "Grande"
    "Rosengren" "Schubert" "monolayers" "or/and" "semi" "Gvaramia" "Jang"
    "the peritoneal HPMC monolayer" "the parietal peritoneum" "trichrome"
    "aptene" "fibroblastoid" "Kokudo" "Medici" "Egorova" "Zeisberg" "EndMT"
    "Igarashi" "Mukhina" "SMAD2-3" "Snail-1" "Cano" "Leopold" "Sebolt" "Murata"
    "spindlelike" "monolayer" "The parietal peritoneum"
    "confocal immunocytochemistry" "HPMC" "HPMCs" "Razani" "Pozo" "Parton"
    "Nichols" "Hansen" "Sessa" "Chidlow" "invaginations" "Strippoli" "Yanez"
    "Margetts" "vasculopathy" "hemoperitoneum" "Aroeira" "Grassmann"
    "Bottinger" "Zavadil" "Smads" "Peinado" "Loureiro" "Thiery" "Kalluri"
    "stepwise" "et " "re-acquisition" "peritoneum" "Non-invasive" "= 8"
    "phospho-ERK1/2" "anti-fibrotic" "anti-inflammatory" "epithelial-like"
    "goes" "soluble asyn" "organelles" "medaka" "2+" "Cd" "Ni" "niquel-"
    "niquel" "Parkinsonism" "Mn" "arisen" "parkinsonism"
    "the endoplasmatic reticulum" "reticulum" "Ceroid" "Neuroid" "Rakeb"
    "Kufor" "Asyn" "Braak's" "brainstem" "Braak" "Lewy" "compacta"
    "Alzheimer's" "bradykinesia" "asyn" "_477180" "_243780.2" "pET32a-GP63"
    "Coomassie" "GU356538.1" "GenBank" "_392410" "_075740" "TVAG" "p70S6K1/2"
    "vaginalis" "Trichomonas" "90 min" "closely mirrors synergism" "DG"
    "superoxides" "C-subunit" "hematocrit" "mortem" "postmortem" "withARF"
    "methoxy" "methoxyestradiol" "ΔΨ" "readout" "thiamine" "mesylate" "ITD"
    "Oligomycin" "oligomycin" "NOD/SCID" "CD34 +" "non-silencing" "mg/kg"
    "anti-proliferative" "EP/EN" "co-efficient" "H3K14Ac" "Normal-like"
    "normal-like" "SV40 viral antigens" "TNBCs" "region-1" "assembly-1"
    "Transducer" "Zhou" "ΔDB" "FoxO3a-3A" "nonhistone" "tubastatin"
    "crebinostat" "Ac" "Casein Kinase 1α" "prognosticators" "wilde" "MetaCore"
    "a typical LC-MS/MS workflow" "workflow" "iv" "anti-leukemic" "MAVER"
    "mutated/null" "IC 50" "non-small" "oncomiR-" "Drug-modulating oncomiRs"
    "5-fluorouracil-" "mg/L" "HIAC" "scr" "Lenti" "=0.511" "=0.033" "=0.055"
    "HAIC" "oncomiRs" "non-tumor" "miR-21 functions" "miR-130a/miRISC"
    "miR-200b" "miR-130a-3p" "miR-34c" "miRISC" "miR-130a" "Anti-Flag" "co-IP"
    "Kcal/mol" "let-7a" "miR-15a" "cytoplasma" "shTip60-887" "shp38α-758"
    "shp38α-756" "BJ" "p38β" "p38αD179A" "MKK6E" "MKK3E" "Dox-" "p38α shRNAs"
    "p38α shRNA" "expressers" "45 min" "Pak" "durotaxis"
    "global MII assembly/dissasembly" "assembly/dissasembly" "PKCβII"
    "soft and stiff ECMs" "~doubled" "8.6 kPa" "WTGFP" "half-time"
    "WT-GFP-MIIA-HC" "morphometry" "dual diffraction-limited punctae"
    "non-phosphorylatable" "CGP53353" "compliant ECMs" "imtermediate" "55kPa"
    "0.7kPa" "IIA" "90min" "threefold and plateaued 45min" "RacV12" "pS1916"
    "ECMs" "fiIaments" "dual punctae" "the dual punctae" "punctae" "Immuno"
    "mApple" "TIRF" "discoid" "lamella" "MIIs" "MIIB" "MIIA" "re-expressing"
    "co-localize" "~80%" "zipper-like" "a less tight dimerization Kd" "nearest"
    "Δ559,560" "DupA502" "SI" "Kd" "refractometer" "MALS" "multiangle" "D5:D5"
    "2E9W" "2EC8" "Waals" "DEFG" "Δ418,419" "×80" "D4D5" "ΔD418,419" "Ig-like"
    "Sl" "`zipper-like" "cooperativety" "an important `driver" "pCDNA3" "1–3"
    "li" "delocalizes" "PFT-α" "alarmin" "stratified squamous epithelia" "UVB"
    "μmol/L" "ALRs" "PYD" "PYHIN" "mean±SD" "Conformational entropy" "Entropy"
    "conformational entropy" "preorganizes" "RosettaLigand" "farther" "β2-β3"
    "β4" "PPI" "β6" "α4" "β1" "RMSD" "N-terminus/catalytic" "the peripheral β1"
    "algorithm" "RMSF" "thevalues" "highervalues" "sidechains" "sidechain"
    "parametersof" "RMSFs" "Cα" "opening/closure" "β1-β2" "FFpSPR-" "kcal/mol"
    "SPARTA+" "RMSDs" "PDB 1F8A" "and 3TDB" "imide" "isosteres" "FFpSPR" "Peng"
    "Path2" "Path1" "β6-β7" "β5-α4" "β4-α1" "pSer/Thr-Pro" "Alzheimer"
    "phosphoSer/Thr-Pro" "allostery" "entropy" "preexists" "Allostery" "β7"
    "HACE" "immunohistochemistry (IHC)" "4x595R" "KKKTI" "MGEMQLSSVTDS" "4E–4G"
    "Boyden" "and 3G" "oligo" "Duolink" "G–1I" "Vaughan" "S4F" "S4E"
    "phsophoinositide" "Hrs" "phosphoinositides" "PITP" "Non-cancerous"
    "diphosphate" "either treated or untreated wildtype" "Un" "lslR273H/+"
    "littermate" "cabon" "-wildtype" "+/R172H" "Δ/" "loxP" "wildtype"
    "headgroup" "KO22" "de-lipidated" "18:0/20:4" "24-hour"
    "phosphatidylinositides" "triphosphate" "bisphosphate-" "bisphosphate"
    "m/z" "MRM" "glycerophospholipids" "Non-malignant" "0/18" "treastuzumab"
    "Angulo" "Gonzalez" "NeoALTTO" "German" "PIK3C" "Spearman" "predictive pCR"
    "Univariate" "RNaseP" "taxan" "traditional Sanger" "= 0.19" "HRs" "exome"
    "littermates" "heterozygote" "HaploReg" "rs4645948" "an intergenic SNP"
    "YRI" "rs2070583" "had at least one other SNP"
    "The previously described SNP rs12740374" "rs12740374" "only 3 SNPs" "Mbp"
    "rs3902354" "rs4970836" "rs4970837" "rs583104" "rs599839" "lambdas"
    "iSelect" "Illumina" "NHGRI" "Lettre" "GWA" "Asians" "HealthABC" "WHI"
    "ARIC" "MetaboChip" "Americans" "= 0.02" "= 0.25" "= 0.27" "five-year"
    "≥50%" "n = 6" "= 8" "biosensors" "DSB" "AP-2a" "Leask" "Rs189037"
    "1.04–2.55" "1.18–2.52" "1.14–2.68" "confounder" "Hsia" "participations"
    "INOA" "Xiong" "wild genotype GG" "Xu" "malignances"
    "the homozygous variant genotype (AA)" "1.18–2.08" "rs140693" "rs1799793"
    "rs11020802" "95%CI" "95% CI" "homozygous variant genotype (AA)"
    "genotype (AA)" "GWAS" "non-smokers" "SPSS" "TaqMan" "rs189037"
    "oxidative stress gene SNPs" "GenomeEUtwin" "lifespans" "19p13.3" "–CEU"
    "Sorensen" "Soerensen" "the other associated SNPs"
    "heterozygous (CT) genotypes" "homozygotes (TT)" "rs4758633" "rs4712047"
    "rs3803304" "rs511744" "rs4946935" "the homozygous minor allele genotype"
    "rs2841505" "rs2536512" "a shorter lifespan"
    "Homozygous minor allele genotypes" "rs107251" "Homozygotes" "Iowa"
    "65+RHS" "Lifespan" "dyf" "Sirtuins" "sirtuins" "multi"
    "polymorphisms (SNP)" "Sirtuin" "= 0.01" "= 0.012" "transducers" "int"
    "coprecipitates" "coil/linker region" "coprecipitate" "cl" "cardless"
    "two-hybrid screenings" "screenings" "pleckstrin" "CARMA2" "CBM" "CARMA"
    "1-3" "CHIR99061" "sVCAM-1" "sICAM-1" "VCAM" "undertaken" "p-GSKα" "GSKα"
    "the antenatal OGTT" "OGTT" "fetal birthweight" "maternal BMI"
    "maternal pre-pregnancy BMI" "birthweight" "GSK3α/β" "endotoxemia"
    "pregravid" "the Gram-negative intestinal microbiota"
    "the TLR4 ligand bacterial lipopolysaccharide (LPS)" "microbiota"
    "pregnant women synthesise" "synthesise" "macrosomia" "diet-controlled GDM"
    "Caesarean" "bacterial endotoxin lipopolysaccharide (LPS)"
    "lipopolysaccharide (LPS)" "lipopolysaccharide"
    "gestational diabetes mellitus (GDM)" "mellitus (GDM)" "GDM" "mellitus"
    "co-treatment" "HFD" "Hu" "stressful" "co-substrate" "begun" "db/db"
    "-siRNA-treated" "GFPu-1" "degron" "-siRNA-" "ULK" "blocker" "DETA"
    "cellular apoptosis/proliferation"
    "the most evolutionarily conserved sirtuin" "sirtuin" "homogenates" "unc"
    "CHX" "lifespan" "Champaign" "Mathematica" "JUNB" "chemoresistance"
    "trisomy" "cryo" "arabinofuranosyl" "Texas" "Todaro" "Sporn" "= 0.003"
    "1PZN" "archaeal Rad51 orthologs" "furiosus" "Pyrococcus" "orthologs"
    "PGAGGY" "non-conservatively" "protomers" "Greater" "crossovers"
    "recombination/repair" "micrographs" "Menten" "Michealis" "protomer"
    "denaturant" "PIDRGG" "aac" "gac" "gat" "ggt" "homologous ssDNA/dsDNA"
    "dsDNA" "ssDNA-" "brca1/2" "naturally occurring RAD51 polymorphisms"
    "Schellman" "Successful recombination/repair" "+1" "NNSC" "WNT/β-catenin"
    "NNSCs" "-S33Y" "S33Y" "Anaplastic histology" "SHH/" "non-competitive"
    "WNT/" "10p" "2Gy" "S2A" "Five-year" "Group 4" "Group 3" "clinicians"
    "important CPT inactivators" "inactivators" "μg" "vitro" "Δ1" "Δ2" "Δ3"
    "TOPO2" "TOPO1" "WST" "Eukaryotic DNA topoisomerases" "topoisomerases"
    "anti-Flag" "circuitry" "pleiotropy" "discrepant" "upto" "active pSTAT3"
    "reconfirm" "miR-21functions" "oncomiR" "pSTAT3/STAT3" "pSTAT3" "Let-7a"
    "× 10" "monotherapies" "monotherapy" "co-inhibition" "WEHI-539" "WEHI"
    "HMLE" "BAD2SA" "Sensitizer" "harakiri" "sensitizer" "re-sensitized"
    "INCBR" "CYTR" "VX" "phosphoinostitide" "κB" "INCB" "iii" "CYT387"
    "co-occur" "GI50" "non-receptor" "JAK2 V617F" "JQ1" "BRD" "transcriptome"
    "in 3D" "LeR" "BOLERO-2" "ZR75" "mTOR" "p4EBP1" "Serine 240/244" "GI"
    "CAMA" "neuroendocrine" "Arteaga" "histotype" "#2" "ER+" "kilobases" "nt"
    "an independent multidimensional dataset" "Kang" "= 18.1" "=2.67E-04"
    "=2.87E-06" "pairwise" "=0.01" "non-CR" "=54" "=109" "hsa-miR-148a"
    "hsa-miR-146a" "multidimensional datasets" "non-carriers" "=8" "=3"
    "BRCA1 /2" "an aggressive molecular subtype" "superSeries" "Kaplan"
    "univariate" "tertiles" "ERE" "stem/progenitor" "SMARC" "untangle" "dGFP"
    "agar" "miR-99b" "miR-99a" "mammospheres" "mammosphere-like" "antagomir"
    "b" "stemness" "BrCSC" "Polo-like kinase1" "BrCSCs"
    "an aggressive tumor subtype" "non-coding" "Basal-like" "co-activator"
    "polymorphism (SNP)" "an important translocation breakpoint" "LTAD"
    "Gleason" "siEZH" "siRUNX1" "siControl" "representative ARBSs" "1.0E −5"
    "ARBS#1" "an active enhancer" "ARBS" "ARBSs" "RUNX" "regrowth" "CRPC"
    "/ CEN8" "Schildhause" "BGJ398" "shorter DFS" "Heist" "Kim"
    "Western Europe" "Europe" "FFPE" "=0.050" "a shorter DFS" "=0.022" "low/no"
    "a significantly shorter DFS" "pTNM" "DFS" "/CEN8" "pack-years" "SqCCs"
    "underwent curative esophagectomy" "esophagectomy" "Korean" "EGJ"
    "histology" "=0.021" "5-year" "=0.029" "=0.019" "≥ 50%" "brighter"
    "rapalogs" "SBRT" "transcatheter" "capillary-like" "AXand" "SMMC" "and50.6"
    "Meier" "mean ± SD" "Non-transfected" "non-transfected" "= 0.002" "= 0.001"
    "TITAN" "SATURN" "Korea" "Rabdocoetsin" "-1~" "afatininb" "Taiwan" "EU"
    "auto-" "protein phosphatase 2A" "incompleteness" "μg/mL"
    "non-small cell lung carcinoma" "anti-tumor" "autoregulates"
    "early growth response-1" "CCN5" "external stressors" "stressors"
    "erythema" "Pre" "DNA/protein" "procollagen" "co-transfected"
    "Non-irradiated" "Wickline" "Lyashenko" "PEST" "frameshift" "amplicon"
    "aneuploidy" "motile" "juxamembrane" "SILAC" "overview" "Tds" "hrs" "SFF"
    "SuperFop" "SuperTop" "qRT"
    "translational initiation alternative ATG codons"
    "#31 contained both a 7 bp" "#4 incorporated both a 4 bp" "Hpy188I"
    "spacer" "RFLP" "gDNA" "#111" "#93" "#79" "#31" "#4" "individual ZFN"
    "highly complex karyotypes" "karyotypes" "TALENs" "un" "PANC" "ZFNs"
    "re-localization" "BxPC3ΔCTNNB1" "ΔCTNNB1" "ZFN" "-31" "#1" "mCRCs"
    "codons" "Sanger" "hepatectomy" "Vauthey" "1.12–1.75" "LMFS" "=0.002"
    "=1.40" "=0.007" "1.08–3.42" "=0.018" "a shorter TTLM" "TTLM" "=0.004"
    "=0.012" "=0.001" "the surprisingly abundant subset" "subproteome"
    "ectodomains" "Weiß" "secretome" "Diehl" "UICC" "Wilmanns" "Velikova"
    "Juhasz" "Laurén" "nr" "Chan" "Gofuku" "HER2+" "Quantikine" "synergism"
    "TNBC" "Brouxhon" "pCR" "proteomes" "Dollé" "pre-" "immunoassay"
    "neoadjuvant" "Hofmann" "quantitative and multiplexed immunoassays"
    "immunoassays" "Perez" "WB" "absorbance" "IEMA" "microtiter" "Katayama"
    "ectodomain" "disintegrins" "secretases" "Hollestelle"
    "content/localization" "multiprotein" "morphogenesis/remodelling"
    "epithelia" "Nika" "Ferrell" "continuum" "quasi" "modules/nodes" "Amit"
    "conditional KO" "Wingren" "Gjorloff" "BioGPS" "Such a unique topology"
    "topology" "Permi" "Saksela" "Evren" "ITIMs" "Combadiere" "Lenardo"
    "Roncagalli" "Shen" "Mingueneau" "Salek" "Yasuda" "Shui" "Bartolo" "-Q4R7"
    "Q4R7" "OVA257-264" "Vα2" "Tyr536/564" "motheaten" "CD178" "Krammer"
    "LCK-pY394" "1G4" "Binstadt" "Nguyen" "Qu" "Bisson" "AP" "in 1G4-CD8"
    "Zhang" "Lu" "Minoo" "Bennett" "PxRPxK" "dPRR1" "wt" "shTHEMIS" "Davis"
    "1G4-CD8" "non-stimulated" "co-purified" "One-STrEP-Tag" "Streptactin"
    "Strep" "Stefanova" "Sankarshanan" "Lorenz" "Fawcett" "peripheral T  conv"
    "reg" "conv" "Patrick" "Lesourne" "Kakugawa" "Johnson" "Fu" "Paster"
    "Brockmeyer" "Acuto" "Germain" "Altan" "Naeher" "Daniels" "Gascoigne"
    "Alon" "∼40%" "non-canonical" "co-workers" "pharmacotherapy" "dormancy"
    "MErT" "intravasate" "pentaene" "NCI-60" "NCI" "co-therapy"
    "mesenchymal-like" "farnesyl" "geranyl" "mevalonate" "biomass" "ErbB"
    "fluvastatin" "safest" "cargos" "A278P" "methyladenine" "non-functional"
    "48 hr" "BALB/c" "re-verified" "Hancock" "Kanto" "smaller VFA" "-26934C/T"
    "WC" "26934C/T" "RPTOR-" "RPTOR" "CC " "Rptor" "cline" "BAT"
    "Non-shivering" "VFA" "BMI" "in/near" "= 0.021" "–c" "c" "non-irradiated"
    "chemo-" "chemo" "immunocytochemistry" "×3" "Transwells" "stem-like" "× 10"
    "g/mL" "ER +" "diagnostic biopsy" "CD532"
    "GTML/ Trp53  KI/KI -derived medulloblastoma neurospheres" "gatekeeper"
    "neurospheres" "GTML/" "penetrance" "Luc" "GTML" "multivariate"
    "co-occurrence" "iFISH" "Group4" "p " "Ramaswamy" "CNS" "CCLG" "biopsy"
    "postrelapse" "serial medulloblastoma biopsies" "biopsies" "2–3 " "S4B"
    "Group3" "circuitries" "co-overexpressed" "3simLA" "STUbL" "ssDNA"
    "indictors" "3sim2ubz" "3sim" "2ubz" "4xSUMO-2" "SIM3" "TBM" "brac"
    "tramtrack" "HA" "non-covalently" "isopeptide" "Flag-4xSUMO-2" "pulldowns"
    "GST-4xSUMO-2" "K33A" "ortholog" "GA" "SIM" "MRN" "UBZs" "SUMO-2/3" "UBZ"
    "HJ" "Holliday" "nucleases" "SIMs" "crosslinks" "interstrand"
    "non-redundant" "non-homologous" "miRs" "Biosystems" "MIR" "RNAhybrid"
    "TargetScan" "MiRanda" "Y576/577" "MCF-7/HER2Δ16H/EGFRKD"
    "migration/invasion" "MCF-7/pcDNA" "MCF-7/HER2Δ16H/miR-7" "MCF-7/miR-7KD"
    "MCF-7/HER2Δ16H" "miR-342-3p" "p"
    "At least five different molecular breast cancer subtypes" "MCF-7/HER2Δ16"
    "HER2Δ16" "Δ16" "MQLMPFGCL" "LI" "Yamada" "02:01-restricted" "IMQLMPFGV"
    "algorithms" "immunotolerance" "only mutated antigens" "TAAs"
    "Mutated antigens" "antigens" "FACSAria" "T790M-B" "MQLMPFGCLL"
    "microbeads" "02:01-binding" "immunotherapy" "TAA" "Immunotherapy"
    "transducer" "ELISPOT" "ITQLMPFGC" "H1975" "NCSLC" "HLA-A2" "T790M-A"
    "IMQLMPFGC" "antigen (HLA)" "BIMAS" "co-cultured" "~50%" "broader"
    "alloantigen" "parent TcM" "allografts" "Tcsubsets" "NPV" "phiphilux+TcM"
    "vs" "memory subsets" "Stepwise" "memory Tc" "non-rejector" "T-helper"
    "The cell-permeable caspase-3 substrate phiphilux" "T-cytotoxic"
    "Allospecific CD154+TcM" "CD154+TcM" "Supernates" "Valencia" "Qiagen"
    "SABiosciences-" "SABiosciences" "ELISArrays" "Multianalyte" "supernates"
    "ELISA" "byrATG" "CD3+T-cells" "Carlsbad" "Invitrogen" "Gaithersburg"
    "Oncoimmune" "non-permeabilizing" "responder" "μg/ml" "Responder" "60-day"
    "cellcept" "FKWBC" "tacrolimus" "non-rejectors" "Pittsburgh's" "Pittsburgh"
    "lysis" "Cambridge" "Genzyme" "anti-thymocyte" "alloresponse"
    "allospecific CD154+TcM" "proportionately more allospecific CD154+TcM"
    "TcM" "CD154+" "phiphilux" "Tc" "co-cultures (MLC)" "PBL" "rATG" "globulin"
    "co-cultures" "multifold" "cellulo" "CCGGAWR" "enhancers" "11.78%±3.98%"
    "19.75%±5.74%" "METpm" "ETS/PAX" "CCGGAG" "CCGGAA" "CMGGAWR" "CGGAAGT"
    "C/A" "A/T" "pMET" "pETS1" "proven" "v" "simplex" "=6" "×10" "non-specific"
    "G/A" "histoscore" "SPO28" "SPO2" "intertumour" "intra-" "intra" "monosomy"
    "Whitney" "Hodgkin" "diploid" "radiation-treated HuMECs"
    "mock-treated HuMECs" "mock-treated control HuMECs" "HuMECs"
    "Three predominant c-MYC genotypes" "centromere" "8q24" "60 Gy" "8p" "der"
    "SNP6.0" "Cytoscan" "breakpoints" "breakpoint" "60Gy" "Jolla" "Affymetrix"
    "Gy" "non-malignant" "= 7" "≥ 3" "= 8" "frozen" "⩾90%" "non-obese"
    "re-plated" "spherosomes" "spherosome" "BD" "size/mothers"
    "receptors/adapters" "GAB" "perhaps" "quantitate" "non-targeting" "UTR"
    "UTRs" "isotype" "normal cervical epithelium" "epithelium" "London"
    "non-cancer" "Oncomine" "melanogaster" "interactome" "oligopyrimidine"
    "siRNA1" "anti-apoptotic" "× 10" "GCNs" "re-establishment" "Vav1CA"
    "early post-natal mouse cerebellum" "GZ" "retrovirus" "=7" "thePtch1"
    "FACS" "Vav1DN" "dataset" "azaCdR" "_e9" "cerebella"
    "early cerebellar GNPs" "ii" "GNPs" "GNP" "≥3" "reprogramme" "H3K27"
    "BRCA2/x" "=0.006" "BRCAx" "BRCA1/2" "Pearson's" "Australia" "Melbourne"
    "Cuningham" "Kathleen" "kConFab" "co-occupied" "reChIP" "co-precipitated"
    "SUM131MO2" "SUM1316MO2" "-aza-dC" "website" "browser" "KB1P-3.12"
    "KB1PR-3.12" "zeste" "5-aza-2" "-deoxycitydine" "deoxycitydine" "MMECs"
    "basal-like" "Li" "the viral genome" "E2F1/3" "Cdc25A/C" "Rb" "Alekseev"
    "viral genomes" "genomes" "MOI" "online suppl" "suppl" "corticosteroids"
    "trifluridine" "HK" "uvea" "conjunctiva" "alpha-subfamily" "progeny"
    "HSV-1" "in 3" "g/ml" "only maternal genotypes" "villus"
    "maternal genotypes"
    "individual maternal MMP-1 -1607 1G/2G and MMP-9 -1562 C/T genotypes"
    "severe preterm" "the potential risk genotype" "non-Hispanic" "codominant"
    "African" "decidua" "PPROM" "Preterm" "1G/2G" "preterm" "–31" "C/T" "hTNFα"
    "+Dox" "TUNEL" "MYPT" "rhotekin-bound RhoA" "myoII" "shSep15+Dox" "shGFP"
    "−Dox" "Sep15i" "Dox" "shSep15" "chosen" "guanylate"
    "the latter polymorphism" "homologs" "SECIS" "UGA" "selenocysteine"
    "selenoproteins" "Chang" "RhoA" "non-apoptotic" "Transwell" "pcDNA3.1-CFL1"
    "siRNA2" "duplexes" "Gy/min" "depolymerization/polymerization"
    "radioresistant" "pcDNA" "si" "U251" "radioresistance" "anti-cancer"
    "shCTRL" "shMyc" "stem cell-like" "neurosphere" "kd" "E-box" "CACGTG" "OHT"
    "hydroxy" "MycER" "oestrogen" "Pearson" "Bio" "TCGA" "cerebellum" "KG"
    "OXPHOS" "Warburg" "48 hrs" "subsets" "undergoes" "subclasses" "Ossovskaya"
    "DFI" "BCSS" "PARP1c " "PARP1nc " "Ku70/80" "ER+ " "poorer" "pleomorphism"
    "5/43" "2/43" "non-cleaved/active" "toxic DSBs" "DSBs" "PARP1nc" "PARP1c"
    "non-cleaved" "polymerase-1" "SDF-1α/CXCR4" "the basic pathophysiology"
    "pathophysiology" "transwell" "dithiocarbamate (PDTC)" "dithiocarbamate"
    "CXCR4/SDF-1α" "SDF-1α" "co-culture" "69-year-old" "fusiong" "newer"
    "Immunohistochemistry" "transcription factor-1" "VENTANA" "D5F3"
    "Oncology (ASCO)" "ASCO" "Oncology" "PFS" "CLTCALK"
    "Kirsten rat sarcoma 2 viral oncogene homolog (KRAS)" "homolog (KRAS)"
    "homolog" "Kirsten" "SqCC" "adenocarcimomas (ACA)" "adenocarcimomas"
    "deeper" "knockin" "∼20%" "destabilise" "onlineS" "A39P" "re-expression"
    "onlines" "titre" "onlineS2" "trisphosphate" "missense"
    "Bannayan-Riley-Ruvalcaba" "endometrium" "Cowden" "Germline" "2–3 " "SLNs"
    "XIV" "fibrillar collagens" "helix" "macroglobulin" "Micrometastases"
    "pTRE2-hPit-1-Luc-shMMP-13" "cells developed micrometastases"
    "micrometastases" "shMMP-1" "&E" "shMMP" "shControl" "S4A" "-shMMP-13"
    "MCF-7-hPit-1-luc-shControl" "MCF-7-hPit-1-luc" "MCF-7-hPit-1-luc-shMMP-13"
    "MCF-7-hPit-1-luc-shMMP-1" "+2" "pRc/RSV" "pGL3B-MMP-1-1633" "USA"
    "Philadelphia" "Pennsylvania" "myofibroblasts" "inactive zymogens"
    "zymogens" "the interstitial collagens" "collagens" "metallo" "doi:10.1186"
    "eQTLs" "the associated SNPs" "hotspots" "Browser" "UCSC" "seeQTL"
    "Pritchard" "eQTL" "Genome" "rs7849191" "two intronic SNPs" "SNPnexus"
    "a genome-wide significant SNP" "rs11999802" "American" "Pardanani"
    "datasets" "the original risk-haplotype-tagging SNPs" "…S13" "PLINK"
    "almost all the statistically significant haplotypes" "Tagger" "148.7-kb"
    "SSLD" "CEU" "Haploview" "a constituent SNP" "ORs" "rs12343867"
    "rs10974944" "rs12340895" "rs2149555" "rs2149556" "rs10119004" "rs12343065"
    "rs7857730" "rs7847294" "rs3780378" "rs10815162"
    "these 15 MPN-associated SNPs" "rs1536798" "rs10974947" "rs10815148"
    "rs3824432" "asym" "asym  " "minimise" "rs3808850" "intronic SNPs" "Asian"
    "HapMap" "Brazilians" "Japanese" "Caucasians" "Swedish"
    "essential thrombocythaemia (ET)" "vera (PV)" "y" "46/1"
    "V617F -negative MPNs and JAK2 SNPs" "rs12342421" "MPN-associated SNPs"
    "JAK2V617F" "Genomes" "germline" "Kong" "Hong" "essential thrombocythaemia"
    "thrombocythaemia" "vera" "Spanish" "Ayaz" "Anagnostou" "Pvull" "Boudjenah"
    "Pvul" "Anagnoston" "ovarian follicles" "multilocus" "Castro" "Ayvaz"
    "PvuI" "Altmae" "Sundarranjan" "consecutives" "2–3" "tubal" "Georgiou"
    "at least 150 IU" "ESHRE" "Embryology" "European" "IFV" "PvuII/XbaI"
    "responders" "the wild GG genotype" "1134.7UI " "1200UI " "CC" "Weinberg"
    "Genotype" "Polymorphism" "hyperresponse" "IU" "oocytes" "pg/mL"
    "rs1256049/A " "rs9340799" "rs2234693" "granulose" "theca" "subtypes"
    "the reproductive system present single-nucleotide polymorphisms" "AFC"
    "2-3" "follicles" "GG" "Elisa" "XbaI" "Taqman" "COH" "rs4986938/G1082A"
    "IVF" "AluI" "RsaI" "Xbal" "PvuII" "exogenous rFSH" "rFSH" "follicle"
    "OGG1/polymorphism" "ation" "homozygotes" "activity/expression" "adducts"
    "Elizur" "OGG1 and" "coworkers" "0.2–1.2" "estimations" "histopathology"
    "8-oxo-7,8-dihydroguanine" "oxoGua" "Cys326Cy" "AD" "oxodGuo"
    "oxodeoxyguanosine" "ethiology" "VGP" "Dong"
    "heterogeneous BRAF  V600E genotype" "epihelioid" "greatest" "ploidy"
    "pathobiology" "re-testing" "codon" "Twenty-one" "melanin"
    "histological subtype" "microsatellites" "LVI" "subtype" "Clark" "Breslow"
    "subclones" "VE1" "IHC" "Wilmott" "Yancovitz" "drawn" "epithelioid"
    "immunohistochemistry" "significantly more A-C haplotypes"
    "significantly more A-T haplotypes" "enhancer" "Broad/MGH" "genotypes"
    "Taiwanese" "ins/del" "some significantly associated haplotypes"
    "Bonferroni" "genotype" "haplotype" "rs3774968" "rs3774964" "rs4648055"
    "rs3774956" "rs230528" "rs1598856" "rs3774932" "Shaanxi"
    "biologically important SNPs" "truly causative SNPs" "insertion/deletion"
    "ATTG" "SNP" "a 15-kb" "exons" "introns" "polymorphism"
    "Significantly more A-C haplotypes" "Significantly more A-T haplotypes"
    "haplotypes" "intron" "rs4648068" "rs230521" "rs28362491" "SNPs"
    "factor-κB1" "polymorphisms" "immunopathology" "severe lymphadenopathy"
    "lymphadenopathy" "Crohn’s" "Crohn" "pLKO" "B*2705" "pre" "NecroX" "Sytox"
    "*5701" "Imagestream" "FM4-64" "effector/effector" "Lo" "undergone" "NV9"
    "*0201-restricted" "antigenemia" "HAART" "naïve" "FL8" "SL9" "KF11" "MFI"
    "Casp8/GAPDH" "InWeb" "GSEAs" "subset" "Cl13" "Armstrong" "non-peptide"
    "HLA-B*2705" "immunodominance" "*2705-restricted" "silico" "KK10"
    "immunodominant" "*2705" "domain-3" "immunoglobulin" "vivo" "ex" "viremia"
    "programmed cell death-1" "antigen" "co-localization" "proto"
    "contiguous quadruplexes" "-GGGGCTGGGCCGGGGACCCGGG"
    "GGGGCTGGGCCGGGGACCCGGG" "°C" "midpoint" "ionic" "Micheli"
    "three contiguous quadruplexes" "three contiguous parallel quadruplexes"
    "1XAV" "dichroism" "bp" "CD" "G-quadruplex" "antiparallel" "et" "Palumbo"
    "QFS" "G-quartets" "tetrad" "Hoogsteen" "Quadruplex" "quadruplexes" "UV"
    "quadruplex" "oxoglutarate" "48 hr" "48hr" "pH" "dithiolane"
    "decarboxylases" "IP-MS" "PaxDb" "proteome" "lipoate" "KO" "hr" "glutamax"
    "LC-MS/MS" "E1α" "SIRT" "decreasedK" "greater" "Lipoyl" "chromatograms"
    "H3K9" "S-acetyldihydrolipoyl-lysine" "co-localized" "immuno" "BCKDH"
    "carboxylases" "biotin" "SAINT" "MitoTracker" "organelle" "urea"
    "hydroxybutyrate" "hyper" "SIRTs3-5" "acyl" "demalonylates"
    "desuccinylates" "dihydrolipoyllysine" "lipoyl-" "lipoyl" "genome" "SIRTs"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-14101-14400*
  '(("MDMX and MDM2" . SPARSER::COLLECTION)
    ("p53-MDM2-MDMXFL/MDMX" . SPARSER::COLLECTION)
    ("MDMX-MDM2" . SPARSER::COLLECTION) ("p53-MDMX" . SPARSER::COLLECTION)
    ("hMDM2:hMDMX" . SPARSER::BIO-COMPLEX)
    ("hetero-oligomers" . SPARSER::PROTEIN-PAIR)
    ("Each of these gene products forms dimers or multimers"
     . SPARSER::COLLECTION)
    ("respective protein" . SPARSER::PROTEIN) ("hmdmx" . SPARSER::PROTEIN)
    ("hMDMX and hMDM2" . SPARSER::COLLECTION) ("hMDMX" . SPARSER::PROTEIN)
    ("p60 and hMDM2-hMDMX" . SPARSER::COLLECTION)
    ("hMDM2-hMDMX" . SPARSER::COLLECTION)
    ("hMDM2 and the hMDMX isoforms" . SPARSER::COLLECTION)
    ("p60 and hmdmx" . SPARSER::COLLECTION)
    ("GFP and hMDMX" . SPARSER::COLLECTION) ("P4 and P5" . SPARSER::COLLECTION)
    ("the bicistronic mRNA" . SPARSER::PROTEIN)
    ("p60 and hMDMX" . SPARSER::COLLECTION)
    ("alanines (CGC)" . SPARSER::AMINO-ACID)
    ("approximately 76 kDa" . SPARSER::PROTEIN) ("mdmx" . SPARSER::PROTEIN)
    ("proteins and nucleotides" . SPARSER::COLLECTION)
    ("p60 and hMDM2" . SPARSER::COLLECTION)
    ("hMDM2 and hMDMX" . SPARSER::COLLECTION)
    ("p53, p63 and p73" . SPARSER::COLLECTION)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("Isoforms" . SPARSER::ISOFORM)
    ("Ubiquitin Conjugating Enzyme" . SPARSER::PROTEIN-FAMILY)
    ("Ubiquitin-Activating Enzyme E1" . SPARSER::PROTEIN)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("p53s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hMDM2" . SPARSER::PROTEIN)
    ("their biological barrier" . SPARSER::PROTEIN)
    ("ATM, Wip1 and p53" . SPARSER::COLLECTION)
    ("ATM and p53" . SPARSER::COLLECTION)
    ("DAXX and p53" . SPARSER::COLLECTION)
    ("DAXX, and DAXX" . SPARSER::COLLECTION)
    ("ectopically expressed wild-type DAXX or mutant DAXX S564A"
     . SPARSER::PROTEIN)
    ("expressed wild-type DAXX or mutant DAXX S564A" . SPARSER::PROTEIN)
    ("DAXX or mutant" . SPARSER::COLLECTION)
    ("DAXX and wild-type p53" . SPARSER::COLLECTION)
    ("p21 and Mdm2" . SPARSER::COLLECTION)
    ("DAXX and Mdm2" . SPARSER::COLLECTION) ("DAXX-" . SPARSER::PROTEIN)
    ("Mdm2 or Rassf1C" . SPARSER::COLLECTION)
    ("SPT and SIM" . SPARSER::COLLECTION) ("SPT" . SPARSER::PROTEIN)
    ("p53, ATM, Mdm2, Chk1, Chk2 and p38 MAPK" . SPARSER::COLLECTION)
    ("a multifunctional adaptor protein and putative histone chaperone"
     . SPARSER::COLLECTION)
    ("a multifunctional adaptor protein" . SPARSER::PROTEIN)
    ("DAXX, p53 and H2AX" . SPARSER::COLLECTION)
    ("p53 (S15) and H2AX (S139)" . SPARSER::COLLECTION)
    ("Wip1 or PPM1D" . SPARSER::COLLECTION) ("genotoxins" . SPARSER::MOLECULE)
    ("H2AX and Chk1" . SPARSER::COLLECTION)
    ("ultraviolet light" . SPARSER::PROTEIN)
    ("Noxa, survivin, Gadd45a, Sesn2, Tigar, Wip1, Mdm2, Puma and p21"
     . SPARSER::COLLECTION)
    ("NCS or VP16" . SPARSER::COLLECTION)
    ("p53 or p21 protein" . SPARSER::COLLECTION)
    ("Mdm2 or p53" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("U2OS sarcoma cells ( Fig. S1A ) stably over-expressing DAXX WT or DAXX S564A"
     . SPARSER::COLLECTION)
    ("Noxa, Mdm2, Puma, Sesn2 and Tigar" . SPARSER::COLLECTION)
    ("Mdm2/p53" . SPARSER::COLLECTION)
    ("ATM and/or ATR ( xref )" . SPARSER::COLLECTION)
    ("VP16 or NCS" . SPARSER::COLLECTION) ("TQ" . SPARSER::DRUG)
    ("FLAG-DAXX" . SPARSER::COLLECTION)
    ("the key kinase(s) and phosphatase(s)" . SPARSER::COLLECTION)
    ("ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related)"
     . SPARSER::COLLECTION)
    ("ATM and Rad3-related" . SPARSER::COLLECTION)
    ("pro-apoptotic p53 target genes" . SPARSER::GENE)
    ("Axin/DAXX/HIPK2/p53" . SPARSER::COLLECTION)
    ("HAUSP, DAXX and p53" . SPARSER::COLLECTION) ("Daxx" . SPARSER::PROTEIN)
    ("a highly conserved multifunctional protein" . SPARSER::PROTEIN)
    ("kinase and Wip1" . SPARSER::COLLECTION)
    ("Gadd45a, Noxa, Mdm2, p21, Puma, Sesn2, Tigar or Wip1"
     . SPARSER::COLLECTION)
    ("Sesn2" . SPARSER::PROTEIN) ("Tigar" . SPARSER::PROTEIN)
    ("genotoxic drugs etoposide and neocarzinostatin" . SPARSER::COLLECTION)
    ("etoposide and neocarzinostatin" . SPARSER::COLLECTION)
    ("a histone chaperone, putative regulator of apoptosis and transcription, and candidate modulator"
     . SPARSER::COLLECTION)
    ("DAXX" . SPARSER::PROTEIN) ("Light chain" . SPARSER::PROTEIN)
    ("Rassf1" . SPARSER::PROTEIN) ("RassF1" . SPARSER::PROTEIN)
    ("2–4 " . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("Gadd45a" . SPARSER::PROTEIN)
    ("Death domain-associated protein 6" . SPARSER::PROTEIN)
    ("an attractive therapeutic target as well as a potential negative predictive biomarker"
     . SPARSER::COLLECTION)
    ("a potential negative predictive biomarker" . SPARSER::MOLECULE)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION)
    ("alternate short EGFR" . SPARSER::PROTEIN)
    ("DNA, RNA and protein" . SPARSER::COLLECTION)
    ("the subsequent mRNA" . SPARSER::PROTEIN)
    ("approximately 300 nucleotides" . SPARSER::NUCLEOTIDE)
    ("acceptor or donor sites" . SPARSER::COLLECTION)
    ("a smaller cohort" . SPARSER::MOLECULE)
    ("genomic EGFRvIII" . SPARSER::PROTEIN)
    ("EGFRvIII and EGFR" . SPARSER::COLLECTION)
    ("expressed EGFRvIII" . SPARSER::PROTEIN)
    ("p16 and EGFRvIII" . SPARSER::COLLECTION) ("p10" . SPARSER::PROTEIN)
    ("the CD44 high-expression group (++/+++) and the CD44 low-expression group (−/+)"
     . SPARSER::COLLECTION)
    ("immunohistochemical streptavidin-peroxidase" . SPARSER::COLLECTION)
    ("streptavidin-peroxidase" . SPARSER::COLLECTION)
    ("personalized medicine and prognosis improvement" . SPARSER::COLLECTION)
    ("CD47, CD44 or c-met" . SPARSER::COLLECTION)
    ("CD47, CD44 and c-met" . SPARSER::COLLECTION)
    ("c-met/HGF" . SPARSER::COLLECTION)
    ("CD47 and c-met" . SPARSER::COLLECTION)
    ("targeted monoclonal antibodies" . SPARSER::ANTIBODY)
    ("TSP" . SPARSER::PROTEIN) ("thrombospondin" . SPARSER::PROTEIN)
    ("Ezrin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase and MAPK" . SPARSER::COLLECTION)
    ("interleukin-8 and vascular endothelial" . SPARSER::COLLECTION)
    ("CD44 and c-met" . SPARSER::COLLECTION) ("EPCAM" . SPARSER::PROTEIN)
    ("HGF/c-met" . SPARSER::COLLECTION)
    ("a highly heterogeneous transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("a rare pathological type" . TYPE) ("CD47/c-met" . SPARSER::COLLECTION)
    ("CD44/c-met" . SPARSER::COLLECTION) ("CD44/CD47" . SPARSER::COLLECTION)
    ("CD44 (or CD47) and c-met" . SPARSER::COLLECTION)
    ("CD44 and CD47" . SPARSER::COLLECTION)
    ("CD44, CD47 and c-met" . SPARSER::COLLECTION) ("CK20" . SPARSER::PROTEIN)
    ("SIRPα" . SPARSER::PROTEIN)
    ("signal regulatory protein" . SPARSER::PROTEIN)
    ("hyaluronic acid" . SPARSER::MOLECULE)
    ("integrin-associated protein" . SPARSER::PROTEIN)
    ("c-met" . SPARSER::PROTEIN) ("CD47" . SPARSER::PROTEIN)
    ("genome-wide RNA" . SPARSER::RNA)
    ("immature monocytes" . SPARSER::PROTEIN)
    ("SES and gene" . SPARSER::COLLECTION)
    ("NF-kB and CREB" . SPARSER::COLLECTION)
    ("three cardinal pro-inflammatory genes" . SPARSER::GENE)
    ("HRS" . SPARSER::PROTEIN)
    ("the pro-inflammatory transcription factor NF-kappaB" . SPARSER::PROTEIN)
    ("pro-inflammatory genes" . SPARSER::GENE)
    ("PTGS2 , ILIB , and IL8" . SPARSER::COLLECTION) ("SES" . SPARSER::PROTEIN)
    ("log-2" . SPARSER::PROTEIN) ("IFI27" . SPARSER::PROTEIN)
    ("cyclo-oxygenase 2" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("interleukin-1 beta" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("cigarettes" . SPARSER::DRUG)
    ("allele and rs2976392" . SPARSER::COLLECTION)
    ("Met/Thr" . SPARSER::COLLECTION)
    ("Relatively greater FPRP" . SPARSER::PROTEIN)
    ("preset" . SPARSER::PROTEIN-FAMILY)
    ("inositol 1,4,5-trisphosphate (Insl,4,5P3) and 4,5-diacylglycerol (DAG) [ xref ]"
     . SPARSER::COLLECTION)
    ("prostate stem cell antigen (PSCA)" . SPARSER::PROTEIN)
    ("PSCA , MUC1 , and PLCE1" . SPARSER::COLLECTION)
    ("nitrated" . SPARSER::MOLECULE)
    ("four previous reported genetic variants" . SPARSER::VARIANT)
    ("95% CI = 1.15–1.90, and AG/GG" . SPARSER::COLLECTION)
    ("–1.65, and AG/AA" . SPARSER::COLLECTION)
    ("–1.90, and AG/GG" . SPARSER::COLLECTION) ("AG" . SPARSER::PROTEIN)
    ("FPRP" . SPARSER::PROTEIN) ("PSCA" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("Mucin 1" . SPARSER::PROTEIN) ("Thy-1" . SPARSER::PROTEIN)
    ("prostate stem cell antigen" . SPARSER::PROTEIN)
    ("MEFs and LPCs" . SPARSER::COLLECTION)
    ("the antibody and un-related protein(s)" . SPARSER::COLLECTION)
    ("LPCs and MEFs" . SPARSER::COLLECTION) ("shRNA (KD)" . SPARSER::PROTEIN)
    ("the dense fibrillar component" . SPARSER::COMPONENT)
    ("FIB" . SPARSER::PROTEIN) ("fibrillarin" . SPARSER::PROTEIN)
    ("the secondary antibody" . SPARSER::PROTEIN)
    ("YAP1 and YAP2" . SPARSER::COLLECTION)
    ("all three transformed LPCs" . SPARSER::PROTEIN)
    ("Indeed all transformed LPCs" . SPARSER::PROTEIN)
    ("LPC" . SPARSER::PROTEIN) ("the transformed LPCs" . SPARSER::PROTEIN)
    ("tumorigenic LPCs" . SPARSER::PROTEIN) ("angiomotin" . SPARSER::PROTEIN)
    ("CK1 or GSK-3" . SPARSER::COLLECTION)
    ("transformed LPCs" . SPARSER::PROTEIN) ("LPCs" . SPARSER::PROTEIN)
    ("The Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("insulin-like growth factor II" . SPARSER::PROTEIN)
    ("developing Wnt/β-catenin pathway inhibitors" . SPARSER::INHIBITOR)
    ("doxorubicin-" . SPARSER::PROTEIN)
    ("The epithelial-mesenchymal transition (EMT) promoter"
     . SPARSER::PROMOTER)
    ("SFRP1, DKK1, or shRNA" . SPARSER::COLLECTION)
    ("β-catenin and Wnt" . SPARSER::COLLECTION)
    ("membrane-associated β-catenin" . SPARSER::PROTEIN)
    ("the cell cycle regulators cyclin D1 [ xref ] and c-Myc [ xref ]"
     . SPARSER::COLLECTION)
    ("Mmp-7" . SPARSER::PROTEIN) ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("chemotherapeutic agents doxorubicin and cisplatin" . SPARSER::COLLECTION)
    ("doxorubicin and cisplatin" . SPARSER::COLLECTION)
    ("Bmi-1 and c-Myc" . SPARSER::COLLECTION) ("ICG-001" . SPARSER::DRUG)
    ("LRP6" . SPARSER::PROTEIN) ("SFRP1" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("Bmi-1" . SPARSER::PROTEIN)
    ("heteromeric transmembrane complexes" . SPARSER::BIO-COMPLEX)
    ("Ras-MAPK" . SPARSER::COLLECTION)
    ("an alternate SMAD-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β/SMAD" . SPARSER::COLLECTION) ("pRC/CMV2" . SPARSER::PROTEIN)
    ("pRC/CMV2-Cav1" . SPARSER::COLLECTION)
    ("CMV2-Cav1" . SPARSER::PROTEIN-PAIR)
    ("exogenous mitogens" . SPARSER::MITOGEN)
    ("pSU6H-" . SPARSER::PROTEIN-FAMILY) ("pSU" . SPARSER::PROTEIN-FAMILY)
    ("p38 MAPK" . SPARSER::PROTEIN)
    ("c-Jun N-terminal kinase (JNK-II, 0.1 μM) and Src family protein tyrosine kinases (PP2, 10 μM and SU6656, 2.7 μM)"
     . SPARSER::COLLECTION)
    ("ERK-1/2 MAPK (with the MEK-1 inhibitor, PD98059, 20 μM), c-Jun N-terminal kinase (JNK-II, 0.1 μM) and Src family protein tyrosine kinases (PP2, 10 μM and SU6656, 2.7 μM)"
     . SPARSER::COLLECTION)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("Cav-1 and Cyclophilin A" . SPARSER::COLLECTION)
    ("classical receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALK5/SMAD" . SPARSER::COLLECTION) ("Pre" . SPARSER::PROTEIN)
    ("SMAD-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble growth factor" . SPARSER::GROWTH-FACTOR)
    ("the principal components" . SPARSER::COMPONENT)
    ("Caveolin" . SPARSER::PROTEIN) ("SMAD and p38 MAPK" . SPARSER::COLLECTION)
    ("GATA-6" . SPARSER::PROTEIN) ("SU6656" . SPARSER::PROTEIN)
    ("MEK-1" . SPARSER::PROTEIN) ("ERK-1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALK5" . SPARSER::PROTEIN) ("Cyclophilin A" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN) ("A-12" . SPARSER::PROTEIN)
    ("fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("non-muscle" . SPARSER::PROTEIN) ("BRAT1 and PIKKs" . SPARSER::COLLECTION)
    ("YY1-PGC-1" . SPARSER::COLLECTION) ("PI3/Akt/mTOR" . SPARSER::COLLECTION)
    ("GSH-bead" . SPARSER::DRUG)
    ("mTOR and other mTOR-related protein (Raptor and Akt)"
     . SPARSER::COLLECTION)
    ("BRAT1 (FL)" . SPARSER::PROTEIN)
    ("fragment and full-length" . SPARSER::COLLECTION)
    ("Raptor and Akt" . SPARSER::COLLECTION)
    ("ATM, DNA-PK, and mTOR" . SPARSER::COLLECTION)
    ("mTOR and mTOR-related proteins" . SPARSER::COLLECTION)
    ("DDR, and BRAT1" . SPARSER::COLLECTION)
    ("ATM and DNA-PK" . SPARSER::COLLECTION)
    ("ATM, DNA-PK, and SMC1" . SPARSER::COLLECTION)
    ("mTOR and downstream protein" . SPARSER::COLLECTION)
    ("PGC-1" . SPARSER::PROTEIN) ("anti-S" . SPARSER::ANTIBODY)
    ("SMC1" . SPARSER::PROTEIN) ("BRAT1" . SPARSER::PROTEIN)
    ("EGFR and MET or ALK" . SPARSER::COLLECTION)
    ("EGFR, ALK and MET" . SPARSER::COLLECTION)
    ("ARID1A or SMARCA4 and EGFR" . SPARSER::COLLECTION)
    ("SMARCA4 and EGFR" . SPARSER::COLLECTION)
    ("SMARCE1 , CBX2 and EGFR" . SPARSER::COLLECTION)
    ("MET or ALK" . SPARSER::COLLECTION)
    ("MET (crizotinib and EMD1214063) or ALK (NVP-TAE684 and ceritinib)"
     . SPARSER::COLLECTION)
    ("crizotinib and EMD1214063" . SPARSER::COLLECTION)
    ("NVP-TAE684 and ceritinib" . SPARSER::COLLECTION)
    ("p-ERK and pAKT" . SPARSER::COLLECTION) ("p-EGFR" . SPARSER::COLLECTION)
    ("-Flag" . SPARSER::COLLECTION) ("Cbx2" . SPARSER::PROTEIN)
    ("Cbx" . SPARSER::PROTEIN) ("SMARCE1 and CBX2" . SPARSER::COLLECTION)
    ("CBX2 and EGFR" . SPARSER::COLLECTION) ("AK" . SPARSER::PROTEIN)
    ("BMI1 or RING1A" . SPARSER::COLLECTION) ("CBX" . SPARSER::PROTEIN)
    ("Egfr" . SPARSER::PROTEIN)
    ("the Polycomb Repressive Complex" . SPARSER::BIO-COMPLEX)
    ("SMARCE1 and EGFR" . SPARSER::COLLECTION)
    ("SMARCA4 and ARID1A" . SPARSER::COLLECTION)
    ("ARID1A or SMARCA4" . SPARSER::COLLECTION)
    ("SMARCE1 , ARID1A or SMARCA4" . SPARSER::COLLECTION)
    ("gene and modulator" . SPARSER::COLLECTION) ("ceritinib" . SPARSER::DRUG)
    ("MET (EMD1214063 and PHA665752) and ALK (Ceritinib)"
     . SPARSER::COLLECTION)
    ("EMD1214063 and PHA665752" . SPARSER::COLLECTION)
    ("Ceritinib" . SPARSER::DRUG)
    ("crizotinib or NVP-TAE684" . SPARSER::COLLECTION)
    ("ARID1A or SMARCE1" . SPARSER::COLLECTION)
    ("ARID1A and SMARCE1" . SPARSER::COLLECTION)
    ("ALK and EGFR" . SPARSER::COLLECTION)
    ("MYC-associated factor X gene" . SPARSER::GENE)
    ("SNF5 , PBRM1 and SMARCA4" . SPARSER::COLLECTION)
    ("Polycomb Repressive Complex component CBX2" . SPARSER::PROTEIN)
    ("MET and ALK" . SPARSER::COLLECTION) ("RING1" . SPARSER::PROTEIN)
    ("RING1A" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("Chromobox Homolog 2" . SPARSER::PROTEIN)
    ("PHA665752" . SPARSER::MOLECULE) ("EMD1214063" . SPARSER::DRUG)
    ("NVP-TAE684" . SPARSER::DRUG) ("BAF57" . SPARSER::PROTEIN)
    ("MED12" . SPARSER::PROTEIN) ("PBRM1" . SPARSER::PROTEIN)
    ("SNF5" . SPARSER::PROTEIN) ("ARID1A" . SPARSER::PROTEIN)
    ("CBX2" . SPARSER::PROTEIN) ("SMARCE1" . SPARSER::PROTEIN)
    ("LGD" . SPARSER::PROTEIN)
    ("EPOR [ xref ] and GHR [ xref , xref ]" . SPARSER::COLLECTION)
    ("developing clinically relevant drugs" . SPARSER::DRUG)
    ("their associated intracellular JAKs" . SPARSER::PROTEIN)
    ("GM-SCF" . SPARSER::COLLECTION)
    ("an alternate tyrosine kinase" . SPARSER::PROTEIN)
    ("lyn" . SPARSER::PROTEIN)
    ("How was the receptor activating ERK" . SPARSER::WH-QUESTION)
    ("helix disruptive Gly-Pro" . SPARSER::COLLECTION)
    ("Gly-Pro" . SPARSER::COLLECTION) ("JAK2/STAT5" . SPARSER::COLLECTION)
    ("JAK2 and STAT5" . SPARSER::COLLECTION)
    ("a strong salt" . SPARSER::MOLECULE)
    ("STAT5 and ERK" . SPARSER::COLLECTION)
    ("STAT5 and ERK2" . SPARSER::COLLECTION)
    ("EPO or fluorescein" . SPARSER::COLLECTION) ("ScFv" . SPARSER::PROTEIN)
    ("fluorescein" . SPARSER::MOLECULE) ("Ding" . SPARSER::PROTEIN)
    ("tilt and rotation (azimuthal)" . SPARSER::COLLECTION)
    ("tilt" . SPARSER::DRUG) ("mpl" . SPARSER::PROTEIN)
    ("EPOR and gp130" . SPARSER::COLLECTION)
    ("GHR and G-CSF-R" . SPARSER::COLLECTION) ("EMP" . SPARSER::PROTEIN)
    ("the C-terminal membrane proximal ECD" . SPARSER::PROTEIN)
    ("constitutive inactive dimers" . SPARSER::DIMER)
    ("gp130/LIF-R" . SPARSER::COLLECTION) ("tasocitinib" . SPARSER::DRUG)
    ("Tofacitinib" . SPARSER::DRUG) ("TRKA" . SPARSER::PROTEIN)
    ("a dual JAK2 and FLT3 inhibitor" . SPARSER::INHIBITOR)
    ("JAK2 and FLT3" . SPARSER::COLLECTION) ("Pacritinib" . SPARSER::DRUG)
    ("Food and Drug Administration (FDA) approval" . SPARSER::COLLECTION)
    ("JAK1 and JAK2" . SPARSER::COLLECTION) ("ruxolitinib" . SPARSER::DRUG)
    ("receptor (MPL)" . SPARSER::RECEPTOR) ("LNK" . SPARSER::PROTEIN)
    ("Electron" . SPARSER::MOLECULE) ("intact JAK2" . SPARSER::PROTEIN)
    ("JAK1 and TYK2 " . SPARSER::COLLECTION)
    ("GH receptor and STAT5" . SPARSER::COLLECTION)
    ("the wild-type GH receptor and the EED" . SPARSER::COLLECTION)
    ("receptor/JAK2" . SPARSER::COLLECTION)
    ("the four JAKs and the serine/threonine kinase GCN2 [ xref ]"
     . SPARSER::COLLECTION)
    ("JAKs" . SPARSER::PROTEIN)
    ("receptor 1 and the amide" . SPARSER::COLLECTION)
    ("a bivalent ligand" . SPARSER::LIGAND)
    ("a left-handed crossover dimer" . SPARSER::DIMER)
    ("phenylalanines" . SPARSER::AMINO-ACID) ("glycines" . SPARSER::AMINO-ACID)
    ("Thr–Thr" . SPARSER::COLLECTION) ("crosslinker" . SPARSER::PROTEIN)
    ("MTS-2-MTS or Cu-o-phenanthroline" . SPARSER::COLLECTION)
    ("MTS-2-MTS" . SPARSER::PROTEIN-PAIR)
    ("phenanthroline" . SPARSER::MOLECULE)
    ("at least one state" . SPARSER::BIO-STATE)
    ("the same dual fragment" . SPARSER::FRAGMENT) ("dwarf" . SPARSER::PROTEIN)
    ("the homologous TPO receptor" . SPARSER::RECEPTOR)
    ("the bivalent cytokine ligand" . SPARSER::MOLECULE)
    ("a flexible linker" . SPARSER::LINKER)
    ("both the EPOR and the TPOR [ xref , xref ]" . SPARSER::COLLECTION)
    ("TPOR" . SPARSER::PROTEIN) ("EPO and GH receptor" . SPARSER::COLLECTION)
    ("the GMRα, βc [ xref ] and the gp130 common subunit [ xref ]"
     . SPARSER::COLLECTION)
    ("the architypal GH receptor" . SPARSER::PROTEIN)
    ("BRET" . SPARSER::PROTEIN) ("site 1 and site 2" . SPARSER::COLLECTION)
    ("ToxR" . SPARSER::PROTEIN)
    ("the weak agonist antibody" . SPARSER::ANTIBODY)
    ("a weak agonist" . SPARSER::AGONIST)
    ("GH receptor/G-CSF" . SPARSER::COLLECTION)
    ("this archetypal cytokine receptor" . SPARSER::RECEPTOR)
    ("3 monoclonal antibodies" . SPARSER::ANTIBODY) ("MAbs" . SPARSER::DRUG)
    ("GM-CSF, IL-3 and IL-5" . SPARSER::COLLECTION)
    ("signalling competent complexes" . SPARSER::BIO-COMPLEX)
    ("LIF, CNTF, OSM and CT-1" . SPARSER::COLLECTION)
    ("gp130-cytokines" . SPARSER::COLLECTION)
    ("oncostatin-M (OSM)" . SPARSER::PROTEIN) ("CNTF" . SPARSER::PROTEIN)
    ("OSM" . SPARSER::PROTEIN) ("LIF" . SPARSER::PROTEIN)
    ("CT-1" . SPARSER::PROTEIN) ("IL6ST, IL6β or CD130" . SPARSER::COLLECTION)
    ("LIF-R, and βc" . SPARSER::COLLECTION) ("types " . TYPE)
    ("IL-6R [ xref , xref ] and LIF-R [ xref , xref ]" . SPARSER::COLLECTION)
    ("PRLR" . SPARSER::PROTEIN) ("EPOR" . SPARSER::PROTEIN)
    ("the archetypal dimeric GHR ECD" . SPARSER::PROTEIN)
    ("GHR" . SPARSER::PROTEIN) ("ECDs" . SPARSER::PROTEIN)
    ("GH and prolactin" . SPARSER::COLLECTION)
    ("prolactin [ xref ] and EPO receptor [ xref ]" . SPARSER::COLLECTION)
    ("homomeric receptors" . SPARSER::PROTEIN) ("CRH" . SPARSER::PROTEIN)
    ("RECEPTORS" . SPARSER::RECEPTOR) ("CYTOKINE" . SPARSER::PROTEIN)
    ("STAT3 or STAT5" . SPARSER::COLLECTION)
    ("These receptors primarily use JAK2" . SPARSER::PROTEIN)
    ("Akt/phosphoinositide 3-kinase" . SPARSER::COLLECTION)
    ("The growth hormone (GH) and erythropoietin (EPO) receptors"
     . SPARSER::COLLECTION)
    ("thrombopoietin (TPO) and leptin receptors" . SPARSER::COLLECTION)
    ("this ubiquitous tyrosine kinase" . SPARSER::PROTEIN)
    ("growth hormone (GH)" . SPARSER::PROTEIN) ("leptin" . SPARSER::PROTEIN)
    ("TPO" . SPARSER::PROTEIN) ("thrombopoietin" . SPARSER::PROTEIN)
    ("interleukins" . SPARSER::PROTEIN) ("STATs" . SPARSER::PROTEIN)
    ("the bivalent ligand" . SPARSER::LIGAND)
    ("Growth hormone (GH) and structurally related cytokines"
     . SPARSER::COLLECTION)
    ("IL-27R" . SPARSER::PROTEIN) ("G-CSF-R" . SPARSER::PROTEIN)
    ("EMP-1" . SPARSER::PROTEIN) ("JAK3" . SPARSER::PROTEIN)
    ("BMS-911543" . SPARSER::DRUG) ("TYK2 " . SPARSER::PROTEIN)
    ("MTS-2" . SPARSER::PROTEIN) ("GMRα" . SPARSER::PROTEIN)
    ("leptin receptor" . SPARSER::PROTEIN) ("G-CSF" . SPARSER::PROTEIN)
    ("G-CSF receptor" . SPARSER::PROTEIN) ("GH RECEPTOR" . SPARSER::PROTEIN)
    ("oncostatin-M" . SPARSER::PROTEIN) ("IL-27" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("CD130" . SPARSER::PROTEIN)
    ("IL6ST" . SPARSER::PROTEIN) ("cytokine–receptor" . SPARSER::PROTEIN)
    ("LIF-R" . SPARSER::PROTEIN) ("IL3Rα" . SPARSER::PROTEIN)
    ("site 2" . SPARSER::PROTEIN) ("site 1" . SPARSER::PROTEIN)
    ("CLASS I" . SPARSER::PROTEIN) ("GH receptor" . SPARSER::PROTEIN)
    ("Growth hormone" . SPARSER::PROTEIN)
    ("granzymes and TNF-alpha" . SPARSER::COLLECTION)
    ("granzymes" . SPARSER::PROTEIN-FAMILY)
    ("intracellular fluorescent protein" . SPARSER::PROTEIN)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("ER or HER2" . SPARSER::COLLECTION)
    ("the therapeutic antibody and their cognate antigens"
     . SPARSER::COLLECTION)
    ("potentially other anti-cancer monoclonal antibodies" . SPARSER::ANTIBODY)
    ("these monoclonal antibodies" . SPARSER::ANTIBODY)
    ("trastuzumab, rituximab, or cetuximab" . SPARSER::COLLECTION)
    ("paclitaxel and trastuzumab" . SPARSER::COLLECTION)
    ("cytometry and forward/side" . SPARSER::COLLECTION)
    ("CD14, and CD56" . SPARSER::COLLECTION) ("/CD56" . SPARSER::COLLECTION)
    ("/CD14" . SPARSER::COLLECTION)
    ("monocytes and CD56" . SPARSER::COLLECTION)
    ("APC-HER2" . SPARSER::COLLECTION) ("complex (IC)" . SPARSER::BIO-COMPLEX)
    ("NK-cell receptor" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("MACH2" . SPARSER::DRUG) ("FcγR" . SPARSER::PROTEIN-FAMILY)
    ("CISH" . SPARSER::PROTEIN) ("CGH" . SPARSER::PROTEIN)
    ("at least 280 kb DNA" . SPARSER::DNA)
    ("HER2 (red signal) and CEP17 (green signal)" . SPARSER::COLLECTION)
    ("HER2 and CEP17" . SPARSER::COLLECTION) ("c17orf37" . SPARSER::PROTEIN)
    ("PNMT" . SPARSER::PROTEIN) ("Sty" . SPARSER::PROTEIN)
    ("Trastuzumab and Lapatinib" . SPARSER::COLLECTION)
    ("HER/EGFR" . SPARSER::COLLECTION)
    ("antibodies or small molecule inhibitors" . SPARSER::COLLECTION)
    ("q-arm" . SPARSER::COLLECTION) ("IKZF3" . SPARSER::PROTEIN)
    ("GRB7" . SPARSER::PROTEIN) ("PGAP3" . SPARSER::PROTEIN)
    ("STARD3" . SPARSER::PROTEIN) ("PPP1R1B" . SPARSER::PROTEIN)
    ("NEUROD2" . SPARSER::PROTEIN) ("CDK12" . SPARSER::PROTEIN)
    ("H-3" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("this mature miRNA" . SPARSER::PROTEIN)
    ("a tumor suppressive miRNA" . SPARSER::PROTEIN)
    ("a ubiquitous Rac activator" . SPARSER::ACTIVATOR)
    ("E2F1, CD146 and KDM1A" . SPARSER::COLLECTION)
    ("an endothelial biomarker" . SPARSER::MOLECULE)
    ("coreceptor" . SPARSER::PROTEIN)
    ("a complex and multistep process [ xref , xref ]" . SPARSER::COLLECTION)
    ("pcDNA3-TIAM1" . SPARSER::COLLECTION)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("KDM1A" . SPARSER::PROTEIN)
    ("sirolimus and everolimus" . SPARSER::COLLECTION)
    ("mucins" . SPARSER::PROTEIN) ("Mucins" . SPARSER::PROTEIN)
    ("defensins" . SPARSER::PROTEIN) ("DBZ or rapamycin" . SPARSER::COLLECTION)
    ("siRNA or mTOR" . SPARSER::COLLECTION)
    ("TSC2 or non-targeting" . SPARSER::COLLECTION)
    ("TSC2/mTOR" . SPARSER::COLLECTION) ("NICD and Hes1" . SPARSER::COLLECTION)
    ("chromogranin" . SPARSER::PROTEIN) ("lysozyme" . SPARSER::PROTEIN)
    ("TSC2-ΔRG" . SPARSER::PROTEIN-PAIR)
    ("Rheb-GTPase-activating protein" . SPARSER::COLLECTION)
    ("dibenzazepine (DBZ) or rapamycin" . SPARSER::COLLECTION)
    ("DBZ" . SPARSER::DRUG) ("REDD1/TSC2/mTOR" . SPARSER::COLLECTION)
    ("Delta" . SPARSER::PROTEIN) ("TOR" . SPARSER::PROTEIN)
    ("absorptive" . SPARSER::PROTEIN) ("TSC2/mTORC1" . SPARSER::COLLECTION)
    ("either Notch inhibitor dibenzazepine (DBZ) or mTORC1 inhibitor rapamycin"
     . SPARSER::COLLECTION)
    ("dibenzazepine (DBZ)" . SPARSER::DRUG) ("dibenzazepine" . SPARSER::DRUG)
    ("Hes5" . SPARSER::PROTEIN) ("MMP7" . SPARSER::PROTEIN)
    ("mucin2" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase-related kinase" . SPARSER::PROTEIN)
    ("MUC2" . SPARSER::PROTEIN) ("tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("invasive CC" . SPARSER::PROTEIN) ("viral protein" . SPARSER::PROTEIN)
    ("NPC, BCa, and HCC" . SPARSER::COLLECTION)
    ("E2F-1, Rb, and p21" . SPARSER::COLLECTION)
    ("CC, NPC, BCa, and HCC" . SPARSER::COLLECTION)
    ("Duplex MSP" . SPARSER::PROTEIN) ("BCa" . SPARSER::PROTEIN)
    ("F-1" . SPARSER::PROTEIN) ("Cyclin-A1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 2" . SPARSER::PROTEIN)
    ("cyclin family" . SPARSER::PROTEIN) ("CCNA1" . SPARSER::PROTEIN)
    ("the BAD protein and BAD-mediated apoptotic pathway PCA"
     . SPARSER::COLLECTION)
    ("protein phosphatase(PP)" . SPARSER::PROTEIN)
    ("PP2A and PP2C" . SPARSER::COLLECTION) ("PP" . SPARSER::PROTEIN)
    ("ribosomal protein S6 kinase alpha-1 (RPS6KA1/RSK) and cAMP-dependent protein kinase [also known as protein kinase A (PKA)]"
     . SPARSER::COLLECTION)
    ("PKB/Akt" . SPARSER::COLLECTION) ("RPS6KA1/RSK" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-xL and Bcl-2" . SPARSER::COLLECTION)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("PPM1A" . SPARSER::PROTEIN)
    ("RPS6KA1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribosomal protein S6 kinase alpha-1" . SPARSER::PROTEIN)
    ("PP2C" . SPARSER::PROTEIN) ("NeuroD1-ALK" . SPARSER::COLLECTION)
    ("MYCN and NeuroD1" . SPARSER::COLLECTION)
    ("whose promoters" . SPARSER::PROMOTER)
    ("ALK and NeuroD1" . SPARSER::COLLECTION)
    ("NeuroD1 and ALK" . SPARSER::COLLECTION) ("NeuroD1" . SPARSER::PROTEIN)
    ("EMT, and drug" . SPARSER::COLLECTION)
    ("an excellent therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ERα and EGFR" . SPARSER::COLLECTION)
    ("Overexpressed Slug" . SPARSER::PROTEIN)
    ("tamoxifen and docetaxel" . SPARSER::COLLECTION)
    ("c-Myc and Oct4" . SPARSER::COLLECTION)
    ("c-Myc, Oct4 and Sox2" . SPARSER::COLLECTION)
    ("CD44 and CD24" . SPARSER::COLLECTION)
    ("c-Myc, Sox2 and Oct4" . SPARSER::COLLECTION)
    ("EMT and stem-like" . SPARSER::COLLECTION) ("ShC" . SPARSER::PROTEIN)
    ("Slug or control ShRNA (MDA/ShCon)" . SPARSER::COLLECTION)
    ("ERα and E-cadherin" . SPARSER::COLLECTION)
    ("MCF7/Slug" . SPARSER::COLLECTION) ("genomic ERα" . SPARSER::PROTEIN)
    ("Transiently overexpressed Slug" . SPARSER::PROTEIN)
    ("overexpressed Slug" . SPARSER::PROTEIN)
    ("Slug and ShSlug" . SPARSER::COLLECTION)
    ("Slug and ERα" . SPARSER::COLLECTION)
    ("ERα, AR and β-catenin" . SPARSER::COLLECTION)
    ("Slug, c-Myc and c-Jun" . SPARSER::COLLECTION)
    ("c-Myc, c-Jun, Sox2 and Oct4" . SPARSER::COLLECTION)
    ("Oct4 and c-Myc" . SPARSER::COLLECTION)
    ("the mammary stem cell state" . SPARSER::BIO-STATE)
    ("Slug and Sox9" . SPARSER::COLLECTION)
    ("erlotinib, gefitinib, and cetuximab" . SPARSER::COLLECTION)
    ("MDR-1/P-glycoprotein" . SPARSER::COLLECTION)
    ("Slug-ERα" . SPARSER::COLLECTION) ("ShC3" . SPARSER::PROTEIN)
    ("ShC2" . SPARSER::PROTEIN) ("Oct-3" . SPARSER::PROTEIN)
    ("homolog 2 ( Drosophila )" . SPARSER::PROTEIN)
    ("C2H2" . SPARSER::MOLECULE) ("Snail2" . SPARSER::PROTEIN)
    ("MDR-1" . SPARSER::PROTEIN) ("/AMPK" . SPARSER::COLLECTION)
    ("MnSOD, Bcl-2, and survivin" . SPARSER::COLLECTION)
    ("selectively killing MnSOD" . SPARSER::PROTEIN)
    ("MnSOD or inhibiting AMPK" . SPARSER::COLLECTION) ("mito" . SPARSER::DRUG)
    ("rapidly dismutates H 2 O 2" . SPARSER::DRUG)
    ("ectopically expressing mitochondria-targeted catalase"
     . SPARSER::PROTEIN)
    ("expressing mitochondria-targeted catalase" . SPARSER::PROTEIN)
    ("MnSOD and its product H 2 O 2" . SPARSER::COLLECTION)
    ("MnSOD and H 2 O 2" . SPARSER::COLLECTION)
    ("MnSOD/oxCaMKII/AMPK" . SPARSER::COLLECTION)
    ("survivin/Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2 and survivin" . SPARSER::COLLECTION)
    ("survivin and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2/survivin" . SPARSER::COLLECTION)
    ("glycolysis-supportive substrates" . SPARSER::SUBSTRATE)
    ("pyruvate and uridine" . SPARSER::COLLECTION)
    ("uridine" . SPARSER::PROTEIN)
    ("paclitaxel or 5-fluorouracil" . SPARSER::COLLECTION)
    ("paclitaxel (a mitotic inhibitor) and 5-fluorouracil (a thymidylate synthase inhibitor)"
     . SPARSER::COLLECTION)
    ("cellular H 2 O 2" . SPARSER::DRUG) ("the major H 2 O 2" . SPARSER::DRUG)
    ("Catalase, glutathione reductase, thioredoxin and thioredoxin reductase"
     . SPARSER::COLLECTION)
    ("mitochondrial electron" . SPARSER::MOLECULE)
    ("Hexokinase and phosphofructokinase activity" . SPARSER::COLLECTION)
    ("Hexokinase" . SPARSER::PROTEIN) ("complete media" . SPARSER::PROTEIN)
    ("efficiently dismutates H 2 O 2" . SPARSER::DRUG)
    ("mt-catalase" . SPARSER::COLLECTION)
    ("H 2 O 2 , and AMPK" . SPARSER::COLLECTION) ("Neo" . SPARSER::PROTEIN)
    ("exogenous H 2 O 2" . SPARSER::DRUG) ("neo and Mn1" . SPARSER::COLLECTION)
    ("ATP/AMP" . SPARSER::PROTEIN-PAIR) ("MCF7/neo" . SPARSER::COLLECTION)
    ("JC-1 ( xref ) and CMXROS ( xref )" . SPARSER::COLLECTION)
    ("CMXROS" . SPARSER::MOLECULE) ("Mn1" . SPARSER::PROTEIN)
    ("MnSOD and LDH" . SPARSER::COLLECTION)
    ("strong oxidant hydrogen peroxide" . SPARSER::DRUG)
    ("healthy mitochondria" . SPARSER::PROTEIN)
    ("MnSOD/AMPK" . SPARSER::COLLECTION) ("MnSOD/SOD2" . SPARSER::COLLECTION)
    ("6-phosphofructokinase" . SPARSER::PROTEIN)
    ("Fe(III)" . SPARSER::MOLECULE) ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("caspase 9" . SPARSER::PROTEIN) ("KN93" . SPARSER::MOLECULE)
    ("thioredoxin reductase" . SPARSER::PROTEIN)
    ("glutathione reductase" . SPARSER::PROTEIN) ("PFK2" . SPARSER::PROTEIN)
    ("phosphofructokinase activity" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN) ("Compound C" . SPARSER::MOLECULE)
    ("Manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("GST-TTD" . SPARSER::COLLECTION) ("p53K381ac" . SPARSER::PROTEIN)
    ("guanidinium" . SPARSER::MOLECULE) ("p300-p53" . SPARSER::COLLECTION)
    ("BD-p53K381ac" . SPARSER::PROTEIN-PAIR)
    ("peptide or p53K381ac" . SPARSER::COLLECTION) ("BD" . SPARSER::PROTEIN)
    ("bromodomain (BD)" . SPARSER::PROTEIN)
    ("histones and p53" . SPARSER::COLLECTION)
    ("CBP-p53" . SPARSER::COLLECTION)
    ("p53 and p300/CBP" . SPARSER::COLLECTION)
    ("p53/p300" . SPARSER::COLLECTION) ("p53 and p300" . SPARSER::COLLECTION)
    ("immunogen" . SPARSER::MOLECULE)
    ("p53 or p53K381ac" . SPARSER::COLLECTION) ("dot-blot" . SPARSER::PROTEIN)
    ("doxorubicin and TSA" . SPARSER::COLLECTION) ("Set7/9" . SPARSER::PROTEIN)
    ("a DNA damage response protein and a p53 co-factor" . SPARSER::COLLECTION)
    ("53BP1, a DNA damage response protein and a p53 co-factor"
     . SPARSER::COLLECTION)
    ("p21 and PUMA" . SPARSER::COLLECTION) ("KMT" . SPARSER::PROTEIN)
    ("SMYD2 and SET8" . SPARSER::COLLECTION) ("KAT" . SPARSER::PROTEIN)
    ("53BP1 and p300" . SPARSER::COLLECTION)
    ("p53S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Set7" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53-binding protein 1" . SPARSER::PROTEIN) ("PHF20" . SPARSER::PROTEIN)
    ("L3MBTL1" . SPARSER::PROTEIN) ("FBXO11" . SPARSER::PROTEIN)
    ("SET8" . SPARSER::PROTEIN) ("SMYD2" . SPARSER::PROTEIN)
    ("SET7/9" . SPARSER::PROTEIN) ("LKB1 or Akt" . SPARSER::COLLECTION)
    ("LKB1, Akt and Nedd8" . SPARSER::COLLECTION)
    ("GTP and glycine levels" . SPARSER::COLLECTION)
    ("bioactive sphingolipids" . SPARSER::MOLECULE)
    ("sphingolipids" . SPARSER::MOLECULE)
    ("HCC and poorest" . SPARSER::COLLECTION)
    ("ring-ligases" . SPARSER::PROTEIN) ("-Nedd8" . SPARSER::COLLECTION)
    ("proteins, LKB1 and Akt" . SPARSER::COLLECTION)
    ("LKB1 and AMPK" . SPARSER::COLLECTION)
    ("HCC, LKB1 and Akt" . SPARSER::COLLECTION)
    ("MLN4924 or Nedd8" . SPARSER::COLLECTION) ("ethanolamine" . SPARSER::DRUG)
    ("healthy hepatocytes" . SPARSER::PROTEIN)
    ("MLN4924 and Nedd8" . SPARSER::COLLECTION)
    ("well-differentiated hepatocytes" . SPARSER::PROTEIN)
    ("Seahorse" . SPARSER::PROTEIN)
    ("the classical inhibitor" . SPARSER::INHIBITOR)
    ("a classical β-oxidation inhibitor" . SPARSER::INHIBITOR)
    ("pivotal metabolites" . SPARSER::PROTEIN) ("PUFA" . SPARSER::MOLECULE)
    ("Phosphatidylcholines" . SPARSER::MOLECULE)
    ("-methyltransferases" . SPARSER::COLLECTION)
    ("phosphatidylcholines (PC)" . SPARSER::MOLECULE)
    ("phosphatidylcholines" . SPARSER::MOLECULE)
    ("c-Jun and Nrf2" . SPARSER::COLLECTION)
    ("Nedd8-cullin" . SPARSER::COLLECTION)
    ("mitochondrial chaperone" . SPARSER::PROTEIN)
    ("ubiquitously expressed protein" . SPARSER::PROTEIN)
    ("expressed protein" . SPARSER::PROTEIN) ("Phb1-" . SPARSER::PROTEIN)
    ("Nedd8 and NAE1" . SPARSER::COLLECTION)
    ("diacylglycerols (DAG)" . SPARSER::DAG) ("diacylglycerols" . SPARSER::DAG)
    ("phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR)"
     . SPARSER::COLLECTION)
    ("Liver kinase B1 (LKB1) and Akt kinases" . SPARSER::COLLECTION)
    ("ubiquitin-ligases" . SPARSER::COLLECTION)
    ("cullin" . SPARSER::PROTEIN-FAMILY) ("Nedd8" . SPARSER::PROTEIN)
    ("LKB1 and Akt" . SPARSER::COLLECTION)
    ("Akt and LKB1" . SPARSER::COLLECTION)
    ("protumoral hepatocytes" . SPARSER::PROTEIN) ("PEMT" . SPARSER::PROTEIN)
    ("NEDP1" . SPARSER::PROTEIN) ("n-3" . SPARSER::PROTEIN)
    ("docosahexaenoic acid" . SPARSER::MOLECULE)
    ("glycine N-methyltransferase" . SPARSER::PROTEIN)
    ("Prohibitin 1" . SPARSER::PROTEIN) ("NAE1" . SPARSER::PROTEIN)
    ("prohibitin 1" . SPARSER::PROTEIN)
    ("neural precursor cell expressed" . SPARSER::PROTEIN)
    ("Phb1" . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("brca1 and rad17" . SPARSER::COLLECTION)
    ("p53, ATM, Chk2, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("53 BP1, MRE11, MDC1, BRCA1-2 and RADs proteins [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("p73 and p63" . SPARSER::COLLECTION)
    ("transcriptional repressive protein" . SPARSER::PROTEIN)
    ("rad17 and brca1" . SPARSER::COLLECTION)
    ("Fas/APO-1" . SPARSER::COLLECTION)
    ("cyclin B1 and id4" . SPARSER::COLLECTION) ("RFS" . SPARSER::PROTEIN)
    ("BLC" . SPARSER::PROTEIN)
    ("colorectal adenocarcinoma samples carrying mutp53" . SPARSER::PROTEIN)
    ("mutp53 and BRCA1 and RAD17" . SPARSER::COLLECTION)
    ("si-p53/si-BRCA1" . SPARSER::COLLECTION)
    ("mutp53, or BRCA1" . SPARSER::COLLECTION)
    ("mutp53 and BRCA1, or GFP" . SPARSER::COLLECTION)
    ("BRCA1, or GFP" . SPARSER::COLLECTION)
    ("phospo-H2AX" . SPARSER::COLLECTION)
    ("BRCA1 and mutp53R175H" . SPARSER::COLLECTION)
    ("efficiently repair DNA" . SPARSER::DNA)
    ("HA-mutp53D281G" . SPARSER::PROTEIN-PAIR)
    ("both BRCA1 (Figures xref ) and RAD17 (Figures xref ) promoters"
     . SPARSER::COLLECTION)
    ("a novel repressive competent complex" . SPARSER::BIO-COMPLEX)
    ("mutp53 and E2F4" . SPARSER::COLLECTION)
    ("concomitantly BRCA1 and RAD17 promoters" . SPARSER::PROMOTER)
    ("p53 and E2F4" . SPARSER::COLLECTION)
    ("mutp53 or E2F4" . SPARSER::COLLECTION)
    ("E2F4 and mutp53" . SPARSER::COLLECTION) ("si-p53" . SPARSER::COLLECTION)
    ("si-GFP" . SPARSER::COLLECTION) ("FB" . SPARSER::PROTEIN)
    ("the repressive DREAM complex" . SPARSER::BIO-COMPLEX)
    ("RAD17 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1, RAD17 and Chk1" . SPARSER::COLLECTION)
    ("BRCA1 , RAD17 and Chk1" . SPARSER::COLLECTION)
    ("tri-oligomers" . SPARSER::COLLECTION)
    ("purified GST-mutp53R175H protein (100, 200 and 500 ng; lanes 7, 8 and 9, respectively) or GST"
     . SPARSER::COLLECTION)
    ("mutp53R175H" . SPARSER::PROTEIN)
    ("GST-mutp53R175H" . SPARSER::COLLECTION)
    ("p53 or mutp53R175H" . SPARSER::COLLECTION)
    ("the supercoiled and high oligomeric forms" . SPARSER::FORM)
    ("vs" . SPARSER::PROTEIN) ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a transcriptional repressive complex" . SPARSER::BIO-COMPLEX)
    ("Mutp53 and E2F4" . SPARSER::COLLECTION)
    ("RCA1 and RAD17" . SPARSER::COLLECTION)
    ("Rad9-Hus1-Rad1" . SPARSER::COLLECTION)
    ("protein (ATM)" . SPARSER::PROTEIN) ("Snk/Plk2" . SPARSER::COLLECTION)
    ("Snk" . SPARSER::PROTEIN) ("p63 and p73" . SPARSER::COLLECTION)
    ("NF-Y, E2F1, NF-kB, ZEB1, SP1, ETS1 and VDR" . SPARSER::COLLECTION)
    ("VDR" . SPARSER::PROTEIN) ("mutated DNA" . SPARSER::DNA)
    ("bearing wt-p53 gene" . SPARSER::GENE)
    ("BRCA1 and RAD17" . SPARSER::COLLECTION) ("β–actin" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("53 BP1" . SPARSER::PROTEIN)
    ("rad17" . SPARSER::PROTEIN) ("APO-1" . SPARSER::PROTEIN)
    ("proliferation-associated" . SPARSER::PROTEIN) ("id4" . SPARSER::PROTEIN)
    ("si-RNA" . SPARSER::RNA) ("Reg2" . SPARSER::PROTEIN)
    ("RCA1" . SPARSER::PROTEIN) ("9-1-1 complex" . SPARSER::|9-1-1|)
    ("Rad1" . SPARSER::PROTEIN) ("Hus1" . SPARSER::PROTEIN)
    ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Rad17" . SPARSER::PROTEIN)
    ("hRAD17" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("Plk2" . SPARSER::PROTEIN) ("NF-Y" . SPARSER::PROTEIN)
    ("RAD17" . SPARSER::PROTEIN) ("the smaller FOXP1" . SPARSER::PROTEIN)
    ("strong immunoglobulin heavy chain ( IG ) promoters" . SPARSER::PROMOTER)
    ("IG" . SPARSER::MOLECULE) ("BCL9-β-catenin" . SPARSER::COLLECTION)
    ("the tryptic peptide" . SPARSER::PEPTIDE)
    ("an intervening proteotypic linker peptide" . SPARSER::PEPTIDE)
    ("biotin" . SPARSER::PROTEIN)
    ("overexpressed tagged protein" . SPARSER::PROTEIN)
    ("FOXP1 and CBP" . SPARSER::COLLECTION)
    ("repressor and activator" . SPARSER::COLLECTION)
    ("β-catenin/TCF7L2" . SPARSER::COLLECTION)
    ("FOXP1, TCF7L2, CBP, and β-catenin" . SPARSER::COLLECTION)
    ("FOXP1 and Wnt" . SPARSER::COLLECTION)
    ("XAV939 and C59" . SPARSER::COLLECTION)
    ("doxorubicin and 4-Hydroxycyclo-phosphamide" . SPARSER::COLLECTION)
    ("antagonists, XAV939 and C59" . SPARSER::COLLECTION)
    ("doxorubicin and 4-Hydroxy-cyclophosphamide" . SPARSER::COLLECTION)
    ("DKK" . SPARSER::PROTEIN) ("DKK1 and XAV939" . SPARSER::COLLECTION)
    ("FOXP1 or β-catenin" . SPARSER::COLLECTION)
    ("the therapeutic antibody rituximab (R) and the chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisone"
     . SPARSER::COLLECTION)
    ("prednisone" . SPARSER::DRUG)
    ("both motifs genome-wide using HOMER" . SPARSER::PROTEIN-FAMILY)
    ("TCF7L2 and FOXP1" . SPARSER::COLLECTION)
    ("FOXP1/TCF7L2" . SPARSER::COLLECTION)
    ("FOXP1 and TCF7L2" . SPARSER::COLLECTION)
    ("TCF7L2 and LEF1" . SPARSER::COLLECTION)
    ("the AXIN2 promoter and other Wnt-responsive promoters"
     . SPARSER::COLLECTION)
    ("TCF7L2 and β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and CBP" . SPARSER::COLLECTION)
    ("TCF7L2, CBP, and β-catenin" . SPARSER::COLLECTION)
    ("AXIN2 and PDE4B1" . SPARSER::COLLECTION)
    ("β-catenin and FOXP1" . SPARSER::COLLECTION)
    ("protein-chromatin" . SPARSER::COLLECTION)
    ("CBP/β-catenin/TCF7L2" . SPARSER::COLLECTION)
    ("exogenous β-catenin" . SPARSER::PROTEIN)
    ("CBP, TCF7L2, and β-catenin" . SPARSER::COLLECTION)
    ("FOXP1, CBP, β-catenin and TCF7L2" . SPARSER::COLLECTION)
    ("β-catenin, TCF7L2 and CBP" . SPARSER::COLLECTION)
    ("CBP/CREBBP" . SPARSER::COLLECTION) ("CREBBP" . SPARSER::PROTEIN)
    ("pan-histone" . SPARSER::PROTEIN)
    ("isoform 5 and isoform" . SPARSER::COLLECTION)
    ("Axin2 and Bozozok" . SPARSER::COLLECTION) ("hpf" . SPARSER::PROTEIN)
    ("wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XAV939, a tankyrase inhibitor that stabilizes AXIN protein and increases β-catenin degradation by the destruction complex ( xref )"
     . SPARSER::COLLECTION)
    ("tankyrase" . SPARSER::PROTEIN) ("GSK3β and DLD1" . SPARSER::COLLECTION)
    ("NKD1 and AXIN2" . SPARSER::COLLECTION)
    ("AXIN2 and NKD1" . SPARSER::COLLECTION)
    ("exogenous Wnt3a ligand" . SPARSER::MOLECULE)
    ("a β-catenin-driven fluorescent reporter gene" . SPARSER::GENE)
    ("removed associated proteins" . SPARSER::PROTEIN)
    ("shotgun" . SPARSER::PROTEIN)
    ("overexpressed fusion proteins" . SPARSER::PROTEIN)
    ("GFP−" . SPARSER::PROTEIN)
    ("both a tumor suppressor and an oncogene" . SPARSER::COLLECTION)
    ("OCT4 , NANOG , NRFA2 , and GDF3" . SPARSER::COLLECTION)
    ("NANOG" . SPARSER::PROTEIN)
    ("a Frizzled receptor and a LRP co-receptor" . SPARSER::COLLECTION)
    ("LRP" . SPARSER::PROTEIN) ("βTrCP1 and βTrCP2" . SPARSER::COLLECTION)
    ("BTRC and FBXW11" . SPARSER::COLLECTION) ("βTrCP1" . SPARSER::PROTEIN)
    ("Wnt pathway inhibitors and knockdown of FOXP1 or Wnt signaling"
     . SPARSER::COLLECTION)
    ("FOXP1 or Wnt" . SPARSER::COLLECTION) ("PMD2" . SPARSER::MOLECULE)
    ("ornithine decarboxylase" . SPARSER::PROTEIN) ("hsp70" . SPARSER::PROTEIN)
    ("Wnt8" . SPARSER::PROTEIN) ("CC-3" . SPARSER::PROTEIN)
    ("Concanavalin A" . SPARSER::DRUG) ("Isoform 5" . SPARSER::PROTEIN)
    ("isoform 6" . SPARSER::PROTEIN) ("SD-1" . SPARSER::PROTEIN)
    ("BCL9" . SPARSER::PROTEIN) ("LEF1" . SPARSER::PROTEIN)
    ("PDE4B" . SPARSER::PROTEIN) ("ICG001" . SPARSER::DRUG)
    ("SOX17" . SPARSER::PROTEIN) ("Isoform 3" . SPARSER::PROTEIN)
    ("isoform 5" . SPARSER::PROTEIN) ("FoxP1" . SPARSER::PROTEIN)
    ("Foxp1" . SPARSER::PROTEIN) ("foxp1" . SPARSER::PROTEIN)
    ("NKD1" . SPARSER::PROTEIN) ("AXIN2" . SPARSER::PROTEIN)
    ("GDF3" . SPARSER::PROTEIN) ("casein kinase 1" . SPARSER::PROTEIN)
    ("GSK3B" . SPARSER::PROTEIN) ("TCF7L2" . SPARSER::PROTEIN)
    ("FOXP1" . SPARSER::PROTEIN)
    ("TET2 , SRSF2 , ASXL1 , SRSF2 or RUNX1" . SPARSER::COLLECTION)
    ("ASM or MCL" . SPARSER::COLLECTION)
    ("patients indeed only bear wild type KIT or iii" . SPARSER::COLLECTION)
    ("KIT or iii" . SPARSER::COLLECTION)
    ("more aggressive forms" . SPARSER::FORM) ("ASM/MCL" . SPARSER::COLLECTION)
    ("tryptase" . SPARSER::PROTEIN)
    ("the mutated KIT D816V allele" . SPARSER::ALLELE)
    ("DNA or RNA/cDNA" . SPARSER::COLLECTION) ("PNA" . SPARSER::PROTEIN)
    ("RNA or DNA" . SPARSER::COLLECTION) ("CdA" . SPARSER::PROTEIN)
    ("cladribine" . SPARSER::PROTEIN) ("CEL" . SPARSER::PROTEIN)
    ("ASM" . SPARSER::PROTEIN) ("PB" . SPARSER::PROTEIN)
    ("type and -burden" . SPARSER::COLLECTION) ("ASXL1" . SPARSER::PROTEIN)
    ("SRSF2" . SPARSER::PROTEIN) ("TET2" . SPARSER::PROTEIN)
    ("Interferon-alpha" . SPARSER::PROTEIN) ("PKC412" . SPARSER::DRUG)
    ("interferon-α" . SPARSER::DRUG) ("CD2" . SPARSER::PROTEIN)
    ("RhoC, and MMP9" . SPARSER::COLLECTION)
    ("P70S6K and P53" . SPARSER::COLLECTION)
    ("P70S6K/P85S6K" . SPARSER::COLLECTION)
    ("P14ARF/MDM2/P53" . SPARSER::COLLECTION)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("P70S6K and Bcl-xL" . SPARSER::COLLECTION)
    ("RhoC and miR-93-5P" . SPARSER::COLLECTION)
    ("diagnostic and prognostic molecular biomarkers" . SPARSER::MOLECULE)
    ("DV  " . SPARSER::MOLECULE) ("DV" . SPARSER::MOLECULE)
    ("RhoC, P70S6K, Bcl-xL, and MMP9" . SPARSER::COLLECTION)
    ("Propidium" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor A ( VEGFA )" . SPARSER::PROTEIN)
    ("paralogue" . SPARSER::PROTEIN) ("the relevant genes" . SPARSER::GENE)
    ("a good biomarker" . SPARSER::MOLECULE) ("RHOC" . SPARSER::PROTEIN)
    ("P14ARF" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor A" . SPARSER::PROTEIN)
    ("CCNB1" . SPARSER::PROTEIN) ("P70S6K" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("P70" . SPARSER::PROTEIN)
    ("member C" . SPARSER::PROTEIN)
    ("Ras homolog gene family" . SPARSER::PROTEIN)
    ("miR-NS, anti-miR-21, miR-34b/c, or miR-34b/c + anti-miR-21"
     . SPARSER::ANTIBODY)
    ("-TTGGCTCACTGCAACCTC-3" . SPARSER::COLLECTION)
    ("-CTGTAATCCCAGCTACTCA-3" . SPARSER::COLLECTION)
    ("-CTTGGCCTCTCACAGTGCTA-3" . SPARSER::COLLECTION)
    ("-CCAAGATATGGTTTTATATTTCCTATGAG-3" . SPARSER::COLLECTION)
    ("-TTTTAAATGCCCACACAGAGG-3" . SPARSER::COLLECTION)
    ("-AATCACCAAAAGCCCAGAAA-3" . SPARSER::COLLECTION)
    ("FOXO3a or IgG" . SPARSER::COLLECTION)
    ("biotinylated secondary antibody" . SPARSER::PROTEIN)
    ("avidin-biotin" . SPARSER::PROTEIN-PAIR)
    ("CDK4, CKD6 or PTEN" . SPARSER::COLLECTION) ("xylene" . SPARSER::MOLECULE)
    ("hsa-miR-34b" . SPARSER::PROTEIN-PAIR)
    ("hsa-miR-21" . SPARSER::COLLECTION)
    ("FOXO3a and PTEN" . SPARSER::COLLECTION)
    ("anti-miR-21, miR-34b, and miR-34c" . SPARSER::COLLECTION)
    ("Hudson" . SPARSER::PROTEIN) ("β-actin and H2A" . SPARSER::COLLECTION)
    ("FOXO3a, p-s253-FOXO3a, and p-s315-FOXO3a" . SPARSER::COLLECTION)
    ("oncogene and miR-34b/c" . SPARSER::COLLECTION)
    ("miRNA-miRNA" . SPARSER::COLLECTION)
    ("miR-21 and miR-34a" . SPARSER::COLLECTION)
    ("miR-Scr" . SPARSER::PROTEIN-PAIR)
    ("PTEN/AKT/FOXO3a" . SPARSER::COLLECTION)
    ("AKT/PTEN" . SPARSER::COLLECTION)
    ("PTEN, CDK4 and CDK6" . SPARSER::COLLECTION)
    ("miR-21-" . SPARSER::PROTEIN) ("miR-21, and CDK4/6" . SPARSER::COLLECTION)
    ("triple expressing anti-miR-21 and miR-34b/c" . SPARSER::COLLECTION)
    ("anti-miR-21 and miR-34b/c" . SPARSER::COLLECTION)
    ("high circulating miR-21 and low miR-34b/c" . SPARSER::COLLECTION)
    ("miR-21, miR-34b, and miR-34c" . SPARSER::COLLECTION)
    ("miR-21 (up-regulated) and miR-34b/c (down-regulated)"
     . SPARSER::COLLECTION)
    ("PI3K/AKT/FOXO3a" . SPARSER::COLLECTION)
    ("miR-21 and miR-34b/c" . SPARSER::COLLECTION)
    ("the miR-21 and miR-34 families" . SPARSER::COLLECTION)
    ("The miR-34 family directly targets/regulates many proteins"
     . SPARSER::PROTEIN)
    ("the most commonly observed aberrant miRNAs" . SPARSER::PROTEIN)
    ("MiR-34a" . SPARSER::MOLECULE) ("PTEN–protein" . SPARSER::COLLECTION)
    ("PI3K/PTEN" . SPARSER::COLLECTION)
    ("a fragile protein" . SPARSER::PROTEIN)
    ("a Fragile Conformation" . SPARSER::BIO-CONFORMATION)
    ("Conformation" . SPARSER::BIO-CONFORMATION) ("DSF" . SPARSER::PROTEIN)
    ("many cancer-associated p53 variants" . SPARSER::VARIANT)
    ("ribonuclease" . SPARSER::PROTEIN) ("angiogenin" . SPARSER::PROTEIN)
    ("enzymes and other proteins" . SPARSER::COLLECTION)
    ("-active" . SPARSER::ACTIVE) ("BRAF and PTEN" . SPARSER::COLLECTION)
    ("certain chemotherapeutic drugs" . SPARSER::DRUG)
    ("lonafarnib and sorafenib" . SPARSER::COLLECTION)
    ("lonafarnib" . SPARSER::DRUG)
    ("the ribosomal protein S6 and the proteins Erk1/2" . SPARSER::COLLECTION)
    ("the NRAS mutant and BRAF mutant" . SPARSER::COLLECTION)
    ("even BRAF inhibitors" . SPARSER::INHIBITOR)
    ("NRAS mutant and BRAF mutant/PTEN-null cell lines" . SPARSER::COLLECTION)
    ("FTI" . SPARSER::DRUG) ("ZA and MEWO" . SPARSER::COLLECTION)
    ("cisplatin and ZA" . SPARSER::COLLECTION)
    ("the proteins Erk1/2 and the ribosomal protein S6" . SPARSER::COLLECTION)
    ("the Erk1/2 and the ribosomal protein S6 proteins" . SPARSER::COLLECTION)
    ("RAS-RAF-MEK" . SPARSER::COLLECTION)
    ("NRAS mutant and double wild-type cells" . SPARSER::COLLECTION)
    ("two BRAF mutant and PTEN-null" . SPARSER::COLLECTION)
    ("two NRAS mutant and two triple wild-type melanoma cell lines"
     . SPARSER::COLLECTION)
    ("25μM ZA and the percentage" . SPARSER::COLLECTION)
    ("ZA and the percentage" . SPARSER::COLLECTION)
    ("the mutational subtypes" . SPARSER::PROTEIN)
    ("NRAS and BRAF" . SPARSER::COLLECTION)
    ("two BRAF mutant and PTEN wild-type lines" . SPARSER::COLLECTION)
    ("zoledronic acid (ZA)" . SPARSER::DRUG)
    ("NRAS, BRAF and PTEN" . SPARSER::COLLECTION) ("ZA" . SPARSER::DRUG)
    ("BRAF, PTEN and NRAS" . SPARSER::COLLECTION)
    ("pamidronate and zoledronate" . SPARSER::COLLECTION)
    ("clodronate" . SPARSER::DRUG) ("bisphosphonate" . SPARSER::MOLECULE)
    ("especially nitrogen containing bisphosphonates" . SPARSER::MOLECULE)
    ("pamidronate or zoledronate" . SPARSER::COLLECTION)
    ("zoledronate" . SPARSER::DRUG) ("pamidronate" . SPARSER::DRUG)
    ("bisphosphonates" . SPARSER::MOLECULE) ("isoprenoids" . SPARSER::MOLECULE)
    ("Bisphosphonates" . SPARSER::MOLECULE) ("FTIs" . SPARSER::DRUG)
    ("cystein" . SPARSER::MOLECULE) ("thioether" . SPARSER::MOLECULE)
    ("Salirasib" . SPARSER::DRUG) ("FTS" . SPARSER::PROTEIN)
    ("protein kinase B/Akt" . SPARSER::COLLECTION)
    ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("KIT—NRAS—BRAF—MEK—ERK" . SPARSER::COLLECTION)
    ("BRAF mutant and BRAF/NRAS wild-type cells" . SPARSER::COLLECTION)
    ("BRAF/NRAS" . SPARSER::COLLECTION) ("RAS/RAF" . SPARSER::COLLECTION)
    ("SRB" . SPARSER::PROTEIN-FAMILY)
    ("BRAF, NRAS and PTEN" . SPARSER::COLLECTION)
    ("calpain2" . SPARSER::PROTEIN) ("N-Ras" . SPARSER::PROTEIN)
    ("Zoledronic acid" . SPARSER::DRUG) ("GSK3 and p53" . SPARSER::COLLECTION)
    ("active or inactive" . SPARSER::COLLECTION)
    ("GSK3β and p 21" . SPARSER::COLLECTION)
    ("GSK3α/β and phospho-GSK3α/β" . SPARSER::COLLECTION)
    ("GSK3α/GSK3β" . SPARSER::COLLECTION) ("DMBA" . SPARSER::MOLECULE)
    ("GSK3β, and cyclin D1" . SPARSER::COLLECTION)
    ("GSK3α-cyclin D1" . SPARSER::COLLECTION)
    ("GSK3β and cyclin D1" . SPARSER::COLLECTION)
    ("pS 9 GSK3β (p = 0.001) and pS 21 GSK3α (p = 0.0001)"
     . SPARSER::COLLECTION)
    ("GSK3α and pSer" . SPARSER::COLLECTION) ("PMLs" . SPARSER::PROTEIN)
    ("GSK3α/β, cyclin D1 and p53" . SPARSER::COLLECTION)
    ("pS 21 GSK3α (p = 0.0032) and pS 9 GSK3β (p = 0.036)"
     . SPARSER::COLLECTION)
    ("GSK3β and pS 21" . SPARSER::COLLECTION)
    ("both the GSK3α and the GSK3β antibody" . SPARSER::COLLECTION)
    ("the normal lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NC and CC" . SPARSER::COLLECTION)
    ("NC, N-CC and CC" . SPARSER::COLLECTION)
    ("GSK3β and GSK3α" . SPARSER::COLLECTION)
    ("GSK3α or GSK3β" . SPARSER::COLLECTION)
    ("Males and females" . SPARSER::COLLECTION) ("Males" . SPARSER::MOLECULE)
    ("active complexes" . SPARSER::BIO-COMPLEX)
    ("NFκB, AP-1, c-Myc and p53" . SPARSER::COLLECTION)
    ("the eastern part" . SPARSER::COMPONENT)
    ("GSK3β-cyclin D1" . SPARSER::COLLECTION)
    ("GSK3α and pS" . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("total and phosphorylated GSK3α/β as well as cyclin D1 and p53"
     . SPARSER::COLLECTION)
    ("total and phosphorylated GSK3α/β" . SPARSER::PROTEIN)
    ("cyclin D1 and p53" . SPARSER::COLLECTION)
    ("phosphatidyl-inositol-3-kinase" . SPARSER::PROTEIN-FAMILY)
    ("p 21" . SPARSER::PROTEIN) ("GSK3s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TG 3" . SPARSER::PROTEIN) ("H12" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 4" . SPARSER::PROTEIN)
    ("pS 21" . SPARSER::PROTEIN)
    ("namely AT2, AT4, Mas, and pro-renin receptors" . SPARSER::RECEPTOR)
    ("at least four other angiotensins" . SPARSER::PROTEIN)
    ("AT2, AT4, Mas, and pro-renin" . SPARSER::COLLECTION)
    ("Ang" . SPARSER::PROTEIN) ("angiotensins" . SPARSER::PROTEIN)
    ("filamentous tau" . SPARSER::PROTEIN) ("AT1/Nox4" . SPARSER::COLLECTION)
    ("MPTP or 6-OHDA" . SPARSER::COLLECTION) ("levodopa" . SPARSER::DRUG)
    ("mannitol" . SPARSER::PROTEIN) ("BBB" . SPARSER::PROTEIN)
    ("dopa" . SPARSER::MOLECULE) ("RAS and dopamine" . SPARSER::COLLECTION)
    ("nucleoporin" . SPARSER::PROTEIN)
    ("nigral matrix and nigrosome" . SPARSER::COLLECTION)
    ("nigral matrix" . SPARSER::PROTEIN-FAMILY)
    ("S100B- and GFAP-immunoreactive" . SPARSER::COLLECTION)
    ("S100B-" . SPARSER::PROTEIN)
    ("both nigral matrix and nigrosome" . SPARSER::COLLECTION)
    ("nigral intraneuronal RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a selective dopaminergic neurotoxin" . SPARSER::PROTEIN)
    ("p47 and Nox2" . SPARSER::COLLECTION)
    ("a multimeric NADPH oxidase" . SPARSER::PROTEIN)
    ("tetrahydropyridine" . SPARSER::MOLECULE) ("losartan" . SPARSER::PROTEIN)
    ("v" . SPARSER::PROTEIN)
    ("the peripheral RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the nigral matrix" . SPARSER::PROTEIN-FAMILY)
    ("matrix and nigrosome" . SPARSER::COLLECTION)
    ("both the matrix and the nigrosome" . SPARSER::COLLECTION)
    ("the less affected calbindin-rich matrix and the first-affected calbindin-poor nigrosome"
     . SPARSER::COLLECTION)
    ("two nigral subregions" . SPARSER::PROTEIN)
    ("AT1 and Nox4" . SPARSER::COLLECTION)
    ("NADPH oxidase (Nox) in the nigral dopamine neurons and microglia"
     . SPARSER::COLLECTION)
    ("AT2" . SPARSER::PROTEIN) ("ACE2" . SPARSER::PROTEIN)
    ("Ang 1" . SPARSER::PROTEIN) ("converting enzyme" . SPARSER::PROTEIN)
    ("interleukin 1β" . SPARSER::PROTEIN) ("D-I" . SPARSER::PROTEIN)
    ("Nox4 " . SPARSER::PROTEIN) ("AT1 " . SPARSER::PROTEIN)
    ("E-G" . SPARSER::PROTEIN) ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("A-F" . SPARSER::PROTEIN) ("nucleoporin 62" . SPARSER::PROTEIN)
    ("BR3" . SPARSER::PROTEIN) ("S100B" . SPARSER::PROTEIN)
    ("Nup62" . SPARSER::PROTEIN) ("Iba1" . SPARSER::PROTEIN)
    ("α-synuclein" . SPARSER::PROTEIN) ("MPP+" . SPARSER::MOLECULE)
    ("6-OHDA" . SPARSER::MOLECULE) ("6-hydroxydopamine" . SPARSER::DRUG)
    ("AT1" . SPARSER::PROTEIN) ("a defective DDR" . SPARSER::PROTEIN)
    ("the DNA damage-dependent chromatin" . SPARSER::PROTEIN)
    ("53BP1 and lamin A/C" . SPARSER::COLLECTION)
    ("a larger protein complex" . SPARSER::BIO-COMPLEX)
    ("cathepsin L (CTSL)" . SPARSER::PROTEIN) ("CTSL" . SPARSER::PROTEIN)
    ("detergent" . SPARSER::MOLECULE) ("pKAP-1" . SPARSER::COLLECTION)
    ("53BP1-lamin" . SPARSER::COLLECTION)
    ("either caffeine or the ATM inhibitor (ATMi) KU55933"
     . SPARSER::COLLECTION)
    ("53BP1-lamin A/C" . SPARSER::COLLECTION)
    ("lamin A/C-53BP1" . SPARSER::COLLECTION)
    ("the fragment and GFP-lamin" . SPARSER::COLLECTION)
    ("HA-53BP1" . SPARSER::COLLECTION) ("53BP1 and GFP" . SPARSER::COLLECTION)
    ("GFP-lamin" . SPARSER::COLLECTION) ("GPF-lamin" . SPARSER::COLLECTION)
    ("NuMa" . SPARSER::PROTEIN)
    ("chromatin and nucleoskeleton" . SPARSER::COLLECTION)
    ("Lmna" . SPARSER::PROTEIN) ("lamin" . SPARSER::PROTEIN)
    ("HGPS" . SPARSER::PROTEIN) ("LMNA" . SPARSER::PROTEIN)
    ("lamins" . SPARSER::PROTEIN-FAMILY) ("Lamins" . SPARSER::PROTEIN)
    ("MCM6" . SPARSER::PROTEIN) ("KAP1" . SPARSER::PROTEIN)
    ("lamin B2" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("cathepsin L" . SPARSER::PROTEIN)
    ("KRAB-associated protein 1" . SPARSER::PROTEIN)
    ("KU55933" . SPARSER::DRUG) ("JMJD2A" . SPARSER::PROTEIN)
    ("LAP2" . SPARSER::PROTEIN)
    ("cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cysteine, methionine, aspartic acid, and histidine"
     . SPARSER::COLLECTION)
    ("amino acids and peptides" . SPARSER::COLLECTION)
    ("carrageenan" . SPARSER::MOLECULE)
    ("NF-κB-dependent pro-inflammatory genes" . SPARSER::GENE)
    ("other inflammatory stimulant" . SPARSER::DRUG)
    ("stimulant" . SPARSER::DRUG)
    ("Cyclooxygenase-1 and Cyclooxygenase-2" . SPARSER::COLLECTION)
    ("NS-398 and LPS" . SPARSER::COLLECTION)
    ("ROS or intracellular Ca 2+ [ xref ]" . SPARSER::COLLECTION)
    ("c-fos and c-jun" . SPARSER::COLLECTION)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p  " . SPARSER::PROTEIN)
    ("response elements (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (PPRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Ptgs2" . SPARSER::PROTEIN) ("PPRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("promoters, mitogens, and growth factors" . SPARSER::COLLECTION)
    ("Ptgs1" . SPARSER::PROTEIN) ("prostanoid" . SPARSER::MOLECULE)
    ("cyclooxygenase and peroxidase" . SPARSER::COLLECTION)
    ("prostanoids" . SPARSER::MOLECULE)
    ("Cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)"
     . SPARSER::COLLECTION)
    ("the bifunctional enzymes" . SPARSER::ENZYME)
    ("PGE 2 and TXB" . SPARSER::COLLECTION)
    ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("Prostaglandin E 2 (PGE 2 ) and stable metabolite" . SPARSER::COLLECTION)
    ("COXs" . SPARSER::PROTEIN) ("Macrophages" . SPARSER::PROTEIN)
    ("initiation factor 4E" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("casein kinase 2" . SPARSER::PROTEIN) ("c-jun" . SPARSER::PROTEIN)
    ("Thromboxane A 2" . SPARSER::MOLECULE)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Thromboxane B 2" . SPARSER::MOLECULE) ("NF-IL6" . SPARSER::PROTEIN)
    ("PGF 2α" . SPARSER::MOLECULE) ("PGI 2" . SPARSER::PROTEIN)
    ("prostaglandin I 2" . SPARSER::MOLECULE) ("PGD 2" . SPARSER::PROTEIN)
    ("PGG 2" . SPARSER::MOLECULE) ("prostaglandin G 2" . SPARSER::MOLECULE)
    ("Cyclooxygenase-1" . SPARSER::PROTEIN)
    ("thromboxane B 2" . SPARSER::MOLECULE)
    ("Prostaglandin E 2" . SPARSER::MOLECULE) ("CdCl 2" . SPARSER::MOLECULE)
    ("cyclooxygenase-1" . SPARSER::PROTEIN)
    ("HCV-associated IR and T2DM" . SPARSER::COLLECTION)
    ("IR and T2DM" . SPARSER::COLLECTION) ("RBV" . SPARSER::DRUG)
    ("HOMA-IR" . SPARSER::COLLECTION) ("antivirals" . SPARSER::DRUG)
    ("IKK/NF-κB" . SPARSER::COLLECTION) ("ribavirin" . SPARSER::DRUG)
    ("plasmid transfected hepatocytes" . SPARSER::PROTEIN)
    ("a previous study wherein HCV 3a core protein" . SPARSER::PROTEIN)
    ("the glucose transporter type 4 (GLUT4) as well as up-regulating phosphoenolpyruvate carboxykinase 2 (PCK2)"
     . SPARSER::COLLECTION)
    ("mTOR/S6K1" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("SOCS3 and proinflammatory cytokines [ xref ]" . SPARSER::COLLECTION)
    ("IRS-1 and IRS-2" . SPARSER::COLLECTION)
    ("the HCV-associated IR" . SPARSER::PROTEIN)
    ("PTEN and IRS-1" . SPARSER::COLLECTION)
    ("another direct phosphorylational substrate" . SPARSER::SUBSTRATE)
    ("Shi" . SPARSER::PROTEIN)
    ("IRS-1 and its Ser307-phosphorylated form" . SPARSER::COLLECTION)
    ("Tyr/Ser" . SPARSER::COLLECTION)
    ("proteins and phosphoinositides" . SPARSER::COLLECTION)
    ("pAkt/Akt" . SPARSER::COLLECTION) ("PTEN or PTEN" . SPARSER::COLLECTION)
    ("shRNA, and IRS-1 and pIRS-1" . SPARSER::COLLECTION)
    ("IRS-1 and pIRS-1" . SPARSER::COLLECTION)
    ("both phosphorylated Akt (pAkt) and total Akt" . SPARSER::COLLECTION)
    ("pIRS-1" . SPARSER::COLLECTION) ("HCV-associated IR" . SPARSER::PROTEIN)
    ("phosphoenolpyruvate carboxykinase 2" . SPARSER::PROTEIN)
    ("type 4" . SPARSER::PROTEIN) ("SOCS7" . SPARSER::PROTEIN)
    ("SOCS3" . SPARSER::PROTEIN) ("IRS-2" . SPARSER::PROTEIN)
    ("Suppressor of cytokine signaling-3" . SPARSER::PROTEIN)
    ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("high RB and low CDKN2A" . SPARSER::COLLECTION)
    ("high cyclin D1, high RB and low CDKN2A" . SPARSER::COLLECTION)
    ("palbociclib" . SPARSER::DRUG)
    ("cyclin D1 and the only expressed isoform" . SPARSER::COLLECTION)
    ("the only expressed isoform" . SPARSER::ISOFORM)
    ("expressed isoform" . SPARSER::ISOFORM)
    ("CRAF and BRAF" . SPARSER::COLLECTION)
    ("the pro-apoptotic gene BCL2L11 (BIM)" . SPARSER::PROTEIN)
    ("Antibody" . SPARSER::PROTEIN) ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("BCL2L11 (BIM)" . SPARSER::PROTEIN)
    ("BCL2L1 and BCL2L12" . SPARSER::COLLECTION)
    ("CDK1, CDK2, cyclin A2 and cyclin B1" . SPARSER::COLLECTION)
    ("RAF and MEK" . SPARSER::COLLECTION) ("Ib" . SPARSER::DRUG)
    ("RAFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRAF and CRAF" . SPARSER::COLLECTION)
    ("MST-2 (MAP3K10) and ASK-1 (MAP3K5)" . SPARSER::COLLECTION)
    ("MST-2" . SPARSER::PROTEIN) ("proteins (SPRY)" . SPARSER::PROTEIN)
    ("DUSP4 and DUSP6" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRAF, BRAF and ARAF" . SPARSER::COLLECTION) ("ARAF" . SPARSER::PROTEIN)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("a pan-RAF inhibitor (PRi, Amgen Compd A), a MEK inhibitor (MEKi, trametinib) or their combination and the effects on proliferation"
     . SPARSER::COLLECTION)
    ("a MEK inhibitor (MEKi, trametinib) or their combination"
     . SPARSER::COLLECTION)
    ("Phospho-Kinase" . SPARSER::PROTEIN) ("PD 0332991" . SPARSER::DRUG)
    ("cyclin D3 " . SPARSER::PROTEIN) ("Cyclin D3" . SPARSER::PROTEIN)
    ("BCL2L12" . SPARSER::PROTEIN) ("PI3Ki" . SPARSER::PROTEIN)
    ("LEE011" . SPARSER::DRUG) ("MEK162" . SPARSER::DRUG)
    ("MAP3K5" . SPARSER::PROTEIN) ("ASK-1" . SPARSER::PROTEIN)
    ("MAP3K10" . SPARSER::PROTEIN) ("DUSP6" . SPARSER::PROTEIN)
    ("BCL2L11" . SPARSER::PROTEIN) ("cyclin D3" . SPARSER::PROTEIN)
    ("Raf and RalGDS" . SPARSER::COLLECTION)
    ("Grb10 [ xref ] and Grb14 [ xref ]" . SPARSER::COLLECTION)
    ("Ras-PI3Kγ" . SPARSER::COLLECTION)
    ("PI3Kγ, PI3Kα, and Grb14" . SPARSER::COLLECTION)
    ("PI3Kγ or Grb14" . SPARSER::COLLECTION)
    ("Ras/PI3Kα" . SPARSER::COLLECTION) ("CNGA1 and Ras" . SPARSER::COLLECTION)
    ("RA-Grb14" . SPARSER::COLLECTION)
    ("considerable tertiary structural homology" . SPARSER::PROTEIN)
    ("anti-CNGA1 and anti-Myc" . SPARSER::COLLECTION)
    ("RA-PI3Kγ" . SPARSER::COLLECTION)
    ("PI3Kα or PI3Kγ and CNGA1" . SPARSER::COLLECTION)
    ("CTR-CNGA1" . SPARSER::COLLECTION) ("Myc and Flag" . SPARSER::COLLECTION)
    ("CNGA1 and PI3Kα or PI3Kγ" . SPARSER::COLLECTION)
    ("PI3Kα or PI3Kγ" . SPARSER::COLLECTION) ("RA-PI3Kα" . SPARSER::COLLECTION)
    ("PI3Kα and PI3Kγ" . SPARSER::COLLECTION) ("CTR" . SPARSER::PROTEIN)
    ("light- and receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("light-" . SPARSER::PROTEIN) ("retinas" . SPARSER::DRUG)
    ("dark-adapted ROS" . SPARSER::PROTEIN) ("ROS (LROS)" . SPARSER::PROTEIN)
    ("proteins, CNGA1 and opsin" . SPARSER::COLLECTION)
    ("anti-PI3Kα, anti-PI3Kβ, anti-PI3Kγ, anti-CNGA1, and anti-opsin"
     . SPARSER::COLLECTION)
    ("opsin" . SPARSER::PROTEIN) ("IA or IB" . SPARSER::COLLECTION)
    ("antibody or non-immune" . SPARSER::COLLECTION)
    ("cGMP" . SPARSER::PROTEIN) ("PI3Kγ and CNGA1" . SPARSER::COLLECTION)
    ("CNG" . SPARSER::PROTEIN) ("Indo-1" . SPARSER::MOLECULE)
    ("pDL2" . SPARSER::PROTEIN) ("P48736" . SPARSER::PROTEIN)
    ("P42336" . SPARSER::PROTEIN) ("PI-3" . SPARSER::PROTEIN)
    ("Grb10" . SPARSER::PROTEIN) ("of 45 " . SPARSER::PROTEIN)
    ("D-G" . SPARSER::PROTEIN) ("G6PDH" . SPARSER::PROTEIN)
    ("PI-103" . SPARSER::DRUG) ("AS604850" . SPARSER::DRUG)
    ("D-F" . SPARSER::PROTEIN) ("PI-4" . SPARSER::PROTEIN)
    ("p110 γ" . SPARSER::PROTEIN) ("Grb14" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 14" . SPARSER::PROTEIN)
    ("CNGA1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOX4, EZH2, HDAC3 and miR-31" . SPARSER::COLLECTION)
    ("PRC2-interacting YY1 or the SOX4-interracting protein GATA4"
     . SPARSER::COLLECTION)
    ("PRC2/EZH2" . SPARSER::COLLECTION)
    ("directly targeting SOX4 and indirectly targeting EZH2 and HDAC3"
     . SPARSER::COLLECTION)
    ("HDAC and DNMT" . SPARSER::COLLECTION)
    ("Polycomb/EZH2" . SPARSER::COLLECTION)
    ("a strong inhibitor" . SPARSER::INHIBITOR)
    ("CDK1, E2F2, EXO1, FOXM1, MCM2, Src or MET" . SPARSER::COLLECTION)
    ("E2F2" . SPARSER::PROTEIN)
    ("promoters or suppressors" . SPARSER::COLLECTION)
    ("SOX4 ( P value = 0.003 ) and HDAC3 ( P value = 0.042 )"
     . SPARSER::COLLECTION)
    ("HDAC3 and H3K27me3" . SPARSER::COLLECTION)
    ("H3K27me3 and HDAC3" . SPARSER::COLLECTION)
    ("HDAC3-antibody" . SPARSER::COLLECTION)
    ("HDAC3, H3K27me3, and Suz12" . SPARSER::COLLECTION)
    ("SOX4 and EZH2, HDAC3 and H3K27me3" . SPARSER::COLLECTION)
    ("EZH2, HDAC3 and H3K27me3" . SPARSER::COLLECTION)
    ("HDACs and other chromatin" . SPARSER::COLLECTION)
    ("DNA methyl-transferases (DNMTs), HDACs and other chromatin"
     . SPARSER::COLLECTION)
    ("microrna" . SPARSER::RNA)
    ("miR-31 directly targets SOX4 and indirectly targets EZH2 and HDAC3"
     . SPARSER::COLLECTION)
    ("indirectly targets EZH2 and HDAC3" . SPARSER::COLLECTION)
    ("miR-31 directly targets SOX4" . SPARSER::PROTEIN)
    ("PRC2, HDAC and DNA" . SPARSER::COLLECTION)
    ("Cytidine" . SPARSER::MOLECULE) ("AZA" . SPARSER::DRUG)
    ("HDAC3, EZH2 and EZH1" . SPARSER::COLLECTION)
    ("inhibitor (SAHA)" . SPARSER::INHIBITOR)
    ("SOX4, HDAC3 and EZH2" . SPARSER::COLLECTION)
    ("p14 (ARF)" . SPARSER::PROTEIN)
    ("CDKN2A and CDKN2B" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("GATA4, RORα and STAT3" . SPARSER::COLLECTION)
    ("developmental genes" . SPARSER::GENE)
    ("proteins, EZH2, SUZ12, and EED" . SPARSER::COLLECTION)
    ("EED" . SPARSER::PROTEIN)
    ("at least two complexes" . SPARSER::BIO-COMPLEX)
    ("PRC1 and PRC2" . SPARSER::COLLECTION)
    ("Dicer, Argonaute 1 and RNA Helicase A" . SPARSER::COLLECTION)
    ("Dicer" . SPARSER::PROTEIN) ("SOX11 and SOX12" . SPARSER::COLLECTION)
    ("SRY" . SPARSER::PROTEIN) ("SoxC" . SPARSER::PROTEIN)
    ("oncogene or tumor" . SPARSER::COLLECTION)
    ("SOX4, EZH2 and miR-31" . SPARSER::COLLECTION)
    ("SOX4, EZH2, and HDAC3, and EZH2" . SPARSER::COLLECTION)
    ("HDAC3, and EZH2" . SPARSER::COLLECTION)
    ("SOX4 and EZH2" . SPARSER::COLLECTION)
    ("SOX4, EZH2 and HDAC3" . SPARSER::COLLECTION)
    ("EZH2 and HDAC3" . SPARSER::COLLECTION)
    ("SOX4 and co-repressor" . SPARSER::COLLECTION) ("MYT1" . SPARSER::PROTEIN)
    ("Suz12" . SPARSER::PROTEIN) ("methyl-transferases" . SPARSER::PROTEIN)
    ("miR-200a" . SPARSER::MOLECULE) ("INK4A" . SPARSER::PROTEIN)
    ("INK4B" . SPARSER::PROTEIN) ("RORα" . SPARSER::PROTEIN)
    ("RNA Helicase A" . SPARSER::PROTEIN) ("Argonaute 1" . SPARSER::PROTEIN)
    ("SOX12" . SPARSER::PROTEIN) ("SOX11" . SPARSER::PROTEIN)
    ("SOX4" . SPARSER::PROTEIN) ("a particular exon" . SPARSER::PROTEIN)
    ("primarily missense variants" . SPARSER::VARIANT)
    ("pathogenic variant" . SPARSER::VARIANT)
    ("variant or variants" . SPARSER::COLLECTION)
    ("one-stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("unique BRCA1 variants" . SPARSER::VARIANT)
    ("proteins and TPT1" . SPARSER::COLLECTION)
    ("Valosin-containing protein and HNRNPK" . SPARSER::COLLECTION)
    ("HNRNPK" . SPARSER::PROTEIN)
    ("wild-type p53 and other p53 isoforms" . SPARSER::COLLECTION)
    ("healthy PBMCs alpha-enolase" . SPARSER::PROTEIN)
    ("reported multiple pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("chemokine and cytokine" . SPARSER::COLLECTION)
    ("the smaller-sized protein" . SPARSER::PROTEIN)
    ("approximately 48 kDa" . SPARSER::PROTEIN)
    ("the most abundantly expressed proteins" . SPARSER::PROTEIN)
    ("expressed proteins" . SPARSER::PROTEIN)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("the only plasminogen receptor" . SPARSER::RECEPTOR)
    ("TXA" . SPARSER::MOLECULE)
    ("the pro-inflammatory cytokine TNF-alpha" . SPARSER::PROTEIN)
    ("minimal alpha-enolase" . SPARSER::PROTEIN)
    ("valosin-containing protein (VCP)" . SPARSER::PROTEIN)
    ("VCP" . SPARSER::PROTEIN) ("TKT and TPT1" . SPARSER::COLLECTION)
    ("TKT" . SPARSER::PROTEIN) ("MG132 and amsacrine" . SPARSER::COLLECTION)
    ("the ubiquitin-associated proteasome inhibitor MG132" . SPARSER::PROTEIN)
    ("p53- and Δ122p53" . SPARSER::COLLECTION) ("p70s6k" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myc and tumor necrosis factor" . SPARSER::COLLECTION)
    ("EEF2, PSMA1, PSMA3, and PSMB8" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("creatine" . SPARSER::PROTEIN)
    ("myc and transforming growth factor" . SPARSER::COLLECTION)
    ("PSMA1, PSMC5, and EIF4H" . SPARSER::COLLECTION)
    ("CAPZB" . SPARSER::PROTEIN) ("CKM" . SPARSER::PROTEIN)
    ("treated and untreated mutant" . SPARSER::MUTANT)
    ("p53-, mΔpro, and Δ122p53" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and p53" . SPARSER::COLLECTION)
    ("p53 and Δ122p53" . SPARSER::COLLECTION)
    ("plasminogen" . SPARSER::PROTEIN) ("amsacrine" . SPARSER::DRUG)
    ("at least 12 isoforms" . SPARSER::ISOFORM)
    ("Valosin-containing protein" . SPARSER::PROTEIN)
    ("TNF- alpha" . SPARSER::PROTEIN)
    ("valosin-containing protein" . SPARSER::PROTEIN)
    ("Heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("s6k" . SPARSER::PROTEIN) ("p70" . SPARSER::PROTEIN)
    ("tryptophan 5-monooxygenase" . SPARSER::PROTEIN)
    ("PSMB8" . SPARSER::PROTEIN) ("PSMA3" . SPARSER::PROTEIN)
    ("plastin-2" . SPARSER::PROTEIN)
    ("creatine kinase M-type" . SPARSER::PROTEIN)
    ("BAY11–7082" . SPARSER::DRUG) ("beta2" . SPARSER::PROTEIN)
    ("ENO1" . SPARSER::PROTEIN) ("( beta" . SPARSER::PROTEIN)
    ("beta-2 microglobulin" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("TPT1" . SPARSER::PROTEIN) ("TPI1" . SPARSER::PROTEIN)
    ("ATPase 5" . SPARSER::PROTEIN)
    ("macropain) 26S Subunit" . SPARSER::PROTEIN)
    ("proteasome (prosome" . SPARSER::PROTEIN) ("PSMC5" . SPARSER::PROTEIN)
    ("proteasome subunit alpha type-1" . SPARSER::PROTEIN)
    ("PSMA1" . SPARSER::PROTEIN) ("lamin B1" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein K" . SPARSER::PROTEIN)
    ("focal adhesion kinase 1" . SPARSER::PROTEIN) ("FAK1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4H" . SPARSER::PROTEIN)
    ("EIF4H" . SPARSER::PROTEIN)
    ("eukaryotic elongation factor" . SPARSER::PROTEIN)
    ("EEF2" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("capping protein" . SPARSER::PROTEIN)
    ("ATP synthase subunit beta, mitochondrial" . SPARSER::PROTEIN)
    ("ATP5B" . SPARSER::PROTEIN) ("Transmembrane Protein" . SPARSER::PROTEIN)
    ("Membrane Protein" . SPARSER::PROTEIN) ("Delta2" . SPARSER::PROTEIN)
    ("Alpha-enolase" . SPARSER::PROTEIN)
    ("POLQ, ΔRAD51, or A-dead" . SPARSER::COLLECTION)
    ("an anti-recombinase" . SPARSER::ANTIBODY)
    ("the anti-recombinase activity" . SPARSER::ANTIBODY)
    ("FANCD2 and POLQ" . SPARSER::COLLECTION)
    ("POLQ or Scr" . SPARSER::COLLECTION)
    ("severe congenital malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("HR and POLQ" . SPARSER::COLLECTION)
    ("FANCA" . SPARSER::PROTEIN) ("ultraviolet (UV) light" . SPARSER::PROTEIN)
    ("RAD51-ssDNA" . SPARSER::COLLECTION)
    ("single-stranded DNA (ssDNA) or fork DNA ( xref and xref )"
     . SPARSER::COLLECTION)
    ("basal ATPase activity" . SPARSER::PROTEIN)
    ("POLQ or ΔPol1" . SPARSER::COLLECTION) ("Peptides" . SPARSER::PEPTIDE)
    ("GST-RAD51" . SPARSER::COLLECTION) ("Flag-POLQ" . SPARSER::COLLECTION)
    ("PARI or BLM" . SPARSER::COLLECTION) ("PARI" . SPARSER::PROTEIN)
    ("Fancd2" . SPARSER::PROTEIN) ("Polq" . SPARSER::PROTEIN)
    ("POLQ" . SPARSER::PROTEIN) ("poly-ADP" . SPARSER::PROTEIN)
    ("OST2" . SPARSER::PROTEIN) ("32P" . SPARSER::|32P|)
    ("Ulp1" . SPARSER::PROTEIN) ("ABT-888" . SPARSER::DRUG)
    ("cis-diamminedichloroplatinum" . SPARSER::DRUG)
    ("Mitomycin C" . SPARSER::DRUG) ("KAP-1" . SPARSER::PROTEIN)
    ("H-10" . SPARSER::PROTEIN) ("B14)" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN) ("Pol2" . SPARSER::PROTEIN)
    ("RFS-1" . SPARSER::PROTEIN)
    ("transiently bound S1 molecules" . SPARSER::MOLECULE)
    ("actinin-rod" . SPARSER::PROTEIN-PAIR)
    ("singly or sparsely bound cofilin molecules" . SPARSER::MOLECULE)
    ("spectrin" . SPARSER::PROTEIN)
    ("alpha-actinin-cofilin" . SPARSER::COLLECTION)
    ("ATP or ADP+Pi" . SPARSER::COLLECTION) ("drebrin" . SPARSER::PROTEIN)
    ("rapidly polymerizing actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("formin" . SPARSER::PROTEIN) ("polymerized actin" . SPARSER::PROTEIN)
    ("at least two distinct types" . TYPE)
    ("a singly bound cofilin molecule" . SPARSER::MOLECULE)
    ("individual bound cofilin molecules" . SPARSER::MOLECULE)
    ("actins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("contiguously bound cofilin molecules" . SPARSER::MOLECULE)
    ("the already bound molecule" . SPARSER::MOLECULE)
    ("an already bound cofilin molecule" . SPARSER::MOLECULE)
    ("ADP or ADP+Pi" . SPARSER::COLLECTION)
    ("cofilin–actin" . SPARSER::COLLECTION)
    ("an ‘inner’ cofilin" . SPARSER::PROTEIN)
    ("that cofilin's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homogenous nucleotide" . SPARSER::NUCLEOTIDE)
    ("ATP or ADP and Pi" . SPARSER::COLLECTION)
    ("ADP and Pi" . SPARSER::COLLECTION)
    ("those observed around cofilin" . SPARSER::PROTEIN)
    ("the apparently singly bound cofilin-rod molecules" . SPARSER::MOLECULE)
    ("Rod" . SPARSER::PROTEIN) ("cofilin-rod" . SPARSER::COLLECTION)
    ("Half helical pitch around sparsely bound cofilin" . SPARSER::PROTEIN)
    ("hexokinase" . SPARSER::PROTEIN)
    ("otherwise apparently bare filaments" . SPARSER::PROTEIN-FAMILY)
    ("shorter cofilin" . SPARSER::PROTEIN)
    ("Right-handed double helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("bacteriorhodopsin" . SPARSER::PROTEIN) ("AFM" . SPARSER::PROTEIN)
    ("only one molecule" . SPARSER::MOLECULE)
    ("proper cofilin" . SPARSER::PROTEIN)
    ("actin and specific actin binding proteins (ABPs)" . SPARSER::COLLECTION)
    ("actin–ABP" . SPARSER::COLLECTION) ("ABP" . SPARSER::PROTEIN)
    ("Actin" . SPARSER::PROTEIN) ("alpha-actinin" . SPARSER::PROTEIN)
    ("1–2 µ" . SPARSER::PROTEIN) ("cofilin 1" . SPARSER::PROTEIN)
    ("α-actinin" . SPARSER::PROTEIN) ("myosin V" . SPARSER::PROTEIN)
    ("a good prognostic biomarker" . SPARSER::MOLECULE)
    ("genes and tumors" . SPARSER::COLLECTION)
    ("nonmetastatic CRC" . SPARSER::PROTEIN) ("rofecoxib" . SPARSER::DRUG)
    ("a significant longer CCS" . SPARSER::PROTEIN) ("CCS" . SPARSER::PROTEIN)
    ("significantly less stage III CC" . SPARSER::PROTEIN)
    ("PIK3CA , KRAS, and BRAF" . SPARSER::COLLECTION)
    ("FU and oxaliplatin" . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("leucovorin" . SPARSER::DRUG) ("FU" . SPARSER::PROTEIN)
    ("uracil" . SPARSER::DRUG)
    ("a prognostic biomarker nor a predictive biomarker" . SPARSER::COLLECTION)
    ("a reproducible prognostic biomarker" . SPARSER::MOLECULE)
    ("KRAS , BRAF, and TP53" . SPARSER::COLLECTION) ("CIT" . SPARSER::PROTEIN)
    ("PIK3CA-" . SPARSER::PROTEIN) ("nonmetastatic CC" . SPARSER::PROTEIN)
    ("MSS and MSI" . SPARSER::COLLECTION)
    ("nonmetastatic colon cancer (CC)" . SPARSER::PROTEIN)
    ("PI3K or dual PI3K-mTOR inhibitors" . SPARSER::COLLECTION)
    ("dual PI3K-mTOR inhibitors" . SPARSER::INHIBITOR)
    ("a heterodimeric class IA PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/AKT/mTOR" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("the retrospective training cohort" . SPARSER::MOLECULE)
    ("CC" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("NEUROG1" . SPARSER::PROTEIN) ("CACNA1G" . SPARSER::PROTEIN)
    ("D5S346" . SPARSER::PROTEIN) ("PI3K-mTOR" . SPARSER::PROTEIN)
    ("3-phosphoinositide-dependent protein kinase-1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("PI3K α" . SPARSER::PROTEIN) ("p110 α" . SPARSER::PROTEIN)
    ("both ITD and wild-type FLT3" . SPARSER::COLLECTION)
    ("ITD- and wild-type FLT3 kinase" . SPARSER::COLLECTION)
    ("Lestaurtinib, Sunitinib, Sorafenib, and AC220" . SPARSER::COLLECTION)
    ("Sunitinib" . SPARSER::DRUG) ("Lestaurtinib" . SPARSER::DRUG)
    ("significantly less prone" . SPARSER::PROTEIN-FAMILY)
    ("MAPK and AKT" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bad protein" . SPARSER::PROTEIN)
    ("FLT3/MAPK" . SPARSER::COLLECTION) ("ITD-" . SPARSER::PROTEIN)
    ("a promising topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("midostaurin and crenolanib" . SPARSER::COLLECTION)
    ("crenolanib" . SPARSER::DRUG) ("midostaurin" . SPARSER::DRUG)
    ("KW" . SPARSER::MOLECULE) ("tandutinib" . SPARSER::DRUG)
    ("nonspecific siRNA" . SPARSER::PROTEIN)
    ("phospho-and total AKT and phospho- and total Bad" . SPARSER::COLLECTION)
    ("AKT, MAPK, STAT5, and Bad" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-MAPK" . SPARSER::COLLECTION)
    ("MAPK and STAT5" . SPARSER::COLLECTION)
    ("AKT and Bad" . SPARSER::COLLECTION)
    ("STAT5 and Bad" . SPARSER::COLLECTION)
    ("AKT, MAPK, STAT5 and Bad" . SPARSER::COLLECTION)
    ("the principal molecules" . SPARSER::MOLECULE)
    ("AKT and MAPK" . SPARSER::COLLECTION)
    ("AKT, MAPK, and STAT5" . SPARSER::COLLECTION)
    ("ligand (FL)" . SPARSER::MOLECULE)
    ("the internal tandem duplication mutant" . SPARSER::MUTANT)
    ("other topoisomerase II poisons" . SPARSER::MOLECULE)
    ("a topoisomerase II inhibitor" . SPARSER::INHIBITOR)
    ("FMO1 and FMO3" . SPARSER::COLLECTION)
    ("monooxygenases" . SPARSER::PROTEIN)
    ("STAT5 and MAPK" . SPARSER::COLLECTION)
    ("FLT3 and null-FLT3" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("AKT, MAPK and STAT5" . SPARSER::COLLECTION)
    ("FLT3-ITD" . SPARSER::COLLECTION)
    ("types and plays" . SPARSER::COLLECTION) ("UGT1A10" . SPARSER::PROTEIN)
    ("UDP-" . SPARSER::PROTEIN) ("FMO3" . SPARSER::PROTEIN)
    ("FMO1" . SPARSER::PROTEIN) ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("RS-4" . SPARSER::PROTEIN) ("Mondo" . SPARSER::PROTEIN)
    ("c-Myc and either MondoA or ChREBP" . SPARSER::COLLECTION)
    ("MondoA or ChREBP" . SPARSER::COLLECTION)
    ("LDHA and HKII" . SPARSER::COLLECTION) ("PKLR" . SPARSER::PROTEIN)
    ("HKII" . SPARSER::PROTEIN) ("Myc-MondoA" . SPARSER::COLLECTION)
    ("Myc and Mxd/Mnt" . SPARSER::COLLECTION)
    ("Mondo-Mlx" . SPARSER::COLLECTION) ("c-Myc-Max" . SPARSER::COLLECTION)
    ("MondoA and ChREBP" . SPARSER::COLLECTION)
    ("a gluconeogenic enzyme" . SPARSER::ENZYME)
    ("here places MondoA" . SPARSER::PROTEIN) ("GLN" . SPARSER::AMINO-ACID)
    ("PFAS" . SPARSER::PROTEIN) ("MLXIP" . SPARSER::PROTEIN)
    ("oleate" . SPARSER::MOLECULE) ("Fasn or Scd" . SPARSER::COLLECTION)
    ("zoledronic acid (ZOL)" . SPARSER::DRUG) ("ZOL" . SPARSER::DRUG)
    ("Fdps" . SPARSER::PROTEIN) ("anaplerotic substrate" . SPARSER::SUBSTRATE)
    ("Srebp1, Fasn and Scd" . SPARSER::COLLECTION) ("Fasn" . SPARSER::PROTEIN)
    ("fatty acid or isoprenoid" . SPARSER::COLLECTION)
    ("IDH" . SPARSER::PROTEIN) ("Slc1A5 or Bcl2" . SPARSER::COLLECTION)
    ("glucose or Gln" . SPARSER::COLLECTION)
    ("metformin (MET)" . SPARSER::DRUG) ("MP" . SPARSER::PROTEIN)
    ("transaminase" . SPARSER::PROTEIN) ("Ldha" . SPARSER::PROTEIN)
    ("pyruvate (Pyr) and lactate (Lac)" . SPARSER::COLLECTION)
    ("Mal, Cit, pyruvate (Pyr) and lactate (Lac)" . SPARSER::COLLECTION)
    ("-Gln" . SPARSER::COLLECTION) ("Cit" . SPARSER::PROTEIN)
    ("citrate" . SPARSER::PROTEIN) ("Mal" . SPARSER::PROTEIN)
    ("malate" . SPARSER::MOLECULE) ("Metabolite" . SPARSER::MOLECULE)
    ("139 soluble metabolites" . SPARSER::PROTEIN)
    ("MondoA ( xref ) or Mlx ( xref )" . SPARSER::COLLECTION)
    ("Bid and Bax" . SPARSER::COLLECTION)
    ("tBid and tBax" . SPARSER::COLLECTION) ("Parp" . SPARSER::PROTEIN)
    ("Slc1A5, Pfas and Tomm20" . SPARSER::COLLECTION)
    ("-ON" . SPARSER::COLLECTION) ("Myc-" . SPARSER::PROTEIN)
    ("Pck2" . SPARSER::PROTEIN) ("RpS6" . SPARSER::PROTEIN)
    ("Slc1A5 or anti-transporter" . SPARSER::COLLECTION)
    ("p-RpS6" . SPARSER::COLLECTION) ("Slc3A2" . SPARSER::PROTEIN)
    ("RpS" . SPARSER::PROTEIN) ("glucose and MondoA" . SPARSER::COLLECTION)
    ("Slc1A5 and Tomm20" . SPARSER::COLLECTION)
    ("c-Myc and MondoA" . SPARSER::COLLECTION) ("Tomm20" . SPARSER::PROTEIN)
    ("Slc1A5" . SPARSER::PROTEIN)
    ("Mlx (in one dataset) and many target genes" . SPARSER::COLLECTION)
    ("MondoA or Mlx" . SPARSER::COLLECTION)
    ("MondoA-Mlx" . SPARSER::COLLECTION) ("N-Myc/MondoA" . SPARSER::COLLECTION)
    ("Myc/MondoA" . SPARSER::COLLECTION)
    ("lipid and sterol biogenesis" . SPARSER::COLLECTION)
    ("lipid and glucose metabolism" . SPARSER::COLLECTION)
    ("SREBP1 and SCD" . SPARSER::COLLECTION)
    ("FASN and PCK2" . SPARSER::COLLECTION) ("FASN" . SPARSER::PROTEIN)
    ("SCD" . SPARSER::PROTEIN) ("shRNA or siRNA" . SPARSER::COLLECTION)
    ("N-Myc-ON" . SPARSER::COLLECTION)
    ("N-Myc and MondoA" . SPARSER::COLLECTION)
    ("Max/Mlx" . SPARSER::COLLECTION) ("Txnip" . SPARSER::PROTEIN)
    ("c-Myc and Mxd4" . SPARSER::COLLECTION)
    ("Max, Mlx and MondoA" . SPARSER::COLLECTION)
    ("Mxd1, Mxd4 and Mnt" . SPARSER::COLLECTION) ("Mnt" . SPARSER::PROTEIN)
    ("c-Myc or N-Myc" . SPARSER::COLLECTION)
    ("c-Myc (CB660+c-Myc) as well as their immortalized derivatives"
     . SPARSER::COLLECTION)
    ("p53 and RB" . SPARSER::COLLECTION)
    ("MondoA, or Mlx" . SPARSER::COLLECTION)
    ("MondoA/Mlx" . SPARSER::COLLECTION) ("Mlxip" . SPARSER::PROTEIN)
    ("c-Myc-ON" . SPARSER::COLLECTION) ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("Mlx and Max" . SPARSER::COLLECTION) ("Metabolites" . SPARSER::PROTEIN)
    ("mitochondrial metabolites" . SPARSER::PROTEIN)
    ("MondoA or carbohydrate response element binding protein"
     . SPARSER::COLLECTION)
    ("centered around Mlx" . SPARSER::PROTEIN)
    ("Max and E-Box" . SPARSER::COLLECTION)
    ("TFAM and other nuclear-encoded mitochondrial genes ( xref )"
     . SPARSER::COLLECTION)
    ("nucleotide, amino acid and lipid" . SPARSER::COLLECTION)
    ("N-Myc, and MYCL" . SPARSER::COLLECTION) ("MYCL" . SPARSER::PROTEIN)
    ("inhibiting MondoA and its target genes" . SPARSER::COLLECTION)
    ("Myc and MondoA" . SPARSER::COLLECTION) ("Mlx" . SPARSER::PROTEIN)
    ("the Myc superfamily member MondoA" . SPARSER::PROTEIN)
    ("MondoA" . SPARSER::PROTEIN) ("Phenol Red" . SPARSER::DRUG)
    ("SLC1A5" . SPARSER::PROTEIN) ("SLC3A2" . SPARSER::PROTEIN)
    ("zoledronic acid" . SPARSER::DRUG)
    ("farnesyl diphosphate synthase" . SPARSER::PROTEIN)
    ("m+2" . SPARSER::MOLECULE) ("acetyl-coA" . SPARSER::MOLECULE)
    ("Srebp1" . SPARSER::PROTEIN) ("α–ketoglutarate" . SPARSER::MOLECULE)
    ("Nutlin-3a" . SPARSER::DRUG) ("PCK2" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("Mxd4" . SPARSER::PROTEIN)
    ("Mxd1" . SPARSER::PROTEIN) ("Thy1" . SPARSER::PROTEIN)
    ("carbohydrate response element binding protein" . SPARSER::PROTEIN)
    ("protein Max" . SPARSER::PROTEIN) ("N-Myc" . SPARSER::PROTEIN)
    ("MMP-1, MMP-3, MMP-9 and urokinase-type plasminogen activator"
     . SPARSER::COLLECTION)
    ("drug and NPs" . SPARSER::COLLECTION)
    ("nonspecific aptamers" . SPARSER::PROTEIN) ("aptamers" . SPARSER::PROTEIN)
    ("drug and GNPs" . SPARSER::COLLECTION) ("aptamer" . SPARSER::PROTEIN)
    ("Aptamer-NP" . SPARSER::PROTEIN-PAIR)
    ("these tumor-suppressive proteins" . SPARSER::PROTEIN)
    ("Ets2, Elf5 and PDEF" . SPARSER::COLLECTION) ("PDEF" . SPARSER::PROTEIN)
    ("Ets1 and its downstream molecule MMP-13" . SPARSER::COLLECTION)
    ("Ets1 and its downstream molecule matrix metalloproteinases (MMPs)"
     . SPARSER::COLLECTION)
    ("p300 and CBP" . SPARSER::COLLECTION) ("whose genesis" . SPARSER::PROTEIN)
    ("v-ets" . SPARSER::PROTEIN-PAIR) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("gefitinib-" . SPARSER::DRUG)
    ("p300 and CREB-binding protein (CBP)" . SPARSER::COLLECTION)
    ("p300 and CREB-binding protein" . SPARSER::COLLECTION)
    ("NPs" . SPARSER::PROTEIN)
    ("6-coumarin-loaded nanoparticles" . SPARSER::MOLECULE)
    ("coumarin" . SPARSER::DRUG) ("GNPs" . SPARSER::PROTEIN)
    ("GNP" . SPARSER::PROTEIN) ("Apt-GNPs" . SPARSER::COLLECTION)
    ("proto-oncoprotein" . SPARSER::COLLECTION)
    ("nanoparticles" . SPARSER::MOLECULE) ("Apt" . SPARSER::PROTEIN)
    ("N-Hydroxysuccinimide" . SPARSER::DRUG) ("m 1" . SPARSER::MOLECULE)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("Elf5" . SPARSER::PROTEIN) ("Ets2" . SPARSER::PROTEIN)
    ("Ets1" . SPARSER::PROTEIN) ("SMAD3-SMAD4" . SPARSER::COLLECTION)
    ("serine-" . SPARSER::AMINO-ACID) ("Ser and Thr" . SPARSER::COLLECTION)
    ("PKCδ and TRIM33" . SPARSER::COLLECTION)
    ("a phosphor-specific antibody" . SPARSER::PROTEIN)
    ("TRIM33-β-catenin" . SPARSER::COLLECTION)
    ("isoform or isoforms" . SPARSER::COLLECTION)
    ("PKCα, PKCδ, and PKCε" . SPARSER::COLLECTION) ("Bis" . SPARSER::PROTEIN)
    ("kinase or kinases" . SPARSER::COLLECTION)
    ("β-catenin S715/S718-2A" . SPARSER::PROTEIN) ("FLASH" . SPARSER::PROTEIN)
    ("p-β-catenin" . SPARSER::COLLECTION)
    ("mainly target proteins" . SPARSER::PROTEIN)
    ("Lysine-48 (K48)-linked polyubiquitin" . SPARSER::PROTEIN)
    ("siRNA or shRNA" . SPARSER::COLLECTION) ("Wnt3a-" . SPARSER::PROTEIN)
    ("both WT β-catenin (β-catenin WT ) and the constitutively active β-catenin S33Y"
     . SPARSER::COLLECTION)
    ("TRIM" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional GSK-3β or β-TrCP" . SPARSER::COLLECTION)
    ("β-catenin 4SA" . SPARSER::PROTEIN)
    ("GSK-3β/β-TrCP" . SPARSER::COLLECTION)
    ("NES-FLAG-TRIM33" . SPARSER::COLLECTION)
    ("NES-TRIM33" . SPARSER::COLLECTION) ("NES" . SPARSER::PROTEIN)
    ("Cyclin D1 or Axin2" . SPARSER::COLLECTION)
    ("Cyclin D1 and Axin2" . SPARSER::COLLECTION)
    ("FLAG-TRIM33" . SPARSER::COLLECTION)
    ("U87/EGFRvIII" . SPARSER::COLLECTION) ("EGFRvIII" . SPARSER::PROTEIN)
    ("TRIM33 and β-catenin" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG)
    ("a tumour suppressor in hepatocellular carcinoma, human chronic myelomonocytic leukemia, and pancreatic cancer xref"
     . SPARSER::COLLECTION)
    ("human chronic myelomonocytic leukemia" . SPARSER::PROTEIN)
    ("Tripartite motif-containing protein" . SPARSER::PROTEIN)
    ("TIF1γ, RFG7, PTC7, and Ectodermin" . SPARSER::COLLECTION)
    ("Ectodermin" . SPARSER::PROTEIN)
    ("generally targets nuclear β-catenin" . SPARSER::PROTEIN)
    ("c-Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("This trimeric complex" . SPARSER::BIO-COMPLEX)
    ("Axin and adenomatous polyposis coli (APC)" . SPARSER::COLLECTION)
    ("two multidomain scaffolding proteins, Axin and adenomatous polyposis coli (APC)"
     . SPARSER::COLLECTION)
    ("TRIM33–β-catenin" . SPARSER::COLLECTION)
    ("GSK-3β or β-TrCP" . SPARSER::COLLECTION)
    ("tripartite motif-containing protein" . SPARSER::PROTEIN)
    ("UbcH5c" . SPARSER::PROTEIN) ("UBE1" . SPARSER::PROTEIN)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("bisindolylmaleimide I" . SPARSER::DRUG) ("DKK-1" . SPARSER::PROTEIN)
    ("pcDNA3 S" . SPARSER::PROTEIN) ("CK2" . SPARSER::PROTEIN)
    ("JNK2" . SPARSER::PROTEIN) ("Jade-1" . SPARSER::PROTEIN)
    ("Siah-1" . SPARSER::PROTEIN) ("Wnt-3a" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("PKCδ" . SPARSER::PROTEIN)
    ("B-box" . SPARSER::PROTEIN) ("PTC7" . SPARSER::PROTEIN)
    ("RFG7" . SPARSER::PROTEIN) ("TIF1γ" . SPARSER::PROTEIN)
    ("c-Cbl" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor-related protein 5" . SPARSER::PROTEIN)
    ("TRIM33" . SPARSER::PROTEIN)
    ("ERK1/2 and their substrates, regulators, and scaffolds [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("substrates, regulators, and scaffolds" . SPARSER::COLLECTION)
    ("Raf/MEK" . SPARSER::COLLECTION) ("Rb and AR" . SPARSER::COLLECTION)
    ("REST" . SPARSER::PROTEIN) ("U0126 and AZD6244" . SPARSER::COLLECTION)
    ("these exogenous ERK proteins" . SPARSER::PROTEIN)
    ("different lentiviral ERK2" . SPARSER::PROTEIN)
    ("neuronal growth factor" . SPARSER::GROWTH-FACTOR)
    ("p21 CIP1 and p16 INK4A" . SPARSER::COLLECTION)
    ("lentiviral ERK2-L73P/S151D" . SPARSER::COLLECTION)
    ("bacterially expressed ERK2-L73P/S151D" . SPARSER::COLLECTION)
    ("the lentivirally expressed ERK2-L73P/S151D" . SPARSER::COLLECTION)
    ("expressed ERK2-L73P/S151D" . SPARSER::COLLECTION)
    ("ΔRaf-1:ER" . SPARSER::BIO-COMPLEX)
    ("wild type ERK2 or other ERK2 mutants" . SPARSER::COLLECTION)
    ("c-MYC and cyclin B1" . SPARSER::COLLECTION)
    ("a pivotal nuclear transcription factor" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("Rb, and E2F1" . SPARSER::COLLECTION)
    ("SRE-luciferase" . SPARSER::COLLECTION)
    ("ERK1/2 or MEK1/2" . SPARSER::COLLECTION)
    ("wild type ERK2 or ERK2-I84A mutant" . SPARSER::COLLECTION)
    ("ERK1 and Thr183/Tyr185" . SPARSER::COLLECTION)
    ("HIS" . SPARSER::AMINO-ACID) ("R65S/D319N" . SPARSER::PROTEIN)
    ("ERK2-R65S/D319N" . SPARSER::COLLECTION) ("L73P/S151D" . SPARSER::PROTEIN)
    ("ERK2-L73P/S151D" . SPARSER::COLLECTION)
    ("Raf or MEK" . SPARSER::COLLECTION)
    ("the phosphoryl acceptor and catalytic nucleophile" . SPARSER::COLLECTION)
    ("phosphoryl" . SPARSER::MOLECULE)
    ("MEK1/2 or most other kinases" . SPARSER::COLLECTION)
    ("phosphomimetic amino acids" . SPARSER::AMINO-ACID)
    ("receptors and signaling components" . SPARSER::COLLECTION)
    ("Tyr and Thr" . SPARSER::COLLECTION)
    ("the ubiquitously expressed Ser/Thr kinase ERK1 and ERK2"
     . SPARSER::COLLECTION)
    ("expressed Ser/Thr kinase ERK1 and ERK2" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("MEK2/MAP2K2" . SPARSER::COLLECTION) ("MEK1/MAP2K1" . SPARSER::COLLECTION)
    ("C-Raf/Raf-1" . SPARSER::COLLECTION)
    ("Raf/MEK/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("androgen receptor, Rb and E2F1" . SPARSER::COLLECTION)
    ("p16 INK4A and p21 CIP1" . SPARSER::COLLECTION)
    ("RSK and ELK1" . SPARSER::COLLECTION)
    ("previously reported ERK2 mutants" . SPARSER::MUTANT)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION) ("Mg 2+" . SPARSER::MOLECULE)
    ("Kinase activity" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("myelin basic protein" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("A-Raf" . SPARSER::PROTEIN) ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 INK4A" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("methylated cytosines" . SPARSER::NUCLEOBASE)
    ("the principal SNS" . SPARSER::PROTEIN)
    ("suppressors and mutators" . SPARSER::COLLECTION)
    ("34.1% MSI and 9.2% non-MSI EC ( p < 0.0002)" . SPARSER::COLLECTION)
    ("KRAS or TP53" . SPARSER::COLLECTION)
    ("MGMT and ADAMTS14" . SPARSER::COLLECTION)
    ("KRAS (48% vs. 54%, p = 0.66) and TP53 (18% vs. 22% p = 1.0)"
     . SPARSER::COLLECTION)
    ("MSI, KRAS and TP53" . SPARSER::COLLECTION)
    ("ADAMTS14 and MGMT" . SPARSER::COLLECTION) ("ADAM" . SPARSER::PROTEIN)
    ("MSS" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("GGC" . SPARSER::PROTEIN) ("GGT" . SPARSER::PROTEIN)
    ("SNS" . SPARSER::PROTEIN)
    ("an ubiquitous DNA repair enzyme" . SPARSER::PROTEIN)
    ("CRC, KRAS and TP53" . SPARSER::COLLECTION) ("MLH1" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("MMR" . SPARSER::PROTEIN)
    ("MSI" . SPARSER::PROTEIN) ("MGMT or ADAMTS14" . SPARSER::COLLECTION)
    ("MGMT and the matrix metalloproteinase gene ADAMTS14"
     . SPARSER::COLLECTION)
    ("gene ( MGMT )" . SPARSER::GENE) ("KRAS and TP53" . SPARSER::COLLECTION)
    ("Colon Cancer" . SPARSER::PROTEIN) ("ADAMTS14" . SPARSER::PROTEIN)
    ("types and genes" . SPARSER::COLLECTION)
    ("tumor protein 53-induced nuclear protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("promoter or repressor" . SPARSER::COLLECTION)
    ("kinase/Akt" . SPARSER::COLLECTION)
    ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("the two major histologic types" . TYPE)
    ("the target gene PTEN (phosphatase and tensin homolog) and the downstream effector"
     . SPARSER::COLLECTION)
    ("MiR-21" . SPARSER::PROTEIN)
    ("runt related transcription factor 3" . SPARSER::PROTEIN)
    ("E–H" . SPARSER::PROTEIN) ("A-D" . SPARSER::PROTEIN)
    ("the oncogenic YAP 5SA mutant or a deletion mutant" . SPARSER::COLLECTION)
    ("shRNA or shRNA" . SPARSER::COLLECTION) ("MGLL" . SPARSER::PROTEIN)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("Monoacylglycerol" . SPARSER::MOLECULE)
    ("glycerol and fatty acid" . SPARSER::COLLECTION)
    ("monoacylglycerols" . SPARSER::MOLECULE) ("hydrolase" . SPARSER::PROTEIN)
    ("physical complexes" . SPARSER::BIO-COMPLEX)
    ("a YAP transcriptional target and an inhibitor" . SPARSER::COLLECTION)
    ("lipase (MAGL)" . SPARSER::PROTEIN) ("MAGL" . SPARSER::PROTEIN)
    ("lipase" . SPARSER::PROTEIN) ("monoacylglycerol" . SPARSER::MOLECULE)
    ("hydrolase activity" . SPARSER::PROTEIN) ("SCC1" . SPARSER::PROTEIN)
    ("Survivin/Birc5" . SPARSER::COLLECTION) ("Birc5" . SPARSER::PROTEIN)
    ("OCI/AML3" . SPARSER::COLLECTION) ("OCI" . SPARSER::PROTEIN)
    ("MCM4, MCM10 and CDK2" . SPARSER::COLLECTION)
    ("CDC7/DBF4" . SPARSER::COLLECTION)
    ("CDC6 , CDT1 , MCM4 and MCM10" . SPARSER::COLLECTION)
    ("CDC6, CDT1 and MCM2–7" . SPARSER::COLLECTION)
    ("Mcm complex components and Rad51 [ xref ]" . SPARSER::COLLECTION)
    ("Mcm" . SPARSER::PROTEIN)
    ("BIRC5, ITGB2, IGFBP3 and p57" . SPARSER::COLLECTION)
    ("Hao" . SPARSER::PROTEIN) ("CDKN2A/p21" . SPARSER::COLLECTION)
    ("the variety and context-dependency" . SPARSER::COLLECTION)
    ("Rb or G1-phase cyclin and CDKs" . SPARSER::COLLECTION)
    ("E2Fs, Rb or G1-phase cyclin and CDKs" . SPARSER::COLLECTION)
    ("cyclin and CDKs" . SPARSER::COLLECTION)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("MCM4 and CDC6" . SPARSER::COLLECTION)
    ("cyclin dependent kinase 2/CDK2" . SPARSER::COLLECTION)
    ("exonuclease 1/EXO1" . SPARSER::COLLECTION)
    ("protein/MCM4" . SPARSER::COLLECTION)
    ("cell division cycle 6/CDC6" . SPARSER::COLLECTION)
    ("the previously described siRNA" . SPARSER::PROTEIN)
    ("the well-studied cell cycle regulator E2F" . SPARSER::PROTEIN-FAMILY)
    ("CCND1 ( cyclin D1 ) and FOXM1 ( foxhead box m1 )" . SPARSER::COLLECTION)
    ("birc5 and cyclin D1" . SPARSER::COLLECTION) ("mst1" . SPARSER::PROTEIN)
    ("cell cycle regulator proteins and apoptosis inhibitors"
     . SPARSER::COLLECTION)
    ("birc5 and birc2" . SPARSER::COLLECTION) ("birc5" . SPARSER::PROTEIN)
    ("the Yes-associated protein (YAP) transcriptional activator"
     . SPARSER::PROTEIN-FAMILY)
    ("ddH2" . SPARSER::PROTEIN) ("CASPASE 3" . SPARSER::PROTEIN)
    ("CASPASE-3" . SPARSER::PROTEIN) ("AML3" . SPARSER::PROTEIN)
    ("DBF4" . SPARSER::PROTEIN) ("CDC7" . SPARSER::PROTEIN)
    ("CDC45" . SPARSER::PROTEIN) ("MCM2" . SPARSER::PROTEIN)
    ("ITGB2" . SPARSER::PROTEIN) ("AURORA KINASE A" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 2" . SPARSER::PROTEIN)
    ("CDT1" . SPARSER::PROTEIN) ("DNA replication factor" . SPARSER::PROTEIN)
    ("EXO1" . SPARSER::PROTEIN) ("exonuclease 1" . SPARSER::PROTEIN)
    ("RAD54L" . SPARSER::PROTEIN) ("MCM10" . SPARSER::PROTEIN)
    ("MCM4" . SPARSER::PROTEIN) ("cell division cycle 6" . SPARSER::PROTEIN)
    ("3 d" . SPARSER::PROTEIN-FAMILY) ("CASPASE3" . SPARSER::PROTEIN)
    ("birc2" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("Lats1/2" . SPARSER::PROTEIN) ("Mst1/2" . SPARSER::PROTEIN)
    ("Ste-20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF-1α and LDH5" . SPARSER::COLLECTION)
    ("Bcl-2 and caspase 3" . SPARSER::COLLECTION)
    ("p53, p21 and caspase 3" . SPARSER::COLLECTION)
    ("a flexible component" . SPARSER::COMPONENT)
    ("p53 and CDK8" . SPARSER::COLLECTION) ("LDHA" . SPARSER::PROTEIN)
    ("INMAP -overexpressing HeLa cells as well as the upregulation γH2AX"
     . SPARSER::COLLECTION)
    ("overexpressed INMAP" . SPARSER::PROTEIN)
    ("INMAP and p21" . SPARSER::COLLECTION)
    ("p53, p21, and PCNA" . SPARSER::COLLECTION)
    ("Haematoxylin" . SPARSER::MOLECULE) ("INMAP" . SPARSER::PROTEIN)
    ("Flag-INMAP" . SPARSER::COLLECTION) ("NuMA-p53" . SPARSER::COLLECTION)
    ("NuMA" . SPARSER::PROTEIN) ("p53 and AP-1" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BAX" . SPARSER::PROTEIN)
    ("p53/p21" . SPARSER::COLLECTION) ("PCNA and Bcl-2" . SPARSER::COLLECTION)
    ("MNi" . SPARSER::PROTEIN) ("LDH 1" . SPARSER::PROTEIN)
    ("LDH1" . SPARSER::PROTEIN) ("CDK8" . SPARSER::PROTEIN)
    ("CENP-B" . SPARSER::PROTEIN) ("LDH5" . SPARSER::PROTEIN)
    ("systemic inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("an essential co-factor" . SPARSER::MOLECULE)
    ("IL-8, IL-6, IL-1β, and GRO-α" . SPARSER::COLLECTION)
    ("IL-8, IL-6, IL-1β and GRO-α" . SPARSER::COLLECTION)
    ("GRO" . SPARSER::PROTEIN) ("SIRT1 and SASP" . SPARSER::COLLECTION)
    ("repetitive DNA and several sets of genes" . SPARSER::COLLECTION)
    ("repetitive DNA" . SPARSER::DNA) ("melanogaster" . SPARSER::PROTEIN)
    ("methyltransferases, G9a and GLP" . SPARSER::COLLECTION)
    ("Cdh1" . SPARSER::PROTEIN) ("GLP" . SPARSER::PROTEIN)
    ("CCAAT" . SPARSER::PROTEIN)
    ("extracellular matrix proteins or other components" . SPARSER::COLLECTION)
    ("IL-8 and IL-6" . SPARSER::COLLECTION)
    ("mRNAs and proteins" . SPARSER::COLLECTION) ("hSIRT1" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("Sirtuin1" . SPARSER::PROTEIN)
    ("The hyperactive Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein kinase B or Akt" . SPARSER::COLLECTION)
    ("p38δ and p38γ" . SPARSER::COLLECTION)
    ("mTORC1/S6K1" . SPARSER::COLLECTION)
    ("p38 and mTOR" . SPARSER::COLLECTION)
    ("arginase activity and Arg-II" . SPARSER::COLLECTION)
    ("p38 and Arg-II" . SPARSER::COLLECTION)
    ("IL-6, IL-8, and TNF-α" . SPARSER::COLLECTION)
    ("endothelial SASP" . SPARSER::PROTEIN)
    ("p38, Arg-II, and S6K1" . SPARSER::COLLECTION)
    ("p-p38 and p-S6" . SPARSER::COLLECTION) ("DA" . SPARSER::MOLECULE)
    ("mTORC1-S6K1" . SPARSER::COLLECTION)
    ("kinases, MKK3 and MKK6" . SPARSER::COLLECTION)
    ("mapk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1)"
     . SPARSER::COLLECTION)
    ("p38α or S6K1" . SPARSER::COLLECTION) ("arginase" . SPARSER::PROTEIN)
    ("cytokines and/or chemokines" . SPARSER::COLLECTION)
    ("IL-6R" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("N-Acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("Interleukin-8" . SPARSER::PROTEIN) ("Interleukin-6" . SPARSER::PROTEIN)
    ("MKP1" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("MK5" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("arginase activity" . SPARSER::PROTEIN)
    ("angiotensin-II" . SPARSER::PROTEIN) ("DAF-2" . SPARSER::PROTEIN)
    ("L-arginine" . SPARSER::MOLECULE)
    ("numerous other contemporary biomarkers" . SPARSER::MOLECULE)
    ("a novel and powerful prognostic biomarker" . SPARSER::MOLECULE)
    ("MMP-1/PAR-1" . SPARSER::COLLECTION)
    ("a particularly powerful and independent biomarker" . SPARSER::MOLECULE)
    ("an interstititial collagenase" . SPARSER::PROTEIN)
    ("zinc-dependent endopeptidases" . SPARSER::PROTEIN)
    ("an especially powerful biomarker" . SPARSER::MOLECULE)
    ("the selection traditional biomarkers" . SPARSER::MOLECULE)
    ("hs-CRP and MPO" . SPARSER::COLLECTION)
    ("adiponectin, TIMP-1 and GDF-15" . SPARSER::COLLECTION)
    ("MPO" . SPARSER::PROTEIN) ("GFR-MDRD" . SPARSER::PROTEIN-PAIR)
    ("ACS" . SPARSER::PROTEIN)
    ("TIMP-1 and Cystatin C, GDF-15 and Cystatin C, and TIMP-1 and GDF-15"
     . SPARSER::COLLECTION)
    ("Cystatin C, GDF-15 and Cystatin C, and TIMP-1 and GDF-15"
     . SPARSER::COLLECTION)
    ("Cystatin C, and TIMP-1 and GDF-15" . SPARSER::COLLECTION)
    ("TIMP-1 and GDF-15" . SPARSER::COLLECTION)
    ("TIMP-1, hs-CRP, Fibrinogen, Adiponectin, NT-proBNP, hemoglobin, Erythropoietin and RDW"
     . SPARSER::COLLECTION)
    ("Erythropoietin" . SPARSER::PROTEIN) ("Adiponectin" . SPARSER::PROTEIN)
    ("Fibrinogen" . SPARSER::PROTEIN) ("ACE" . SPARSER::PROTEIN)
    ("proBNP" . SPARSER::PROTEIN) ("GFR" . SPARSER::PROTEIN)
    ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("contemporary biomarkers" . SPARSER::MOLECULE)
    ("adiponectin" . SPARSER::PROTEIN) ("myeloperoxidase" . SPARSER::PROTEIN)
    ("CRP" . SPARSER::PROTEIN) ("ST2" . SPARSER::PROTEIN)
    ("PAR-1" . SPARSER::PROTEIN) ("Cystatin C" . SPARSER::PROTEIN)
    ("Natriuretic Peptide" . SPARSER::PROTEIN) ("Pro-B" . SPARSER::PROTEIN)
    ("C-Reactive Protein" . SPARSER::PROTEIN) ("Cystatin-C" . SPARSER::PROTEIN)
    ("G-protein-coupled receptor" . SPARSER::PROTEIN)
    ("TIMP-1" . SPARSER::PROTEIN) ("cystatin C" . SPARSER::PROTEIN)
    ("GDF-15" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("MMP-2 and MMP-7" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-3" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 MAPK" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("caspase-8, -9 and -3" . SPARSER::COLLECTION) ("SCC-4" . SPARSER::PROTEIN)
    ("Oriental herbal medicine" . SPARSER::DRUG)
    ("MMP-2 (molecular weight 63 kDa) and MMP-9 (molecular weight 92 kDa)"
     . SPARSER::COLLECTION)
    ("ERK and p38 MAPK" . SPARSER::COLLECTION)
    ("PD98059 and SB203580" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("ERK1/2 (molecular weight 42 and 44 kDa for p42 and p44, respectively) and p38 (molecular weight 38 kDa) MAPK"
     . SPARSER::COLLECTION)
    ("p42 and p44" . SPARSER::COLLECTION)
    ("ERK1/2, p38 and JNK" . SPARSER::COLLECTION)
    ("p38-MAPK" . SPARSER::PROTEIN-PAIR)
    ("a cell-permeable pan-caspase inhibitor Z-VAD-FMK" . SPARSER::DRUG)
    ("Bcl-2 (molecular weight 26 kDa) and Bcl-xL (molecular weight 16 kDa)"
     . SPARSER::COLLECTION)
    ("esterase" . SPARSER::PROTEIN) ("isoquinoline" . SPARSER::DRUG)
    ("alcohol and betel quid ( xref )" . SPARSER::COLLECTION)
    ("a cell-permeable pan-caspase inhibitor" . SPARSER::INHIBITOR)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("Bax, Bad and Apaf-1" . SPARSER::COLLECTION)
    ("-3 and poly(ADP-ribose) polymerase (PARP)" . SPARSER::COLLECTION)
    ("Berberine" . SPARSER::MOLECULE) ("berberine" . SPARSER::MOLECULE)
    ("apoptotic protease activating factor-1" . SPARSER::PROTEIN)
    ("protein FADD" . SPARSER::PROTEIN) ("Annexin-5" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("Z-VAD-FMK" . SPARSER::DRUG) ("Apaf-1" . SPARSER::PROTEIN)
    ("kinases, or promoter" . SPARSER::COLLECTION)
    ("the benign and malignant types" . TYPE)
    ("both the benign and malignant parts" . SPARSER::COMPONENT)
    ("the benign and malignant parts" . SPARSER::COMPONENT)
    ("CD117" . SPARSER::PROTEIN)
    ("nucleotide, protein and lipid" . SPARSER::COLLECTION)
    ("Jak/STAT" . SPARSER::COLLECTION)
    ("E2F and its targets" . SPARSER::COLLECTION) ("MCL" . SPARSER::PROTEIN)
    ("PGC-1α, TFAM and SDHA" . SPARSER::COLLECTION) ("SDHA" . SPARSER::PROTEIN)
    ("bezafibrate" . SPARSER::DRUG) ("KDM5A/RBP2" . SPARSER::COLLECTION)
    ("Rb1" . SPARSER::PROTEIN) ("E2F and pRB" . SPARSER::COLLECTION)
    ("DMD" . SPARSER::PROTEIN)
    ("differentiated cells many bona fide E2F1" . SPARSER::PROTEIN)
    ("fully functional mitochondria" . SPARSER::PROTEIN)
    ("intact mitochondria" . SPARSER::PROTEIN) ("E2f1" . SPARSER::PROTEIN)
    ("DP1 and DP2" . SPARSER::COLLECTION)
    ("mitochondria-associated dE2F/dDP target genes" . SPARSER::GENE)
    ("knockdown mitochondria-associated E2F" . SPARSER::PROTEIN-FAMILY)
    ("mitochondria-associated E2F" . SPARSER::PROTEIN-FAMILY)
    ("E2F and mitochondria" . SPARSER::COLLECTION)
    ("repressive complexes" . SPARSER::BIO-COMPLEX)
    ("COX8 , CYB5-M , CYP51A1 , FDXR and SUCLG1" . SPARSER::COLLECTION)
    ("FDXR" . SPARSER::PROTEIN)
    ("nuclear respiratory factors NRF1" . SPARSER::PROTEIN)
    ("HCF1-Ronin" . SPARSER::COLLECTION) ("NRF2/GABP" . SPARSER::COLLECTION)
    ("Ronin" . SPARSER::PROTEIN) ("GABP" . SPARSER::PROTEIN)
    ("mutant or dE2f1" . SPARSER::COLLECTION)
    ("only two E2F genes" . SPARSER::GENE) ("E2F and DP" . SPARSER::COLLECTION)
    ("dDP" . SPARSER::DRUG) ("CASP3 and CASP7" . SPARSER::COLLECTION)
    ("ARF" . SPARSER::PROTEIN) ("pRB and E2F" . SPARSER::COLLECTION)
    ("E2F/DP" . SPARSER::COLLECTION)
    ("mitochondria-associated genes" . SPARSER::GENE)
    ("PD0332991" . SPARSER::DRUG) ("CDK4/6" . SPARSER::PROTEIN)
    ("RBP2" . SPARSER::PROTEIN) ("KDM5A" . SPARSER::PROTEIN)
    ("PDK4" . SPARSER::PROTEIN)
    ("pyruvate dehydrogenase kinase 4" . SPARSER::PROTEIN)
    ("dE2F" . SPARSER::PROTEIN) ("SUCLG1" . SPARSER::PROTEIN)
    ("CYP51A1" . SPARSER::PROTEIN) ("CYB5-M" . SPARSER::PROTEIN)
    ("COX8" . SPARSER::PROTEIN) ("E2F4" . SPARSER::PROTEIN)
    ("HCF1" . SPARSER::PROTEIN) ("CASP7" . SPARSER::PROTEIN)
    ("CASP3" . SPARSER::PROTEIN) ("APAF1" . SPARSER::PROTEIN)
    ("camptothecin and doxorubicin" . SPARSER::COLLECTION)
    ("the topoisomerase-II inhibitor doxorubicin or the topoisomerase-I inhibitor camptopthecin ( xref and Supplementary Fig. S2)"
     . SPARSER::COLLECTION)
    ("ERCC4 or ERRC6" . SPARSER::COLLECTION)
    ("ERCC6 or ERCC4" . SPARSER::COLLECTION) ("ERCC6-" . SPARSER::PROTEIN)
    ("rucaparib" . SPARSER::DRUG) ("EMSY" . SPARSER::PROTEIN)
    ("the respective NER gene" . SPARSER::GENE)
    ("platinum and PARPi sensitivity" . SPARSER::COLLECTION)
    ("Defective HR" . SPARSER::PROTEIN) ("repair bulky DNA" . SPARSER::DNA)
    ("cisplatin and carboplatin" . SPARSER::COLLECTION)
    ("defective HR" . SPARSER::PROTEIN)
    ("Platinum and PARP" . SPARSER::COLLECTION)
    ("topoisomerase-I" . SPARSER::PROTEIN)
    ("topoisomerase-II" . SPARSER::PROTEIN) ("D-7" . SPARSER::PROTEIN)
    ("XAB2" . SPARSER::PROTEIN) ("RFC1" . SPARSER::PROTEIN)
    ("MMS19" . SPARSER::PROTEIN) ("MNAT1" . SPARSER::PROTEIN)
    ("RAD23B" . SPARSER::PROTEIN) ("LIG1" . SPARSER::PROTEIN)
    ("ERCC8" . SPARSER::PROTEIN) ("ERCC3" . SPARSER::PROTEIN)
    ("ERCC5" . SPARSER::PROTEIN) ("Cockayne syndrome" . SPARSER::PROTEIN)
    ("ERCC6" . SPARSER::PROTEIN)
    ("p21,  Notch1 and BTG2" . SPARSER::COLLECTION)
    ("genes or pathways" . SPARSER::COLLECTION)
    ("the mutated allele" . SPARSER::ALLELE)
    ("exogenous miR-21" . SPARSER::PROTEIN)
    ("leukemia and various other non-hematological solid tumors ( xref – xref ) miR-21"
     . SPARSER::COLLECTION)
    ("SPRY2 and miR-21" . SPARSER::COLLECTION) ("RPMI 8226" . SPARSER::PROTEIN)
    ("group and NC" . SPARSER::COLLECTION) ("Lao" . SPARSER::PROTEIN)
    ("a specific signaling pathway inhibitor and a member of the Sprouty (SPRY) family"
     . SPARSER::COLLECTION)
    ("SPRY" . SPARSER::PROTEIN) ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("miR-21 and SPRY2" . SPARSER::COLLECTION)
    ("miR-21 and sprouty homolog 2" . SPARSER::COLLECTION)
    ("SPRY1" . SPARSER::PROTEIN) ("SPRY2" . SPARSER::PROTEIN)
    ("sprouty homolog 2" . SPARSER::PROTEIN)
    ("a well-known diagnostic biomarker" . SPARSER::MOLECULE)
    ("an abundant oncoembryonal protein" . SPARSER::PROTEIN)
    ("these respective genes" . SPARSER::GENE)
    ("MAPK (C-Raf and B-Raf) and VEGFR-2" . SPARSER::COLLECTION)
    ("PI3K , AKT , or PTEN" . SPARSER::COLLECTION)
    ("5FU, CDDP, sorafenib, and tivantinib" . SPARSER::COLLECTION)
    ("unresectable HCC" . SPARSER::PROTEIN)
    ("5-FU and cisplatin" . SPARSER::COLLECTION)
    ("both sorafenib (Figure xref ) or tivantinib" . SPARSER::COLLECTION)
    ("both sorafenib (Figure xref ) and tivantinib (Figure xref )"
     . SPARSER::COLLECTION)
    ("tivantinib and sorafenib" . SPARSER::COLLECTION)
    ("RPF" . SPARSER::PROTEIN)
    ("an important HCC-specific diagnostic biomarker" . SPARSER::MOLECULE)
    ("AFP" . SPARSER::PROTEIN) ("c-Met/PI3K/PTEN/Akt" . SPARSER::COLLECTION)
    ("Luc" . SPARSER::PROTEIN) ("luc-mut" . SPARSER::PROTEIN-PAIR)
    ("PTEN or CDKN1A" . SPARSER::COLLECTION) ("luc-3" . SPARSER::COLLECTION)
    ("iodide ( PI )" . SPARSER::PROTEIN)
    ("a miR-93 high group (–ΔCq>1.4, n=25) and a miR-93 low group (–ΔCq<1.4, n=22)"
     . SPARSER::COLLECTION)
    ("HCC and non-HCC" . SPARSER::COLLECTION)
    ("a plasma membrane lipid phosphatase and tumor suppressor"
     . SPARSER::COLLECTION)
    ("protein (PTEN)" . SPARSER::PROTEIN) ("/Tensin" . SPARSER::COLLECTION)
    ("Tensin" . SPARSER::PROTEIN) ("cirrhosis" . SPARSER::PROTEIN)
    ("C-Raf and B-Raf" . SPARSER::COLLECTION)
    ("Ras-mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("the approved systemic therapeutic drug sorafenib" . SPARSER::DRUG)
    ("sorafenib and tivantinib" . SPARSER::COLLECTION)
    ("tivantinib" . SPARSER::DRUG) ("c-Met/PI3K/Akt" . SPARSER::COLLECTION)
    ("PTEN and CDKN1A" . SPARSER::COLLECTION) ("Alpha-" . SPARSER::PROTEIN)
    ("p110 gamma" . SPARSER::PROTEIN) ("p110-beta" . SPARSER::PROTEIN)
    ("miR-181a" . SPARSER::MOLECULE)
    ("Tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("α-fetoprotein" . SPARSER::PROTEIN) ("p110-alpha" . SPARSER::PROTEIN)
    ("class 1A" . SPARSER::PROTEIN) ("miR-125a-5p" . SPARSER::MOLECULE)
    ("phosphatidylinositol 3,4,5-triphosphate" . SPARSER::PIP3)
    ("VEGFR-2" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor-2" . SPARSER::PROTEIN)
    ("C-Raf" . SPARSER::PROTEIN) ("-variant" . SPARSER::VARIANT)
    ("clinically well-annotated cohorts" . SPARSER::MOLECULE)
    ("E-cadherin, N-cadherin and VIM" . SPARSER::COLLECTION)
    ("RAF-1/ERK" . SPARSER::COLLECTION) ("exogenous KRAS" . SPARSER::PROTEIN)
    ("the mesenchymal cell markers N-cadherin and VIM" . SPARSER::COLLECTION)
    ("N-cadherin and VIM" . SPARSER::COLLECTION)
    ("VIM and FN1" . SPARSER::COLLECTION) ("VIM" . SPARSER::PROTEIN)
    ("Kirsten rat sarcoma viral oncogene homolog)" . SPARSER::PROTEIN)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("progesterone receptor (PR) and HER2 (ERBB2)" . SPARSER::COLLECTION)
    ("estrogen receptor and trastuzumab" . SPARSER::COLLECTION)
    ("inhibitors or therapies" . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG) ("P200" . SPARSER::PROTEIN)
    ("A ‘" . SPARSER::PROTEIN) ("Na3VO 4" . SPARSER::MOLECULE)
    ("RAF-1" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("BAX and BAX" . SPARSER::COLLECTION)
    ("DRAM1, BAX or BID" . SPARSER::COLLECTION)
    ("a classical apoptosis inducer" . SPARSER::MOLECULE)
    ("BAX or tBID" . SPARSER::COLLECTION) ("UVRAG" . SPARSER::PROTEIN)
    ("BAX and BID" . SPARSER::COLLECTION)
    ("Another classical apoptotic stimulus etoposide" . SPARSER::DRUG)
    ("BAX and cathepsin B" . SPARSER::COLLECTION)
    ("a symbolic enzyme" . SPARSER::ENZYME) ("NAG" . SPARSER::PROTEIN)
    ("cathepsin B (green) and Lamp2 (red)" . SPARSER::COLLECTION)
    ("mitochondria and form" . SPARSER::COLLECTION)
    ("BAX and LysoTracker" . SPARSER::COLLECTION)
    ("BAX-EGFP" . SPARSER::COLLECTION) ("LysoTracker" . SPARSER::DRUG)
    ("protein and DRAM1" . SPARSER::COLLECTION)
    ("BAX/DRAM1" . SPARSER::COLLECTION) ("BAX and Bcl-2" . SPARSER::COLLECTION)
    ("Bcl-2 and BAX" . SPARSER::COLLECTION) ("DRAM1-BAX" . SPARSER::COLLECTION)
    ("exogenous DRAM1" . SPARSER::PROTEIN) ("pcDNA4" . SPARSER::PROTEIN)
    ("chloroquine and bafilomycin" . SPARSER::COLLECTION)
    ("p62 and LC3" . SPARSER::COLLECTION)
    ("the ALP inhibitors chloroquine (20  μ M) and bafilomycin (100 nM)"
     . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG) ("DRAM1-pcDNA4" . SPARSER::COLLECTION)
    ("activated caspase-8 or the lysosomal cathepsin B" . SPARSER::COLLECTION)
    ("tBID" . SPARSER::PROTEIN) ("procaspase-9 and -3" . SPARSER::COLLECTION)
    ("ATPase activity and lysosomal" . SPARSER::COLLECTION)
    ("digestive enzymes" . SPARSER::ENZYME)
    ("mitochondrial cytochrome c" . SPARSER::PROTEIN)
    ("tBid" . SPARSER::PROTEIN)
    ("upregulated DRAM1 recruited BAX" . SPARSER::PROTEIN)
    ("DRAM1 and BAX" . SPARSER::COLLECTION)
    ("cathepsin B and cytochrome c" . SPARSER::COLLECTION)
    ("BAX and DRAM1" . SPARSER::COLLECTION)
    ("the mitochondrial complex II inhibitor, 3-nitropropionic acid (3NP), or an anticancer drug"
     . SPARSER::COLLECTION)
    ("BIX-01294" . SPARSER::DRUG) ("C1S" . SPARSER::PROTEIN)
    ("Lamp2" . SPARSER::PROTEIN) ("procaspase-9" . SPARSER::PROTEIN)
    ("cathepsin B" . SPARSER::PROTEIN)
    ("damage-regulated autophagy modulator" . SPARSER::PROTEIN)
    ("DRAM1" . SPARSER::PROTEIN) ("Mei" . SPARSER::MOLECULE)
    ("p-FAK" . SPARSER::PROTEIN-PAIR) ("EphA2" . SPARSER::PROTEIN)
    ("EphA" . SPARSER::PROTEIN-FAMILY) ("NC or agomir" . SPARSER::COLLECTION)
    ("CTGF and survivin" . SPARSER::COLLECTION) ("agomir" . SPARSER::PROTEIN)
    ("agomir-NC (5  μ M) or agomir-141 (5  μ M)" . SPARSER::COLLECTION)
    ("agomir-NC" . SPARSER::PROTEIN-PAIR)
    ("TAZ and TEAD" . SPARSER::COLLECTION)
    ("TAZ and TAZ" . SPARSER::COLLECTION) ("TAZ and miR" . SPARSER::COLLECTION)
    ("-TAZ" . SPARSER::COLLECTION) ("respective mutant" . SPARSER::MUTANT)
    ("pRL-TK" . SPARSER::COLLECTION) ("pRL" . SPARSER::PROTEIN)
    ("pGL" . SPARSER::PROTEIN)
    ("differentially expressed miRNAs and target genes" . SPARSER::COLLECTION)
    ("expressed miRNAs" . SPARSER::PROTEIN) ("frozen" . SPARSER::PROTEIN)
    ("miRNAs and mRNA" . SPARSER::COLLECTION)
    ("RUNX, PPARγ, Pax3, TBX5 and TTF-1" . SPARSER::COLLECTION)
    ("ERBB2 and ERBB1" . SPARSER::COLLECTION) ("MiRNA" . SPARSER::PROTEIN)
    ("new light" . SPARSER::PROTEIN) ("salt and nitrate" . SPARSER::COLLECTION)
    ("nitrate" . SPARSER::MOLECULE)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Gene 2" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("TBX5" . SPARSER::PROTEIN)
    ("Transcriptional coactivator with PDZ-binding motif" . SPARSER::PROTEIN)
    ("integrin beta-1" . SPARSER::PROTEIN) ("MiR-29c" . SPARSER::PROTEIN)
    ("erythrocyte membrane protein band 4.1" . SPARSER::PROTEIN)
    ("a possible tumor repressor" . SPARSER::REPRESSOR)
    ("amino-acid catabolism" . SPARSER::PROTEIN)
    ("the essential regulator" . SPARSER::REGULATOR)
    ("SIRT4 and GDH" . SPARSER::COLLECTION)
    ("CtBP and SIRT4" . SPARSER::COLLECTION)
    ("anaplerotic substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE) ("Ammonia" . SPARSER::MOLECULE)
    ("SIRT4 and CtBP" . SPARSER::COLLECTION) ("GDH" . SPARSER::PROTEIN)
    ("Bis-2-" . SPARSER::PROTEIN) ("CtBP1 and CtBP2" . SPARSER::COLLECTION)
    ("heterodimers or homodimers" . SPARSER::COLLECTION)
    ("CtBP" . SPARSER::PROTEIN) ("ammonia" . SPARSER::MOLECULE)
    ("pyruvate and lactate" . SPARSER::COLLECTION) ("Bis-2" . SPARSER::PROTEIN)
    ("G9a" . SPARSER::PROTEIN) ("CtBP2" . SPARSER::PROTEIN)
    ("CtBP1" . SPARSER::PROTEIN) ("exosomal CAV1" . SPARSER::PROTEIN)
    ("components and organelles" . SPARSER::COLLECTION)
    ("intra-vesicular CAV1" . SPARSER::PROTEIN)
    ("the normoxic monolayers" . SPARSER::PROTEIN)
    ("cytokeratin and CAV1" . SPARSER::COLLECTION)
    ("pan-cytokeratin and CAV1" . SPARSER::COLLECTION)
    ("hypoxic RM" . SPARSER::MOLECULE) ("normoxic RM" . SPARSER::MOLECULE)
    ("the normoxic RM" . SPARSER::MOLECULE)
    ("hypoxia and normoxia" . SPARSER::COLLECTION)
    ("no monomeric 21 kDa form" . SPARSER::FORM)
    ("RM or IM" . SPARSER::COLLECTION) ("Solutions" . SPARSER::MOLECULE)
    ("Antibodies and gold" . SPARSER::COLLECTION)
    ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exosomal proteins" . SPARSER::PROTEIN)
    ("horseradish peroxidase-linked secondary antibody" . SPARSER::PROTEIN)
    ("CD63, CD9 and CD81" . SPARSER::COLLECTION)
    ("ExoQuick-TC" . SPARSER::COLLECTION) ("APMA" . SPARSER::PROTEIN)
    ("100 μg/ml streptomycin and 250 ng/ml Fungizone (all from Sigma Aldrich)"
     . SPARSER::COLLECTION)
    ("Fungizone" . SPARSER::DRUG) ("hydrocortisone" . SPARSER::DRUG)
    ("ESA" . SPARSER::PROTEIN)
    ("cytometry and immunohistochemistry" . SPARSER::COLLECTION)
    ("DEC" . SPARSER::PROTEIN)
    ("triple immunostaining comprised cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("RM and IM" . SPARSER::COLLECTION) ("DAB" . SPARSER::MOLECULE)
    ("4% neutral-buffered formalin" . SPARSER::MOLECULE)
    ("formalin" . SPARSER::MOLECULE)
    ("ECL Western blotting substrate" . SPARSER::SUBSTRATE)
    ("biotinylated polyclonal swine anti-rabbit secondary antibody"
     . SPARSER::PROTEIN)
    ("monoclonal rabbit CAV-1 antibody" . SPARSER::ANTIBODY)
    ("sulphate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("snap-frozen" . SPARSER::PROTEIN-PAIR)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypoxia-mimicker" . SPARSER::PROTEIN-PAIR) ("CAV" . SPARSER::PROTEIN)
    ("CAV1and αSMA" . SPARSER::COLLECTION) ("CaDEC12" . SPARSER::PROTEIN)
    ("discs" . SPARSER::BIO-COMPLEX)
    ("proteins and glycoproteins" . SPARSER::COLLECTION)
    ("its components in oral cancer growth" . SPARSER::COMPONENT)
    ("TME" . SPARSER::PROTEIN) ("CAFs" . SPARSER::PROTEIN)
    ("CAV1-TME" . SPARSER::PROTEIN-PAIR)
    ("HSC-3-CaDEC12" . SPARSER::COLLECTION) ("HSC-3" . SPARSER::PROTEIN)
    ("αSMA " . SPARSER::PROTEIN) ("CD81" . SPARSER::PROTEIN)
    ("CD9" . SPARSER::PROTEIN) ("AE3" . SPARSER::PROTEIN)
    ("CD146" . SPARSER::PROTEIN)
    ("epidermal surface antigen" . SPARSER::PROTEIN)
    ("PANC-1and BxPC-3cells" . SPARSER::COLLECTION)
    ("p53, claudin 1, TCF-8, and FoxOs" . SPARSER::COLLECTION)
    ("visfatin and Sirt1" . SPARSER::COLLECTION)
    ("snail and slug" . SPARSER::COLLECTION)
    ("Cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ac" . SPARSER::PROTEIN)
    ("PBEF, Sirt1, and Ac-p53" . SPARSER::COLLECTION)
    ("Ac-p53" . SPARSER::COLLECTION) ("PBEF and Sirt1" . SPARSER::COLLECTION)
    ("PBEF" . SPARSER::PROTEIN)
    ("β-catenin and vimentin" . SPARSER::COLLECTION)
    ("slug, snail, and TCF-8" . SPARSER::COLLECTION)
    ("β-catenin, and claudin 1" . SPARSER::COLLECTION)
    ("p-Erk2" . SPARSER::COLLECTION) ("p-Erk1" . SPARSER::COLLECTION)
    ("Erk1 and Erk2" . SPARSER::COLLECTION)
    ("CDC2 and cyclin B1" . SPARSER::COLLECTION)
    ("CDC2, cyclin B1, and CDK2" . SPARSER::COLLECTION)
    ("CDK2, cyclin B1, cyclin D1, p21 Waf1/Cip1, p27 Kip1, and p53"
     . SPARSER::COLLECTION)
    ("p-p53" . SPARSER::COLLECTION) ("p-AURKA" . SPARSER::COLLECTION)
    ("AURKA and its downstream target p53" . SPARSER::COLLECTION)
    ("EMT, and redox" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mTOR"
     . SPARSER::COLLECTION)
    ("the ALS’s" . SPARSER::PROTEIN)
    ("a possible early biomarker" . SPARSER::MOLECULE)
    ("RalA" . SPARSER::PROTEIN) ("AURKA" . SPARSER::PROTEIN)
    ("visfatin" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("Alisertib (ALS)" . SPARSER::DRUG) ("claudin 1" . SPARSER::PROTEIN)
    ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Erk1" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("p-53" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Aurora kinase A" . SPARSER::PROTEIN)
    ("histone and nonhistone" . SPARSER::COLLECTION)
    ("p53 and FoxOs" . SPARSER::COLLECTION)
    ("Atg5, Atg7, and Atg8" . SPARSER::COLLECTION)
    ("snail/slug" . SPARSER::COLLECTION) ("zonula" . SPARSER::PROTEIN)
    ("vincristine, taxol, temozolomide, doxorubicin, ursolic acid, honokiol, quercetin, and fisetin"
     . SPARSER::COLLECTION)
    ("fisetin" . SPARSER::DRUG) ("quercetin" . SPARSER::MOLECULE)
    ("honokiol" . SPARSER::DRUG) ("vincristine" . SPARSER::DRUG)
    ("CDK/cyclin" . SPARSER::COLLECTION) ("CDC2/cyclin" . SPARSER::COLLECTION)
    ("p27 Kip1 and p53" . SPARSER::COLLECTION)
    ("seeking new effective drugs" . SPARSER::DRUG)
    ("AMPK and p38 MAPK" . SPARSER::COLLECTION)
    ("PTEN and beclin 1" . SPARSER::COLLECTION)
    ("PTEN, beclin 1, LC3-I, and LC3-II" . SPARSER::COLLECTION)
    ("p-PI3K" . SPARSER::COLLECTION)
    ("PI3K, Akt, and mTOR" . SPARSER::COLLECTION)
    ("a potent, irreversible, and selective PI3K inhibitor and a blocker"
     . SPARSER::COLLECTION)
    ("/mTOR" . SPARSER::COLLECTION) ("Plumbagin (PLB)" . SPARSER::DRUG)
    ("Atg proteins and other regulating molecules" . SPARSER::COLLECTION)
    ("PI3K/protein kinase B/mammalian target of rapamycin"
     . SPARSER::COLLECTION)
    ("PI3K and p38 MAPK" . SPARSER::COLLECTION)
    ("/protein kinase B/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("cyclin B1, cyclin D1, p21 Waf1/Cip1, p27 Kip1, and p53"
     . SPARSER::COLLECTION)
    ("CDK1/CDC2" . SPARSER::COLLECTION) ("naphthoquinone" . SPARSER::MOLECULE)
    ("PLB" . SPARSER::PROTEIN) ("Plumbagin" . SPARSER::DRUG)
    ("ursolic acid" . SPARSER::MOLECULE) ("Sirt 1" . SPARSER::PROTEIN)
    ("AMPK 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4- phosphate" . SPARSER::MOLECULE)
    ("TCF-8" . SPARSER::PROTEIN)
    ("zinc finger E-box-binding homeobox 1" . SPARSER::PROTEIN)
    ("zona occludens protein 1" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN)
    ("microtubule-associated protein 1A" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("BTK and BLNK" . SPARSER::COLLECTION) ("BLNK" . SPARSER::PROTEIN)
    ("distal BCR" . SPARSER::PROTEIN) ("proximal BCR" . SPARSER::PROTEIN)
    ("the latter receptor" . SPARSER::RECEPTOR)
    ("SYK and BTK" . SPARSER::COLLECTION) ("SYK or BTK" . SPARSER::COLLECTION)
    ("fostamatinib (targets SYK) and ibrutinib (targets BTK)"
     . SPARSER::COLLECTION)
    ("functional S1PR1" . SPARSER::PROTEIN)
    ("β 1 or CCR7" . SPARSER::COLLECTION)
    ("β 1 and CCL21" . SPARSER::COLLECTION)
    ("ibrutinib or fostamatinib" . SPARSER::COLLECTION)
    ("fostamatinib or ibrutinib" . SPARSER::COLLECTION)
    ("BCR-" . SPARSER::PROTEIN) ("SYK" . SPARSER::PROTEIN)
    ("CAL" . SPARSER::PROTEIN)
    ("fostamatinib and ibrutinib" . SPARSER::COLLECTION)
    ("ibrutinib and fostamatinib" . SPARSER::COLLECTION)
    ("IgH" . SPARSER::PROTEIN)
    ("ibrutinib, idelalisib, and fostamatinib" . SPARSER::COLLECTION)
    ("tyrosine kinase, PI3Kδ, and spleen tyrosine kinase"
     . SPARSER::COLLECTION)
    ("fostamatinib" . SPARSER::DRUG) ("TGX-221" . SPARSER::DRUG)
    ("PI3Kβ" . SPARSER::PROTEIN) ("anti-IgM" . SPARSER::PROTEIN)
    ("CD49d" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("CXCR5" . SPARSER::PROTEIN)
    ("S1P 1" . SPARSER::PROTEIN) ("CXCL13" . SPARSER::PROTEIN)
    ("α L β 2" . SPARSER::PROTEIN) ("CCL21" . SPARSER::PROTEIN)
    ("S1P" . SPARSER::PROTEIN) ("spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("PI3Kδ" . SPARSER::PROTEIN)
    ("receptor and integrins" . SPARSER::COLLECTION)
    ("cortical actin filaments" . SPARSER::PROTEIN-FAMILY)
    ("ß-catenin" . SPARSER::COLLECTION) ("RhoA or RhoC" . SPARSER::COLLECTION)
    ("a homotypic cell-cell adhesion receptor" . SPARSER::RECEPTOR)
    ("the miRNA miR21" . SPARSER::PROTEIN)
    ("receptor and VEGF" . SPARSER::COLLECTION) ("RhoGDI" . SPARSER::PROTEIN)
    ("RhoA and RhoC" . SPARSER::COLLECTION) ("RhoC" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("GEFs" . SPARSER::PROTEIN)
    ("an active GTP-bound state and an inactive GDP-bound state"
     . SPARSER::COLLECTION)
    ("integrins and cadherins" . SPARSER::COLLECTION)
    ("receptors and integrins" . SPARSER::COLLECTION)
    ("RhoB" . SPARSER::PROTEIN) ("LMP-1" . SPARSER::PROTEIN)
    ("GEFH1" . SPARSER::PROTEIN) ("B-D" . SPARSER::PROTEIN)
    ("GEF-H1" . SPARSER::PROTEIN) ("GTPase activating" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Rho GTPase" . SPARSER::PROTEIN)
    ("ovarian cancer families" . SPARSER::PROTEIN-FAMILY)
    ("variant and Malay" . SPARSER::COLLECTION)
    ("cohort unveiled CHEK2 p" . SPARSER::PROTEIN)
    ("estrogen and progesterone receptor" . SPARSER::COLLECTION)
    ("UK and the Netherlands [ xref , xref – xref ]" . SPARSER::COLLECTION)
    ("delC" . SPARSER::PROTEIN) ("P53 and BRCA1" . SPARSER::COLLECTION)
    ("CDS1" . SPARSER::PROTEIN) ("RAD53" . SPARSER::PROTEIN)
    ("Cell cycle checkpoint kinase" . SPARSER::PROTEIN)
    ("CHEK2" . SPARSER::PROTEIN)
    ("more reliable molecular biomarkers" . SPARSER::MOLECULE)
    ("BRAF and MEK-selective inhibitors" . SPARSER::COLLECTION)
    ("AKT1 and AKT3" . SPARSER::COLLECTION) ("RTK/NRAS" . SPARSER::COLLECTION)
    ("PNP-Mel" . SPARSER::COLLECTION) ("Mel" . SPARSER::PROTEIN)
    ("PNP" . SPARSER::PROTEIN) ("NRAS or BRAF" . SPARSER::COLLECTION)
    ("pathogenetic variants" . SPARSER::VARIANT)
    ("PIK3CA and BRAF or NRAS" . SPARSER::COLLECTION)
    ("BRAF or NRAS" . SPARSER::COLLECTION)
    ("anti-BRAF or anti-MEK" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("vemurafenib or dabrafenib" . SPARSER::COLLECTION)
    ("BRAF/MEK/ERK" . SPARSER::COLLECTION)
    ("PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("BRAF , NRAS , and PIK3CA" . SPARSER::COLLECTION)
    ("NRAS and PIK3CA" . SPARSER::COLLECTION)
    ("key pathogenetic effectors" . SPARSER::EFFECTOR)
    ("NRAS or MEK" . SPARSER::COLLECTION) ("RG7204" . SPARSER::DRUG)
    ("EMT and non-EMT" . SPARSER::COLLECTION)
    ("CSC state and the epithelial-like ALDH + CSC state [ xref ]"
     . SPARSER::COLLECTION)
    ("EMT-" . SPARSER::PROTEIN)
    ("Imetelstat and trastuzumab" . SPARSER::COLLECTION)
    ("Trastuzumab and imetelstat" . SPARSER::COLLECTION)
    ("trastuzumab and imetelstat" . SPARSER::COLLECTION)
    ("HER2 and ALDH" . SPARSER::COLLECTION)
    ("a measureable CD44 + /CD24" . SPARSER::COLLECTION)
    ("CD44/CD24" . SPARSER::COLLECTION) ("phosphoramidate" . SPARSER::MOLECULE)
    ("imetelstat and trastuzumab" . SPARSER::COLLECTION)
    ("a telomerase antagonistic oligonucleotide" . SPARSER::MOLECULE)
    ("GRN" . SPARSER::PROTEIN) ("mTOR and components" . SPARSER::COLLECTION)
    ("trkB" . SPARSER::PROTEIN)
    ("mTOR as well as its upstream/downstream effectors" . SPARSER::COLLECTION)
    ("anticonvulsant" . SPARSER::DRUG)
    ("mTOR and its signaling cascade components" . SPARSER::COLLECTION)
    ("translational machinery components such as elongation and initiation"
     . SPARSER::COLLECTION)
    ("structural and functional synaptic proteins" . SPARSER::PROTEIN)
    ("translational machinery components" . SPARSER::COMPONENT)
    ("p70S6K, eIF4B or PSD-95" . SPARSER::COLLECTION)
    ("mTOR (***p < 0.0001, Figure  xref B; ***p < 0.0001, Figure  xref B; 2-tailed t tests) and 4E-BP1 (***p < 0.0001, Figure  xref D; ***p < 0.0001, Figure  xref D; 2-tailed t tests)"
     . SPARSER::COLLECTION)
    ("both total and phosphorylated Akt (**p = 0.002, Figure  xref A; **p = 0.004, Figure  xref A; 2-tailed t tests), mTOR (***p < 0.0001, Figure  xref B; ***p < 0.0001, Figure  xref B; 2-tailed t tests) and 4E-BP1 (***p < 0.0001, Figure  xref D; ***p < 0.0001, Figure  xref D; 2-tailed t tests)"
     . SPARSER::COLLECTION)
    ("both total and phosphorylated Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt, mTOR, S6K, and 4E-BP1" . SPARSER::COLLECTION)
    ("GFAP or βIII-Tubulin" . SPARSER::COLLECTION)
    ("GFAP (glial) and βIII-Tubulin" . SPARSER::COLLECTION)
    ("Tubulin" . SPARSER::PROTEIN) ("TrkB-Shc" . SPARSER::COLLECTION)
    ("TrkB/Akt" . SPARSER::COLLECTION)
    ("p70S6K and eIF4B" . SPARSER::COLLECTION)
    ("4E-BP1/eIF4E" . SPARSER::COLLECTION)
    ("Total and phosphorylated mTOR" . SPARSER::PROTEIN)
    ("p85 and Akt" . SPARSER::COLLECTION)
    ("p85, Akt, mTOR, phospho-mTOR, p70S6K and eIF4B" . SPARSER::COLLECTION)
    ("phospho-mTOR" . SPARSER::PROTEIN)
    ("mTOR and its upstream/downstream effectors" . SPARSER::COLLECTION)
    ("VPA-" . SPARSER::PROTEIN) ("autistic traits" . SPARSER::PROTEIN)
    ("an antiepileptic drug" . SPARSER::DRUG) ("VPA" . SPARSER::PROTEIN)
    ("4E-BP1 or eIF4E" . SPARSER::COLLECTION)
    ("Akt, mTOR and 4E-BP1" . SPARSER::COLLECTION)
    ("valproic acid-" . SPARSER::MOLECULE)
    ("kinase, eIF4B and PSD-95" . SPARSER::COLLECTION)
    ("the postsynaptic organizing molecule PSD-95" . SPARSER::PROTEIN)
    ("gyrus" . SPARSER::PROTEIN) ("Components" . SPARSER::COMPONENT)
    ("nTrk2" . SPARSER::PROTEIN) ("initiation factor 4B" . SPARSER::PROTEIN)
    ("NF1" . SPARSER::PROTEIN) ("FMR1" . SPARSER::PROTEIN)
    ("MeCP2" . SPARSER::PROTEIN) ("neuronal)" . SPARSER::PROTEIN)
    ("P35" . SPARSER::PROTEIN) ("neuroligin 3" . SPARSER::PROTEIN)
    ("Valproic acid" . SPARSER::MOLECULE) ("Eif4ebp" . SPARSER::PROTEIN-FAMILY)
    ("PSD-95" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("valproic acid" . SPARSER::MOLECULE)
    ("porcine RVA NSP1 proteins" . SPARSER::PROTEIN)
    ("the pleiotropic effects other PDL" . SPARSER::MOLECULE)
    ("the RV-host" . SPARSER::MOLECULE) ("RV-host" . SPARSER::MOLECULE)
    ("SCF-associated E2 ubiquitin-conjugating enzyme" . SPARSER::ENZYME)
    ("the larger SCF complex" . SPARSER::BIO-COMPLEX)
    ("other viral immune antagonists" . SPARSER::MOLECULE)
    ("β-TrCP and IRFs" . SPARSER::COLLECTION) ("DS" . SPARSER::PROTEIN)
    ("FY" . SPARSER::PROTEIN) ("CD4 and tetherin" . SPARSER::COLLECTION)
    ("This chimeric NSP1" . SPARSER::PROTEIN)
    ("specifically targets IRFs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("simian SA11-4F NSP1" . SPARSER::PROTEIN) ("masks" . SPARSER::PROTEIN)
    ("OSU NSP1 and an R510A mutant" . SPARSER::COLLECTION)
    ("Alanine" . SPARSER::AMINO-ACID)
    ("NSP1 and β-TrCP:RING:E2" . SPARSER::COLLECTION)
    ("β-TrCP:RING:E2" . SPARSER::COLLECTION)
    ("the SCF complex and a C-terminal WD40 domain that mediates"
     . SPARSER::COLLECTION)
    ("β-TrCP:NSP1" . SPARSER::BIO-COMPLEX)
    ("tandem—to nonphosphorylatable alanine" . SPARSER::AMINO-ACID)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("CKI" . SPARSER::PROTEIN) ("bovine UK NSP1" . SPARSER::PROTEIN)
    ("porcine (Gottfried and YM) RVA NSP1 proteins" . SPARSER::PROTEIN)
    ("IAL28, ST3, and WI61" . SPARSER::COLLECTION) ("IAL" . SPARSER::PROTEIN)
    ("DS-1 and KU" . SPARSER::COLLECTION)
    ("A2 and A1-Wa" . SPARSER::COLLECTION)
    ("histidine and aspartic acid" . SPARSER::COLLECTION)
    ("wt or ΔC13" . SPARSER::COLLECTION)
    ("antagonist and β-TrCP" . SPARSER::COLLECTION)
    ("NSP1 and FLAG-β-TrCP" . SPARSER::COLLECTION)
    ("FLAG-β-TrCP" . SPARSER::COLLECTION) ("IRFs" . SPARSER::PROTEIN)
    ("viral (Vpu, LMP1, and A49) proteins" . SPARSER::PROTEIN)
    ("clusters—A3, A11, A12, and A13/A14" . SPARSER::COLLECTION)
    ("Wa" . SPARSER::MOLECULE)
    ("A3, A11, A12, and A13/A14" . SPARSER::COLLECTION)
    ("porcine NSP1 proteins" . SPARSER::PROTEIN)
    ("unrelated viral proteins—Epstein-Barr virus (EBV) LMP1"
     . SPARSER::PROTEIN)
    ("a nonfunctional NSP1" . SPARSER::PROTEIN)
    ("available NSP1" . SPARSER::PROTEIN)
    ("nonstructural protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an antiviral state" . SPARSER::BIO-STATE)
    ("NF-κB and IRF3" . SPARSER::COLLECTION)
    ("NF-κB and another transcription factor" . SPARSER::COLLECTION)
    ("mitochondrial antiviral signaling protein (MAVS)" . SPARSER::PROTEIN)
    ("protein (MAVS)" . SPARSER::PROTEIN)
    ("RIG-I and MDA5" . SPARSER::COLLECTION) ("MAVS" . SPARSER::PROTEIN)
    ("RIG-I and melanoma differentiation-associated protein 5"
     . SPARSER::COLLECTION)
    ("RLRs" . SPARSER::PROTEIN)
    ("five or six nonstructural proteins" . SPARSER::PROTEIN)
    ("dsRNA" . SPARSER::RNA) ("dimeric NF-κB" . SPARSER::PROTEIN)
    ("PRRs or other receptors" . SPARSER::COLLECTION)
    ("their respective PAMPs" . SPARSER::PROTEIN) ("PAMP" . SPARSER::PROTEIN)
    ("receptor (RLR)" . SPARSER::RECEPTOR)
    ("receptor (TLR)" . SPARSER::RECEPTOR) ("PAMPs" . SPARSER::PROTEIN)
    ("NLR" . SPARSER::PROTEIN) ("RLR" . SPARSER::PROTEIN)
    ("PRRs" . SPARSER::PROTEIN) ("which targets IκB" . SPARSER::PROTEIN)
    ("an associated inhibitor protein" . SPARSER::PROTEIN)
    ("Other viral proteins" . SPARSER::PROTEIN) ("PDL" . SPARSER::MOLECULE)
    ("β-TrCP or other immunomodulatory proteins" . SPARSER::COLLECTION)
    ("other immunomodulatory proteins" . SPARSER::PROTEIN)
    ("its nonstructural protein NSP1" . SPARSER::PROTEIN)
    ("An associated inhibitor" . SPARSER::INHIBITOR) ("DSG" . SPARSER::DRUG)
    ("pH 3" . SPARSER::MOLECULE) ("bis-Tris" . SPARSER::MOLECULE)
    ("IRAK1" . SPARSER::PROTEIN)
    ("IL-1R-associated kinase 1" . SPARSER::PROTEIN)
    ("IFNAR1" . SPARSER::PROTEIN) ("C-R" . SPARSER::PROTEIN)
    ("Aspartic acid" . SPARSER::AMINO-ACID)
    ("aspartic acid" . SPARSER::AMINO-ACID) ("DS-1" . SPARSER::PROTEIN)
    ("IκBβ" . SPARSER::PROTEIN) ("ST3" . SPARSER::PROTEIN)
    ("A11" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNF receptor-associated factor 2" . SPARSER::PROTEIN)
    ("MDA5" . SPARSER::PROTEIN)
    ("melanoma differentiation-associated protein 5" . SPARSER::PROTEIN)
    ("UBCH5" . SPARSER::PROTEIN) ("IL-1R" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("NSP1" . SPARSER::PROTEIN)
    ("a diagnostic, prognostic, or predictive biomarker" . SPARSER::MOLECULE)
    ("Oct4/Tcl1/Akt" . SPARSER::COLLECTION)
    ("its target genes and functional roles in the context of human cancer cells"
     . SPARSER::COLLECTION)
    ("a well-characterized monoclonal anti-Oct4A antibody" . SPARSER::ANTIBODY)
    ("the hepatocellular carcinoma marker cytokeratin-19" . SPARSER::PROTEIN)
    ("an agonist of the AhR and a putative chemotherapeutic agent"
     . SPARSER::COLLECTION)
    ("AhR" . SPARSER::PROTEIN) ("pT308" . SPARSER::PROTEIN)
    ("Akt-pT308" . SPARSER::COLLECTION) ("Akt and Oct4" . SPARSER::COLLECTION)
    ("Wnt and TGFβ" . SPARSER::COLLECTION)
    ("Oct4 or Oct4-pT235" . SPARSER::COLLECTION)
    ("the anti-Oct4 and anti-pOct-T235" . SPARSER::COLLECTION)
    ("Oct4 and pOct-T235" . SPARSER::COLLECTION)
    ("U87 and U251" . SPARSER::COLLECTION)
    ("anti-Oct4 and anti-pOct-T235" . SPARSER::COLLECTION)
    ("Oct4-pg1" . SPARSER::COLLECTION)
    ("anti-Oct4 or anti-Oct4-pT235" . SPARSER::COLLECTION)
    ("a strong band of 45 kDa" . SPARSER::PROTEIN)
    ("OCT4-pg4" . SPARSER::COLLECTION) ("OCT4-pg3" . SPARSER::COLLECTION)
    ("Oct4 and Akt-phosphorylated Oct4-pT235" . SPARSER::COLLECTION)
    ("Akt-Oct4" . SPARSER::COLLECTION)
    ("Oct4 and Oct4-pT235" . SPARSER::COLLECTION)
    ("hypoxia and FGF2" . SPARSER::COLLECTION)
    ("OTF3C or OTF3P1" . SPARSER::COLLECTION)
    ("OCT4-pg1" . SPARSER::COLLECTION)
    ("an indispensable transcription factor" . SPARSER::PROTEIN)
    ("ECCs" . SPARSER::MOLECULE) ("ECC" . SPARSER::MOLECULE)
    ("authentic OCT4 gene" . SPARSER::GENE) ("Akt-induced" . SPARSER::PROTEIN)
    ("Tcl1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine/threonine-protein kinase" . SPARSER::PROTEIN)
    ("cytokeratin-19" . SPARSER::PROTEIN) ("CD201" . SPARSER::PROTEIN)
    ("pg4" . SPARSER::PROTEIN) ("pg3" . SPARSER::PROTEIN)
    ("A’" . SPARSER::PROTEIN) ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN)
    ("Vitamin A" . SPARSER::MOLECULE) ("OTF3P1" . SPARSER::PROTEIN)
    ("OTF3C" . SPARSER::PROTEIN) ("pg1" . SPARSER::PROTEIN)
    ("POU5F1B" . SPARSER::PROTEIN) ("POU5F1P1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor" . SPARSER::PROTEIN)
    ("tau and amyloid" . SPARSER::COLLECTION)
    ("a fully functional p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("variant and AD" . SPARSER::COLLECTION) ("amyloid" . SPARSER::PROTEIN)
    ("cip" . SPARSER::PROTEIN) ("protein or mRNA" . SPARSER::COLLECTION)
    ("TSG101 and E2F-1" . SPARSER::COLLECTION)
    ("ASK1, procaspase 3 and SAPK" . SPARSER::COLLECTION)
    ("/cyclin/CDK2" . SPARSER::COLLECTION)
    ("WISp39, ASK1, procaspase 3, SAPK, TSG101 and E2F-1"
     . SPARSER::COLLECTION)
    ("cyclins, CDKs, PCNA, ASK1, procaspase 3, SAPK, TSG101, E2F-1, and WISp39"
     . SPARSER::COLLECTION)
    ("CDK2/cyclin" . SPARSER::COLLECTION) ("transfectants" . SPARSER::PROTEIN)
    ("Cytometry" . SPARSER::PROTEIN)
    ("the temporal and occipital lobe" . SPARSER::PROTEIN)
    ("the frontal and occipital lobe" . SPARSER::PROTEIN)
    ("the temporal lobe" . SPARSER::PROTEIN)
    ("the occipital lobe" . SPARSER::PROTEIN)
    ("significantly greater p-tau" . SPARSER::COLLECTION)
    ("the frontal lobe" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("ApoE4" . SPARSER::PROTEIN) ("GEN" . SPARSER::PROTEIN)
    ("RNAs and proteins" . SPARSER::COLLECTION)
    ("TSG101 and/or E2F1" . SPARSER::COLLECTION)
    ("E2F1 (aa 1–90) and the pro-apoptotic proteins" . SPARSER::COLLECTION)
    ("SAPK (aa 1–84) and ASK1 (aa 1–140)" . SPARSER::COLLECTION)
    ("the pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("/cyclin/CDK" . SPARSER::COLLECTION) ("cyclin/CDK" . SPARSER::COLLECTION)
    ("the stress activated protein kinase (SAPK) and apoptosis signal-regulating kinase 1 (ASK1)"
     . SPARSER::COLLECTION)
    ("stress activated protein kinase (SAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin/CDK2" . SPARSER::COLLECTION) ("cyclin/CDK4" . SPARSER::COLLECTION)
    ("p21 cip1 , p27 kip1 and p57" . SPARSER::COLLECTION)
    ("CDKIs" . SPARSER::DRUG) ("CDKI" . SPARSER::DRUG)
    ("the exact complement" . SPARSER::PROTEIN)
    ("the cancer-associated variant" . SPARSER::VARIANT)
    ("bank" . SPARSER::PROTEIN)
    ("a cancer-associated variant" . SPARSER::VARIANT)
    ("ApoE" . SPARSER::PROTEIN) ("Beta-actin" . SPARSER::PROTEIN)
    ("beta-amyloid" . SPARSER::PROTEIN) ("(beta" . SPARSER::PROTEIN)
    ("procaspase 3" . SPARSER::PROTEIN) ("WISp39" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("stress activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kip2" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("Apolipoprotein E" . SPARSER::PROTEIN)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E3 ubiquitin ligase Itch ( xref ) and WW domain-containing E3 ubiquitin protein ligase"
     . SPARSER::COLLECTION)
    ("Itch" . SPARSER::PROTEIN) ("HCCs" . SPARSER::PROTEIN)
    ("major HCC" . SPARSER::PROTEIN)
    ("growth-associated genes" . SPARSER::GENE)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("large tumor suppressor (LATS)" . SPARSER::PROTEIN)
    ("lentivirus-small hairpin (sh)RNA" . SPARSER::RNA)
    ("Yes-associated protein (YAP) and large tumor suppressor"
     . SPARSER::COLLECTION)
    ("macrophage-stimulating protein" . SPARSER::PROTEIN)
    ("connective-tissue growth factor" . SPARSER::PROTEIN)
    ("large tumor suppressor" . SPARSER::PROTEIN)
    ("severe hypoxia" . SPARSER::PROTEIN)
    ("acute exposure hypoxia" . SPARSER::PROTEIN)
    ("p53 and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1 and VEGF" . SPARSER::COLLECTION) ("cobalt" . SPARSER::MOLECULE)
    ("VEGF and EPO" . SPARSER::COLLECTION) ("EPO" . SPARSER::PROTEIN)
    ("the control group or the irradiation group" . SPARSER::COLLECTION)
    ("the hypoxia and irradiation group" . SPARSER::COLLECTION)
    ("group or normoxia" . SPARSER::COLLECTION)
    ("mimetic hypoxia" . SPARSER::PROTEIN)
    ("the control group and the hypoxia group (p>0.05)" . SPARSER::COLLECTION)
    ("HIF-1α, VEGF, and p53" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor (HIF)" . SPARSER::PROTEIN)
    ("VEGF and P53" . SPARSER::COLLECTION)
    ("gene and protein" . SPARSER::COLLECTION)
    ("cytometry (FCM)" . SPARSER::PROTEIN)
    ("HIF-1α, VEGF, and P53" . SPARSER::COLLECTION)
    ("CoCl2" . SPARSER::MOLECULE)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HDAC3 and Bak" . SPARSER::COLLECTION)
    ("pro-apoptotic molecule Bak" . SPARSER::PROTEIN)
    ("IκB or the increase pIκB" . SPARSER::COLLECTION)
    ("NF-κB or its subunits" . SPARSER::COLLECTION)
    ("ANKYRIN" . SPARSER::PROTEIN) ("HDAC3, and HDAC3" . SPARSER::COLLECTION)
    ("HDAC3 and NF-κB" . SPARSER::COLLECTION)
    ("ZBP-89 and HDAC3" . SPARSER::COLLECTION)
    ("the pro-apoptotic Bak" . SPARSER::PROTEIN)
    ("an apoptotic inducer" . SPARSER::PROTEIN)
    ("IκB and pIκB" . SPARSER::COLLECTION)
    ("IκB or pIκB" . SPARSER::COLLECTION)
    ("Pin1 +/+ and Pin1 −/− cells (Figures  xref a and b)"
     . SPARSER::COLLECTION)
    ("c and d" . SPARSER::COLLECTION) ("MIHA" . SPARSER::PROTEIN)
    ("HDAC3 and pHDAC3" . SPARSER::COLLECTION)
    ("ZBP-89 and Pin1" . SPARSER::COLLECTION)
    ("Pin1 and 14-3-3" . SPARSER::COLLECTION)
    ("histones and forms" . SPARSER::COLLECTION)
    ("HDAC3 and its related molecules" . SPARSER::COLLECTION)
    ("HDAC3 or IκB" . SPARSER::COLLECTION)
    ("being inhibitors of IκB degradation and SN50 being an inhibitor of p65/p50 translocation"
     . SPARSER::COLLECTION)
    ("pro-apoptotic Bak" . SPARSER::PROTEIN) ("CREB3" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("histone deacetylase 3" . SPARSER::PROTEIN) ("ZBP-89" . SPARSER::PROTEIN)
    ("Histone deacetylase 3" . SPARSER::PROTEIN)
    ("INSR OR CD220 OR HHF5" . SPARSER::COLLECTION)
    ("CD220 OR HHF5" . SPARSER::COLLECTION) ("PRISM" . SPARSER::PROTEIN)
    ("three Caucasian cohorts and one Asian cohort" . SPARSER::COLLECTION)
    ("three Caucasian cohorts" . SPARSER::MOLECULE)
    ("AA, and AA" . SPARSER::COLLECTION)
    ("insulin receptor ( INSR )" . SPARSER::PROTEIN)
    ("gene ( FTO )" . SPARSER::GENE) ("DENN/MADD" . SPARSER::COLLECTION)
    ("LHR" . SPARSER::PROTEIN) ("THADA" . SPARSER::PROTEIN)
    ("MADD" . SPARSER::PROTEIN) ("DENN" . SPARSER::PROTEIN)
    ("INS" . SPARSER::PROTEIN) ("FTO" . SPARSER::PROTEIN)
    ("HHF5" . SPARSER::PROTEIN) ("CD220" . SPARSER::PROTEIN)
    ("P450scc" . SPARSER::PROTEIN)
    ("aminopeptidase activity" . SPARSER::PROTEIN)
    ("luteinizing hormone receptor" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBN3" . SPARSER::PROTEIN) ("the angiostatic peptide" . SPARSER::PEPTIDE)
    ("ang" . SPARSER::PROTEIN)
    ("laminins, vitronectin and fibronectin" . SPARSER::COLLECTION)
    ("vitronectin" . SPARSER::PROTEIN) ("bad" . SPARSER::PROTEIN)
    ("MVD" . SPARSER::PROTEIN) ("TSP-1 and p53" . SPARSER::COLLECTION)
    ("CD31, EPB41L3, RASSF2 and TSP-1" . SPARSER::COLLECTION)
    ("gene and cell line" . SPARSER::COLLECTION)
    ("MSP and PSQ" . SPARSER::COLLECTION) ("MSP and BS" . SPARSER::COLLECTION)
    ("MSP and PSQ/BS" . SPARSER::COLLECTION) ("BS" . SPARSER::PROTEIN)
    ("TSP-1 and RASSF2" . SPARSER::COLLECTION)
    ("trichostatin" . SPARSER::MOLECULE)
    ("a large oligomeric extracellular matrix (ECM) protein"
     . SPARSER::PROTEIN)
    ("SAPK-JNK" . SPARSER::COLLECTION)
    ("the better-known RASSF1 gene" . SPARSER::GENE)
    ("The Ras association (RalGDS/AF-6) domain family member 2 (RASSF2) protein"
     . SPARSER::PROTEIN)
    ("RalGDS/AF-6" . SPARSER::COLLECTION) ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("RalGDS" . SPARSER::PROTEIN) ("AF-6" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase/extracellular signal-regulated kinase"
     . SPARSER::COLLECTION)
    ("membrane-associated proteins" . SPARSER::PROTEIN)
    ("DAL-1/4.1B" . SPARSER::COLLECTION)
    ("EPB41L3 and RASSF2" . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("EPB41L3, RASSF2 and TSP-1" . SPARSER::COLLECTION)
    ("p53, ki-67, and CD31" . SPARSER::COLLECTION)
    ("EPB41L3 and TSP-1" . SPARSER::COLLECTION)
    ("EPB41L3 , RASSF2 and TSP-1" . SPARSER::COLLECTION)
    ("p14" . SPARSER::PROTEIN) ("TSP1" . SPARSER::PROTEIN)
    ("RASSF1" . SPARSER::PROTEIN) ("family member 2" . SPARSER::PROTEIN)
    ("4.1B" . SPARSER::PROTEIN) ("DAL-1" . SPARSER::PROTEIN)
    ("TSP-1" . SPARSER::PROTEIN) ("RASSF2" . SPARSER::PROTEIN)
    ("EPB41L3" . SPARSER::PROTEIN)
    ("A two-tailed Wilcoxon signed rank" . SPARSER::PROTEIN)
    ("the two-tailed
Wilcoxon signed rank"
     . SPARSER::PROTEIN)
    ("a subsequent transcriptome analysis
+/- Myc"
     . SPARSER::PROTEIN)
    ("RP:CB" . SPARSER::BIO-COMPLEX) ("CB" . SPARSER::PROTEIN)
    ("RP" . SPARSER::PROTEIN)
    ("far
more Myc"
     . SPARSER::PROTEIN)
    ("use either two-tailed Wilcoxon signed rank" . SPARSER::PROTEIN)
    ("a subsequent transcriptome analysis +/- Myc" . SPARSER::PROTEIN)
    ("Oncogene" . SPARSER::ONCOGENE) ("Myc and RNAPII" . SPARSER::COLLECTION)
    ("genome-wide transcriptional elongation" . SPARSER::PROTEIN)
    ("far more Myc" . SPARSER::PROTEIN) ("Myc-Max" . SPARSER::COLLECTION)
    ("active genes" . SPARSER::GENE)
    ("a
tetracycline-repressible MYC transgene"
     . SPARSER::PROTEIN)
    ("overexpressed c-Myc" . SPARSER::PROTEIN) ("VIS" . SPARSER::PROTEIN)
    ("c- Myc" . SPARSER::PROTEIN) ("CS-1" . SPARSER::PROTEIN)
    ("primate lentiviral Vpu proteins" . SPARSER::PROTEIN)
    ("IFNβ and ISG" . SPARSER::COLLECTION)
    ("most primate lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("IFNβ and ~3-" . SPARSER::COLLECTION)
    ("ICAM-1, HLA-B, IFI44L, and tetherin" . SPARSER::COLLECTION)
    ("IFNβ and several NF-κB- and IFN-dependent genes" . SPARSER::COLLECTION)
    ("several NF-κB- and IFN-dependent genes" . SPARSER::COLLECTION)
    ("HLAC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ICAM-1 and MHC-I" . SPARSER::COLLECTION)
    ("HGF and eotaxin" . SPARSER::COLLECTION)
    ("IGFBP1 and IGFBP2" . SPARSER::COLLECTION)
    ("NF-κB and IRF-3" . SPARSER::COLLECTION)
    ("the mutated promoter" . SPARSER::PROMOTER)
    ("antiviral genes" . SPARSER::GENE) ("SS" . SPARSER::PROTEIN)
    ("the parental forms" . SPARSER::FORM)
    ("β-TrCP and CKII" . SPARSER::COLLECTION)
    ("p65 and Vpu" . SPARSER::COLLECTION)
    ("substantially less active" . SPARSER::ACTIVE) ("EK" . SPARSER::PROTEIN)
    ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("β-TrCP and the poxvirus A49 protein" . SPARSER::COLLECTION)
    ("the former increased IKKβ-induced NF-κB" . SPARSER::PROTEIN)
    ("tetherin and IKKβ" . SPARSER::COLLECTION)
    ("CD4 and MHC-I" . SPARSER::COLLECTION)
    ("a biscistronic RNA" . SPARSER::RNA)
    ("this accessory gene" . SPARSER::GENE)
    ("Vprs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mus" . SPARSER::PROTEIN)
    ("primate lentiviral Nef proteins" . SPARSER::PROTEIN)
    ("Primate Lentiviral Nef Proteins" . SPARSER::PROTEIN)
    ("Vif" . SPARSER::PROTEIN) ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rev" . SPARSER::PROTEIN-FAMILY) ("these accessory genes" . SPARSER::GENE)
    ("vpu" . SPARSER::PROTEIN) ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the accessory protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNAPII" . SPARSER::PROTEIN)
    ("the cellular RNA polymerase II (RNAPII)" . SPARSER::PROTEIN)
    ("interferon and interferon-stimulated genes (ISGs)" . SPARSER::COLLECTION)
    ("Vpu" . SPARSER::PROTEIN) ("antiviral host genes" . SPARSER::GENE)
    ("IFI44L" . SPARSER::PROTEIN) ("IGFBP1" . SPARSER::PROTEIN)
    ("IRF-3" . SPARSER::PROTEIN) ("IFNβ" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("protein Nef" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ib" . SPARSER::DRUG) ("Erk and Akt" . SPARSER::COLLECTION)
    ("damnacanthal inhibiting several tyrosine kinase receptors"
     . SPARSER::RECEPTOR)
    ("damnacanthal directly targets c-Met" . SPARSER::PROTEIN)
    ("c-Met and Akt" . SPARSER::COLLECTION)
    ("Hep G2 hepatocarcinoma cell Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGFR, erbB2, EGFR and insulin receptor" . SPARSER::COLLECTION)
    ("erbB2" . SPARSER::PROTEIN) ("Ick" . SPARSER::PROTEIN)
    ("its major micronutrients" . SPARSER::MOLECULE)
    ("micronutrients" . SPARSER::MOLECULE) ("phytochemical" . SPARSER::DRUG)
    ("Refs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("analgesic" . SPARSER::DRUG)
    ("Noni" . SPARSER::DRUG) ("damnacanthal targets c-Met" . SPARSER::PROTEIN)
    ("noni" . SPARSER::DRUG) ("R-250" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE)
    ("metalloproteinases 2" . SPARSER::PROTEIN) ("HT-1080" . SPARSER::PROTEIN)
    ("p56" . SPARSER::PROTEIN) ("Morinda citrifolia" . SPARSER::DRUG)
    ("TGF β and both proteins" . SPARSER::COLLECTION)
    ("IGFBP2 and ER- α" . SPARSER::COLLECTION) ("ER/PR" . SPARSER::COLLECTION)
    ("Native Hawaiian breast cancer patients—a group" . SPARSER::MOLECULE)
    ("IGF1, IGFR1, IGFBP2, and IGFBP3" . SPARSER::COLLECTION)
    ("expressing IGFBP3" . SPARSER::PROTEIN)
    ("IGF1, IGF1R, IGFBP2, or IGFBP3" . SPARSER::COLLECTION)
    ("at least one hormone receptor" . SPARSER::RECEPTOR)
    ("HER2-" . SPARSER::PROTEIN) ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER-" . SPARSER::PROTEIN)
    ("IGFBP2 ( P  < 0.0001) and IGFBP3 ( P  < 0.0001)" . SPARSER::COLLECTION)
    ("ER (72%) and PR (62%)" . SPARSER::COLLECTION)
    ("expressed HER2" . SPARSER::PROTEIN)
    ("proteins (IGFBP)" . SPARSER::PROTEIN)
    ("IGF1R and IGF2R" . SPARSER::COLLECTION)
    ("IGFBP2 and IGFBP3" . SPARSER::COLLECTION)
    ("epidermal growth factor receptor-2" . SPARSER::COLLECTION)
    ("ER/PR/HER2" . SPARSER::COLLECTION)
    ("TGF β" . SPARSER::HUMAN-PROTEIN-FAMILY) ("α 5 β 1" . SPARSER::PROTEIN)
    ("ER- α" . SPARSER::PROTEIN) ("IGFR1" . SPARSER::PROTEIN)
    ("IGF2R" . SPARSER::PROTEIN) ("IGFBP2" . SPARSER::PROTEIN)
    ("Lian-ning" . SPARSER::COLLECTION)
    ("their respective targeted kinases" . SPARSER::PROTEIN)
    ("p38- and JNK-specific siRNAs" . SPARSER::COLLECTION)
    ("SB202190 and SP600125" . SPARSER::COLLECTION)
    ("ERK, p38, and JNK" . SPARSER::COLLECTION)
    ("a naturally polyphenolic phytoalexin" . SPARSER::MOLECULE)
    ("wine" . SPARSER::MOLECULE) ("phytoalexin" . SPARSER::MOLECULE)
    ("Lyn and Hck" . SPARSER::COLLECTION) ("Hck" . SPARSER::PROTEIN)
    ("Lyn" . SPARSER::PROTEIN)
    ("all currently available tyrosine kinase inhibitors" . SPARSER::INHIBITOR)
    ("dasatinib or nilotinib" . SPARSER::COLLECTION)
    ("nilotinib" . SPARSER::DRUG) ("/STAT" . SPARSER::COLLECTION)
    ("/JNK" . SPARSER::COLLECTION)
    ("MAPK/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("c-Raf" . SPARSER::COLLECTION)
    ("Ras/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("p38- or JNK-specific siRNAs" . SPARSER::COLLECTION)
    ("Resveratrol" . SPARSER::PROTEIN) ("H2AX-wt" . SPARSER::COLLECTION)
    ("H2AX and other signaling proteins" . SPARSER::COLLECTION)
    ("pH3" . SPARSER::MOLECULE) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-cbl" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BCR–ABL" . SPARSER::PROTEIN) ("BCR–ABL fusion gene" . SPARSER::PROTEIN)
    ("Shang-bin" . SPARSER::COLLECTION) ("Xin-xin" . SPARSER::COLLECTION)
    ("bin" . SPARSER::PROTEIN) ("mei" . SPARSER::MOLECULE)
    ("a potentially safer drug" . SPARSER::DRUG)
    ("a reciprocal ROS and p38/JNK interacting" . SPARSER::COLLECTION)
    ("a reciprocal ROS" . SPARSER::PROTEIN)
    ("p38 or JNK" . SPARSER::COLLECTION)
    ("the canonical p38-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSTP1 or CBR1" . SPARSER::COLLECTION)
    ("GSTP1 and CBR1" . SPARSER::COLLECTION)
    ("The differential cytotoxic" . SPARSER::PROTEIN)
    ("the actual cellular components" . SPARSER::COMPONENT)
    ("ROS, p38, or JNK" . SPARSER::COLLECTION)
    ("p-JNK/JNK" . SPARSER::COLLECTION) ("p-p38/p38" . SPARSER::COLLECTION)
    ("a p38- or a JNK- inhibitor (SB or SP, respectively) differentially"
     . SPARSER::COLLECTION)
    ("JNK-" . SPARSER::PROTEIN) ("p38-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p38 (SB203580, SB) or JNK (SP600125, SP)" . SPARSER::COLLECTION)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("p38/JNK" . SPARSER::COLLECTION) ("PL and NAC" . SPARSER::COLLECTION)
    ("the fluorescent ROS indicator DCFH-DA" . SPARSER::DRUG)
    ("annexin V/PI" . SPARSER::COLLECTION) ("FCM" . SPARSER::MOLECULE)
    ("glutathione S-transferase pi 1 (GSTP1) or carbonyl reductase 1 (CBR1)"
     . SPARSER::COLLECTION)
    ("traditional Ayurvedic medicine" . SPARSER::DRUG)
    ("ROS-p38/JNK" . SPARSER::COLLECTION) ("Piperlongumine" . SPARSER::DRUG)
    ("the apoptotic proteins (Bax, Bcl-2 and caspase-3) and autophagic proteins (Beclin-1 and LC3B)"
     . SPARSER::COLLECTION)
    ("autophagic proteins" . SPARSER::PROTEIN)
    ("Bax, Bcl-2 and caspase-3" . SPARSER::COLLECTION)
    ("Beclin-1 and LC3B" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("apoptotic and autophagic signaling proteins" . SPARSER::PROTEIN)
    ("alkaloid" . SPARSER::MOLECULE) ("PL" . SPARSER::PROTEIN)
    ("piperlongumine" . SPARSER::DRUG) ("PL 10" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("CBR1" . SPARSER::PROTEIN) ("carbonyl reductase 1" . SPARSER::PROTEIN)
    ("GSTP1" . SPARSER::PROTEIN)
    ("glutathione S-transferase pi 1" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("the tailed duplex DNA" . SPARSER::DNA)
    ("Rad52, Rad51, RPA and ssDNA" . SPARSER::COLLECTION)
    ("mitomycin C and IR" . SPARSER::COLLECTION)
    ("hydroxyurea, and camptothecin" . SPARSER::COLLECTION)
    ("more nicked-circular DNA" . SPARSER::DNA)
    ("nicked circular DNA" . SPARSER::DNA)
    ("the circular ssDNA" . SPARSER::PROTEIN)
    ("both nicked-circular DNA" . SPARSER::DNA)
    ("nicked-circular DNA" . SPARSER::DNA)
    ("at least one overhanging ssDNA" . SPARSER::PROTEIN)
    ("circular ssDNA" . SPARSER::PROTEIN)
    ("SO 4 or CaCl" . SPARSER::COLLECTION)
    ("γH2AX and Rad51" . SPARSER::COLLECTION)
    ("Rad51 or γH2AX" . SPARSER::COLLECTION)
    ("HDHB shRNA or control shRNA" . SPARSER::COLLECTION)
    ("a homologous duplex DNA" . SPARSER::DNA)
    ("the recombinogenic Rad51-ssDNA filament" . SPARSER::PROTEIN-FAMILY)
    ("Rad51-ssDNA" . SPARSER::COLLECTION)
    ("ssDNA, RPA, Rad52, and Rad51" . SPARSER::COLLECTION)
    ("GFP-HDHB" . SPARSER::COLLECTION)
    ("anti-Rad51, Rad52, and RPA" . SPARSER::COLLECTION)
    ("Rad51 and RPA" . SPARSER::COLLECTION) ("Doxycycline" . SPARSER::DRUG)
    ("neomycin" . SPARSER::DRUG)
    ("mitomycin C, and differentially" . SPARSER::COLLECTION)
    ("IR, mitomycin C and camptothecin" . SPARSER::COLLECTION)
    ("mitomycin C, or IR" . SPARSER::COLLECTION)
    ("Rad51 and γH2AX" . SPARSER::COLLECTION)
    ("Rad51, Rad52, RPA and ssDNA" . SPARSER::COLLECTION)
    ("Ectopically expressed HDHB" . SPARSER::PROTEIN)
    ("etoposide, or topoisomerase" . SPARSER::COLLECTION)
    ("primase" . SPARSER::PROTEIN) ("Dda" . SPARSER::DRUG)
    ("its homologous DNA" . SPARSER::DNA) ("homologous DNA" . SPARSER::DNA)
    ("Rad51AP1" . SPARSER::PROTEIN) ("AP1" . SPARSER::PROTEIN)
    ("the homologous DNA" . SPARSER::DNA) ("-ssDNA" . SPARSER::COLLECTION)
    ("a serious type" . TYPE) ("expressed HDHB" . SPARSER::PROTEIN)
    ("Rad51, Rad52, RPA, and ssDNA" . SPARSER::COLLECTION)
    ("HDHB" . SPARSER::PROTEIN) ("DNA helicase B (HDHB)" . SPARSER::PROTEIN)
    ("hRad51" . SPARSER::PROTEIN) ("creatine kinase" . SPARSER::PROTEIN)
    ("To-Pro-3" . SPARSER::MOLECULE) ("RPA34" . SPARSER::PROTEIN)
    ("DNA primase" . SPARSER::PROTEIN) ("Rdh54" . SPARSER::PROTEIN)
    ("Mer3" . SPARSER::PROTEIN) ("Rad57" . SPARSER::PROTEIN)
    ("Rad55" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Rfa1" . SPARSER::PROTEIN) ("Rad52" . SPARSER::PROTEIN)
    ("DNA helicase B" . SPARSER::PROTEIN) ("erythropoietin" . SPARSER::PROTEIN)
    ("a shorter fragment" . SPARSER::FRAGMENT) ("Fragment" . SPARSER::FRAGMENT)
    ("hnRNP-A1 and SRp55" . SPARSER::COLLECTION)
    ("the mutated alleles" . SPARSER::ALLELE)
    ("protein, missense and nonsense" . SPARSER::COLLECTION)
    ("SRp55 and hnRNP-A1" . SPARSER::COLLECTION)
    ("JAK2-V617F mutated alleles" . SPARSER::ALLELE)
    ("YWHAZ" . SPARSER::PROTEIN) ("JAK2-STAT" . SPARSER::COLLECTION)
    ("approximately 70 kDa" . SPARSER::PROTEIN)
    ("missing exon" . SPARSER::PROTEIN)
    ("mutated and total alleles" . SPARSER::ALLELE)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("protein kinase domain" . SPARSER::PROTEIN-FAMILY)
    ("UPF1" . SPARSER::PROTEIN) ("hnRNP-A1" . SPARSER::PROTEIN)
    ("SC35" . SPARSER::PROTEIN) ("SRp55" . SPARSER::PROTEIN)
    ("cystine" . SPARSER::MOLECULE)
    ("aspartate and serine" . SPARSER::COLLECTION)
    ("arginine, and codon" . SPARSER::COLLECTION) ("RM" . SPARSER::MOLECULE)
    ("IIB" . SPARSER::PROTEIN) ("Gemcitabine or 5FU" . SPARSER::COLLECTION)
    ("Gemcitabine" . SPARSER::DRUG) ("the pancreatobiliary type" . TYPE)
    ("intestinal, pancreatobiliary or mixed types" . TYPE)
    ("Hormone" . SPARSER::MOLECULE)
    ("AMPK and AMPK-related kinases" . SPARSER::COLLECTION)
    ("CREB and its co-activator" . SPARSER::COLLECTION)
    ("Given BCRP's" . SPARSER::PROTEIN) ("Given BCRP" . SPARSER::PROTEIN)
    ("xenobiotics and anti-neoplastic" . SPARSER::COLLECTION)
    ("xenobiotics" . SPARSER::MOLECULE) ("EGF-EGFR" . SPARSER::COLLECTION)
    ("CREB and CRTC2" . SPARSER::COLLECTION)
    ("the respective mRNAs" . SPARSER::PROTEIN)
    ("CREB and BCRP" . SPARSER::COLLECTION) ("p-AMPK" . SPARSER::COLLECTION)
    ("AKT and CREB" . SPARSER::COLLECTION)
    ("CRTC2, and BCRP" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("either negative control siRNA (NC) or CREB siRNA" . SPARSER::COLLECTION)
    ("siRNA (NC)" . SPARSER::PROTEIN) ("ZD1839 or PI3K" . SPARSER::COLLECTION)
    ("LY294002 or MAPK" . SPARSER::COLLECTION) ("FTC" . SPARSER::DRUG)
    ("Mitoxantrone" . SPARSER::DRUG) ("mitoxantrone" . SPARSER::DRUG)
    ("EGFR, CREB, AKT, and ERK" . SPARSER::COLLECTION)
    ("CREs" . SPARSER::PROTEIN) ("a functional CRE" . SPARSER::PROTEIN)
    ("CRE/CREB" . SPARSER::COLLECTION) ("kinase (AMPK)" . SPARSER::KINASE)
    ("P300/CBP" . SPARSER::COLLECTION) ("p-CREB binding" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) and fibroblast growth factor (FGF)"
     . SPARSER::COLLECTION)
    ("cAMP/PKA" . SPARSER::COLLECTION)
    ("a cAMP-driven transcription factor" . SPARSER::PROTEIN)
    ("The basic leucine zipper transcription factor p-CREB"
     . SPARSER::COLLECTION)
    ("p-CREB" . SPARSER::COLLECTION) ("antineoplastic drugs" . SPARSER::DRUG)
    ("ATP-binding cassette (ABC)" . SPARSER::PROTEIN)
    ("cancer resistance protein (BCRP)" . SPARSER::PROTEIN)
    ("CREB or CRTC2" . SPARSER::COLLECTION) ("RAS/MAPK" . SPARSER::COLLECTION)
    ("EGFR, AKT, ERK and CREB" . SPARSER::COLLECTION)
    ("c-AMP response element binding protein (CREB)" . SPARSER::PROTEIN)
    ("response element (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("BCRP" . SPARSER::PROTEIN) ("CRE" . SPARSER::PROTEIN)
    ("SIK-1" . SPARSER::PROTEIN)
    ("Ca2 + /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("ZD1839" . SPARSER::DRUG)
    ("P300" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("CREB binding" . SPARSER::PROTEIN-FAMILY)
    ("cAMP-dependent" . SPARSER::PROTEIN)
    ("cAMP response element binding protein" . SPARSER::PROTEIN)
    ("aryl hydrocarbon" . SPARSER::PROTEIN)
    ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("cancer resistance protein" . SPARSER::PROTEIN)
    ("CRTC2" . SPARSER::PROTEIN)
    ("c-AMP response element binding protein" . SPARSER::PROTEIN)
    ("cyclic-AMP" . SPARSER::MOLECULE)
    ("the internal lysine" . SPARSER::AMINO-ACID)
    ("PCNA or REV7" . SPARSER::COLLECTION)
    ("PCNA and the B family TLS polymerase Polζ" . SPARSER::COLLECTION)
    ("REV1, PIASy, and p53" . SPARSER::COLLECTION)
    ("a complex and hostile environment" . SPARSER::COLLECTION)
    ("STS and ROS" . SPARSER::COLLECTION)
    ("p53 and its negative regulators" . SPARSER::COLLECTION)
    ("p53-dependent pro-apoptotic target genes" . SPARSER::GENE)
    ("Puma , Bax , and Noxa" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and its downstream effectors" . SPARSER::COLLECTION)
    ("REV1-p53" . SPARSER::COLLECTION) ("REV1 and SUMO3" . SPARSER::COLLECTION)
    ("p21-luc" . SPARSER::COLLECTION)
    ("p53 and its interacting proteins" . SPARSER::COLLECTION)
    ("pro-apoptotic and metabolic target genes" . SPARSER::GENE)
    ("TIGAR, and SESTRIN2" . SPARSER::COLLECTION) ("TIGAR" . SPARSER::PROTEIN)
    ("REV1 and p53" . SPARSER::COLLECTION)
    ("full-length or variant" . SPARSER::COLLECTION)
    ("p53 and REV1" . SPARSER::COLLECTION)
    ("The eukaryotic REV1 protein" . SPARSER::PROTEIN)
    ("SUMO or PIASy" . SPARSER::COLLECTION)
    ("wild-type REV1 and the SUMOylation-deficient mutant (K119R)"
     . SPARSER::COLLECTION)
    ("Oct4 and Huntingtin" . SPARSER::COLLECTION)
    ("REV1-PIASy" . SPARSER::COLLECTION)
    ("REV1 and PIASy" . SPARSER::COLLECTION)
    ("SENP1 or SENP6" . SPARSER::COLLECTION) ("PIASy" . SPARSER::PROTEIN)
    ("Myc-REV1" . SPARSER::COLLECTION) ("SUMO2 or SUMO3" . SPARSER::COLLECTION)
    ("both exogenous and endogenous ROS" . SPARSER::PROTEIN)
    ("DXR and STS" . SPARSER::COLLECTION)
    ("short-interfering RNA" . SPARSER::RNA)
    ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("the chemotherapeutic drug doxorubicin (DXR)" . SPARSER::PROTEIN)
    ("SUMO1 and the highly-related SUMO2 and SUMO3 (SUMO2/3)"
     . SPARSER::COLLECTION)
    ("the highly-related SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("Nutrient" . SPARSER::MOLECULE) ("accessory subunit" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("SENP5" . SPARSER::PROTEIN)
    ("H 2 DCFDA" . SPARSER::DRUG) ("β-ACTIN" . SPARSER::PROTEIN)
    ("AG -3" . SPARSER::PROTEIN) ("CA -3" . SPARSER::PROTEIN)
    ("SESTRIN2" . SPARSER::PROTEIN) ("G -3" . SPARSER::PROTEIN)
    ("C -3" . SPARSER::PROTEIN) ("T -3" . SPARSER::PROTEIN)
    ("NP 40" . SPARSER::MOLECULE) ("REV7" . SPARSER::PROTEIN)
    ("SENP6" . SPARSER::PROTEIN) ("SENP1" . SPARSER::PROTEIN)
    ("Ubc9" . SPARSER::PROTEIN) ("SUMO3" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("types and ethnicities" . SPARSER::COLLECTION)
    ("different pathological type" . TYPE)
    ("a multifunctional signaling protein" . SPARSER::PROTEIN)
    ("KRas and HRas" . SPARSER::COLLECTION) ("HRas" . SPARSER::PROTEIN)
    ("KRas" . SPARSER::PROTEIN) ("EF" . SPARSER::PROTEIN)
    ("phospholipase C (PLC)" . SPARSER::PROTEIN) ("HNC" . SPARSER::PROTEIN)
    ("the 26th exon" . SPARSER::PROTEIN)
    ("PLCE1 and C20orf54" . SPARSER::COLLECTION) ("CDC25" . SPARSER::PROTEIN)
    ("C20orf54" . SPARSER::PROTEIN) ("PLCE1" . SPARSER::PROTEIN)
    ("Phospholipase C epsilon 1" . SPARSER::PROTEIN)
    ("Shc/Grb2" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("PAC" . SPARSER::BIO-COMPLEX) ("complex (PAC)" . SPARSER::BIO-COMPLEX)
    ("FADD and caspase-8" . SPARSER::COLLECTION) ("Mani" . SPARSER::PROTEIN)
    ("an indispensable component" . SPARSER::COMPONENT)
    ("PI3K/MAPK" . SPARSER::COLLECTION) ("ethynyl" . SPARSER::MOLECULE)
    ("PANC-1 and PanD3" . SPARSER::COLLECTION)
    ("PI3K or MAPK" . SPARSER::COLLECTION) ("AKT/GSK3 β" . SPARSER::COLLECTION)
    ("Fc" . SPARSER::PROTEIN) ("CD95-Fc or NaCl" . SPARSER::COLLECTION)
    ("CD95-Fc" . SPARSER::COLLECTION) ("CD95L–CD95" . SPARSER::COLLECTION)
    ("CD95/CD95L" . SPARSER::COLLECTION) ("SCK" . SPARSER::PROTEIN)
    ("N-cadherin and fibronectin" . SPARSER::COLLECTION)
    ("E-cadherin, keratin-19 and elastases" . SPARSER::COLLECTION)
    ("elastases" . SPARSER::PROTEIN) ("underwent EMT" . SPARSER::PROTEIN)
    ("CD24 and CD44" . SPARSER::COLLECTION) ("CD24−" . SPARSER::PROTEIN)
    ("CD95-" . SPARSER::PROTEIN) ("PanD" . SPARSER::PROTEIN)
    ("CD95 and EMT" . SPARSER::COLLECTION)
    ("CD95 and CD95L" . SPARSER::COLLECTION)
    ("CD95 and its downstream signalling pathway components"
     . SPARSER::COLLECTION)
    ("PDACs" . SPARSER::MOLECULE)
    ("FADD and caspase-8/10" . SPARSER::COLLECTION)
    ("p38, JNK or extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("FADD" . SPARSER::PROTEIN) ("DISC" . SPARSER::BIO-COMPLEX)
    ("N-cadherin, fibronectin and vimentin" . SPARSER::COLLECTION)
    ("EMT and stemness" . SPARSER::COLLECTION) ("1–2 " . SPARSER::PROTEIN)
    ("A–D" . SPARSER::PROTEIN) ("Grb2" . SPARSER::PROTEIN)
    ("MAPK/ERK kinase kinase 1" . SPARSER::PROTEIN)
    ("MEKK-1" . SPARSER::PROTEIN) ("Shc2" . SPARSER::PROTEIN)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("keratin-19" . SPARSER::PROTEIN) ("CD95L" . SPARSER::PROTEIN)
    ("CD95 ligand" . SPARSER::PROTEIN) ("Apo-1" . SPARSER::PROTEIN)
    ("TGF- β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("predominant excitatory neurotransmitter receptors" . SPARSER::RECEPTOR)
    ("AMPA" . SPARSER::MOLECULE)
    ("RHEB (20 & 3 fold) and TIMP1 (26 & 17 fold)" . SPARSER::COLLECTION)
    ("NCAM1 (3 & 3), CREM (6 & 5 fold), NFKB1 (8 & 6 fold), RHEB (20 & 3 fold) and TIMP1 (26 & 17 fold)"
     . SPARSER::COLLECTION)
    ("regulated synaptic plasticity genes" . SPARSER::GENE)
    ("each synaptic plasticity gene" . SPARSER::GENE)
    ("the dysregulated synaptic plasticity genes" . SPARSER::GENE)
    ("an integral chloride channel" . SPARSER::PROTEIN)
    ("benzodiazepine" . SPARSER::DRUG) ("GABA" . SPARSER::MOLECULE)
    ("an important presynaptic regulator" . SPARSER::REGULATOR)
    ("dicysteine" . SPARSER::MOLECULE)
    ("neurotransmitters" . SPARSER::MOLECULE) ("NMDAR" . SPARSER::PROTEIN)
    ("NOS/sGC/PKG" . SPARSER::COLLECTION) ("PKG" . SPARSER::PROTEIN)
    ("sGC" . SPARSER::PROTEIN) ("NOS" . SPARSER::PROTEIN)
    ("receptor, NOS1, CaMKs, CREBP and NFkB" . SPARSER::COLLECTION)
    ("CaMKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("28 synaptic plasticity genes and up-regulation of 8 genes"
     . SPARSER::COLLECTION)
    ("28 synaptic plasticity genes" . SPARSER::GENE)
    ("the synaptic plasticity genes" . SPARSER::GENE)
    ("25 synaptic plasticity genes" . SPARSER::GENE)
    ("many other synaptic plasticity genes" . SPARSER::GENE)
    ("36 synaptic plasticity genes" . SPARSER::GENE)
    ("AKT1, CAMK2G, CEBPB, GABRA5, GRM5, GRIA3, NFKBIB, NOS1, RAB3A and TNF-α"
     . SPARSER::COLLECTION)
    ("NFKBIB" . SPARSER::PROTEIN) ("CEBPB" . SPARSER::PROTEIN)
    ("synaptic genes" . SPARSER::GENE)
    ("HIV-1 clade B gp120 and Tat" . SPARSER::COLLECTION)
    ("Glutamine and Glutamate" . SPARSER::COLLECTION)
    ("neuronal receptors" . SPARSER::PROTEIN)
    ("late response (LR) genes" . SPARSER::GENE)
    ("immediate-early (IE) response genes" . SPARSER::GENE)
    ("These synaptic plasticity genes" . SPARSER::GENE)
    ("CREM, NFkB1, RHEB, NCAM and TIMP1" . SPARSER::COLLECTION)
    ("NCAM" . SPARSER::PROTEIN) ("RHEB" . SPARSER::PROTEIN)
    ("CREM" . SPARSER::PROTEIN) ("LTP" . SPARSER::PROTEIN)
    ("these 84 synaptic plasticity genes" . SPARSER::GENE)
    ("neuronal plasticity genes" . SPARSER::GENE)
    ("HIV clade B and C viral infections differentially" . SPARSER::PROTEIN)
    ("NMDA" . SPARSER::MOLECULE)
    ("metabotropic glutamate receptors" . SPARSER::RECEPTOR)
    ("complex (ADC)" . SPARSER::BIO-COMPLEX)
    ("further dysregulated synaptic plasticity genes" . SPARSER::GENE)
    ("synaptic plasticity genes" . SPARSER::GENE)
    ("glutamine and glutamate" . SPARSER::COLLECTION)
    ("36 and 25 synaptic genes" . SPARSER::GENE)
    ("84 key synaptic plasticity genes" . SPARSER::GENE)
    ("Ca (2+)" . SPARSER::CALCIUM-ION) ("Gria1" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN) ("NCAM1" . SPARSER::PROTEIN)
    ("chloride channel" . SPARSER::PROTEIN) ("Ca2 +" . SPARSER::CALCIUM-ION)
    ("RAB3A" . SPARSER::PROTEIN) ("NOS1" . SPARSER::PROTEIN)
    ("GRIA3" . SPARSER::PROTEIN) ("GRM5" . SPARSER::PROTEIN)
    ("GABRA5" . SPARSER::PROTEIN) ("CAMK2G" . SPARSER::PROTEIN)
    ("Glutamine synthetase" . SPARSER::PROTEIN) ("TIMP1" . SPARSER::PROTEIN)
    ("NFkB1" . SPARSER::PROTEIN) ("SP2" . SPARSER::PROTEIN)
    ("A-2" . SPARSER::PROTEIN) ("p40phox and p67phox" . SPARSER::COLLECTION)
    ("indomethacin and NS-398" . SPARSER::COLLECTION)
    ("thromboxane A 2 and/or prostaglandin H 2 receptor antagonist"
     . SPARSER::COLLECTION)
    ("thromboxane A 2 and prostaglandin H 2" . SPARSER::COLLECTION)
    ("indomethacin (COX inhibitor) or NS-398 (COX-2 inhibitor)"
     . SPARSER::COLLECTION)
    ("thromboxane A 2 and prostacyclin" . SPARSER::COLLECTION)
    ("prostacyclin" . SPARSER::MOLECULE)
    ("neutrophils and monocytes" . SPARSER::COLLECTION)
    ("FPRs" . SPARSER::PROTEIN) ("FPR" . SPARSER::PROTEIN)
    ("leukotriene" . SPARSER::MOLECULE) ("tempol" . SPARSER::DRUG)
    ("Rho/Rho kinase" . SPARSER::COLLECTION) ("SQ" . SPARSER::MOLECULE)
    ("PG" . SPARSER::PROTEIN) ("prostaglandin" . SPARSER::PROTEIN)
    ("thromboxane" . SPARSER::MOLECULE) ("LXA 4-" . SPARSER::MOLECULE)
    ("indomethacin" . SPARSER::DRUG) ("COX" . SPARSER::PROTEIN)
    ("cyclooxygenase" . SPARSER::PROTEIN) ("Von" . SPARSER::PROTEIN)
    ("eicosanoids" . SPARSER::MOLECULE) ("phox" . SPARSER::MOLECULE)
    ("microglia" . SPARSER::PROTEIN)
    ("neutrophil and eosinophil" . SPARSER::COLLECTION)
    ("cytokine and ROS" . SPARSER::COLLECTION)
    ("G protein–coupled receptor (GPCR)" . SPARSER::PROTEIN)
    ("RhoA, phospho-myosin light chain, COX-2 and p67phox"
     . SPARSER::COLLECTION)
    ("COX-2 and NAD(P)H" . SPARSER::COLLECTION)
    ("both RhoA/Rho kinase inhibitor and ROS scavenger" . SPARSER::COLLECTION)
    ("RhoA/Rho kinase" . SPARSER::COLLECTION) ("lipoxin" . SPARSER::MOLECULE)
    ("lipoxins" . SPARSER::MOLECULE) ("NOX-1" . SPARSER::PROTEIN)
    ("p40phox" . SPARSER::PROTEIN) ("Superoxide anion" . SPARSER::MOLECULE)
    ("superoxide anions" . SPARSER::MOLECULE) ("p47phox" . SPARSER::PROTEIN)
    ("prostaglandin H 2" . SPARSER::MOLECULE)
    ("thromboxane A 2" . SPARSER::MOLECULE) ("FPR 1" . SPARSER::PROTEIN)
    ("FPR2" . SPARSER::PROTEIN) ("superoxide anion" . SPARSER::MOLECULE)
    ("p-67" . SPARSER::PROTEIN) ("TXA 2" . SPARSER::MOLECULE)
    ("SC560" . SPARSER::DRUG) ("FPR-1" . SPARSER::PROTEIN)
    ("PGH 2" . SPARSER::MOLECULE) ("NS-398" . SPARSER::DRUG)
    ("COX-1" . SPARSER::PROTEIN) ("SC-560" . SPARSER::DRUG)
    ("L – 10" . SPARSER::PROTEIN) ("p47" . SPARSER::PROTEIN)
    ("FPR-2" . SPARSER::PROTEIN)
    ("G protein–coupled receptor" . SPARSER::PROTEIN)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("Lipoxin A 4" . SPARSER::MOLECULE)
    ("p67phox" . SPARSER::PROTEIN)
    ("formyl peptide receptor" . SPARSER::PROTEIN)
    ("LXA 4" . SPARSER::MOLECULE) ("Lipoxin A4" . SPARSER::MOLECULE)
    ("relevant molecular targets" . SPARSER::TARGET-PROTEIN)
    ("keratinocytes and MECs" . SPARSER::COLLECTION)
    ("FAK and TRAIL" . SPARSER::COLLECTION)
    ("Src(Y527F) or myrPI3K" . SPARSER::COLLECTION)
    ("three simultaneous types" . TYPE)
    ("dehydrogenase (LDH)" . SPARSER::PROTEIN)
    ("keratin 10 and filaggrin" . SPARSER::COLLECTION)
    ("filaggrin" . SPARSER::PROTEIN) ("at least three types" . TYPE)
    ("pepstatin" . SPARSER::DRUG)
    ("kinase, and Rho family" . SPARSER::COLLECTION)
    ("Cdc42/Rac" . SPARSER::COLLECTION)
    ("SRC, PI3K, or GRB2" . SPARSER::COLLECTION)
    ("AKTs" . SPARSER::PROTEIN-FAMILY) ("myrHA-AKT1" . SPARSER::COLLECTION)
    ("Y527F mutant or Src(Y527F)" . SPARSER::COLLECTION)
    ("PI3K or myrPI3K" . SPARSER::COLLECTION)
    ("myristoylated" . SPARSER::PROTEIN)
    ("paxillin and SRC" . SPARSER::COLLECTION)
    ("Myristoylated" . SPARSER::PROTEIN)
    ("SRC, AKT, and ERK" . SPARSER::COLLECTION)
    ("SRC and AKT" . SPARSER::COLLECTION)
    ("AKT, and growth factor receptor-bound protein 2" . SPARSER::COLLECTION)
    ("a typical inducer" . SPARSER::PROTEIN) ("STS" . SPARSER::PROTEIN)
    ("staurosporine" . SPARSER::DRUG) ("phosphatidylserine" . SPARSER::PROTEIN)
    ("exogenous ECM" . SPARSER::PROTEIN) ("polyHEMA" . SPARSER::MOLECULE)
    ("kinase (FAK)" . SPARSER::KINASE) ("innate ECM" . SPARSER::PROTEIN)
    ("abnormal or ectopic ECM" . SPARSER::PROTEIN)
    ("underwent anoikis" . SPARSER::PROTEIN) ("MCF-10 A" . SPARSER::PROTEIN)
    ("Anoikis" . SPARSER::PROTEIN) ("N-acetyltransferase" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::GROWTH-FACTOR)
    ("necrostatin-1" . SPARSER::MOLECULE) ("keratin 10" . SPARSER::PROTEIN)
    ("caspase 14" . SPARSER::PROTEIN) ("E64d" . SPARSER::MOLECULE)
    ("Z-VAD-fmk" . SPARSER::DRUG) ("β 1" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate 3-kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NPC, and miR-34c" . SPARSER::COLLECTION)
    ("miR-ctrl" . SPARSER::COLLECTION) ("ctrl" . SPARSER::PROTEIN)
    ("miR-34c" . SPARSER::PROTEIN) ("Wt" . SPARSER::PROTEIN)
    ("miR-Ctrl" . SPARSER::COLLECTION)
    ("miR-29c, miR-26a and miR" . SPARSER::COLLECTION)
    ("DAC" . SPARSER::PROTEIN) ("proto-oncogene (MET)" . SPARSER::PROTEIN)
    ("EF2" . SPARSER::PROTEIN) ("NOTCH4" . SPARSER::PROTEIN)
    ("Fos-related antigen 1" . SPARSER::PROTEIN) ("FRA-1" . SPARSER::PROTEIN)
    ("BMCC1-RhoA-ROCK-PIP5K-AKT" . SPARSER::COLLECTION)
    ("phosphatidylinositol (PtdIns)(3,4,5) P  3"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aggressive NB" . SPARSER::PROTEIN)
    ("mitochondrial BCL2 and other antiapoptotic BCL2 family proteins"
     . SPARSER::COLLECTION)
    ("mitochondrial BCL2" . SPARSER::PROTEIN)
    ("BCL2 and E1" . SPARSER::COLLECTION) ("BNIP" . SPARSER::PROTEIN)
    ("type and origin" . SPARSER::COLLECTION)
    ("ATM and downstream targets" . SPARSER::COLLECTION)
    ("p53-S15" . SPARSER::COLLECTION)
    ("proapoptotic NOXA and BIM" . SPARSER::COLLECTION)
    ("NOXA and BIM" . SPARSER::COLLECTION)
    ("CDDP or ADR" . SPARSER::COLLECTION) ("whose p53 gene" . SPARSER::GENE)
    ("expressing full-length BMCC1" . SPARSER::PROTEIN)
    ("GFP-" . SPARSER::PROTEIN) ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase-3 and caspase-6" . SPARSER::COLLECTION)
    ("BMCC1 or BMCC1ΔC" . SPARSER::COLLECTION)
    ("full-length and BMCC1ΔC" . SPARSER::COLLECTION)
    ("BIM and BCL2" . SPARSER::COLLECTION)
    ("BMCC1 or BMCC1ΔC and BCL2" . SPARSER::COLLECTION)
    ("BMCC1 and BCL2" . SPARSER::COLLECTION)
    ("BMCC1 and BMCC1" . SPARSER::COLLECTION)
    ("PDK1 and AKT" . SPARSER::COLLECTION)
    ("ATM and its downstream substrates" . SPARSER::COLLECTION)
    ("Chk2, p53 and H2A" . SPARSER::COLLECTION)
    ("caspase-9 and PARP1" . SPARSER::COLLECTION) ("ADR" . SPARSER::PROTEIN)
    ("ATM and Chk2" . SPARSER::COLLECTION)
    ("cleaved caspase-9 and poly (ADP-ribose) polymerase"
     . SPARSER::COLLECTION)
    ("p21 and NOXA" . SPARSER::COLLECTION)
    ("Chk2 (Thr68) and p53 (Ser15)" . SPARSER::COLLECTION)
    ("NGF, and BMCC1" . SPARSER::COLLECTION)
    ("retinoic acid and NGF" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR) ("-AKT" . SPARSER::COLLECTION)
    ("RhoA and Lbc" . SPARSER::COLLECTION) ("RhoGEF" . SPARSER::PROTEIN)
    ("favorable NB" . SPARSER::PROTEIN) ("TrkA" . SPARSER::PROTEIN)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("unfavorable NB" . SPARSER::PROTEIN)
    ("AKT and its upstream kinase PDK1" . SPARSER::COLLECTION)
    ("NB and non-NB" . SPARSER::COLLECTION) ("BCH" . SPARSER::PROTEIN)
    ("NIP2 and Cdc42GAP" . SPARSER::COLLECTION) ("NB" . SPARSER::PROTEIN)
    ("CA4" . SPARSER::PROTEIN) ("CX2" . SPARSER::PROTEIN)
    ("AC1" . SPARSER::PROTEIN) ("pCDNA3" . SPARSER::PROTEIN)
    ("brain-specific" . SPARSER::PROTEIN)
    ("P  3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIP5K" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4-phosphate 5-kinase" . SPARSER::PROTEIN)
    ("BNIP-S α" . SPARSER::PROTEIN) ("N-5" . SPARSER::PROTEIN)
    ("N-1" . SPARSER::PROTEIN) ("caspase-6" . SPARSER::PROTEIN)
    ("PRUNE2" . SPARSER::PROTEIN) ("caspase-9" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("UNC5D" . SPARSER::PROTEIN)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("BNIP2" . SPARSER::PROTEIN) ("BMCC1" . SPARSER::PROTEIN)
    ("Cdc42GAP" . SPARSER::PROTEIN) ("NIP2" . SPARSER::PROTEIN)
    ("Prof" . SPARSER::PROTEIN) ("a western blot" . SPARSER::PROTEIN)
    ("the relevant receptor" . SPARSER::RECEPTOR) ("FRAP" . SPARSER::PROTEIN)
    ("MCC or APC" . SPARSER::COLLECTION) ("MELT-repeat" . SPARSER::DRUG)
    ("Bub1:Bub3" . SPARSER::BIO-COMPLEX)
    ("robust MCC-APC/C complex" . SPARSER::BIO-COMPLEX)
    ("APC/C" . SPARSER::PROTEIN) ("MCC-APC/C" . SPARSER::COLLECTION)
    ("Bub1-BubR1" . SPARSER::COLLECTION) ("Bub1-TPR" . SPARSER::COLLECTION)
    ("very bright GFP-Bub1" . SPARSER::COLLECTION)
    ("BubR1-Bub3" . SPARSER::COLLECTION)
    ("Mad1 and Bub1" . SPARSER::COLLECTION)
    ("a rapidly cycling BubR1/Bub3 complex" . SPARSER::BIO-COMPLEX)
    ("Mad1/Mad2" . SPARSER::COLLECTION)
    ("which targets Cdc20" . SPARSER::PROTEIN)
    ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an asymmetric conformational dimer" . SPARSER::DIMER)
    ("Mad2, O-Mad2 and C-Mad2" . SPARSER::COLLECTION)
    ("whose first part" . SPARSER::COMPONENT) ("IPs" . SPARSER::PROTEIN)
    ("Mad2 and Cdc20" . SPARSER::COLLECTION) ("Mad2" . SPARSER::PROTEIN)
    ("LacI-Bub1" . SPARSER::COLLECTION) ("LacI" . SPARSER::PROTEIN)
    ("Knl1 or other kinetochore proteins" . SPARSER::COLLECTION)
    ("a helical conformation" . SPARSER::BIO-CONFORMATION)
    ("the crucial Bub1 and BubR1" . SPARSER::COLLECTION)
    ("runs" . SPARSER::PROTEIN-FAMILY) ("Bub1/BubR1" . SPARSER::COLLECTION)
    ("Bub1–BubR1" . SPARSER::COLLECTION)
    ("a stoichiometric complex" . SPARSER::BIO-COMPLEX)
    ("Bub1/Bub3" . SPARSER::COLLECTION)
    ("BubR1 and BubR1/Bub3" . SPARSER::COLLECTION) ("TPR" . SPARSER::PROTEIN)
    ("TPRs" . SPARSER::PROTEIN) ("MCC and APC/C" . SPARSER::COLLECTION)
    ("Mps1 and MELT" . SPARSER::COLLECTION) ("GFP-BubR1" . SPARSER::COLLECTION)
    ("the Knl1 receptor and its associated partner Mis12"
     . SPARSER::COLLECTION)
    ("its associated partner Mis12" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Bub1 B3BD /Bub3/MELT P ternary complex" . SPARSER::BIO-COMPLEX)
    ("Bub3, Bub1 209–270 /Bub3, or BubR1 362-–431 /Bub3" . SPARSER::COLLECTION)
    ("/Bub3" . SPARSER::COLLECTION) ("MBP-Knl1" . SPARSER::COLLECTION)
    ("protein (MBP)" . SPARSER::PROTEIN) ("MBP" . SPARSER::PROTEIN)
    ("maltose" . SPARSER::MOLECULE) ("amylose" . SPARSER::MOLECULE)
    ("GFP-Bub1" . SPARSER::COLLECTION)
    ("Bub1, BubR1, and Bub3" . SPARSER::COLLECTION)
    ("Bub1 or Knl1" . SPARSER::COLLECTION) ("Reversine" . SPARSER::DRUG)
    ("Mps1 and Bub1" . SPARSER::COLLECTION)
    ("Bub1 or BubR1" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN)
    ("Casc5, Spc105, Spc7, AF15q14, and Blinkin" . SPARSER::COLLECTION)
    ("Casc5" . SPARSER::PROTEIN) ("Blinkin" . SPARSER::PROTEIN)
    ("Knl1" . SPARSER::PROTEIN) ("Met-Glu-Leu-Thr" . SPARSER::COLLECTION)
    ("MELT" . SPARSER::DRUG) ("propeller" . SPARSER::PROTEIN-FAMILY)
    ("a soluble APC/C inhibitor" . SPARSER::INHIBITOR)
    ("centromeres" . SPARSER::PROTEIN)
    ("the mitotic checkpoint complex (MCC)" . SPARSER::BIO-COMPLEX)
    ("complex (MCC)" . SPARSER::BIO-COMPLEX) ("cyclosome" . SPARSER::PROTEIN)
    ("MCC" . SPARSER::PROTEIN) ("BubR1/Bub3" . SPARSER::COLLECTION)
    ("Mad" . SPARSER::PROTEIN) ("LECA" . SPARSER::PROTEIN)
    ("Bub1 and BubR1" . SPARSER::COLLECTION) ("C-N" . SPARSER::PROTEIN)
    ("KNL1" . SPARSER::PROTEIN) ("RO3306" . SPARSER::DRUG)
    ("Cdc27" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("C–D" . SPARSER::PROTEIN) ("KI1" . SPARSER::PROTEIN)
    ("Mis12" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S. cerevisiae" . SPARSER::PROTEIN) ("Bub1 B" . SPARSER::PROTEIN)
    ("Mps1" . SPARSER::PROTEIN) ("AF15q14" . SPARSER::PROTEIN)
    ("Spc7" . SPARSER::PROTEIN) ("Spc105" . SPARSER::PROTEIN)
    ("Sgo1" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN)
    ("an antidiabetic drug target" . SPARSER::TARGET-PROTEIN)
    ("the pan-HDACs inhibitors sodium butyrate or the class I HDAC inhibitor MS-275"
     . SPARSER::COLLECTION)
    ("butyrate" . SPARSER::PROTEIN) ("Atf3/ATF3" . SPARSER::COLLECTION)
    ("siH" . SPARSER::MOLECULE) ("ATF3 and CHOP" . SPARSER::COLLECTION)
    ("a 3-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Palmitate" . SPARSER::PROTEIN)
    ("CHOP and ATF3" . SPARSER::COLLECTION) ("entinostat" . SPARSER::DRUG)
    ("HDAC1 and HDAC3" . SPARSER::COLLECTION) ("Atf3" . SPARSER::PROTEIN)
    ("the dietary saturated fatty acid palmitate" . SPARSER::MOLECULE)
    ("palmitate" . SPARSER::PROTEIN) ("siH3" . SPARSER::MOLECULE)
    ("TATA box binding protein" . SPARSER::PROTEIN)
    ("transcription factor 3" . SPARSER::PROTEIN) ("Type 2" . SPARSER::PROTEIN)
    ("MS-275" . SPARSER::DRUG)
    ("activating transcription factor 3" . SPARSER::PROTEIN)
    ("Oct4-Sox2" . SPARSER::COLLECTION) ("PTEN or TNC" . SPARSER::COLLECTION)
    ("Sp1 and Oct4" . SPARSER::COLLECTION)
    ("Sp1, Klf4 and ZNF219" . SPARSER::COLLECTION)
    ("-KRAS-RalB-NFκB" . SPARSER::COLLECTION)
    ("a bona fide tumor suppressor gene" . SPARSER::PROTEIN)
    ("PTEN and oncogene" . SPARSER::COLLECTION) ("Stat1" . SPARSER::PROTEIN)
    ("oncogene and tumor" . SPARSER::COLLECTION)
    ("only 75 common genes" . SPARSER::GENE)
    ("an indispensable effector" . SPARSER::EFFECTOR)
    ("S6E and SF" . SPARSER::COLLECTION)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("Oct4, TNC and PTEN" . SPARSER::COLLECTION)
    ("Oct4 and PTEN" . SPARSER::COLLECTION)
    ("Oct4, PTEN and TNC" . SPARSER::COLLECTION)
    ("LY294002 and SAHA" . SPARSER::COLLECTION)
    ("LY294002 or SAHA" . SPARSER::COLLECTION) ("Balb/c" . SPARSER::COLLECTION)
    ("AKT/GSK3β" . SPARSER::COLLECTION)
    ("cisplatin (Figure xref ) or SAHA (Figure xref )" . SPARSER::COLLECTION)
    ("PTEN/AKT" . SPARSER::COLLECTION) ("DAPA" . SPARSER::PROTEIN-FAMILY)
    ("Sp1 and HDAC1/2" . SPARSER::COLLECTION) ("si-Oct4" . SPARSER::COLLECTION)
    ("HDAC1/2-containing repressive complex" . SPARSER::BIO-COMPLEX)
    ("Oct4-" . SPARSER::PROTEIN) ("PTEN-2" . SPARSER::COLLECTION)
    ("Oct4 and Sp1" . SPARSER::COLLECTION)
    ("Sp1 and ZNF219" . SPARSER::COLLECTION)
    ("Klf4, Sp1, Stat3 and ZNF219" . SPARSER::COLLECTION)
    ("promoter- and enhancer-associated genes" . SPARSER::COLLECTION)
    ("enhancer-associated genes" . SPARSER::GENE)
    ("promoter-" . SPARSER::PROMOTER)
    ("promoter-associated and enhancer-associated genes" . SPARSER::GENE)
    ("TNC, HDAC4, LAMB1 and GSK3A" . SPARSER::COLLECTION)
    ("PTEN, DKK3, FBXO31 and RAB37" . SPARSER::COLLECTION)
    ("EOMES , and PAX6" . SPARSER::COLLECTION) ("EOMES" . SPARSER::PROTEIN)
    ("ESRRB" . SPARSER::PROTEIN) ("3,350 unique RefSeq genes" . SPARSER::GENE)
    ("SAHA and MS275" . SPARSER::COLLECTION)
    ("low PTEN and high TNC" . SPARSER::COLLECTION)
    ("Sp1, Klf4, ZNF219 and Stat3" . SPARSER::COLLECTION)
    ("Sox2, Nanog and Klf4" . SPARSER::COLLECTION)
    ("Pit-1, Oct1/2 and UNC-86" . SPARSER::COLLECTION)
    ("Oct4 and Nanog" . SPARSER::COLLECTION)
    ("highly expressed Oct4 transcription factor" . SPARSER::PROTEIN)
    ("expressed Oct4 transcription factor" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor or anaplastic lymphoma kinase"
     . SPARSER::COLLECTION)
    ("PTEN and TNC" . SPARSER::COLLECTION) ("TNC" . SPARSER::PROTEIN)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("Dickkopf-1" . SPARSER::PROTEIN) ("S9B" . SPARSER::PROTEIN)
    ("RAB37" . SPARSER::PROTEIN) ("FBXO31" . SPARSER::PROTEIN)
    ("DKK3" . SPARSER::PROTEIN) ("STAG3" . SPARSER::PROTEIN)
    ("GSK3A" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("PCSK6" . SPARSER::PROTEIN) ("ZFP42" . SPARSER::PROTEIN)
    ("TCF3" . SPARSER::PROTEIN) ("JARID2" . SPARSER::PROTEIN)
    ("MS275" . SPARSER::DRUG) ("CL1–5" . SPARSER::PROTEIN)
    ("CL1–0" . SPARSER::PROTEIN) ("Tenascin-C" . SPARSER::PROTEIN)
    ("ZNF219" . SPARSER::PROTEIN) ("UNC-86" . SPARSER::PROTEIN)
    ("POU5F1" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("This location-based interactomes" . SPARSER::PROTEIN)
    ("proteins often form distinct protein" . SPARSER::PROTEIN)
    ("RBPJ and FOXO3" . SPARSER::COLLECTION)
    ("the well-studied FOXO3" . SPARSER::PROTEIN)
    ("RBPJ/CBF1" . SPARSER::COLLECTION)
    ("this location-specific (i.e. chromatin-associated and soluble) interactomes"
     . SPARSER::PROTEIN)
    ("JUN/FOS" . SPARSER::COLLECTION)
    ("FOXN2 soluble fractions" . SPARSER::COMPONENT)
    ("these soluble TF-associated proteins" . SPARSER::PROTEIN)
    ("soluble cytosolic proteins" . SPARSER::PROTEIN)
    ("soluble nuclear proteins" . SPARSER::PROTEIN)
    ("weakly or transiently interacting proteins" . SPARSER::PROTEIN)
    ("a given protein (which may lead to its mislocalization, misfolding or both) and very weak binding proteins"
     . SPARSER::COLLECTION)
    ("very weak binding proteins" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("tubulins and RNA-binding proteins" . SPARSER::COLLECTION)
    ("shock proteins, tubulins and RNA-binding proteins" . SPARSER::COLLECTION)
    ("matrixes" . SPARSER::PROTEIN-FAMILY)
    ("chromatin-associated proteins" . SPARSER::PROTEIN)
    ("the associated proteins" . SPARSER::PROTEIN)
    ("predominantly form functional complexes" . SPARSER::BIO-COMPLEX)
    ("FOXA2 and ETS1" . SPARSER::COLLECTION)
    ("these proteins only form functional complexes" . SPARSER::BIO-COMPLEX)
    ("chromatin and soluble fractions" . SPARSER::COLLECTION)
    ("FOXC2 and FOXJ2" . SPARSER::COLLECTION)
    ("TFs form unique protein" . SPARSER::PROTEIN)
    ("RBPJ ( xref ) and FOXO3 ( xref )" . SPARSER::COLLECTION)
    ("their associated proteins" . SPARSER::PROTEIN)
    ("CREBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CREB1/NFATC1" . SPARSER::COLLECTION)
    ("JUN, CREB1 and ATF1/2" . SPARSER::COLLECTION)
    ("JUN/CREB/ATF2" . SPARSER::COLLECTION)
    ("JUN/CREB/ATF" . SPARSER::COLLECTION)
    ("FOS, ATF2/3/7 and CREB5" . SPARSER::COLLECTION)
    ("chromatin and soluble fractions ( xref )" . SPARSER::COLLECTION)
    ("CREB1 and ATFs" . SPARSER::COLLECTION)
    ("CREB1 and NFATC1/2" . SPARSER::COLLECTION)
    ("JUN/CREB/ATF/NFATC" . SPARSER::COLLECTION) ("NFATC" . SPARSER::PROTEIN)
    ("βTRCP or βTRCP2" . SPARSER::COLLECTION)
    ("βTRCP and βTRCP2" . SPARSER::COLLECTION)
    ("CDC25A (Busino et al , xref ) and CTNNB1 (Hart et al , xref )"
     . SPARSER::COLLECTION)
    ("CUL1, SKP1 (Lyapina et al , xref ; Wu et al , xref ), USP37 (Burrows et al , xref ), USP47 (Peschiaroli et al , xref ), EEF2K (Meloche & Roux, xref ), CDC25A (Busino et al , xref ) and CTNNB1 (Hart et al , xref )"
     . SPARSER::COLLECTION)
    ("BTRC" . SPARSER::PROTEIN)
    ("chromatin and co-regulate" . SPARSER::COLLECTION)
    ("MDM2/MDM4" . SPARSER::COLLECTION)
    ("Many ubiquitin (Ub) E3 ligases/F-box proteins (FBXs) and proteasome subunits"
     . SPARSER::COLLECTION)
    ("FOXM1-associated proteins" . SPARSER::PROTEIN)
    ("IARS, DARS, EPRS, PARS2, QARS and C22orf28" . SPARSER::COLLECTION)
    ("EPRS" . SPARSER::PROTEIN) ("DARS" . SPARSER::PROTEIN)
    ("IARS" . SPARSER::PROTEIN)
    ("LIN9, LIN37, LIN54, MYBL2 and S100A7" . SPARSER::COLLECTION)
    ("DREAM" . SPARSER::PROTEIN)
    ("subunits and deubiquitinase" . SPARSER::COLLECTION)
    ("peptidase ( P  = 7.16e-4) and transmembrane proteins ( P  = 0.037)"
     . SPARSER::COLLECTION)
    ("kinase ( P  = 6.08e-5), peptidase ( P  = 7.16e-4) and transmembrane proteins ( P  = 0.037)"
     . SPARSER::COLLECTION)
    ("peptidase" . SPARSER::PROTEIN)
    ("our comparative interactomes" . SPARSER::PROTEIN)
    ("eight potential positive regulators and six potential negative regulators of MAX"
     . SPARSER::COLLECTION)
    ("MAX and FOXO3" . SPARSER::COLLECTION)
    ("MAX, FOXM1 and FOXO3" . SPARSER::COLLECTION)
    ("CREB1-associated protein ATF1" . SPARSER::PROTEIN)
    ("RBPJ-associated protein L3MBTL3" . SPARSER::PROTEIN)
    ("NFATC1-associated protein JUN" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAX-associated protein L3MBTL2" . SPARSER::PROTEIN)
    ("NFIX" . SPARSER::PROTEIN)
    ("SIN3A, SAP130, ARID4B, MORC2, FOXK1 and FOXK2" . SPARSER::COLLECTION)
    ("CCI" . SPARSER::PROTEIN) ("elegans" . SPARSER::PROTEIN)
    ("von" . SPARSER::PROTEIN) ("INTeractome" . SPARSER::PROTEIN)
    ("RPS" . SPARSER::PROTEIN)
    ("fraction and specificity" . SPARSER::COLLECTION)
    ("NTPCR" . SPARSER::PROTEIN)
    ("the generic preys (HSPs) and other non-specific binding proteins (actin, tubulin, RPLs)"
     . SPARSER::COLLECTION)
    ("the generic preys" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("chromatin ( xref ) and soluble fractions ( xref )" . SPARSER::COLLECTION)
    ("soluble fractions" . SPARSER::COMPONENT)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("3,751 unique preys" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("preys" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble fraction" . SPARSER::COMPONENT)
    ("HMG proteins and other chromatin components" . SPARSER::COLLECTION)
    ("very little histones, HMG proteins and other chromatin components"
     . SPARSER::COLLECTION)
    ("first isolated soluble fractions" . SPARSER::COMPONENT)
    ("DNA or RNA" . SPARSER::COLLECTION)
    ("MYC, MAX, TP53, NFKB1, JUN, FOS, SMAD4, TEAD2, RBPJ, TCF4, ATF6, CREB1, ETS1, GLI1, IRF3, MEF2A, NFATC1, PPARG and STAT3"
     . SPARSER::COLLECTION)
    ("PPARG" . SPARSER::PROTEIN) ("RBPJ" . SPARSER::PROTEIN)
    ("FOS" . SPARSER::PROTEIN) ("chromatins" . SPARSER::BIO-COMPLEX)
    ("indeed form distinct complexes" . SPARSER::BIO-COMPLEX)
    ("the soluble fractions" . SPARSER::COMPONENT)
    ("abundant associated proteins" . SPARSER::PROTEIN)
    ("FOXA, FOXD, FOXO, FOXP and FOXM" . SPARSER::COLLECTION)
    ("FOXA" . SPARSER::PROTEIN) ("Drosophila melanogaster" . SPARSER::PROTEIN)
    ("TFs form distinct location-specific protein" . SPARSER::PROTEIN)
    ("FOXD3" . SPARSER::PROTEIN) ("MXD4" . SPARSER::PROTEIN)
    ("MXI1" . SPARSER::PROTEIN) ("BAZ1A" . SPARSER::PROTEIN)
    ("ARHGEF2" . SPARSER::PROTEIN) ("TAF5L" . SPARSER::PROTEIN)
    ("RBL1" . SPARSER::PROTEIN) ("CDC27" . SPARSER::PROTEIN)
    ("ZC3H11A" . SPARSER::PROTEIN) ("SMARCA1" . SPARSER::PROTEIN)
    ("IARS2" . SPARSER::PROTEIN) ("PES1" . SPARSER::PROTEIN)
    ("ORC2L" . SPARSER::PROTEIN) ("DDX52" . SPARSER::PROTEIN)
    ("H2AFY" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("EEF1D" . SPARSER::PROTEIN) ("TFDP1" . SPARSER::PROTEIN)
    ("MECP2" . SPARSER::PROTEIN) ("VRK3" . SPARSER::PROTEIN)
    ("TFAP2A" . SPARSER::PROTEIN) ("EPC2" . SPARSER::PROTEIN)
    ("ATF7" . SPARSER::PROTEIN) ("ERK5" . SPARSER::PROTEIN)
    ("CBF1" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("FOXJ2" . SPARSER::PROTEIN)
    ("EEF2K" . SPARSER::PROTEIN) ("USP47" . SPARSER::PROTEIN)
    ("USP37" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("PSMD8" . SPARSER::PROTEIN) ("FBXW11" . SPARSER::PROTEIN)
    ("SKP1" . SPARSER::PROTEIN) ("RFX1" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("C22orf28" . SPARSER::PROTEIN)
    ("PARS2" . SPARSER::PROTEIN) ("S100A7" . SPARSER::PROTEIN)
    ("MYBL2" . SPARSER::PROTEIN) ("LIN54" . SPARSER::PROTEIN)
    ("LIN9" . SPARSER::PROTEIN) ("E3s" . SPARSER::MOLECULE)
    ("e-5" . SPARSER::PROTEIN) ("NFATC2" . SPARSER::PROTEIN)
    ("ZNF131" . SPARSER::PROTEIN) ("KDM1" . SPARSER::PROTEIN)
    ("L3MBTL" . SPARSER::PROTEIN) ("ATF1" . SPARSER::PROTEIN)
    ("E2F6" . SPARSER::PROTEIN) ("L3MBTL2" . SPARSER::PROTEIN)
    ("FOXK2" . SPARSER::PROTEIN) ("FOXK1" . SPARSER::PROTEIN)
    ("MORC2" . SPARSER::PROTEIN) ("ARID4B" . SPARSER::PROTEIN)
    ("SAP130" . SPARSER::PROTEIN) ("COPS5" . SPARSER::PROTEIN)
    ("CBX3" . SPARSER::PROTEIN) ("CUL7" . SPARSER::PROTEIN)
    ("SIN3A" . SPARSER::PROTEIN) ("NFATC1" . SPARSER::PROTEIN)
    ("MEF2A" . SPARSER::PROTEIN) ("GLI1" . SPARSER::PROTEIN)
    ("TEAD2" . SPARSER::PROTEIN) ("FOXM1" . SPARSER::PROTEIN)
    ("SH" . SPARSER::PROTEIN-FAMILY) ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("ipilimumab" . SPARSER::DRUG)
    ("significantly longer TTP" . SPARSER::PROTEIN)
    ("anatomic PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TTP" . SPARSER::PROTEIN)
    ("platelet-derived growth factor and stem cell factor"
     . SPARSER::COLLECTION)
    ("oncogenes and biologic behavior [ xref ]" . SPARSER::COLLECTION)
    ("PMD" . SPARSER::PROTEIN) ("SMD" . SPARSER::DRUG)
    ("FDG" . SPARSER::PROTEIN) ("TTP 1" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("stem cell factor" . SPARSER::PROTEIN)
    ("protein-tyrosine kinase" . SPARSER::PROTEIN)
    ("bevacizumab" . SPARSER::DRUG)
    ("PI3K inhibitor BKM120 and PARP" . SPARSER::COLLECTION)
    ("PARP and PI3K" . SPARSER::COLLECTION)
    ("PIK3CA , AKT1 , AKT2 and AKT3" . SPARSER::COLLECTION)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("glass" . SPARSER::MOLECULE) ("PI3K inhibitor BKM120" . SPARSER::DRUG)
    ("PI3Kα" . SPARSER::PROTEIN) ("active and inactive" . SPARSER::COLLECTION)
    ("a bound NF-κB or a pioneering polymerase" . SPARSER::COLLECTION)
    ("Nucleosomes" . SPARSER::PROTEIN)
    ("already-accessible chromatin" . SPARSER::PROTEIN)
    ("particular Alu" . SPARSER::PROTEIN)
    ("-GGRRNNYYCC-3" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("ALCAM and 221-kbp" . SPARSER::COLLECTION)
    ("NFKB1 and 458-kbp" . SPARSER::COLLECTION) ("ALCAM" . SPARSER::PROTEIN)
    ("a typical down-regulated gene" . SPARSER::GENE)
    ("a typical immediate-early up-regulated gene" . SPARSER::GENE)
    ("NFKBIA" . SPARSER::PROTEIN)
    ("constitutively expressed genes" . SPARSER::GENE)
    ("expressed genes" . SPARSER::GENE)
    ("the three-dimensional conformation" . SPARSER::BIO-CONFORMATION)
    ("‘wave’" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("single-nucleosome" . SPARSER::PROTEIN)
    ("Nucleosome" . SPARSER::BIO-COMPLEX)
    ("super-enhancers" . SPARSER::PROTEIN)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("s  2" . SPARSER::MOLECULE) ("18 h" . SPARSER::PROTEIN)
    ("EDN1" . SPARSER::PROTEIN) ("ZFPM2" . SPARSER::PROTEIN)
    ("SAMD4A" . SPARSER::PROTEIN) ("EXT1" . SPARSER::PROTEIN)
    ("LIN37" . SPARSER::PROTEIN) ("PTEN and AR" . SPARSER::COLLECTION)
    ("PARP-PI3K" . SPARSER::COLLECTION)
    ("DICER , or TP53 and BRCA1" . SPARSER::COLLECTION)
    ("competing endogeneous RNA" . SPARSER::RNA)
    ("TP53 , BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("AR (<50% of tumour cells) or no AR" . SPARSER::COLLECTION)
    ("AR and PTEN" . SPARSER::COLLECTION)
    ("AKT1, AKT2 and AKT3" . SPARSER::COLLECTION)
    ("Protein–protein" . SPARSER::COLLECTION)
    ("at least one allele" . SPARSER::ALLELE) ("transgenes" . SPARSER::PROTEIN)
    ("a bacterial artificial chromosome transgene" . SPARSER::PROTEIN)
    ("negative or weak PTEN" . SPARSER::PROTEIN)
    ("BRCA1 and PTEN" . SPARSER::COLLECTION)
    ("smaller cohorts" . SPARSER::MOLECULE)
    ("TP53 and BRCA1" . SPARSER::COLLECTION)
    ("PI3K and androgen receptor" . SPARSER::COLLECTION)
    ("TP53 and BRCA1/2" . SPARSER::COLLECTION)
    ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("AKT3" . SPARSER::PROTEIN)
    ("ACTA2" . SPARSER::PROTEIN)
    ("salt and reaction product" . SPARSER::COLLECTION)
    ("substrate and PIP 2" . SPARSER::COLLECTION)
    ("other monomeric enzymes" . SPARSER::ENZYME)
    ("eukaryotic Sac1" . SPARSER::PROTEIN)
    ("an insect-derived salivary inositol phosphatase" . SPARSER::PHOSPHATASE)
    ("myotubularins" . SPARSER::PROTEIN)
    ("soluble lipidic or liposomal substrates" . SPARSER::SUBSTRATE)
    ("enzyme and substrate" . SPARSER::COLLECTION)
    ("PTEN and PTEN-L" . SPARSER::COLLECTION)
    ("membrane-permeable translational variant" . SPARSER::VARIANT)
    ("salts" . SPARSER::DRUG)
    ("PTEN and other phosphoinositide phosphatases" . SPARSER::COLLECTION)
    ("the target enzyme and its substrate" . SPARSER::COLLECTION)
    ("the coupling enzyme and its substrate [ xref ]" . SPARSER::COLLECTION)
    ("monomeric PTEN" . SPARSER::PROTEIN) ("a dimeric form" . SPARSER::FORM)
    ("anion" . SPARSER::MOLECULE) ("PTEN, and PTEN-L" . SPARSER::COLLECTION)
    ("thioguanine" . SPARSER::DRUG) ("nucleobase" . SPARSER::NUCLEOBASE)
    ("soluble lipidic and liposomal substrates" . SPARSER::SUBSTRATE)
    ("-nitrophenylphosphate" . SPARSER::MOLECULE)
    ("nitrophenylphosphate" . SPARSER::MOLECULE)
    ("dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("-trisphosphate" . SPARSER::COLLECTION)
    ("phosphatidylinositol-" . SPARSER::PROTEIN) ("d -1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("diC 8" . SPARSER::DRUG) ("L-S" . SPARSER::PROTEIN)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("Sac1" . SPARSER::PROTEIN)
    ("NH 3" . SPARSER::MOLECULE) ("min −1" . SPARSER::PROTEIN)
    ("purine nucleoside phosphorylase" . SPARSER::PROTEIN)
    ("PLC1" . SPARSER::PROTEIN) ("3.1.3.67" . SPARSER::PROTEIN)
    ("-methyltransferase" . SPARSER::COLLECTION)
    ("family and let-7" . SPARSER::COLLECTION)
    ("PCA-STMN1" . SPARSER::COLLECTION)
    ("STMN1 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("miR-101" . SPARSER::PROTEIN) ("NPC-cell" . SPARSER::MOLECULE)
    ("DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM)"
     . SPARSER::COLLECTION)
    ("DNA-dependent protein kinase and ataxia telangiectasia mutated"
     . SPARSER::COLLECTION)
    ("the associated protein" . SPARSER::PROTEIN) ("e −D" . SPARSER::MOLECULE)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("miR-29c" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("Stathmin 1" . SPARSER::PROTEIN)
    ("monomeric ubiquitin" . SPARSER::PROTEIN)
    ("USP3 and USP16" . SPARSER::COLLECTION)
    ("Plk1 and 53BP1" . SPARSER::COLLECTION)
    ("the DNA damage-induced foci" . SPARSER::PROTEIN)
    ("RPE" . SPARSER::PROTEIN) ("a radiomimetic drug NCS" . SPARSER::PROTEIN)
    ("DMSO or Plk1" . SPARSER::COLLECTION) ("NCS" . SPARSER::PROTEIN)
    ("centrosomes" . SPARSER::PROTEIN) ("OPT" . SPARSER::PROTEIN)
    ("SSP and STP" . SPARSER::COLLECTION) ("STP" . SPARSER::PROTEIN)
    ("SSP" . SPARSER::PROTEIN) ("Cdk1 and p38a" . SPARSER::COLLECTION)
    ("Cdk1/cyclin" . SPARSER::COLLECTION) ("EGFP-53BP1" . SPARSER::COLLECTION)
    ("Cdh" . SPARSER::PROTEIN)
    ("subcellular compartment Plk1" . SPARSER::PROTEIN)
    ("a commercially available antibody" . SPARSER::PROTEIN)
    ("FHA" . SPARSER::PROTEIN-FAMILY) ("mitotic 53BP1" . SPARSER::PROTEIN)
    ("neocarzinostatin" . SPARSER::PROTEIN)
    ("Cdk1 and Plk1" . SPARSER::COLLECTION)
    ("53BP1 and Plk1" . SPARSER::COLLECTION)
    ("Plk1 and Cdk1" . SPARSER::COLLECTION)
    ("ATM kinase and RNF8/RNF168 ubiquitin ligases" . SPARSER::COLLECTION)
    ("RNF8/RNF168" . SPARSER::COLLECTION) ("Ro3306" . SPARSER::DRUG)
    ("N-Ethylmaleimide" . SPARSER::MOLECULE) ("TX-100" . SPARSER::DRUG)
    ("B/Cdk1" . SPARSER::PROTEIN) ("gamma-tubulin" . SPARSER::PROTEIN)
    ("H11" . SPARSER::PROTEIN) ("pS15" . SPARSER::PROTEIN)
    ("Ro 3306" . SPARSER::DRUG) ("USP16" . SPARSER::PROTEIN)
    ("USP3" . SPARSER::PROTEIN) ("Ubiquitin ligase" . SPARSER::PROTEIN)
    ("PP4" . SPARSER::PROTEIN) ("Protein phosphatase" . SPARSER::PROTEIN)
    ("cdc20" . SPARSER::PROTEIN)
    ("E3 ubiquitin-protein ligase RNF168" . SPARSER::PROTEIN)
    ("cdc27" . SPARSER::PROTEIN) ("p38a" . SPARSER::PROTEIN)
    ("SB202190" . SPARSER::DRUG) ("RO-3306" . SPARSER::DRUG)
    ("Wip1" . SPARSER::PROTEIN) ("PPM1D" . SPARSER::PROTEIN)
    ("K13" . SPARSER::PROTEIN) ("RING finger protein" . SPARSER::PROTEIN)
    ("RING finger protein 8" . SPARSER::PROTEIN)
    ("cyclin dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("breast cancer type 1 susceptibility protein" . SPARSER::PROTEIN)
    ("p53 binding protein 1" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("peptides and domains" . SPARSER::COLLECTION)
    ("PTCH1-PPxY" . SPARSER::PROTEIN-PAIR) ("TGFB" . SPARSER::PROTEIN)
    ("ligand (EYPPYPPPPYPSG)" . SPARSER::MOLECULE)
    ("arginines" . SPARSER::AMINO-ACID)
    ("SMAD7 (ELESPPPPYSRYPM) and AMOT p130 (MRYQHPPEYGAARP) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("p130 (MRYQHPPEYGAARP)" . SPARSER::PROTEIN)
    ("LATS and PTCH1" . SPARSER::COLLECTION)
    ("β2 and β3" . SPARSER::COLLECTION) ("Ile and Lys" . SPARSER::COLLECTION)
    ("interfacial water molecules" . SPARSER::MOLECULE)
    ("UEV" . SPARSER::PROTEIN-FAMILY)
    ("the enthalpic and entropic components" . SPARSER::COMPONENT)
    ("LATS1 and PTCH1" . SPARSER::COLLECTION) ("PTCH1-b" . SPARSER::COLLECTION)
    ("b" . SPARSER::PROTEIN) ("at least one ligand" . SPARSER::MOLECULE)
    ("ligand (YQGPPPPYPKHL)" . SPARSER::MOLECULE)
    ("LATS1-b" . SPARSER::COLLECTION)
    ("LATS1, LATS2 and PTCH1" . SPARSER::COLLECTION)
    ("overexpressed proteins" . SPARSER::PROTEIN)
    ("This mutant and the YAP" . SPARSER::COLLECTION)
    ("Flag-PTCH1" . SPARSER::COLLECTION) ("ALDA" . SPARSER::PROTEIN)
    ("PY" . SPARSER::MOLECULE)
    ("using PTCH1 and YAP mutants" . SPARSER::COLLECTION)
    ("four consecutive prolines (RYSPPPPYSSHS)" . SPARSER::AMINO-ACID)
    ("monomeric proteins" . SPARSER::PROTEIN) ("DSC" . SPARSER::PROTEIN)
    ("Patched" . SPARSER::PROTEIN)
    ("p73 [ xref ] and AMOTL1 (Angiomotin-Like-1)" . SPARSER::COLLECTION)
    ("P46937–1" . SPARSER::COLLECTION) ("Wnt and TGF" . SPARSER::COLLECTION)
    ("anchors" . SPARSER::ANCHOR)
    ("the YAP gene and its products" . SPARSER::COLLECTION)
    ("kinase-associated protein" . SPARSER::PROTEIN)
    ("functionally relevant ligands" . SPARSER::LIGAND)
    ("PTCH1 and LATS" . SPARSER::COLLECTION)
    ("oncogene and stemness" . SPARSER::COLLECTION)
    ("second type" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("PATCHED1" . SPARSER::PROTEIN) ("p53BP2" . SPARSER::PROTEIN)
    ("PDB2" . SPARSER::PROTEIN) ("K 1" . SPARSER::PROTEIN)
    ("g −1" . SPARSER::PROTEIN) ("min -1" . SPARSER::PROTEIN)
    ("M −1" . SPARSER::PROTEIN) ("M -1" . SPARSER::PROTEIN)
    ("cm -1" . SPARSER::PROTEIN) ("mL -1" . SPARSER::PROTEIN)
    ("Glutathione-S-Transferase" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN) ("AMOTL1" . SPARSER::PROTEIN)
    ("YAP2" . SPARSER::PROTEIN) ("P46937" . SPARSER::PROTEIN)
    ("Yap1" . SPARSER::PROTEIN) ("14–3–3" . SPARSER::PROTEIN)
    ("Large Tumor Suppressor" . SPARSER::PROTEIN) ("Nat" . SPARSER::PROTEIN)
    ("a relatively safe drug" . SPARSER::DRUG) ("Amlexanox" . SPARSER::DRUG)
    ("a Food and Drug Administration-approved drug that selectively inhibits TBK1"
     . SPARSER::COLLECTION)
    ("flu" . SPARSER::PROTEIN) ("naïve and effector" . SPARSER::COLLECTION)
    ("TBK1 and its homologue IKKε" . SPARSER::COLLECTION)
    ("IFNs" . SPARSER::DRUG) ("the migration-regulatory genes" . SPARSER::GENE)
    ("the transcription factor KLF2 and its target gene product S1PR1"
     . SPARSER::COLLECTION)
    ("Foxo1 and KLF2" . SPARSER::COLLECTION)
    ("mTORC1 and Foxo1" . SPARSER::COLLECTION)
    ("monocytes or macrophages" . SPARSER::COLLECTION)
    ("protein (PLP)" . SPARSER::PROTEIN) ("PLP" . SPARSER::PROTEIN)
    ("AKT and its target protein Foxo1" . SPARSER::COLLECTION)
    ("the Food and Drug Administration-approved" . SPARSER::COLLECTION)
    ("amlexanox" . SPARSER::DRUG) ("S1PR1 and KLF2" . SPARSER::COLLECTION)
    ("AKT as well as the AKT-mTORC1 downstream proteins Foxo1"
     . SPARSER::COLLECTION)
    ("AKT (AKTi) and its upstream regulator PI3 kinase (LY294002)"
     . SPARSER::COLLECTION)
    ("AKTi" . SPARSER::PROTEIN) ("KLF2 and S1PR1" . SPARSER::COLLECTION)
    ("CCR7 and CD62L" . SPARSER::COLLECTION)
    ("the transcription factor KLF2 and its target gene S1PR1"
     . SPARSER::COLLECTION)
    ("AKT and P-AKT" . SPARSER::COLLECTION)
    ("exogenously expressed AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("expressed AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("overexpressed TBK1" . SPARSER::PROTEIN)
    ("AKT and its downstream targets" . SPARSER::COLLECTION)
    ("Foxo1 and mTORC1" . SPARSER::COLLECTION)
    ("p38 and ERK" . SPARSER::COLLECTION)
    ("Ninj1 gene and competent expression of several other cell adhesion molecules"
     . SPARSER::COLLECTION)
    ("Rag1" . SPARSER::PROTEIN) ("Tcrb" . SPARSER::PROTEIN)
    ("IL-17A (Th17) or GM-CSF" . SPARSER::COLLECTION)
    ("MOG" . SPARSER::PROTEIN) ("autoantigen" . SPARSER::DRUG)
    ("Rag" . SPARSER::PROTEIN) ("Tbk1-TKO" . SPARSER::COLLECTION)
    ("interleukin (IL-2) and granulocyte–macrophage colony-stimulating factor (GM-CSF; xref )"
     . SPARSER::COLLECTION)
    ("two other cytokines, interleukin (IL-2) and granulocyte–macrophage colony-stimulating factor (GM-CSF; xref )"
     . SPARSER::COLLECTION)
    ("CD4-Cre" . SPARSER::COLLECTION) ("NEMO-" . SPARSER::PROTEIN)
    ("the IKK regulatory subunit NEMO or the IKK catalytic subunit IKKβ ( xref )"
     . SPARSER::COLLECTION)
    ("the typical IKK complex" . SPARSER::BIO-COMPLEX)
    ("CD28 agonistic antibodies (anti-CD3 and anti-CD28) or mitogens (PMA and ionomycin)"
     . SPARSER::COLLECTION)
    ("CD28 agonistic antibodies" . SPARSER::ANTIBODY)
    ("-TKO" . SPARSER::COLLECTION) ("TKO" . SPARSER::PROTEIN)
    ("agonistic antibodies" . SPARSER::ANTIBODY) ("Tbk1" . SPARSER::PROTEIN)
    ("typical IKK components" . SPARSER::COMPONENT)
    ("structural homology" . SPARSER::PROTEIN)
    ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("its homologous kinase IKKε" . SPARSER::PROTEIN)
    ("myelin" . SPARSER::PROTEIN) ("AKT-mTORC1" . SPARSER::COLLECTION)
    ("AKT and its downstream kinase mTORC1" . SPARSER::COLLECTION)
    ("S1pr1" . SPARSER::PROTEIN) ("LYVE-1" . SPARSER::PROTEIN)
    ("H37" . SPARSER::PROTEIN) ("Lys-Trp" . SPARSER::MOLECULE)
    ("Leu-Gly" . SPARSER::MOLECULE) ("Arg-Val" . SPARSER::MOLECULE)
    ("inhibitor 1" . SPARSER::PROTEIN) ("C-4" . SPARSER::PROTEIN)
    ("K-23" . SPARSER::PROTEIN) ("E-4" . SPARSER::PROTEIN)
    ("B-1" . SPARSER::PROTEIN) ("IKK2" . SPARSER::PROTEIN)
    ("KLF2" . SPARSER::PROTEIN) ("S1PR1" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate receptor 1" . SPARSER::PROTEIN)
    ("MRT67307" . SPARSER::DRUG) ("Foxo1" . SPARSER::PROTEIN)
    ("Ninj1" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("myelin oligodendrocyte glycoprotein" . SPARSER::PROTEIN)
    ("IKKε" . SPARSER::PROTEIN) ("Pro and Arg" . SPARSER::COLLECTION)
    ("the heterozygous form" . SPARSER::FORM)
    ("Arg or Pro" . SPARSER::COLLECTION) ("Ins" . SPARSER::PROTEIN)
    ("Guo" . SPARSER::MOLECULE)
    ("only single genes or single gene alleles" . SPARSER::COLLECTION)
    ("multiple genes and environmental factors" . SPARSER::COLLECTION)
    ("allele Pro (OR = 2.1, CI 1.2–3.4) and genotype Pro/Pro (OR = 3.9, CI 0.13-12.7)"
     . SPARSER::COLLECTION)
    ("61 (0.47%) Arg and 69 (0.53%) Pro" . SPARSER::COLLECTION)
    ("82 (0.63%) Arg and 48 (0.37%) Pro" . SPARSER::COLLECTION)
    ("Arg/Pro" . SPARSER::COLLECTION)
    ("proline or arginine" . SPARSER::COLLECTION)
    ("MYOC , ASB10 , WDR36 , NTF4 , and TBK1" . SPARSER::COLLECTION)
    ("MYOC" . SPARSER::PROTEIN) ("ment" . SPARSER::PROTEIN)
    ("Pro/Pro" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION) ("P72" . SPARSER::PROTEIN)
    ("TBK1" . SPARSER::PROTEIN) ("NTF4" . SPARSER::PROTEIN)
    ("WDR36" . SPARSER::PROTEIN) ("ASB10" . SPARSER::PROTEIN)
    ("STAT3 and Mcl-1" . SPARSER::COLLECTION)
    ("SOCS-3 and PIAS" . SPARSER::COLLECTION)
    ("EGFR and HER-2" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) and IL-6 [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("STAT3 and mTORC1" . SPARSER::COLLECTION)
    ("ERP57 and STAT3" . SPARSER::COLLECTION)
    ("Mn-SOD, PRDX2, and CLIC1" . SPARSER::COLLECTION)
    ("fenretinide" . SPARSER::DRUG)
    ("protein and chaperone" . SPARSER::COLLECTION)
    ("ERp57 and Mcl-1" . SPARSER::COLLECTION)
    ("ERp57, STAT3, and Mcl-1" . SPARSER::COLLECTION)
    ("interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) (Fig. xref )"
     . SPARSER::COLLECTION)
    ("Mcl-1 and cyclin D1" . SPARSER::COLLECTION)
    ("phosphorylated STAT3 and its target genes" . SPARSER::COLLECTION)
    ("Mcl-1, cyclin D1, and p53" . SPARSER::COLLECTION)
    ("ERp57 or STAT3" . SPARSER::COLLECTION)
    ("ERp57 and calreticulin" . SPARSER::COLLECTION)
    ("calreticulin" . SPARSER::PROTEIN) ("STAT3-Mcl-1" . SPARSER::COLLECTION)
    ("overexpressed ERp57" . SPARSER::PROTEIN)
    ("a multifunctional chaperone" . SPARSER::PROTEIN)
    ("GRP58/PDIA3" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-xl, and survivin" . SPARSER::COLLECTION)
    ("cytokines and growth-factor" . SPARSER::COLLECTION)
    ("ERp57-STAT3" . SPARSER::COLLECTION)
    ("STAT3 or Mcl-1" . SPARSER::COLLECTION)
    ("ERp57-STAT3-Mcl-1" . SPARSER::COLLECTION)
    ("This physical complex" . SPARSER::BIO-COMPLEX)
    ("ERp57 and STAT3" . SPARSER::COLLECTION) ("CH3" . SPARSER::MOLECULE)
    ("S3I-201" . SPARSER::MOLECULE) ("SOCS-3" . SPARSER::PROTEIN)
    ("ERP57" . SPARSER::PROTEIN) ("CLIC1" . SPARSER::PROTEIN)
    ("PRDX2" . SPARSER::PROTEIN) ("Mn-SOD" . SPARSER::PROTEIN)
    ("disulfide isomerase" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("PDIA3" . SPARSER::PROTEIN)
    ("GRP58" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERp57" . SPARSER::PROTEIN) ("NOTCH1 and TP53" . SPARSER::COLLECTION)
    ("IGHV 4-39 and IGHV 1-69" . SPARSER::COLLECTION)
    ("IGHV 1-69 and IGHV 3-21" . SPARSER::COLLECTION)
    ("only 15 used IGHV 1-69" . SPARSER::PROTEIN)
    ("IGHV 1-69 or IGHV 3-21" . SPARSER::COLLECTION)
    ("IGHV 3-21 and IGHV 1-69" . SPARSER::COLLECTION)
    ("the favorable cohort" . SPARSER::MOLECULE)
    ("4 prognostic cohorts" . SPARSER::MOLECULE)
    ("using IGHV 4-39 (4 of 19 vs. 19 of 268; P =0.03) and IGHV 1-69 (6 of 15 vs. 17 of 255; P <0.001)"
     . SPARSER::COLLECTION)
    ("SF3B1 , NOTCH1 and TP53" . SPARSER::COLLECTION)
    ("SF3B1 or TP53" . SPARSER::COLLECTION)
    ("SF3B1 or MYD88" . SPARSER::COLLECTION)
    ("IGHV 1-69 (n=15; 5%) and IGHV 3-21 (N=9; 3%)" . SPARSER::COLLECTION)
    ("NOTCH1 and SF3B1" . SPARSER::COLLECTION)
    ("SF3B1, NOTCH1, MYD88, BIRC3 and TP53" . SPARSER::COLLECTION)
    ("SF3B1 , NOTCH1 , MYD88 and BIRC3" . SPARSER::COLLECTION)
    ("un-mutated immunoglobulin heavy-chain variable region ( IGHV ) state"
     . SPARSER::BIO-STATE)
    ("TP53 and germline" . SPARSER::COLLECTION)
    ("SF3B1 and NOTCH1" . SPARSER::COLLECTION) ("SF3B1" . SPARSER::PROTEIN)
    ("2-4" . SPARSER::PROTEIN) ("ZAP70" . SPARSER::PROTEIN)
    ("IGHV 3-21" . SPARSER::PROTEIN) ("IGHV 1-69" . SPARSER::PROTEIN)
    ("IGHV 4-59" . SPARSER::PROTEIN) ("IGHV 4-39" . SPARSER::PROTEIN)
    ("IGHV 3-7" . SPARSER::PROTEIN) ("IGHV 3-23" . SPARSER::PROTEIN)
    ("IGHV 4-34" . SPARSER::PROTEIN) ("BIRC3" . SPARSER::PROTEIN)
    ("MYD88" . SPARSER::PROTEIN) ("SF3" . SPARSER::PROTEIN)
    ("p53 and an E3 ligase-deficient Mdm2 mutant" . SPARSER::COLLECTION)
    ("histone deacetylase and corepressors" . SPARSER::COLLECTION)
    ("HDAC1 or HDAC3" . SPARSER::COLLECTION)
    ("survivin and Mdm2" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("survivin and MDM2" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, HDAC3 and HDAC4" . SPARSER::COLLECTION)
    ("siRNA or survivin" . SPARSER::COLLECTION)
    ("Chk2 and γH2AX" . SPARSER::COLLECTION)
    ("IR or IR/HDAC2 siRNA" . SPARSER::COLLECTION)
    ("IR/HDAC2" . SPARSER::COLLECTION) ("-γH2AX" . SPARSER::COLLECTION)
    ("ATM/ATR" . SPARSER::COLLECTION) ("IR and HDAC2" . SPARSER::COLLECTION)
    ("survivin and HDAC2" . SPARSER::COLLECTION)
    ("beta-catenin and survivin" . SPARSER::COLLECTION)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("siRNA and MG132" . SPARSER::COLLECTION)
    ("SAHA or HDAC2" . SPARSER::COLLECTION)
    ("HDAC1 or -3" . SPARSER::COLLECTION)
    ("SAHA or siRNA" . SPARSER::COLLECTION)
    ("survivin and p53" . SPARSER::COLLECTION)
    ("HDAC1, HDAC2, HDAC3, and HDAC4" . SPARSER::COLLECTION)
    ("p53(−/−) and p53(+/+)" . SPARSER::COLLECTION)
    ("acetyl-p53, p21, puma and acetyl-histone" . SPARSER::COLLECTION)
    ("acetyl-histone" . SPARSER::PROTEIN)
    ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mdm2 and survivin" . SPARSER::COLLECTION)
    ("p53-survivin" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor 1 alpha (HIF1α) and vascular endothelial growth factor (VEGF) [ xref ]"
     . SPARSER::COLLECTION)
    ("Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("Istodax" . SPARSER::DRUG) ("romidepsin" . SPARSER::DRUG)
    ("depsipeptide" . SPARSER::DRUG) ("Zolinza" . SPARSER::DRUG)
    ("vorinostat" . SPARSER::DRUG) ("E2F and Stat3" . SPARSER::COLLECTION)
    ("Mdm2-survivin" . SPARSER::COLLECTION)
    ("HDAC2 and survivin" . SPARSER::COLLECTION)
    ("caspase 7" . SPARSER::PROTEIN) ("p-ATM" . SPARSER::PROTEIN)
    ("histone 4" . SPARSER::PROTEIN) ("Class I" . SPARSER::PROTEIN)
    ("Nutlin-3A" . SPARSER::DRUG)
    ("Suberoylanilide hydroxamic acid" . SPARSER::MOLECULE)
    ("hypoxia-inducible factor 1 alpha" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("histone deacetylase 2" . SPARSER::PROTEIN)
    ("MET, MAPK, AKT and STAT3" . SPARSER::COLLECTION)
    ("exogenous MET-Flag" . SPARSER::COLLECTION)
    ("MET-Flag" . SPARSER::COLLECTION) ("exogenous HGF" . SPARSER::PROTEIN)
    ("ptc" . SPARSER::HUMAN-PROTEIN-FAMILY) ("the MET -WT" . SPARSER::PROTEIN)
    ("formed larger acini" . SPARSER::PROTEIN)
    ("larger acini" . SPARSER::PROTEIN) ("AKT and STAT3" . SPARSER::COLLECTION)
    ("endogenous and exogenous MET and its downstream targets"
     . SPARSER::COLLECTION)
    ("AKT, MAPK and STAT3" . SPARSER::COLLECTION)
    ("Two recurrent germline mutations (as these SNPs are potentially functional) MET- N375S (n = 9) and MET- T1010I (n = 5)"
     . SPARSER::COLLECTION)
    ("Two recurrent germline mutations (as these SNPs are potentially functional) MET- N375S"
     . SPARSER::PROTEIN)
    ("The hepatocyte growth factor (HGF) and its receptor"
     . SPARSER::COLLECTION)
    ("moderate or low penetrance genes" . SPARSER::GENE)
    ("MET-" . SPARSER::PROTEIN) ("T200" . SPARSER::PROTEIN)
    ("dual inhibitors" . SPARSER::INHIBITOR)
    ("established MNK inhibitors and clinically relevant retinoids"
     . SPARSER::COLLECTION)
    ("our proprietary NRs" . SPARSER::PROTEIN)
    ("the established MNK inhibitors (cercosporamide and CGP57380) and clinically relevant retinoids-ATRA and 4-HPR"
     . SPARSER::COLLECTION)
    ("cercosporamide and CGP57380" . SPARSER::COLLECTION)
    ("MNK1, MNK2, and peIF4E" . SPARSER::COLLECTION)
    ("p-eIF4E" . SPARSER::COLLECTION)
    ("fibroblast growth factor 2, FGF2 and vascular endothelial"
     . SPARSER::COLLECTION)
    ("eIF4E, eIF4G and eIF4A" . SPARSER::COLLECTION)
    ("LNCaP and MR49F" . SPARSER::COLLECTION)
    ("Androgen-AR" . SPARSER::COLLECTION) ("enzalutamide" . SPARSER::DRUG)
    ("MNK1 and MNK2" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("AR and MNK proteins" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax and caspase" . SPARSER::COLLECTION)
    ("cell cycle regulatory cyclin D1" . SPARSER::PROTEIN)
    ("Bax and caspase" . SPARSER::COLLECTION)
    ("MNK1, and peIF4E" . SPARSER::COLLECTION)
    ("MNK1 and AR" . SPARSER::COLLECTION) ("AR or MNK1" . SPARSER::COLLECTION)
    ("AR and MNK1" . SPARSER::COLLECTION)
    ("MNK1 and peIF4E" . SPARSER::COLLECTION)
    ("AR and/or MNK siRNA" . SPARSER::COLLECTION)
    ("the clinically relevant retinoids ATRA and 4-HPR" . SPARSER::COLLECTION)
    ("cell adhesive cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("proteins, Bax and PARP-1" . SPARSER::COLLECTION)
    ("AR and MNK/peIF4E" . SPARSER::COLLECTION)
    ("ATRA, 4-HPR, and MNK" . SPARSER::COLLECTION)
    ("MNK1, MNK2 and peIF4E" . SPARSER::COLLECTION)
    ("CGP57380 and cercosporamide" . SPARSER::COLLECTION)
    ("cercosporamide" . SPARSER::DRUG)
    ("both full-length AR (fAR) and its target gene" . SPARSER::COLLECTION)
    ("AR and its responsive protein" . SPARSER::COLLECTION)
    ("ATRA, 4-HPR, Casodex, MDV3100 or AA" . SPARSER::COLLECTION)
    ("Casodex or AA" . SPARSER::COLLECTION)
    ("casodex, AA and MDV3100" . SPARSER::COLLECTION) ("MR" . SPARSER::PROTEIN)
    ("ATRA and 4-HPR" . SPARSER::COLLECTION)
    ("Abiraterone acetate (AA) (Zytiga) and MDV3100 (Enzalutamide)"
     . SPARSER::COLLECTION)
    ("Abiraterone acetate (AA)" . SPARSER::DRUG) ("Casodex" . SPARSER::DRUG)
    ("VN" . SPARSER::PROTEIN) ("HPR" . SPARSER::PROTEIN)
    ("-retinoic acid (ATRA)" . SPARSER::MOLECULE)
    ("-retinoic acid" . SPARSER::MOLECULE) ("ATRA" . SPARSER::DRUG)
    ("precisely eIF4E" . SPARSER::PROTEIN) ("key mRNAs" . SPARSER::PROTEIN)
    ("AR and eIF4E" . SPARSER::COLLECTION)
    ("clinically relevant retinoids" . SPARSER::DRUG)
    ("retinoids" . SPARSER::DRUG) ("NRs" . SPARSER::PROTEIN)
    ("PCa" . SPARSER::PROTEIN) ("Mnk1" . SPARSER::PROTEIN)
    ("ARR2" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("acridine orange" . SPARSER::MOLECULE) ("MNK2" . SPARSER::PROTEIN)
    ("CGP57380" . SPARSER::DRUG) ("Abiraterone acetate" . SPARSER::DRUG)
    ("ER-α" . SPARSER::PROTEIN) ("P450" . SPARSER::PROTEIN-FAMILY)
    ("Retinoic acid" . SPARSER::MOLECULE) ("MNK1" . SPARSER::PROTEIN)
    ("cap-binding protein" . SPARSER::PROTEIN) ("Src-" . SPARSER::PROTEIN)
    ("Src and many other receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("EGFR, PDGFR, FGFR, CSF-1R, HER2/neu and c-Met" . SPARSER::COLLECTION)
    ("the earliest identifiable pre-neoplastic biomarkers" . SPARSER::MOLECULE)
    ("Apc/β-catenin" . SPARSER::COLLECTION)
    ("Src and Hakai1" . SPARSER::COLLECTION)
    ("Src, pSrc and Hakai1" . SPARSER::COLLECTION)
    ("Src or Hakai1" . SPARSER::COLLECTION) ("Hakai" . SPARSER::PROTEIN)
    ("their respective specific siRNAs" . SPARSER::PROTEIN)
    ("pSrc" . SPARSER::PROTEIN) ("Src/E-cadherin" . SPARSER::COLLECTION)
    ("their respective siRNAs" . SPARSER::PROTEIN)
    ("β-catenin and two known downstream targets" . SPARSER::COLLECTION)
    ("Wnt/β-catenin pathway cyclin D1 (CCND1) and Axin2" . SPARSER::COLLECTION)
    ("Slit2 and DMH/DSS-" . SPARSER::COLLECTION)
    ("Slit2 or Robo1" . SPARSER::COLLECTION) ("DSS-" . SPARSER::PROTEIN)
    ("Slit2 and Robol" . SPARSER::COLLECTION) ("DMH/DSS" . SPARSER::COLLECTION)
    ("the secretory protein Slit2" . SPARSER::PROTEIN)
    ("Robo1 and Robo4" . SPARSER::COLLECTION)
    ("a repulsive axon guidance cue" . SPARSER::PROTEIN-FAMILY)
    ("Slit2 and Robo1" . SPARSER::COLLECTION)
    ("Slit2/Robo1" . SPARSER::COLLECTION) ("DMH" . SPARSER::PROTEIN)
    ("Apc" . SPARSER::PROTEIN) ("Robo" . SPARSER::PROTEIN-FAMILY)
    ("Roundabout" . SPARSER::PROTEIN) ("CSF-1R" . SPARSER::PROTEIN)
    ("Axin2" . SPARSER::PROTEIN) ("Robo4" . SPARSER::PROTEIN)
    ("Robo1" . SPARSER::PROTEIN) ("Slit2" . SPARSER::PROTEIN)
    ("-2 monoclonal antibody trastuzumab or the dual Her-1/2 inhibitor lapatinib"
     . SPARSER::COLLECTION)
    ("thioredoxin-ROS" . SPARSER::COLLECTION)
    ("hyperglycemia" . SPARSER::PROTEIN) ("Glucose" . SPARSER::PROTEIN)
    ("the dual Her-1/2 inhibitor lapatinib" . SPARSER::DRUG)
    ("several downstream signaling proteins and cell cycle regulatory proteins"
     . SPARSER::COLLECTION)
    ("ErbB1 and EGFR" . SPARSER::COLLECTION)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("cetuximab, trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("20 μg/ml trastuzumab or 0.5 μM lapatinib" . SPARSER::COLLECTION)
    ("10 μg/ml cetuximab, 20 μg/ml trastuzumab or 0.5 μM lapatinib"
     . SPARSER::COLLECTION)
    ("a dual Her-1" . SPARSER::PROTEIN) ("CDK2/cyclin E" . SPARSER::COLLECTION)
    ("p27 and TXNIP" . SPARSER::COLLECTION)
    ("the external cohort" . SPARSER::MOLECULE)
    ("TXNIP or p27" . SPARSER::COLLECTION)
    ("also known as Vitamin D3 up-regulated protein 1 (VDUP-1) or thioredoxin binding protein"
     . SPARSER::COLLECTION)
    ("TRX" . SPARSER::PROTEIN) ("TXNIP and p27" . SPARSER::COLLECTION)
    ("protein (TXNIP)" . SPARSER::PROTEIN) ("TXNIP" . SPARSER::PROTEIN)
    ("A 20" . SPARSER::PROTEIN) ("Texas red" . SPARSER::DRUG)
    ("NLRP3" . SPARSER::PROTEIN) ("Her-4" . SPARSER::PROTEIN)
    ("TBP-2" . SPARSER::PROTEIN) ("VDUP-1" . SPARSER::PROTEIN)
    ("Vitamin D3 up-regulated protein 1" . SPARSER::PROTEIN)
    ("Her-1" . SPARSER::PROTEIN)
    ("Cdkn1a (coding p21) and Cyclin D1 (Figure xref - xref )"
     . SPARSER::COLLECTION)
    ("KLF4, Cdkn1a (coding p21) and Cyclin D1 (Figure xref - xref )"
     . SPARSER::COLLECTION)
    ("CDK and p-CDK" . SPARSER::COLLECTION) ("p-CDK" . SPARSER::COLLECTION)
    ("CDK1 and p-CDK1 (Figure xref )" . SPARSER::COLLECTION)
    ("PI3K or AKT" . SPARSER::COLLECTION)
    ("MST1/2 and LATS1/2" . SPARSER::COLLECTION)
    ("CD44, PI3K and ERK" . SPARSER::COLLECTION)
    ("CD44 and its downstream targets AKT and ERK" . SPARSER::COLLECTION)
    ("p-ERK and p-AKT" . SPARSER::COLLECTION)
    ("PI3K and ERK" . SPARSER::COLLECTION)
    ("PI3K or ERK" . SPARSER::COLLECTION) ("RAS and ERK" . SPARSER::COLLECTION)
    ("which employs CD44" . SPARSER::PROTEIN)
    ("KLF4, Nanog, OCT4, and Sox2" . SPARSER::COLLECTION)
    ("CDK1 and p-CDK1" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION) ("p-CDK1" . SPARSER::COLLECTION)
    ("Pcna and Ki67" . SPARSER::COLLECTION) ("Pcna" . SPARSER::PROTEIN)
    ("NF2 and LATS1/2" . SPARSER::COLLECTION) ("MST1/2" . SPARSER::PROTEIN)
    ("LATS1/2" . SPARSER::PROTEIN) ("p-MST1/2" . SPARSER::COLLECTION)
    ("p-LATS1/2" . SPARSER::COLLECTION) ("p-NF2/NF2" . SPARSER::COLLECTION)
    ("p-NF2" . SPARSER::COLLECTION)
    ("an upstream regulator of ERK, AKT and Hippo-YAP pathways"
     . SPARSER::COLLECTION)
    ("cysteine-rich angiogenic inducer 61 ( Cyr61 ) and inhibin beta-a ( Inhba )"
     . SPARSER::COLLECTION)
    ("Ankrd1" . SPARSER::PROTEIN) ("inhibin" . SPARSER::PROTEIN)
    ("Sod2" . SPARSER::PROTEIN)
    ("ERK [ xref , xref ] and AKT [ xref , xref - xref ]"
     . SPARSER::COLLECTION)
    ("a ubiquitously expressed cell-surface proteoglycan" . SPARSER::PROTEIN)
    ("expressed cell-surface proteoglycan" . SPARSER::PROTEIN)
    ("proteoglycan" . SPARSER::PROTEIN)
    ("Salvador homologue 1 (SAV1) and MOB kinase activator 1A/B (MOB1A/B)"
     . SPARSER::COLLECTION)
    ("Salvador" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trisphosphate" . SPARSER::PROTEIN) ("kinase (MEK)" . SPARSER::KINASE)
    ("extracellular-signal-regulated kinase (ERK)" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN) ("Neurofibromin 2" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("ankyrin repeat domain 1" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("MOB1A" . SPARSER::PROTEIN) ("MOB kinase activator 1A" . SPARSER::PROTEIN)
    ("SAV1" . SPARSER::PROTEIN)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("phosphatases and the receptors" . SPARSER::COLLECTION)
    ("The human IGF1R homodimer and IGF1/insulin receptor hybrids"
     . SPARSER::COLLECTION)
    ("IGF1/insulin receptor" . SPARSER::COLLECTION)
    ("IR pY1328" . SPARSER::PROTEIN)
    ("study both the IR and IGF1R homodimers" . SPARSER::HOMODIMER)
    ("Site 1 and Site 2" . SPARSER::COLLECTION)
    ("developing inhibitory monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("homodimer and insulin/IGF1" . SPARSER::COLLECTION)
    ("IR, IGF1R and insulin/IGF1" . SPARSER::COLLECTION)
    ("The secondary anti-rabbit antibody" . SPARSER::ANTIBODY)
    ("The Western blot" . SPARSER::PROTEIN)
    ("IGF1R and IR-A" . SPARSER::COLLECTION)
    ("IR or IGF1R" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("IGF1 and IGF2" . SPARSER::COLLECTION)
    ("the vasoactive molecule nitric oxide (NO)" . SPARSER::MOLECULE)
    ("nitric oxide (NO)" . SPARSER::MOLECULE)
    ("pre-adipocytes" . SPARSER::COLLECTION)
    ("IGF1R and IR" . SPARSER::COLLECTION) ("Ligands" . SPARSER::LIGAND)
    ("highly homologous tetramers" . SPARSER::TETRAMER)
    ("the Insulin Receptor (IR) and Insulin-like Growth Factor 1 Receptor (IGF1R)"
     . SPARSER::COLLECTION)
    ("IR and IGF1R" . SPARSER::COLLECTION)
    ("the Insulin Receptor (IR) and the Insulin-like Growth Factor 1 Receptor (IGF1R)"
     . SPARSER::COLLECTION)
    ("Insulin Receptor (IR)" . SPARSER::PROTEIN)
    ("p-nitrophenyl" . SPARSER::MOLECULE) ("Site 2" . SPARSER::PROTEIN)
    ("Site 1" . SPARSER::PROTEIN) ("N-20" . SPARSER::PROTEIN)
    ("IGF2" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor" . SPARSER::PROTEIN)
    ("alpha subunit" . SPARSER::PROTEIN) ("beta subunit" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor 1 Receptor" . SPARSER::PROTEIN)
    ("Insulin Receptor" . SPARSER::PROTEIN) ("MBE" . SPARSER::PROTEIN)
    ("CK7 and AMACR" . SPARSER::COLLECTION) ("AMACR" . SPARSER::PROTEIN)
    ("adenine and thymidine" . SPARSER::COLLECTION)
    ("thymidine and guanine" . SPARSER::COLLECTION) ("GAG" . SPARSER::PROTEIN)
    ("commercially available wild type male human genomic DNA" . SPARSER::DNA)
    ("our retrospective MA cohort" . SPARSER::MOLECULE)
    ("a retrospective cohort" . SPARSER::MOLECULE)
    ("a retrospective MA cohort" . SPARSER::MOLECULE)
    ("Pinto" . SPARSER::PROTEIN) ("WT1 and CD57" . SPARSER::COLLECTION)
    ("dystrophic" . SPARSER::PROTEIN) ("CD57" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("carboplatin" . SPARSER::DRUG)
    ("HER2 and re-sensitize" . SPARSER::COLLECTION)
    ("trastuzumab or any anti-HER2 therapies making conclusions"
     . SPARSER::COLLECTION)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("the endometrial cohort" . SPARSER::MOLECULE)
    ("PIK3CA, KRAS, PTEN and TP53" . SPARSER::COLLECTION)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein and gene" . SPARSER::COLLECTION)
    ("PIK3CA, KRAS and PTEN" . SPARSER::COLLECTION)
    ("KRAS (7%) and PTEN (7%)" . SPARSER::COLLECTION)
    ("PIK3CA (16%), TP53 (14%), KRAS (7%) and PTEN (7%)" . SPARSER::COLLECTION)
    ("this entire cohort" . SPARSER::MOLECULE) ("ECD" . SPARSER::PROTEIN)
    ("a dual HER1/HER2 (ERBB1/ERBB2) inhibitor" . SPARSER::INHIBITOR)
    ("ERBB1/ERBB2" . SPARSER::COLLECTION) ("HER1/HER2" . SPARSER::COLLECTION)
    ("trastuzumab, pertuzumab and lapatinib" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("HER3 and HER4" . SPARSER::COLLECTION)
    ("HER1/EGFR" . SPARSER::COLLECTION)
    ("a 185-kDa transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("aggressive subtypes" . SPARSER::PROTEIN) ("HR 3" . SPARSER::PROTEIN)
    ("P95" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("p95" . SPARSER::PROTEIN) ("the ovarian cohort" . SPARSER::MOLECULE)
    ("a potential prognostic biomarker" . SPARSER::MOLECULE)
    ("ovarian cancer TMAs" . SPARSER::MOLECULE)
    ("Biomarkers" . SPARSER::MOLECULE)
    ("a positive prognostic biomarker" . SPARSER::MOLECULE)
    ("the ovarian tumor TMA" . SPARSER::MOLECULE) ("ON" . SPARSER::PROTEIN)
    ("OV" . SPARSER::MOLECULE) ("the paclitaxel resistant" . SPARSER::DRUG)
    ("a functional SAC" . SPARSER::PROTEIN) ("alamarBlue" . SPARSER::DRUG)
    ("an essential kinase" . SPARSER::KINASE)
    ("predictive biomarker" . SPARSER::MOLECULE)
    ("HER2 and PRP4K" . SPARSER::COLLECTION)
    ("the high-grade serous ovarian TMA" . SPARSER::MOLECULE)
    ("the immunological cell markers CD3 and CD68" . SPARSER::COLLECTION)
    ("CD3 and CD68" . SPARSER::COLLECTION) ("TMAs" . SPARSER::MOLECULE)
    ("a possible molecular target" . SPARSER::TARGET-PROTEIN)
    ("an essential pre-mRNA" . SPARSER::RNA)
    ("kinase, MAD1 and MAD2" . SPARSER::COLLECTION) ("MAPT" . SPARSER::PROTEIN)
    ("MAPs" . SPARSER::PROTEIN)
    ("docetaxel, paclitaxel and cabazitaxel" . SPARSER::COLLECTION)
    ("cabazitaxel" . SPARSER::DRUG) ("snRNP" . SPARSER::BIO-COMPLEX)
    ("HER2/ERBB2" . SPARSER::COLLECTION)
    ("mitotic checkpoint proteins" . SPARSER::PROTEIN)
    ("Taxanes" . SPARSER::DRUG)
    ("anthracyclines or platinum" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("Lapatinib Ditosylate" . SPARSER::DRUG) ("CA125" . SPARSER::DRUG)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("K-2" . SPARSER::PROTEIN)
    ("K-1" . SPARSER::PROTEIN) ("BTF4" . SPARSER::PROTEIN)
    ("MAD1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MPS1" . SPARSER::PROTEIN)
    ("P-gp" . SPARSER::PROTEIN) ("P-glycoprotein" . SPARSER::PROTEIN)
    ("ATP-binding cassette transporter" . SPARSER::PROTEIN)
    ("splicing factor" . SPARSER::PROTEIN) ("PRPF4B" . SPARSER::PROTEIN)
    ("PRP4" . SPARSER::PROTEIN) ("splicing factor 4" . SPARSER::PROTEIN)
    ("oncogene (MYCNA)" . SPARSER::ONCOGENE) ("E2F-DP" . SPARSER::COLLECTION)
    ("pRb" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("isolated unilateral RB" . SPARSER::PROTEIN)
    ("patient RB43" . SPARSER::PROTEIN) ("RB1 and RB23" . SPARSER::COLLECTION)
    ("RB23, RB46 and RB56" . SPARSER::COLLECTION)
    ("RB7 and RB42" . SPARSER::COLLECTION)
    ("RB10, RB25 and RB27" . SPARSER::COLLECTION)
    ("a hemizygous form" . SPARSER::FORM)
    ("the bilateral form" . SPARSER::FORM)
    ("an essential part" . SPARSER::COMPONENT)
    ("methylated CpG di-nucleotides" . SPARSER::MOLECULE)
    ("introns" . SPARSER::PROTEIN) ("MycN" . SPARSER::PROTEIN)
    ("sporadic unilateral RB" . SPARSER::PROTEIN) ("PIN1" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("RB2" . SPARSER::PROTEIN)
    ("RB5" . SPARSER::MOLECULE) ("RB7" . SPARSER::PROTEIN)
    ("Loss of Heterozygosity" . SPARSER::PROTEIN)
    ("di-nucleotides" . SPARSER::MOLECULE)
    ("Rb and E2F1" . SPARSER::COLLECTION)
    ("slug and ZEB1" . SPARSER::COLLECTION)
    ("receptors and MMPs" . SPARSER::COLLECTION) ("Rb" . SPARSER::PROTEIN)
    ("Rb-E2F" . SPARSER::COLLECTION)
    ("snail, slug, twist1 or twist2" . SPARSER::COLLECTION)
    ("these mesenchymal genes" . SPARSER::GENE)
    ("mesenchymal promoters" . SPARSER::PROMOTER)
    ("β-arrestin-1, vimentin and FN" . SPARSER::COLLECTION)
    ("E2F-regulated mesenchymal genes" . SPARSER::GENE)
    ("vimentin (r=0.59, p <0.0001) and fibronectin (r=0.52; p <0.0001)"
     . SPARSER::COLLECTION)
    ("Vimentin and fibronectin" . SPARSER::COLLECTION)
    ("shcontrol" . SPARSER::PROTEIN) ("shcontrol-luc" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("E2F1-" . SPARSER::PROTEIN)
    ("pcDNA3 or β-arrestin-1" . SPARSER::COLLECTION)
    ("pcDNA3" . SPARSER::PROTEIN)
    ("E2F1 and WT-β-arrestin-1" . SPARSER::COLLECTION)
    ("pcDNA3-β-arrestin-1" . SPARSER::PROTEIN-PAIR)
    ("normal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-arrestin-1 and p300" . SPARSER::COLLECTION)
    ("E2F1, β-arrestin-1 and p300" . SPARSER::COLLECTION)
    ("Dasatinib and PP2" . SPARSER::COLLECTION)
    ("siRNA or E2F1" . SPARSER::COLLECTION)
    ("E2F1, shcontrol and shβ-arrestin1" . SPARSER::COLLECTION)
    ("control siRNA or two different E2F1 siRNAs" . SPARSER::COLLECTION)
    ("a control irrelevant antibody" . SPARSER::PROTEIN)
    ("E2F1, Rb, β-arrestin-1, p300, and Ac-H3" . SPARSER::COLLECTION)
    ("E2F1, β-arrestin-1, p300, and Ac-H3" . SPARSER::COLLECTION)
    ("E2F1 and β-arrestin-1" . SPARSER::COLLECTION)
    ("the shortest mutant vim-245+24" . SPARSER::PROTEIN)
    ("vim-245+24" . SPARSER::PROTEIN) ("vim-387+24" . SPARSER::PROTEIN)
    ("vimentin-Luc and fibronectin-Luc" . SPARSER::COLLECTION)
    ("fibronectin-Luc" . SPARSER::PROTEIN-PAIR)
    ("vimentin-Luc" . SPARSER::PROTEIN-PAIR)
    ("Vimentin and Fibronectin" . SPARSER::COLLECTION)
    ("E2F1 and Rb" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin and ZO1" . SPARSER::COLLECTION)
    ("tight junction protein ZO1 and epithelial markers E-cadherin and β-catenin"
     . SPARSER::COLLECTION)
    ("Src and α7nAChR" . SPARSER::COLLECTION)
    ("these mesenchymal promoters" . SPARSER::PROMOTER)
    ("siRNA or β-arrestin-1" . SPARSER::COLLECTION)
    ("nicotine or TGF-β" . SPARSER::COLLECTION)
    ("vimentin or fibronectin" . SPARSER::COLLECTION)
    ("the mesenchymal genes fibronectin and vimentin" . SPARSER::COLLECTION)
    ("shRNA and siRNAs" . SPARSER::COLLECTION)
    ("stably expressing β-arrestin-1 specific shRNA" . SPARSER::PROTEIN)
    ("expressing β-arrestin-1 specific shRNA" . SPARSER::PROTEIN)
    ("fibronectin and vimentin" . SPARSER::COLLECTION)
    ("mesenchymal genes" . SPARSER::GENE)
    ("E-cadherin and catenins" . SPARSER::COLLECTION)
    ("ubiquitously expressed non-visual arrestins"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("expressed non-visual arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("visual arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nitrosamines" . SPARSER::MOLECULE)
    ("nicotinic acetylcholine receptors" . SPARSER::RECEPTOR)
    ("the addictive component" . SPARSER::COMPONENT)
    ("significantly more β-arrestin-1 and E2F1" . SPARSER::COLLECTION)
    ("β-arrestin-1 and E2F1" . SPARSER::COLLECTION)
    ("vimentin, fibronectin, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("the mesenchymal genes" . SPARSER::GENE)
    ("mesenchymal genes vimentin and fibronectin" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("the major addictive component" . SPARSER::COMPONENT)
    ("Nicotine" . SPARSER::DRUG) ("Cigarette" . SPARSER::DRUG)
    ("twist2" . SPARSER::PROTEIN) ("twist1" . SPARSER::PROTEIN)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("CHRNA7" . SPARSER::PROTEIN)
    ("ZO1" . SPARSER::PROTEIN)
    ("tight junction protein ZO-1" . SPARSER::PROTEIN)
    ("β-arrestin1" . SPARSER::PROTEIN) ("FN1" . SPARSER::PROTEIN)
    ("pFN 1" . SPARSER::PROTEIN) ("SB 431542" . SPARSER::DRUG)
    ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("β-arrestins" . SPARSER::PROTEIN) ("arrestin1" . SPARSER::PROTEIN)
    ("β-arrestin-2" . SPARSER::PROTEIN) ("β-arrestin-1" . SPARSER::PROTEIN)
    ("this tunable-combinatorial signaling complex" . SPARSER::BIO-COMPLEX)
    ("BRAF-CRAF-MEK1/MEK2" . SPARSER::COLLECTION)
    ("MEK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an activation-associated complex" . SPARSER::BIO-COMPLEX)
    ("further downstream inhibitors" . SPARSER::INHIBITOR)
    ("a highly plastic or tunable RAF-MEK complex" . SPARSER::BIO-COMPLEX)
    ("RAF-MEK" . SPARSER::COLLECTION)
    ("this plastic complex" . SPARSER::BIO-COMPLEX)
    ("BRAF-CRAF-MEK" . SPARSER::COLLECTION)
    ("highly over-expressing V600E BRAF or minimally over-expressing V600E/R509H BRAF"
     . SPARSER::COLLECTION)
    ("V600E/R662L BRAF or WT BRAF" . SPARSER::COLLECTION)
    ("oligomers" . SPARSER::PROTEIN) ("MEK1 or FLAG-" . SPARSER::COLLECTION)
    ("FLAG-" . SPARSER::PROTEIN-FAMILY) ("BRAF and HA-" . SPARSER::COLLECTION)
    ("HA-" . SPARSER::PROTEIN) ("BRAF or KSR2" . SPARSER::COLLECTION)
    ("MEK1-KSR2" . SPARSER::COLLECTION) ("MEK1-BRAF" . SPARSER::COLLECTION)
    ("BRAF-MEK" . SPARSER::COLLECTION) ("BRAF-" . SPARSER::PROTEIN)
    ("both F129L MEK1 and Q56P MEK1" . SPARSER::COLLECTION)
    ("MEK1, BRAF and HA" . SPARSER::COLLECTION)
    ("either HA-tagged WT BRAF or V600E BRAF" . SPARSER::COLLECTION)
    ("MEK1-" . SPARSER::PROTEIN) ("MEK1-MEK2" . SPARSER::COLLECTION)
    ("both WT MEK1 and WT MEK2" . SPARSER::COLLECTION)
    ("CRAF or KSR2" . SPARSER::COLLECTION)
    ("BRAF, MEK1, or MEK2" . SPARSER::COLLECTION)
    ("BRAF-MEK2" . SPARSER::COLLECTION) ("MEK-KSR2-BRAF" . SPARSER::COLLECTION)
    ("over-expressed V600E BRAF and MUT MEK" . SPARSER::COLLECTION)
    ("CRAF and CRAF" . SPARSER::COLLECTION)
    ("BRAF and MEK1" . SPARSER::COLLECTION)
    ("BRAF or V600E/R509H" . SPARSER::COLLECTION)
    ("BRAF-CRAF" . SPARSER::COLLECTION)
    ("F129L MEK1 ( xref ) or Q56P MEK1 ( xref )" . SPARSER::COLLECTION)
    ("DDR2, DDR3, DDR4, and DDR5" . SPARSER::COLLECTION)
    ("DDR2, DDR3, and DDR5" . SPARSER::COLLECTION)
    ("CRAF or BRAF" . SPARSER::COLLECTION)
    ("both V600E  BRAF and F129L  MEK1 ( xref )" . SPARSER::COLLECTION)
    ("DDR2 and DDR3" . SPARSER::COLLECTION)
    ("V600E  BRAF and F129L  MEK1 ( xref )" . SPARSER::COLLECTION)
    ("p-MEK" . SPARSER::COLLECTION) ("NRAS and PTEN" . SPARSER::COLLECTION)
    ("NRAS-" . SPARSER::PROTEIN)
    ("M249 SDR-DDR up-expressed mutant NRAS" . SPARSER::PROTEIN)
    ("p-CRAF" . SPARSER::COLLECTION) ("SDR-" . SPARSER::PROTEIN)
    ("SDR-DDR" . SPARSER::COLLECTION) ("SDR" . SPARSER::PROTEIN)
    ("concurrent heterozygous Q61K  NRAS" . SPARSER::PROTEIN)
    ("BRAF , NRAS, KRAS, MEK1 and MEK2" . SPARSER::COLLECTION)
    ("naïve" . SPARSER::PROTEIN) ("BRAF/MEK" . SPARSER::COLLECTION)
    ("dual MAPK" . SPARSER::PROTEIN) ("NRAS or KRAS" . SPARSER::COLLECTION)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION)
    ("both WT NRAS and WT BRAF" . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("trametinib, selumetinib, cobimetinib, and binimetinib"
     . SPARSER::COLLECTION)
    ("binimetinib" . SPARSER::DRUG) ("cobimetinib" . SPARSER::DRUG)
    ("selumetinib" . SPARSER::DRUG)
    ("vemurafenib and dabrafenib" . SPARSER::COLLECTION)
    ("MEK1 or MEK2" . SPARSER::COLLECTION)
    ("RAS or BRAF" . SPARSER::COLLECTION)
    ("RAS and BRAF" . SPARSER::COLLECTION) ("CRAF" . SPARSER::PROTEIN)
    ("BRAF and MEK" . SPARSER::COLLECTION) ("AZD6244" . SPARSER::DRUG)
    ("PLX4032" . SPARSER::DRUG) ("β-globin" . SPARSER::PROTEIN)
    ("p-MEK1" . SPARSER::PROTEIN) ("KSR2" . SPARSER::PROTEIN)
    ("DDR3" . SPARSER::PROTEIN) ("DDR2" . SPARSER::PROTEIN)
    ("p-RSK" . SPARSER::PROTEIN) ("SCH772984" . SPARSER::DRUG)
    ("DP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DUSP4" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("SPl" . SPARSER::PROTEIN)
    ("a p53-dependent intronic promoter" . SPARSER::PROMOTER)
    ("the homozygous GG allele" . SPARSER::ALLELE) ("Spl" . SPARSER::PROTEIN)
    ("Stata" . SPARSER::PROTEIN) ("VIP" . SPARSER::PROTEIN)
    ("promoter and susceptibility" . SPARSER::COLLECTION)
    ("gene 2" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("a codon 12 mutated KRAS allele" . SPARSER::ALLELE)
    ("MET and caveolin" . SPARSER::COLLECTION)
    ("MET
and caveolin"
     . SPARSER::COLLECTION)
    ("the cell adhesion associated protein AKAP12 and the
cell surface organizer Caveolin 1"
     . SPARSER::COLLECTION)
    ("KRAS and DCLK1" . SPARSER::COLLECTION)
    ("isoform 3 or isoform 4" . SPARSER::COLLECTION)
    ("HGF receptor
and Caveolin-1"
     . SPARSER::COLLECTION)
    ("doublecortin-like
kinase-1 (DCLK1) and A-kinase anchor protein"
     . SPARSER::COLLECTION)
    ("casein,
MAP and MOK"
     . SPARSER::COLLECTION)
    ("MOK" . SPARSER::PROTEIN) ("MAP" . SPARSER::PROTEIN)
    ("MAP2K2
(MEK2) and ERK2 as well as CDC42BPB, NEK9 and PAK4 (Figure xref A and B)"
     . SPARSER::COLLECTION)
    ("ERK2 as well as CDC42BPB, NEK9 and PAK4 (Figure xref A and B)"
     . SPARSER::COLLECTION)
    ("CDC42BPB, NEK9 and PAK4" . SPARSER::COLLECTION)
    ("receptor-Ras" . SPARSER::COLLECTION)
    ("caveolin and MET" . SPARSER::COLLECTION)
    ("TJP2/ZO-2" . SPARSER::COLLECTION)
    ("proteins
and phosphopeptides"
     . SPARSER::COLLECTION)
    ("AKAP12 and DCLK1" . SPARSER::COLLECTION)
    ("One protein and 29 phosphosites" . SPARSER::COLLECTION)
    ("very few proteins or phosphosites" . SPARSER::COLLECTION)
    ("proteins or phosphosites" . SPARSER::COLLECTION)
    ("1A and 1C" . SPARSER::COLLECTION)
    ("protein and phosphopeptide" . SPARSER::COLLECTION)
    ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("2359 unique proteins" . SPARSER::PROTEIN)
    ("arginine and lysine" . SPARSER::COLLECTION)
    ("DCLK1 and
MET"
     . SPARSER::COLLECTION)
    ("proteins and phosphosites" . SPARSER::COLLECTION)
    ("isogenic human SW48 CRC" . SPARSER::PROTEIN)
    ("HRAS, KRAS, and NRAS" . SPARSER::COLLECTION) ("HRAS" . SPARSER::PROTEIN)
    ("monomeric
GTPases"
     . SPARSER::GTPASE)
    ("the highly homologous p21 Ras family" . SPARSER::PROTEIN-FAMILY)
    ("doublecortin" . SPARSER::PROTEIN)
    ("isoform and tumor" . SPARSER::COLLECTION)
    ("HGF
receptor"
     . SPARSER::PROTEIN)
    ("Caveolin 1" . SPARSER::PROTEIN)
    ("cell adhesion associated" . SPARSER::PROTEIN)
    ("isoform 4" . SPARSER::PROTEIN) ("tight junction" . SPARSER::PROTEIN)
    ("HGF receptor" . SPARSER::PROTEIN)
    ("A-kinase anchor protein" . SPARSER::PROTEIN)
    ("doublecortin-like
kinase-1"
     . SPARSER::PROTEIN)
    ("NEK9" . SPARSER::PROTEIN) ("CDC42BPB" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("MAP2K2" . SPARSER::PROTEIN)
    ("HGF-receptor" . SPARSER::PROTEIN) ("TJP2" . SPARSER::PROTEIN)
    ("MAP1B" . SPARSER::PROTEIN) ("SERPINB5" . SPARSER::DRUG)
    ("ANX11" . SPARSER::PROTEIN) ("ANX3" . SPARSER::PROTEIN)
    ("SEC23" . SPARSER::PROTEIN-FAMILY) ("ALDH3A1" . SPARSER::PROTEIN)
    ("ZO-2" . SPARSER::PROTEIN) ("AKAP12" . SPARSER::PROTEIN)
    ("class 1" . SPARSER::PROTEIN-FAMILY) ("TiO 2" . SPARSER::MOLECULE)
    ("- 2" . SPARSER::PROTEIN) ("l -arginine" . SPARSER::MOLECULE)
    ("s
5A"
     . SPARSER::PROTEIN)
    ("GTPase
activating"
     . SPARSER::PROTEIN)
    ("p21 Ras" . SPARSER::PROTEIN) ("DCLK1" . SPARSER::PROTEIN)
    ("colon
cancer"
     . SPARSER::PROTEIN)
    ("Medina" . SPARSER::MOLECULE) ("a mature polypeptide" . SPARSER::PEPTIDE)
    ("anti- and pro-inflammatory" . SPARSER::COLLECTION)
    ("a pro-inflammatory molecule" . SPARSER::MOLECULE)
    ("NF-κB and inflammatory fatty acids/phospholipids" . SPARSER::COLLECTION)
    ("Raf-1/ERK" . SPARSER::COLLECTION)
    ("a membrane-associated protein" . SPARSER::PROTEIN)
    ("both 15LO1 protein and its phospholipid product 15HETE-PE"
     . SPARSER::COLLECTION)
    ("phospholipids, proteins and lipoproteins" . SPARSER::COLLECTION)
    ("Ionophore" . SPARSER::MOLECULE) ("HODEs" . SPARSER::MOLECULE)
    ("HETEs" . SPARSER::MOLECULE) ("eicosanoid" . SPARSER::MOLECULE)
    ("active hydroperoxy and epoxy metabolites" . SPARSER::COLLECTION)
    ("hydroperoxy" . SPARSER::MOLECULE) ("NF-κB and ERK" . SPARSER::COLLECTION)
    ("locostatin" . SPARSER::DRUG)
    ("IL-6, TNF-α and interferon-γ" . SPARSER::COLLECTION)
    ("isoproterenol and albuterol" . SPARSER::COLLECTION)
    ("GRK2/RKIP" . SPARSER::COLLECTION) ("albuterol" . SPARSER::DRUG)
    ("isoproterenol" . SPARSER::PROTEIN)
    ("lipoxygenase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("NF-κB, PI3K and interferon-regulatory" . SPARSER::COLLECTION)
    ("integrins and ion channels" . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION) ("phosphatidyl" . SPARSER::MOLECULE)
    ("RKIP/TRAF6" . SPARSER::COLLECTION)
    ("the assembly IKK complex and increases IκB phosphorylation and degradation"
     . SPARSER::COLLECTION)
    ("TRAF6 and TAK1" . SPARSER::COLLECTION) ("etc" . SPARSER::PROTEIN)
    ("pSS" . SPARSER::PROTEIN-FAMILY) ("-1 and -3" . SPARSER::COLLECTION)
    ("FLS" . SPARSER::PROTEIN) ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("many pro-inflammatory genes" . SPARSER::GENE)
    ("a dimeric transcription factor" . SPARSER::PROTEIN)
    ("IKKα and IKKβ" . SPARSER::COLLECTION) ("NIK" . SPARSER::PROTEIN)
    ("COS" . SPARSER::MOLECULE)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PEBP1/RKIP" . SPARSER::COLLECTION) ("PEBPs" . SPARSER::PROTEIN)
    ("RKP" . SPARSER::PROTEIN) ("proteins and perhaps" . SPARSER::COLLECTION)
    ("MAPK and NF-κB" . SPARSER::COLLECTION)
    ("lipoxygenase family" . SPARSER::PROTEIN) ("β2AR" . SPARSER::PROTEIN)
    ("G-protein coupled receptor kinase 2" . SPARSER::PROTEIN)
    ("LO1" . SPARSER::PROTEIN) ("MUC5AC" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY)
    ("inositol-3 kinase" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("IL-1RI" . SPARSER::PROTEIN) ("CCL13" . SPARSER::PROTEIN)
    ("CCL2" . SPARSER::PROTEIN) ("interleukin-1" . SPARSER::PROTEIN)
    ("tumor-necrosis factor" . SPARSER::PROTEIN)
    ("Factor-κB" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PEBP-1" . SPARSER::PROTEIN) ("PEBP4" . SPARSER::PROTEIN)
    ("PEBP1" . SPARSER::PROTEIN)
    ("new therapeutic reagents" . SPARSER::MOLECULE)
    ("GRK2 and Raf-1" . SPARSER::COLLECTION)
    ("GRK2 and RKIP" . SPARSER::COLLECTION)
    ("multifunctional protein" . SPARSER::PROTEIN)
    ("mononucleotide (FMN)" . SPARSER::MOLECULE)
    ("GTP and flavin" . SPARSER::COLLECTION)
    ("mononucleotide" . SPARSER::MOLECULE) ("flavin" . SPARSER::MOLECULE)
    ("Raf-1 and GRK2" . SPARSER::COLLECTION) ("Locostatin" . SPARSER::DRUG)
    ("Bulky ligand" . SPARSER::LIGAND) ("RKIP-Raf-1" . SPARSER::COLLECTION)
    ("HETE" . SPARSER::MOLECULE)
    ("a naturally occurring ligand" . SPARSER::LIGAND)
    ("amides" . SPARSER::MOLECULE)
    ("Proteins constantly sample conformations" . SPARSER::BIO-CONFORMATION)
    ("Kin" . SPARSER::PROTEIN)
    ("Raf and G protein-coupled receptor kinase 2" . SPARSER::COLLECTION)
    ("those involving MAP kinase (MAPK) and the β-adrenergic receptor (β-AR)"
     . SPARSER::COLLECTION)
    ("MAP kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Raf/MAP kinase" . SPARSER::COLLECTION) ("adrenergic" . SPARSER::PROTEIN)
    ("long chain" . SPARSER::PROTEIN) ("H-N" . SPARSER::PROTEIN)
    ("H- 15" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase 2" . SPARSER::PROTEIN)
    ("GRK2" . SPARSER::PROTEIN) ("mimicking RKIP’s" . SPARSER::PROTEIN)
    ("individual kinases" . SPARSER::KINASE)
    ("NFκB, and GSK3β" . SPARSER::COLLECTION)
    ("targets or effectors" . SPARSER::COLLECTION)
    ("RKIP and BACH1" . SPARSER::COLLECTION)
    ("HDAC or EZH2" . SPARSER::COLLECTION)
    ("BACH1 and RKIP" . SPARSER::COLLECTION)
    ("the metastasis suppressor RKIP and the metastasis promoter BACH1"
     . SPARSER::COLLECTION)
    ("RKIP, HMGA2, MMP1, CXCR4, and OPN" . SPARSER::COLLECTION)
    ("TET1 and HOXA9" . SPARSER::COLLECTION) ("HOXA" . SPARSER::PROTEIN)
    ("TET" . SPARSER::PROTEIN) ("oxidase (LOX)" . SPARSER::PROTEIN)
    ("RKIP and HMGA2" . SPARSER::COLLECTION)
    ("collagen and elastin" . SPARSER::COLLECTION)
    ("LOX and SDC2" . SPARSER::COLLECTION) ("syn" . SPARSER::PROTEIN)
    ("microRNAs and extracellular matrix" . SPARSER::COLLECTION)
    ("CXCR4, MMP1, and OPN" . SPARSER::COLLECTION)
    ("HMGA2 and BACH1" . SPARSER::COLLECTION) ("OPN" . SPARSER::PROTEIN)
    ("CNC" . SPARSER::PROTEIN) ("RKIP-" . SPARSER::PROTEIN)
    ("Raf-MEK-ERK-Myc" . SPARSER::COLLECTION) ("Taxol" . SPARSER::DRUG)
    ("Raf-1-MEK-ERK" . SPARSER::COLLECTION) ("poisons" . SPARSER::MOLECULE)
    ("Raf-1 and B-Raf" . SPARSER::COLLECTION)
    ("review RKIP’s" . SPARSER::PROTEIN) ("HOXA9" . SPARSER::PROTEIN)
    ("TET1" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("SDC2" . SPARSER::PROTEIN) ("BACH1" . SPARSER::PROTEIN)
    ("LIN28" . SPARSER::PROTEIN)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("aurora kinase B" . SPARSER::PROTEIN)
    ("K-Ras/RalB-NF-κB" . SPARSER::COLLECTION)
    ("suppressor and drug" . SPARSER::COLLECTION)
    ("KRAS/RalB-NF-κB" . SPARSER::COLLECTION) ("RalB" . SPARSER::PROTEIN)
    ("MEK and NRAS" . SPARSER::COLLECTION) ("AF" . SPARSER::PROTEIN)
    ("MEK and Raf" . SPARSER::COLLECTION)
    ("an important prognostic biomarker" . SPARSER::MOLECULE)
    ("chaperones" . SPARSER::PROTEIN)
    ("vimentin and fibronectin" . SPARSER::COLLECTION)
    ("E-cadherin and cytokeratin 18" . SPARSER::COLLECTION)
    ("NF-κB and downstream Snail" . SPARSER::COLLECTION)
    ("RKIP and E-cadherin" . SPARSER::COLLECTION)
    ("NPI-0052 or bortezomib" . SPARSER::COLLECTION)
    ("the proteasome inhibitor NPI-0052 or the NO donor DETANONOate"
     . SPARSER::COLLECTION)
    ("Snail and NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and Snail" . SPARSER::COLLECTION) ("iNOS" . SPARSER::PROTEIN)
    ("ROS and/or a singlet oxygen ( 1 O2)" . SPARSER::COLLECTION)
    ("photosensitizer, light, and oxygen" . SPARSER::COLLECTION)
    ("NF-κB and p38 MAPK" . SPARSER::COLLECTION) ("Rituximab" . SPARSER::DRUG)
    ("NF-κB and downstream targets Snail and YY1" . SPARSER::COLLECTION)
    ("both chemotherapeutic drugs" . SPARSER::DRUG)
    ("p50 and p65" . SPARSER::COLLECTION)
    ("CDDP and TRAIL" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("Fas and DR5" . SPARSER::COLLECTION) ("DR4 and DR5" . SPARSER::COLLECTION)
    ("DR4, DR5, DcR1 and DcR2" . SPARSER::COLLECTION)
    ("DcR1" . SPARSER::PROTEIN) ("cFLIP" . SPARSER::PROTEIN)
    ("TNF-α, FasL, and TRAIL" . SPARSER::COLLECTION)
    ("perforin/granzyme" . SPARSER::COLLECTION)
    ("FasL and TRAIL" . SPARSER::COLLECTION)
    ("Bortezomib and NPI-0052" . SPARSER::COLLECTION)
    ("marizomib" . SPARSER::DRUG) ("Bortezomib" . SPARSER::DRUG)
    ("YY1 and RKIP" . SPARSER::COLLECTION)
    ("NF-κB and downstream both Snail and YY1" . SPARSER::COLLECTION)
    ("RKIP and PTEN" . SPARSER::COLLECTION)
    ("Snail and YY1" . SPARSER::COLLECTION)
    ("Snail, and YY1" . SPARSER::COLLECTION)
    ("EMT-inducer" . SPARSER::COLLECTION)
    ("JAK-1 and JAK-2" . SPARSER::COLLECTION)
    ("STAT3 and RKIP" . SPARSER::COLLECTION)
    ("IL-6 and STAT3" . SPARSER::COLLECTION)
    ("RKIP and STAT3" . SPARSER::COLLECTION)
    ("several chemotherapeutic drugs" . SPARSER::DRUG)
    ("cisplatinum" . SPARSER::DRUG) ("protein (RKIP)" . SPARSER::PROTEIN)
    ("EGF and GPCR" . SPARSER::COLLECTION) ("PEBP" . SPARSER::PROTEIN)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("alkaloids, and taxanes" . SPARSER::COLLECTION)
    ("alkaloids" . SPARSER::MOLECULE)
    ("NF-κB, Snail and YY1" . SPARSER::COLLECTION)
    ("chemotherapeutic and immunotherapeutic cytotoxic drugs" . SPARSER::DRUG)
    ("NF-κB/Snail/YY1/RKIP" . SPARSER::COLLECTION) ("RKIP" . SPARSER::PROTEIN)
    ("a3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("αvβ3" . SPARSER::PROTEIN)
    ("cytokeratin 18" . SPARSER::PROTEIN)
    ("lin28" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NPI 0052" . SPARSER::DRUG)
    ("NPI0052" . SPARSER::DRUG) ("DcR2" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("TNFR-1" . SPARSER::PROTEIN)
    ("NPI-0052" . SPARSER::DRUG) ("HIF-2" . SPARSER::PROTEIN)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("JAK-2" . SPARSER::PROTEIN)
    ("JAK-1" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("NFR2" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("KEAP-1" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("NRF2" . SPARSER::PROTEIN) ("GRK-2" . SPARSER::PROTEIN)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MDR1" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN)
    ("PTEN/PI3K/Akt/GSK3β/β-catenin" . SPARSER::COLLECTION)
    ("Akt and GSK3β" . SPARSER::COLLECTION)
    ("inflammatory PGE2" . SPARSER::DRUG)
    ("CyclinD1 and c-Myc" . SPARSER::COLLECTION)
    ("axin and adenomatous polyposis coli (APC)" . SPARSER::COLLECTION)
    ("serine and threonine" . SPARSER::COLLECTION) ("axin" . SPARSER::PROTEIN)
    ("monocytes, neutrophils and macrophages" . SPARSER::COLLECTION)
    ("Cho group's" . SPARSER::MOLECULE)
    ("PTEN, Akt and GSK3β" . SPARSER::COLLECTION)
    ("GSK3β and Akt" . SPARSER::COLLECTION)
    ("c-Myc and cyclin D1" . SPARSER::COLLECTION)
    ("PBS or isotype" . SPARSER::COLLECTION)
    ("IgG or PBS" . SPARSER::COLLECTION)
    ("antibody and PBS" . SPARSER::COLLECTION)
    ("antibody or PBS" . SPARSER::COLLECTION)
    ("CRAMP protein and CRAMP mRNA" . SPARSER::COLLECTION)
    ("cathelicidin (CRAMP)" . SPARSER::PROTEIN-FAMILY)
    ("DSS" . SPARSER::PROTEIN) ("AOM" . SPARSER::PROTEIN)
    ("macrophages or SW480" . SPARSER::COLLECTION)
    ("macrophages and SW480" . SPARSER::COLLECTION)
    ("exogenous cathelicidin" . SPARSER::PROTEIN-FAMILY)
    ("hCAP-18/LL-37" . SPARSER::COLLECTION) ("cathelin" . SPARSER::PROTEIN)
    ("PTEN/PI3K/Akt" . SPARSER::COLLECTION)
    ("Cathelicidin" . SPARSER::PROTEIN-FAMILY)
    ("an antimicrobial peptide" . SPARSER::PEPTIDE)
    ("cathelicidin" . SPARSER::PROTEIN-FAMILY)
    ("Colon cancer" . SPARSER::PROTEIN) ("CD11b" . SPARSER::PROTEIN)
    ("M-CSF" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN) ("PIP2" . SPARSER::PIP2)
    ("CyclinD1" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("casein kinase1" . SPARSER::PROTEIN) ("hCAP18" . SPARSER::DRUG)
    ("CD68" . SPARSER::PROTEIN) ("LL-37" . SPARSER::PROTEIN)
    ("signal peptide" . SPARSER::PROTEIN) ("HCAP18" . SPARSER::DRUG)
    ("hCAP-18" . SPARSER::PROTEIN)
    ("histone deacetylase inhibitors and Pak inhibitors" . SPARSER::COLLECTION)
    ("SMO , AKT1 , KLF4 and TRAF7" . SPARSER::COLLECTION)
    ("two new group I Pak small-molecule inhibitors, Frax716 and 1036"
     . SPARSER::COLLECTION)
    ("the pan-Pak inhibitor PF3758309 or the group I-specific Pak inhibitor Frax597"
     . SPARSER::COLLECTION)
    ("Mek or Akt" . SPARSER::COLLECTION)
    ("Mek (PD0325901) and Akt (GSK690693)" . SPARSER::COLLECTION)
    ("Frax597 or Frax1036" . SPARSER::COLLECTION)
    ("IPA3 and PF3758309" . SPARSER::COLLECTION)
    ("general cellular redox" . SPARSER::PROTEIN)
    ("Raf1 and Mek1" . SPARSER::COLLECTION) ("Mek1" . SPARSER::PROTEIN)
    ("Raf1" . SPARSER::PROTEIN) ("MN" . SPARSER::PROTEIN)
    ("Pak4" . SPARSER::PROTEIN)
    ("both group I and group II Paks [ xref ]" . SPARSER::COLLECTION)
    ("diet-containing doxycycline" . SPARSER::DRUG) ("BLI" . SPARSER::PROTEIN)
    ("Pak1 or Pak2" . SPARSER::COLLECTION)
    ("Pak1 and Pak2" . SPARSER::COLLECTION)
    ("Pak1 and Pak3" . SPARSER::COLLECTION) ("Pak3" . SPARSER::PROTEIN)
    ("a reasonable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Cdc42 and Rac" . SPARSER::COLLECTION)
    ("particular Pak1" . SPARSER::PROTEIN) ("mater" . SPARSER::PROTEIN)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("B-A" . SPARSER::PROTEIN)
    ("pH 3" . SPARSER::MOLECULE) ("FK228" . SPARSER::DRUG)
    ("AR42" . SPARSER::DRUG) ("TRAF7" . SPARSER::PROTEIN)
    ("phospho-protein" . SPARSER::PROTEIN) ("PD325901" . SPARSER::DRUG)
    ("PF3758309" . SPARSER::DRUG) ("Pak2" . SPARSER::PROTEIN)
    ("Men1" . SPARSER::PROTEIN) ("Frax597" . SPARSER::DRUG)
    ("group I" . SPARSER::PROTEIN)
    ("doxycycline and paclitaxel" . SPARSER::COLLECTION)
    ("ERBB1 or ERBB 3" . SPARSER::COLLECTION)
    ("c-SRC inhibitor as well as lapatinib and MET kinase inhibitor"
     . SPARSER::COLLECTION)
    ("lapatinib and MET" . SPARSER::COLLECTION)
    ("SRC, MET, and Axl" . SPARSER::COLLECTION) ("Axl" . SPARSER::PROTEIN)
    ("PI3K-AKT and ERK" . SPARSER::COLLECTION)
    ("hypoxia/HIF-1" . SPARSER::COLLECTION)
    ("pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("DUSP2 and HIF-1α" . SPARSER::COLLECTION)
    ("the dual specificity protein phosphatase 2" . SPARSER::PROTEIN)
    ("ERBB2, ERK, and AKT" . SPARSER::COLLECTION) ("DMOG" . SPARSER::DRUG)
    ("ERK and BIM" . SPARSER::COLLECTION)
    ("lapatinib and trametinib" . SPARSER::COLLECTION)
    ("dabrafenib" . SPARSER::DRUG) ("Trametinib" . SPARSER::DRUG)
    ("PI3 kinase or MEK" . SPARSER::COLLECTION)
    ("either phosphoinositide 3-kinase (PI3K) inhibitor (LY294002) or MEK inhibitor (UO126)"
     . SPARSER::COLLECTION)
    ("hypoxia and lapatinib" . SPARSER::COLLECTION) ("c" . SPARSER::PROTEIN)
    ("c-SRC" . SPARSER::COLLECTION) ("BIM and p27 Kip1" . SPARSER::COLLECTION)
    ("ERBB2/EGFR" . SPARSER::COLLECTION)
    ("the Bcl-2-family pro-apoptotic protein BIM and cell cycle inhibitor p27 Kip1"
     . SPARSER::COLLECTION)
    ("the Bcl-2-family pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("MCF-10A-ERBB2" . SPARSER::COLLECTION)
    ("normal oxygen" . SPARSER::MOLECULE) ("MMTV-" . SPARSER::PROTEIN)
    ("ERBB2-" . SPARSER::PROTEIN)
    ("prolyl hydroxylase (PHD)" . SPARSER::PROTEIN) ("PHD" . SPARSER::PROTEIN)
    ("AKT and extracellular signal-regulated kinase (ERK)"
     . SPARSER::COLLECTION)
    ("AKT and extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("hypoxic ERBB2" . SPARSER::PROTEIN)
    ("lapatinib and MEK" . SPARSER::COLLECTION) ("trametinib" . SPARSER::DRUG)
    ("ERBB2/HER2" . SPARSER::COLLECTION) ("ERBB 3" . SPARSER::PROTEIN)
    ("k-ras" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("B-RAF" . SPARSER::PROTEIN) ("anti-ERBB2" . SPARSER::DRUG)
    ("Hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DUSP2" . SPARSER::PROTEIN)
    ("the EGFR antibody cetuximab and the ERBB3 antibody MM-121"
     . SPARSER::COLLECTION)
    ("TKI-naïve" . SPARSER::PROTEIN-PAIR)
    ("ERBB3, GAB1 and GAB2" . SPARSER::COLLECTION)
    ("GAB1 and ERBB3" . SPARSER::COLLECTION)
    ("p85, GAB1 and GAB2" . SPARSER::COLLECTION)
    ("both ERBB3 and GAB1/GAB2" . SPARSER::COLLECTION)
    ("GAB1/GAB2" . SPARSER::COLLECTION) ("functional ERBB3" . SPARSER::PROTEIN)
    ("ERBB3, and active" . SPARSER::COLLECTION)
    ("EGFR homodimers or EGFR/ERBB2 heterodimers" . SPARSER::COLLECTION)
    ("EGFR, ERBB2 and ERBB3" . SPARSER::COLLECTION)
    ("erlotinib and ERBB3" . SPARSER::COLLECTION)
    ("ERBB2/ERBB3" . SPARSER::COLLECTION)
    ("ERBB3, GAB1, and GAB2" . SPARSER::COLLECTION)
    ("GAB1 or GAB1+GAB2" . SPARSER::COLLECTION)
    ("MET and ERBB2" . SPARSER::COLLECTION)
    ("MET or ERBB2" . SPARSER::COLLECTION)
    ("ERBB2 and MET" . SPARSER::COLLECTION)
    ("EGFR, GAB1, GAB2, AKT and ERK" . SPARSER::COLLECTION)
    ("EGFR transgenes" . SPARSER::PROTEIN)
    ("withNkx2.1-Cre ERT2 ( xref ) and Erbb3 flox/flox alleles ( xref )"
     . SPARSER::COLLECTION)
    ("Nkx2.1-Cre" . SPARSER::COLLECTION) ("GAB1 or GAB2" . SPARSER::COLLECTION)
    ("GAB2 and IRS1" . SPARSER::COLLECTION) ("PC-9" . SPARSER::PROTEIN)
    ("p85 and EGFR" . SPARSER::COLLECTION)
    ("IRS1 and EGFR" . SPARSER::COLLECTION)
    ("IRS1 and GAB2" . SPARSER::COLLECTION)
    ("proteins and receptors" . SPARSER::COLLECTION)
    ("GAB1, GAB2, IRS1 and IRS2" . SPARSER::COLLECTION)
    ("the GRB2-associated binder protein (GAB) and insulin receptor substrate (IRS) protein families---have"
     . SPARSER::COLLECTION)
    ("the GRB2-associated binder protein (GAB)" . SPARSER::PROTEIN)
    ("IRS" . SPARSER::PROTEIN) ("EGFR and p85" . SPARSER::COLLECTION)
    ("EGFR and ERBB3" . SPARSER::COLLECTION)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("IA" . SPARSER::MOLECULE) ("Class" . CLASS)
    ("Jak/Stat" . SPARSER::COLLECTION) ("Stat" . SPARSER::PROTEIN)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS and RAF" . SPARSER::COLLECTION)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt and phospho-Akt" . SPARSER::COLLECTION)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("thirteenCCSP-rtTA" . SPARSER::COLLECTION)
    ("threeCCSP-rtTA" . SPARSER::COLLECTION) ("rtTA" . SPARSER::PROTEIN)
    ("differentTetO-EGFR" . SPARSER::COLLECTION)
    ("andTetO-EGFR" . SPARSER::COLLECTION) ("CCSP-rtTA" . SPARSER::COLLECTION)
    ("EGFR and Cre" . SPARSER::COLLECTION)
    ("Erbb3 ( xref ) and a TetO-Cre transgene ( xref )" . SPARSER::COLLECTION)
    ("TetO-Cre" . SPARSER::COLLECTION)
    ("EGFR or only EGFR L858R (L858R)" . SPARSER::COLLECTION)
    ("only EGFR L858R" . SPARSER::PROTEIN) ("TetO-EGFR" . SPARSER::COLLECTION)
    ("CCSP" . SPARSER::PROTEIN) ("TetO" . SPARSER::PROTEIN)
    ("ERBB3 and EGFR" . SPARSER::COLLECTION)
    ("the EGFR antibody cetuximab and an anti-ERBB3 antibody MM-121"
     . SPARSER::COLLECTION)
    ("EGFR and ERBB2" . SPARSER::COLLECTION)
    ("the phosphoinositide 3-kinase (PI3K) and signal transducer"
     . SPARSER::COLLECTION)
    ("the protein (DEL) and ii" . SPARSER::COLLECTION)
    ("protein (DEL)" . SPARSER::PROTEIN) ("EGFR-ERBB3" . SPARSER::COLLECTION)
    ("family, and ERBB3" . SPARSER::COLLECTION)
    ("EGFR, ERBB2, ERBB3 and ERBB4" . SPARSER::COLLECTION)
    ("ERBB2 or MET" . SPARSER::COLLECTION)
    ("GAB1 and GAB2" . SPARSER::COLLECTION)
    ("tetracycline- and tamoxifen-" . SPARSER::COLLECTION)
    ("tamoxifen-" . SPARSER::MOLECULE) ("tetracycline-" . SPARSER::DRUG)
    ("IRS2" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("Nkx2.1" . SPARSER::PROTEIN) ("MM-121" . SPARSER::DRUG)
    ("p85" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("GAB1" . SPARSER::PROTEIN) ("Erbb3" . SPARSER::PROTEIN)
    ("phosphatidyl-inositol 3-kinase" . SPARSER::PROTEIN)
    ("Imatinib and Dasatinib" . SPARSER::COLLECTION)
    ("Imatinib" . SPARSER::DRUG) ("NUP214/ABL1" . SPARSER::COLLECTION)
    ("chronic lymphoblastic leukemia (CLL)" . SPARSER::PROTEIN)
    ("MLL" . SPARSER::PROTEIN)
    ("endogenous PAX5 [ xref ] and b" . SPARSER::COLLECTION)
    ("Gadd45b and Lats2" . SPARSER::COLLECTION) ("Gadd45b" . SPARSER::PROTEIN)
    ("exclusively PAX5 fusion genes" . SPARSER::GENE)
    ("cMyc and Ccnd2" . SPARSER::COLLECTION)
    ("IL7R-Stat5" . SPARSER::COLLECTION) ("/LCK" . SPARSER::COLLECTION)
    ("IKZF1 and BTG1" . SPARSER::COLLECTION)
    ("CDKN2A/CDKN2B" . SPARSER::COLLECTION)
    ("PAX5/POM121C" . SPARSER::COLLECTION) ("PAX5/SOX5" . SPARSER::COLLECTION)
    ("PAX5/CHFR" . SPARSER::COLLECTION) ("CHFR" . SPARSER::PROTEIN)
    ("Zap70" . SPARSER::PROTEIN) ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("MIGR-GFP" . SPARSER::COLLECTION) ("MIGR" . SPARSER::PROTEIN)
    ("GEP" . SPARSER::PROTEIN)
    ("an aberrant transcription factor" . SPARSER::PROTEIN)
    ("pre-BI" . SPARSER::COLLECTION) ("BI" . SPARSER::PROTEIN)
    ("a transcriptional activator and a repressor" . SPARSER::COLLECTION)
    ("BCR/ABL1" . SPARSER::COLLECTION) ("BCR" . SPARSER::PROTEIN)
    ("wt and PAX5" . SPARSER::COLLECTION)
    ("effectors, cMyc and Ccnd2" . SPARSER::COLLECTION)
    ("Ccnd2" . SPARSER::PROTEIN) ("PAX5/ETV6" . SPARSER::COLLECTION)
    ("cMyc" . SPARSER::PROTEIN) ("BCP" . SPARSER::PROTEIN)
    ("PFA 1" . SPARSER::PROTEIN) ("CRLF2" . SPARSER::PROTEIN)
    ("P2RY8" . SPARSER::PROTEIN) ("EBF1" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("NUP214" . SPARSER::PROTEIN)
    ("Lats2" . SPARSER::PROTEIN) ("PAX 5" . SPARSER::PROTEIN)
    ("CD127" . SPARSER::PROTEIN) ("IL7Rα" . SPARSER::PROTEIN)
    ("IKZF1" . SPARSER::PROTEIN) ("POM121C" . SPARSER::PROTEIN)
    ("SOX5" . SPARSER::PROTEIN) ("IL7" . SPARSER::PROTEIN)
    ("Pax5" . SPARSER::PROTEIN) ("BIBF1120" . SPARSER::DRUG)
    ("pre-BCR" . SPARSER::BIO-COMPLEX) ("ETV6" . SPARSER::PROTEIN)
    ("tipifarnib (CPT-11) and bortezomib (PS-341)" . SPARSER::COLLECTION)
    ("bortezomib" . SPARSER::DRUG) ("tipifarnib" . SPARSER::DRUG)
    ("BCL2L1 and XIAP" . SPARSER::COLLECTION)
    ("OTUD7B and TAX1BP1" . SPARSER::COLLECTION)
    ("CYLD, A20, and OTUD7B" . SPARSER::COLLECTION)
    ("X-linked IAP ( XIAP )" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("CYLD, TAX1BP1, and OTUD7B, and NF-κB" . SPARSER::COLLECTION)
    ("OTUD7B, and NF-κB" . SPARSER::COLLECTION)
    ("functionally relevant effectors" . SPARSER::EFFECTOR)
    ("CYLD, TAX1BP1, or OTUD7B" . SPARSER::COLLECTION)
    ("CYLD, TAX1BP1, and OTUD7B" . SPARSER::COLLECTION)
    ("K63-polyubiquitin" . SPARSER::COLLECTION)
    ("NF-κB/p65" . SPARSER::COLLECTION) ("IκBα-mut" . SPARSER::COLLECTION)
    ("CYLD, TAX1BP1 and OTUD7B" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent cisplatin" . SPARSER::MOLECULE)
    ("NGEC-2" . SPARSER::COLLECTION)
    ("these serial negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("RIP1, NEMO, and B-cell CLL/lymphoma 3" . SPARSER::COLLECTION)
    ("DUB" . SPARSER::PROTEIN) ("NEMO" . SPARSER::PROTEIN)
    ("TRAF2 or the cIAPs [ xref , xref ]" . SPARSER::COLLECTION)
    ("TNFRSF1A-associated via death domain (TRADD)" . SPARSER::PROTEIN)
    ("a receptor-associated complex" . SPARSER::BIO-COMPLEX)
    ("TNFR-associated factor 2" . SPARSER::PROTEIN)
    ("receptor (TNFR)" . SPARSER::RECEPTOR)
    ("cIAP2, and receptor-interacting protein 1" . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN) ("TNFR" . SPARSER::PROTEIN)
    ("A20, and OTU deubiquitinase 7B" . SPARSER::COLLECTION)
    ("CYLD" . SPARSER::PROTEIN) ("MnCl 2" . SPARSER::DRUG)
    ("k63" . SPARSER::PROTEIN) ("Ago1" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("p84" . SPARSER::PROTEIN)
    ("PS-341" . SPARSER::DRUG) ("CPT-11" . SPARSER::DRUG)
    ("X-linked IAP" . SPARSER::PROTEIN) ("BCL3" . SPARSER::PROTEIN)
    ("B-cell CLL/lymphoma 3" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("cIAP2" . SPARSER::PROTEIN) ("cIAP1" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN)
    ("TNFRSF1A-associated via death domain" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN)
    ("receptor-interacting protein 1" . SPARSER::PROTEIN)
    ("TAX1BP1" . SPARSER::PROTEIN)
    ("Tax1-binding protein 1" . SPARSER::PROTEIN) ("OTUD7B" . SPARSER::PROTEIN)
    ("OTU deubiquitinase 7B" . SPARSER::PROTEIN)
    ("clinically useful prognostic biomarkers" . SPARSER::MOLECULE)
    ("anti-EGFR and COX-2" . SPARSER::COLLECTION)
    ("epiregulin, COX-2, MMP-1 and MMP-2" . SPARSER::COLLECTION)
    ("COX-2, fibronectin and ANGPTL4" . SPARSER::COLLECTION)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("EGF, IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("MMP-2, MMP-9 and VEGF" . SPARSER::COLLECTION)
    ("EGFR-COX-2-fibronectin" . SPARSER::COLLECTION)
    ("inflammatory cytokines and growth factors" . SPARSER::COLLECTION)
    ("HER2 and HER3" . SPARSER::COLLECTION)
    ("Hematoxylin and eosin (H&E)" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("COX-2 and fibronectin" . SPARSER::COLLECTION)
    ("fibronectin and COX-2" . SPARSER::COLLECTION)
    ("EGF- and PGE 2" . SPARSER::COLLECTION) ("EGF-" . SPARSER::PROTEIN)
    ("phospho-FAK and phospho-Rac1/cdc42" . SPARSER::COLLECTION)
    ("vimentin and N-cadherin" . SPARSER::COLLECTION)
    ("fibronectin and phospho-Rac1/cdc42" . SPARSER::COLLECTION)
    ("FAK/Rac1/cdc42" . SPARSER::COLLECTION)
    ("fibronectin, phospho-Rac1/cdc42 and phospho-FAK" . SPARSER::COLLECTION)
    ("vimentin, and N-cadherin" . SPARSER::COLLECTION)
    ("MMP-1, MMP-3 or MMP-9" . SPARSER::COLLECTION)
    ("MMP-1, MMP-2, MMP-3 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-1, MMP-3 and MMP-9" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-3" . SPARSER::COLLECTION)
    ("MMP-1, MMP-3, MMP-9 and MMP-2" . SPARSER::COLLECTION)
    ("EGF or PGE 2" . SPARSER::COLLECTION)
    ("fibronectin/FAK/Rac1/cdc42" . SPARSER::COLLECTION)
    ("PGE 2 and EGF" . SPARSER::COLLECTION) ("celecoxib" . SPARSER::DRUG)
    ("EGF and PGE 2" . SPARSER::COLLECTION) ("shCOX-2" . SPARSER::COLLECTION)
    ("MMP-1, MMP-2, MMP-3, MMP-9 and fibronectin" . SPARSER::COLLECTION)
    ("EGFR and COX-2" . SPARSER::COLLECTION)
    ("COX-2 and EGFR" . SPARSER::COLLECTION) ("ARNT" . SPARSER::PROTEIN)
    ("ultraviolet B irradiation and tumor promoters" . SPARSER::PROMOTER)
    ("IL2 and tumor necrosis factor" . SPARSER::COLLECTION)
    ("EGF and platelet-derived growth factor" . SPARSER::COLLECTION)
    ("Prostaglandin" . SPARSER::PROTEIN) ("Cetuximab" . SPARSER::DRUG)
    ("cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("fibronectin/Rac1/cdc42" . SPARSER::COLLECTION)
    ("-1, MMP-2, MMP-3, MMP-9, and fibronectin" . SPARSER::COLLECTION)
    ("Rac1/cdc42" . SPARSER::COLLECTION)
    ("EGF and prostaglandin E 2" . SPARSER::COLLECTION)
    ("MMP-10" . SPARSER::PROTEIN) ("PTGS2" . SPARSER::PROTEIN)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("fibronectin 1" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("p-Rac1" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("L-15" . SPARSER::PROTEIN) ("ANGPTL4" . SPARSER::PROTEIN)
    ("EP2" . SPARSER::PROTEIN) ("ELMO1" . SPARSER::PROTEIN)
    ("α5β1" . SPARSER::PROTEIN)
    ("aryl hydrocarbon receptor nuclear translocator" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE)
    ("c-myc as well as components" . SPARSER::COLLECTION)
    ("present exogenous and endogenous antigenic peptides" . SPARSER::PEPTIDE)
    ("peptide-receptive class II molecules" . SPARSER::MOLECULE)
    ("GILT and HLA-DM" . SPARSER::COLLECTION)
    ("the critical endolysosomal reductase GILT" . SPARSER::PROTEIN)
    ("conformation or peptide" . SPARSER::COLLECTION)
    ("exogenous peptides" . SPARSER::PEPTIDE)
    ("elevated cellular c-MYC" . SPARSER::PROTEIN)
    ("the antigenic peptides" . SPARSER::PEPTIDE)
    ("Antigenic peptides" . SPARSER::PEPTIDE)
    ("cathepsins and GILT" . SPARSER::COLLECTION)
    ("the professional APCs" . SPARSER::PROTEIN) ("APCs" . SPARSER::PROTEIN)
    ("TOF" . SPARSER::PROTEIN) ("paraformaldehyde" . SPARSER::DRUG)
    ("exogenous peptide" . SPARSER::PEPTIDE) ("avidin" . SPARSER::PROTEIN)
    ("HLA-DR and HLA-DR4" . SPARSER::COLLECTION) ("Rank" . SPARSER::PROTEIN)
    ("HSA" . SPARSER::PROTEIN)
    ("c-MYC, EBNA-1 and EBNA-2" . SPARSER::COLLECTION)
    ("lysosomal thiol reductase (GILT)" . SPARSER::PROTEIN)
    ("HLA-DM/DO molecules in B-cells as well as tumors" . SPARSER::COLLECTION)
    ("class II-associated invariant chain peptide (CLIP)" . SPARSER::PEPTIDE)
    ("peptide (CLIP)" . SPARSER::PEPTIDE)
    ("NF-κB and interferon" . SPARSER::COLLECTION)
    ("the only viral protein" . SPARSER::PROTEIN)
    ("A sporadic form" . SPARSER::FORM) ("a highly aggressive type" . TYPE)
    ("cytidine deaminase (AID)" . SPARSER::PROTEIN) ("AID" . SPARSER::PROTEIN)
    ("t(8:22) and t(8:2)" . SPARSER::COLLECTION)
    ("the p53 tumor suppressor and inhibition of cyclin D1 as well as indirect suppression of anti-apoptotic BCL2 and induction of pro-apoptotic BAX and Bim ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("pro-apoptotic BAX and Bim" . SPARSER::COLLECTION)
    ("BAX and Bim" . SPARSER::COLLECTION) ("polymerases" . SPARSER::PROTEIN)
    ("transcriptional cofactors" . SPARSER::PROTEIN)
    ("an avian retroviral oncogene" . SPARSER::ONCOGENE)
    ("47kDa" . SPARSER::PROTEIN) ("enolase" . SPARSER::PROTEIN)
    ("GILT" . SPARSER::PROTEIN) ("antigenic peptides" . SPARSER::PEPTIDE)
    ("distinct co-factors" . SPARSER::MOLECULE)
    ("enolase 1" . SPARSER::PROTEIN) ("alpha-enolase" . SPARSER::PROTEIN)
    ("MS-MS" . SPARSER::PROTEIN) ("MAP1" . SPARSER::PROTEIN)
    ("Pin 1" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("6-aminohexanoic acid" . SPARSER::DRUG) ("DR4" . SPARSER::PROTEIN)
    ("EBNA-2" . SPARSER::PROTEIN)
    ("lysosomal thiol reductase" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::PROTEIN) ("EBNA-1" . SPARSER::PROTEIN)
    ("c- myc" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("EGFR and/or LAPTM4B" . SPARSER::COLLECTION)
    ("erlotinib or hydroxychloroquine" . SPARSER::COLLECTION)
    ("hydroxychloroquine" . SPARSER::DRUG)
    ("K-Ras or p53" . SPARSER::COLLECTION)
    ("Sec5 and Rubicon" . SPARSER::COLLECTION)
    ("Sec5 and LAPTM4B" . SPARSER::COLLECTION)
    ("Sec5, Sec6, and Rubicon" . SPARSER::COLLECTION)
    ("Erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("EGFR-LAPTM4B-Sec5" . SPARSER::COLLECTION)
    ("Erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("TKIs, erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("Erlotinib and Gefitinib" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG) ("LAPTM4B or Sec5" . SPARSER::COLLECTION)
    ("Rubicon and Sec5" . SPARSER::COLLECTION)
    ("GST or EGFR-CT" . SPARSER::COLLECTION)
    ("Rubicon-Beclin 1" . SPARSER::COLLECTION)
    ("these components blocked autophagy ( xref , xref and xref )"
     . SPARSER::COMPONENT)
    ("Beclin 1 and the autophagy inhibitor Rubicon" . SPARSER::COLLECTION)
    ("VPS34 or ATG14" . SPARSER::COLLECTION)
    ("EGFR, LAPTM4B and Sec5" . SPARSER::COLLECTION)
    ("Sec6, Sec8 and Exo70" . SPARSER::COLLECTION)
    ("Sec6 and Sec8" . SPARSER::COLLECTION)
    ("Exo70 and Exo84" . SPARSER::COLLECTION) ("Sec6" . SPARSER::PROTEIN)
    ("EGFR, LAPTM4B and Exo70" . SPARSER::COLLECTION)
    ("Sec8" . SPARSER::PROTEIN) ("LAPTM4B and inactive" . SPARSER::COLLECTION)
    ("Exocyst" . SPARSER::BIO-COMPLEX)
    ("LAPTM4B and EGFR" . SPARSER::COLLECTION)
    ("LAPTM4B and LC3-II" . SPARSER::COLLECTION)
    ("EGFR or LAPTM4B" . SPARSER::COLLECTION)
    ("c-Met and FGFR2" . SPARSER::COLLECTION)
    ("PDGFRB, FGFR2, and c-Met" . SPARSER::COLLECTION)
    ("LAPTM4B-EGFR" . SPARSER::COLLECTION)
    ("neither FGFR2 nor c-Met" . SPARSER::COLLECTION)
    ("c-Met and FGFR2, and c-Met" . SPARSER::COLLECTION)
    ("FGFR2, and c-Met" . SPARSER::COLLECTION)
    ("EGFR-LAPTM4B" . SPARSER::COLLECTION) ("EGFR-KD" . SPARSER::COLLECTION)
    ("PDGFRB, FGFR2, or c-Met" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN) ("PI3K/ATK" . SPARSER::COLLECTION)
    ("ATK" . SPARSER::PROTEIN)
    ("an abnormally overexpressed protein" . SPARSER::PROTEIN)
    ("overexpressed protein" . SPARSER::PROTEIN)
    ("The lysosomal-associated transmembrane protein 4B" . SPARSER::PROTEIN)
    ("tetra" . SPARSER::MOLECULE) ("At least some EGFR" . SPARSER::PROTEIN)
    ("EGFR TKIs or neutralizing antibody" . SPARSER::COLLECTION)
    ("Beclin 1, VPS34, ATG14 and VPS15" . SPARSER::COLLECTION)
    ("LAPTM4B and Sec5" . SPARSER::COLLECTION) ("Rubicon" . SPARSER::PROTEIN)
    ("EGFR and LAPTM4B" . SPARSER::COLLECTION) ("Sec5" . SPARSER::PROTEIN)
    ("exocyst" . SPARSER::BIO-COMPLEX) ("Inactive" . SPARSER::INACTIVE)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nedd4" . SPARSER::PROTEIN) ("Exo84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Exo70" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TSG101" . SPARSER::PROTEIN)
    ("Kinase Activity" . SPARSER::PROTEIN)
    ("Atg8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VPS15" . SPARSER::PROTEIN)
    ("ATG14" . SPARSER::PROTEIN) ("VPS34" . SPARSER::PROTEIN)
    ("yeast)" . SPARSER::PROTEIN) ("Atg6" . SPARSER::PROTEIN)
    ("LAPTM4B" . SPARSER::PROTEIN) ("TGF-β2 and SPARC" . SPARSER::COLLECTION)
    ("VEGF or pBcl-2" . SPARSER::COLLECTION) ("PHDs" . SPARSER::PROTEIN)
    ("proteins, VEGF and pBcl-2" . SPARSER::COLLECTION)
    ("proteins, α-SMA and fibronectin" . SPARSER::COLLECTION)
    ("Bcl-2 or pBcl-2" . SPARSER::COLLECTION)
    ("a pro-apoptotic protein" . SPARSER::PROTEIN)
    ("nuclear compartment-associated Bcl-2" . SPARSER::PROTEIN)
    ("Bax, Bcl-2, or pBcl-2" . SPARSER::COLLECTION)
    ("GAPDH and LDH" . SPARSER::COLLECTION) ("LDH" . SPARSER::PROTEIN)
    ("GSK-3β, pGSK-3β, and GS" . SPARSER::COLLECTION)
    ("GSK-3β, pGSK-3β, GS, and pGS" . SPARSER::COLLECTION)
    ("biologic or clinical relevance" . SPARSER::COLLECTION)
    ("Bcl-2 and pBcl-2" . SPARSER::COLLECTION) ("CAS" . SPARSER::PROTEIN)
    ("nuclear β-catenin and mesenchymal marker proteins" . SPARSER::COLLECTION)
    ("mesenchymal marker proteins" . SPARSER::PROTEIN)
    ("the hypoxic media" . SPARSER::PROTEIN)
    ("β-catenin and VEGF" . SPARSER::COLLECTION) ("TNKS" . SPARSER::PROTEIN)
    ("Tankyrase" . SPARSER::PROTEIN)
    ("the scaffolding proteins Axin and adenomatous polyposis coli (APC)"
     . SPARSER::COLLECTION)
    ("β-catenin and VEGF/pBcl-2" . SPARSER::COLLECTION)
    ("β-catenin, VEGF, and pBcl-2" . SPARSER::COLLECTION)
    ("proteins, α-SMA, and fibronectin" . SPARSER::COLLECTION)
    ("EMT/E-cadherin" . SPARSER::COLLECTION)
    ("fresh serum-free media" . SPARSER::PROTEIN)
    ("continuous atmospheric oxygen" . SPARSER::MOLECULE)
    ("triplicate and fresh serum-free media" . SPARSER::PROTEIN)
    ("Fresh serum-free media" . SPARSER::PROTEIN)
    ("hypoxia or atmospheric oxygen" . SPARSER::COLLECTION)
    ("multi" . SPARSER::PROTEIN)
    ("GSK-3β and phosphoglycogen" . SPARSER::COLLECTION)
    ("GS" . SPARSER::PROTEIN-FAMILY) ("pGS" . SPARSER::PROTEIN)
    ("fibronectin and α-SMA" . SPARSER::COLLECTION)
    ("proteins, fibronectin, and α-SMA" . SPARSER::COLLECTION)
    ("TGF-β/Wnt" . SPARSER::COLLECTION) ("AXIN" . SPARSER::PROTEIN)
    ("cre/lox-p" . SPARSER::COLLECTION)
    ("Wnts and their frizzled receptors" . SPARSER::COLLECTION)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TGF-β and bFGF" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("VEGF and pBcl-2" . SPARSER::COLLECTION)
    ("α-SMA and fibronectin" . SPARSER::COLLECTION)
    ("SB216763 or XAV939" . SPARSER::COLLECTION)
    ("β-catenin and phospho-β-catenin" . SPARSER::COLLECTION)
    ("a specific inhibitor of GSK-3β catalytic activity and XAV939"
     . SPARSER::COLLECTION)
    ("a multifactorial complex" . SPARSER::BIO-COMPLEX)
    ("atmospheric oxygen" . SPARSER::MOLECULE) ("TGF-β2" . SPARSER::PROTEIN)
    ("Von–Hippel Lindau" . SPARSER::PROTEIN) ("Wnt 3a" . SPARSER::PROTEIN)
    ("UO126" . SPARSER::DRUG) ("FKBP38" . SPARSER::PROTEIN)
    ("T-antigen" . SPARSER::PROTEIN) ("prolyl hydroxylase" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("αSMA" . SPARSER::PROTEIN)
    ("Glycogen Synthase" . SPARSER::PROTEIN-FAMILY)
    ("GSK3-β" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("JC-1" . SPARSER::MOLECULE) ("XAV939" . SPARSER::DRUG)
    ("many tumor-promoting genes and downregulation of tumor suppressor genes and aberrant silencing"
     . SPARSER::COLLECTION)
    ("iodine" . SPARSER::MOLECULE) ("hypoparathyroidism" . SPARSER::PROTEIN)
    ("Thyroid" . SPARSER::PROTEIN)
    ("the well-differentiated papillary carcinoma group" . SPARSER::MOLECULE)
    ("BRAFV" . SPARSER::PROTEIN) ("OR 1" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::MOLECULE)
    ("certain neuroprotective proteins" . SPARSER::PROTEIN)
    ("HDAC1-HDAC3" . SPARSER::COLLECTION)
    ("a cell-permeable peptide form" . SPARSER::FORM)
    ("the C-terminal 21 amino acids of c-Fos and c-Fos (360–380)"
     . SPARSER::COLLECTION)
    ("c-Fos and c-Fos" . SPARSER::COLLECTION)
    ("a neuroprotective protein complex" . SPARSER::BIO-COMPLEX)
    ("c-Fos, HDAC3, and Htt" . SPARSER::COLLECTION)
    ("c-Abl and CK-I" . SPARSER::COLLECTION)
    ("c-Abl or CK-I" . SPARSER::COLLECTION)
    ("a highly neurotoxic protein" . SPARSER::PROTEIN)
    ("PI3 kinase-Akt" . SPARSER::COLLECTION)
    ("Htt and c-Fos" . SPARSER::COLLECTION)
    ("c-Fos-HDAC3-Htt" . SPARSER::COLLECTION)
    ("c-Fos and HDAC3" . SPARSER::COLLECTION) ("NP" . SPARSER::PROTEIN)
    ("nonstriatal brain parts" . SPARSER::COMPONENT)
    ("Huntingtin" . SPARSER::PROTEIN) ("VAV-c-Fos" . SPARSER::COLLECTION)
    ("VAV" . SPARSER::PROTEIN) ("a neurotoxic protein" . SPARSER::PROTEIN)
    ("a Neuroprotective Protein" . SPARSER::PROTEIN) ("DEF" . SPARSER::PROTEIN)
    ("MEK inhibitors (U0126 and PD98059) and c-Abl inhibitor (Gleevec)"
     . SPARSER::COLLECTION)
    ("U0126 and PD98059" . SPARSER::COLLECTION) ("Gleevec" . SPARSER::DRUG)
    ("TBB, or HDAC" . SPARSER::COLLECTION) ("TBB" . SPARSER::PROTEIN)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("PI-3 kinase-Akt" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::DRUG)
    ("c-Abl, and Casein" . SPARSER::COLLECTION) ("Casein" . SPARSER::PROTEIN)
    ("the longer form" . SPARSER::FORM) ("a shorter form" . SPARSER::FORM)
    ("LK-treated CGN" . SPARSER::PROTEIN) ("EGFP-c-Fos" . SPARSER::COLLECTION)
    ("c-Fos-Flag" . SPARSER::COLLECTION)
    ("ATF6 and ATF6b" . SPARSER::COLLECTION)
    ("LK-treated CGNs" . SPARSER::PROTEIN)
    ("c-Fos and FosB" . SPARSER::COLLECTION)
    ("JunB and JunD" . SPARSER::COLLECTION)
    ("Fos and Jun" . SPARSER::COLLECTION)
    ("c-Fos and Other Proteins" . SPARSER::COLLECTION)
    ("many neuronal types" . TYPE) ("monooxygenase" . SPARSER::PROTEIN)
    ("neither c-Jun nor ATF2" . SPARSER::COLLECTION)
    ("c-Jun and ATF2" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("Fos, Jun, and ATF" . SPARSER::COLLECTION)
    ("Fos and ATF" . SPARSER::COLLECTION)
    ("the Fos proteins (c-Fos, FosB, Fra-1, and Fra-2) and the Jun proteins (c-Jun, JunB, and JunD)"
     . SPARSER::COLLECTION)
    ("c-Fos, FosB, Fra-1, and Fra-2" . SPARSER::COLLECTION)
    ("c-Jun, JunB, and JunD" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("This cell-permeable peptide" . SPARSER::PEPTIDE)
    ("Fos-CTF" . SPARSER::COLLECTION) ("CTF" . SPARSER::PROTEIN)
    ("a cell-permeable peptide" . SPARSER::PEPTIDE)
    ("mut-Htt" . SPARSER::COLLECTION) ("HCA" . SPARSER::PROTEIN)
    ("LK" . SPARSER::PROTEIN) ("PI3 kinase" . SPARSER::PROTEIN)
    ("ATF6" . SPARSER::PROTEIN) ("IGF-1-" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("sodium hydroxide" . SPARSER::MOLECULE) ("IC261" . SPARSER::DRUG)
    ("KN62" . SPARSER::DRUG) ("B-2" . SPARSER::PROTEIN)
    ("ATF3" . SPARSER::PROTEIN) ("ATF2" . SPARSER::PROTEIN)
    ("Fra-2" . SPARSER::PROTEIN) ("Fra-1" . SPARSER::PROTEIN)
    ("histone deacetylase-3" . SPARSER::PROTEIN) ("CK-I" . SPARSER::PROTEIN)
    ("c-Abl" . SPARSER::PROTEIN) ("REFS" . SPARSER::PROTEIN)
    ("mevalonate" . SPARSER::PROTEIN)
    ("mevalonate–RHO" . SPARSER::PROTEIN-PAIR)
    ("internal enzymes" . SPARSER::ENZYME)
    ("VGLL4–TEAD4" . SPARSER::PROTEIN-PAIR)
    ("YAP target genes and poor prognosis" . SPARSER::COLLECTION)
    ("vestigial" . SPARSER::PROTEIN-FAMILY) ("TAZ–TEAD" . SPARSER::COLLECTION)
    ("photosensitizer" . SPARSER::DRUG) ("Verteporfin" . SPARSER::DRUG)
    ("mainly tumour suppressors" . SPARSER::SUPPRESSOR)
    ("RHOA" . SPARSER::PROTEIN)
    ("which releases ABL1 tyrosine kinase" . SPARSER::PROTEIN)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DVL" . SPARSER::PROTEIN)
    ("viral small T oncoproteins" . SPARSER::PROTEIN)
    ("a viral GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("verteporfin" . SPARSER::DRUG) ("cancer-associated Gα" . SPARSER::PROTEIN)
    ("TRIO–RAC" . SPARSER::COLLECTION) ("–RHO" . SPARSER::COLLECTION)
    ("TRIO" . SPARSER::PROTEIN) ("Gα" . SPARSER::PROTEIN)
    ("GNAQ or GNA11" . SPARSER::COLLECTION) ("GNAQ" . SPARSER::PROTEIN)
    ("GPCRs and G proteins" . SPARSER::COLLECTION)
    ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homologue (SCRIB)" . SPARSER::PROTEIN)
    ("MST and LATS" . SPARSER::COLLECTION) ("SCRIB" . SPARSER::DRUG)
    ("scribble" . SPARSER::PROTEIN) ("Merlin" . SPARSER::PROTEIN)
    ("mature mi RNAs" . SPARSER::RNA) ("receptor (LIFR)" . SPARSER::RECEPTOR)
    ("LIFR" . SPARSER::PROTEIN) ("MST" . SPARSER::PROTEIN)
    ("hetero trimeric G proteins" . SPARSER::PROTEIN)
    ("a unique extracellular ligand" . SPARSER::LIGAND)
    ("AMOT" . SPARSER::PROTEIN) ("Angiomotin" . SPARSER::PROTEIN)
    ("LATS" . SPARSER::PROTEIN) ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cysteine-rich angiogenic inducer" . SPARSER::PROTEIN)
    ("secretory proteins" . SPARSER::PROTEIN)
    ("an integral part and a nexus" . SPARSER::COLLECTION)
    ("especially G protein-coupled receptors" . SPARSER::RECEPTOR)
    ("tumour suppressors and those" . SPARSER::COLLECTION)
    ("yes-associated protein (YAP) and transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("the large tumour suppressor 1 (LATS1) and LATS2" . SPARSER::COLLECTION)
    ("REF" . SPARSER::PROTEIN)
    ("Yes-associated protein (YAP) and transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("Yes-associated protein (YAP)" . SPARSER::PROTEIN)
    ("LIM domain-containing protein AJUBA" . SPARSER::PROTEIN)
    ("TEAD4" . SPARSER::PROTEIN) ("family member 4" . SPARSER::PROTEIN)
    ("G17" . SPARSER::PROTEIN) ("TP53I3" . SPARSER::PROTEIN)
    ("PIG3" . SPARSER::PROTEIN) ("TP73" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("ABL1 tyrosine kinase" . SPARSER::PROTEIN)
    ("βTRCP" . SPARSER::PROTEIN)
    ("baculoviral IAP repeat-containing protein 5" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("GNA11" . SPARSER::PROTEIN) ("Liver kinase B1" . SPARSER::PROTEIN)
    ("Nf2" . SPARSER::PROTEIN) ("NF2" . SPARSER::PROTEIN)
    ("neurofibromin 2" . SPARSER::PROTEIN) ("tissue type" . SPARSER::PROTEIN)
    ("DDX17" . SPARSER::PROTEIN) ("Gα i" . SPARSER::PROTEIN)
    ("CYR61" . SPARSER::PROTEIN) ("STK3" . SPARSER::PROTEIN)
    ("STK4" . SPARSER::PROTEIN) ("STE20" . SPARSER::PROTEIN)
    ("NICD or PIP" . SPARSER::COLLECTION) ("AR and PIP" . SPARSER::COLLECTION)
    ("FAK, ERK and Akt" . SPARSER::COLLECTION)
    ("HER2 or PIP" . SPARSER::COLLECTION)
    ("Hey1 and Hey1L" . SPARSER::COLLECTION) ("Neu " . SPARSER::PROTEIN)
    ("Py" . SPARSER::MOLECULE) ("Dlk1 or Notch1" . SPARSER::COLLECTION)
    ("NICD and PIP" . SPARSER::COLLECTION)
    ("PIP and Abp" . SPARSER::COLLECTION) ("PIP/GCDFP15" . SPARSER::COLLECTION)
    ("the androgen-binding proteins [ xref ] and PIP [ xref ]"
     . SPARSER::COLLECTION)
    ("Mastermind" . SPARSER::PROTEIN-FAMILY)
    ("Postn or NICD" . SPARSER::COLLECTION) ("Dlk1" . SPARSER::PROTEIN)
    ("Dlk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FAK and Akt" . SPARSER::COLLECTION)
    ("MMTV-Neu-NDL" . SPARSER::COLLECTION) ("NeuNDL" . SPARSER::PROTEIN)
    ("NeuNDL-Postn" . SPARSER::PROTEIN-PAIR) ("dpc" . SPARSER::MOLECULE)
    ("Notch1 or PIP" . SPARSER::COLLECTION) ("PyMT" . SPARSER::PROTEIN)
    ("AR and prolactin-induced protein" . SPARSER::COLLECTION)
    ("MMTV-PyMT" . SPARSER::COLLECTION) ("MMTV-Neu" . SPARSER::COLLECTION)
    ("NDL" . SPARSER::PROTEIN)
    ("collagen, fibronectin, tenascin-C, and Postn" . SPARSER::COLLECTION)
    ("ErbB-2/Neu" . SPARSER::COLLECTION) ("HER3/ErbB3" . SPARSER::COLLECTION)
    ("periostin" . SPARSER::PROTEIN) ("PIP/GCDFP-15" . SPARSER::COLLECTION)
    ("androgen receptor (AR) and AR target genes" . SPARSER::COLLECTION)
    ("protein and Hey1" . SPARSER::COLLECTION) ("-Neu" . SPARSER::COLLECTION)
    ("Postn" . SPARSER::PROTEIN) ("Periostin" . SPARSER::PROTEIN)
    ("GCDFP15" . SPARSER::PROTEIN) ("C-G" . SPARSER::PROTEIN)
    ("1L" . SPARSER::PROTEIN) ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta catenin" . SPARSER::PROTEIN) ("MAML1" . SPARSER::PROTEIN)
    ("– 3" . SPARSER::PROTEIN) ("α v β 5" . SPARSER::PROTEIN)
    ("α v β 3" . SPARSER::PROTEIN) ("tenascin-C" . SPARSER::PROTEIN)
    ("OSF-2" . SPARSER::PROTEIN)
    ("osteoblast-specific factor-2" . SPARSER::PROTEIN)
    ("GCDFP-15" . SPARSER::PROTEIN)
    ("prolactin-induced protein" . SPARSER::PROTEIN)
    ("c-Met-" . SPARSER::PROTEIN) ("HGF and a ligand" . SPARSER::COLLECTION)
    ("a fully human monoclonal antibody" . SPARSER::DRUG)
    ("pT1 and pT2–4" . SPARSER::COLLECTION) ("Antagonists" . SPARSER::MOLECULE)
    ("HGF or c-Met" . SPARSER::COLLECTION) ("INF" . SPARSER::PROTEIN)
    ("HGF and its receptor" . SPARSER::COLLECTION)
    ("HGF/c-Met" . SPARSER::COLLECTION) ("pT1" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("Akt/GSK3β" . SPARSER::COLLECTION) ("cAMP" . SPARSER::CAMP)
    ("different growth factors or their receptors" . SPARSER::COLLECTION)
    ("AP-1, NF-κB, and β-catenin" . SPARSER::COLLECTION)
    ("proteins and cyclin D1" . SPARSER::COLLECTION)
    ("a multifunctional oncoprotein" . SPARSER::PROTEIN)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-x" . SPARSER::COLLECTION)
    ("Fas, FasL, and caspase-3" . SPARSER::COLLECTION)
    ("cell cycle-associated genes as well as IFN-γ in IL-18-overexpressed CRL1623 cells"
     . SPARSER::COLLECTION)
    ("cell cycle-associated genes" . SPARSER::GENE)
    ("kenpaullone (KP)" . SPARSER::DRUG) ("KP" . SPARSER::PROTEIN)
    ("GSK-3β and p-GSK-3β proteins" . SPARSER::COLLECTION)
    ("p-GSK-3β" . SPARSER::COLLECTION) ("caspase-" . SPARSER::PROTEIN)
    ("IFN-γ and cytochrome c" . SPARSER::COLLECTION)
    ("apoptosis-associated genes" . SPARSER::GENE)
    ("-IL-18" . SPARSER::COLLECTION)
    ("promoter or tumor" . SPARSER::COLLECTION)
    ("GSK-3, GSK-3α and GSK-3β" . SPARSER::COLLECTION)
    ("ccL21" . SPARSER::PROTEIN) ("ccL" . SPARSER::DRUG)
    ("a pleiotropic proinflammatory cytokine" . SPARSER::PROTEIN)
    ("IGIF" . SPARSER::PROTEIN) ("kenpaullone" . SPARSER::DRUG)
    ("flow cytometric Annexin V/propidium iodide (PI)" . SPARSER::PROTEIN)
    ("CRL" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BDE-99" . SPARSER::DRUG)
    ("CRM1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("E2F-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl-x" . SPARSER::PROTEIN)
    ("hMSH2" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("cyclin A1" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("ccr7" . SPARSER::PROTEIN) ("tumor antigen" . SPARSER::DRUG)
    ("Interleukin-18" . SPARSER::PROTEIN) ("phosphorylase" . SPARSER::PROTEIN)
    ("Biomarker" . SPARSER::MOLECULE) ("FAS" . SPARSER::PROTEIN)
    ("erlotinib and capecitabine" . SPARSER::COLLECTION)
    ("thymidine phosphorylase, thymidylate synthase, and dihydropyrimidine dehydrogenase"
     . SPARSER::COLLECTION)
    ("thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, and orotate"
     . SPARSER::COLLECTION)
    ("an Eastern Cooperative Oncology Group (ECOG) PS" . SPARSER::PROTEIN)
    ("Group (ECOG)" . SPARSER::MOLECULE) ("DCR" . SPARSER::PROTEIN)
    ("PRs" . SPARSER::PROTEIN)
    ("capecitabine and erlotinib" . SPARSER::COLLECTION)
    ("orotate" . SPARSER::MOLECULE) ("prodrug" . SPARSER::DRUG)
    ("purine and pyrimidine" . SPARSER::COLLECTION)
    ("Capecitabine" . SPARSER::DRUG) ("antifolate" . SPARSER::MOLECULE)
    ("Pemetrexed" . SPARSER::DRUG)
    ("antifolates and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("PS " . SPARSER::PROTEIN) ("PS" . SPARSER::PROTEIN)
    ("EGFR and K-ras" . SPARSER::COLLECTION)
    ("Erlotinib (150 mg/day) and capecitabine (1000 mg/m2 twice daily on days 1–14)"
     . SPARSER::COLLECTION)
    ("antifolates" . SPARSER::MOLECULE)
    ("Thymidine phosphorylase" . SPARSER::PROTEIN)
    ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("Dihydropyrimidine Dehydrogenase" . SPARSER::PROTEIN)
    ("Thymidine Phosphorylase" . SPARSER::PROTEIN)
    ("Thymidylate Synthase" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("dihydropyrimidine dehydrogenase" . SPARSER::PROTEIN)
    ("thymidylate synthase" . SPARSER::PROTEIN)
    ("thymidine phosphorylase" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("m2" . SPARSER::MOLECULE) ("PI3K/AKT/mTORC" . SPARSER::COLLECTION)
    ("AKT and mTORC1" . SPARSER::COLLECTION) ("p-p70S6" . SPARSER::COLLECTION)
    ("p-4EBP1" . SPARSER::COLLECTION) ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("maritoclax" . SPARSER::DRUG) ("obatoclax" . SPARSER::DRUG)
    ("delta" . SPARSER::PROTEIN)
    ("acute ABT-199 treatment MCL-1" . SPARSER::PROTEIN)
    ("BCL-2 and BAX" . SPARSER::COLLECTION)
    ("an essential cellular protein" . SPARSER::PROTEIN)
    ("Navitoclax" . SPARSER::DRUG) ("RAD001 and GS-1101" . SPARSER::COLLECTION)
    ("PI3K δ and mTORC1" . SPARSER::COLLECTION)
    ("GS-1101 and RAD001" . SPARSER::COLLECTION)
    ("PI3K or mTOR" . SPARSER::COLLECTION) ("NOXA/MCL-1" . SPARSER::COLLECTION)
    ("BIM/MCL-1" . SPARSER::COLLECTION) ("Bax and Bak" . SPARSER::COLLECTION)
    ("ABT-199 and NVP-BEZ235" . SPARSER::COLLECTION)
    ("BIM and NOXA" . SPARSER::COLLECTION)
    ("MCL-1 or BCL-xL and BIM" . SPARSER::COLLECTION)
    ("BCL-xL and BIM" . SPARSER::COLLECTION)
    ("AKT and p-70S6 kinase" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-xL" . SPARSER::COLLECTION)
    ("ABT-199 (400 nM) and NVP-BEZ235 (40 nM)" . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("clinically relevant pharmacological inhibitors" . SPARSER::INHIBITOR)
    ("Annexin V-PI" . SPARSER::COLLECTION)
    ("the respective siRNAs" . SPARSER::PROTEIN)
    ("MCL-1, BCL-xL, and AKT" . SPARSER::COLLECTION)
    ("BCL-2, MCL-1, and BCL-xL" . SPARSER::COLLECTION)
    ("ABT" . SPARSER::MOLECULE)
    ("MCL-1, BCL-xL, and BCL-2" . SPARSER::COLLECTION)
    ("Mcl-1 , Bcl-xL , and Bcl-2" . SPARSER::COLLECTION)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("acute ABT-199" . SPARSER::DRUG)
    ("BCL-xL, BCL-2, and BIM" . SPARSER::COLLECTION)
    ("BIM, NOXA, and PUMA" . SPARSER::COLLECTION)
    ("MCL-1, and BCL-xL" . SPARSER::COLLECTION) ("OCL" . SPARSER::MOLECULE)
    ("the most effective chemotherapeutic drugs" . SPARSER::DRUG)
    ("BCL-xL and MCL-1" . SPARSER::COLLECTION)
    ("navitoclax or ABT-263" . SPARSER::COLLECTION)
    ("BCL-2, BCL-xL, and BCL-w" . SPARSER::COLLECTION)
    ("MCL-1 and BFL-1" . SPARSER::COLLECTION) ("BAX/BAK" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("mTOR, GSK3, FOXO, and NF- κ B" . SPARSER::COLLECTION)
    ("BCL-2, BCL-xL, MCL-1, BFL-1, and BCL-w" . SPARSER::COLLECTION)
    ("BIM, BID, PUMA, and NOXA" . SPARSER::COLLECTION)
    ("BAX and BAK" . SPARSER::COLLECTION) ("BAK" . SPARSER::PROTEIN)
    ("AKT, MCL-1, and BCL-xL" . SPARSER::COLLECTION)
    ("idelalisib" . SPARSER::DRUG)
    ("a dual inhibitor of p-AKT and mTOR" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("PI3K, AKT, and mTOR" . SPARSER::COLLECTION)
    ("NVP-BEZ235 and GS-1101" . SPARSER::COLLECTION)
    ("navitoclax" . SPARSER::DRUG) ("MCL-1 and BCL-xL" . SPARSER::COLLECTION)
    ("β -actin" . SPARSER::PROTEIN) ("S6 Kinase" . SPARSER::PROTEIN-FAMILY)
    ("Mec-2" . SPARSER::PROTEIN) ("UMI-77" . SPARSER::DRUG)
    ("GSK3- β" . SPARSER::PROTEIN) ("4-EBP1" . SPARSER::PROTEIN)
    ("p-70" . SPARSER::PROTEIN) ("BEZ235" . SPARSER::DRUG)
    ("BH3-only protein" . SPARSER::PROTEIN) ("ABT-737-" . SPARSER::DRUG)
    ("ABT-263" . SPARSER::DRUG) ("BFL-1" . SPARSER::PROTEIN)
    ("NF- κ B" . SPARSER::PROTEIN) ("PI3K δ" . SPARSER::PROTEIN)
    ("GS-1101" . SPARSER::DRUG) ("NVP-BEZ235" . SPARSER::DRUG)
    ("ABT199" . SPARSER::DRUG) ("Akt and eIF2" . SPARSER::COLLECTION)
    ("GCN2-ATF4" . SPARSER::COLLECTION) ("asparaginase" . SPARSER::PROTEIN)
    ("S6K-IRS1" . SPARSER::COLLECTION)
    ("rapamycin and H 2 O 2" . SPARSER::COLLECTION) ("Akti" . SPARSER::PROTEIN)
    ("MEFs or HT1080" . SPARSER::COLLECTION)
    ("H 2 O 2 or pro-oxidant" . SPARSER::COLLECTION)
    ("isothiocyanate (PEITC)" . SPARSER::MOLECULE)
    ("antioxidant and pro" . SPARSER::COLLECTION) ("erastin" . SPARSER::DRUG)
    ("PEITC" . SPARSER::DRUG) ("isothiocyanate" . SPARSER::MOLECULE)
    ("PAO" . SPARSER::PROTEIN) ("isogenic MEFs" . SPARSER::PROTEIN)
    ("Akt and eIF" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("ATF4 and ATF5" . SPARSER::COLLECTION) ("PEK" . SPARSER::PROTEIN)
    ("globin" . SPARSER::PROTEIN) ("heme" . SPARSER::PROTEIN)
    ("HRI" . SPARSER::PROTEIN) ("mTORC2-Akt" . SPARSER::COLLECTION)
    ("PERK and GCN2" . SPARSER::COLLECTION) ("PERK" . SPARSER::PROTEIN)
    ("eIF2" . SPARSER::PROTEIN) ("1–1 " . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("Akt3" . SPARSER::PROTEIN)
    ("Akt 1" . SPARSER::PROTEIN) ("S6 kinases" . SPARSER::PROTEIN-FAMILY)
    ("GDC-0941" . SPARSER::DRUG) ("PI3K-Akt" . SPARSER::PROTEIN)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN) ("ATF5" . SPARSER::PROTEIN)
    ("activating transcription factor 4" . SPARSER::PROTEIN)
    ("heme-regulated inhibitor" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("ATF4" . SPARSER::PROTEIN)
    ("GCN2" . SPARSER::PROTEIN)
    ("cardiac fetal contractile genes" . SPARSER::GENE)
    ("Nox2 or Nox1" . SPARSER::COLLECTION)
    ("Nox2, Nox1 and Nox3" . SPARSER::COLLECTION)
    ("cardiac-specific Nox4" . SPARSER::PROTEIN)
    ("particularly mTORC1 complex" . SPARSER::BIO-COMPLEX)
    ("Nox4 or Nox4-derived ROS" . SPARSER::COLLECTION)
    ("Akt-mTOR-NFκB" . SPARSER::COLLECTION)
    ("NFκB and mTOR" . SPARSER::COLLECTION)
    ("complex (IKK)" . SPARSER::BIO-COMPLEX)
    ("IKKα, IKKβ, and IKKγ" . SPARSER::COLLECTION)
    ("an inactive dimeric complex" . SPARSER::BIO-COMPLEX)
    ("p65 and p50" . SPARSER::COLLECTION) ("mTOR/S6K" . SPARSER::COLLECTION)
    ("4EBP1 and S6 ribosomal protein" . SPARSER::COLLECTION)
    ("LVs" . SPARSER::MOLECULE) ("CArG" . SPARSER::PROTEIN)
    ("many immediate-early genes" . SPARSER::GENE)
    ("the group of proteins or signaling intermediates" . SPARSER::COLLECTION)
    ("vasoactive agonists" . SPARSER::AGONIST)
    ("phenylephrine" . SPARSER::DRUG) ("fetal genes" . SPARSER::GENE)
    ("Akt/mTOR" . SPARSER::COLLECTION)
    ("LV and cardiomyocyte" . SPARSER::COLLECTION)
    ("profibrotic cytokines" . SPARSER::PROTEIN)
    ("FN, TGF-β, ANP and tropomyosin" . SPARSER::COLLECTION)
    ("bot" . SPARSER::PROTEIN) ("S6K and 4EBP1" . SPARSER::COLLECTION)
    ("the fetal cardiac genes and an essential component of a molecular switch"
     . SPARSER::COLLECTION)
    ("fetal contractile genes" . SPARSER::GENE)
    ("the fetal cardiac genes" . SPARSER::GENE)
    ("Myocardin" . SPARSER::PROTEIN)
    ("hypertrophic markers ANP, tropomyosin and myocardin"
     . SPARSER::COLLECTION)
    ("ANP, tropomyosin and myocardin" . SPARSER::COLLECTION)
    ("fibrotic markers FN and TGF-β1" . SPARSER::COLLECTION)
    ("FN and TGF-β1" . SPARSER::COLLECTION)
    ("Nox4 and Nox1" . SPARSER::COLLECTION)
    ("S6K and 4EBP-1" . SPARSER::COLLECTION)
    ("S6 kinase and 4EBP-1" . SPARSER::COLLECTION)
    ("Akt/mTOR/NFκB" . SPARSER::COLLECTION)
    ("beta myosin heavy chain (MyH7 or βMHC) and tropomyosin"
     . SPARSER::COLLECTION)
    ("atrial natriuretic peptide (ANP), myocardin, beta myosin heavy chain (MyH7 or βMHC) and tropomyosin"
     . SPARSER::COLLECTION)
    ("atrial natriuretic peptide (ANP)" . SPARSER::PROTEIN)
    ("MyH7 or βMHC" . SPARSER::COLLECTION)
    ("transgene or AngII" . SPARSER::COLLECTION)
    ("tropomyosin" . SPARSER::PROTEIN) ("myocardin" . SPARSER::PROTEIN)
    ("ANP" . SPARSER::PROTEIN)
    ("autocrine cytokines and growth factors" . SPARSER::COLLECTION)
    ("FN, TGF-β1 or cytokines/growth factors" . SPARSER::COLLECTION)
    ("TGF-β1 and CTGF" . SPARSER::COLLECTION)
    ("transforming growth factor-beta1 (TGF-β1) and connective tissue growth factor (CTGF) mRNAs"
     . SPARSER::COLLECTION)
    ("the fibrotic cytokines, transforming growth factor-beta1 (TGF-β1) and connective tissue growth factor (CTGF) mRNAs"
     . SPARSER::COLLECTION)
    ("the fibrotic cytokines" . SPARSER::PROTEIN) ("DHE" . SPARSER::DRUG)
    ("Nox4 and AngII" . SPARSER::COLLECTION)
    ("Nox2 and Nox3" . SPARSER::COLLECTION)
    ("a rabbit monoclonal IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mouse endogenous Nox4 (induced by AngII) and the human Nox4"
     . SPARSER::COLLECTION)
    ("LV" . SPARSER::MOLECULE) ("CTL and Tg" . SPARSER::COLLECTION)
    ("angiotensin" . SPARSER::PROTEIN) ("renin" . SPARSER::PROTEIN)
    ("Nox2" . SPARSER::PROTEIN) ("electrons" . SPARSER::MOLECULE)
    ("Duox1, and Duox2" . SPARSER::COLLECTION) ("Nox1" . SPARSER::PROTEIN)
    ("Duox" . SPARSER::PROTEIN)
    ("hNox4 transgene and/or AngII-infusion" . SPARSER::COLLECTION)
    ("cardiac fetal genes" . SPARSER::GENE)
    ("Akt-mTOR and NFκB" . SPARSER::COLLECTION)
    ("Nox4 and Nox4" . SPARSER::COLLECTION)
    ("toll like receptor-4" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("IKKα" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("serum response factor" . SPARSER::PROTEIN) ("GKT 137831" . SPARSER::DRUG)
    ("endothelin-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("4EBP-1" . SPARSER::PROTEIN) ("MyH7" . SPARSER::PROTEIN)
    ("natriuretic peptide" . SPARSER::PROTEIN)
    ("transforming growth factor-beta1" . SPARSER::PROTEIN)
    ("Nox3" . SPARSER::PROTEIN) ("p22phox" . SPARSER::PROTEIN)
    ("histone deacetylase 4" . SPARSER::PROTEIN) ("Duox2" . SPARSER::PROTEIN)
    ("angiotensin II" . SPARSER::PROTEIN) ("predate" . SPARSER::DRUG)
    ("EGF, HBEGF, and TGFA" . SPARSER::COLLECTION)
    ("HBEGF, EGF, TGFA, BTC, and EREG" . SPARSER::COLLECTION)
    ("HBEGF, TGFA and EGF" . SPARSER::COLLECTION)
    ("other truncated isoforms of the EGFR produced by alternate mRNA splicing or proteolytic cleavage of the full-length receptor [ xref ]"
     . SPARSER::COLLECTION)
    ("alternate mRNA" . SPARSER::PROTEIN)
    ("glycosylphosphatidylinositol" . SPARSER::MOLECULE)
    ("BTC and EREG" . SPARSER::COLLECTION)
    ("HBEGF, EGF and TGFA" . SPARSER::COLLECTION)
    ("AREG and BTC" . SPARSER::COLLECTION)
    ("TGFA and EGF" . SPARSER::COLLECTION)
    ("growth factors, HBEGF, EGF, TGFA, EREG or BTC" . SPARSER::COLLECTION)
    ("P110/EGFR" . SPARSER::COLLECTION) ("ERBB1/EGFR" . SPARSER::COLLECTION)
    ("BTC, AREG and EREG" . SPARSER::COLLECTION)
    ("HBEGF and TGFA" . SPARSER::COLLECTION)
    ("EGF, TGFA, HBEGF, AREG, EREG and BTC" . SPARSER::COLLECTION)
    ("neuregulin/heregulin" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN)
    ("amphiregulin (AREG) and epiregulin (EREG) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("betacellulin (BTC), amphiregulin (AREG) and epiregulin (EREG) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("epiregulin (EREG)" . SPARSER::PROTEIN)
    ("EGF, TGFA and HBEGF" . SPARSER::COLLECTION) ("EREG" . SPARSER::PROTEIN)
    ("AREG" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("BTC" . SPARSER::PROTEIN) ("/ERBB" . SPARSER::COLLECTION)
    ("EGF and related proteins" . SPARSER::COLLECTION)
    ("proteinuria" . SPARSER::PROTEIN)
    ("HBEGF, EGF, TGFA, epiregulin, and betacellulin" . SPARSER::COLLECTION)
    ("betacellulin" . SPARSER::PROTEIN) ("epiregulin" . SPARSER::PROTEIN)
    ("HBEGF, TGFA, and EGF" . SPARSER::COLLECTION)
    ("PTL and SGA" . SPARSER::COLLECTION) ("HTR-8" . SPARSER::PROTEIN)
    ("growth factor (HBEGF)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HBEGF" . SPARSER::PROTEIN) ("heparin" . SPARSER::PROTEIN)
    ("p110/EGFR" . SPARSER::COLLECTION) ("fetuses" . SPARSER::PROTEIN)
    ("PTL" . SPARSER::PROTEIN) ("heparan sulfate" . SPARSER::MOLECULE)
    ("5–2" . SPARSER::PROTEIN) ("KRT7" . SPARSER::PROTEIN)
    ("cytokeratin-7" . SPARSER::PROTEIN) ("P110" . SPARSER::PROTEIN)
    ("H/R" . SPARSER::PROTEIN) ("ERBB4" . SPARSER::PROTEIN)
    ("p110" . SPARSER::PROTEIN)
    ("very few telomere-associated SSB1" . SPARSER::PROTEIN)
    ("TERT, and SSB1" . SPARSER::COLLECTION)
    ("telomere-associated SSB1" . SPARSER::PROTEIN)
    ("TRF1, TRF2, TIN2, Rap1, TPP1, and POT1" . SPARSER::COLLECTION)
    ("hSSB1 and mSsb1" . SPARSER::COLLECTION)
    ("SSB1/TERT" . SPARSER::COLLECTION) ("TRAP" . SPARSER::PROTEIN)
    ("RAD51 or MRE11" . SPARSER::COLLECTION)
    ("hTERT or Ku80" . SPARSER::COLLECTION)
    ("RAD51, hSSB1, MRE11 and hTERT" . SPARSER::COLLECTION)
    ("RAD51, hSSB1, MRE11 and KU80" . SPARSER::COLLECTION)
    ("pecific antibodies" . SPARSER::ANTIBODY)
    ("KU80, and hTERT" . SPARSER::COLLECTION) ("l-Scel" . SPARSER::COLLECTION)
    ("Scel" . SPARSER::PROTEIN) ("thymidine" . SPARSER::PROTEIN)
    ("cellular TRF1" . SPARSER::PROTEIN)
    ("hSSB1 and either TRF1 or TRF2 ( xref )" . SPARSER::COLLECTION)
    ("homodimeric TRF1 and TRF2" . SPARSER::COLLECTION)
    ("SSB1 and TERT" . SPARSER::COLLECTION)
    ("TERT and SSB1" . SPARSER::COLLECTION)
    ("POT1 ( xref ) or TPP1 ( xref )" . SPARSER::COLLECTION)
    ("POT1-TPP1" . SPARSER::COLLECTION) ("hSSB1/hTERT" . SPARSER::COLLECTION)
    ("telomere-associated hTERT" . SPARSER::PROTEIN)
    ("ΔOB-hSSB1" . SPARSER::COLLECTION)
    ("hTERT and hSSB1" . SPARSER::COLLECTION)
    ("telomere-associated hSSB1" . SPARSER::PROTEIN)
    ("hSSB1 or hTERT" . SPARSER::COLLECTION)
    ("hSSB1 and hTERT" . SPARSER::COLLECTION)
    ("GFP-hSSB1" . SPARSER::COLLECTION)
    ("SSB1 and hTERT" . SPARSER::COLLECTION)
    ("Flag-hTERT" . SPARSER::COLLECTION)
    ("conditional deletion mutant" . SPARSER::MUTANT)
    ("TRF1 or TRF2" . SPARSER::COLLECTION) ("Cre-ERT2" . SPARSER::COLLECTION)
    ("the adjacent adenine" . SPARSER::NUCLEOBASE)
    ("C-rich telomeric oligonucleotides (AATCCC) or GC duplex oligonucleotides ( xref )"
     . SPARSER::COLLECTION)
    ("GC duplex oligonucleotides" . SPARSER::MOLECULE)
    ("C-rich telomeric oligonucleotides (AATCCC)" . SPARSER::MOLECULE)
    ("single-stranded G-rich telomeric oligonucleotides (TTAGGG)"
     . SPARSER::MOLECULE)
    ("the larger adenine" . SPARSER::NUCLEOBASE)
    ("the protein’s" . SPARSER::PROTEIN)
    ("aromatic amino acids" . SPARSER::AMINO-ACID)
    ("only two DNA" . SPARSER::DNA) ("GT" . SPARSER::PROTEIN)
    ("RPA and ATR" . SPARSER::COLLECTION)
    ("telomeric ssDNA" . SPARSER::PROTEIN) ("Ssb1" . SPARSER::PROTEIN)
    ("Ssb" . SPARSER::PROTEIN) ("SSB1 and SSB2" . SPARSER::COLLECTION)
    ("the integrator complex subunit 3 (INTS3) and C9orf80"
     . SPARSER::COLLECTION)
    ("a heterotrimeric protein complex" . SPARSER::BIO-COMPLEX)
    ("hSSB1 and hSSB2" . SPARSER::COLLECTION)
    ("NABP2 and NABP1" . SPARSER::COLLECTION) ("orf" . SPARSER::PROTEIN)
    ("several DNA repair-associated proteins" . SPARSER::PROTEIN)
    ("OB" . SPARSER::PROTEIN) ("oligosaccharide" . SPARSER::MOLECULE)
    ("a unique ribonuleoprotien enzyme" . SPARSER::ENZYME)
    ("TR or TERC" . SPARSER::COLLECTION)
    ("TPP1 and POT1" . SPARSER::COLLECTION) ("interstitial DNA" . SPARSER::DNA)
    ("TIN2, TPP1 and Rap1" . SPARSER::COLLECTION)
    ("TRF1, TRF2, and POT1" . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("shelterin" . SPARSER::PROTEIN)
    ("SSB1-TERT" . SPARSER::COLLECTION) ("Est1" . SPARSER::PROTEIN)
    ("Cdc13" . SPARSER::PROTEIN) ("Sae2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("l −1" . SPARSER::PROTEIN) ("Telomerase activity" . SPARSER::PROTEIN)
    ("ERT2" . SPARSER::PROTEIN) ("Pot1" . SPARSER::PROTEIN)
    ("SSB2" . SPARSER::PROTEIN) ("INTS3" . SPARSER::PROTEIN)
    ("integrator complex subunit 3" . SPARSER::PROTEIN)
    ("NABP1" . SPARSER::PROTEIN) ("NABP2" . SPARSER::PROTEIN)
    ("hSSB2" . SPARSER::PROTEIN) ("hSSB1" . SPARSER::PROTEIN)
    ("single-stranded DNA binding protein 1" . SPARSER::PROTEIN)
    ("functional RNA" . SPARSER::RNA) ("Rap1" . SPARSER::PROTEIN)
    ("TPP1" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("POT1" . SPARSER::PROTEIN) ("SSB1" . SPARSER::PROTEIN)
    ("single-stranded DNA binding protein" . SPARSER::PROTEIN)
    ("Cho" . SPARSER::PROTEIN)
    ("glutathione, thioredoxin and non-protein" . SPARSER::COLLECTION)
    ("thioredoxin" . SPARSER::PROTEIN)
    ("Nrf2 and its downstream genes" . SPARSER::COLLECTION)
    ("Nfr2" . SPARSER::PROTEIN) ("pathological states" . SPARSER::BIO-STATE)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the kelch-like ECH-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("a basic redox-sensitive bZIP transcription factor" . SPARSER::PROTEIN)
    ("anti-oxidant response element (ARE)"
     . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("erythroid-2" . SPARSER::COLLECTION) ("erythroid" . SPARSER::PROTEIN)
    ("cul3" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("anti-oxidant response element" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("anti-oxidants" . SPARSER::DRUG) ("factor 2" . SPARSER::PROTEIN)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("PHA-665752 (a highly specific c-Met inhibitor) or down-regulating c-Met expression with siRNA [ xref ]"
     . SPARSER::COLLECTION)
    ("c-Met and HGF" . SPARSER::COLLECTION) ("ERBB" . SPARSER::PROTEIN)
    ("MetMab" . SPARSER::DRUG) ("taxol and cisplatin" . SPARSER::COLLECTION)
    ("nimotuzumab" . SPARSER::DRUG) ("TP" . SPARSER::PROTEIN)
    ("taxol" . SPARSER::DRUG) ("HR " . SPARSER::PROTEIN)
    ("HGF and c-Met" . SPARSER::COLLECTION)
    ("cancer-associated receptors" . SPARSER::PROTEIN)
    ("DDP" . SPARSER::PROTEIN) ("PHA-665752" . SPARSER::DRUG)
    ("ERBB3" . SPARSER::PROTEIN) ("c-Met" . SPARSER::PROTEIN)
    ("late gene promoters" . SPARSER::PROMOTER)
    ("only intronless viral mRNAs" . SPARSER::PROTEIN)
    ("intronless viral mRNA" . SPARSER::PROTEIN)
    ("bimodal regulator" . SPARSER::REGULATOR)
    ("that Pin1’s" . SPARSER::PROTEIN) ("juglone" . SPARSER::DRUG)
    ("posttranscriptional elongation and cellular factor-dependent viral pre-mRNA"
     . SPARSER::COLLECTION)
    ("cellular factor-dependent viral pre-mRNA" . SPARSER::RNA)
    ("posttranscriptional elongation" . SPARSER::PROTEIN)
    ("well-studied promoter markers nut-1" . SPARSER::PROTEIN)
    ("vGPCR or vIL-6" . SPARSER::COLLECTION)
    ("RNAP II transcriptional elongation" . SPARSER::PROTEIN)
    ("hSpt5 and Rta" . SPARSER::COLLECTION) ("hSpt5" . SPARSER::PROTEIN)
    ("p53, c-Jun, Nanog and Akt" . SPARSER::COLLECTION)
    ("The most applicable examples" . SPARSER::EXAMPLE)
    ("Pin1 and Rta" . SPARSER::COLLECTION)
    ("polymerase (RNAP)" . SPARSER::PROTEIN) ("RNAP" . SPARSER::PROTEIN)
    ("transcriptional elongation" . SPARSER::PROTEIN)
    ("VHL" . SPARSER::PROTEIN)
    ("transcription factor and Pin1" . SPARSER::COLLECTION)
    ("the viral allele" . SPARSER::ALLELE)
    ("two viral promoters" . SPARSER::PROMOTER)
    ("the essential Rta cofactor" . SPARSER::MOLECULE)
    ("T-P" . SPARSER::PROTEIN)
    ("cellular isomerase Pin1 and KSHV lytic switch Rta" . SPARSER::COLLECTION)
    ("TAF" . SPARSER::PROTEIN) ("Rta and PPIase Pin1" . SPARSER::COLLECTION)
    ("the viral DNA polymerase" . SPARSER::PROTEIN)
    ("Pin1 and other mitotic substrates [ xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("other mitotic substrates" . SPARSER::SUBSTRATE)
    ("kinesin or myosin" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cellular PKC" . SPARSER::PROTEIN)
    ("viral nonstructural proteins NS5A and NS5B" . SPARSER::COLLECTION)
    ("NS5A and NS5B" . SPARSER::COLLECTION) ("integrase" . SPARSER::PROTEIN)
    ("substrates and pathways" . SPARSER::COLLECTION)
    ("a truly pleiotropic enzyme" . SPARSER::ENZYME)
    ("kinase or phosphatase" . SPARSER::COLLECTION)
    ("serines and threonines" . SPARSER::COLLECTION)
    ("threonines" . SPARSER::AMINO-ACID) ("serines" . SPARSER::AMINO-ACID)
    ("the essential mitotic kinase" . SPARSER::KINASE)
    ("NIMA" . SPARSER::PROTEIN-FAMILY)
    ("ryanodine and inositol 1,4,5-triphosphate" . SPARSER::COLLECTION)
    ("ryanodine" . SPARSER::PROTEIN) ("Cyps and FKBPs" . SPARSER::COLLECTION)
    ("FK506 and rapamycin" . SPARSER::COLLECTION)
    ("cyclosporine" . SPARSER::DRUG) ("activator (PTPA)" . SPARSER::ACTIVATOR)
    ("PTPA" . SPARSER::PROTEIN) ("Cyps" . SPARSER::PROTEIN)
    ("cyclophilins" . SPARSER::PROTEIN)
    ("Peptidyl-prolyl" . SPARSER::PROTEIN-PAIR)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("isomerases" . SPARSER::ISOMERASE)
    ("palindromic CANT DNA" . SPARSER::DNA)
    ("essential cofactors" . SPARSER::PROTEIN)
    ("determining Rta’s" . SPARSER::PROTEIN)
    ("Rta-L3P" . SPARSER::PROTEIN-PAIR) ("LZ" . SPARSER::PROTEIN)
    ("prolines" . SPARSER::AMINO-ACID) ("leucines" . SPARSER::AMINO-ACID)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("RBP-Jk and promoter" . SPARSER::COLLECTION)
    ("neither EBNA2 nor NICD" . SPARSER::COLLECTION)
    ("EBNA2 and NICD" . SPARSER::COLLECTION) ("BTD" . SPARSER::PROTEIN)
    ("the NICD and use RBP-Jk" . SPARSER::COLLECTION)
    ("Rta-" . SPARSER::PROTEIN)
    ("both proteins as well as target promoters [ xref , xref , xref , xref , xref , xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("34 Rta transcriptionally-activated viral genes" . SPARSER::GENE)
    ("Rta-RBP-Jk" . SPARSER::COLLECTION)
    ("downstream viral and cellular genes" . SPARSER::GENE)
    ("Hey and Hes" . SPARSER::COLLECTION) ("Hes" . SPARSER::PROTEIN)
    ("Hey" . SPARSER::PROTEIN-FAMILY)
    ("vascular endothelial growth factor (VEGF) and other cytokines"
     . SPARSER::COLLECTION)
    ("NICD" . SPARSER::PROTEIN)
    ("viral and cellular promoters" . SPARSER::PROMOTER)
    ("CSL" . SPARSER::PROTEIN)
    ("nut-1 and viral DNA polymerase [ xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("viral DNA polymerase" . SPARSER::PROTEIN)
    ("viral thymidine kinase" . SPARSER::PROTEIN)
    ("selective downstream viral genes" . SPARSER::GENE)
    ("a growth factor- and cytokine-responsive regulator"
     . SPARSER::COLLECTION)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("The aforementioned CBP" . SPARSER::PROTEIN)
    ("Grp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BiP" . SPARSER::PROTEIN)
    ("Sp1-" . SPARSER::PROTEIN) ("Pim1 and Pim3" . SPARSER::COLLECTION)
    ("proto" . SPARSER::PROTEIN)
    ("selective viral promoters" . SPARSER::PROMOTER)
    ("poly(ADP-ribose) polymerase 1 (PARP1) and human kinase"
     . SPARSER::COLLECTION)
    ("Rta protein’s" . SPARSER::PROTEIN)
    ("HDAC and Sp1, K-RBP and IRF7" . SPARSER::COLLECTION)
    ("Sp1, K-RBP and IRF7" . SPARSER::COLLECTION)
    ("Rta and downstream genes" . SPARSER::COLLECTION)
    ("a transcription factor and DNA replication regulator [ xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("AP" . SPARSER::PROTEIN) ("vFLIP" . SPARSER::PROTEIN)
    ("CBP and RBP-Jk" . SPARSER::COLLECTION)
    ("latency-associated nuclear antigen (LANA)-1 and K-bZIP"
     . SPARSER::COLLECTION)
    ("-1 and K-bZIP" . SPARSER::COLLECTION) ("LANA" . SPARSER::PROTEIN)
    ("IRF" . SPARSER::PROTEIN) ("viral genomic DNA" . SPARSER::DNA)
    ("EBP" . SPARSER::PROTEIN)
    ("cellular or viral cofactors" . SPARSER::PROTEIN)
    ("octamer" . SPARSER::PROTEIN)
    ("authentic direct promoters" . SPARSER::PROMOTER)
    ("viral shutoff exonuclease (vSOX) and vOX2 [ xref ]"
     . SPARSER::COLLECTION)
    ("viral shutoff exonuclease" . SPARSER::PROTEIN)
    ("viral interleukin" . SPARSER::PROTEIN)
    ("partial homology of Rta’s" . SPARSER::PROTEIN)
    ("interferon (IFN)" . SPARSER::PROTEIN)
    ("vIL-6, vGPCR and ORF8" . SPARSER::COLLECTION)
    ("vGPCR" . SPARSER::PROTEIN) ("viral protein (VP)" . SPARSER::PROTEIN)
    ("VP" . SPARSER::PROTEIN)
    ("viral and cellular proteins" . SPARSER::PROTEIN)
    ("viral genes" . SPARSER::GENE) ("viral promoters" . SPARSER::PROMOTER)
    ("downstream viral promoters" . SPARSER::PROMOTER)
    ("Both Rta and basic leucine zipper K-bZIP (K8)" . SPARSER::COLLECTION)
    ("EBV transcriptional transactivators Rta (BRLF1, 20%) and Zta (BZLF1, 22%)"
     . SPARSER::COLLECTION)
    ("syntenic orthologs" . SPARSER::PROTEIN)
    ("bZIP" . SPARSER::PROTEIN-FAMILY) ("TPA" . SPARSER::MOLECULE)
    ("dominant negative (DN) mutants" . SPARSER::MUTANT)
    ("phorbol-13-acetate (TPA)" . SPARSER::MOLECULE)
    ("viral glycoproteins" . SPARSER::PROTEIN)
    ("proto-oncoproteins and cytokines" . SPARSER::COLLECTION)
    ("proto-oncoproteins" . SPARSER::COLLECTION)
    ("viral proteins" . SPARSER::PROTEIN)
    ("~25 unique viral microRNA" . SPARSER::RNA)
    ("TRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("~120 nm icosahedral capsids" . SPARSER::PROTEIN)
    ("capsids" . SPARSER::PROTEIN) ("opt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the viral Mta protein" . SPARSER::PROTEIN)
    ("essential genes" . SPARSER::GENE)
    ("RBP-Jk and Oct-1" . SPARSER::COLLECTION) ("Rta" . SPARSER::PROTEIN)
    ("PABPC1" . SPARSER::PROTEIN) ("Notch4" . SPARSER::PROTEIN)
    ("γ-secretase" . SPARSER::PROTEIN) ("elongation factor" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN)
    ("hypoxia inducible factor 1" . SPARSER::PROTEIN)
    ("PPIase Pin1" . SPARSER::PROTEIN) ("KRMP1" . SPARSER::PROTEIN)
    ("lamin A/C" . SPARSER::PROTEIN) ("IKKγ" . SPARSER::PROTEIN)
    ("NS5B" . SPARSER::PROTEIN) ("NS5A" . SPARSER::PROTEIN)
    ("IRF3" . SPARSER::PROTEIN) ("cytidine deaminase" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN) ("TRK-fused gene" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("Cyclin D" . SPARSER::PROTEIN)
    ("pT-P" . SPARSER::PROTEIN) ("inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("FKBP12" . SPARSER::PROTEIN) ("phosphatase 2" . SPARSER::PROTEIN)
    ("FK506" . SPARSER::DRUG) ("EBNA2" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("MIR2" . SPARSER::PROTEIN)
    ("Hes1" . SPARSER::PROTEIN) ("single-pass" . SPARSER::PROTEIN-FAMILY)
    ("Delta-" . SPARSER::PROTEIN) ("XBP-1" . SPARSER::PROTEIN)
    ("X-box binding protein 1" . SPARSER::PROTEIN) ("Sp3" . SPARSER::PROTEIN)
    ("Viral G protein coupled receptor" . SPARSER::PROTEIN)
    ("Pim3" . SPARSER::PROTEIN) ("Pim1" . SPARSER::PROTEIN)
    ("TIF1β" . SPARSER::PROTEIN) ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRF7" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN) ("Hey1" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("CREB binding protein" . SPARSER::PROTEIN) ("Oct1" . SPARSER::PROTEIN)
    ("ORF45" . SPARSER::PROTEIN) ("vOX2" . SPARSER::PROTEIN)
    ("IRF family" . SPARSER::PROTEIN) ("ORF8" . SPARSER::PROTEIN)
    ("vIL-6" . SPARSER::PROTEIN) ("K1" . SPARSER::PROTEIN)
    ("phorbol-13-acetate" . SPARSER::MOLECULE)
    ("Replication and transcription activator" . SPARSER::PROTEIN)
    ("ORF50" . SPARSER::PROTEIN) ("nut-1" . SPARSER::PROTEIN)
    ("RBP-Jk" . SPARSER::PROTEIN) ("lapatanib" . SPARSER::DRUG)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("p27 and BrdU" . SPARSER::COLLECTION) ("mitogens" . SPARSER::MITOGEN)
    ("mitogen" . SPARSER::MITOGEN)
    ("the predominant ubiquitin ligase" . SPARSER::PROTEIN)
    ("Stathmin" . SPARSER::PROTEIN) ("urethane" . SPARSER::MOLECULE)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("the homeobox gene Nkx3.1 and the tumor suppressor PTEN"
     . SPARSER::COLLECTION)
    ("inhibitor and tumor" . SPARSER::COLLECTION)
    ("γ-tubulin" . SPARSER::PROTEIN) ("P27" . SPARSER::PROTEIN)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Nkx3.1" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a larger cohort" . SPARSER::MOLECULE)
    ("ATM and NOTCH1" . SPARSER::COLLECTION)
    ("TRAIL-R1 and TRAIL-R2" . SPARSER::COLLECTION)
    ("particular NOTCH1 and ATM" . SPARSER::COLLECTION)
    ("NOTCH1 and ATM" . SPARSER::COLLECTION)
    ("BAX and MDM2" . SPARSER::COLLECTION)
    ("MDM2 and BAX" . SPARSER::COLLECTION)
    ("CDKN1A , BAX and TNFRSF10A and TNFRSF10B" . SPARSER::COLLECTION)
    ("TNFRSF10A and TNFRSF10B" . SPARSER::COLLECTION)
    ("TP53 and NOTCH1" . SPARSER::COLLECTION)
    ("the principal functional domains FAT" . SPARSER::PROTEIN)
    ("PI3K/PI4K" . SPARSER::COLLECTION) ("FAT" . SPARSER::PROTEIN)
    ("ATM, MDM2 , NOTCH1 and NOTCH2" . SPARSER::COLLECTION)
    ("NOTCH1 and NOTCH2" . SPARSER::COLLECTION) ("Ion" . SPARSER::MOLECULE)
    ("p53/MDM2" . SPARSER::COLLECTION) ("p53 and NOTCH1" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated ( ATM ) [ xref - xref ] and NOTCH1 [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated ( ATM )" . SPARSER::PROTEIN)
    ("more recently additional promising novel candidate genes"
     . SPARSER::GENE)
    ("ATM or NOTCH1" . SPARSER::COLLECTION)
    ("NOTCH1 (n=10) genes, rare mutations of NOTCH2 (n=2) and CDKN1A/p21 (n=1) and no mutations in BAX , MDM2 , TNFRSF10A and TNFRSF10B genes"
     . SPARSER::COLLECTION)
    ("NOTCH2 (n=2) and CDKN1A/p21 (n=1)" . SPARSER::COLLECTION)
    ("TP53 (n=10) and NOTCH1 (n=10) genes" . SPARSER::COLLECTION)
    ("BAX , MDM2 , TNFRSF10A and TNFRSF10B" . SPARSER::COLLECTION)
    ("TRAIL-R2" . SPARSER::PROTEIN) ("TRAIL-R1" . SPARSER::PROTEIN)
    ("TP5" . SPARSER::PROTEIN) ("PI4K" . SPARSER::PROTEIN)
    ("Nutlin-3 as" . SPARSER::DRUG) ("TNFRSF10B" . SPARSER::PROTEIN)
    ("TNFRSF10A" . SPARSER::PROTEIN) ("NOTCH2" . SPARSER::PROTEIN)
    ("the cancer-relevant lncRNA" . SPARSER::RNA)
    ("a pro-proliferative state" . SPARSER::BIO-STATE)
    ("rRNA" . SPARSER::PROTEIN)
    ("MIR17HG , SNHG15 and SNHG16" . SPARSER::COLLECTION)
    ("miRNAs and snoRNAs" . SPARSER::COLLECTION) ("snoRNAs" . SPARSER::RNA)
    ("bidirectional promoters" . SPARSER::PROMOTER)
    ("MYC (fast turnover: t 1/2 =30 minutes) and GAPDH (slow turnover: t 1/2 =215 minutes)"
     . SPARSER::COLLECTION)
    ("PROMoter" . SPARSER::PROMOTER) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("intron-exon" . SPARSER::COLLECTION) ("exon-exon" . SPARSER::COLLECTION)
    ("VPS" . SPARSER::PROTEIN) ("ribosomal RNA-depleted RNA" . SPARSER::RNA)
    ("the bidirectional promoters" . SPARSER::PROMOTER)
    ("The MYC-bound bidirectional promoters" . SPARSER::PROMOTER)
    ("2,747 bidirectional promoters" . SPARSER::PROMOTER)
    ("total RNA and nuclear RNA" . SPARSER::COLLECTION)
    ("ribosomal RNAs and spliceosome-associated RNAs" . SPARSER::COLLECTION)
    ("RNAs, ribosomal RNAs and spliceosome-associated RNAs"
     . SPARSER::COLLECTION)
    ("spliceosome-associated RNAs" . SPARSER::RNA)
    ("MYC and non-coding" . SPARSER::COLLECTION)
    ("a classical transcription factor" . SPARSER::PROTEIN)
    ("The classic example" . SPARSER::EXAMPLE)
    ("MYC-MAX" . SPARSER::COLLECTION) ("MAX" . SPARSER::PROTEIN)
    ("lncRNA" . SPARSER::RNA) ("RPL10" . SPARSER::PROTEIN)
    ("RPLP0" . SPARSER::PROTEIN) ("miR-92a" . SPARSER::MOLECULE)
    ("U87" . SPARSER::PROTEIN) ("KTN1" . SPARSER::PROTEIN)
    ("MCM3AP" . SPARSER::PROTEIN) ("MIR17HG" . SPARSER::PROTEIN)
    ("v19" . SPARSER::PROTEIN) ("protein MAX" . SPARSER::PROTEIN)
    ("IGFIR" . SPARSER::PROTEIN) ("VCAN and HAPLN1" . SPARSER::COLLECTION)
    ("a MYB transcriptional co-factor" . SPARSER::MOLECULE)
    ("MYB, NOTCH1, and RUNX1" . SPARSER::COLLECTION)
    ("Cytotoxic" . SPARSER::PROTEIN)
    ("either control or 2 different lentiviral VCAN shRNAs" . SPARSER::RNA)
    ("hsa-miR-29" . SPARSER::COLLECTION)
    ("a unique ACC miRNA" . SPARSER::PROTEIN)
    ("many eukaryotic genes" . SPARSER::GENE)
    ("AML1/CBFA/PEBP2" . SPARSER::COLLECTION) ("CBFA" . SPARSER::PROTEIN)
    ("aka" . SPARSER::PROTEIN) ("HAPLN1/VCAN" . SPARSER::COLLECTION)
    ("this uncommon epithelial tumor ACC" . SPARSER::PROTEIN)
    ("MYB, NOTCH1, RUNX1, and FBXW7" . SPARSER::COLLECTION)
    ("RUNX1 and NOTCH1" . SPARSER::COLLECTION)
    ("at least 4 ACC" . SPARSER::PROTEIN) ("cryptic" . SPARSER::PROTEIN)
    ("MYB, or iii" . SPARSER::COLLECTION) ("asterix" . SPARSER::PROTEIN-FAMILY)
    ("c-KIT [ xref ] and fibroblast growth factor receptor 1 (FGFR1)"
     . SPARSER::COLLECTION)
    ("MYB target genes or MYB interaction genes (Figure xref )"
     . SPARSER::COLLECTION)
    ("MEC and ADC" . SPARSER::COLLECTION) ("RIN" . SPARSER::PROTEIN)
    ("MYB and RUNX1" . SPARSER::COLLECTION) ("/NOTCH1" . SPARSER::COLLECTION)
    ("well-annotated malignant SGT" . SPARSER::PROTEIN)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("the largest RNA polymerase II subunit" . SPARSER::FRAGMENT)
    ("salivary gland ACC" . SPARSER::PROTEIN)
    ("MYB:NFIB" . SPARSER::BIO-COMPLEX)
    ("human T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("SGT" . SPARSER::PROTEIN)
    ("the etiologic fusion oncogene" . SPARSER::ONCOGENE)
    ("allowed positional mapping" . SPARSER::PROTEIN)
    ("CRTC1-MAML2" . SPARSER::COLLECTION)
    ("these malignant SGTs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SGTs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MYB-NFIB" . SPARSER::COLLECTION)
    ("NFIB" . SPARSER::PROTEIN) ("NOTCH1 and RUNX1" . SPARSER::COLLECTION)
    ("VCAN/HAPLN1" . SPARSER::COLLECTION) ("VCAN" . SPARSER::PROTEIN)
    ("1160 mRNAs and 22 miRNAs" . SPARSER::COLLECTION)
    ("global mRNA/miRNA" . SPARSER::COLLECTION)
    ("mRNA/miRNA" . SPARSER::COLLECTION) ("ADC" . SPARSER::PROTEIN)
    ("MYB" . SPARSER::PROTEIN) ("Trypsin Inhibitor" . SPARSER::PROTEIN)
    ("NFIB 3" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("versican proteoglycan" . SPARSER::PROTEIN) ("CSPG2" . SPARSER::PROTEIN)
    ("PEBP2" . SPARSER::PROTEIN) ("AML1" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("HMGA2" . SPARSER::PROTEIN) ("MAML2" . SPARSER::PROTEIN)
    ("CRTC1" . SPARSER::PROTEIN) ("HAPLN1" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN)
    ("estrogen receptor, progesterone receptor, and HER2"
     . SPARSER::COLLECTION)
    ("HIF or TAZ" . SPARSER::COLLECTION)
    ("TAZ and SIAH1" . SPARSER::COLLECTION)
    ("TAZ and its positive regulator SIAH1" . SPARSER::COLLECTION)
    ("intratumoral hypoxia" . SPARSER::PROTEIN)
    ("HIF-1 and TAZ" . SPARSER::COLLECTION)
    ("HIF- and TAZ-regulated genes" . SPARSER::COLLECTION)
    ("HIF-1α and TAZ" . SPARSER::COLLECTION) ("HIF-" . SPARSER::PROTEIN-FAMILY)
    ("both HIF [ xref ] and TAZ [ xref ]" . SPARSER::COLLECTION)
    ("TAZ or HIF-2α" . SPARSER::COLLECTION)
    ("HIFs and TAZ" . SPARSER::COLLECTION)
    ("NTC, sh1α, sh2α, or shT1" . SPARSER::COLLECTION)
    ("HIF and TAZ" . SPARSER::COLLECTION)
    ("pGL2-CTGF:pSV-Renilla" . SPARSER::BIO-COMPLEX)
    ("pGL2-CTGF" . SPARSER::COLLECTION) ("-GGAATG-3" . SPARSER::COLLECTION)
    ("SIAH1 or LATS2" . SPARSER::COLLECTION)
    ("NTC or sh2α" . SPARSER::COLLECTION)
    ("HIF-1α or TAZ" . SPARSER::COLLECTION)
    ("HIF-1α, SIAH1, and TAZ" . SPARSER::COLLECTION)
    ("Alexa 568-conjugated phalloidin and DAPI" . SPARSER::COLLECTION)
    ("phalloidin and DAPI" . SPARSER::COLLECTION)
    ("SIAH1 mRNA (Fig. xref ) and protein (Fig. xref )" . SPARSER::COLLECTION)
    ("ubiquitin and shSI1-1 or NTC" . SPARSER::COLLECTION)
    ("LATS2 and SIAH1" . SPARSER::COLLECTION)
    ("SIAH1 and SIAH2" . SPARSER::COLLECTION)
    ("ubiquitin-protein" . SPARSER::COLLECTION)
    ("HIF-1α in non-hypoxic cells and LATS2 in hypoxic cells (Fig. xref )"
     . SPARSER::COLLECTION)
    ("HIF-1α and SIAH1" . SPARSER::COLLECTION)
    ("α-tubulin and histone" . SPARSER::COLLECTION)
    ("NTC and sh2α" . SPARSER::COLLECTION)
    ("Alexa 568-conjugated phalloidin" . SPARSER::MOLECULE)
    ("LATS1 and LATS2" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-1" . SPARSER::COLLECTION) ("shT" . SPARSER::PROTEIN)
    ("CTGF, PAI-1, and survivin" . SPARSER::COLLECTION)
    ("CTGF, PAI-1, and Survivin" . SPARSER::COLLECTION)
    ("-CGT-3" . SPARSER::COLLECTION) ("CGT" . SPARSER::PROTEIN)
    ("Renilla" . SPARSER::PROTEIN) ("pSV-Renilla" . SPARSER::COLLECTION)
    ("pSV" . SPARSER::PROTEIN) ("HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("-GCGTGGCACACA-3" . SPARSER::COLLECTION) ("-CACA-3" . SPARSER::COLLECTION)
    ("-RCGTG-3" . SPARSER::COLLECTION)
    ("HIF-1α (sh1α) or HIF-2α (sh2α) or a non-targeting control shRNA (NTC)"
     . SPARSER::COLLECTION)
    ("HIF-2α (sh2α) or a non-targeting control shRNA (NTC)"
     . SPARSER::COLLECTION)
    ("HIF-1α (sh1α) or HIF-2α (sh2α)" . SPARSER::COLLECTION)
    ("shRNA (NTC)" . SPARSER::PROTEIN) ("NTC" . SPARSER::PROTEIN)
    ("revealed intense HIF-1α" . SPARSER::PROTEIN)
    ("CXCR3, L1CAM, LOX, P4HA1, P4HA2, PDGFB, PLOD1, PLOD2, SLC2A1, and VEGFA"
     . SPARSER::COLLECTION)
    ("VEGFA" . SPARSER::PROTEIN) ("PDGFB" . SPARSER::PROTEIN)
    ("LOX" . SPARSER::PROTEIN) ("HIF-1α and HIF-2α" . SPARSER::COLLECTION)
    ("an O 2 -regulated HIF-1α or HIF-2α subunit and a constitutively expressed HIF-1"
     . SPARSER::COLLECTION)
    ("HIFs" . SPARSER::PROTEIN) ("LATS1 or LATS2" . SPARSER::COLLECTION)
    ("CTGF , SERPINE1 , and BIRC5" . SPARSER::COLLECTION)
    ("CTGF" . SPARSER::PROTEIN) ("TEAD" . SPARSER::PROTEIN)
    ("aldehyde" . SPARSER::MOLECULE) ("TAZ and HIF-1" . SPARSER::COLLECTION)
    ("HIF-1α, TAZ, or SIAH1" . SPARSER::COLLECTION)
    ("Intratumoral hypoxia" . SPARSER::PROTEIN) ("s21" . SPARSER::PROTEIN)
    ("Rho Kinase" . SPARSER::PROTEIN) ("SIAH2" . SPARSER::PROTEIN)
    ("HIF-1β" . SPARSER::PROTEIN) ("SLC2A1" . SPARSER::PROTEIN)
    ("PLOD2" . SPARSER::PROTEIN) ("PLOD1" . SPARSER::PROTEIN)
    ("P4HA2" . SPARSER::PROTEIN) ("P4HA1" . SPARSER::PROTEIN)
    ("L1CAM" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CXCR3" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor 1" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("SERPINE1" . SPARSER::PROTEIN)
    ("LATS2" . SPARSER::PROTEIN) ("SIAH1" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("ADPR-cyclases" . SPARSER::COLLECTION)
    ("cyclases" . SPARSER::PROTEIN)
    ("CaMKI, CaMKIV, and CaMKII" . SPARSER::COLLECTION)
    ("CaMKIV" . SPARSER::PROTEIN) ("CaMKI" . SPARSER::PROTEIN)
    ("CaMK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("calbindin, calretinin, troponin, and calmodulin" . SPARSER::COLLECTION)
    ("troponin" . SPARSER::PROTEIN) ("calretinin" . SPARSER::PROTEIN)
    ("calbindin" . SPARSER::PROTEIN) ("CaMKK" . SPARSER::PROTEIN)
    ("caspase-3 and PARP" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("propidium iodide (PI) staining and flow cytometry" . SPARSER::COLLECTION)
    ("modest (0.5% O 2 ) hypoxia" . SPARSER::PROTEIN)
    ("NADH" . SPARSER::MOLECULE) ("BTP-2" . SPARSER::COLLECTION)
    ("inositol-trisphosphate" . SPARSER::PROTEIN-PAIR)
    ("TRPC" . SPARSER::PROTEIN) ("CaMKII or AMPK" . SPARSER::COLLECTION)
    ("CaMKII and AMPK" . SPARSER::COLLECTION) ("BAPTA" . SPARSER::MOLECULE)
    ("chelator" . SPARSER::MOLECULE) ("CaM" . SPARSER::PROTEIN)
    ("total or phosphorylated LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("AMPK-TSC2" . SPARSER::COLLECTION) ("NQO1 and NQO1" . SPARSER::COLLECTION)
    ("AMPK and its target protein" . SPARSER::COLLECTION)
    ("dicumarol" . SPARSER::DRUG) ("AMPK and ACC" . SPARSER::COLLECTION)
    ("ACC" . SPARSER::PROTEIN) ("oxygen and glucose" . SPARSER::COLLECTION)
    ("hypoxia and glucose" . SPARSER::COLLECTION)
    ("sulforaphane" . SPARSER::PROTEIN)
    ("NF-κB, Akt, and mitogen-activated protein kinases" . SPARSER::COLLECTION)
    ("quinine" . SPARSER::DRUG) ("quinones" . SPARSER::MOLECULE)
    ("proteins, Bcl-2 and survivin" . SPARSER::COLLECTION)
    ("p21 and p53" . SPARSER::COLLECTION)
    ("mTOR (mammalian target of rapamycin) and its downstream regulators"
     . SPARSER::COLLECTION)
    ("coenzyme" . SPARSER::MOLECULE) ("GLUT1 and GLUT4" . SPARSER::COLLECTION)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("β1 and β2" . SPARSER::COLLECTION) ("cADPR" . SPARSER::MOLECULE)
    ("/CaMKII/AMPK" . SPARSER::COLLECTION)
    ("CaMKII/AMPK" . SPARSER::COLLECTION) ("RyR" . SPARSER::PROTEIN)
    ("/CaMKII" . SPARSER::COLLECTION) ("CaMKII" . SPARSER::PROTEIN)
    ("mTOR/S6K/4E-BP1" . SPARSER::COLLECTION)
    ("Oxygen and glucose" . SPARSER::COLLECTION) ("DiOC6" . SPARSER::DRUG)
    ("nM 3" . SPARSER::DRUG) ("CO 3" . SPARSER::PROTEIN)
    ("K 2" . SPARSER::PROTEIN) ("A-3" . SPARSER::PROTEIN)
    ("CA-3" . SPARSER::PROTEIN) ("N 2" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("pS6K" . SPARSER::PROTEIN)
    ("Ca 2+ /CaM" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("highly expressed in cancer" . SPARSER::PROTEIN)
    ("terminal transferase" . SPARSER::PROTEIN)
    ("cyclic ADP-ribose" . SPARSER::MOLECULE) ("U-73122" . SPARSER::MOLECULE)
    ("phospholipase C" . SPARSER::PROTEIN) ("SKF-96365" . SPARSER::DRUG)
    ("protein kinase kinase" . SPARSER::PROTEIN) ("1–8 " . SPARSER::PROTEIN)
    ("NFE2-related factor 2" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("ribosomal protein S6 kinase" . SPARSER::PROTEIN)
    ("ACC1" . SPARSER::PROTEIN) ("GLUT4" . SPARSER::PROTEIN)
    ("GLUT1" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AMP-activated" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("GPX" . SPARSER::PROTEIN)
    ("GPX7 and ABCC4" . SPARSER::COLLECTION)
    ("MGMT and GST" . SPARSER::COLLECTION)
    ("etoposide (a rarely neurotoxic agent) instead of the highly neurotoxic taxanes"
     . SPARSER::COLLECTION)
    ("the highly neurotoxic taxanes" . SPARSER::DRUG)
    ("taxanes" . SPARSER::DRUG)
    ("a platinum and a taxane drug" . SPARSER::COLLECTION)
    ("two neurotoxic drugs" . SPARSER::DRUG) ("IMS" . SPARSER::PROTEIN-FAMILY)
    ("platinum and taxane" . SPARSER::COLLECTION)
    ("RAD51, and RRMI" . SPARSER::COLLECTION)
    ("platinum or platinum-taxane" . SPARSER::COLLECTION)
    ("a platinum drug and a taxane" . SPARSER::COLLECTION)
    ("platinum and platinum-taxane" . SPARSER::COLLECTION)
    ("DRG" . SPARSER::PROTEIN)
    ("a platinum drug or a platinum drug" . SPARSER::COLLECTION)
    ("taxane" . SPARSER::DRUG) ("MutS Homolog 3" . SPARSER::PROTEIN)
    ("ATP-Binding Cassette Sub-Family C member 2" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("alpha 4" . SPARSER::PROTEIN)
    ("GSTA4" . SPARSER::PROTEIN) ("GSTP-1" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("methyl-transferase" . SPARSER::PROTEIN) ("ABCC4" . SPARSER::PROTEIN)
    ("ATP-binding cassette sub-family C member 4" . SPARSER::PROTEIN)
    ("GPX7" . SPARSER::PROTEIN) ("glutathione peroxidase 7" . SPARSER::PROTEIN)
    ("CtIP, BLM and Exo1" . SPARSER::COLLECTION)
    ("TRF1 and TRF2" . SPARSER::COLLECTION)
    ("Mre11/CtIP" . SPARSER::COLLECTION) ("BRCA1/53BP1" . SPARSER::COLLECTION)
    ("proficient BRCA1" . SPARSER::PROTEIN) ("three arbitrary classes" . CLASS)
    ("Mre11 (Figure xref ) as well as CtIP (Figure xref )"
     . SPARSER::COLLECTION)
    ("XRCC1 as well as Mre11" . SPARSER::COLLECTION) ("Brdu" . SPARSER::DRUG)
    ("Functional GFP" . SPARSER::PROTEIN)
    ("Mre11 and CtIP" . SPARSER::COLLECTION)
    ("functional 53BP1" . SPARSER::PROTEIN) ("Eco" . SPARSER::PROTEIN)
    ("Substrates" . SPARSER::SUBSTRATE)
    ("an extrachromosomal reporter substrate" . SPARSER::SUBSTRATE)
    ("pGL3-MCS" . SPARSER::COLLECTION) ("MCS" . SPARSER::PROTEIN)
    ("residual γ-H2AX foci" . SPARSER::PROTEIN)
    ("53BP1 and DNA-PKcs" . SPARSER::COLLECTION)
    ("residual IR-induced γ-H2AX foci" . SPARSER::PROTEIN)
    ("HR and DNA" . SPARSER::COLLECTION)
    ("BRCA1 and 53BP1" . SPARSER::COLLECTION) ("BRCA1-" . SPARSER::PROTEIN)
    ("distal DNA" . SPARSER::DNA)
    ("the MRE11/RAD50/NBS1 (MRN) complex and CtIP ( xref , xref , xref , xref – xref )"
     . SPARSER::COLLECTION)
    ("MRE11/RAD50/NBS1" . SPARSER::COLLECTION)
    ("XRCC1, DNA ligase III and PARP-1" . SPARSER::COLLECTION)
    ("XRCC4–ligase IV" . SPARSER::COLLECTION)
    ("proteins, Ku70 and Ku80" . SPARSER::COLLECTION)
    ("53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("functional BRCA1" . SPARSER::PROTEIN) ("RIF1" . SPARSER::PROTEIN)
    ("TRF1" . SPARSER::PROTEIN) ("DNA-Pkcs" . SPARSER::PROTEIN)
    ("LIG3" . SPARSER::PROTEIN) ("L-mimosine" . SPARSER::MOLECULE)
    ("PR4" . SPARSER::PROTEIN) ("PF4" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("ligase IV" . SPARSER::PROTEIN) ("DNA–PKcs" . SPARSER::PROTEIN)
    ("DNA–PK" . SPARSER::PROTEIN)
    ("MnSOD , Prx3 , Prx5 , Trx2 , TR2 , and UCP-2" . SPARSER::COLLECTION)
    ("Trx2" . SPARSER::PROTEIN) ("Trx" . SPARSER::PROTEIN)
    ("Prx" . SPARSER::PROTEIN) ("SIRT1-NFκB" . SPARSER::COLLECTION)
    ("nicotinamide and etoposide" . SPARSER::COLLECTION)
    ("nicotinamide" . SPARSER::PROTEIN)
    ("SIRT1 and E2F3" . SPARSER::COLLECTION)
    ("Fas and Bax" . SPARSER::COLLECTION) ("DNA and RNA" . SPARSER::COLLECTION)
    ("cytotoxin" . SPARSER::PROTEIN) ("antimetabolite" . SPARSER::DRUG)
    ("p53, p21 and miR-34a" . SPARSER::COLLECTION)
    ("virtually every type" . TYPE) ("pre-miRs" . SPARSER::COLLECTION)
    ("ac" . SPARSER::PROTEIN) ("/cyclin" . SPARSER::COLLECTION)
    ("the miR-34a or the 5-FU group" . SPARSER::COLLECTION)
    ("SIRT1 and p21" . SPARSER::COLLECTION) ("-p53" . SPARSER::COLLECTION)
    ("miR-34a and 5-FU" . SPARSER::COLLECTION)
    ("p53, SIRT1 and miR-34a" . SPARSER::COLLECTION) ("ncRNA" . SPARSER::RNA)
    ("tumor-suppressor genes and non-coding RNAs (ncRNAs)"
     . SPARSER::COLLECTION)
    ("ncRNAs" . SPARSER::RNA) ("SIRT1/p53" . SPARSER::COLLECTION)
    ("acetylated-p53 (ac-p53) and p21" . SPARSER::COLLECTION)
    ("ac-p53" . SPARSER::COLLECTION) ("MicroRNA" . SPARSER::RNA)
    ("UCP-2" . SPARSER::PROTEIN) ("TR2" . SPARSER::PROTEIN)
    ("Prx3" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("CCNE2" . SPARSER::PROTEIN) ("cyclin E2" . SPARSER::PROTEIN)
    ("miR-10b" . SPARSER::MOLECULE) ("tumor protein p53" . SPARSER::PROTEIN)
    ("Sirtuin 1" . SPARSER::PROTEIN) ("p36" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("hydroquinone" . SPARSER::MOLECULE) ("herbimycin" . SPARSER::PROTEIN)
    ("a predominant membrane NADPH oxidase" . SPARSER::PROTEIN)
    ("active NOX1 and 2 complex" . SPARSER::BIO-COMPLEX)
    ("Rac and p47 phox" . SPARSER::COLLECTION)
    ("NOX1 or NOX2" . SPARSER::COLLECTION)
    ("H 2 O 2 and O" . SPARSER::COLLECTION) ("oxidase" . SPARSER::PROTEIN)
    ("extracellular catalase" . SPARSER::PROTEIN)
    ("diapocynin" . SPARSER::DRUG) ("H 2 O 2 and Src" . SPARSER::COLLECTION)
    ("induced extracellular H 2 O 2" . SPARSER::DRUG)
    ("kinases and PTPs" . SPARSER::COLLECTION)
    ("N-acetylcysteine and dithiothreitol" . SPARSER::COLLECTION)
    ("dithiothreitol" . SPARSER::PROTEIN)
    ("CSK binding protein (CBP)" . SPARSER::PROTEIN)
    ("CSK and CHK" . SPARSER::COLLECTION) ("CHK" . SPARSER::PROTEIN)
    ("CSK" . SPARSER::PROTEIN) ("this basal H 2 O 2" . SPARSER::DRUG)
    ("PTP1B ( xref , xref ) and SHP-1 ( xref )" . SPARSER::COLLECTION)
    ("Hg" . SPARSER::MOLECULE) ("FLAG-Src" . SPARSER::COLLECTION)
    ("cysteine/alanine" . SPARSER::COLLECTION) ("apocynin" . SPARSER::MOLECULE)
    ("NOX" . SPARSER::PROTEIN) ("GSH-ester or catalase" . SPARSER::COLLECTION)
    ("removed extracellular H 2 O 2" . SPARSER::DRUG)
    ("GSH, or catalase" . SPARSER::COLLECTION) ("Media" . SPARSER::PROTEIN)
    ("Catalase" . SPARSER::PROTEIN) ("orthovanadate" . SPARSER::MOLECULE)
    ("most likely involving cysteines of both Src and the PTPs that regulate its activity"
     . SPARSER::COLLECTION)
    ("both Src and the PTPs" . SPARSER::COLLECTION)
    ("a potent multifunctional growth factor" . SPARSER::GROWTH-FACTOR)
    ("β1" . SPARSER::PROTEIN) ("various reactive oxidants" . SPARSER::MOLECULE)
    ("peroxynitrite, and hydrogen peroxide" . SPARSER::COLLECTION)
    ("peroxynitrite" . SPARSER::MOLECULE) ("acrolein" . SPARSER::MOLECULE)
    ("oxidants" . SPARSER::MOLECULE) ("cys" . SPARSER::AMINO-ACID)
    ("reactive electrophiles" . SPARSER::MOLECULE)
    ("electrophiles" . SPARSER::MOLECULE)
    ("C-terminal Src kinase (Csk) and Csk homologous kinase (Chk)"
     . SPARSER::COLLECTION)
    ("Csk homologous kinase" . SPARSER::KINASE)
    ("kinases and protein" . SPARSER::COLLECTION)
    ("PTP1B, SHP1, PTPα, or PTPγ" . SPARSER::COLLECTION)
    ("Chk" . SPARSER::PROTEIN) ("Csk" . SPARSER::PROTEIN)
    ("Apocynin" . SPARSER::MOLECULE) ("extracellular H 2 O 2" . SPARSER::DRUG)
    ("GSH-ester and catalase" . SPARSER::COLLECTION)
    ("GSH-ester" . SPARSER::DRUG) ("GSH" . SPARSER::DRUG)
    ("vanadate" . SPARSER::MOLECULE) ("Vanadate" . SPARSER::MOLECULE)
    ("Transforming growth factor-β1" . SPARSER::COLLECTION)
    ("DUOX1" . SPARSER::PROTEIN) ("p47 phox" . SPARSER::PROTEIN)
    ("NOX4" . SPARSER::PROTEIN) ("NOX2" . SPARSER::PROTEIN)
    ("NOX1" . SPARSER::PROTEIN) ("N-acetylcysteine" . SPARSER::DRUG)
    ("CSK binding protein" . SPARSER::PROTEIN) ("SHP-1" . SPARSER::PROTEIN)
    ("MgSO 4" . SPARSER::DRUG) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("get 1" . SPARSER::PROTEIN) ("v-Src" . SPARSER::PROTEIN)
    ("PTP1B" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Disulfide" . SPARSER::MOLECULE)
    ("their respective oxidation state" . SPARSER::BIO-STATE)
    ("A differential thiol" . SPARSER::MOLECULE)
    ("the free DNA and p53-bound DNA" . SPARSER::COLLECTION)
    ("50 nM tetramer and 125 nM tetramer" . SPARSER::COLLECTION)
    ("tetramer and 25 nM Gadd45 DNA" . SPARSER::COLLECTION)
    ("a similarly
redox-active tyrosine"
     . SPARSER::AMINO-ACID)
    ("a pseudo-wild-type p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Observable and quantifiable peptide fragments" . SPARSER::FRAGMENT)
    ("acetonitrile" . SPARSER::MOLECULE) ("TFA" . SPARSER::PROTEIN)
    ("tryptic peptides" . SPARSER::PEPTIDE) ("Trypsin" . SPARSER::PROTEIN)
    ("lysyl endopeptidase (WAKO)" . SPARSER::PROTEIN)
    ("Aldrich" . SPARSER::PROTEIN) ("DTT and TCEP" . SPARSER::COLLECTION)
    ("TCEP" . SPARSER::MOLECULE) ("disulfides" . SPARSER::MOLECULE)
    ("Dithiothreitol" . SPARSER::PROTEIN) ("hydrochloride" . SPARSER::MOLECULE)
    ("guanidine" . SPARSER::MOLECULE)
    ("50 nM tetramer and C275S-p53" . SPARSER::COLLECTION)
    ("FLA" . SPARSER::PROTEIN) ("HEP-1" . SPARSER::COLLECTION)
    ("HEP" . SPARSER::PROTEIN)
    ("-GGAAAAAAAAAAAAAAAAAAACC-3" . SPARSER::COLLECTION)
    ("BSA" . SPARSER::PROTEIN) ("Amps" . SPARSER::AMP)
    ("Mutants" . SPARSER::MUTANT) ("GAT" . SPARSER::PROTEIN)
    ("TGC" . SPARSER::PROTEIN) ("GAA" . SPARSER::PROTEIN)
    ("Complement" . SPARSER::PROTEIN) ("CTA" . SPARSER::PROTEIN)
    ("GCA" . SPARSER::PROTEIN) ("Oligonucleotides" . SPARSER::MOLECULE)
    ("an adenine or a thymine" . SPARSER::COLLECTION)
    ("pyrimidine, and W" . SPARSER::COLLECTION) ("thiols" . SPARSER::MOLECULE)
    ("respective
iodoacetamide-modified peptide"
     . SPARSER::PEPTIDE)
    ("Differential thiol" . SPARSER::MOLECULE) ("CL 3" . SPARSER::PROTEIN)
    ("lysyl endopeptidase" . SPARSER::PROTEIN)
    ("N -ethylmaleimide" . SPARSER::MOLECULE)
    ("response
element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Transcription
factor"
     . SPARSER::PROTEIN)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("relevant biomarkers" . SPARSER::MOLECULE)
    ("relevant pathway biomarkers" . SPARSER::MOLECULE)
    ("an investigational drug" . SPARSER::DRUG) ("AEs" . SPARSER::PROTEIN)
    ("ALP" . SPARSER::PROTEIN)
    ("epirubicin, cisplatin, and capecitabine" . SPARSER::COLLECTION)
    ("MET and HGF" . SPARSER::COLLECTION)
    ("MET and/or HGF" . SPARSER::COLLECTION) ("capecitabine" . SPARSER::DRUG)
    ("epirubicin" . SPARSER::DRUG) ("rilotumumab" . SPARSER::DRUG)
    ("Rilotumumab" . SPARSER::DRUG) ("IgG2" . SPARSER::BIO-COMPLEX)
    ("scatter factor" . SPARSER::PROTEIN)
    ("temozolomide, and streptozotocin" . SPARSER::COLLECTION)
    ("ileal" . SPARSER::PROTEIN) ("NET" . SPARSER::PROTEIN)
    ("dacarbazine (a precursor of the same active metabolite than temozolomide) and streptozotocin"
     . SPARSER::COLLECTION)
    ("the most frequently methylated genes" . SPARSER::GENE)
    ("HIC , RASSFA1 and APC" . SPARSER::COLLECTION)
    ("HIC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the 12 genes studied by MS-PCR" . SPARSER::GENE)
    ("gastrointestinal NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("methylated MGMT promoter" . SPARSER::PROMOTER)
    ("Streptozotocin" . SPARSER::DRUG)
    ("streptozotocin and dacarbazine" . SPARSER::COLLECTION)
    ("a more reliable predictive biomarker" . SPARSER::MOLECULE)
    ("-guanine" . SPARSER::COLLECTION)
    ("dacarbazine ( xref ; xref ) and temozolomide ( xref ; xref ; xref ; xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("sunitinib and everolimus" . SPARSER::COLLECTION)
    ("sunitinib" . SPARSER::DRUG)
    ("temozolomide, dacarbazine and streptozotocin" . SPARSER::COLLECTION)
    ("temozolomide, dacarbazine or streptozotocin" . SPARSER::COLLECTION)
    ("streptozotocin" . SPARSER::DRUG) ("dacarbazine" . SPARSER::DRUG)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("6–16" . SPARSER::PROTEIN)
    ("TIMP3" . SPARSER::PROTEIN) ("MINT2" . SPARSER::PROTEIN)
    ("MINT1" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("MEN1" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("O 6 -Methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("AKT-FOXO3a" . SPARSER::COLLECTION) ("ERK1 or ERK2" . SPARSER::COLLECTION)
    ("AKT and/or BRCA1-IRIS inhibitors" . SPARSER::COLLECTION)
    ("intact AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-2, Bcl-xL and NF-κB" . SPARSER::COLLECTION)
    ("BRCA1-IRIS " . SPARSER::COLLECTION) ("IRIS " . SPARSER::PROTEIN)
    ("peptide " . SPARSER::PEPTIDE) ("paclitaxel " . SPARSER::DRUG)
    ("mammary fat" . SPARSER::PROTEIN) ("AKT " . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR " . SPARSER::PROTEIN) ("Skp2 " . SPARSER::PROTEIN)
    ("estrogen, progesterone and HER2" . SPARSER::COLLECTION)
    ("EGFR, AKT, MDM2, Skp2 and survivin" . SPARSER::COLLECTION)
    ("-FOXO3a" . SPARSER::COLLECTION) ("-survivin" . SPARSER::COLLECTION)
    ("anti-BRCA1-IRIS" . SPARSER::COLLECTION)
    ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXC2 (compare Figure  xref Q4 to Q3) and vimentin (compare Figure  xref R4 to R3)"
     . SPARSER::COLLECTION)
    ("FOXC2 (compare Figure  xref Q2 to Q1) and vimentin (compare Figure  xref R2 to R1)"
     . SPARSER::COLLECTION)
    ("biomarkers, Oct-4, Sox-2 and Nanog" . SPARSER::COLLECTION)
    ("three-dimensional matrigel" . SPARSER::PROTEIN)
    ("EGFR, ErbB2, ErbB3 and cortactin" . SPARSER::COLLECTION)
    ("smaller/rounder/organized acini" . SPARSER::PROTEIN)
    ("N2 and N3" . SPARSER::COLLECTION)
    ("IRIS peptide and BRCA1-IRIS silencing" . SPARSER::COLLECTION)
    ("LY294002 (hereafter LY) or the ERK inhibitor" . SPARSER::COLLECTION)
    ("MDA-MB468" . SPARSER::PROTEIN)
    ("Cyclin D1, survivin and vimentin" . SPARSER::COLLECTION)
    ("int" . SPARSER::PROTEIN)
    ("BRCA1-IRIS-specific inhibitor" . SPARSER::INHIBITOR)
    ("A BRCA1-IRIS mimetic inhibitory peptide" . SPARSER::PEPTIDE)
    ("the dual EGFR/ErbB2 inhibitor" . SPARSER::INHIBITOR)
    ("EGFR, ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("EGFR/ ErbB2 (Lapatinib) or EGFR/ErbB2/ErbB3 (Sapitnib) inhibitors"
     . SPARSER::COLLECTION)
    ("Erlotinib" . SPARSER::DRUG) ("p-JNK" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("MDM2 and Skp2" . SPARSER::COLLECTION) ("Skp2" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("AKT and/or ERK" . SPARSER::COLLECTION)
    ("Cyclin D1, survivin and Bcl-xL" . SPARSER::COLLECTION)
    ("p-FOXO3a" . SPARSER::COLLECTION)
    ("Cyclin D1 and survivin" . SPARSER::COLLECTION)
    ("FOXO3a and FOXO1" . SPARSER::COLLECTION) ("-EGFR" . SPARSER::COLLECTION)
    ("EGFR and ErbB3" . SPARSER::COLLECTION)
    ("survivin and Cyclin D1" . SPARSER::COLLECTION)
    ("p-FOXO" . SPARSER::COLLECTION)
    ("luciferase (siLuc, negative control) or BRCA1-IRIS (siIRIS)-specific siRNAs"
     . SPARSER::COLLECTION)
    ("BRCA-IRIS" . SPARSER::COLLECTION)
    ("SCID mice mammary fat" . SPARSER::PROTEIN)
    ("AKT/survivin" . SPARSER::COLLECTION) ("Drugs" . SPARSER::DRUG)
    ("AKT, or mitogen-activated protein kinases" . SPARSER::COLLECTION)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("FOXO’s" . SPARSER::PROTEIN-FAMILY)
    ("family (IAP)" . SPARSER::PROTEIN-FAMILY) ("Paclitaxel" . SPARSER::DRUG)
    ("a novel inhibitory mimetic peptide" . SPARSER::PEPTIDE)
    ("AKT and survivin" . SPARSER::COLLECTION) ("-EGF" . SPARSER::COLLECTION)
    ("/EGF" . SPARSER::COLLECTION) ("BRCA1-IRIS" . SPARSER::COLLECTION)
    ("IRIS" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein 1" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("MDM2 " . SPARSER::PROTEIN) ("FOXC2" . SPARSER::PROTEIN)
    ("Sox-2" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PI3" . SPARSER::PROTEIN)
    ("SP600125" . SPARSER::PROTEIN) ("p-Y" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-xL" . SPARSER::PROTEIN) ("anti-ErbB2" . SPARSER::DRUG)
    ("Forkhead box O3" . SPARSER::PROTEIN)
    ("activated protein kinase" . SPARSER::PROTEIN)
    ("FOXO3a" . SPARSER::PROTEIN) ("class O" . SPARSER::PROTEIN)
    ("ER and co-repressor" . SPARSER::COLLECTION)
    ("folate" . SPARSER::MOLECULE) ("overexpressed HER2" . SPARSER::PROTEIN)
    ("IGFBP3 and S100P" . SPARSER::COLLECTION)
    ("PGR, GREB1 and pS2" . SPARSER::COLLECTION) ("PGR" . SPARSER::PROTEIN)
    ("wt ER and the ER L372R mutant" . SPARSER::COLLECTION)
    ("E 2 and anti-estrogens" . SPARSER::COLLECTION)
    ("Tamoxifen and raloxifene" . SPARSER::COLLECTION)
    ("raloxifene" . SPARSER::PROTEIN) ("Tamoxifen" . SPARSER::MOLECULE)
    ("its classical target genes" . SPARSER::GENE)
    ("CBP and p300" . SPARSER::COLLECTION) ("/ER" . SPARSER::COLLECTION)
    ("Estrogen" . SPARSER::MOLECULE) ("TAFII30" . SPARSER::PROTEIN)
    ("FRα" . SPARSER::PROTEIN) ("ERRB2" . SPARSER::PROTEIN)
    ("pS2" . SPARSER::PROTEIN) ("GREB1" . SPARSER::PROTEIN)
    ("IGFBP3" . SPARSER::PROTEIN) ("EP300" . SPARSER::PROTEIN)
    ("Phenol red" . SPARSER::DRUG) ("17β-estradiol" . SPARSER::PROTEIN)
    ("hormone-sensitive" . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("RX" . SPARSER::PROTEIN) ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trastuzumab and hormone" . SPARSER::COLLECTION)
    ("pAkt's" . SPARSER::PROTEIN-FAMILY)
    ("Overexpressed pAkt" . SPARSER::PROTEIN-FAMILY)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK2141795" . SPARSER::DRUG) ("IL-10 and IL-6" . SPARSER::COLLECTION)
    ("STAT5, STAT6 and ERK1/2" . SPARSER::COLLECTION)
    ("IL-15Ra" . SPARSER::PROTEIN) ("GM-CSFR" . SPARSER::COLLECTION)
    ("STAT5 and ERK1/2" . SPARSER::COLLECTION) ("CSFR" . SPARSER::PROTEIN)
    ("GM" . SPARSER::PROTEIN)
    ("CD40, CD80, CD86, CD83 and HLA-DR" . SPARSER::COLLECTION)
    ("MCP-1, IL-8, RANTES and eotaxin" . SPARSER::COLLECTION)
    ("eotaxin" . SPARSER::PROTEIN) ("RANTES" . SPARSER::PROTEIN)
    ("DC-related molecule (DC-SIGN, DC-LAMP) and migration marker CCR7"
     . SPARSER::COLLECTION)
    ("costimulatory receptors" . SPARSER::PROTEIN)
    ("cytokine/chemokine" . SPARSER::COLLECTION)
    ("significantly less CCR7" . SPARSER::PROTEIN)
    ("an immature state" . SPARSER::BIO-STATE)
    ("TNFα and LPS" . SPARSER::COLLECTION)
    ("both LPS (1 μg ml −1 ) and TNFα (50 ng ml −1 )" . SPARSER::COLLECTION)
    ("IFN-γ and TNFα" . SPARSER::COLLECTION)
    ("either p38 MAPK inhibitor (SB203580) or STAT3 inhibitor (stattic)"
     . SPARSER::COLLECTION)
    ("TNFα/LPS" . SPARSER::COLLECTION)
    ("STAT5- and STAT6-responsive genes" . SPARSER::COLLECTION)
    ("STAT5-" . SPARSER::PROTEIN) ("STAT3-" . SPARSER::PROTEIN)
    ("STAT3, STAT5, STAT6, ERK1/2 MAPK and p38 MAPK pathways in CD11c-gated imIL-4 and imIL-15 DCs and mIL-4 and mIL-15 DCs based on phosphoprotein flow cytometry, and representative flow cytometry"
     . SPARSER::COLLECTION)
    ("MAPK and p38 MAPK" . SPARSER::COLLECTION)
    ("IL-4Rα and IL-15Rα" . SPARSER::COLLECTION)
    ("STAT3 or p38 MAPK" . SPARSER::COLLECTION)
    ("GM-CSF and IL-4 or IL-15" . SPARSER::COLLECTION)
    ("IL-4 or IL-15" . SPARSER::COLLECTION)
    ("STAT6 and ERK1/2" . SPARSER::COLLECTION)
    ("STAT and MAPK" . SPARSER::COLLECTION)
    ("the IL-4-DC- or IL-15-DC-primed memory or primary T-cell"
     . SPARSER::PROTEIN)
    ("different effector and memory CD4 and CD8 T-cell subsets"
     . SPARSER::COLLECTION)
    ("phosphoprotein" . SPARSER::PROTEIN) ("mDCs" . SPARSER::PROTEIN)
    ("IFN-γ, TNFα and IL-6" . SPARSER::COLLECTION)
    ("several key inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-1α, IL-1β, IL-6, TNFα, TNFβ and IFN-γ" . SPARSER::COLLECTION)
    ("immune-modulatory cytokines" . SPARSER::PROTEIN)
    ("IL-12 and interferon-γ" . SPARSER::COLLECTION)
    ("CD80 and CD83" . SPARSER::COLLECTION)
    ("significantly more CCR7" . SPARSER::PROTEIN)
    ("MHC molecules and costimulatory proteins" . SPARSER::COLLECTION)
    ("costimulatory proteins" . SPARSER::PROTEIN) ("mIL" . SPARSER::PROTEIN)
    ("-IL-15" . SPARSER::COLLECTION)
    ("the strong immune effector" . SPARSER::EFFECTOR)
    ("IL-4 and IL-15" . SPARSER::COLLECTION)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("GM-CSF and IL-15" . SPARSER::COLLECTION)
    ("IL-4 and granulocyte–macrophage colony-stimulating factor"
     . SPARSER::COLLECTION)
    ("class I and class II major histocompatibility complex (MHC) and costimulatory molecules"
     . SPARSER::COLLECTION)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("costimulatory molecules" . SPARSER::MOLECULE)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("LPS/TNFα" . SPARSER::COLLECTION)
    ("Further analysis using specific inhibitors" . SPARSER::INHIBITOR)
    ("STAT3 and p38 MAPK" . SPARSER::COLLECTION)
    ("STAT5 or STAT3" . SPARSER::COLLECTION)
    ("STAT6 and extracellular signal-regulated kinase 1/2"
     . SPARSER::COLLECTION)
    ("STAT3 and p38" . SPARSER::COLLECTION) ("/TNFα" . SPARSER::COLLECTION)
    ("interferon-γ (IFN-γ) and tumor necrosis factor-α (TNFα)"
     . SPARSER::COLLECTION)
    ("IL-6, interferon-γ (IFN-γ) and tumor necrosis factor-α (TNFα)"
     . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("CD8 and CD4" . SPARSER::COLLECTION)
    ("flow cytometry and quantitative RNA" . SPARSER::COLLECTION)
    ("quantitative RNA" . SPARSER::RNA) ("IL-7" . SPARSER::PROTEIN)
    ("2–4 " . SPARSER::PROTEIN) ("CD116" . SPARSER::PROTEIN)
    ("M-T" . SPARSER::PROTEIN) ("SK1" . SPARSER::PROTEIN)
    ("H4A" . SPARSER::PROTEIN) ("LAMP-1" . SPARSER::PROTEIN)
    ("FUN-1" . SPARSER::MOLECULE) ("4-1BBL" . SPARSER::PROTEIN)
    ("CD137L" . SPARSER::PROTEIN) ("γC" . SPARSER::PROTEIN)
    ("PD-L1" . SPARSER::PROTEIN) ("gp120" . SPARSER::DRUG)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("brefeldin A" . SPARSER::MOLECULE) ("pp38" . SPARSER::PROTEIN)
    ("pERK1/2" . SPARSER::PROTEIN) ("IL-15Rα" . SPARSER::PROTEIN)
    ("IL-15 receptor" . SPARSER::PROTEIN) ("IL-4Rα" . SPARSER::PROTEIN)
    ("IL-4 receptor" . SPARSER::PROTEIN) ("target cell" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("CD62L" . SPARSER::PROTEIN) ("Wilms tumor 1" . SPARSER::PROTEIN)
    ("pp65" . SPARSER::PROTEIN) ("TNFβ" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("CD40" . SPARSER::PROTEIN)
    ("CD86" . SPARSER::PROTEIN) ("costimulatory molecule" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("CD209" . SPARSER::PROTEIN)
    ("DC-SIGN" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("granulocyte–macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-4" . SPARSER::PROTEIN)
    ("5 treated adult recurrent or progressive PXAs" . SPARSER::PROTEIN-FAMILY)
    ("IDH1/IDH2" . SPARSER::COLLECTION) ("CNAs" . SPARSER::PROTEIN)
    ("the available cohort" . SPARSER::MOLECULE)
    ("almost all examples" . SPARSER::EXAMPLE)
    ("this commercial antibody" . SPARSER::PROTEIN)
    ("focal epithelioid" . SPARSER::PROTEIN)
    ("necrotic foci" . SPARSER::PROTEIN)
    ("the original cohort" . SPARSER::MOLECULE)
    ("a focal component" . SPARSER::COMPONENT)
    ("had focal epithelioid" . SPARSER::PROTEIN) ("MRIs" . SPARSER::PROTEIN)
    ("T1-weighted MRI" . SPARSER::PROTEIN) ("vemurafinib" . SPARSER::DRUG)
    ("our larger E-GBM cohort" . SPARSER::MOLECULE)
    ("more focal epithelioid" . SPARSER::PROTEIN)
    ("PXA" . SPARSER::PROTEIN-FAMILY)
    ("the most widely-utilized BRAF mutation-specific antibody"
     . SPARSER::ANTIBODY)
    ("glial fibrillary protein (GFAP)" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN) ("reticulin" . SPARSER::MOLECULE)
    ("glial" . SPARSER::PROTEIN) ("PXAs" . SPARSER::PROTEIN-FAMILY)
    ("our original cohort" . SPARSER::MOLECULE)
    ("Epithelioid" . SPARSER::PROTEIN) ("IDH2" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("INI-1" . SPARSER::PROTEIN)
    ("the tumour suppressor genes or DNA repair genes" . SPARSER::COLLECTION)
    ("a detectable methylated MGMT promoter" . SPARSER::PROMOTER)
    ("the normal ovarian tissue group" . SPARSER::MOLECULE)
    ("O  6 -methylguanine DNA methyltransferase ( MGMT )" . SPARSER::PROTEIN)
    ("AGT" . SPARSER::PROTEIN) ("cytosines" . SPARSER::NUCLEOBASE)
    ("MSP" . SPARSER::PROTEIN) ("LMP" . SPARSER::PROTEIN)
    ("methyltransferase ( MGMT )" . SPARSER::PROTEIN)
    ("MGMT" . SPARSER::PROTEIN) ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("CA-125" . SPARSER::DRUG) ("O  6" . SPARSER::PROTEIN)
    ("O  6 -methylguanine DNA methyltransferase" . SPARSER::PROTEIN)
    ("O 6" . SPARSER::PROTEIN) ("ick" . SPARSER::PROTEIN)
    ("ath" . SPARSER::MOLECULE) ("The mature form" . SPARSER::FORM)
    ("a key developmental regulator" . SPARSER::REGULATOR)
    ("p21 or p27" . SPARSER::COLLECTION)
    ("only some miRNAs" . SPARSER::PROTEIN)
    ("Supplemental Table S2" . SPARSER::MOLECULE)
    ("p21 and p27" . SPARSER::COLLECTION)
    ("G2 accumulation and G2/M" . SPARSER::COLLECTION)
    ("Waf1/Cip1 and p27/" . SPARSER::COLLECTION)
    ("ATM or ATM" . SPARSER::COLLECTION)
    ("ATM, Rad51, Rad54, XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("DNA-PKcs, Artemis, Ku70, Lig4 and XRCC4" . SPARSER::COLLECTION)
    ("Artemis" . SPARSER::PROTEIN) ("BRM" . SPARSER::PROTEIN)
    ("FLAG-DICER" . SPARSER::COLLECTION) ("SV" . SPARSER::MOLECULE)
    ("p21/p27" . SPARSER::COLLECTION) ("at least one miRNA" . SPARSER::PROTEIN)
    ("/p27 Kip1" . SPARSER::COLLECTION)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("S6B" . SPARSER::PROTEIN) ("hsa-let-7" . SPARSER::RNA)
    ("waf1" . SPARSER::PROTEIN) ("G2 accumulation" . SPARSER::PROTEIN)
    ("DICER 1" . SPARSER::PROTEIN) ("I-SceI" . SPARSER::PROTEIN)
    ("let7" . SPARSER::RNA) ("sip21" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("p-H3" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("XRCC2" . SPARSER::PROTEIN) ("Rad54" . SPARSER::PROTEIN)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("XRCC4" . SPARSER::PROTEIN)
    ("Lig4" . SPARSER::PROTEIN) ("pre-miRNA" . SPARSER::RNA)
    ("USP10, USP7, USP24, USP29, USP2a and USP42" . SPARSER::COLLECTION)
    ("DUBs and E3" . SPARSER::COLLECTION) ("DDB1-Cul4" . SPARSER::COLLECTION)
    ("constantly target p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IR, and cisplatin" . SPARSER::COLLECTION) ("Claspin" . SPARSER::PROTEIN)
    ("p53 and target p53" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("COP1, Pirh2, ARF-BP1, MSL2 and Parc" . SPARSER::COLLECTION)
    ("Parc" . SPARSER::PROTEIN) ("CPD" . SPARSER::PROTEIN)
    ("DDB2 and USP24" . SPARSER::COLLECTION) ("hypoxanthine" . SPARSER::DRUG)
    ("p53 and USP24" . SPARSER::COLLECTION)
    ("Flag-USP24" . SPARSER::COLLECTION) ("p53-Mdm2" . SPARSER::COLLECTION)
    ("nutlin and roscovitine" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG) ("nutlin" . SPARSER::DRUG)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("DDB1 and Mdm2" . SPARSER::COLLECTION)
    ("specifically target p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DDB1-Cul4A" . SPARSER::COLLECTION)
    ("Mdm2 and DDB1" . SPARSER::COLLECTION)
    ("a major transcription factor" . SPARSER::PROTEIN)
    ("Caspase-Glo" . SPARSER::COLLECTION) ("Glo" . SPARSER::PROTEIN)
    ("Caspase" . SPARSER::PROTEIN) ("caffeine or siRNA" . SPARSER::COLLECTION)
    ("CUL4-DDB1" . SPARSER::COLLECTION) ("ubiquitin-" . SPARSER::PROTEIN)
    ("USP" . SPARSER::PROTEIN) ("UBL" . SPARSER::PROTEIN)
    ("HAUSP and USP2a" . SPARSER::COLLECTION)
    ("Mdm2 and MdmX" . SPARSER::COLLECTION) ("MdmX" . SPARSER::PROTEIN)
    ("p53 and Mdm2" . SPARSER::COLLECTION) ("HAUSP" . SPARSER::PROTEIN)
    ("DUBs" . SPARSER::PROTEIN) ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("Ubiquitin" . SPARSER::PROTEIN) ("Functional USP24" . SPARSER::PROTEIN)
    ("Cul4" . SPARSER::PROTEIN) ("stress-induced protein" . SPARSER::PROTEIN)
    ("response mediator protein" . SPARSER::PROTEIN)
    ("USP28" . SPARSER::PROTEIN) ("MSL2" . SPARSER::PROTEIN)
    ("ARF-BP1" . SPARSER::PROTEIN) ("Pirh2" . SPARSER::PROTEIN)
    ("COP1" . SPARSER::PROTEIN) ("p53 regulator" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("KU-55933" . SPARSER::DRUG)
    ("DDB1" . SPARSER::PROTEIN) ("CUL4" . SPARSER::PROTEIN)
    ("DDB2" . SPARSER::PROTEIN) ("USP42" . SPARSER::PROTEIN)
    ("USP10" . SPARSER::PROTEIN) ("USP2" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("USP24" . SPARSER::PROTEIN)
    ("NF-κB and IKK-" . SPARSER::COLLECTION) ("IKK-" . SPARSER::PROTEIN)
    ("chemokines and leukocyte adhesion molecules" . SPARSER::COLLECTION)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("ICAM-1, VCAM-1 and E-selectin, NF-κB, and matrix" . SPARSER::COLLECTION)
    ("E-selectin, NF-κB, and matrix" . SPARSER::COLLECTION)
    ("inflammatory chemokines and vascular adhesion molecules"
     . SPARSER::COLLECTION)
    ("inflammatory chemokines" . SPARSER::PROTEIN)
    ("the pathologic state" . SPARSER::BIO-STATE)
    ("MCP-1 and IL-6" . SPARSER::COLLECTION) ("p50/p65" . SPARSER::COLLECTION)
    ("these chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("pro-inflammatory chemokines and adhesion molecules"
     . SPARSER::COLLECTION)
    ("MCP-1, VCAM-1, E-selectin and ICAM-1" . SPARSER::COLLECTION)
    ("chemokines and leukocyte adhesion molecules [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("the circulating chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("MCP" . SPARSER::PROTEIN)
    ("chemokines and adhesion molecule" . SPARSER::COLLECTION)
    ("ICAM-1, VCAM-1 and E-selectin" . SPARSER::COLLECTION)
    ("VCAM-1 and F4/80-positive macrophages" . SPARSER::COLLECTION)
    ("Adhesion molecules and chemokines" . SPARSER::COLLECTION)
    ("Monocytes" . SPARSER::PROTEIN) ("Dietary luteolin" . SPARSER::DRUG)
    ("Verhoeff-Van" . SPARSER::COLLECTION) ("Van" . SPARSER::PROTEIN)
    ("hematoxylin" . SPARSER::MOLECULE)
    ("luteolin almost completely blocked F4/80-positive monocytes-derived macrophages"
     . SPARSER::PROTEIN)
    ("strong VCAM-1" . SPARSER::PROTEIN)
    ("mouse vascular monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("MCP-1 and IL-8" . SPARSER::COLLECTION)
    ("MCP-1, IL-8, and VCAM-1" . SPARSER::COLLECTION)
    ("food" . SPARSER::MOLECULE)
    ("chemotactic cytokines and vascular adhesion molecules"
     . SPARSER::COLLECTION)
    ("chemotactic cytokines" . SPARSER::PROTEIN)
    ("MCP-1, VCAM-1, and ICAM-1" . SPARSER::COLLECTION)
    ("both chemotactic cytokines and vascular adhesion molecules"
     . SPARSER::COLLECTION)
    ("vascular adhesion molecules" . SPARSER::MOLECULE)
    ("both chemotactic cytokines" . SPARSER::PROTEIN)
    ("Hy" . SPARSER::MOLECULE)
    ("chemokines and adhesion molecules" . SPARSER::COLLECTION)
    ("LDL" . SPARSER::PROTEIN) ("the vascular vasculature" . SPARSER::PROTEIN)
    ("bioflavonoid" . SPARSER::DRUG)
    ("VCAM-1, ICAM-1, and E-Selectin" . SPARSER::COLLECTION)
    ("interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1)"
     . SPARSER::COLLECTION)
    ("Verhoeff-van" . SPARSER::COLLECTION) ("elastin" . SPARSER::PROTEIN)
    ("the chemokine monocyte chemotactic protein-1 (MCP-1) and adhesion molecules ICAM-1 and VCAM-1"
     . SPARSER::COLLECTION)
    ("the chemokine monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("hy" . SPARSER::MOLECULE) ("luteolin" . SPARSER::DRUG)
    ("Luteolin" . SPARSER::DRUG) ("E-selectin" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("AT -3" . SPARSER::PROTEIN)
    ("TG -3" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("TNF-alpha" . SPARSER::PROTEIN) ("E-Selectin" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("interleukin-8" . SPARSER::PROTEIN) ("Rho/ROCK" . SPARSER::COLLECTION)
    ("IL-1 and TNF-α" . SPARSER::COLLECTION)
    ("JNK and c-Jun" . SPARSER::COLLECTION) ("MKK4/JNK" . SPARSER::COLLECTION)
    ("Both TAK1 [ xref ] and MEKK1 [ xref ]" . SPARSER::COLLECTION)
    ("this kinase or signaling components" . SPARSER::COLLECTION)
    ("p46 and p54" . SPARSER::COLLECTION) ("IκBα/NF-κB" . SPARSER::COLLECTION)
    ("TNF-α and other pro-inflammatory cytokines" . SPARSER::COLLECTION)
    ("other pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("JNK and ROCK" . SPARSER::COLLECTION)
    ("MKK4 and MKK7" . SPARSER::COLLECTION)
    ("JNK and MKK4" . SPARSER::COLLECTION)
    ("IκBα and p38 MAPK" . SPARSER::COLLECTION) ("RISC" . SPARSER::PROTEIN)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION)
    ("PRK1/PKN1" . SPARSER::COLLECTION)
    ("PRK (PKN) and the citron kinase [ xref ]" . SPARSER::COLLECTION)
    ("citron" . SPARSER::PROTEIN) ("PRK" . SPARSER::PROTEIN)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("inhibitor (RI)" . SPARSER::INHIBITOR)
    ("a potent pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("JNK and its upstream kinase MKK4" . SPARSER::COLLECTION)
    ("NF-κB and p38" . SPARSER::COLLECTION)
    ("external cues" . SPARSER::PROTEIN-FAMILY) ("TNBS" . SPARSER::MOLECULE)
    ("Rho and this kinase" . SPARSER::COLLECTION)
    ("The Rho-associated kinase" . SPARSER::KINASE)
    ("kinases, MKK4 and MKK7" . SPARSER::COLLECTION)
    ("approximately 46 and 54 kDa" . SPARSER::PROTEIN)
    ("kinase (JNK)" . SPARSER::KINASE)
    ("Jun, Fos, and ATF" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("pro-inflammatory chemokines" . SPARSER::PROTEIN)
    ("MKK4 and JNK" . SPARSER::COLLECTION)
    ("the p54 JNK isoform and phosphorylation of the upstream MKK4 kinase"
     . SPARSER::COLLECTION)
    ("DLD" . SPARSER::PROTEIN) ("the Rho-associated kinase" . SPARSER::KINASE)
    ("JIP1" . SPARSER::PROTEIN) ("MEKK1" . SPARSER::PROTEIN)
    ("ROCK1 protein" . SPARSER::PROTEIN) ("PRK2" . SPARSER::PROTEIN)
    ("PKN1" . SPARSER::PROTEIN) ("PRK1" . SPARSER::PROTEIN)
    ("p46" . SPARSER::PROTEIN) ("MKK7" . SPARSER::PROTEIN)
    ("MKK4" . SPARSER::PROTEIN) ("p54" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("new potentially relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Sema6A and MICAL1" . SPARSER::COLLECTION)
    ("Plexins" . SPARSER::PROTEIN-FAMILY) ("Vemurafenib" . SPARSER::DRUG)
    ("Semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("receptor and semaphorins" . SPARSER::COLLECTION)
    ("neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("ErbB-2/ErbB-3" . SPARSER::COLLECTION)
    ("Sema6A/Plexin" . SPARSER::COLLECTION)
    ("trans-membrane proteins and its receptors" . SPARSER::COLLECTION)
    ("SEMA/PLEXIN" . SPARSER::COLLECTION) ("PLEXIN" . SPARSER::PROTEIN)
    ("SEMA" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H2B-S14" . SPARSER::COLLECTION)
    ("a pro-apoptotic kinase" . SPARSER::KINASE)
    ("Sema/Plexin" . SPARSER::COLLECTION) ("Plexin" . SPARSER::PROTEIN)
    ("Sema6A and Plexin-A4" . SPARSER::COLLECTION)
    ("PlexinA4 and PlexinA2" . SPARSER::COLLECTION)
    ("Plexin-A2 and Plexin-A4" . SPARSER::COLLECTION)
    ("PlexinA2 and PlexinA4" . SPARSER::COLLECTION)
    ("PlexinA2" . SPARSER::PROTEIN) ("metastatic foci" . SPARSER::PROTEIN)
    ("anoikis" . SPARSER::PROTEIN) ("poli" . SPARSER::PROTEIN)
    ("Fibronectin" . SPARSER::PROTEIN) ("Trypan" . SPARSER::DRUG)
    ("Annexin-V/PI" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("Sema6A and Mical-1" . SPARSER::COLLECTION)
    ("sema/plexin" . SPARSER::COLLECTION)
    ("only one NRAS Q61R" . SPARSER::PROTEIN)
    ("BRAF-mutant and NRAS-mutant" . SPARSER::COLLECTION)
    ("flavoprotein" . SPARSER::MOLECULE)
    ("its different components in regulating cell survival"
     . SPARSER::COMPONENT)
    ("sema" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("semaphorin-plexin" . SPARSER::COLLECTION) ("CasL" . SPARSER::PROTEIN)
    ("plexin" . SPARSER::PROTEIN)
    ("a ligand of Plexin A2 and A4 [ xref - xref ]" . SPARSER::COLLECTION)
    ("semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("activated BRAF V600E or NRAS Q61R [ xref ]" . SPARSER::COLLECTION)
    ("relevant molecules" . SPARSER::MOLECULE)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("Sema" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plexins" . SPARSER::PROTEIN-FAMILY)
    ("Sema6A and Mical1" . SPARSER::COLLECTION) ("Mical1" . SPARSER::PROTEIN)
    ("SEMA6A and MICAL1" . SPARSER::COLLECTION)
    ("BRAF V600E and NRAS Q61R" . SPARSER::COLLECTION)
    ("SEMA6A 1" . SPARSER::PROTEIN) ("Hsp-70" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("Sema3C" . SPARSER::PROTEIN)
    ("Sema3A" . SPARSER::PROTEIN) ("ErbB-2" . SPARSER::PROTEIN)
    ("ErbB-3" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("Plexin-A4" . SPARSER::PROTEIN) ("Plexin-A2" . SPARSER::PROTEIN)
    ("PlexinA4" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("NDR1" . SPARSER::PROTEIN) ("VEGFR2" . SPARSER::PROTEIN)
    ("Plexin A2" . SPARSER::PROTEIN) ("MST-1" . SPARSER::PROTEIN)
    ("Mical-1" . SPARSER::PROTEIN)
    ("semaphorin family" . SPARSER::PROTEIN-FAMILY)
    ("Sema6A" . SPARSER::PROTEIN) ("MICAL1" . SPARSER::PROTEIN)
    ("SEMA6A" . SPARSER::PROTEIN) ("antineoplasic drugs" . SPARSER::DRUG)
    ("PARP1 and EGFR" . SPARSER::COLLECTION) ("p38/MAPK" . SPARSER::COLLECTION)
    ("RAD51 and BRCA1" . SPARSER::COLLECTION)
    ("MAD2 and BUB3" . SPARSER::COLLECTION)
    ("Aurora B kinase and the kinetochore protein CENP-A"
     . SPARSER::COLLECTION)
    ("PJ34 or erlotinib" . SPARSER::COLLECTION)
    ("PJ34 and erlotinib" . SPARSER::COLLECTION)
    ("Kinases and GRP3" . SPARSER::COLLECTION) ("Kinases" . SPARSER::KINASE)
    ("only cell bearing γH2AX foci" . SPARSER::PROTEIN)
    ("bearing γH2AX foci" . SPARSER::PROTEIN) ("DR" . SPARSER::MOLECULE)
    ("FANCG" . SPARSER::PROTEIN) ("FANC" . SPARSER::PROTEIN-FAMILY)
    ("endonuclease" . SPARSER::PROTEIN)
    ("the protein phosphatases CDC25A (which is a Chk1 substrate) and CDC25C"
     . SPARSER::COLLECTION)
    ("ATM and ATR" . SPARSER::COLLECTION)
    ("BARD1 and BRIP1" . SPARSER::COLLECTION)
    ("Nucleotide" . SPARSER::NUCLEOTIDE) ("XPC" . SPARSER::PROTEIN)
    ("XPA" . SPARSER::PROTEIN)
    ("Up-regulated mRNAs included p53-dependent genes" . SPARSER::GENE)
    ("bcl2 and BH3-only" . SPARSER::COLLECTION)
    ("CDKN1A/p21" . SPARSER::COLLECTION) ("BBC3/PUMA" . SPARSER::COLLECTION)
    ("PTEN and BUB1B" . SPARSER::COLLECTION) ("EMBO-EBI" . SPARSER::COLLECTION)
    ("EBI" . SPARSER::PROTEIN) ("AURKB" . SPARSER::PROTEIN)
    ("the currently used chemotherapeutic drug TMZ or IR"
     . SPARSER::COLLECTION)
    ("TMZ or IR" . SPARSER::COLLECTION)
    ("PJ34 or olaparib" . SPARSER::COLLECTION)
    ("the clinically relevant PARPi olaparib" . SPARSER::DRUG)
    ("mainly PARPs synthesizing proteins" . SPARSER::PROTEIN)
    ("PJ34 (IC 20 nM) and olaparib (IC 5 nM)" . SPARSER::COLLECTION)
    ("GSCs" . SPARSER::PROTEIN) ("PJ34 and olaparib" . SPARSER::COLLECTION)
    ("olaparib" . SPARSER::DRUG) ("EGFR and PARP" . SPARSER::COLLECTION)
    ("-Akt-1" . SPARSER::COLLECTION)
    ("p53, or phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("temozolomide (TMZ)" . SPARSER::DRUG) ("TMZ" . SPARSER::DRUG)
    ("temozolomide" . SPARSER::DRUG)
    ("PARP and co-treatment" . SPARSER::COLLECTION) ("SAC" . SPARSER::PROTEIN)
    ("either functional or mutated PTEN" . SPARSER::PROTEIN)
    ("Sodium Chloride" . SPARSER::DRUG) ("p60" . SPARSER::PROTEIN)
    ("rad51" . SPARSER::PROTEIN) ("pSG5" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("TR3" . SPARSER::PROTEIN) ("Ribonuclease A" . SPARSER::PROTEIN)
    ("AZD2281" . SPARSER::DRUG) ("N2" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG) ("CDC20" . SPARSER::PROTEIN)
    ("BUB3" . SPARSER::PROTEIN) ("MAD2" . SPARSER::PROTEIN)
    ("CENP-A" . SPARSER::PROTEIN) ("GRP3" . SPARSER::PROTEIN)
    ("Fanconi anemia" . SPARSER::PROTEIN) ("FEN1" . SPARSER::PROTEIN)
    ("Exo1" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("CDC25A" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("bcl2" . SPARSER::PROTEIN) ("BBC3" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("PJ34" . SPARSER::DRUG)
    ("Akt-1" . SPARSER::PROTEIN) ("Ink4a" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE) ("BUBR1" . SPARSER::PROTEIN)
    ("an excellent example" . SPARSER::EXAMPLE)
    ("a single pre-trans-splicing molecule" . SPARSER::MOLECULE)
    ("trans-" . SPARSER::PROTEIN-FAMILY)
    ("both p53 alleles or wt-p53 allele" . SPARSER::COLLECTION)
    ("ribozymes and siRNAs" . SPARSER::COLLECTION)
    ("mdm2 or mdm4" . SPARSER::COLLECTION)
    ("a powerful transcription factor" . SPARSER::PROTEIN)
    ("caspase-3 and Bax" . SPARSER::COLLECTION)
    ("caspase-3, Bax, PUMA and PARP" . SPARSER::COLLECTION)
    ("cell-cycle-related proteins" . SPARSER::PROTEIN)
    ("cell-cycle-related genes" . SPARSER::GENE)
    ("trans-splicing-generated p53 RNA" . SPARSER::RNA)
    ("molecule (PTM)" . SPARSER::MOLECULE) ("intron" . SPARSER::PROTEIN)
    ("IgM" . SPARSER::PROTEIN) ("spliceosome" . SPARSER::BIO-COMPLEX)
    ("HIGM1" . SPARSER::PROTEIN) ("an exogenous mRNA" . SPARSER::PROTEIN)
    ("a special form" . SPARSER::FORM) ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("ribozymes and siRNAs [ xref - xref ]" . SPARSER::COLLECTION)
    ("ribozymes" . SPARSER::RNA) ("wt" . SPARSER::PROTEIN)
    ("wt-p53" . SPARSER::COLLECTION) ("Cyclin E" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("Cyclin A2" . SPARSER::PROTEIN) ("mdm4" . SPARSER::PROTEIN)
    ("Ad-p53" . SPARSER::DRUG) ("mdm2" . SPARSER::PROTEIN)
    ("cyclin A2" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("HER3 or MET" . SPARSER::COLLECTION)
    ("homodimers or heterodimers" . SPARSER::COLLECTION)
    ("FGFR2/EGFR" . SPARSER::COLLECTION) ("FGFRs" . SPARSER::PROTEIN)
    ("NRG1 and HGF" . SPARSER::COLLECTION)
    ("HER3 and MET" . SPARSER::COLLECTION) ("FGFR2-" . SPARSER::PROTEIN)
    ("AZD4547 (FGFR2 TKI) and cetuximab (EGFR antibody)" . SPARSER::COLLECTION)
    ("FGFs" . SPARSER::PROTEIN)
    ("EGFR, HER3, MET, PDGFR and IGFR" . SPARSER::COLLECTION)
    ("IGFR" . SPARSER::PROTEIN)
    ("MET, HER3, IGF-1R and INSR" . SPARSER::COLLECTION)
    ("INSR" . SPARSER::PROTEIN) ("HER3, EGFR and MET" . SPARSER::COLLECTION)
    ("a typical example" . SPARSER::EXAMPLE) ("HER3/MET" . SPARSER::COLLECTION)
    ("EGFR/MET" . SPARSER::COLLECTION) ("EGFR/HER3" . SPARSER::COLLECTION)
    ("FGFR2, EGFR, HER3 and MET" . SPARSER::COLLECTION)
    ("PBS, AZD4547 or cetuximab" . SPARSER::COLLECTION)
    ("cetuximab and their combination" . SPARSER::COLLECTION)
    ("SNU-16" . SPARSER::PROTEIN)
    ("AZD4547 or cetuximab" . SPARSER::COLLECTION)
    ("AZD4547 (FGFR2 TKI) and cetuximab (EGFR monoclonal antibody)"
     . SPARSER::COLLECTION)
    ("FGFR2 and EGFR" . SPARSER::COLLECTION)
    ("secondary RTK inhibitors" . SPARSER::INHIBITOR)
    ("EGF, NRG1 or HGF" . SPARSER::COLLECTION)
    ("EGFR/HER3/MET" . SPARSER::COLLECTION)
    ("FGFR2 and other certain RTKs" . SPARSER::COLLECTION)
    ("AZD4547, EGF, NRG1 and HGF" . SPARSER::COLLECTION)
    ("FRS2, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("FGFR2, FRS2, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("the secondary active RTKs" . SPARSER::PROTEIN)
    ("pan-HER and PF04217903" . SPARSER::COLLECTION)
    ("NRG1 and EGF" . SPARSER::COLLECTION)
    ("neuregulin 1 (NRG1) and insulin-like growth factor (IGF) (50 ng/mL)"
     . SPARSER::COLLECTION)
    ("insulin-like growth factor (IGF)" . SPARSER::PROTEIN)
    ("AZD4547, SNU16 and KATOIII" . SPARSER::COLLECTION)
    ("IGF" . SPARSER::PROTEIN) ("ERK1/2 and AKT" . SPARSER::COLLECTION)
    ("FGFR2 and other resistance-enriched RTKs" . SPARSER::COLLECTION)
    ("AZD4547 (FGFR2 inhibitor) and cetuximab (EGFR monoclonal antibody)"
     . SPARSER::COLLECTION)
    ("Dovitinib" . SPARSER::DRUG) ("ponatinib" . SPARSER::DRUG)
    ("dovitinib" . SPARSER::DRUG) ("GCs" . SPARSER::PROTEIN)
    ("AZD4547 and cetuximab" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, HER3 and MET" . SPARSER::COLLECTION) ("p-p42" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("PF04217903" . SPARSER::DRUG) ("AZD8931" . SPARSER::DRUG)
    ("NRG1" . SPARSER::PROTEIN) ("neuregulin 1" . SPARSER::PROTEIN)
    ("FRS2" . SPARSER::PROTEIN) ("FGFR substrate 2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("APP- and tau-transgenic mice" . SPARSER::COLLECTION)
    ("tau- and Aβ-pathologies" . SPARSER::COLLECTION)
    ("APP-" . SPARSER::PROTEIN)
    ("tau and APP-transgenic" . SPARSER::COLLECTION)
    ("these mitotic phosphoproteins" . SPARSER::PROTEIN)
    ("OGD" . SPARSER::PROTEIN)
    ("lipids, membranes, proteins and DNA" . SPARSER::COLLECTION)
    ("Pin1 and HIF-1" . SPARSER::COLLECTION) ("amide" . SPARSER::MOLECULE)
    ("Pin1 and substrate" . SPARSER::COLLECTION)
    ("a nucleophile and attack" . SPARSER::COLLECTION)
    ("substrate and form" . SPARSER::COLLECTION)
    ("nucleophile" . SPARSER::MOLECULE)
    ("DAPK1 and Pin1" . SPARSER::COLLECTION) ("Oxygen" . SPARSER::MOLECULE)
    ("PPIases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tau and Aβ" . SPARSER::COLLECTION)
    ("Pin1 shRNA cells stably re-expressing shRNA-resistant Pin1 or Pin1 C113A"
     . SPARSER::COLLECTION)
    ("Pin1 or Pin1" . SPARSER::COLLECTION)
    ("antibody or Pin1" . SPARSER::COLLECTION) ("Redox" . SPARSER::PROTEIN)
    ("APP and Aβ" . SPARSER::COLLECTION) ("p-tau" . SPARSER::COLLECTION)
    ("Tau and APP" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("Flag-Pin1" . SPARSER::COLLECTION) ("streptavidin" . SPARSER::PROTEIN)
    ("maleimide" . SPARSER::DRUG)
    ("Pin1 (oxyPin1) using an antibody-based method for the monitoring of Pin1’s"
     . SPARSER::PROTEIN)
    ("oxidative state" . SPARSER::BIO-STATE) ("trap" . SPARSER::PROTEIN)
    ("pre-treated Pin1" . SPARSER::PROTEIN)
    ("ligand and oxygen atom" . SPARSER::COLLECTION)
    ("Gln" . SPARSER::AMINO-ACID) ("Nal" . SPARSER::PROTEIN)
    ("Pip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("sulfonic form" . SPARSER::FORM)
    ("Cysteine" . SPARSER::AMINO-ACID) ("thiol" . SPARSER::MOLECULE)
    ("H 2 O 2 or diamine" . SPARSER::COLLECTION) ("tau-" . SPARSER::PROTEIN)
    ("subregions" . SPARSER::PROTEIN) ("soluble Pin1" . SPARSER::PROTEIN)
    ("the unique peptidyl-prolyl cis/trans isomerase Pin1" . SPARSER::PROTEIN)
    ("Proline" . SPARSER::AMINO-ACID) ("tau and APP" . SPARSER::COLLECTION)
    ("tau" . SPARSER::PROTEIN)
    ("The unique proline isomerase Pin1" . SPARSER::PROTEIN)
    ("isomerase" . SPARSER::ISOMERASE) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("MgSO4" . SPARSER::DRUG) ("PDB 2" . SPARSER::PROTEIN)
    ("3–1" . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("H2O2" . SPARSER::DRUG) ("GSK-3β" . SPARSER::PROTEIN)
    ("BACE1" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("AP4" . SPARSER::PROTEIN) ("DAPK1" . SPARSER::PROTEIN)
    ("HIF-1" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("oxygen atom" . SPARSER::MOLECULE) ("pK a" . SPARSER::PROTEIN)
    ("skin-permeable anti-Cav-1 peptides" . SPARSER::PEPTIDE)
    ("relatively safe molecules" . SPARSER::MOLECULE)
    ("artificial collagens or HA dermal fillers" . SPARSER::MOLECULE)
    ("hyaluronidases" . SPARSER::DRUG)
    ("HA dermal fillers" . SPARSER::MOLECULE) ("linkers" . SPARSER::LINKER)
    ("Hyaluronic acid (HA) dermal fillers" . SPARSER::MOLECULE)
    ("fillers" . SPARSER::MOLECULE) ("very safe molecules" . SPARSER::MOLECULE)
    ("Cav-1 and collagens" . SPARSER::COLLECTION)
    ("DFs or Cav-1" . SPARSER::COLLECTION) ("DFs" . SPARSER::PROTEIN)
    ("caveolins" . SPARSER::PROTEIN-FAMILY)
    ("hetero-oligomeric complex" . SPARSER::BIO-COMPLEX)
    ("at least four proteins" . SPARSER::PROTEIN)
    ("Cav-1 and collagen" . SPARSER::COLLECTION)
    ("C-peptide" . SPARSER::MOLECULE) ("CAV-1" . SPARSER::PROTEIN)
    ("Hyaluronic acid" . SPARSER::MOLECULE) ("6.3" . SPARSER::PROTEIN)
    ("CD-" . SPARSER::PROTEIN) ("β-CD" . SPARSER::MOLECULE)
    ("membrane component" . SPARSER::PROTEIN)
    ("muscle specific" . SPARSER::PROTEIN) ("caveolin-3" . SPARSER::PROTEIN)
    ("β-cyclodextrin" . SPARSER::MOLECULE) ("Cav-1" . SPARSER::PROTEIN)
    ("EGFR, ErbB2 and mutp53" . SPARSER::COLLECTION)
    ("MAPK and PI3K" . SPARSER::COLLECTION)
    ("mutp53–HSF1" . SPARSER::COLLECTION)
    ("a dual ErbB2/EGFR inhibitor" . SPARSER::INHIBITOR)
    ("Lapatinib" . SPARSER::DRUG) ("-promoter" . SPARSER::PROMOTER)
    ("WAP" . SPARSER::PROTEIN)
    ("mutp53 KI (knockin) mice (R175H, R273H and R248W) manifest GOF"
     . SPARSER::PROTEIN)
    ("GOF" . SPARSER::PROTEIN) ("EGFR and ErbB2" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("p53 and Ki67" . SPARSER::COLLECTION) ("p53 null MECs" . SPARSER::PROTEIN)
    ("acini" . SPARSER::PROTEIN) ("mutp53/HER2" . SPARSER::COLLECTION)
    ("PI-MEC" . SPARSER::COLLECTION) ("MEC" . SPARSER::PROTEIN)
    ("PI-MECs" . SPARSER::COLLECTION) ("primary MECs" . SPARSER::PROTEIN)
    ("mutp53 and ErbB2" . SPARSER::COLLECTION)
    ("aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN) ("MECs" . SPARSER::PROTEIN)
    ("p53H/H" . SPARSER::PROTEIN) ("mammary SCs" . SPARSER::PROTEIN)
    ("TICs" . SPARSER::PROTEIN) ("Mutp53" . SPARSER::PROTEIN)
    ("Heterozygous cohorts" . SPARSER::MOLECULE)
    ("the heterozygous cohorts" . SPARSER::MOLECULE)
    ("ErbB2 and p53-/+" . SPARSER::COLLECTION)
    ("Four experimental cohorts" . SPARSER::MOLECULE)
    ("ErbB2 and p53-/-" . SPARSER::COLLECTION)
    ("ErbB2, and p53-/+" . SPARSER::COLLECTION)
    ("p53 R172 H" . SPARSER::PROTEIN) ("mutp53 and ErbB" . SPARSER::COLLECTION)
    ("mutp53" . SPARSER::PROTEIN)
    ("mutp53-Epidermal Growth Factor Receptors" . SPARSER::PROTEIN-PAIR)
    ("iPS" . SPARSER::PROTEIN) ("SCs" . SPARSER::PROTEIN)
    ("the p53 tumor suppressor and members of the Epidermal Growth Factor Receptor family"
     . SPARSER::COLLECTION)
    ("ErbB2 and EGFR" . SPARSER::COLLECTION) ("MMTV" . SPARSER::PROTEIN)
    ("NK1" . SPARSER::PROTEIN) ("ALDH 1" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSF1" . SPARSER::PROTEIN)
    ("Factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Whey Acidic Protein" . SPARSER::PROTEIN) ("Wnt-1" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("Sox9" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN) ("CD29" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB1" . SPARSER::PROTEIN) ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("cyclinEs" . SPARSER::PROTEIN-FAMILY)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("their respective target gene" . SPARSER::GENE)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("cyclinD2-3" . SPARSER::COLLECTION) ("CDK6" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CyclinD2" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("cyclinD2" . SPARSER::PROTEIN)
    ("p53, Bcl2 and IL-6" . SPARSER::COLLECTION)
    ("enhanceosome" . SPARSER::BIO-COMPLEX)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNFα, IL-1β and IL-6" . SPARSER::COLLECTION)
    ("p16INK4a and p53" . SPARSER::COLLECTION)
    ("HMGA1 and HMGB1" . SPARSER::COLLECTION)
    ("BRCA1 (breast cancer 1, early onset) and Nbs1 (nibrin)"
     . SPARSER::COLLECTION)
    ("a genotoxic molecule" . SPARSER::MOLECULE) ("nibrin" . SPARSER::PROTEIN)
    ("NF-κB and vice versa [ xref , xref ]" . SPARSER::COLLECTION)
    ("anti-apoptotic Bcl2 protein and other pro-survival genes"
     . SPARSER::COLLECTION)
    ("RB" . SPARSER::PROTEIN) ("p300, RelA and E2" . SPARSER::COLLECTION)
    ("Cip" . SPARSER::PROTEIN) ("IL-6, IL-8 and HMGB1" . SPARSER::COLLECTION)
    ("SMS" . SPARSER::PROTEIN) ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("G 2 /M or sub-G 1 phases" . SPARSER::COLLECTION)
    ("E2 (28%) or TNF-α (22%)" . SPARSER::COLLECTION)
    ("either E2 (45%) or TNF-α (48%)" . SPARSER::COLLECTION)
    ("E2 or their combination" . SPARSER::COLLECTION)
    ("p27 (7-fold) and p16 (∼3-fold)" . SPARSER::COLLECTION)
    ("p53 (∼6-fold) and p27 (10-fold)" . SPARSER::COLLECTION)
    ("Prism" . SPARSER::PROTEIN) ("running water" . SPARSER::MOLECULE)
    ("methanol" . SPARSER::MOLECULE) ("were run" . SPARSER::PROTEIN-FAMILY)
    ("BP" . SPARSER::PROTEIN) ("run" . SPARSER::PROTEIN-FAMILY)
    ("EDTA" . SPARSER::MOLECULE) ("trypsinized" . SPARSER::PROTEIN)
    ("Annexin V or PI" . SPARSER::COLLECTION) ("MPL" . SPARSER::PROTEIN)
    ("Resazurin" . SPARSER::DRUG) ("MU" . SPARSER::PROTEIN)
    ("MUG" . SPARSER::PROTEIN)
    ("specific primary antibodies and appropriate secondary antibodies"
     . SPARSER::COLLECTION)
    ("appropriate secondary antibodies" . SPARSER::ANTIBODY)
    ("Rox" . SPARSER::PROTEIN)
    ("resazurin (Himedia) and PI (propidium iodide)" . SPARSER::COLLECTION)
    ("resazurin" . SPARSER::DRUG)
    ("p27Kip1 (cyclin-dependent kinase inhibitor p27) and high-mobility group protein A (HMGA)"
     . SPARSER::COLLECTION)
    ("β-actin (A2228, Sigma–Aldrich) and horseradish peroxidase (HRP)-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories)"
     . SPARSER::COLLECTION)
    ("horseradish peroxidase (HRP)-conjugated secondary antibodies"
     . SPARSER::ANTIBODY)
    ("peroxidase (HRP)" . SPARSER::PROTEIN)
    ("E2, p53 and HMG-1" . SPARSER::COLLECTION)
    ("Sigma–Aldrich" . SPARSER::PROTEIN-PAIR) ("p-RelA" . SPARSER::COLLECTION)
    ("HRP" . SPARSER::PROTEIN) ("streptomycin" . SPARSER::DRUG)
    ("p53 and pRB" . SPARSER::COLLECTION) ("pRB" . SPARSER::PROTEIN)
    ("E2 and TNF-α" . SPARSER::COLLECTION) ("keratinocytes" . SPARSER::PROTEIN)
    ("viral early genes" . SPARSER::GENE) ("SASP" . SPARSER::PROTEIN)
    ("the viral oncogenes" . SPARSER::ONCOGENE)
    ("TNF-α and E2" . SPARSER::COLLECTION)
    ("interleukin (IL)" . SPARSER::PROTEIN)
    ("protein A (HMGA)" . SPARSER::PROTEIN) ("HMGB" . SPARSER::PROTEIN-FAMILY)
    ("HMGA" . SPARSER::PROTEIN-FAMILY)
    ("anti-apoptotic Bcl2 (B-cell lymphoma 2) protein and other pro-survival genes"
     . SPARSER::COLLECTION)
    ("survivin and hTERT" . SPARSER::COLLECTION)
    ("p53, p21, p27 and p16" . SPARSER::COLLECTION)
    ("-β-galactosidase" . SPARSER::COLLECTION) ("TNF" . SPARSER::PROTEIN)
    ("Nbs1" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ataxia telangiectasia and Rad3-related protein" . SPARSER::PROTEIN)
    ("p16INk4a" . SPARSER::PROTEIN) ("Waf1" . SPARSER::PROTEIN)
    ("HMGB1" . SPARSER::PROTEIN) ("HMGA1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16INK4a" . SPARSER::PROTEIN) ("HMG-1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("p27Kip1" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("caspase 8" . SPARSER::PROTEIN) ("Bcl2" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("inflammation-driven colon cancer" . SPARSER::PROTEIN)
    ("a multifunctional kinase" . SPARSER::KINASE)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("IBD and CRC" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION) ("mTORC" . SPARSER::PROTEIN)
    ("eIF4E and S6K1" . SPARSER::COLLECTION)
    ("PAK1 and p" . SPARSER::COLLECTION) ("SAPK/JNK/p38" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a scaffolding protein and a nodal kinase" . SPARSER::COLLECTION)
    ("AKT and mTOR" . SPARSER::COLLECTION)
    ("MEK and AKT" . SPARSER::COLLECTION)
    ("ERK1/2 and AKT1" . SPARSER::COLLECTION)
    ("IPA3 and a higher dose" . SPARSER::COLLECTION)
    ("membranous β-catenin" . SPARSER::PROTEIN)
    ("PAK1-β catenin" . SPARSER::COLLECTION)
    ("β-catenin and PAK1" . SPARSER::COLLECTION)
    ("PAK1 and β-catenin" . SPARSER::COLLECTION)
    ("K-Ras (DLD-1, LoVo, HCT116) and p53 (HT29, HCT116 p53 −/− )"
     . SPARSER::COLLECTION)
    ("raptor" . SPARSER::PROTEIN) ("LY294002, and mTOR" . SPARSER::COLLECTION)
    ("LY294002 and U0126" . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("IBD or CAC" . SPARSER::COLLECTION)
    ("p-AKT1" . SPARSER::COLLECTION) ("p-mTOR" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("AKT1 and mTOR" . SPARSER::COLLECTION)
    ("CAC, p53 and K-Ras" . SPARSER::COLLECTION)
    ("sporadic CRC" . SPARSER::PROTEIN)
    ("NF-κB, JNK, and p38MAPK" . SPARSER::COLLECTION)
    ("ASA and PAK1" . SPARSER::COLLECTION) ("Mesalamine" . SPARSER::DRUG)
    ("mucosal barrier" . SPARSER::PROTEIN)
    ("PI3K-AKT/mTOR" . SPARSER::COLLECTION)
    ("PAK1, and beta-catenin" . SPARSER::COLLECTION)
    ("MEK, PI3K, and mTOR" . SPARSER::COLLECTION)
    ("MEK/PI3K/mTOR" . SPARSER::COLLECTION)
    ("IBD and CAC" . SPARSER::COLLECTION) ("CAC" . SPARSER::PROTEIN)
    ("IBD" . SPARSER::PROTEIN) ("Wnt-β catenin" . SPARSER::COLLECTION)
    ("ASA" . SPARSER::PROTEIN) ("mesalamine" . SPARSER::DRUG)
    ("IF4e" . SPARSER::PROTEIN) ("phospholipase-D" . SPARSER::PROTEIN)
    ("scaffolding protein" . SPARSER::PROTEIN) ("DLD-1" . SPARSER::PROTEIN)
    ("PDK2" . SPARSER::PROTEIN) ("alpha-tubulin" . SPARSER::PROTEIN)
    ("PI3 Kinase" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("IPA3" . SPARSER::MOLECULE) ("RAC1" . SPARSER::PROTEIN)
    ("β–catenin" . SPARSER::PROTEIN) ("PPAR-γ" . SPARSER::PROTEIN)
    ("p21 activated kinase 1" . SPARSER::PROTEIN)
    ("state and gene" . SPARSER::COLLECTION)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY) ("KITLG" . SPARSER::PROTEIN)
    ("glucocorticoid" . SPARSER::PROTEIN) ("UTX" . SPARSER::PROTEIN)
    ("PERP" . SPARSER::PROTEIN)
    ("polycomb (PcG-H3K27me3) or heterochromatin ( xref )"
     . SPARSER::COLLECTION)
    ("CTCF, polycomb (PcG-H3K27me3) or heterochromatin ( xref )"
     . SPARSER::COLLECTION)
    ("PcG-H3K27me3" . SPARSER::COLLECTION) ("GDNF" . SPARSER::PROTEIN)
    ("HiC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("well-studied p53-regulated genes" . SPARSER::GENE)
    ("nucleosomes" . SPARSER::BIO-COMPLEX)
    ("the DNA-damaging chemotherapeutic agent DXR" . SPARSER::PROTEIN)
    ("MIRb" . SPARSER::PROTEIN) ("significantly higher PWM" . SPARSER::DRUG)
    ("Alu and L2 family p53REs" . SPARSER::COLLECTION)
    ("the endogenous retroviral elements MER61, LTR10B1, and MLT1H"
     . SPARSER::COLLECTION)
    ("MER61, LTR10B1, and MLT1H" . SPARSER::COLLECTION)
    ("MER" . SPARSER::PROTEIN)
    ("pre-existing accessible chromatin (DHS)" . SPARSER::PROTEIN)
    ("down-regulated genes displayed active promoters" . SPARSER::PROMOTER)
    ("PWMs" . SPARSER::DRUG) ("PWM" . SPARSER::DRUG)
    ("Growth arrest and DNA-damage-inducible, alpha) and BCL2A1"
     . SPARSER::COLLECTION)
    ("open-chromatin" . SPARSER::PROTEIN)
    ("only minimal H3K4" . SPARSER::PROTEIN)
    ("H3K27me3, and CTCF" . SPARSER::COLLECTION) ("TGFA" . SPARSER::PROTEIN)
    ("H3K27me3 and H3K4" . SPARSER::COLLECTION) ("RRAD" . SPARSER::PROTEIN)
    ("active promoters" . SPARSER::PROMOTER)
    ("highly-inducible p53 genes" . SPARSER::GENE)
    ("repressive chromatin" . SPARSER::PROTEIN)
    ("PcG/H3K27me3" . SPARSER::COLLECTION) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("the highly-induced p53 gene GDF15" . SPARSER::PROTEIN)
    ("Stress-induced H3K4" . SPARSER::PROTEIN)
    ("their associated HMM" . SPARSER::DRUG)
    ("weak enhancer/open chromatin" . SPARSER::BIO-COMPLEX)
    ("active promoter" . SPARSER::PROMOTER)
    ("polycomb and heterochromatin" . SPARSER::COLLECTION)
    ("an active promoter" . SPARSER::PROMOTER) ("State" . SPARSER::BIO-STATE)
    ("which displays insulating CTCF" . SPARSER::PROTEIN)
    ("Histone" . SPARSER::PROTEIN) ("-GDF15" . SPARSER::COLLECTION)
    ("Our study sheds new light" . SPARSER::PROTEIN)
    ("state and p53RE" . SPARSER::COLLECTION)
    ("chemotherapeutic agent doxorubicin (DXR)" . SPARSER::PROTEIN)
    ("doxorubicin (DXR)" . SPARSER::PROTEIN)
    ("CCCTC-binding factor (CTCF)" . SPARSER::PROTEIN) ("HMM" . SPARSER::DRUG)
    ("response elements and evolutionary conservation of p53REs"
     . SPARSER::COLLECTION)
    ("DNA and subsequent transcriptional activation xref"
     . SPARSER::COLLECTION)
    ("p53 and the genome" . SPARSER::COLLECTION) ("pyrimidine" . SPARSER::DRUG)
    ("state and sequence" . SPARSER::COLLECTION)
    ("genome-wide chromatin state" . SPARSER::BIO-STATE)
    ("Mer" . SPARSER::PROTEIN) ("nucleosome" . SPARSER::BIO-COMPLEX)
    ("CTCF" . SPARSER::PROTEIN) ("DNase" . SPARSER::PROTEIN)
    ("p53 and H3K4" . SPARSER::COLLECTION) ("DXR" . SPARSER::PROTEIN)
    ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JMJD3" . SPARSER::PROTEIN)
    ("RNF144B" . SPARSER::PROTEIN) ("GPR87" . SPARSER::PROTEIN)
    ("CYP4F3" . SPARSER::PROTEIN) ("ANK1" . SPARSER::PROTEIN)
    ("EPHA2" . SPARSER::PROTEIN) ("DDR1" . SPARSER::PROTEIN)
    ("Response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("5FU" . SPARSER::DRUG) ("BCL2A1" . SPARSER::PROTEIN)
    ("Growth arrest and DNA-damage-inducible" . SPARSER::PROTEIN)
    ("GADD45A" . SPARSER::PROTEIN) ("alpha)" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::PROTEIN)
    ("Sulfatase 2" . SPARSER::PROTEIN) ("SULF2" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE)
    ("Growth Differentiation Factor 15" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN)
    ("Pyroglutamyl-Peptidase I" . SPARSER::PROTEIN)
    ("PGPEP1" . SPARSER::PROTEIN) ("CCCTC-binding factor" . SPARSER::PROTEIN)
    ("Zinc finger" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("Tumor suppressor p53" . SPARSER::PROTEIN)
    ("etoposide, hydroxydaunorubicin, or cyclophosphamide"
     . SPARSER::COLLECTION)
    ("transcriptionally active genes" . SPARSER::GENE)
    ("the S-tagged p30 II protein" . SPARSER::PROTEIN)
    ("large ribosomal subunit protein L18a" . SPARSER::PROTEIN)
    ("related HTLV-2 p28 II proteins" . SPARSER::PROTEIN)
    ("interactomes" . SPARSER::PROTEIN) ("DNA-repair" . SPARSER::DNA)
    ("the genotoxic chemical" . SPARSER::MOLECULE)
    ("transfectedc-myc" . SPARSER::COLLECTION)
    ("the acetylation-defective c-MYC mutants" . SPARSER::MUTANT)
    ("Camptothecin" . SPARSER::DRUG)
    ("the acetylation-defective Lys→Arg substitution mutants"
     . SPARSER::MUTANT)
    ("a transcriptional cofactor" . SPARSER::MOLECULE)
    ("c-MYC/TIP60/p300" . SPARSER::COLLECTION) ("TREs" . SPARSER::PROTEIN)
    ("the transcriptional cofactors" . SPARSER::PROTEIN)
    ("The p30 II accessory protein" . SPARSER::PROTEIN)
    ("retroviral proteins" . SPARSER::PROTEIN)
    ("etoposide, hydroxydaunorubicin, and cyclophosphamide"
     . SPARSER::COLLECTION)
    ("prednisolone" . SPARSER::DRUG) ("CHOP" . SPARSER::PROTEIN)
    ("hydroxydaunorubicin" . SPARSER::DRUG) ("ACH" . SPARSER::PROTEIN)
    ("The K323R/K417R and R5 acetylation-defective mutants" . SPARSER::MUTANT)
    ("bromodeoxyuridine" . SPARSER::DRUG)
    ("p30 II (HA)/c-MYC" . SPARSER::COLLECTION)
    ("the wildtype c-MYC or acetylation-defective mutant proteins"
     . SPARSER::COLLECTION)
    ("acetylation-defective mutant proteins" . SPARSER::PROTEIN)
    ("thec-myc" . SPARSER::COLLECTION) ("FITC" . SPARSER::MOLECULE)
    ("sphingolipid" . SPARSER::MOLECULE)
    ("wildtype c-MYC or the Lys→Arg acetylation-defective mutants"
     . SPARSER::COLLECTION)
    ("the Lys→Arg acetylation-defective mutants" . SPARSER::MUTANT)
    ("-inhibitor" . SPARSER::INHIBITOR) ("TSA" . SPARSER::PROTEIN)
    ("Trichostatin" . SPARSER::MOLECULE)
    ("The endogenous p30 II protein" . SPARSER::PROTEIN)
    ("Acetyl" . SPARSER::MOLECULE) ("the p30 II -GFP" . SPARSER::COLLECTION)
    ("Untransfectedc-myc" . SPARSER::COLLECTION)
    ("GFP, and c-MYC" . SPARSER::COLLECTION)
    ("cotransfectedc-myc" . SPARSER::COLLECTION)
    ("the acetylation-defective Lys→Arg c-MYC mutants" . SPARSER::MUTANT)
    ("The HTLV-1 p30 II protein" . SPARSER::PROTEIN)
    ("c-MYC/GFP" . SPARSER::COLLECTION) ("Thec-myc" . SPARSER::COLLECTION)
    ("TGR" . SPARSER::PROTEIN) ("the transformed foci" . SPARSER::PROTEIN)
    ("CMV-HTLV-1 p30 II -GFP" . SPARSER::COLLECTION)
    ("usingc-myc" . SPARSER::COLLECTION)
    ("Acetylation-defective Lys→Arg c-MYC substitution mutants"
     . SPARSER::MUTANT)
    ("the p30 II /c-MYC complex" . SPARSER::BIO-COMPLEX)
    ("Peptide" . SPARSER::PEPTIDE)
    ("cross-linked bound oligonucleosomal protein" . SPARSER::PROTEIN)
    ("antibodies and Protein A-agarose" . SPARSER::COLLECTION)
    ("c-MYC, TIP60, and p300" . SPARSER::COLLECTION)
    ("c-MYC and its associated transcriptional cofactors TIP60"
     . SPARSER::COLLECTION)
    ("its associated transcriptional cofactors TIP60" . SPARSER::PROTEIN)
    ("the retroviral p30 II accessory protein" . SPARSER::PROTEIN)
    ("TRRAP/p434" . SPARSER::COLLECTION) ("TRRAP" . SPARSER::PROTEIN)
    ("TIP60 and p300" . SPARSER::COLLECTION)
    ("either CMV-HTLV-1 p30 II -GFP" . SPARSER::COLLECTION)
    ("TIP60-FLAG" . SPARSER::COLLECTION)
    ("the p30 II (HA-tagged) protein" . SPARSER::PROTEIN)
    ("The p30 II -GFP" . SPARSER::COLLECTION) ("siRNA-" . SPARSER::PROTEIN)
    ("p30 II /c-MYC nuclear complexes" . SPARSER::BIO-COMPLEX)
    ("the HTLV-1 p30 II (HA-tagged) protein" . SPARSER::PROTEIN)
    ("p30 II -GFP" . SPARSER::COLLECTION)
    ("the CMV-HTLV-1 p30 II -GFP" . SPARSER::COLLECTION)
    ("HEK" . SPARSER::PROTEIN) ("HTLV-1 p30 II -GFP" . SPARSER::COLLECTION)
    ("retroviral accessory proteins" . SPARSER::PROTEIN)
    ("another basic domain/helix-loop-helix/leucine zipper (bHLHZip)-family transcription factor"
     . SPARSER::PROTEIN)
    ("PCAF/GCN5" . SPARSER::COLLECTION)
    ("cofactors/acetyltransferases" . SPARSER::COLLECTION)
    ("the viral pX proteins" . SPARSER::PROTEIN)
    ("promoter, and xref" . SPARSER::COLLECTION)
    ("The viral Tax protein" . SPARSER::PROTEIN)
    ("The p13 II protein" . SPARSER::PROTEIN)
    ("the RNA Pol II elongation complex" . SPARSER::BIO-COMPLEX)
    ("The related p28 II protein" . SPARSER::PROTEIN)
    ("the p30 II protein" . SPARSER::PROTEIN) ("-p30" . SPARSER::COLLECTION)
    ("Gal4" . SPARSER::PROTEIN) ("Gal" . SPARSER::PROTEIN)
    ("arginine- and serine/threonine-rich regions which share"
     . SPARSER::COLLECTION)
    ("an alternative doubly-spliced pX mRNA" . SPARSER::PROTEIN)
    ("The p30 II protein" . SPARSER::PROTEIN)
    ("arginine-" . SPARSER::AMINO-ACID) ("HAT" . SPARSER::PROTEIN)
    ("HBZ, and p13" . SPARSER::COLLECTION)
    ("the p30 II accessory protein" . SPARSER::PROTEIN)
    ("JunD" . SPARSER::PROTEIN)
    ("the HTLV-1 basic domain/leucine zipper (HBZ) protein" . SPARSER::PROTEIN)
    ("the major oncoprotein" . SPARSER::PROTEIN)
    ("proviral and cellular genes" . SPARSER::GENE)
    ("NF-kappaB, and SRF" . SPARSER::COLLECTION)
    ("p300/CREB-binding protein" . SPARSER::COLLECTION)
    ("CREB/ATF-1" . SPARSER::COLLECTION) ("SRF" . SPARSER::PROTEIN)
    ("accessory proteins" . SPARSER::PROTEIN) ("pX" . SPARSER::PROTEIN)
    ("HBZ" . SPARSER::PROTEIN) ("p12" . SPARSER::PROTEIN)
    ("p30 II /c-MYC" . SPARSER::COLLECTION) ("/c-MYC" . SPARSER::COLLECTION)
    ("Acetylation-defective c-MYC Lys→Arg substitution mutants"
     . SPARSER::MUTANT)
    ("inc-myc" . SPARSER::COLLECTION)
    ("The human T-cell leukemia retrovirus type-1 (HTLV-1) p30 II protein"
     . SPARSER::PROTEIN)
    ("C2-Ceramide" . SPARSER::MOLECULE) ("N3" . SPARSER::PROTEIN)
    ("CCL-2" . SPARSER::PROTEIN) ("TGR1" . SPARSER::PROTEIN)
    ("L18a" . SPARSER::PROTEIN) ("S-tag" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("C2-ceramide" . SPARSER::MOLECULE) ("tip60" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("Tax protein" . SPARSER::PROTEIN) ("TIP60" . SPARSER::PROTEIN)
    ("p28" . SPARSER::PROTEIN) ("NLS1" . SPARSER::PROTEIN)
    ("Oct-1" . SPARSER::PROTEIN) ("CREB-binding protein" . SPARSER::PROTEIN)
    ("p67" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("ATF-1" . SPARSER::PROTEIN) ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p30" . SPARSER::PROTEIN)
    ("a modified BTG3 peptide or its derivatives" . SPARSER::COLLECTION)
    ("BTG3 and PTEN" . SPARSER::COLLECTION)
    ("a Btg3 conditional allele" . SPARSER::ALLELE) ("Btg3" . SPARSER::PROTEIN)
    ("phospho-ERK and phospho-AKT" . SPARSER::COLLECTION)
    ("loss of heterozygosity or promoter" . SPARSER::COLLECTION)
    ("BTG3 and Tob" . SPARSER::COLLECTION)
    ("BTG3 and phospho-AKT" . SPARSER::COLLECTION) ("mHW" . SPARSER::PROTEIN)
    ("BTG3-mHW" . SPARSER::PROTEIN-PAIR) ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("an exogenous myc-tagged BTG3" . SPARSER::PROTEIN)
    ("Tet" . SPARSER::PROTEIN) ("a C5-derived peptide" . SPARSER::PEPTIDE)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibronectin and ZEB1" . SPARSER::COLLECTION)
    ("β -catenin/TCF" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("fibronectin, and vimentin" . SPARSER::COLLECTION)
    ("AKT and GSK3 β" . SPARSER::COLLECTION)
    ("AKT-GSK3β" . SPARSER::COLLECTION) ("BTG3-AKT" . SPARSER::COLLECTION)
    ("PH-AKT" . SPARSER::COLLECTION) ("GFP-PH-Grp1" . SPARSER::COLLECTION)
    ("GFP-fused" . SPARSER::COLLECTION) ("GFP-PH-AKT" . SPARSER::COLLECTION)
    ("membrane-associated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BTG3 and AKT" . SPARSER::COLLECTION)
    ("PH and kinase" . SPARSER::COLLECTION)
    ("AKT-GSK3 β" . SPARSER::COLLECTION)
    ("factor- κ B and FOXO" . SPARSER::COLLECTION)
    ("BTG1 and BTG2" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin E" . SPARSER::COLLECTION)
    ("BTG2 and BTG3" . SPARSER::COLLECTION)
    ("antiproliferative protein family" . SPARSER::PROTEIN-FAMILY)
    ("Tis21" . SPARSER::PROTEIN) ("BTG/Tob" . SPARSER::COLLECTION)
    ("Tob" . SPARSER::PROTEIN) ("β -catenin/T-cell" . SPARSER::COLLECTION)
    ("anti- β" . SPARSER::PROTEIN) ("Foxn1" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("GSK-3 β" . SPARSER::PROTEIN)
    ("α -tubulin" . SPARSER::PROTEIN) ("T-1" . SPARSER::PROTEIN)
    ("F-12 " . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("Btg2" . SPARSER::PROTEIN) ("BTG family" . SPARSER::PROTEIN-FAMILY)
    ("a 3D" . SPARSER::PROTEIN) ("1–C" . SPARSER::PROTEIN)
    ("CT99021" . SPARSER::DRUG) ("homeobox 1" . SPARSER::PROTEIN)
    ("general receptor of phosphoinositides 1" . SPARSER::PROTEIN)
    ("Grp1" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::PROTEIN)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("kinase-1" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("factor- κ B" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("protein arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN)
    ("CCR4-associated factor 1" . SPARSER::PROTEIN)
    ("CAF1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cyclin E" . SPARSER::PROTEIN)
    ("Tob1" . SPARSER::PROTEIN) ("BTG2" . SPARSER::PROTEIN)
    ("BTG1" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("gene 3" . SPARSER::PROTEIN) ("BTG3" . SPARSER::PROTEIN)
    ("siRNA and miRNA" . SPARSER::COLLECTION)
    ("-ACGTAGACATTCCCC-3" . SPARSER::COLLECTION)
    ("-CTCAGCGGGATACGCTTCTT-3" . SPARSER::COLLECTION)
    ("-GAGAGTGCCACGTGCATACG-3" . SPARSER::COLLECTION)
    ("LBA, and RNA" . SPARSER::COLLECTION) ("SIGMA" . SPARSER::PROTEIN-FAMILY)
    ("TAP-TERT" . SPARSER::COLLECTION) ("DTT" . SPARSER::MOLECULE)
    ("NaCl" . SPARSER::PROTEIN) ("Tris" . SPARSER::MOLECULE)
    ("LBA" . SPARSER::PROTEIN) ("Differentially" . SPARSER::PROTEIN)
    ("hg" . SPARSER::MOLECULE)
    ("-CGGCGACCACGACAGGTTCAGAGTTCTACAG-3" . SPARSER::COLLECTION)
    ("-AATGATACGGCGACCACGACAGGTTCAGAGTTCTACAG-3" . SPARSER::COLLECTION)
    ("-ACAGGTTCAGAGTTCTACAG-3" . SPARSER::COLLECTION)
    ("-CAAGCAGAAGACGGCATACGA-3" . SPARSER::COLLECTION)
    ("chloroform" . SPARSER::MOLECULE)
    ("polynucleotide kinase (NEB)" . SPARSER::PROTEIN)
    ("pyrophosphatase" . SPARSER::PROTEIN)
    ("Antarctic phosphatase" . SPARSER::PHOSPHATASE) ("NEB" . SPARSER::PROTEIN)
    ("San" . SPARSER::PROTEIN)
    ("miRNAs and precursor miRNAs" . SPARSER::COLLECTION)
    ("ethanol" . SPARSER::PROTEIN)
    ("-GGAGGCTCTTCTTAGGGAAGC-3" . SPARSER::COLLECTION)
    ("-GCACTGTCTGAGGAGACTACA-3" . SPARSER::COLLECTION)
    ("-CGGCAGACACTGTGATCATTT-3" . SPARSER::COLLECTION)
    ("-CCCGTGGACTTCAAGAAGATA-3" . SPARSER::COLLECTION)
    ("-GACATGGAGAACAAGCTGTTT-3" . SPARSER::COLLECTION)
    ("-CCTGCGTTTGGTGGATGATTT-3" . SPARSER::COLLECTION)
    ("TERT-specific siRNAs or the calibrator negative control siRNA"
     . SPARSER::COLLECTION)
    ("the specific siRNAs or the calibrator negative control siRNA"
     . SPARSER::COLLECTION)
    ("-GGGAGACTGTGATCCGGTAG-3" . SPARSER::COLLECTION)
    ("-CACAGGAATTAGGCACAGCA-3" . SPARSER::COLLECTION)
    ("-CAGGGTCCCAGAACTACCAA-3" . SPARSER::COLLECTION)
    ("-TCTGTACATTCAAAAGAAAGAGATTC-3" . SPARSER::COLLECTION)
    ("-ATCAGCCAGTGCAGGAACTT-3" . SPARSER::COLLECTION)
    ("-AGCTGACGTGGAAGATGAGC-3" . SPARSER::COLLECTION)
    ("TRIzol" . SPARSER::DRUG)
    ("-AAUGCUUUGCAACUUGCUCTT-3" . SPARSER::COLLECTION)
    ("-GAGCAAGUUGCAAAGCAUUTT-3" . SPARSER::COLLECTION)
    ("1 mM sodium pyruvate (Invitrogen) and 50 μM 2-mercaptoethanol (Invitrogen)"
     . SPARSER::COLLECTION)
    ("mercaptoethanol" . SPARSER::MOLECULE) ("HEPES" . SPARSER::MOLECULE)
    ("miR-1, miR-21, miR-29a and miR-208a" . SPARSER::COLLECTION)
    ("mature miR-21, miR-29a and miR-208a" . SPARSER::COLLECTION)
    ("miR-21, miR-29a and miR-208a" . SPARSER::COLLECTION)
    ("mature miR-1" . SPARSER::PROTEIN)
    ("immature (pri- and pre-) miR-1 and miR-29a" . SPARSER::COLLECTION)
    ("miR-1 and miR-29a" . SPARSER::COLLECTION) ("pre-" . SPARSER::PROTEIN)
    ("DICER, and BRG1" . SPARSER::COLLECTION) ("myogenic" . SPARSER::PROTEIN)
    ("MyoD" . SPARSER::PROTEIN) ("TERT-BRG1" . SPARSER::COLLECTION)
    ("TERT and BRG1" . SPARSER::COLLECTION)
    ("β-catenin-TCF" . SPARSER::COLLECTION)
    ("MYC, OCT4 and SOX2" . SPARSER::COLLECTION)
    ("OCT4 and SOX2" . SPARSER::COLLECTION)
    ("Oct4, Sox2, Nanog and Tcf3" . SPARSER::COLLECTION)
    ("TFIIB" . SPARSER::PROTEIN)
    ("the Pol II-transcribed miRNA promoters" . SPARSER::PROMOTER)
    ("cellular mRNAs" . SPARSER::PROTEIN) ("Primary miRNAs" . SPARSER::PROTEIN)
    ("the mature miRNAs" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN) ("TBN" . SPARSER::PROTEIN)
    ("primary miRNA" . SPARSER::PROTEIN)
    ("ACTB and GAPDH" . SPARSER::COLLECTION) ("ACTB" . SPARSER::PROTEIN)
    ("both primary miRNAs and mRNAs" . SPARSER::COLLECTION)
    ("miRNAs and mRNAs" . SPARSER::COLLECTION)
    ("the primary miRNAs" . SPARSER::PROTEIN)
    ("almost all miRNAs" . SPARSER::PROTEIN)
    ("Primary miRNA" . SPARSER::PROTEIN)
    ("TERC and RMRP" . SPARSER::COLLECTION) ("RMRP" . SPARSER::RNA)
    ("physically-interacting RNAs" . SPARSER::RNA)
    ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("mature miRNAs" . SPARSER::PROTEIN)
    ("selected mature miRNAs" . SPARSER::PROTEIN)
    ("only nine and eight miRNAs" . SPARSER::PROTEIN)
    ("sh-GFP" . SPARSER::COLLECTION) ("only six miRNAs" . SPARSER::PROTEIN)
    ("DICER or DROSHA" . SPARSER::COLLECTION)
    ("many ribosomal RNAs" . SPARSER::RNA) ("rRNAs" . SPARSER::RNA)
    ("tRNAs" . SPARSER::PROTEIN) ("tRNA" . SPARSER::PROTEIN)
    ("TERT or a control siRNA" . SPARSER::COLLECTION)
    ("human monocytic leukemia cell line THP-1" . SPARSER::PROTEIN)
    ("RNA ( RMRP )" . SPARSER::RNA)
    ("post-transcriptional gene" . SPARSER::GENE)
    ("TERT-RdRP" . SPARSER::COLLECTION)
    ("BRG1 (also called SMARCA4) and nucleostemin (NS) [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("nucleostemin (NS)" . SPARSER::PROTEIN) ("RdRP" . SPARSER::PROTEIN)
    ("several proteins and a non-coding RNA" . SPARSER::COLLECTION)
    ("the minimal essential components" . SPARSER::COMPONENT)
    ("TWIST1 [ xref , xref ] and NF-κB [ xref ]" . SPARSER::COLLECTION)
    ("primary miRNAs" . SPARSER::PROTEIN)
    ("either BRG1 (also called SMARCA4) or nucleostemin" . SPARSER::COLLECTION)
    ("nucleostemin" . SPARSER::PROTEIN) ("THP-1" . SPARSER::PROTEIN)
    ("mature microRNAs" . SPARSER::RNA)
    ("enzymes, DROSHA and DICER" . SPARSER::COLLECTION)
    ("DICER" . SPARSER::PROTEIN) ("DROSHA" . SPARSER::PROTEIN)
    ("U3" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("miR-1" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("Tcf3" . SPARSER::PROTEIN) ("pre-miRNAs" . SPARSER::RNA)
    ("AGO2" . SPARSER::PROTEIN)
    ("RNA-dependent RNA polymerase" . SPARSER::PROTEIN)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("pri-miRNA" . SPARSER::RNA) ("pri-miRNAs" . SPARSER::RNA)
    ("XPO5" . SPARSER::PROTEIN) ("SMARCA4" . SPARSER::PROTEIN)
    ("BRG1" . SPARSER::PROTEIN) ("RNase III" . SPARSER::PROTEIN)
    ("PAK4 and PKD1" . SPARSER::COLLECTION) ("SSH" . SPARSER::MOLECULE)
    ("LIMK or TESKs" . SPARSER::COLLECTION)
    ("LIMK and TESK" . SPARSER::COLLECTION)
    ("proteins and chronophin" . SPARSER::COLLECTION)
    ("LIMK" . SPARSER::PROTEIN) ("PKCβ and PKD" . SPARSER::COLLECTION)
    ("PLC/PKCβ/PKD" . SPARSER::COLLECTION)
    ("PLCβ2 and β3" . SPARSER::COLLECTION)
    ("PLCβ2, ‑β3, and ‑e" . SPARSER::COLLECTION)
    ("PLC/PKCβ" . SPARSER::COLLECTION) ("PLC/PKC/PKD" . SPARSER::COLLECTION)
    ("polymorphonuclear neutrophils" . SPARSER::PROTEIN)
    ("peripheral neutrophil chemotaxis" . SPARSER::PROTEIN)
    ("PLC/PKC/PKD1" . SPARSER::COLLECTION) ("global actin" . SPARSER::PROTEIN)
    ("SSH2 and 14‑3‑3" . SPARSER::COLLECTION)
    ("ADF/cofilin" . SPARSER::COLLECTION)
    ("a dominant-negative PKCβII mutant (PKCβII-DN) or a constitutively active PKCβII mutant (PKCβII-CA)"
     . SPARSER::COLLECTION)
    ("PKCβII" . SPARSER::PROTEIN) ("PKCβII-GFP" . SPARSER::COLLECTION)
    ("anti-PKCα or -β–specific" . SPARSER::COLLECTION)
    ("PKCs and PKDs" . SPARSER::COLLECTION) ("DAGs" . SPARSER::DAG)
    ("toxin" . SPARSER::MOLECULE) ("Gαi" . SPARSER::PROTEIN)
    ("PLCγ2-GFP" . SPARSER::COLLECTION)
    ("PLCβ2 and PLCβ3" . SPARSER::COLLECTION)
    ("HL60 and Raw 264.7cells" . SPARSER::COLLECTION)
    ("PLCβ2, ‑β3, and ‑γ2" . SPARSER::COLLECTION)
    ("Neutrophils" . SPARSER::PROTEIN) ("DAGR-GFP" . SPARSER::COLLECTION)
    ("heterotrimeric proteins" . SPARSER::PROTEIN)
    ("DAG and the subsequent translocation of PKD1 to the membrane"
     . SPARSER::COLLECTION)
    ("PKD1-GFP" . SPARSER::COLLECTION) ("glycine" . SPARSER::AMINO-ACID)
    ("Gαi-GPCRs" . SPARSER::PROTEIN-PAIR)
    ("PKD1–green fluorescent protein (GFP)" . SPARSER::COLLECTION)
    ("PKD2–cyan fluorescent protein (CFP)" . SPARSER::PROTEIN)
    ("PKD3-GFP" . SPARSER::COLLECTION)
    ("PKD1–green fluorescent protein" . SPARSER::COLLECTION)
    ("Chemoattractants" . SPARSER::PROTEIN) ("pkd1" . SPARSER::PROTEIN)
    ("pkd" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("robust chemotaxis" . SPARSER::PROTEIN)
    ("f-Met-Leu-Phe" . SPARSER::COLLECTION) ("EZ-TAXI" . SPARSER::COLLECTION)
    ("fMLP" . SPARSER::PROTEIN) ("TAXI" . SPARSER::PROTEIN)
    ("EZ" . SPARSER::PROTEIN-FAMILY) ("HL60" . SPARSER::PROTEIN)
    ("PKD1, PKD2, and PKD3" . SPARSER::COLLECTION)
    ("protein, PLC, PKCβ, and PKDs" . SPARSER::COLLECTION)
    ("SSH2/cofilin" . SPARSER::COLLECTION)
    ("PLC, PKC, or PKD" . SPARSER::COLLECTION)
    ("PLC, PKC, and PKD" . SPARSER::COLLECTION)
    ("PKC and PKD" . SPARSER::COLLECTION) ("PKDs" . SPARSER::PROTEIN)
    ("inositol-3" . SPARSER::COLLECTION) ("DAG" . SPARSER::DAG)
    ("LIM kinases and testicular protein kinases (TESKs)"
     . SPARSER::COLLECTION)
    ("slingshot proteins (SSHs) and chronophin" . SPARSER::COLLECTION)
    ("testicular protein kinases" . SPARSER::PROTEIN)
    ("chronophin" . SPARSER::PROTEIN) ("ADF" . SPARSER::PROTEIN)
    ("new actin" . SPARSER::PROTEIN) ("cdc42 and Rac1/2" . SPARSER::COLLECTION)
    ("Chemokine" . SPARSER::PROTEIN)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("chemoattractants" . SPARSER::PROTEIN) ("slingshot" . SPARSER::PROTEIN)
    ("PLC/PKC" . SPARSER::COLLECTION) ("neutrophil" . SPARSER::PROTEIN)
    ("Chemotaxis" . SPARSER::PROTEIN) ("neutrophils" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PKD" . SPARSER::PROTEIN)
    ("PLC" . SPARSER::PROTEIN) ("Fluo-4" . SPARSER::DRUG)
    ("NaVO 3" . SPARSER::MOLECULE) ("Anti–" . SPARSER::ANTIBODY)
    ("PKCμ" . SPARSER::PROTEIN) ("CSF-1" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("PAK4" . SPARSER::PROTEIN)
    ("p21–activated kinase 4" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("Gö 6983" . SPARSER::DRUG) ("PLCβ3" . SPARSER::PROTEIN)
    ("Gαq" . SPARSER::PROTEIN) ("1–4" . SPARSER::PROTEIN)
    ("derived factor-1" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("PKD3" . SPARSER::PROTEIN) ("PKD2" . SPARSER::PROTEIN)
    ("SSH1" . SPARSER::PROTEIN) ("PLCβ2" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3) ("Phospholipase C" . SPARSER::PROTEIN)
    ("PI3Kγ" . SPARSER::PROTEIN) ("cdc42" . SPARSER::PROTEIN)
    ("G protein–coupled" . SPARSER::PROTEIN) ("PKD1" . SPARSER::PROTEIN)
    ("PLCγ2" . SPARSER::PROTEIN) ("SSH2" . SPARSER::PROTEIN)
    ("hyperactive mTORC1" . SPARSER::PROTEIN)
    ("senescence-associated β-galactosidase" . SPARSER::PROTEIN)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic
Bad"
     . SPARSER::PROTEIN)
    ("Atg12 and Mcl - 1" . SPARSER::COLLECTION)
    ("Bcl - 2/Bcl - xL" . SPARSER::COLLECTION)
    ("Beclin1/Vps32" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("Atg16" . SPARSER::PROTEIN)
    ("Atg5 , Beclin1 ,
and p62"
     . SPARSER::COLLECTION)
    ("Tsc2" . SPARSER::PROTEIN) ("mTORC1 and PLK1" . SPARSER::COLLECTION)
    ("CDK1/cyclin" . SPARSER::COLLECTION)
    ("Complex
(TSC)"
     . SPARSER::BIO-COMPLEX)
    ("pro-apoptotic Bad" . SPARSER::PROTEIN) ("Bad" . SPARSER::PROTEIN)
    ("ATG16L2 and ATG9B" . SPARSER::COLLECTION) ("Atg3" . SPARSER::PROTEIN)
    ("proteins and genes" . SPARSER::COLLECTION)
    ("autophagosomal cargo proteins" . SPARSER::PROTEIN)
    ("PARP and caspase 3" . SPARSER::COLLECTION)
    ("poly (ADP-ribose) polymerase
(PARP) and D175-caspase 3 (cleaved caspase 3)"
     . SPARSER::COLLECTION)
    ("polymerase
(PARP)"
     . SPARSER::PROTEIN)
    ("TSC1 or TSC2" . SPARSER::COLLECTION)
    ("MEF
and tuberin"
     . SPARSER::COLLECTION)
    ("Tsc1" . SPARSER::PROTEIN) ("nocodazole" . SPARSER::DRUG)
    ("p62 and LC3B-I" . SPARSER::COLLECTION)
    ("hamartin or tuberin" . SPARSER::COLLECTION)
    ("p70S6K, ribosomal protein S6, and 4E-BP1" . SPARSER::COLLECTION)
    ("ULK1/ULK2" . SPARSER::COLLECTION)
    ("mTORC1,
rapamycin and rapamycin"
     . SPARSER::COLLECTION)
    ("AMPK and REDD1" . SPARSER::COLLECTION) ("refs" . SPARSER::PROTEIN)
    ("ERK1/2, and RSK1" . SPARSER::COLLECTION)
    ("AKT/PKB" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("a functional heterodimer that negatively
regulates cell growth via tuberin's"
     . SPARSER::HETERODIMER)
    ("p62, LC3B-I and GFP-LC3" . SPARSER::COLLECTION)
    ("hamartin and tuberin" . SPARSER::COLLECTION)
    ("Hamartin and tuberin" . SPARSER::COLLECTION)
    ("hamartin/tuberin" . SPARSER::COLLECTION)
    ("the centrosomal and mitotic kinase
polo-like kinase 1"
     . SPARSER::PROTEIN)
    ("Hamartin" . SPARSER::PROTEIN) ("Complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("hamartin and
tuberin"
     . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX) ("Beclin 1" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("GW843682X" . SPARSER::DRUG) ("L -glutamine" . SPARSER::MOLECULE)
    ("p16 Ink4a" . SPARSER::PROTEIN) ("Mcl - 1 protein" . SPARSER::PROTEIN)
    ("Vps32" . SPARSER::PROTEIN) ("Atg9" . SPARSER::PROTEIN-FAMILY)
    ("TACC3" . SPARSER::PROTEIN) ("PLK2" . SPARSER::PROTEIN)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mcl - 1" . SPARSER::PROTEIN)
    ("Bcl - xL" . SPARSER::PROTEIN) ("ATG16L1" . SPARSER::PROTEIN)
    ("ATG9B" . SPARSER::PROTEIN) ("ATG16L2" . SPARSER::PROTEIN)
    ("SQSTM1" . SPARSER::PROTEIN) ("S5B" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("ULK2" . SPARSER::PROTEIN)
    ("REDD1" . SPARSER::PROTEIN) ("RSK1" . SPARSER::PROTEIN)
    ("GTPase Activating Protein" . SPARSER::PROTEIN)
    ("Bcl - 2" . SPARSER::PROTEIN) ("BI-2536" . SPARSER::DRUG)
    ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("TGFBRI as well as TGFBRII" . SPARSER::COLLECTION)
    ("TGFBRI or SMAD3" . SPARSER::COLLECTION)
    ("BUB1 and SMAD2" . SPARSER::COLLECTION)
    ("BUB1 as well as a small molecule inhibitor" . SPARSER::COLLECTION)
    ("BUB1-TGFBRI" . SPARSER::COLLECTION) ("microtubules" . SPARSER::PROTEIN)
    ("BMPR2, RPS6KB1, NEK6 and JAK2" . SPARSER::COLLECTION)
    ("important biological regulators" . SPARSER::REGULATOR)
    ("traditional luciferase" . SPARSER::PROTEIN)
    ("TGFBRI, TGFBRII, and BUB1" . SPARSER::COLLECTION)
    ("TGFBRII and BUB1" . SPARSER::COLLECTION)
    ("BUB1, TGFBRI, and TGFBRII" . SPARSER::COLLECTION)
    ("the target of BUB1’s" . SPARSER::TARGET-PROTEIN)
    ("Myc-BUB1" . SPARSER::COLLECTION)
    ("the heteromeric receptor complex" . SPARSER::BIO-COMPLEX)
    ("SARA" . SPARSER::PROTEIN)
    ("this heteromeric receptor complex" . SPARSER::BIO-COMPLEX)
    ("TGFβ, and TGFBRI" . SPARSER::COLLECTION)
    ("receptor (TGFBRII)" . SPARSER::RECEPTOR) ("TGFBRII" . SPARSER::PROTEIN)
    ("TGFBRI-TGFBRII" . SPARSER::COLLECTION)
    ("TGFBRI and/or BUB1" . SPARSER::COLLECTION)
    ("TGFBRI and BUB1" . SPARSER::COLLECTION)
    ("BUB1 and TGFBRI" . SPARSER::COLLECTION) ("punctate" . SPARSER::PROTEIN)
    ("SMAD2/3" . SPARSER::PROTEIN) ("SMAD2/3-SMAD4" . SPARSER::COLLECTION)
    ("R-SMAD/SMAD4" . SPARSER::COLLECTION)
    ("TGFBRI or BUB1" . SPARSER::COLLECTION)
    ("TGFBRI- or BUB1-targeted siRNA" . SPARSER::COLLECTION)
    ("TGFBRI-" . SPARSER::PROTEIN)
    ("Flag-tagged SMAD3 and His-tagged TGFBRI" . SPARSER::COLLECTION)
    ("MAPK, and AKT" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN) ("–AKT" . SPARSER::COLLECTION)
    ("A549-BTR and MDA-231-1833-BTR" . SPARSER::COLLECTION)
    ("the kinases BMPR2 (in A549-BTR cells) and RPS6KB1 (in MDA-231-1833-BTR cells)"
     . SPARSER::COLLECTION)
    ("receptor (TGFBRI)" . SPARSER::RECEPTOR) ("BTR" . SPARSER::PROTEIN)
    ("BUB1 kinase (2OH-BNPP1) and a kinase-deficient mutant"
     . SPARSER::COLLECTION)
    ("the ternary complex" . SPARSER::BIO-COMPLEX)
    ("AKT and p38" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("TGFBRI and TGFBRII" . SPARSER::COLLECTION)
    ("Ser/Thr" . SPARSER::COLLECTION) ("benzimidazoles" . SPARSER::DRUG)
    ("TGFβ receptor 1 (TGFBRI) and TGFBRII" . SPARSER::COLLECTION)
    ("receptor 1 (TGFBRI)" . SPARSER::PROTEIN) ("TGFBRI" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("1 − 2" . SPARSER::PROTEIN) ("DF-1" . SPARSER::PROTEIN)
    ("tert -butyl" . SPARSER::MOLECULE) ("TGFβ1" . SPARSER::PROTEIN)
    ("L21" . SPARSER::PROTEIN) ("TGFBR1" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NEK6" . SPARSER::PROTEIN)
    ("SMAD anchor for receptor activation" . SPARSER::PROTEIN)
    ("R-SMAD" . SPARSER::PROTEIN-FAMILY) ("R-SMADs" . SPARSER::PROTEIN-FAMILY)
    ("c-JUN" . SPARSER::PROTEIN) ("RPS6KB1" . SPARSER::PROTEIN)
    ("BMPR2" . SPARSER::PROTEIN) ("OH-" . SPARSER::MOLECULE)
    ("BUB1" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("receptor 1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::PROTEIN)
    ("metabolites" . SPARSER::MOLECULE)
    ("the adrenal androgen DHEA" . SPARSER::DRUG)
    ("ER, AR, PR, or GR" . SPARSER::COLLECTION) ("GR" . SPARSER::PROTEIN)
    ("estrone" . SPARSER::DRUG) ("DHEA" . SPARSER::DRUG)
    ("c-Src/PI3-K/AKT" . SPARSER::COLLECTION)
    ("the nonaromatizable androgens" . SPARSER::DRUG)
    ("nilutamide, or AR" . SPARSER::COLLECTION) ("casodex" . SPARSER::DRUG)
    ("exogenous androgen or AR" . SPARSER::COLLECTION)
    ("androgen or AR" . SPARSER::COLLECTION)
    ("AR and SP1" . SPARSER::COLLECTION) ("SP1" . SPARSER::PROTEIN)
    ("flutamide and bicalutamide" . SPARSER::COLLECTION)
    ("finasteride and dutasteride" . SPARSER::COLLECTION)
    ("prostatic" . SPARSER::PROTEIN) ("goserelin" . SPARSER::DRUG)
    ("dutasteride" . SPARSER::DRUG) ("finasteride" . SPARSER::DRUG)
    ("bicalutamide" . SPARSER::DRUG) ("flutamide" . SPARSER::DRUG)
    ("antagonists" . SPARSER::MOLECULE) ("almost every type" . TYPE)
    ("met" . SPARSER::AMINO-ACID)
    ("AR and cancer-associated vasculature" . SPARSER::COLLECTION)
    ("cancer-associated vasculature" . SPARSER::PROTEIN)
    ("PI3-K/AKT" . SPARSER::COLLECTION) ("KS" . SPARSER::PROTEIN)
    ("gonadal" . SPARSER::PROTEIN-FAMILY)
    ("AR, and androgens" . SPARSER::COLLECTION)
    ("AR and 5α-reductase-1" . SPARSER::COLLECTION)
    ("receptors and aromatase" . SPARSER::COLLECTION)
    ("androgen/AR" . SPARSER::COLLECTION)
    ("a pivotal molecule" . SPARSER::MOLECULE)
    ("androgens and AR" . SPARSER::COLLECTION)
    ("the nonaromatizable DHT and DHT analog" . SPARSER::ANALOG)
    ("DHT and DHT" . SPARSER::COLLECTION) ("nilutamide" . SPARSER::DRUG)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("functional androgen receptor (AR)" . SPARSER::PROTEIN)
    ("myocardial ischemia" . SPARSER::PROTEIN) ("Androgens" . SPARSER::DRUG)
    ("retinoid" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("anti-diabetic" . SPARSER::DRUG) ("anti-angiogenic" . SPARSER::DRUG)
    ("TSC and the shagreen" . SPARSER::COLLECTION)
    ("hamartin" . SPARSER::PROTEIN) ("calmodulin" . SPARSER::PROTEIN)
    ("GAPD" . SPARSER::PROTEIN) ("CCD" . SPARSER::PROTEIN)
    ("tuberin" . SPARSER::PROTEIN) ("TAD2" . SPARSER::PROTEIN)
    ("Tuberous sclerosis complex 1 and TSC2 genes" . SPARSER::COLLECTION)
    ("the pathogenic genes" . SPARSER::GENE)
    ("Akt-mTOR-S6kinase" . SPARSER::COLLECTION) ("insA" . SPARSER::PROTEIN)
    ("TSC1 and TSC2" . SPARSER::COLLECTION)
    ("exon-intron" . SPARSER::PROTEIN-PAIR)
    ("severe mental retardation" . SPARSER::PROTEIN)
    ("epilepsy" . SPARSER::PROTEIN) ("valproate" . SPARSER::DRUG)
    ("multifocal spike wave and spike-slow wave complex" . SPARSER::COLLECTION)
    ("multifocal spike wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY) ("spike" . SPARSER::PROTEIN)
    ("seizures" . SPARSER::PROTEIN) ("complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC" . SPARSER::PROTEIN) ("CCD1" . SPARSER::PROTEIN)
    ("S6kinase" . SPARSER::PROTEIN-FAMILY) ("Akt-mTOR" . SPARSER::PROTEIN)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("Concanamycin" . SPARSER::MOLECULE)
    ("TFEB" . SPARSER::PROTEIN) ("S6 kinase and ULK-1" . SPARSER::COLLECTION)
    ("Folliculin" . SPARSER::PROTEIN)
    ("SLC38A9 and endogenous RAGC" . SPARSER::COLLECTION)
    ("LAMTOR1 and LAMTOR3" . SPARSER::COLLECTION) ("RAGA" . SPARSER::PROTEIN)
    ("their mutational state" . SPARSER::BIO-STATE)
    ("RAPTOR and LAMTOR" . SPARSER::COLLECTION)
    ("-histidine" . SPARSER::COLLECTION) ("-leucine" . SPARSER::COLLECTION)
    ("-asparagine" . SPARSER::COLLECTION) ("-arginine" . SPARSER::COLLECTION)
    ("asparagine" . SPARSER::AMINO-ACID)
    ("some polar amino acids" . SPARSER::AMINO-ACID)
    ("valinomycin" . SPARSER::MOLECULE) ("-glutamine" . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN)
    ("leucine and arginine" . SPARSER::COLLECTION)
    ("the described mutations affected lysosomal" . SPARSER::PROTEIN)
    ("FLCN-FNIP2" . SPARSER::COLLECTION) ("FLCN" . SPARSER::PROTEIN)
    ("VA" . SPARSER::MOLECULE)
    ("RAPTOR as well as SLC38A9 ( xref , xref )" . SPARSER::COLLECTION)
    ("CD63 and the late endosome/multivesicular bodies lipid LBPA"
     . SPARSER::COLLECTION)
    ("Giantin" . SPARSER::PROTEIN) ("LBPA" . SPARSER::MOLECULE)
    ("LAMTOR1, LAMTOR3, RAGA and RAGC" . SPARSER::COLLECTION)
    ("SLC36A4/PAT4" . SPARSER::COLLECTION)
    ("SLC38A1 and SLC38A2" . SPARSER::COLLECTION)
    ("SLC36A1/PAT1" . SPARSER::COLLECTION)
    ("SLC38A9 and RAGA" . SPARSER::COLLECTION)
    ("LAMTOR" . SPARSER::PROTEIN-FAMILY) ("SDS" . SPARSER::PROTEIN)
    ("peptide-" . SPARSER::PEPTIDE) ("PNGase" . SPARSER::PROTEIN)
    ("a lysosomal membrane-resident protein" . SPARSER::PROTEIN)
    ("the RAG GTPases and the Ragulator complex" . SPARSER::COLLECTION)
    ("-ATPase" . SPARSER::COLLECTION)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("L-Asparagine" . SPARSER::MOLECULE) ("- 3" . SPARSER::PROTEIN)
    ("L-Glutamine" . SPARSER::MOLECULE)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("DNAse I" . SPARSER::PROTEIN)
    ("CS6" . SPARSER::PROTEIN) ("NH4Cl" . SPARSER::MOLECULE)
    ("METAP2" . SPARSER::PROTEIN) ("RCC1" . SPARSER::PROTEIN)
    ("ATP6V1A" . SPARSER::PROTEIN) ("ATP6V1B2" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("Torin 1" . SPARSER::DRUG)
    ("ULK-1" . SPARSER::PROTEIN) ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("FNIP2" . SPARSER::PROTEIN) ("v-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("EEA1" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("LAMTOR3" . SPARSER::PROTEIN) ("PAT4" . SPARSER::PROTEIN)
    ("SLC36A4" . SPARSER::PROTEIN) ("SLC38A7" . SPARSER::PROTEIN)
    ("PAT1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLC36A1" . SPARSER::PROTEIN)
    ("SLC38A2" . SPARSER::PROTEIN) ("SLC38A1" . SPARSER::PROTEIN)
    ("LAMTOR1" . SPARSER::PROTEIN) ("Amino acids" . SPARSER::AMINO-ACID)
    ("SLC38A9" . SPARSER::PROTEIN)
    ("solute carrier family 38" . SPARSER::PROTEIN)
    ("member 9" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("p53 and TNFα" . SPARSER::COLLECTION)
    ("NF-kB, and p53" . SPARSER::COLLECTION) ("sulfate" . SPARSER::MOLECULE)
    ("indoxyl" . SPARSER::MOLECULE) ("RelA and NF-kB2" . SPARSER::COLLECTION)
    ("inhibitor (PDTC)" . SPARSER::INHIBITOR)
    ("activators and repressors" . SPARSER::COLLECTION)
    ("RelA and NFκB2" . SPARSER::COLLECTION)
    ("pro and anti-apoptotic" . SPARSER::COLLECTION)
    ("p53 mRNA as well as protein" . SPARSER::COLLECTION)
    ("IFNγ, IL-2, IL10, GM-CSF, TGF-β, CXCL1, IL-6, MIP-2, and MCP-1"
     . SPARSER::COLLECTION)
    ("dl" . SPARSER::MOLECULE) ("these protein's" . SPARSER::PROTEIN)
    ("NF-kB2 and relA" . SPARSER::COLLECTION)
    ("NF-kB and relA" . SPARSER::COLLECTION)
    ("relA and NF-kB2" . SPARSER::COLLECTION) ("NF-kB2" . SPARSER::PROTEIN)
    ("relA, NF-kB, and p53" . SPARSER::COLLECTION)
    ("a severe FA" . SPARSER::PROTEIN)
    ("creatinine and BUN" . SPARSER::COLLECTION)
    ("NF-kB and p53" . SPARSER::COLLECTION)
    ("the associated genes" . SPARSER::GENE)
    ("the proinflammtory molecules" . SPARSER::MOLECULE)
    ("Nod" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RH" . SPARSER::MOLECULE)
    ("Rel" . SPARSER::PROTEIN)
    ("RelB, c-rel, NF-kB1/p50 and NF-kB2/p52" . SPARSER::COLLECTION)
    ("RelA/p65" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("RelA" . SPARSER::PROTEIN)
    ("pro-inflammatory cytokine" . SPARSER::PROTEIN)
    ("NGAL" . SPARSER::PROTEIN)
    ("serum creatinine or blood urea nitrogen" . SPARSER::COLLECTION)
    ("ischemia" . SPARSER::PROTEIN) ("carbamate" . SPARSER::MOLECULE)
    ("dithio" . SPARSER::MOLECULE)
    ("relA, NF-kB2, and p53" . SPARSER::COLLECTION)
    ("genes and proteins" . SPARSER::COLLECTION) ("relA" . SPARSER::PROTEIN)
    ("NFκB2" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("oxidized glutathione" . SPARSER::MOLECULE) ("C-20" . SPARSER::PROTEIN)
    ("NaHCO3" . SPARSER::DRUG) ("c-rel" . SPARSER::PROTEIN)
    ("neutrophil gelatinase-associated lipocalin" . SPARSER::PROTEIN)
    ("KIM-1" . SPARSER::PROTEIN) ("IL-18" . SPARSER::PROTEIN)
    ("interleukin-18" . SPARSER::PROTEIN)
    ("Rac1 and its upstream effectors Tiam1 and Vav2" . SPARSER::COLLECTION)
    ("Tiam1 and Vav2" . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("establishing endothelial junctional barrier" . SPARSER::PROTEIN)
    ("effectors phosphatidylinositide 3-kinase ( xref ) and Tiam1 (T cell lymphoma invasion and metastasis-inducing protein 1; xref ) and GTP"
     . SPARSER::COLLECTION)
    ("Tiam1 (T cell lymphoma invasion and metastasis-inducing protein 1; xref ) and GTP"
     . SPARSER::COLLECTION)
    ("RhoA" . SPARSER::PROTEIN) ("RhoA–ROCK" . SPARSER::COLLECTION)
    ("MLCII" . SPARSER::PROTEIN) ("CFP" . SPARSER::PROTEIN)
    ("VE-t" . SPARSER::COLLECTION) ("light chain (MLCII)" . SPARSER::PROTEIN)
    ("Dendra2" . SPARSER::PROTEIN) ("an optimal fit" . SPARSER::PROTEIN-FAMILY)
    ("monomer and dimer" . SPARSER::COLLECTION)
    ("monomer and trans-dimer" . SPARSER::COLLECTION)
    ("VE-cadherin monomers (reaction a ) and trans-dimers (reaction d )"
     . SPARSER::COLLECTION)
    ("VE-cadherin–Dendra2" . SPARSER::COLLECTION)
    ("control photoinsensitive (PI) Rac1" . SPARSER::PROTEIN)
    ("PI-Rac1" . SPARSER::COLLECTION) ("PA-Rac1" . SPARSER::COLLECTION)
    ("growth factor and tumor necrosis factor" . SPARSER::COLLECTION)
    ("Rac1 and RhoA" . SPARSER::COLLECTION)
    ("Cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("catenins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the primary restrictive barrier" . SPARSER::PROTEIN)
    ("sodium sulfate" . SPARSER::MOLECULE)
    ("sodium bicarbonate" . SPARSER::DRUG) ("P190RhoGAP" . SPARSER::PROTEIN)
    ("p190RhoGAP" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("phosphatidylinositide 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("light chain" . SPARSER::PROTEIN) ("myosin-II" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("Rho kinase" . SPARSER::PROTEIN) ("VE-cadherin" . SPARSER::PROTEIN)
    ("Skeletal muscle" . SPARSER::PROTEIN) ("myostatin" . SPARSER::PROTEIN)
    ("proteins and chymotrypsin-like" . SPARSER::COLLECTION)
    ("IL-6 and IL-1β" . SPARSER::COLLECTION) ("interleukin" . SPARSER::PROTEIN)
    ("hypertrophic genes" . SPARSER::GENE) ("Calcineurin" . SPARSER::PROTEIN)
    ("calcineurin" . SPARSER::PROTEIN) ("phospholamban" . SPARSER::PROTEIN)
    ("myocardial Ca2+" . SPARSER::CALCIUM-ION)
    ("cardiac muscle and skeletal muscle" . SPARSER::COLLECTION)
    ("H 2 O 2 and NO vasodilators ( xref )" . SPARSER::COLLECTION)
    ("vasodilators" . SPARSER::DRUG) ("HF" . SPARSER::PROTEIN)
    ("components of CVD prevention and endothelial function"
     . SPARSER::COLLECTION)
    ("Habitual PA" . SPARSER::PROTEIN) ("habitual PA" . SPARSER::PROTEIN)
    ("soluble mediators" . SPARSER::PROTEIN) ("myoblasts" . SPARSER::PROTEIN)
    ("phosphocreatine" . SPARSER::MOLECULE) ("MRS" . SPARSER::PROTEIN)
    ("LFS" . SPARSER::PROTEIN) ("synthetase" . SPARSER::PROTEIN)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("Max" . SPARSER::PROTEIN)
    ("VO" . SPARSER::MOLECULE) ("nodal" . SPARSER::PROTEIN)
    ("pertinent variants" . SPARSER::VARIANT)
    ("further genetic variants" . SPARSER::VARIANT)
    ("these disease-associated variants" . SPARSER::VARIANT)
    ("CRF" . SPARSER::PROTEIN) ("occupational PA" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("NFATc3" . SPARSER::PROTEIN)
    ("Ca2+/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("transcription factor GATA-4" . SPARSER::PROTEIN)
    ("phosphatase 1" . SPARSER::PROTEIN) ("SERCA2" . SPARSER::PROTEIN)
    ("ATPase 2" . SPARSER::PROTEIN) ("Ca2+" . SPARSER::CALCIUM-ION)
    ("cardiac muscle" . SPARSER::PROTEIN) ("NADPH oxidase" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN) ("P-31" . SPARSER::PROTEIN)
    ("ACSL1" . SPARSER::PROTEIN) ("family member 1" . SPARSER::PROTEIN)
    ("acyl-CoA" . SPARSER::MOLECULE) ("CREB1" . SPARSER::PROTEIN)
    ("cAMP responsive element binding protein 1" . SPARSER::PROTEIN)
    ("KIF5B" . SPARSER::PROTEIN) ("member 5" . SPARSER::PROTEIN)
    ("kinesin family" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN)
    ("Treslin and TopBP1" . SPARSER::COLLECTION)
    ("Cdc45/GINS" . SPARSER::COLLECTION) ("hydroxyurea" . SPARSER::DRUG)
    ("Treslin-TopBP1" . SPARSER::COLLECTION)
    ("Treslin and the key checkpoint-effector kinase Chk1"
     . SPARSER::COLLECTION)
    ("IdU" . SPARSER::DRUG)
    ("doxycycline and later examined origin firing by DNA fiber analysis ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("ATR" . SPARSER::PROTEIN) ("caffeine" . SPARSER::MOLECULE)
    ("the activated replicative helicase" . SPARSER::PROTEIN)
    ("dUTP" . SPARSER::MOLECULE) ("digoxigenin" . SPARSER::MOLECULE)
    ("PCNA and DNA polymerase" . SPARSER::COLLECTION)
    ("PCNA, and DNA polymerase" . SPARSER::COLLECTION)
    ("epsilon" . SPARSER::PROTEIN) ("HSS and NPE" . SPARSER::COLLECTION)
    ("HSS" . SPARSER::PROTEIN) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("dATP" . SPARSER::DATP)
    ("a soluble nuclear fraction" . SPARSER::COMPONENT) ("EdU" . SPARSER::DRUG)
    ("aphidicolin (APH)" . SPARSER::MOLECULE) ("APH" . SPARSER::PROTEIN)
    ("aphidicolin" . SPARSER::PROTEIN) ("TRCT" . SPARSER::PROTEIN)
    ("GST-TRCT" . SPARSER::COLLECTION) ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homologues" . SPARSER::PROTEIN)
    ("approximately 100 amino acids" . SPARSER::AMINO-ACID)
    ("Mapping" . SPARSER::PROTEIN) ("the anti-Chk1" . SPARSER::ANTIBODY)
    ("Treslin and Chk1" . SPARSER::COLLECTION) ("ethidium" . SPARSER::MOLECULE)
    ("both the full-length protein and C-terminal fragment"
     . SPARSER::COLLECTION)
    ("full-length Treslin and the C-terminal 1253-1909 fragment"
     . SPARSER::COLLECTION)
    ("Treslin-SF" . SPARSER::COLLECTION)
    ("analyzed associated proteins" . SPARSER::PROTEIN)
    ("TS" . SPARSER::PROTEIN) ("CDKs" . SPARSER::PROTEIN)
    ("TopBP1-Treslin" . SPARSER::COLLECTION)
    ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TopBP1 and a recently discovered TopBP1-binding protein"
     . SPARSER::COLLECTION)
    ("Ticrr" . SPARSER::PROTEIN) ("Cdc45 and GINS" . SPARSER::COLLECTION)
    ("Cdc45-MCM-GINS" . SPARSER::COLLECTION) ("CMG" . SPARSER::MOLECULE)
    ("GINS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the origin recognition complex (ORC) and Cdc6" . SPARSER::COLLECTION)
    ("Cdt1 and the mini-chromosome maintenance (MCM) complex"
     . SPARSER::COLLECTION)
    ("origin recognition complex (ORC)" . SPARSER::PROTEIN)
    ("MCM" . SPARSER::PROTEIN) ("ORC" . SPARSER::BIO-COMPLEX)
    ("Treslin-Chk1" . SPARSER::COLLECTION)
    ("the checkpoint-regulatory kinase Chk1" . SPARSER::PROTEIN)
    ("the replicative helicase" . SPARSER::PROTEIN)
    ("helicase" . SPARSER::PROTEIN) ("Treslin" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("UCN-01" . SPARSER::DRUG)
    ("Cdk1" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("Wee1" . SPARSER::PROTEIN) ("actinomycin D" . SPARSER::MOLECULE)
    ("Sld5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AZD7762" . SPARSER::DRUG)
    ("Cdc25" . SPARSER::PROTEIN) ("C - t" . SPARSER::PROTEIN)
    ("S-protein" . SPARSER::PROTEIN) ("220 kD)" . SPARSER::PROTEIN)
    ("TopBP1" . SPARSER::PROTEIN) ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc6" . SPARSER::PROTEIN)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc45" . SPARSER::PROTEIN) ("PPARγ and NF-κB" . SPARSER::COLLECTION)
    ("ERK 1/2, p65 and Nox4" . SPARSER::COLLECTION)
    ("rosiglitazone" . SPARSER::DRUG) ("ERK and NF-κB" . SPARSER::COLLECTION)
    ("ERK1/2 and NF-κB" . SPARSER::COLLECTION)
    ("p38 nor JNK" . SPARSER::COLLECTION) ("ERK and p65" . SPARSER::COLLECTION)
    ("ERK 1/2 and p65" . SPARSER::COLLECTION) ("CAPE" . SPARSER::PROTEIN)
    ("si" . SPARSER::PROTEIN) ("si-PPARγ" . SPARSER::PROTEIN-PAIR)
    ("NF-κB-" . SPARSER::PROTEIN) ("ERK1/2-NF-κB-Nox4" . SPARSER::COLLECTION)
    ("both mitogen-activated protein kinases that regulate PPARγ transcriptional activity and the pro-inflammatory transcription factor"
     . SPARSER::COLLECTION)
    ("the pro-inflammatory transcription factor" . SPARSER::PROTEIN)
    ("hypoxia and a VEGF receptor antagonist [ xref ]" . SPARSER::COLLECTION)
    ("severe PH" . SPARSER::PROTEIN)
    ("exogenous synthetic thiazolidinedione ligands" . SPARSER::LIGAND)
    ("thiazolidinedione" . SPARSER::DRUG)
    ("pulmonary vascular endothelial" . SPARSER::PROTEIN)
    ("response elements (PPRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("peroxisome" . SPARSER::PROTEIN) ("RXR" . SPARSER::PROTEIN)
    ("PPAR" . SPARSER::PROTEIN)
    ("Peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("Peroxisome" . SPARSER::PROTEIN)
    ("ERK 1/2 and NF-κB" . SPARSER::COLLECTION)
    ("PEG-catalase" . SPARSER::COLLECTION) ("catalase" . SPARSER::PROTEIN)
    ("NF-κB or Nox4" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase, ERK 1/2, and NF-κB"
     . SPARSER::COLLECTION)
    ("Pyk2" . SPARSER::PROTEIN) ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("peroxisome proliferator-activated receptor-gamma" . SPARSER::PROTEIN)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE) ("GKT137831" . SPARSER::DRUG)
    ("PD98059" . SPARSER::MOLECULE) ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("Nox4" . SPARSER::PROTEIN) ("NADPH oxidase 4" . SPARSER::PROTEIN)
    ("TGFβ/Nodal/Activin" . SPARSER::COLLECTION)
    ("type I (ALK4/7) and type II (ActRIIB) activin-like kinase receptors"
     . SPARSER::COLLECTION)
    ("heterodimeric complexes" . SPARSER::BIO-COMPLEX)
    ("N-cadherin, Vimentin and Snail" . SPARSER::COLLECTION)
    ("the mesenchymal markers N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("EMT and MMPs" . SPARSER::COLLECTION)
    ("the type I (ALK4/7) receptor and its co-receptor Cripto-1"
     . SPARSER::COLLECTION)
    ("type II and type I" . SPARSER::COLLECTION)
    ("Nodal and form" . SPARSER::COLLECTION)
    ("strong (3+; Figure xref ) Nodal" . SPARSER::PROTEIN)
    ("MMP2 and CXCR4" . SPARSER::COLLECTION)
    ("SDF-1/CXCR4" . SPARSER::COLLECTION)
    ("N-cadherin and Vimentin" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN) ("Nodal/Activin" . SPARSER::COLLECTION)
    ("Activin" . SPARSER::PROTEIN)
    ("activin-like kinase receptors type I (ALK4/7) and type II (ActRIIB) and the co-receptor Cripto-1"
     . SPARSER::COLLECTION)
    ("type II (ActRIIB) and the co-receptor Cripto-1" . SPARSER::COLLECTION)
    ("ActRIIB" . SPARSER::PROTEIN) ("activin" . SPARSER::PROTEIN)
    ("a potent embryonic morphogen" . SPARSER::PROTEIN)
    ("morphogen" . SPARSER::PROTEIN) ("hESC-associated genes" . SPARSER::GENE)
    ("the most common histological type" . TYPE) ("PDAC" . SPARSER::MOLECULE)
    ("matrix metalloproteinase-2 (MMP2) and CXC chemokine receptor"
     . SPARSER::COLLECTION)
    ("Nodal" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Alk4" . SPARSER::PROTEIN)
    ("ALK 4" . SPARSER::PROTEIN) ("Actinomycin D" . SPARSER::MOLECULE)
    ("U87 MG" . SPARSER::PROTEIN)
    ("stromal cell-derived factor 1" . SPARSER::PROTEIN)
    ("Cripto-1" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("ALK4" . SPARSER::PROTEIN) ("SB431542" . SPARSER::DRUG)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("vital reagents and analytical tools" . SPARSER::COLLECTION)
    ("vital reagents" . SPARSER::MOLECULE) ("Zhi-xin" . SPARSER::COLLECTION)
    ("xin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Fan" . SPARSER::PROTEIN)
    ("sorafenib and FoxM1" . SPARSER::COLLECTION)
    ("p27 and p53" . SPARSER::COLLECTION)
    ("E2F, CDK2, CDK4, and C-MYC" . SPARSER::COLLECTION)
    ("E2F, CDK2, C-MYC, p53, and p27" . SPARSER::COLLECTION)
    ("FoxM1 and sorafenib" . SPARSER::COLLECTION)
    ("VEGF, FLT3, c-Kit, and MAPK" . SPARSER::COLLECTION)
    ("thiostrepton" . SPARSER::PROTEIN) ("sorafenib-" . SPARSER::DRUG)
    ("MMP2 and Ki-67" . SPARSER::COLLECTION)
    ("siRNA and sorafenib" . SPARSER::COLLECTION)
    ("Raf/MEK/MAPK" . SPARSER::COLLECTION)
    ("kinase, survivin, and polo-like kinase-1" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("c-Kit, and Raf" . SPARSER::COLLECTION)
    ("the Food and Drug Administration (FDA)" . SPARSER::COLLECTION)
    ("most chemotherapeutic drugs" . SPARSER::DRUG) ("RFA" . SPARSER::PROTEIN)
    ("MMP-2 and Ki-67" . SPARSER::COLLECTION)
    ("FoxM1, MMP-2, and Ki-67" . SPARSER::COLLECTION)
    ("Sorafenib" . SPARSER::DRUG) ("p53 and FoxM1" . SPARSER::COLLECTION)
    ("p27" . SPARSER::PROTEIN) ("C-MYC" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("p19 ARF" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN) ("mmp2" . SPARSER::PROTEIN)
    ("PLK1" . SPARSER::PROTEIN) ("polo-like kinase-1" . SPARSER::PROTEIN)
    ("CDC25B" . SPARSER::PROTEIN) ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G 2 /M" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("Forkhead box M1" . SPARSER::PROTEIN) ("ALS" . SPARSER::PROTEIN)
    ("fragile X mental retardation" . SPARSER::PROTEIN)
    ("iron" . SPARSER::MOLECULE) ("striatal Rhes" . SPARSER::PROTEIN)
    ("modulators" . SPARSER::PROTEIN) ("SUMO1 and SUMO2" . SPARSER::COLLECTION)
    ("IGF1/Akt" . SPARSER::COLLECTION)
    ("PIAS1, SUMO2, IKK, and HDAC4" . SPARSER::COLLECTION)
    ("drosophila" . SPARSER::PROTEIN)
    ("several preclinical HD" . SPARSER::PROTEIN)
    ("BDNF-TrkB" . SPARSER::COLLECTION) ("TrkB" . SPARSER::PROTEIN)
    ("BDNF" . SPARSER::PROTEIN)
    ("Drosophila and N171-82Q" . SPARSER::COLLECTION)
    ("MPTP" . SPARSER::PROTEIN)
    ("Rhes ( xref ) and mTOR ( xref )" . SPARSER::COLLECTION)
    ("Rhes and mTOR" . SPARSER::COLLECTION)
    ("the mitochondrialtranscriptional regulator" . SPARSER::REGULATOR)
    ("a striatal-enriched GTPase protein" . SPARSER::PROTEIN)
    ("untreated contralateral striatum" . SPARSER::PROTEIN)
    ("mHTT/eGFP" . SPARSER::COLLECTION) ("Amphetamine" . SPARSER::DRUG)
    ("amphetamine" . SPARSER::DRUG) ("Ikbke" . SPARSER::PROTEIN)
    ("IκB kinase (IKK), a kinase that induces mHTT degradation and targets mHTT"
     . SPARSER::COLLECTION)
    ("PIAS1 and SUMO2" . SPARSER::COLLECTION)
    ("LC3-II ( xref ) and Beclin-1" . SPARSER::COLLECTION)
    ("the autophagosome-membrane-associated protein" . SPARSER::PROTEIN)
    ("HMGCR, HMGCS1, DHCR7, and CYP51" . SPARSER::COLLECTION)
    ("prion" . SPARSER::PROTEIN-FAMILY)
    ("expression sterol biosynthesic enzymes" . SPARSER::ENZYME)
    ("demethylase" . SPARSER::PROTEIN) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("sterol regulatory element-binding proteins" . SPARSER::PROTEIN)
    ("SREBPs" . SPARSER::PROTEIN-FAMILY) ("sterol" . SPARSER::PROTEIN)
    ("the PGC1-α-regulated genes cAMP response element-binding protein (CREB)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cAMP response element-binding protein (CREB)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("normal (Q7) Htt" . SPARSER::PROTEIN)
    ("Htt" . SPARSER::PROTEIN) ("eGFP" . SPARSER::PROTEIN)
    ("a recently identified neuroprotective antioxidant enzyme"
     . SPARSER::ENZYME)
    ("SOD2, cyt-c, and ANT1" . SPARSER::COLLECTION) ("MSN" . SPARSER::PROTEIN)
    ("mTOR, or components" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("mHTT" . SPARSER::PROTEIN) ("Rhes and mTORC1" . SPARSER::COLLECTION)
    ("Rheb or Rhes" . SPARSER::COLLECTION)
    ("Rhes-mHTT" . SPARSER::PROTEIN-PAIR) ("neurotoxin" . SPARSER::PROTEIN)
    ("DOPA" . SPARSER::MOLECULE) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("huntingtin (HTT)" . SPARSER::PROTEIN)
    ("Rhes/mTORC1" . SPARSER::COLLECTION) ("Rhes" . SPARSER::PROTEIN)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY) ("striatum" . SPARSER::PROTEIN)
    ("huntingtin" . SPARSER::PROTEIN) ("polyglutamine" . SPARSER::MOLECULE)
    ("HD" . SPARSER::PROTEIN) ("Beclin1" . SPARSER::PROTEIN)
    ("DP2" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN) ("SUMO1" . SPARSER::PROTEIN)
    ("beclin 1" . SPARSER::PROTEIN) ("beclin1" . SPARSER::PROTEIN)
    ("Lkb-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PGC-1α" . SPARSER::PROTEIN)
    ("RAD001" . SPARSER::DRUG) ("HDAC4" . SPARSER::PROTEIN)
    ("DHCR7" . SPARSER::PROTEIN)
    ("7-dehydrocholesterol reductase" . SPARSER::PROTEIN)
    ("CYP51" . SPARSER::PROTEIN) ("HMGCS1" . SPARSER::PROTEIN)
    ("TORC1" . SPARSER::PROTEIN) ("CREB 1" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("Glutathione peroxidase" . SPARSER::PROTEIN)
    ("ANT1" . SPARSER::PROTEIN) ("cyt-c" . SPARSER::PROTEIN)
    ("PGC1" . SPARSER::PROTEIN) ("coactivator 1" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("DARPP-32" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("Mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("Subclones" . SPARSER::PROTEIN)
    ("fludarabine, cyclophosphamide, and rituximab" . SPARSER::COLLECTION)
    ("methylprednisolone" . SPARSER::DRUG) ("alemtuzumab" . SPARSER::DRUG)
    ("rituximab" . SPARSER::DRUG) ("cyclophosphamide" . SPARSER::DRUG)
    ("fludarabine" . SPARSER::DRUG) ("nail" . SPARSER::PROTEIN)
    ("Partial" . SPARSER::PROTEIN)
    ("the relapsed or refractory cohort" . SPARSER::MOLECULE)
    ("the previously untreated cohort" . SPARSER::MOLECULE)
    ("Oct" . SPARSER::PROTEIN) ("ofatumumab" . SPARSER::DRUG)
    ("tyrosine kinase (BTK)" . SPARSER::PROTEIN) ("BTK" . SPARSER::PROTEIN)
    ("Ibrutinib" . SPARSER::DRUG) ("Dec" . SPARSER::PROTEIN)
    ("ibrutinib" . SPARSER::DRUG) ("β 2 -microglobulin" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("PCI-32765" . SPARSER::DRUG)
    ("9-27" . SPARSER::PROTEIN) ("inosine and adenosine" . SPARSER::COLLECTION)
    ("adenosine" . SPARSER::PROTEIN) ("inosine" . SPARSER::MOLECULE)
    ("purines and pyrimidines" . SPARSER::COLLECTION)
    ("pyrimidines" . SPARSER::DRUG) ("purines" . SPARSER::DRUG)
    ("polyamine" . SPARSER::MOLECULE) ("p53/p73" . SPARSER::COLLECTION)
    ("nucleosides and ROS" . SPARSER::COLLECTION)
    ("nucleosides" . SPARSER::MOLECULE)
    ("NADPH and ribose" . SPARSER::COLLECTION) ("NADPH" . SPARSER::PROTEIN)
    ("Cox4i1" . SPARSER::PROTEIN) ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G6PD" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("phosphoglycerate dehydrogenase" . SPARSER::PROTEIN)
    ("GLS2" . SPARSER::PROTEIN) ("p73" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sorafenib" . SPARSER::DRUG) ("SMAD7 or SMAD4" . SPARSER::COLLECTION)
    ("pro- and anti-proliferative" . SPARSER::COLLECTION)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("chromosomal loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("I-1 and I-2" . SPARSER::COLLECTION)
    ("PTEN and SMAD7" . SPARSER::COLLECTION)
    ("other potential disease-associated genes" . SPARSER::GENE)
    ("his" . SPARSER::AMINO-ACID) ("SMAD4 or BMPR1A" . SPARSER::COLLECTION)
    ("BMP" . SPARSER::PROTEIN) ("TGF-β/SMAD4" . SPARSER::COLLECTION)
    ("insC" . SPARSER::PROTEIN) ("son" . SPARSER::PROTEIN)
    ("I-2" . SPARSER::PROTEIN) ("I-1" . SPARSER::PROTEIN)
    ("autosomal dominant" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("BMPR1A" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("SMAD7" . SPARSER::PROTEIN)
    ("snail, slug, ZEB1, ZEB2, and bHLH" . SPARSER::COLLECTION)
    ("slug" . SPARSER::PROTEIN) ("snail" . SPARSER::PROTEIN)
    ("repressors" . SPARSER::REPRESSOR)
    ("transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("Ca ++ -dependent transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("mesenchymal proteins" . SPARSER::PROTEIN)
    ("vimentin and smooth-muscle-actin, and cadherin" . SPARSER::COLLECTION)
    ("a high expression group (n=77) and a low expression group (n=34)"
     . SPARSER::COLLECTION)
    ("histological type" . TYPE)
    ("the healthy control group" . SPARSER::MOLECULE)
    ("Soluble cadherin fragments" . SPARSER::FRAGMENT)
    ("Soluble E-cad" . SPARSER::PROTEIN)
    ("transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("soluble E-cad" . SPARSER::PROTEIN)
    ("serum soluble E-cad" . SPARSER::PROTEIN) ("ZEB2" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN)
    ("granzyme, perforin, FasL and etc." . SPARSER::COLLECTION)
    ("granzyme" . SPARSER::PROTEIN-FAMILY)
    ("VEGF, PGE2, MIP-2, CXCL1, CXCL5, CXCL6 and CXCL8" . SPARSER::COLLECTION)
    ("IL-17 and IL-23" . SPARSER::COLLECTION)
    ("IL-17 and IL-23p19" . SPARSER::COLLECTION) ("Ontak" . SPARSER::MOLECULE)
    ("GITR" . SPARSER::PROTEIN) ("Gao" . SPARSER::PROTEIN)
    ("MSCs" . SPARSER::PROTEIN) ("primary HCC" . SPARSER::PROTEIN)
    ("IL-4 and IL-10" . SPARSER::COLLECTION)
    ("RORγt and Foxp3" . SPARSER::COLLECTION)
    ("GATA-3 and STAT-6" . SPARSER::COLLECTION)
    ("IL-17 and IFN-γ" . SPARSER::COLLECTION) ("Cytokines" . SPARSER::PROTEIN)
    ("TGF-β and IL-21" . SPARSER::COLLECTION)
    ("TGF-β and IL-6" . SPARSER::COLLECTION)
    ("IL-4, IL-5 and IL-13" . SPARSER::COLLECTION)
    ("substances and plays" . SPARSER::COLLECTION)
    ("substances" . SPARSER::SUBSTANCE) ("a key cytokine" . SPARSER::PROTEIN)
    ("STAT1 and Th1-differentiation-specific" . SPARSER::COLLECTION)
    ("Interleukin-12 (IL-12) and interferon-γ (IFN-γ)" . SPARSER::COLLECTION)
    ("the internal control gene" . SPARSER::GENE)
    ("mRNA and GATA-3" . SPARSER::COLLECTION) ("Th2-" . SPARSER::PROTEIN)
    ("GATA-3 and retinoic acid-related orphan receptor gamma or ROR gamma t (RORγt)"
     . SPARSER::COLLECTION)
    ("ROR" . SPARSER::PROTEIN-FAMILY) ("Runx1 and Runx3" . SPARSER::COLLECTION)
    ("IFNγ and IL4" . SPARSER::COLLECTION) ("Runx" . SPARSER::PROTEIN)
    ("RORγt and FOXP3" . SPARSER::COLLECTION)
    ("T-bet/GATA-3" . SPARSER::COLLECTION)
    ("mRNA/GATA-3" . SPARSER::COLLECTION)
    ("T-bet, GATA-3, RORγt and FOXP3" . SPARSER::COLLECTION)
    ("T-bet, GATA-3, RORγt and FOXP" . SPARSER::COLLECTION)
    ("CXCL8" . SPARSER::PROTEIN) ("CXCL6" . SPARSER::PROTEIN)
    ("CXCL5" . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("MIP-2" . SPARSER::PROTEIN) ("IL-23" . SPARSER::PROTEIN)
    ("IL-23p19" . SPARSER::PROTEIN) ("CTLA-4" . SPARSER::PROTEIN)
    ("IL-2 receptor" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("Foxp3" . SPARSER::PROTEIN) ("STAT-6" . SPARSER::PROTEIN)
    ("IL-21" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("STAT6" . SPARSER::PROTEIN) ("IL-4R" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("IL-12R" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("Interleukin-12" . SPARSER::PROTEIN)
    ("AT-3" . SPARSER::PROTEIN) ("T-5" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN) ("IL4" . SPARSER::PROTEIN)
    ("IFNγ" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("FOXP3" . SPARSER::PROTEIN) ("RORγt" . SPARSER::PROTEIN)
    ("GATA-3" . SPARSER::PROTEIN) ("T-bet" . SPARSER::PROTEIN)
    ("FOXA1 and/or AR" . SPARSER::COLLECTION) ("FOXA1-" . SPARSER::PROTEIN)
    ("off-chromatin" . SPARSER::PROTEIN)
    ("a bifunctional regulator" . SPARSER::REGULATOR)
    ("acinus" . SPARSER::PROTEIN) ("holo-AR" . SPARSER::COLLECTION)
    ("the AR and the FOXA1 cistromes" . SPARSER::COLLECTION)
    ("receptor or FOXA1" . SPARSER::COLLECTION)
    ("ERα and FOXA1" . SPARSER::COLLECTION)
    ("TNFSF10 and IGFBP-3" . SPARSER::COLLECTION)
    ("ATAD2 and MYC" . SPARSER::COLLECTION)
    ("ATAD2 and MAFB" . SPARSER::COLLECTION)
    ("IGFBP-3 , and TMEFF2" . SPARSER::COLLECTION)
    ("the latter gene group" . SPARSER::MOLECULE)
    ("NR5A2, VLDLR and CAMK1" . SPARSER::COLLECTION)
    ("CAMK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VLDLR" . SPARSER::PROTEIN)
    ("AR and RNA polymerase II" . SPARSER::COLLECTION)
    ("AR or FOXA1" . SPARSER::COLLECTION)
    ("FOXA1 and HOXD13" . SPARSER::COLLECTION)
    ("The new ARBs" . SPARSER::PROTEIN)
    ("PIAS1 or FOXA1" . SPARSER::COLLECTION)
    ("the new ARBs" . SPARSER::PROTEIN) ("new ARBs" . SPARSER::PROTEIN)
    ("AR and FOXA1" . SPARSER::COLLECTION)
    ("ATAD2 and BCL6 , PIAS1 or FOXA1" . SPARSER::COLLECTION)
    ("BCL6 , PIAS1 or FOXA1" . SPARSER::COLLECTION)
    ("MAFB, ATAD2, CLDN8, RASD1, BCL6 , and IGFBP-3" . SPARSER::COLLECTION)
    ("AR and PIAS1" . SPARSER::COLLECTION)
    ("PIAS1, AR, and FOXA1" . SPARSER::COLLECTION)
    ("anti-PIAS1 and anti-FOXA1" . SPARSER::COLLECTION)
    ("ATAD2 and FKBP5" . SPARSER::COLLECTION)
    ("PIAS1 and FOXA1" . SPARSER::COLLECTION)
    ("NKX3.1 and GATA" . SPARSER::COLLECTION)
    ("At least one ARE and FOXA1 motif" . SPARSER::COLLECTION)
    ("At least one ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("FOXA1 and SUMO2/3" . SPARSER::COLLECTION)
    ("at least one ARB and ≥25%" . SPARSER::COLLECTION)
    ("ARB and ≥25%" . SPARSER::COLLECTION) ("ARB" . SPARSER::PROTEIN)
    ("Pol" . SPARSER::PROTEIN) ("ARBs" . SPARSER::PROTEIN)
    ("IGFBP-3 (cluster 7) and TMEFF2 ( cluster 8)" . SPARSER::COLLECTION)
    ("MAFB" . SPARSER::PROTEIN) ("xenobiotic" . SPARSER::MOLECULE)
    ("neuregulin" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("RASD1 and HPGD" . SPARSER::COLLECTION) ("HPGD" . SPARSER::PROTEIN)
    ("FC" . SPARSER::PROTEIN) ("PIAS1 or PIAS1" . SPARSER::COLLECTION)
    ("LUC" . SPARSER::PROTEIN) ("the only PIAS protein" . SPARSER::PROTEIN)
    ("PIAS1 and AR" . SPARSER::COLLECTION) ("STAT (PIAS)" . SPARSER::PROTEIN)
    ("nucleosomal histones and AR" . SPARSER::COLLECTION)
    ("histones and AR" . SPARSER::COLLECTION)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN) ("coactivators" . SPARSER::PROTEIN)
    ("differential FOXA1" . SPARSER::PROTEIN)
    ("The dimeric AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("the receptor's" . SPARSER::RECEPTOR)
    ("AR or its coregulator proteins" . SPARSER::COLLECTION)
    ("both natural and synthetic androgens" . SPARSER::DRUG)
    ("HOXD13 and GATA" . SPARSER::COLLECTION) ("GATA" . SPARSER::PROTEIN)
    ("an AR- and SUMO-interacting protein" . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HOXB13" . SPARSER::PROTEIN)
    ("SRC-3" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("NKX3.1" . SPARSER::PROTEIN) ("8B" . SPARSER::PROTEIN)
    ("IGFBP-3" . SPARSER::PROTEIN) ("TNFSF10" . SPARSER::PROTEIN)
    ("CLDN8" . SPARSER::PROTEIN) ("MAGEH1" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("ATAD2" . SPARSER::PROTEIN)
    ("TMEFF2" . SPARSER::PROTEIN) ("RASD1" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN) ("NR5A2" . SPARSER::PROTEIN)
    ("KLK2" . SPARSER::PROTEIN) ("SP-RING" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("PIAS4" . SPARSER::PROTEIN)
    ("PIAS3" . SPARSER::PROTEIN) ("PIAS2" . SPARSER::PROTEIN)
    ("small ubiquitin-related modifier" . SPARSER::PROTEIN)
    ("forkhead box A1" . SPARSER::PROTEIN)
    ("GATA-binding protein 2" . SPARSER::PROTEIN) ("HOXD13" . SPARSER::PROTEIN)
    ("SUMO2" . SPARSER::PROTEIN) ("PIAS1" . SPARSER::PROTEIN)
    ("BARD" . SPARSER::PROTEIN) ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("serine or tyrosine" . SPARSER::COLLECTION)
    ("active Stat5a/b and antiandrogen-liganded AR" . SPARSER::COLLECTION)
    ("phosphorylation-competent Stat5" . SPARSER::PROTEIN)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION) ("ligases" . SPARSER::LIGASE)
    ("MDV3100 and Stat5a/b" . SPARSER::COLLECTION)
    ("Stat5a/b and AR" . SPARSER::COLLECTION)
    ("AR or AR" . SPARSER::COLLECTION) ("Antiandrogen" . SPARSER::DRUG)
    ("Stat5a/b and antiandrogen-liganded AR" . SPARSER::COLLECTION)
    ("both MG132 and protein synthesis inhibitor cyclohexamide ( xref )"
     . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE) ("Stat5a/b" . SPARSER::PROTEIN)
    ("Stat5a/b-AR" . SPARSER::COLLECTION)
    ("both androgen- and antiandrogen-liganded AR" . SPARSER::COLLECTION)
    ("androgen-" . SPARSER::PROTEIN) ("-C-ter" . SPARSER::COLLECTION)
    ("Stat5a-NTCCD" . SPARSER::PROTEIN-PAIR) ("C-ter" . SPARSER::PROTEIN)
    ("Stat5a-C-ter" . SPARSER::PROTEIN-PAIR)
    ("FLAG-Stat5a" . SPARSER::COLLECTION) ("MYC-AR" . SPARSER::COLLECTION)
    ("Flutamide, Bicalutamide and MDV3100" . SPARSER::COLLECTION)
    ("Prolactin" . SPARSER::PROTEIN)
    ("10 nM prolactin and/or 1 nM DHT" . SPARSER::COLLECTION)
    ("PSA" . SPARSER::PROTEIN) ("Rv" . SPARSER::MOLECULE)
    ("Flutamide, Bicalutamide or MDV3100" . SPARSER::COLLECTION)
    ("DHT, Flutamide, Bicalutamide or MDV3100" . SPARSER::COLLECTION)
    ("AR and Stat5a/b" . SPARSER::COLLECTION)
    ("AR ( xref ) or wild-type Stat5a and AR" . SPARSER::COLLECTION)
    ("Stat5a and prolactin receptor" . SPARSER::COLLECTION)
    ("Stat5a and AR" . SPARSER::COLLECTION)
    ("phosphorylation-dead Stat5a(Y694F) and dominant-negative Stat5a/b ( xref )"
     . SPARSER::COLLECTION)
    ("wild-type Stat5, phosphorylation-dead Stat5a(Y694F) and dominant-negative Stat5a/b ( xref )"
     . SPARSER::COLLECTION)
    ("dihydrotestosterone (DHT)" . SPARSER::DRUG)
    ("dihydrotestosterone" . SPARSER::DRUG)
    ("either phosphorylation-dead Stat5a (AdStat5aY694F) or dominant-negative Stat5a/b (AdDNStat5)"
     . SPARSER::COLLECTION)
    ("phosphorylation-dead Stat5a (AdStat5aY694F) or dominant-negative Stat5a/b (AdDNStat5)"
     . SPARSER::COLLECTION)
    ("either wild-type Stat5a (AdWTStat5), phosphorylation-dead Stat5a (AdStat5aY694F) or dominant-negative Stat5a/b (AdDNStat5)"
     . SPARSER::COLLECTION)
    ("prolactin receptor and AR" . SPARSER::COLLECTION)
    ("Antiandrogens" . SPARSER::DRUG)
    ("two highly homologous isoforms" . SPARSER::ISOFORM)
    ("Stat5a and Stat5b" . SPARSER::COLLECTION) ("Stat5a" . SPARSER::PROTEIN)
    ("a transcriptionally inactive AR complex" . SPARSER::BIO-COMPLEX)
    ("Food and Drug Administration-approved agents such as the androgen biosynthesis inhibitor abiraterone acetate (Zytiga®)"
     . SPARSER::COLLECTION)
    ("Xtandi" . SPARSER::DRUG) ("Enzalutamide" . SPARSER::DRUG)
    ("Zytiga" . SPARSER::DRUG)
    ("Flutamide and Bicalutamide" . SPARSER::COLLECTION)
    ("circulatory androgens" . SPARSER::DRUG) ("Flutamide" . SPARSER::DRUG)
    ("Bicalutamide" . SPARSER::DRUG) ("antiandrogen" . SPARSER::DRUG)
    ("antiandrogens" . SPARSER::DRUG) ("aa 1" . SPARSER::PROTEIN)
    ("E6-AP" . SPARSER::PROTEIN) ("MYC-tagged" . SPARSER::PROTEIN)
    ("transmembrane protease, serine 2" . SPARSER::PROTEIN)
    ("prolactin receptor" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("TMPRSS2" . SPARSER::PROTEIN) ("Serum Albumin" . SPARSER::PROTEIN)
    ("anti-androgen" . SPARSER::DRUG) ("sodium chloride" . SPARSER::DRUG)
    ("Stat3" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("Stat5b" . SPARSER::PROTEIN) ("Transcription factor" . SPARSER::PROTEIN)
    ("abiraterone acetate" . SPARSER::DRUG) ("MDV3100" . SPARSER::DRUG)
    ("Stat5" . SPARSER::PROTEIN) ("KRAS, and PIK3CA" . SPARSER::COLLECTION)
    ("growth factor or epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("growth factor or epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("different macroscopic subtypes" . SPARSER::PROTEIN)
    ("Konda et al., all the 19 depressed lesions harbored HGD"
     . SPARSER::PROTEIN)
    ("HGD" . SPARSER::PROTEIN) ("curative resected CRCs" . SPARSER::PROTEIN)
    ("Serrated" . SPARSER::PROTEIN) ("metastatic CRC" . SPARSER::PROTEIN)
    ("EGFR and other cell surface growth factor receptors"
     . SPARSER::COLLECTION)
    ("EGFR/KRAS/BRAF" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("EGFR, HER2 and AKT" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("granular type" . TYPE)
    ("KRAS, BRAF, PIK3CA and AKT" . SPARSER::COLLECTION)
    ("/AKT" . SPARSER::COLLECTION) ("-kinase" . SPARSER::KINASE)
    ("Ras/Raf/MAPK" . SPARSER::COLLECTION)
    ("APC, KRAS, and p53" . SPARSER::COLLECTION)
    ("macroscopic subtypes" . SPARSER::PROTEIN) ("CRCs" . SPARSER::PROTEIN)
    ("Three different macroscopic subtypes" . SPARSER::PROTEIN)
    ("KRAS, BRAF or PIK3CA" . SPARSER::COLLECTION)
    ("serrated" . SPARSER::PROTEIN)
    ("EGFR (exon 18–24) and HER2 (exon18-24)" . SPARSER::COLLECTION)
    ("different morphologic subtypes" . SPARSER::PROTEIN)
    ("beta-catenin" . SPARSER::PROTEIN)
    ("MK2206 or GSK690693" . SPARSER::COLLECTION)
    ("naturally occurring kinase-dead AKT mutants" . SPARSER::MUTANT)
    ("residual AKT1" . SPARSER::PROTEIN)
    ("shRNA-hairpins" . SPARSER::COLLECTION) ("shRNA-" . SPARSER::PROTEIN)
    ("wild type AKT1 ( xref ) or AKT2 ( xref )" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG)
    ("wild type AKT1 or wild type AKT2" . SPARSER::COLLECTION)
    ("MET and PI3K-pathway" . SPARSER::COLLECTION)
    ("letter" . SPARSER::MOLECULE) ("pLPCX-HA-AKT2" . SPARSER::COLLECTION)
    ("Myr" . SPARSER::MOLECULE)
    ("TRIPZ tetracycline-inducible lentiviral shRNAs" . SPARSER::RNA)
    ("THS" . SPARSER::PROTEIN) ("Type" . TYPE) ("Medicine" . SPARSER::DRUG)
    ("Dr" . SPARSER::MOLECULE) ("UT" . SPARSER::PROTEIN-FAMILY)
    ("Salt" . SPARSER::MOLECULE) ("Sepharose" . SPARSER::MOLECULE)
    ("Alexa-488 anti-mouse secondary antibody" . SPARSER::PROTEIN)
    ("reagent" . SPARSER::MOLECULE) ("Gold" . SPARSER::MOLECULE)
    ("Phalloidin" . SPARSER::MOLECULE) ("DAPI" . SPARSER::DRUG)
    ("HA, vinculin, and β-actin" . SPARSER::COLLECTION)
    ("Sigma" . SPARSER::PROTEIN-FAMILY) ("vinculin" . SPARSER::PROTEIN)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("MK2206, GSK690693, and crizotinib" . SPARSER::COLLECTION)
    ("TX" . SPARSER::PROTEIN)
    ("Chemicals and antibodies" . SPARSER::COLLECTION)
    ("Chemicals" . SPARSER::MOLECULE)
    ("this cancer-associated PH-domain mutant" . SPARSER::MUTANT)
    ("E17K-AKT1 and a kinase-defective allele" . SPARSER::COLLECTION)
    ("a kinase-defective allele" . SPARSER::ALLELE)
    ("media (RPMI)" . SPARSER::PROTEIN) ("RPMI" . SPARSER::PROTEIN)
    ("PRAS40 and BAD" . SPARSER::COLLECTION)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("kinase-defective AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P 3 and PtdIns" . SPARSER::COLLECTION) ("PtdIns" . SPARSER::PROTEIN)
    ("pleckstrin homology (PH)" . SPARSER::PROTEIN)
    ("AKT 1 and AKT 2" . SPARSER::COLLECTION)
    ("AKT1 or AKT2" . SPARSER::COLLECTION)
    ("AKT1 W80A or AKT2 W80A" . SPARSER::COLLECTION)
    ("wild-type AKT1 or wild-type AKT2" . SPARSER::COLLECTION)
    ("alanine" . SPARSER::AMINO-ACID) ("tryptophan" . SPARSER::AMINO-ACID)
    ("the ATP-competitive AKT inhibitors GSK690693 ( xref ) and GDC0068 ( xref )"
     . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG) ("PRAS40, GSK3β, and BAD" . SPARSER::COLLECTION)
    ("the ATP-competitive AKT inhibitors GSK690693 ( xref ; xref ) and GDC0068 ( xref )"
     . SPARSER::COLLECTION)
    ("several ATP-competitive" . SPARSER::ATP)
    ("chemicals" . SPARSER::MOLECULE) ("this protein's" . SPARSER::PROTEIN)
    ("Part" . SPARSER::COMPONENT) ("AKT1/AKT2" . SPARSER::COLLECTION)
    ("MET, HER2, or Phosphatidyl-Inositol-3-Kinase" . SPARSER::COLLECTION)
    ("PIP3" . SPARSER::PIP3) ("AKt1" . SPARSER::PROTEIN)
    ("Akt1" . SPARSER::PROTEIN) ("K+" . SPARSER::MOLECULE)
    ("Na+" . SPARSER::MOLECULE) ("BKM-120" . SPARSER::DRUG)
    ("s 5a" . SPARSER::PROTEIN) ("B12" . SPARSER::PROTEIN)
    ("Foxo3a" . SPARSER::PROTEIN) ("pErk1/2" . SPARSER::PROTEIN)
    ("12-O-tetradecanoylphorbol-13-acetate" . SPARSER::DRUG)
    ("V-AKT" . SPARSER::PROTEIN) ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("pleckstrin homology" . SPARSER::PROTEIN) ("AKT 2" . SPARSER::PROTEIN)
    ("AKT 1" . SPARSER::PROTEIN) ("IGF-IR" . SPARSER::PROTEIN)
    ("ErbB3" . SPARSER::PROTEIN) ("MK2006" . SPARSER::DRUG)
    ("PRAS40" . SPARSER::PROTEIN) ("GDC0068" . SPARSER::DRUG)
    ("GSK690693" . SPARSER::DRUG) ("MK2206" . SPARSER::DRUG)
    ("Phosphatidyl-Inositol-3-Kinase" . SPARSER::PROTEIN-FAMILY)
    ("the caveolar protein caveolin-1" . SPARSER::PROTEIN)
    ("BGs and langerin" . SPARSER::COLLECTION) ("clathrin-" . SPARSER::PROTEIN)
    ("caveolin-" . SPARSER::PROTEIN)
    ("monodansylcadaverine (MDC)" . SPARSER::DRUG) ("MDC" . SPARSER::PROTEIN)
    ("monodansylcadaverine" . SPARSER::DRUG)
    ("CCR5 nor langerin" . SPARSER::COLLECTION)
    ("CD4, CCR5 nor langerin" . SPARSER::COLLECTION) ("VSV" . SPARSER::PROTEIN)
    ("Alu" . SPARSER::PROTEIN) ("LAMP2/CD63" . SPARSER::COLLECTION)
    ("lysosomal-associated membrane protein" . SPARSER::PROTEIN)
    ("tetraspanin" . SPARSER::PROTEIN-FAMILY)
    ("multilaminar lysosomal" . SPARSER::PROTEIN)
    ("trypsin" . SPARSER::PROTEIN)
    ("langerin as well as caveolin-1 (Figure  xref A)" . SPARSER::COLLECTION)
    ("Filipin" . SPARSER::MOLECULE) ("filipin" . SPARSER::MOLECULE)
    ("langerin and vice versa (Figure  xref D)" . SPARSER::COLLECTION)
    ("caveolin-1 and langerin" . SPARSER::COLLECTION)
    ("the major caveolar structural protein caveolin-1" . SPARSER::PROTEIN)
    ("THP-langerin" . SPARSER::COLLECTION) ("subdomains" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("Langerin" . SPARSER::PROTEIN)
    ("functional langerin" . SPARSER::PROTEIN) ("clathrin" . SPARSER::PROTEIN)
    ("caveolar structure protein caveolin-1" . SPARSER::PROTEIN)
    ("langerin and caveolin-1" . SPARSER::COLLECTION)
    ("BGs" . SPARSER::PROTEIN) ("langerin" . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("U5" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("CD1a" . SPARSER::PROTEIN) ("RD1" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN) ("CD63" . SPARSER::PROTEIN)
    ("LAMP2" . SPARSER::PROTEIN) ("Caveolin-1" . SPARSER::PROTEIN)
    ("anti-viral" . SPARSER::DRUG)
    ("STAT3, NFκB and CD44" . SPARSER::COLLECTION)
    ("STAT3–NFκB" . SPARSER::COLLECTION)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN) ("phytochemicals" . SPARSER::DRUG)
    ("S-phase kinase-associated protein" . SPARSER::PROTEIN)
    ("SURVIVIN" . SPARSER::PROTEIN)
    ("curcumin (10 μM) and EGCG (10 μM)" . SPARSER::COLLECTION)
    ("/HER2" . SPARSER::COLLECTION) ("/PR" . SPARSER::COLLECTION)
    ("STAT3 and NFkB" . SPARSER::COLLECTION)
    ("Curcumin and EGCG" . SPARSER::COLLECTION)
    ("MCF7-HER" . SPARSER::COLLECTION)
    ("curcumin- and EGCG-treated cells" . SPARSER::COLLECTION)
    ("curcumin-" . SPARSER::DRUG) ("MCF7-HER2" . SPARSER::COLLECTION)
    ("curcumin or EGCG" . SPARSER::COLLECTION)
    ("receptor, Akt, NFκB and hypoxia-inducible factor" . SPARSER::COLLECTION)
    ("a major catechin" . SPARSER::MOLECULE) ("catechin" . SPARSER::MOLECULE)
    ("the principal curcuminoid" . SPARSER::DRUG)
    ("curcuminoid" . SPARSER::DRUG)
    ("curcumin and epigallocatechin-3-gallate (EGCG)" . SPARSER::COLLECTION)
    ("curcumin and epigallocatechin-3-gallate" . SPARSER::COLLECTION)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("Wingless-Int" . SPARSER::PROTEIN-PAIR)
    ("STAT3 and NFκB" . SPARSER::COLLECTION)
    ("STAT3-NFkB" . SPARSER::COLLECTION)
    ("curcumin and EGCG" . SPARSER::COLLECTION)
    ("performing western blot" . SPARSER::PROTEIN) ("NFkB" . SPARSER::PROTEIN)
    ("curcumin and epigallocatechin gallate" . SPARSER::COLLECTION)
    ("EGCG" . SPARSER::DRUG) ("BCL-xL" . SPARSER::PROTEIN)
    ("SKP2" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("IGF1" . SPARSER::PROTEIN)
    ("Insulin-like growth factor" . SPARSER::PROTEIN)
    ("epigallocatechin-3-gallate" . SPARSER::DRUG)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("epigallocatechin gallate" . SPARSER::DRUG)
    ("Signal Transducer and Activator of Transcription 3" . SPARSER::PROTEIN)
    ("p16 and p21" . SPARSER::COLLECTION)
    ("p53 and the ubiquitin ligase Mdm2" . SPARSER::COLLECTION)
    ("the pulmonary vasculature" . SPARSER::PROTEIN)
    ("inhibitor or activator" . SPARSER::COLLECTION)
    ("vascular SMCs" . SPARSER::PROTEIN)
    ("systemic vascular SMCs" . SPARSER::PROTEIN)
    ("Neither imetelstat nor TA65 affected PH in TERT −/− mice"
     . SPARSER::COLLECTION)
    ("inhibitor and TA65" . SPARSER::COLLECTION)
    ("TERC and TERT" . SPARSER::COLLECTION)
    ("TERT  −/− and TERC  −/− mice" . SPARSER::COLLECTION)
    ("proliferating cultured PA-SMCs" . SPARSER::COLLECTION)
    ("5HTT" . SPARSER::PROTEIN) ("SM22-5HTT" . SPARSER::COLLECTION)
    ("Neither imetelstat nor TA65 affected RVSP" . SPARSER::COLLECTION)
    ("30 partially reversed PH" . SPARSER::PROTEIN)
    ("reversed PH" . SPARSER::PROTEIN)
    ("lung TERT mRNA ( P <0.01) and protein ( P <0.025)" . SPARSER::COLLECTION)
    ("Imetelstat" . SPARSER::DRUG) ("p16-" . SPARSER::PROTEIN)
    ("senescent p21-" . SPARSER::PROTEIN) ("p21-" . SPARSER::PROTEIN)
    ("RV" . SPARSER::MOLECULE) ("TERT or TERC" . SPARSER::COLLECTION)
    ("cultured PA-SMCs expressed TERT protein" . SPARSER::PROTEIN)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("normoxia" . SPARSER::PROTEIN) ("CD44 and α-SMA" . SPARSER::COLLECTION)
    ("the outer media" . SPARSER::PROTEIN)
    ("TERT, α-SMA, and CD44" . SPARSER::COLLECTION)
    ("spontaneous PH" . SPARSER::PROTEIN)
    ("experimental PH" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("PAH" . SPARSER::PROTEIN)
    ("hypoxia-induced PH in wild-type mice or partially reversed established PH in SM22- 5HTT  + mice"
     . SPARSER::COLLECTION)
    ("partially reversed established PH" . SPARSER::PROTEIN)
    ("reversed established PH" . SPARSER::PROTEIN) ("SM22-" . SPARSER::PROTEIN)
    ("fewer Ki67-stained proliferating PA-SMCs" . SPARSER::COLLECTION)
    ("chronic hypoxia" . SPARSER::PROTEIN)
    ("generations 2, 3, and 4 developed less severe PH" . SPARSER::PROTEIN)
    ("The TERT inhibitor imetelstat and the TERT activator TA65"
     . SPARSER::COLLECTION)
    ("TA" . SPARSER::PROTEIN) ("imetelstat" . SPARSER::DRUG)
    ("idiopathic PH" . SPARSER::PROTEIN)
    ("hypoxia or serotonin-transporter" . SPARSER::COLLECTION)
    ("PA-SMCs" . SPARSER::COLLECTION) ("SMCs" . SPARSER::PROTEIN)
    ("HTT" . SPARSER::PROTEIN) ("serotonin" . SPARSER::MOLECULE)
    ("PA-SMC" . SPARSER::COLLECTION) ("SMC" . SPARSER::PROTEIN)
    ("PH" . SPARSER::PROTEIN) ("TERC" . SPARSER::PROTEIN)
    ("nutlin-3a" . SPARSER::DRUG) ("telomerase activity" . SPARSER::PROTEIN)
    ("Tel2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tel1" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Waf1/Cip1" . SPARSER::PROTEIN) ("d −1" . SPARSER::PROTEIN)
    ("5-HTT" . SPARSER::PROTEIN) ("SM22" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("NF-κB and β-catenin" . SPARSER::COLLECTION)
    ("post-EMT" . SPARSER::PROTEIN) ("α-SMA, and ERK1/2" . SPARSER::COLLECTION)
    ("this drug's" . SPARSER::DRUG) ("TGF-β1 and VEGF" . SPARSER::COLLECTION)
    ("MEK-ERK-Snail-1" . SPARSER::COLLECTION) ("MEK/ERK" . SPARSER::COLLECTION)
    ("SMADs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SMAD2 and SMAD3" . SPARSER::COLLECTION)
    ("type 1 and type 2" . SPARSER::COLLECTION) ("Egr1" . SPARSER::PROTEIN)
    ("claudins and occludin" . SPARSER::COLLECTION)
    ("metalloproteinases, integrins and ECM" . SPARSER::COLLECTION)
    ("claudins" . SPARSER::PROTEIN) ("Dok1" . SPARSER::PROTEIN)
    ("Ras/MAPK" . SPARSER::COLLECTION) ("Dok" . SPARSER::PROTEIN)
    ("Cav1 or CSD" . SPARSER::COLLECTION) ("caveolin" . SPARSER::PROTEIN)
    ("serine and tyrosine" . SPARSER::COLLECTION)
    ("Src, AKT, and H-Ras" . SPARSER::COLLECTION)
    ("junction-associated proteins" . SPARSER::PROTEIN)
    ("α-SMA and Snail-1" . SPARSER::COLLECTION)
    ("MLECs, and Cav1" . SPARSER::COLLECTION)
    ("a semi-permeable barrier" . SPARSER::PROTEIN)
    ("intercellular junction proteins" . SPARSER::PROTEIN)
    ("pre" . SPARSER::PROTEIN) ("pre-EMT" . SPARSER::COLLECTION)
    ("dexamethasone or tamoxifen" . SPARSER::COLLECTION)
    ("α-SMA and vimentin" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN)
    ("Cav1 and E-cadherin" . SPARSER::COLLECTION)
    ("Cav1 and Snail-1" . SPARSER::COLLECTION)
    ("MEK/ERK1/2" . SPARSER::COLLECTION)
    ("cytokeratin-FSP-1" . SPARSER::COLLECTION)
    ("cytokeratin (MC marker) and FSP-1 (used as a marker of myofibroblasts and EMT conversion)"
     . SPARSER::COLLECTION)
    ("the peritoneal EMT" . SPARSER::PROTEIN)
    ("collagen, and FN" . SPARSER::COLLECTION) ("MLECs" . SPARSER::PROTEIN)
    ("MLEC" . SPARSER::PROTEIN) ("MEK-ERK1-2" . SPARSER::COLLECTION)
    ("dextran" . SPARSER::DEXTRAN)
    ("E-cadherin and other proteins" . SPARSER::COLLECTION)
    ("MEK-ERK1/2" . SPARSER::COLLECTION)
    ("ERK-Snail-1" . SPARSER::PROTEIN-PAIR)
    ("SPARC, metalloproteases, serpins, and thrombospondin-1"
     . SPARSER::COLLECTION)
    ("serpins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SPARC" . SPARSER::PROTEIN)
    ("fibromodulin" . SPARSER::PROTEIN) ("FN and PAI-1" . SPARSER::COLLECTION)
    ("MeT" . SPARSER::AMINO-ACID) ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a major inducer" . SPARSER::PROTEIN)
    ("AKT and ERK1/2" . SPARSER::COLLECTION) ("punctate " . SPARSER::PROTEIN)
    ("α-SMA and the ECM proteins FN and type I collagen (Fig xref )"
     . SPARSER::COLLECTION)
    ("FN and type I" . SPARSER::COLLECTION)
    ("FN and α-SMA" . SPARSER::COLLECTION)
    ("γ-catenin and occludin" . SPARSER::COLLECTION)
    ("occludin" . SPARSER::PROTEIN)
    ("the mesenchymal marker α-SMA" . SPARSER::PROTEIN)
    ("Caveolins" . SPARSER::PROTEIN-FAMILY)
    ("a mesenchymal state" . SPARSER::BIO-STATE)
    ("ERK1/2-NF-κB-Snail-1" . SPARSER::COLLECTION)
    ("TAK1-NF-κB" . SPARSER::COLLECTION)
    ("a permeable barrier" . SPARSER::PROTEIN) ("PM" . SPARSER::PROTEIN)
    ("GTPases, and PI3K" . SPARSER::COLLECTION) ("trimers" . SPARSER::TRIMER)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("two type I and two type II transmembrane serine–threonine kinase receptors"
     . SPARSER::COLLECTION)
    ("a heterotetrameric complex" . SPARSER::BIO-COMPLEX)
    ("serine–threonine" . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE) ("MAPKs" . SPARSER::PROTEIN)
    ("ILK" . SPARSER::PROTEIN) ("Snail-1" . SPARSER::PROTEIN)
    ("bHLH" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("soluble growth factors and cytokines" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("TGF" . SPARSER::DRUG)
    ("fibronectin (FN) and collagen" . SPARSER::COLLECTION)
    ("components (ECM)" . SPARSER::COMPONENT)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("complex and stepwise" . SPARSER::COLLECTION)
    ("mesenchymal state" . SPARSER::BIO-STATE)
    ("E-cadherin and ZO-1" . SPARSER::COLLECTION)
    ("MEK-ERK1/2-Snail-1" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("laminin" . SPARSER::PROTEIN) ("FN" . SPARSER::PROTEIN)
    ("group D" . SPARSER::PROTEIN) ("group C" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("1–2 " . SPARSER::PROTEIN) ("l type" . SPARSER::PROTEIN)
    ("For 3" . SPARSER::PROTEIN)
    ("Reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SP8" . SPARSER::PROTEIN) ("Fsp1" . SPARSER::PROTEIN)
    ("CD54" . SPARSER::PROTEIN) ("ICAM-2" . SPARSER::PROTEIN)
    ("CD32" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("type 1" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("Ras family" . SPARSER::PROTEIN) ("ERK1" . SPARSER::PROTEIN)
    ("thrombospondin-1" . SPARSER::PROTEIN) ("LTBP2" . SPARSER::PROTEIN)
    ("gremlin-1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("SMAD1" . SPARSER::PROTEIN) ("id1" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("CI-1040" . SPARSER::DRUG)
    ("JAM-A" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("caveolin-1" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Smad4" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("Smad1" . SPARSER::PROTEIN) ("FSP-1" . SPARSER::PROTEIN)
    ("Cav1" . SPARSER::PROTEIN) ("asyn and ATP13A2" . SPARSER::COLLECTION)
    ("asyn" . SPARSER::PROTEIN) ("ATP13A2 and HSPA8" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN) ("HSC70 and HSP73" . SPARSER::COLLECTION)
    ("hydrolases" . SPARSER::PROTEIN) ("fish" . SPARSER::PROTEIN)
    ("selenium-" . SPARSER::MOLECULE)
    ("protein and asyn" . SPARSER::COLLECTION)
    ("ATP13A2 AND ALPHA-SYNUCLEIN" . SPARSER::COLLECTION)
    ("cation" . SPARSER::MOLECULE) ("NCL" . SPARSER::PROTEIN)
    ("ATPases" . SPARSER::PROTEIN) ("neurotransmitter" . SPARSER::MOLECULE)
    ("SNCA" . SPARSER::PROTEIN) ("ATP13A2 and asyn" . SPARSER::COLLECTION)
    ("ATP13A2 and alpha-synuclein" . SPARSER::COLLECTION)
    ("a complex and multifactorial disorder" . SPARSER::COLLECTION)
    ("HSP73" . SPARSER::PROTEIN) ("HSPA8" . SPARSER::PROTEIN)
    ("a chain" . SPARSER::PROTEIN) ("cathepsin D" . SPARSER::PROTEIN)
    ("Zn 2+" . SPARSER::MOLECULE) ("ATP13A1" . SPARSER::PROTEIN)
    ("ALPHA-SYNUCLEIN" . SPARSER::PROTEIN)
    ("alpha-synuclein" . SPARSER::PROTEIN) ("ATP13A2" . SPARSER::PROTEIN)
    ("PI3K/AKT/mTOR/S6K" . SPARSER::COLLECTION) ("oxide" . SPARSER::MOLECULE)
    ("caryophyllene" . SPARSER::DRUG) ("oligopeptidase" . SPARSER::PROTEIN)
    ("endopeptidase" . SPARSER::PROTEIN) ("zinc-binding" . SPARSER::PROTEIN)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("metalloprotease" . SPARSER::PROTEIN)
    ("The 170 kDa and 85 kDa mTOR fragment" . SPARSER::COLLECTION)
    ("PBS" . SPARSER::PROTEIN) ("rather intermediate form" . SPARSER::FORM)
    ("p70S6K" . SPARSER::PROTEIN) ("IPTG" . SPARSER::MOLECULE)
    ("the largest surface protease family and the second largest surface protein family"
     . SPARSER::COLLECTION)
    ("the second largest surface protein family" . SPARSER::PROTEIN-FAMILY)
    ("the largest surface protease family" . SPARSER::PROTEIN-FAMILY)
    ("mTOR, AKT, and p70S6" . SPARSER::COLLECTION)
    ("proteases, and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("mTOR complex 1 (mTORC1) and concomitant activation of 4E-BP1"
     . SPARSER::COLLECTION)
    ("mTORC1 and its downstream targets p70S6K1/2 [ xref ]"
     . SPARSER::COLLECTION)
    ("IFN-α and IFN-β" . SPARSER::COLLECTION) ("IFN" . SPARSER::DRUG)
    ("spp" . SPARSER::PROTEIN)
    ("proteases, and metalloproteinases" . SPARSER::COLLECTION)
    ("ESP" . SPARSER::PROTEIN) ("surface protein" . SPARSER::PROTEIN)
    ("DNA Polymerase" . SPARSER::PROTEIN) ("MP50" . SPARSER::PROTEIN)
    ("S6K" . SPARSER::PROTEIN) ("S6K1" . SPARSER::PROTEIN)
    ("protein kinase-B" . SPARSER::PROTEIN) ("p70S6K1" . SPARSER::PROTEIN)
    ("IFN-α" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("1,10-phenanthroline" . SPARSER::MOLECULE) ("GP63" . SPARSER::PROTEIN)
    ("BCR-ABL and FLT3" . SPARSER::COLLECTION)
    ("the mitochondrial PTP" . SPARSER::PROTEIN)
    ("critical cellular macromolecules" . SPARSER::MOLECULE)
    ("phosphoenolpyruvate and ADP" . SPARSER::COLLECTION)
    ("phosphoenolpyruvate" . SPARSER::MOLECULE)
    ("platelets" . SPARSER::PROTEIN) ("PTP" . SPARSER::PROTEIN)
    ("albumin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("creatinine" . SPARSER::PROTEIN) ("hemoglobin" . SPARSER::MOLECULE)
    ("TKI (dasatinib or quizartinib) and oligomycin-A" . SPARSER::COLLECTION)
    ("dasatinib or quizartinib" . SPARSER::COLLECTION)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("Dasatinib" . SPARSER::DRUG)
    ("p185-BCR-ABL/GFP" . SPARSER::COLLECTION)
    ("closely mimic human BCR-ABL + B-ALL" . SPARSER::PROTEIN)
    ("TKI and oligomycin-A" . SPARSER::COLLECTION)
    ("oxygen and hydrogen peroxide" . SPARSER::COLLECTION)
    ("superoxide and subsequent oxidative damage" . SPARSER::COLLECTION)
    ("imatinib and oligomycin-A" . SPARSER::COLLECTION)
    ("deoxyguanosine" . SPARSER::MOLECULE)
    ("imatinib and/or oligomycin-A" . SPARSER::COLLECTION)
    ("AMP" . SPARSER::AMP) ("AMPK" . SPARSER::PROTEIN)
    ("both imatinib and oligomycin-A treatments decrease ATP levels in K562"
     . SPARSER::COLLECTION)
    ("dysfunctional mitochondria" . SPARSER::PROTEIN)
    ("galactose" . SPARSER::MOLECULE)
    ("antimycin (complex III inhibitor) and rotenone (inhibitor of electron transfer from complex I to ubiquinone; xref , top)"
     . SPARSER::COLLECTION)
    ("rotenone" . SPARSER::PROTEIN) ("antimycin" . SPARSER::DRUG)
    ("driving tyrosine kinase" . SPARSER::PROTEIN)
    ("Doxorubicin and cytarabine" . SPARSER::COLLECTION)
    ("doxorubicin and cytarabine" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE) ("doxorubicin" . SPARSER::PROTEIN)
    ("methylcellulose" . SPARSER::DRUG) ("lestaurtinib" . SPARSER::DRUG)
    ("quizartinib and oligomycin-A" . SPARSER::COLLECTION)
    ("MV" . SPARSER::PROTEIN) ("NOMO-1" . SPARSER::PROTEIN)
    ("driving TK" . SPARSER::PROTEIN) ("quizartinib" . SPARSER::DRUG)
    ("Synergizes" . SPARSER::PROTEIN)
    ("a competitive glucose analog" . SPARSER::ANALOG)
    ("SUP-B15" . SPARSER::COLLECTION) ("SUP" . SPARSER::PROTEIN)
    ("available therapeutics" . SPARSER::THERAPEUTICS)
    ("imatinib and DLAT" . SPARSER::COLLECTION)
    ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("dihydrolipoamide S-acetyltransferase (DLAT)" . SPARSER::PROTEIN)
    ("whose inhibition synergizes" . SPARSER::PROTEIN)
    ("analog" . SPARSER::ANALOG) ("residual glucose" . SPARSER::PROTEIN)
    ("/protein kinase B" . SPARSER::COLLECTION) ("pentose" . SPARSER::MOLECULE)
    ("acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("The resultant fusion protein" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("NFκB" . SPARSER::PROTEIN)
    ("cyclophilin-D" . SPARSER::PROTEIN) ("p185" . SPARSER::PROTEIN)
    ("SOD1" . SPARSER::PROTEIN) ("complex I" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("as 2" . SPARSER::PROTEIN) ("5–2 µ" . SPARSER::PROTEIN)
    ("lactic acid" . SPARSER::MOLECULE)
    ("dihydrolipoamide S-acetyltransferase" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("B-ALL" . SPARSER::PROTEIN)
    ("AC220" . SPARSER::DRUG) ("p210" . SPARSER::PROTEIN)
    ("pro-B" . SPARSER::DRUG) ("c-kit" . SPARSER::PROTEIN)
    ("B15" . SPARSER::PROTEIN) ("GLUT-1" . SPARSER::PROTEIN)
    ("phosphoinositide 3" . SPARSER::PROTEIN)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("SDF-1/CXCL12" . SPARSER::COLLECTION)
    ("E-cadherin and p53" . SPARSER::COLLECTION)
    ("intronic p53 response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Survivin" . SPARSER::PROTEIN) ("HER2 and TNBCs" . SPARSER::COLLECTION)
    ("HER2 and TNBC subtypes" . SPARSER::COLLECTION)
    ("EGFR/HER2" . SPARSER::COLLECTION)
    ("EGFR/Cdc42/Toca-1" . SPARSER::COLLECTION)
    ("EGFR and Cdc42" . SPARSER::COLLECTION)
    ("HER2 and TNBC subtypes [ xref ]" . SPARSER::COLLECTION)
    ("extreme p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EP" . SPARSER::PROTEIN)
    ("antisera" . SPARSER::PROTEIN) ("fluorescent ECM" . SPARSER::PROTEIN)
    ("sh-p53/sh-Toca-1" . SPARSER::COLLECTION) ("sh-p53" . SPARSER::COLLECTION)
    ("p53/Toca-1" . SPARSER::COLLECTION)
    ("promoter or intron" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("p53 antibody (DO-1) or a control IgG" . SPARSER::COLLECTION)
    ("toca1/fnbp1l" . SPARSER::COLLECTION) ("p22" . SPARSER::PROTEIN)
    ("a previously unidentified p53 target gene" . SPARSER::GENE)
    ("p53 and p21" . SPARSER::COLLECTION)
    ("p53 and p21 proteins" . SPARSER::COLLECTION)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("Toca-1, p53 and p21WAF1" . SPARSER::COLLECTION)
    ("p53 and gain-of-function" . SPARSER::COLLECTION)
    ("Toca-1 and p53" . SPARSER::COLLECTION)
    ("HER2 and TNBC" . SPARSER::COLLECTION) ("caldesmon" . SPARSER::PROTEIN)
    ("inducers" . SPARSER::MOLECULE)
    ("/progesterone receptor" . SPARSER::COLLECTION)
    ("diaphanous-related formins" . SPARSER::PROTEIN)
    ("formins" . SPARSER::PROTEIN) ("dynamin" . SPARSER::PROTEIN)
    ("PKN" . SPARSER::PROTEIN) ("a crescent-shaped dimer" . SPARSER::DIMER)
    ("homology-Bin" . SPARSER::PROTEIN-PAIR) ("Amphiphysin" . SPARSER::PROTEIN)
    ("Bin" . SPARSER::PROTEIN)
    ("an essential adaptor protein" . SPARSER::PROTEIN)
    ("Cdc42/Toca-1/N-WASP" . SPARSER::COLLECTION)
    ("N-WASP or cortactin" . SPARSER::COLLECTION)
    ("cortactin" . SPARSER::PROTEIN) ("p53 and Toca-1" . SPARSER::COLLECTION)
    ("camptothecin or Nutlin-3" . SPARSER::COLLECTION)
    ("pregnancy-associated plasma protein A" . SPARSER::PROTEIN)
    ("GADD45" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("fnbp1l" . SPARSER::PROTEIN) ("p21 proteins" . SPARSER::PROTEIN)
    ("p21 protein" . SPARSER::PROTEIN) ("Toca-1 " . SPARSER::PROTEIN)
    ("IL-2R" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("P40" . SPARSER::PROTEIN) ("Abi1" . SPARSER::PROTEIN)
    ("HR1" . SPARSER::PROTEIN-FAMILY) ("CIP4" . SPARSER::PROTEIN)
    ("Cdc42-interacting protein" . SPARSER::PROTEIN)
    ("Arp2/3" . SPARSER::PROTEIN) ("FNBP1L" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("filamentous actin" . SPARSER::BIO-COMPLEX)
    ("toca1" . SPARSER::PROTEIN) ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("Toca-1" . SPARSER::PROTEIN) ("Cdc42" . SPARSER::PROTEIN)
    ("FoxO3a or FoxO1" . SPARSER::COLLECTION)
    ("phospho-4EBP1 and phospho-S6" . SPARSER::COLLECTION)
    ("FoxO1 or FoxO3a" . SPARSER::COLLECTION)
    ("Flag-FoxO1-ΔDB" . SPARSER::COLLECTION) ("ΔDB" . SPARSER::PROTEIN)
    ("FoxO1-ΔDB" . SPARSER::PROTEIN-PAIR) ("FoxO1-" . SPARSER::PROTEIN)
    ("Atg4c, Atg7, LC3, Atg12, and Bnip3" . SPARSER::COLLECTION)
    ("Atg4c" . SPARSER::PROTEIN) ("Atg5" . SPARSER::PROTEIN)
    ("labile" . SPARSER::PROTEIN)
    ("FoxO3a siRNA or control siRNA" . SPARSER::COLLECTION)
    ("mRFP-GFP-LC3" . SPARSER::COLLECTION) ("chloroquine" . SPARSER::PROTEIN)
    ("complex and cell" . SPARSER::COLLECTION) ("Atg7" . SPARSER::PROTEIN)
    ("Atg" . SPARSER::DRUG)
    ("regulating anabolic and catabolic states" . SPARSER::BIO-STATE)
    ("FoxOs" . SPARSER::PROTEIN-FAMILY) ("macromolecules" . SPARSER::MOLECULE)
    ("amino acid and cell" . SPARSER::COLLECTION)
    ("FoxO1 and FoxO3a" . SPARSER::COLLECTION)
    ("FoxO3a and FoxO1" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3Kinase" . SPARSER::PROTEIN) ("FoxO3" . SPARSER::PROTEIN)
    ("Bnip3" . SPARSER::PROTEIN) ("Atg12" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN) ("C-3" . SPARSER::PROTEIN)
    ("D-glucose" . SPARSER::MOLECULE) ("APG8A" . SPARSER::PROTEIN)
    ("PI3K-AKT-mTOR" . SPARSER::PROTEIN) ("FoxO3a" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("cadherin–catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acetylase" . SPARSER::PROTEIN)
    ("β-catenin and the human iPSC-derived NPCs" . SPARSER::COLLECTION)
    ("the membrane/cytoplasmic fraction and not" . SPARSER::COLLECTION)
    ("ACY-1215 and siRNA" . SPARSER::COLLECTION)
    ("the insoluble fractions" . SPARSER::COMPONENT)
    ("ACY-1215 and MG-132" . SPARSER::COLLECTION)
    ("CK1α
and GSK3β"
     . SPARSER::COLLECTION)
    ("NPC" . SPARSER::MOLECULE) ("tubacin" . SPARSER::DRUG)
    ("BG" . SPARSER::PROTEIN) ("Cpd" . SPARSER::PROTEIN)
    ("SAHA" . SPARSER::DRUG) ("IIb" . SPARSER::DRUG)
    ("CK1α and GSK3β" . SPARSER::COLLECTION)
    ("HDACs and HATs" . SPARSER::COLLECTION) ("HDACs" . SPARSER::PROTEIN)
    ("Axin" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor (PCAF)" . SPARSER::PROTEIN)
    ("transducin" . SPARSER::PROTEIN) ("NPCs" . SPARSER::MOLECULE)
    ("HDAC" . SPARSER::PROTEIN)
    ("suberoylanilide hydroxamic acid" . SPARSER::DRUG)
    ("β-tubulin" . SPARSER::PROTEIN) ("histone-H3" . SPARSER::PROTEIN)
    ("ddH 2" . SPARSER::PROTEIN) ("l -ornithine" . SPARSER::DRUG)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("ubiquitin
ligase"
     . SPARSER::PROTEIN)
    ("HDAC1" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("HDAC6 inhibitor ACY-1215" . SPARSER::DRUG) ("ACY-1215" . SPARSER::DRUG)
    ("HDAC3" . SPARSER::PROTEIN) ("CI-994" . SPARSER::DRUG)
    ("SW480" . SPARSER::PROTEIN) ("HDAC6" . SPARSER::PROTEIN)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("CK1α" . SPARSER::PROTEIN) ("Casein Kinase 1" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("other innovative anti-leukemic drugs" . SPARSER::DRUG)
    ("nicotinamide nucleotide transhydrogenase (NNT)" . SPARSER::PROTEIN)
    ("NNT" . SPARSER::PROTEIN)
    ("10 up-regulated proteins and 7 down-regulated proteins ( xref )"
     . SPARSER::COLLECTION)
    ("ILF3-p21" . SPARSER::COLLECTION)
    ("both primary p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dysfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("primary p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 wild-type B leukemic cells DCA" . SPARSER::PROTEIN)
    ("ILF3 and p21" . SPARSER::COLLECTION) ("ILF3/p21" . SPARSER::COLLECTION)
    ("dichloroacetate (DCA)" . SPARSER::MOLECULE) ("DCA" . SPARSER::PROTEIN)
    ("dichloroacetate" . SPARSER::MOLECULE) ("purine" . SPARSER::DRUG)
    ("P13" . SPARSER::PROTEIN) ("POLR2A" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("P21" . SPARSER::PROTEIN)
    ("nicotinamide nucleotide transhydrogenase" . SPARSER::PROTEIN)
    ("ANT2" . SPARSER::PROTEIN)
    ("interleukin enhancer-binding factor 3" . SPARSER::PROTEIN)
    ("ILF3" . SPARSER::PROTEIN) ("AP-1 and miR-21" . SPARSER::COLLECTION)
    ("Cisplatin" . SPARSER::DRUG)
    ("VP-16, cisplatin, 5-fluorouracil, and docetaxel" . SPARSER::COLLECTION)
    ("Jun and Fos" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin D1, cyclin E1, CDK2, and CDK4" . SPARSER::COLLECTION)
    ("AKT and GSK3β" . SPARSER::COLLECTION)
    ("the associated target genes" . SPARSER::GENE)
    ("GSK3β, cyclin D1, cyclin E1, CDK2, and CDK4" . SPARSER::COLLECTION)
    ("miR-21 and their targets" . SPARSER::COLLECTION)
    ("PTEN/PDCD4/RECK" . SPARSER::COLLECTION)
    ("AP-1/miR-21" . SPARSER::COLLECTION)
    ("miR-21 and AP-1" . SPARSER::COLLECTION) ("p-c-Jun" . SPARSER::COLLECTION)
    ("JunB and c-Fos" . SPARSER::COLLECTION)
    ("c-Jun, JunB, and c-Fos" . SPARSER::COLLECTION)
    ("JunB" . SPARSER::PROTEIN) ("primary miR-21" . SPARSER::PROTEIN)
    ("pri-miR-21" . SPARSER::COLLECTION)
    ("Chemotherapeutic drugs" . SPARSER::DRUG)
    ("PTEN, PDCD4, and RECK" . SPARSER::COLLECTION) ("RECK" . SPARSER::PROTEIN)
    ("ts-miR" . SPARSER::COLLECTION)
    ("tumor suppressive miRNAs" . SPARSER::PROTEIN)
    ("ts-miRs" . SPARSER::COLLECTION)
    ("Several effective biomarkers and new imaging techniques"
     . SPARSER::COLLECTION)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("AP-1 and microRNA-21-mediated" . SPARSER::COLLECTION)
    ("pirarubicin" . SPARSER::DRUG) ("fluorouracil" . SPARSER::DRUG)
    ("CCK-8" . SPARSER::PROTEIN) ("Amino Acid" . SPARSER::AMINO-ACID)
    ("Not1" . SPARSER::PROTEIN) ("GADD153" . SPARSER::PROTEIN)
    ("Bcl-w" . SPARSER::PROTEIN) ("P85" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN) ("CDK2" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("PDCD4" . SPARSER::PROTEIN) ("cyclin G1" . SPARSER::PROTEIN)
    ("L11-miR-130a-Ago2" . SPARSER::COLLECTION)
    ("miR-130a-" . SPARSER::PROTEIN) ("Ago2-miR-130a" . SPARSER::COLLECTION)
    ("L11-" . SPARSER::PROTEIN)
    ("miR-130a directly targets c-Myc" . SPARSER::PROTEIN)
    ("MAPK and androgen receptor" . SPARSER::COLLECTION)
    ("TRAIL" . SPARSER::PROTEIN) ("a key miRNA" . SPARSER::PROTEIN)
    ("pGL3-" . SPARSER::PROTEIN)
    ("a novel L11-associated miRNA" . SPARSER::PROTEIN)
    ("both c-myc mRNA (Fig. xref ) and miR-130a (Fig. xref )"
     . SPARSER::COLLECTION)
    ("the nucleolar L11" . SPARSER::PROTEIN)
    ("nucleolar fractions" . SPARSER::COMPONENT)
    ("c-Myc mRNA (Fig. xref , compare the ratio of column 4 to column 3 with the ratio of column 2 to column 1) and protein (Fig. xref , compare the ratio of lane 4 to lane 3 with the ratio of lane 2 to lane 1)"
     . SPARSER::COLLECTION)
    ("L11 and the eIF4G" . SPARSER::COLLECTION)
    ("an essential scaffold protein" . SPARSER::PROTEIN)
    ("L11 and Ago2" . SPARSER::COLLECTION)
    ("mRNA and miR-130a" . SPARSER::COLLECTION)
    ("IgG or anti-L11" . SPARSER::COLLECTION)
    ("HuR, eIF4G, and ribosomal protein L5" . SPARSER::COLLECTION)
    ("eIF" . SPARSER::PROTEIN) ("miR-130a and c-myc" . SPARSER::COLLECTION)
    ("U6 or GAPDH" . SPARSER::COLLECTION)
    ("BS-1, BS-2, and BS-3" . SPARSER::COLLECTION)
    ("miRNA:mRNA" . SPARSER::BIO-COMPLEX) ("pGL3-myc-3" . SPARSER::COLLECTION)
    ("pGL3-myc" . SPARSER::COLLECTION)
    ("miR-130a directly targets c-myc mRNA" . SPARSER::PROTEIN)
    ("miRIDIAN miR-130a hairpin inhibitor" . SPARSER::INHIBITOR)
    ("the proto-oncogene MET [ xref ] and several components"
     . SPARSER::COLLECTION)
    ("miR-130a" . SPARSER::PROTEIN) ("L11-miR-130a" . SPARSER::COLLECTION)
    ("Flag-L11" . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("the nucleolar components" . SPARSER::COMPONENT)
    ("Mature miRNAs" . SPARSER::PROTEIN)
    ("endoribonuclease" . SPARSER::PROTEIN)
    ("tristetraprolin (TPP)" . SPARSER::PROTEIN) ("TPP" . SPARSER::PROTEIN)
    ("tristetraprolin" . SPARSER::PROTEIN)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("c-myc mRNA as well as Ago2" . SPARSER::COLLECTION)
    ("β-gal" . SPARSER::PROTEIN) ("LT1" . SPARSER::PROTEIN)
    ("G-3" . SPARSER::PROTEIN) ("DICER1" . SPARSER::PROTEIN)
    ("RPL5" . SPARSER::PROTEIN) ("ribosomal protein L5" . SPARSER::PROTEIN)
    ("BS1" . SPARSER::PROTEIN) ("BS-3" . SPARSER::PROTEIN)
    ("BS-2" . SPARSER::PROTEIN) ("BS-1" . SPARSER::PROTEIN)
    ("miR-16" . SPARSER::PROTEIN) ("ribosomal protein L11" . SPARSER::PROTEIN)
    ("CRD-BP" . SPARSER::PROTEIN) ("AUF1" . SPARSER::PROTEIN)
    ("Ago2" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("p38α or p38β" . SPARSER::COLLECTION)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("S33 and S46" . SPARSER::COLLECTION)
    ("the p21 WAF1 promoter or p21 WAF1 expression" . SPARSER::COLLECTION)
    ("the PUMA promoter and PUMA expression" . SPARSER::COLLECTION)
    ("PRAK" . SPARSER::PROTEIN)
    ("DNA-damage induced apoptosis in the other cell lines" . SPARSER::DNA)
    ("lacZ" . SPARSER::PROTEIN) ("MKK3 and MKK6" . SPARSER::COLLECTION)
    ("HA-p38α" . SPARSER::COLLECTION) ("Tip60-p53-PUMA" . SPARSER::COLLECTION)
    ("the PUMA promoter, which encompasses the p53 binding sites [ xref ]"
     . SPARSER::PROMOTER)
    ("p38α or Tip60" . SPARSER::COLLECTION)
    ("p38α-Tip60" . SPARSER::COLLECTION) ("p38-Tip60" . SPARSER::COLLECTION)
    ("PUMA and p21" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21 WAF1 [ xref ] and PUMA [ xref ]" . SPARSER::COLLECTION)
    ("WAF1 and PUMA" . SPARSER::COLLECTION)
    ("a chemotherapeutic drug" . SPARSER::DRUG)
    ("Doxorubicin" . SPARSER::PROTEIN)
    ("p38-Tip60-p53-PUMA" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("MYST" . SPARSER::PROTEIN-FAMILY) ("hMOF and Tip60" . SPARSER::COLLECTION)
    ("hMOF" . SPARSER::PROTEIN) ("Mdm2 and Mdmx" . SPARSER::COLLECTION)
    ("p300/CBP" . SPARSER::COLLECTION) ("CBP/p300" . SPARSER::COLLECTION)
    ("Mdmx" . SPARSER::PROTEIN) ("PCAF" . SPARSER::PROTEIN)
    ("CBP" . SPARSER::PROTEIN)
    ("multi domain proapoptotic protein Bax and/or Bak" . SPARSER::COLLECTION)
    ("Bak" . SPARSER::PROTEIN) ("p38 and Tip60" . SPARSER::COLLECTION)
    ("p53-PUMA" . SPARSER::COLLECTION) ("p38α and Tip60" . SPARSER::COLLECTION)
    ("a multifunctional acetyltransferase" . SPARSER::PROTEIN)
    ("α at" . SPARSER::PROTEIN) ("p38 α" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("EF1α" . SPARSER::PROTEIN)
    ("p38γ" . SPARSER::PROTEIN) ("S46" . SPARSER::PROTEIN)
    ("MKK6" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG) ("PUMA protein" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("Mdm2" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("WAF1" . SPARSER::PROTEIN) ("p38α" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("mast cell" . SPARSER::PROTEIN)
    ("Rac1 and collagen" . SPARSER::COLLECTION)
    ("fibronectin and collagen" . SPARSER::COLLECTION)
    ("the IIA isoform or its association with FAs" . SPARSER::COLLECTION)
    ("neighboring FA" . SPARSER::PROTEIN)
    ("locally driving integrin" . SPARSER::PROTEIN)
    ("driving integrin" . SPARSER::PROTEIN)
    ("radial SF and FA" . SPARSER::COLLECTION)
    ("SF and FA" . SPARSER::COLLECTION) ("acto-myosin" . SPARSER::COLLECTION)
    ("either GFP-S1916A MIIA HC or GFP-S1916D MIIA HC" . SPARSER::COLLECTION)
    ("WT-GFP-MIIA HC or GFP-S1916A MIIA HC" . SPARSER::COLLECTION)
    ("TFM" . SPARSER::PROTEIN) ("HC and re-expressing" . SPARSER::COLLECTION)
    ("mApple-paxillin-labeled FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GFP-S1916D MIIA HC or GFP-S1916A MIIA HC" . SPARSER::COLLECTION)
    ("mApple" . SPARSER::PROTEIN)
    ("bipolar mini-filaments" . SPARSER::PROTEIN-FAMILY)
    ("mApple-paxillin" . SPARSER::COLLECTION)
    ("MIIA and the fraction" . SPARSER::COLLECTION)
    ("GFP MIIA HC or GFP-S1916A MIIA HC ( xref , xref )" . SPARSER::COLLECTION)
    ("MIIAs" . SPARSER::PROTEIN) ("mature FA" . SPARSER::PROTEIN)
    ("Rac1 and PKC" . SPARSER::COLLECTION)
    ("PKCs increased pS1916 MIIA HC" . SPARSER::PROTEIN)
    ("Rac1-" . SPARSER::PROTEIN) ("Rac1 and PKCs" . SPARSER::COLLECTION)
    ("MIIA-HC" . SPARSER::COLLECTION) ("polyacrylamide" . SPARSER::DRUG)
    ("GFP-MIIA-HC" . SPARSER::COLLECTION)
    ("the FA-associated fraction" . SPARSER::COMPONENT)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("triton" . SPARSER::MOLECULE)
    ("peripheral SFs and a small fraction" . SPARSER::COLLECTION)
    ("peripheral SFs" . SPARSER::PROTEIN)
    ("FAs and pS1916" . SPARSER::COLLECTION)
    ("HC and paxillin" . SPARSER::COLLECTION)
    ("fibronectin or collagen" . SPARSER::COLLECTION) ("pS" . SPARSER::PROTEIN)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("Integrin" . SPARSER::PROTEIN)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("individual bipolar MIIA mini-filaments" . SPARSER::PROTEIN-FAMILY)
    ("dual diffraction-limited puncta" . SPARSER::PROTEIN)
    ("MIIA" . SPARSER::PROTEIN) ("GFP-MIIA" . SPARSER::COLLECTION)
    ("the substrate-adhered FA fraction" . SPARSER::COMPONENT)
    ("dorsal and ventral SFs" . SPARSER::PROTEIN) ("SF" . SPARSER::PROTEIN)
    ("radial SFs, and FAs" . SPARSER::COLLECTION)
    ("SFs, and FAs" . SPARSER::COLLECTION) ("radial SFs" . SPARSER::PROTEIN)
    ("SFs" . SPARSER::PROTEIN)
    ("immuno-localized MII (either A or B isoforms) and paxillin"
     . SPARSER::COLLECTION)
    ("fluorescent phalloidin" . SPARSER::MOLECULE)
    ("phalloidin" . SPARSER::MOLECULE)
    ("blue fluorescent protein (BFP)" . SPARSER::PROTEIN)
    ("BFP" . SPARSER::PROTEIN) ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRPM7, and casein" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("rod and non-helical" . SPARSER::COLLECTION) ("rod" . SPARSER::PROTEIN)
    ("PAK" . SPARSER::PROTEIN-FAMILY)
    ("ATPase and filament" . SPARSER::COLLECTION)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("long-lived FA" . SPARSER::PROTEIN)
    ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("Rac1 and integrin" . SPARSER::COLLECTION)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("heavy chain (HC)" . SPARSER::PROTEIN) ("integrin-" . SPARSER::PROTEIN)
    ("HC" . SPARSER::PROTEIN) ("PKC" . SPARSER::PROTEIN)
    ("FA and actin" . SPARSER::COLLECTION) ("FA" . SPARSER::PROTEIN)
    ("MII" . SPARSER::PROTEIN) ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCα" . SPARSER::PROTEIN) ("assembly/disassembly" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("PKC β" . SPARSER::PROTEIN) ("Go6976" . SPARSER::DRUG)
    ("Pak1" . SPARSER::PROTEIN) ("TRPM7" . SPARSER::PROTEIN)
    ("Rho family" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("Non-muscle" . SPARSER::PROTEIN) ("RTK and perhaps" . SPARSER::COLLECTION)
    ("RTKs and other membrane receptors" . SPARSER::COLLECTION)
    ("robust KIT" . SPARSER::PROTEIN)
    ("homotypic receptor" . SPARSER::RECEPTOR)
    ("monomeric RPTPα" . SPARSER::PROTEIN)
    ("dimeric KIT molecules" . SPARSER::MOLECULE)
    ("inactive receptor monomers" . SPARSER::MONOMER)
    ("The excellent fit" . SPARSER::PROTEIN-FAMILY)
    ("full size dimeric KIT" . SPARSER::PROTEIN)
    ("a constitutively-activated ligand-independent oncogenic receptor"
     . SPARSER::RECEPTOR)
    ("a highly regulated ligand stimulated RTK" . SPARSER::PROTEIN)
    ("IB" . SPARSER::DRUG) ("KIT or PDGFR" . SPARSER::COLLECTION)
    ("KIT or PDGF-receptor" . SPARSER::COLLECTION) ("PDGFR" . SPARSER::PROTEIN)
    ("mutated D5 molecules" . SPARSER::MOLECULE) ("RI" . SPARSER::MOLECULE)
    ("Soluble variants" . SPARSER::VARIANT)
    ("dimeric D5 oncogenic KIT mutant" . SPARSER::MUTANT)
    ("EMD" . SPARSER::PROTEIN) ("fits" . SPARSER::PROTEIN-FAMILY)
    ("van" . SPARSER::PROTEIN) ("KIT:SCF" . SPARSER::BIO-COMPLEX)
    ("ABCC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Dimer" . SPARSER::DIMER)
    ("Dup" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TM" . SPARSER::PROTEIN)
    ("deafness" . SPARSER::PROTEIN) ("Tyrosine" . SPARSER::AMINO-ACID)
    ("KIT-SCF" . SPARSER::COLLECTION) ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("macrophage colony stimulating factor receptor (CSF1R/ Fms ) and the Fms related tyrosine kinase 3 (Flt3/Flk2)"
     . SPARSER::COLLECTION)
    ("Flt3/Flk2" . SPARSER::COLLECTION)
    ("cellular homolog of" . SPARSER::PROTEIN)
    ("SCF and its receptor" . SPARSER::COLLECTION) ("Cajal" . SPARSER::PROTEIN)
    ("CCP4" . SPARSER::PROTEIN) ("CoCl 2" . SPARSER::MOLECULE)
    ("RPTPα" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("KIT ligand" . SPARSER::PROTEIN)
    ("transmembrane domain (TM)" . SPARSER::PROTEIN)
    ("Flk2" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("Fms related tyrosine kinase 3" . SPARSER::PROTEIN)
    ("CSF1R" . SPARSER::PROTEIN)
    ("colony stimulating factor receptor" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("PDGFRα" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("its receptor" . SPARSER::PROTEIN)
    ("Stem cell factor" . SPARSER::PROTEIN) ("Bao-ning" . SPARSER::COLLECTION)
    ("WANG" . SPARSER::PROTEIN) ("ning" . SPARSER::PROTEIN-FAMILY)
    ("SHI" . SPARSER::PROTEIN) ("Xin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("IFI16-HIN" . SPARSER::COLLECTION)
    ("IFI16 and IFNB1" . SPARSER::COLLECTION)
    ("the anti-IFI16" . SPARSER::ANTIBODY)
    ("Nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Western blot" . SPARSER::PROTEIN)
    ("IFI16-HIN200" . SPARSER::COLLECTION)
    ("Etoposide or Nutlin-3" . SPARSER::COLLECTION)
    ("Nutlin-3 or Etoposide" . SPARSER::COLLECTION)
    ("Etoposide" . SPARSER::PROTEIN)
    ("IFI16 and Nutlin-3" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("HIN" . SPARSER::PROTEIN-FAMILY) ("pyrin" . SPARSER::PROTEIN)
    ("p53 and MDM2" . SPARSER::COLLECTION) ("modifiers" . SPARSER::MOLECULE)
    ("pifithrin" . SPARSER::DRUG) ("IFI16 and IFNB" . SPARSER::COLLECTION)
    ("IFNB" . SPARSER::PROTEIN) ("Interferon-γ" . SPARSER::PROTEIN)
    ("histone acetyl-transferase" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("IFNB1" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("AIM2" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN)
    ("HIN200" . SPARSER::PROTEIN-FAMILY) ("double minute 2" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("IFI16" . SPARSER::PROTEIN)
    ("orthosteric inhibitors" . SPARSER::INHIBITOR)
    ("disulfide" . SPARSER::MOLECULE)
    ("the mitotic phosphatase Cdc25C" . SPARSER::PROTEIN)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("CSPs" . SPARSER::PROTEIN) ("a unique form" . SPARSER::FORM)
    ("FFpSPR and the trans ligand" . SPARSER::COLLECTION)
    ("ligand and FFpSPR" . SPARSER::COLLECTION)
    ("both FFpSPR and the trans ligand" . SPARSER::COLLECTION)
    ("the PPIase, both FFpSPR and the trans ligand" . SPARSER::COLLECTION)
    ("FFpSPR and the trans and cis ligands" . SPARSER::COLLECTION)
    ("mapping, Peng and co-workers" . SPARSER::COLLECTION)
    ("conformation and vice" . SPARSER::COLLECTION)
    ("a tripartite enzyme" . SPARSER::ENZYME)
    ("representative conformations" . SPARSER::BIO-CONFORMATION)
    ("mutant and wild-type RMSFs ( xref )" . SPARSER::COLLECTION)
    ("both the apo form ( xref ) and the FFpSPR-bound form ( xref )"
     . SPARSER::COLLECTION)
    ("tip" . SPARSER::PROTEIN)
    ("a representative conformation" . SPARSER::BIO-CONFORMATION)
    ("a tripartite molecule" . SPARSER::MOLECULE) ("FFpSPR" . SPARSER::PROTEIN)
    ("FFpSPR-Pin1" . SPARSER::COLLECTION) ("Ile" . SPARSER::AMINO-ACID)
    ("Met" . SPARSER::AMINO-ACID) ("ps" . SPARSER::PROTEIN)
    ("trans and cis" . SPARSER::COLLECTION)
    ("actual ligands" . SPARSER::LIGAND) ("PC1-PC2" . SPARSER::COLLECTION)
    ("the first two principal components" . SPARSER::COMPONENT)
    ("PC1 and PC2" . SPARSER::COLLECTION) ("PC1" . SPARSER::PROTEIN)
    ("liganded" . SPARSER::MOLECULE) ("CSP" . SPARSER::PROTEIN)
    ("cis and trans" . SPARSER::COLLECTION)
    ("the latter forms" . SPARSER::FORM)
    ("sit" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("explicit solvent" . SPARSER::MOLECULE)
    ("a Pin1 substrate (FFpSPR) and two peptidomimetics" . SPARSER::COLLECTION)
    ("cis or trans" . SPARSER::COLLECTION) ("alkene" . SPARSER::MOLECULE)
    ("pSP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Substrate" . SPARSER::SUBSTRATE)
    ("a strong dynamic component" . SPARSER::COMPONENT)
    ("thrombomodulin" . SPARSER::PROTEIN) ("thrombin" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("Bank (PDB)" . SPARSER::PROTEIN)
    ("a nonpeptidic ligand" . SPARSER::LIGAND) ("PEG" . SPARSER::PROTEIN)
    ("mitotic phosphoproteins" . SPARSER::PROTEIN)
    ("cis/trans isomerase" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION) ("pSer" . SPARSER::PROTEIN)
    ("prolyl" . SPARSER::PROTEIN) ("apo" . SPARSER::PROTEIN)
    ("PPIase" . SPARSER::PROTEIN) ("protein C" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PC2" . SPARSER::PROTEIN) ("PDB 1" . SPARSER::PROTEIN)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("two domains" . SPARSER::PROTEIN)
    ("Thr-Pro" . SPARSER::MOLECULE) ("trans isomerase" . SPARSER::PROTEIN)
    ("Pin1" . SPARSER::PROTEIN) ("TMA" . SPARSER::MOLECULE)
    ("numerous junctional proteins" . SPARSER::PROTEIN)
    ("activated c-MET or potentially simply overexpressing HUWE1"
     . SPARSER::COLLECTION)
    ("TIAM1/RAC" . SPARSER::COLLECTION) ("SCF" . SPARSER::PROTEIN)
    ("TIAM1 and RAC" . SPARSER::COLLECTION)
    ("HUWE1-TIAM1" . SPARSER::COLLECTION) ("HGF/MET" . SPARSER::COLLECTION)
    ("MET/HGF" . SPARSER::COLLECTION) ("HUWE1 and c-MET" . SPARSER::COLLECTION)
    ("TIAM1 and c-MET" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("HUWE1, TIAM1, and c-MET" . SPARSER::COLLECTION)
    ("Example" . SPARSER::EXAMPLE)
    ("HUWE1, c-MET, and TIAM1" . SPARSER::COLLECTION)
    ("c-MET, TIAM1, and HUWE1" . SPARSER::COLLECTION)
    ("the nondegradable 4x595R TIAM1" . SPARSER::PROTEIN)
    ("siRNA and TIAM1" . SPARSER::COLLECTION) ("Ctrl" . SPARSER::PROTEIN)
    ("E-CADHERIN, β-CATENIN, and F-ACTIN" . SPARSER::COLLECTION)
    ("TIAM1 and K48-Ub" . SPARSER::COLLECTION)
    ("arginine" . SPARSER::AMINO-ACID) ("acceptor" . SPARSER::MOLECULE)
    ("a previously identified substrate" . SPARSER::SUBSTRATE)
    ("Ub or ATP" . SPARSER::COLLECTION) ("Lysine" . SPARSER::AMINO-ACID)
    ("nonfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("shRNA and siRNA" . SPARSER::COLLECTION)
    ("endogenous TIAM1 and endogenous HUWE1" . SPARSER::COLLECTION)
    ("E-CADHERIN and TIAM1" . SPARSER::COLLECTION)
    ("exogenous TIAM1" . SPARSER::PROTEIN) ("Ligase" . SPARSER::LIGASE)
    ("TIAM1-HA" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("specific subcellular fractions" . SPARSER::COMPONENT)
    ("TIAM1 and HUWE1" . SPARSER::COLLECTION)
    ("TIAM1-RAC" . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("both putative oncoprotein and tumor suppressor" . SPARSER::COLLECTION)
    ("whose substrates" . SPARSER::SUBSTRATE)
    ("HECT, UBA, and WWE" . SPARSER::COLLECTION)
    ("p53 and MYC" . SPARSER::COLLECTION) ("WWE" . SPARSER::PROTEIN-FAMILY)
    ("UBA" . SPARSER::PROTEIN) ("HECT" . SPARSER::PROTEIN)
    ("ubiquitin-conjugase" . SPARSER::COLLECTION)
    ("conjugase" . SPARSER::PROTEIN) ("junctional proteins" . SPARSER::PROTEIN)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("HUWE1 and TIAM1" . SPARSER::COLLECTION) ("RAC" . SPARSER::PROTEIN)
    ("Sulforhodamine B" . SPARSER::MOLECULE) ("β-TRCP" . SPARSER::PROTEIN)
    ("CDC6" . SPARSER::PROTEIN) ("F-ACTIN" . SPARSER::BIO-COMPLEX)
    ("β-CATENIN" . SPARSER::PROTEIN) ("E-CADHERIN" . SPARSER::PROTEIN)
    ("E–4" . SPARSER::PROTEIN) ("HUWE1 " . SPARSER::PROTEIN)
    ("G–1" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("Tiam1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("E-CADHERIN " . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("TIAM1" . SPARSER::PROTEIN) ("HUWE1" . SPARSER::PROTEIN)
    ("an exact enzyme" . SPARSER::ENZYME)
    ("K-RAS and p53" . SPARSER::COLLECTION)
    ("PI 3-Kinase/AKT" . SPARSER::COLLECTION)
    ("Hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the triple phosphate form" . SPARSER::FORM)
    ("shorter acyl" . SPARSER::PROTEIN)
    ("PIP and phosphatidylcholine" . SPARSER::COLLECTION)
    ("transporter" . SPARSER::PROTEIN) ("Lipid" . SPARSER::LIPID)
    ("wildtype p53 genes and a significant amount" . SPARSER::COLLECTION)
    ("lox-stop-lox" . SPARSER::COLLECTION)
    ("the currently known PIP" . SPARSER::PROTEIN)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("scaffolds" . SPARSER::SCAFFOLD) ("Tp53" . SPARSER::PROTEIN)
    ("PI and PC" . SPARSER::COLLECTION)
    ("phosphatidic acid phosphatase" . SPARSER::PHOSPHATASE)
    ("synthase" . SPARSER::PROTEIN) ("diacylglycerol" . SPARSER::PROTEIN)
    ("PC and PI" . SPARSER::COLLECTION)
    ("phosphatidylcholine (PC)" . SPARSER::MOLECULE)
    ("further shed light" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("littermate primary MEFs" . SPARSER::PROTEIN)
    ("alox-stop-lox" . SPARSER::COLLECTION) ("lox" . SPARSER::PROTEIN)
    ("wildtype primary MEFs" . SPARSER::PROTEIN) ("MEFs" . SPARSER::PROTEIN)
    ("disparate PI" . SPARSER::PROTEIN) ("Kras" . SPARSER::PROTEIN)
    ("normal FBS" . SPARSER::PROTEIN)
    ("fatty acids- another component" . SPARSER::COMPONENT)
    ("FBS" . SPARSER::PROTEIN) ("PIP and PIP 2" . SPARSER::COLLECTION)
    ("PI, PIP, PIP 2 and PIP 3" . SPARSER::COLLECTION)
    ("phosphoinositide" . SPARSER::PROTEIN)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("parent ions" . SPARSER::MOLECULE) ("bis" . SPARSER::PROTEIN)
    ("ester" . SPARSER::MOLECULE) ("esters" . SPARSER::MOLECULE)
    ("glycerol" . SPARSER::PROTEIN)
    ("phosphatidylinositol (PI)" . SPARSER::MOLECULE)
    ("scaffold" . SPARSER::SCAFFOLD) ("PIPs" . SPARSER::PROTEIN)
    ("PTEN/PI3-Kinase" . SPARSER::COLLECTION) ("sugar" . SPARSER::MOLECULE)
    ("PIP" . SPARSER::PROTEIN) ("Phosphatidylinositol" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("PI 3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("oleic acid" . SPARSER::MOLECULE) ("1B" . SPARSER::PROTEIN)
    ("PIP 2" . SPARSER::PIP2) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI-3 kinase" . SPARSER::PROTEIN)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("candidate predictive biomarkers" . SPARSER::MOLECULE)
    ("the PI3K-pathway-related components PIK3CA , PTEN and INPP4B"
     . SPARSER::COLLECTION)
    ("PIK3CA , PTEN and INPP4B" . SPARSER::COLLECTION)
    ("a dual phosphatase" . SPARSER::PHOSPHATASE)
    ("the PI3K-pathway-related proteins, pAkt, PTEN, and INPP4B"
     . SPARSER::COLLECTION)
    ("proteins, pAkt, PTEN, and INPP4B" . SPARSER::COLLECTION)
    ("MET or PIK3CA" . SPARSER::COLLECTION)
    ("compared trastuzumab- and lapatinib-containing regimens"
     . SPARSER::COLLECTION)
    ("trastuzumab-" . SPARSER::DRUG) ("PTEN or INPP4B" . SPARSER::COLLECTION)
    ("pAKT, PTEN, and INPP4B" . SPARSER::COLLECTION)
    ("pAKT" . SPARSER::PROTEIN-FAMILY) ("PTEN, or pAkt" . SPARSER::COLLECTION)
    ("PTEN and INPP4B" . SPARSER::COLLECTION)
    ("an anthracycline- and taxan-containing regimen" . SPARSER::COLLECTION)
    ("anthracycline-" . SPARSER::MOLECULE)
    ("anthracycline" . SPARSER::MOLECULE)
    ("HER2 and insulin-like growth factor-1 receptor" . SPARSER::COLLECTION)
    ("TKRs" . SPARSER::PROTEIN) ("pAKt" . SPARSER::PROTEIN-FAMILY)
    ("PTEN, pAkt, and INPP4B" . SPARSER::COLLECTION)
    ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("phosphatase and tensin homolog (PTEN) and inositol polyphosphate 4-phosphatase-II (INPP4B)"
     . SPARSER::COLLECTION)
    ("polyphosphate" . SPARSER::MOLECULE) ("inositol" . SPARSER::PROTEIN)
    ("MIB1" . SPARSER::PROTEIN) ("progesterone receptor" . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("PIK3" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1 receptor" . SPARSER::PROTEIN)
    ("INPP4B" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("coronary vasculature" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN) ("fine-mapping" . SPARSER::PROTEIN)
    ("QC" . SPARSER::PROTEIN) ("CHS" . SPARSER::PROTEIN)
    ("African ancestry-specific genetic variants" . SPARSER::VARIANT)
    ("incident CHD" . SPARSER::PROTEIN) ("CHD" . SPARSER::PROTEIN)
    ("c -myc" . SPARSER::PROTEIN) ("ADRA1A" . SPARSER::PROTEIN)
    ("−3" . SPARSER::PROTEIN) ("Mv1" . SPARSER::MOLECULE)
    ("Major Histocompatibility Complex" . SPARSER::PROTEIN)
    ("PFK1" . SPARSER::PROTEIN) ("SORT1" . SPARSER::PROTEIN)
    ("bright" . SPARSER::PROTEIN) ("gene and lung" . SPARSER::COLLECTION)
    ("broken DNA" . SPARSER::DNA) ("Chen" . SPARSER::PROTEIN)
    ("Tie" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nicotine" . SPARSER::DRUG)
    ("dopamine" . SPARSER::PROTEIN)
    ("numerous mutagens and carcinogens" . SPARSER::COLLECTION)
    ("mutagens" . SPARSER::MOLECULE) ("smoke" . SPARSER::MOLECULE)
    ("Tobacco" . SPARSER::DRUG) ("DTC" . SPARSER::MOLECULE)
    ("A allele or not" . SPARSER::COLLECTION) ("ataxia" . SPARSER::PROTEIN)
    ("global cancer statistics state" . SPARSER::BIO-STATE)
    ("AP-2" . SPARSER::PROTEIN) ("PMS1" . SPARSER::PROTEIN)
    ("MBD4" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("MRE11A" . SPARSER::PROTEIN) ("autosomal recessive" . SPARSER::PROTEIN)
    ("estrogen or another factor" . SPARSER::COLLECTION)
    ("SIRT3 and rs2841505" . SPARSER::COLLECTION)
    ("SIRT3 and rs4712047" . SPARSER::COLLECTION) ("ADA" . SPARSER::PROTEIN)
    ("APOE" . SPARSER::PROTEIN) ("oxidative stress genes" . SPARSER::GENE)
    ("SIRT3 , SIRT5 , FOXO3 and SOD3" . SPARSER::COLLECTION)
    ("AKT and FOXO3" . SPARSER::COLLECTION) ("Male" . SPARSER::MOLECULE)
    ("the homozygous TT genotype group" . SPARSER::MOLECULE)
    ("the GC or the GG genotype (1.8 and 2.2 years, respectively)"
     . SPARSER::COLLECTION)
    ("the GC or the GG genotype (2.1 and 1.0 years, respectively)"
     . SPARSER::COLLECTION)
    ("SIRT3 and FOXO3" . SPARSER::COLLECTION)
    ("SIRT1 , SIRT2 , SIRT4 , FOXO1 , and TP53" . SPARSER::COLLECTION)
    ("SIRT5 and SOD3" . SPARSER::COLLECTION)
    ("the TG or the TT genotype (0.5 and 1.3 years, respectively)"
     . SPARSER::COLLECTION)
    ("Cohort" . SPARSER::MOLECULE) ("p " . SPARSER::PROTEIN)
    ("candidate oxidative stress genes and genes" . SPARSER::COLLECTION)
    ("genes and genes" . SPARSER::COLLECTION)
    ("AKT1, SIRT1 and FOXO3A" . SPARSER::COLLECTION)
    ("CAMKIV" . SPARSER::PROTEIN)
    ("FOXO1 , FOXO3 and p53" . SPARSER::COLLECTION)
    ("MnSOD or SOD2" . SPARSER::COLLECTION) ("MnSOD" . SPARSER::PROTEIN)
    ("Forkhead" . SPARSER::PROTEIN) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("SIRT1, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("NAD" . SPARSER::MOLECULE)
    ("sirtuins and sirtuin-related genotypes" . SPARSER::COLLECTION)
    ("SIRT3 , SIRT5 and AKT1" . SPARSER::COLLECTION)
    ("SIRT3 , SIRT5 , SIRT6 , FOXO3 and SOD3" . SPARSER::COLLECTION)
    ("FOXO3 , SOD3 , and AKT1" . SPARSER::COLLECTION)
    ("free-radical" . SPARSER::MOLECULE) ("Sirt6" . SPARSER::PROTEIN)
    ("FC1" . SPARSER::PROTEIN) ("GPX1" . SPARSER::PROTEIN)
    ("CAMK4" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("SOD2" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sir-2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SOD3" . SPARSER::PROTEIN)
    ("CARMA3/BCL10/MALT1" . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("transducers" . SPARSER::PROTEIN)
    ("BCL10 and MALT1" . SPARSER::COLLECTION)
    ("Net1 and DEPDC7" . SPARSER::COLLECTION) ("Net1" . SPARSER::PROTEIN)
    ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TNFα and IL-1β" . SPARSER::COLLECTION)
    ("lysophosphatidic acid (LPA) and phorbol myristic acid (PMA) ( xref )"
     . SPARSER::COLLECTION)
    ("LPA" . SPARSER::LPA)
    ("IL-6, IL-8, CCL20 and I-κBα" . SPARSER::COLLECTION)
    ("a naturally occurring dominant negative form" . SPARSER::FORM)
    ("IL-6 and CCL20" . SPARSER::COLLECTION)
    ("CARMA2 and CARMA3" . SPARSER::COLLECTION)
    ("polypeptide" . SPARSER::PEPTIDE) ("antiserum" . SPARSER::PROTEIN)
    ("sh and DEPDC7" . SPARSER::COLLECTION)
    ("sh or CARMA2" . SPARSER::COLLECTION) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("CARMA2" . SPARSER::PROTEIN) ("GAL4-CARMA2" . SPARSER::PROTEIN-PAIR)
    ("sh" . SPARSER::PROTEIN-FAMILY) ("interactors" . SPARSER::PROTEIN)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Regulator" . SPARSER::REGULATOR)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CARMA3, BCL10 and MALT1" . SPARSER::COLLECTION)
    ("JNK and NF-κB" . SPARSER::COLLECTION) ("MAGUK" . SPARSER::PROTEIN-FAMILY)
    ("BCL10, MALT1 and CARMA" . SPARSER::COLLECTION)
    ("kappaB" . SPARSER::PROTEIN) ("A20" . SPARSER::PROTEIN)
    ("Rho-GAP" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("I-κBα" . SPARSER::PROTEIN) ("CCL20" . SPARSER::PROTEIN)
    ("70 kD" . SPARSER::PROTEIN) ("βGal" . SPARSER::PROTEIN)
    ("protein A" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("AH109" . SPARSER::DRUG) ("lysophosphatidic acid" . SPARSER::LPA)
    ("interleukin-1β" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("kinase-like" . SPARSER::PROTEIN-FAMILY)
    ("CARMA1" . SPARSER::PROTEIN) ("G protein-coupled" . SPARSER::PROTEIN)
    ("CARMA3" . SPARSER::PROTEIN) ("DEPDC7" . SPARSER::PROTEIN)
    ("MALT1" . SPARSER::PROTEIN) ("BCL10" . SPARSER::PROTEIN)
    ("LPS and IL-1β" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines and adhesion molecules" . SPARSER::COLLECTION)
    ("β-catenin and/or NF-κB" . SPARSER::COLLECTION)
    ("LPS- or IL-1β-" . SPARSER::COLLECTION) ("IL-1β-" . SPARSER::PROTEIN)
    ("STAT1-3" . SPARSER::COLLECTION) ("The soluble forms" . SPARSER::FORM)
    ("ICAM and VCAM" . SPARSER::COLLECTION)
    ("IL-1β and LPS" . SPARSER::COLLECTION) ("ICAM" . SPARSER::PROTEIN-FAMILY)
    ("the pro-inflammatory cytokines IL-6, IL-1β, MCP-1 and TNF-α"
     . SPARSER::COLLECTION)
    ("IL-6, IL-1β, MCP-1 and TNF-α" . SPARSER::COLLECTION)
    ("IL-1β and/or IL-6 and the chemokines IL-8 and MCP-1"
     . SPARSER::COLLECTION)
    ("IL-6 and the chemokines IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokine TNF-α" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("bacterial endotoxin LPS" . SPARSER::PROTEIN)
    ("Sterile" . SPARSER::PROTEIN-FAMILY)
    ("pro-inflammatory molecules" . SPARSER::MOLECULE)
    ("ser" . SPARSER::AMINO-ACID)
    ("pro-inflammatory mediators in omental adipose tissue and skeletal muscle that were stimulated with TLR4 ligand and bacterial product LPS and the pro-inflammatory cytokine IL-1β"
     . SPARSER::COLLECTION)
    ("bacterial product LPS and the pro-inflammatory cytokine IL-1β"
     . SPARSER::COLLECTION)
    ("bacterial product LPS" . SPARSER::PROTEIN)
    ("Chemical" . SPARSER::MOLECULE)
    ("pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) and chemokines (IL-8 and MCP-1)"
     . SPARSER::COLLECTION)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP)
    ("LPS-induced pro-inflammatory cytokines and chemokines"
     . SPARSER::COLLECTION)
    ("-1 and sICAM-1" . SPARSER::COLLECTION) ("sICAM-1" . SPARSER::COLLECTION)
    ("the soluble forms" . SPARSER::FORM)
    ("VCAM-1 and ICAM-1" . SPARSER::COLLECTION)
    ("two pro-inflammatory chemokines" . SPARSER::PROTEIN)
    ("LPS- or IL-1β-induced pro-inflammatory chemokines" . SPARSER::COLLECTION)
    ("IL-1β-induced pro-inflammatory chemokines" . SPARSER::PROTEIN)
    ("the TLR4 ligand bacterial endotoxin LPS and the pro-inflammatory cytokine IL-1β"
     . SPARSER::COLLECTION)
    ("the TLR4 ligand bacterial endotoxin LPS" . SPARSER::PROTEIN)
    ("LPS- or IL-1β-induced pro-inflammatory cytokines" . SPARSER::COLLECTION)
    ("IL-1β-induced pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("LPS-" . SPARSER::PROTEIN) ("GSK3α/β" . SPARSER::PROTEIN)
    ("p-GSK3α/β" . SPARSER::PROTEIN-PAIR) ("p-GSK3β" . SPARSER::COLLECTION)
    ("GSK" . SPARSER::PROTEIN) ("TNF-α, IL-1β and LPS" . SPARSER::COLLECTION)
    ("glycogen" . SPARSER::PROTEIN) ("TLR" . SPARSER::PROTEIN-FAMILY)
    ("Pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("glucose, lipids, and amino acids" . SPARSER::COLLECTION)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("the pro-inflammatory chemokines IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines TNF-α, IL-1β and IL-6"
     . SPARSER::COLLECTION)
    ("TNF-α, IL-1β and IL-6" . SPARSER::COLLECTION)
    ("IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("ICAM-1 and VCAM-1" . SPARSER::COLLECTION)
    ("LPS or IL-1β" . SPARSER::COLLECTION) ("NGT" . SPARSER::PROTEIN)
    ("the pro-inflammatory cytokine IL-1β" . SPARSER::PROTEIN)
    ("LPS" . SPARSER::PROTEIN) ("endotoxin" . SPARSER::MOLECULE)
    ("pro-inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("transcription factor 7-like 2" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN)
    ("cAMP-response element binding protein" . SPARSER::PROTEIN)
    ("amino acid transporter" . SPARSER::PROTEIN) ("SB216763" . SPARSER::DRUG)
    ("GSK3α" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY) ("TLR4" . SPARSER::PROTEIN)
    ("MCP-1" . SPARSER::PROTEIN) ("CHIR99021" . SPARSER::MOLECULE)
    ("IL-1β" . SPARSER::PROTEIN) ("GSK3" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("protein and OGT" . SPARSER::COLLECTION)
    ("SIRT1 protein ( xref ) and proteasome reporter protein"
     . SPARSER::COLLECTION)
    ("SIRT1 and β-TrCP1" . SPARSER::COLLECTION)
    ("Proteasomal" . SPARSER::PROTEIN)
    ("CREB, ChREBP, FOXO1, FOXO3, and PPARs" . SPARSER::COLLECTION)
    ("PPARs" . SPARSER::PROTEIN) ("ChREBP" . SPARSER::PROTEIN)
    ("kinase (CK)" . SPARSER::KINASE) ("PKA" . SPARSER::PROTEIN)
    ("CK" . SPARSER::PROTEIN) ("casein" . SPARSER::PROTEIN)
    ("SIRT1 exclusively uses NAD +" . SPARSER::MOLECULE)
    ("OGT ( xref ), GlcNAcylation ( xref ), and 26S proteasome functionality ( xref )"
     . SPARSER::COLLECTION)
    ("ATPase and OGT" . SPARSER::COLLECTION)
    ("an ATPase and a key component" . SPARSER::COLLECTION)
    ("the ubiquitin E3 ligase β-TrCP1" . SPARSER::PROTEIN)
    ("ULK1 and Sirt1" . SPARSER::COLLECTION) ("Sirt1" . SPARSER::PROTEIN)
    ("OGT and O-GlcNAc" . SPARSER::COLLECTION)
    ("a key component of the regulatory complex (19S) of the 26S proteasome and an ATPase xref"
     . SPARSER::COLLECTION)
    ("significantly less GFP protein" . SPARSER::PROTEIN)
    ("-GFP" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("β-TrCP1" . SPARSER::PROTEIN) ("epoxomicin" . SPARSER::DRUG)
    ("Baf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a well-recognized inducer" . SPARSER::PROTEIN)
    ("-siRNA" . SPARSER::COLLECTION)
    ("both NONOate ( xref ) and A23187 ( xref ) markedly prolonged SIRT1 protein stability"
     . SPARSER::COLLECTION)
    ("translational elongation" . SPARSER::PROTEIN)
    ("Diethylenetriamine" . SPARSER::MOLECULE)
    ("a gaseous hormone (NO)" . SPARSER::MOLECULE)
    ("polyubiquitin" . SPARSER::PROTEIN) ("proteasomes" . SPARSER::PROTEIN)
    ("Cilostazol" . SPARSER::DRUG) ("PDE" . SPARSER::PROTEIN)
    ("monocytes" . SPARSER::PROTEIN) ("resveratrol" . SPARSER::PROTEIN)
    ("ULK1 and OGT" . SPARSER::COLLECTION)
    ("ULK1 and SIRT1" . SPARSER::COLLECTION) ("proteasomal" . SPARSER::PROTEIN)
    ("OGT" . SPARSER::PROTEIN) ("GlcNAc" . SPARSER::PROTEIN-FAMILY)
    ("ULK1-siRNA" . SPARSER::COLLECTION) ("ligase" . SPARSER::LIGASE)
    ("Rapamycin" . SPARSER::DRUG) ("MEF" . SPARSER::PROTEIN)
    ("CHX" . SPARSER::PROTEIN) ("NONOate" . SPARSER::MOLECULE)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("Ulk1" . SPARSER::PROTEIN) ("chymotrypsin-like" . SPARSER::PROTEIN)
    ("O-GlcNAcase" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("U20" . SPARSER::PROTEIN) ("Green fluorescent protein" . SPARSER::PROTEIN)
    ("p62" . SPARSER::PROTEIN) ("LC3B" . SPARSER::PROTEIN)
    ("PDE3" . SPARSER::PROTEIN) ("JNK1" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sirtuin-1" . SPARSER::PROTEIN) ("Rpt2" . SPARSER::PROTEIN)
    ("O-GlcNAc" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("the recently developed covalent inhibitors" . SPARSER::INHIBITOR)
    ("antibodies or non-competitive" . SPARSER::COLLECTION)
    ("RTK" . SPARSER::PROTEIN) ("other ligand-driven RTKs" . SPARSER::PROTEIN)
    ("the competitive kinase inhibitor crizotinib" . SPARSER::DRUG)
    ("receptor, BRAF and FLT3" . SPARSER::COLLECTION)
    ("leukemogenic transcription factor fusion proteins" . SPARSER::PROTEIN)
    ("competitive inhibitors" . SPARSER::INHIBITOR)
    ("the competitive MET tyrosine kinase inhibitor crizotinib"
     . SPARSER::DRUG)
    ("IL" . SPARSER::PROTEIN) ("HGF and inhibitor" . SPARSER::COLLECTION)
    ("transcription factor 1, β-catenin, YAP1 and BAD" . SPARSER::COLLECTION)
    ("MSI2, cyclin D1 and JUNB" . SPARSER::COLLECTION)
    ("the prognostically favorable t(15;17) and t(8;21)" . SPARSER::COLLECTION)
    ("the prognostically favorable t" . SPARSER::PROTEIN)
    ("the t(15;17) and t(8;21) cytogenetic subtypes" . SPARSER::COLLECTION)
    ("t(8;21) cytogenetic subtypes" . SPARSER::PROTEIN)
    ("acute promyelocytic leukemia" . SPARSER::PROTEIN)
    ("cytidine" . SPARSER::MOLECULE) ("Proteomic RPPA" . SPARSER::PROTEIN)
    ("RTKs" . SPARSER::PROTEIN) ("Ligand" . SPARSER::LIGAND)
    ("FLT3 , KIT and NRAS" . SPARSER::COLLECTION)
    ("CBL , PTEN and PTPN11" . SPARSER::COLLECTION) ("CBL" . SPARSER::PROTEIN)
    ("KIT" . SPARSER::PROTEIN) ("myeloid" . SPARSER::PROTEIN)
    ("β  2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("M 2" . SPARSER::MOLECULE)
    ("cyclin D1" . SPARSER::PROTEIN) ("MSI2" . SPARSER::PROTEIN)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("YAP1" . SPARSER::PROTEIN)
    ("transcription factor 1" . SPARSER::PROTEIN) ("Ara-C" . SPARSER::DRUG)
    ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("Fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("FLT3" . SPARSER::PROTEIN) ("IDs" . SPARSER::PROTEIN)
    ("Pro" . SPARSER::AMINO-ACID) ("Glu" . SPARSER::AMINO-ACID)
    ("ID" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("RadA" . SPARSER::PROTEIN) ("orthologs" . SPARSER::PROTEIN)
    ("DMC1 and RAD51" . SPARSER::COLLECTION) ("meiotic" . SPARSER::DRUG)
    ("protein–protein" . SPARSER::COLLECTION)
    ("hybrid foci" . SPARSER::PROTEIN)
    ("RAD51 and forms" . SPARSER::COLLECTION)
    ("heterozygous RAD51 variants" . SPARSER::VARIANT)
    ("completely covering ssDNA" . SPARSER::PROTEIN)
    ("covering ssDNA" . SPARSER::PROTEIN) ("recombinases" . SPARSER::PROTEIN)
    ("RAD51 and perhaps" . SPARSER::COLLECTION) ("agarose" . SPARSER::MOLECULE)
    ("the more electropositive D149N variant" . SPARSER::VARIANT)
    ("Complexes" . SPARSER::BIO-COMPLEX) ("BRC" . SPARSER::PROTEIN)
    ("RAD51 and p53" . SPARSER::COLLECTION) ("Arg" . SPARSER::AMINO-ACID)
    ("proteins and regulators" . SPARSER::COLLECTION)
    ("exogenous regulators" . SPARSER::REGULATOR)
    ("Tumor-associated variants" . SPARSER::VARIANT)
    ("the heterozygous state" . SPARSER::BIO-STATE)
    ("molecule or vice" . SPARSER::COLLECTION) ("mixtures" . SPARSER::MOLECULE)
    ("20 μM ssDNA and a 4 + 4 μM mixture" . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT) ("ssDNA/protein" . SPARSER::COLLECTION)
    ("Variant" . SPARSER::VARIANT) ("ADP or ATP" . SPARSER::COLLECTION)
    ("ADP or no nucleotide (Supplementary Figure S4)" . SPARSER::COLLECTION)
    ("ssDNA and dsDNA" . SPARSER::COLLECTION) ("duplex DNA" . SPARSER::DNA)
    ("LM and HM" . SPARSER::COLLECTION) ("ssDNA" . SPARSER::PROTEIN)
    ("RAD51–ssDNA" . SPARSER::PROTEIN-PAIR) ("LM" . SPARSER::MOLECULE)
    ("helical RAD51–DNA filaments" . SPARSER::PROTEIN-FAMILY)
    ("EM" . SPARSER::PROTEIN) ("fix" . SPARSER::PROTEIN)
    ("KCl" . SPARSER::MOLECULE)
    ("a higher-than-normal constitutive ATPase activity" . SPARSER::PROTEIN)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("ATP or ssDNA" . SPARSER::COLLECTION)
    ("the three tumor-associated variants" . SPARSER::VARIANT)
    ("ADP or ATPγS" . SPARSER::COLLECTION)
    ("nearly identical fragment" . SPARSER::FRAGMENT)
    ("ions or protein partners" . SPARSER::COLLECTION)
    ("solvent" . SPARSER::MOLECULE) ("−1" . SPARSER::PROTEIN)
    ("the helical filament" . SPARSER::PROTEIN-FAMILY)
    ("filamentous yeast Rad51" . SPARSER::PROTEIN)
    ("monomer and filament" . SPARSER::COLLECTION)
    ("BRCA2, PALB2 and p53" . SPARSER::COLLECTION)
    ("Asp" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("Exon" . SPARSER::PROTEIN)
    ("DNA helicases and motor proteins" . SPARSER::COLLECTION)
    ("BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("BLM and RAD54" . SPARSER::COLLECTION) ("helicases" . SPARSER::PROTEIN)
    ("paralogs" . SPARSER::PROTEIN) ("ATPase" . SPARSER::PROTEIN)
    ("The RAD51 presynaptic filament" . SPARSER::PROTEIN-FAMILY)
    ("helical presynaptic filament" . SPARSER::PROTEIN-FAMILY)
    ("tumor-associated variants" . SPARSER::VARIANT)
    ("p53, PALB2, BRCA1 and Ataxia telangiectasia mutated (ATM) "
     . SPARSER::COLLECTION)
    ("BRCA2 and BLM" . SPARSER::COLLECTION)
    ("p53, PALB2, BRCA1 and Ataxia telangiectasia mutated"
     . SPARSER::COLLECTION)
    ("brca2" . SPARSER::PROTEIN)
    ("46 well-characterized brca1/2 -negative breast cancer families"
     . SPARSER::PROTEIN-FAMILY)
    ("nucleoprotein" . SPARSER::PROTEIN) ("salt" . SPARSER::MOLECULE)
    ("Tumor-associated D149N, R150Q and G151D mutations map"
     . SPARSER::PROTEIN)
    ("BRCA2 and other proteins" . SPARSER::COLLECTION)
    ("a presynaptic filament" . SPARSER::PROTEIN-FAMILY)
    ("filament" . SPARSER::PROTEIN-FAMILY)
    ("tumor suppressor protein" . SPARSER::PROTEIN) ("D–F" . SPARSER::PROTEIN)
    ("per 3" . SPARSER::PROTEIN) ("ATPase activity" . SPARSER::PROTEIN)
    ("ATPγS" . SPARSER::PROTEIN) ("and −1" . SPARSER::PROTEIN)
    ("B-factor" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("DMC1" . SPARSER::PROTEIN) ("HsRAD51" . SPARSER::PROTEIN)
    ("p11" . SPARSER::PROTEIN) ("mp18" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN) ("RAD54" . SPARSER::PROTEIN)
    ("ATP-dependent" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("brca1" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("MED" . SPARSER::PROTEIN)
    ("SHH and WNT" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("1D" . SPARSER::PROTEIN) ("MED 8" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("or 2 " . SPARSER::MOLECULE)
    ("lithium chloride" . SPARSER::DRUG) ("Lithium chloride" . SPARSER::DRUG)
    ("GSK3 β" . SPARSER::PROTEIN) ("γH2AX" . SPARSER::PROTEIN)
    ("SF2" . SPARSER::PROTEIN)
    ("intra-nuclear TOPO1 and a novel regulator" . SPARSER::COLLECTION)
    ("an essential biological response modifier" . SPARSER::DRUG)
    ("CPTs" . SPARSER::PROTEIN) ("TOPO1 and TOPO2" . SPARSER::COLLECTION)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("there indeed several proteins" . SPARSER::PROTEIN)
    ("homodimer" . SPARSER::HOMODIMER) ("monomer" . SPARSER::MONOMER)
    ("CPT and other anticancer drugs" . SPARSER::COLLECTION)
    ("Poly (ADP-ribose) polymerase 1 (PARP-1) and tyrosyl-DNA phosphodiesterase1 (TDP1)"
     . SPARSER::COLLECTION)
    ("some ABC transporters and DNA repair proteins" . SPARSER::COLLECTION)
    ("the cleavable complex" . SPARSER::BIO-COMPLEX)
    ("specifically trapping and stabilizing drug-induced cleavable complexes"
     . SPARSER::BIO-COMPLEX)
    ("ccs" . SPARSER::PROTEIN)
    ("YB-1 and various DNA repair proteins [ xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("cellular ROS" . SPARSER::PROTEIN)
    ("which targets TOPO1" . SPARSER::PROTEIN)
    ("YB-1-TOPO-1" . SPARSER::COLLECTION)
    ("weak nuclease activity" . SPARSER::PROTEIN)
    ("the cellular essential DNA regulator TOPO1" . SPARSER::PROTEIN)
    ("carboxy" . SPARSER::MOLECULE) ("aa" . SPARSER::MOLECULE)
    ("N-acetyl-cysteine (NAC)" . SPARSER::DRUG)
    ("Flag-YB-1" . SPARSER::COLLECTION) ("vivo" . SPARSER::PROTEIN)
    ("CSD" . SPARSER::PROTEIN) ("GST or GST-YB-1 Δ1" . SPARSER::COLLECTION)
    ("either full-length YB-1 or its mutant derivatives" . SPARSER::COLLECTION)
    ("protein and GST" . SPARSER::COLLECTION)
    ("ThioHis-TOPO1" . SPARSER::COLLECTION) ("TOPO1" . SPARSER::PROTEIN)
    ("GST-YB-1" . SPARSER::COLLECTION) ("YB-1-TOPO1" . SPARSER::COLLECTION)
    ("goat" . SPARSER::PROTEIN) ("topoisomerase" . SPARSER::PROTEIN)
    ("drug-induced cleavable complexes" . SPARSER::BIO-COMPLEX)
    ("cleavable complex" . SPARSER::BIO-COMPLEX)
    ("Topoisomerase" . SPARSER::PROTEIN)
    ("condensation and de-condensation" . SPARSER::COLLECTION)
    ("paclitaxel, and etoposide" . SPARSER::COLLECTION)
    ("YB-1 and TOPO1" . SPARSER::COLLECTION) ("ADM" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG)
    ("DNA topoisomerase 1 (TOPO1) and DNA topoisomerase 2 (TOPO2)"
     . SPARSER::COLLECTION)
    ("the essential DNA metabolism regulators" . SPARSER::REGULATOR)
    ("TOPO" . SPARSER::PROTEIN)
    ("a potential useful prognostic biomarker" . SPARSER::MOLECULE)
    ("biological response modifier" . SPARSER::DRUG)
    ("pre-replicative complex" . SPARSER::BIO-COMPLEX)
    ("TDP1" . SPARSER::PROTEIN)
    ("tyrosyl-DNA phosphodiesterase1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("N-acetyl-cysteine" . SPARSER::DRUG)
    ("M2" . SPARSER::MOLECULE)
    ("Glutathione S -transferase" . SPARSER::PROTEIN)
    ("Lamin B1" . SPARSER::PROTEIN) ("VP-16" . SPARSER::PROTEIN)
    ("Y-box-binding protein-1" . SPARSER::PROTEIN)
    ("DNA topoisomerase 2" . SPARSER::PROTEIN)
    ("DNA topoisomerase 1" . SPARSER::PROTEIN) ("YB-1" . SPARSER::PROTEIN)
    ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("siRNA, curcumin and Stattic" . SPARSER::COLLECTION)
    ("antisense" . SPARSER::PROTEIN) ("STAT3 and miR-21" . SPARSER::COLLECTION)
    ("IL-6/STAT3" . SPARSER::COLLECTION)
    ("deregulating cellular miRNAs" . SPARSER::PROTEIN)
    ("hepatitis B viral protein" . SPARSER::PROTEIN) ("HBx" . SPARSER::PROTEIN)
    ("the viral derivatives" . SPARSER::DERIVATIVE)
    ("its associated miR" . SPARSER::PROTEIN)
    ("viral oncoprotein" . SPARSER::PROTEIN) ("E6/E7" . SPARSER::COLLECTION)
    ("miR-34a and miR-218 [ xref – xref ]" . SPARSER::COLLECTION)
    ("HPV oncoprotein E6 and cellular microRNAs" . SPARSER::COLLECTION)
    ("sharp" . SPARSER::PROTEIN)
    ("a specific rationally-designed small molecule inhibitor"
     . SPARSER::INHIBITOR)
    ("miRs, miR-21 and Let-7a" . SPARSER::COLLECTION)
    ("E6-siRNA" . SPARSER::COLLECTION) ("tyr" . SPARSER::AMINO-ACID)
    ("STAT3 and PTEN" . SPARSER::COLLECTION)
    ("cellular miRNA" . SPARSER::PROTEIN)
    ("the viral oncoprotein E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("commercially available HPV16 E6 siRNA" . SPARSER::PROTEIN)
    ("viral oncogene E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endogenous mature miRNA" . SPARSER::PROTEIN)
    ("miRIDIAN microRNA inhibitor" . SPARSER::INHIBITOR)
    ("the cellular miR-21" . SPARSER::PROTEIN)
    ("target and negative regulator" . SPARSER::COLLECTION)
    ("Curcumin or Stattic" . SPARSER::COLLECTION)
    ("Curcumin and Stattic-treated cells" . SPARSER::COLLECTION)
    ("Curcumin" . SPARSER::DRUG) ("curcumin or Stattic" . SPARSER::COLLECTION)
    ("curcumin, or Stattic" . SPARSER::COLLECTION)
    ("their viral oncoproteins E6 and E7" . SPARSER::COLLECTION)
    ("Active" . SPARSER::ACTIVE) ("viral oncogenes" . SPARSER::ONCOGENE)
    ("E6 and E7" . SPARSER::COLLECTION)
    ("miR-21 and Let-7a" . SPARSER::COLLECTION)
    ("viral oncoprotein E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-21 and a correspondingly reduced pSTAT3/STAT3" . SPARSER::COLLECTION)
    ("cellular PTEN" . SPARSER::PROTEIN)
    ("curcumin and Stattic" . SPARSER::COLLECTION) ("Stattic" . SPARSER::DRUG)
    ("curcumin and stattic" . SPARSER::COLLECTION) ("stattic" . SPARSER::DRUG)
    ("curcumin" . SPARSER::DRUG)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("NF-2" . SPARSER::PROTEIN)
    ("U6" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("let-7" . SPARSER::RNA) ("miR-21" . SPARSER::PROTEIN)
    ("Let-7" . SPARSER::RNA)
    ("inhibitors, or monotherapies" . SPARSER::COLLECTION)
    ("JAK2 and RAS" . SPARSER::COLLECTION)
    ("a dual BCL-2/BCL-X L inhibitor" . SPARSER::INHIBITOR)
    ("BCL-2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("JAK2/STAT/PIM1" . SPARSER::COLLECTION)
    ("AKT, and ERK" . SPARSER::COLLECTION) ("PI3K/mTOR" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("JAK1 or TYK2" . SPARSER::COLLECTION)
    ("soluble growth factors or cytokines" . SPARSER::COLLECTION)
    ("growth factors or cytokines" . SPARSER::COLLECTION)
    ("ERK or AKT" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("JAK2-PIM1/ERK" . SPARSER::COLLECTION)
    ("RAS or its effector pathways AKT and ERK" . SPARSER::COLLECTION)
    ("JAK and the RAS effector pathways AKT and ERK" . SPARSER::COLLECTION)
    ("BAD/BCL-X" . SPARSER::COLLECTION)
    ("the activation state of BAD and its consequent downstream regulation"
     . SPARSER::COLLECTION)
    ("JAK2-driven MPNs" . SPARSER::PROTEIN)
    ("BCL-2/BCL-X" . SPARSER::COLLECTION)
    ("the other anti-apoptotic proteins BCL-2 and myeloid cell leukemia 1 (MCL-1)"
     . SPARSER::COLLECTION)
    ("BCL-2, BCL-X L , and BCL-2-like protein 2 (BCL-w)" . SPARSER::COLLECTION)
    ("the relevant anti-apoptotic target" . SPARSER::TARGET-PROTEIN)
    ("JAK and BAD" . SPARSER::COLLECTION)
    ("myr-AKT and BAD2SA" . SPARSER::COLLECTION)
    ("INCB or an AKT inhibitor" . SPARSER::COLLECTION)
    ("AKT or RAS" . SPARSER::COLLECTION)
    ("JAK2 and PIM1/ERK in JAK2 V617F -positive cells ( xref )"
     . SPARSER::COLLECTION)
    ("PIM1/ERK" . SPARSER::COLLECTION)
    ("JAK or PIM1+ERK" . SPARSER::COLLECTION)
    ("the relevant BAD kinases" . SPARSER::PROTEIN)
    ("ERK and PIM1" . SPARSER::COLLECTION)
    ("PIM1 and ERK" . SPARSER::COLLECTION)
    ("BIM and BID" . SPARSER::COLLECTION) ("BAD and HRK" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-X" . SPARSER::COLLECTION) ("MOMP" . SPARSER::PROTEIN)
    ("B-cell lymphoma 2 (BCL-2)-like protein 11 (BIM) and BH3-interacting domain death agonist (BID)"
     . SPARSER::COLLECTION)
    ("HRK" . SPARSER::PROTEIN) ("phorbol" . SPARSER::DRUG)
    ("NOXA" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PUMA" . SPARSER::PROTEIN)
    ("BID" . SPARSER::PROTEIN) ("BIM" . SPARSER::PROTEIN)
    ("pro-apoptotic BH3-only proteins" . SPARSER::PROTEIN)
    ("RAS or AKT" . SPARSER::COLLECTION)
    ("BCL-2-associated death promoter (BAD)" . SPARSER::PROMOTER)
    ("promoter (BAD)" . SPARSER::PROMOTER) ("RAS or RAS" . SPARSER::COLLECTION)
    ("AKT or AKT" . SPARSER::COLLECTION) ("MEK or ERK" . SPARSER::COLLECTION)
    ("INCBR" . SPARSER::PROTEIN) ("CYTR" . SPARSER::PROTEIN)
    ("Set2-CYTR and Set2-INCBR" . SPARSER::COLLECTION)
    ("Set2-INCBR" . SPARSER::COLLECTION) ("Set2-CYTR" . SPARSER::COLLECTION)
    ("KRAS or NRAS" . SPARSER::COLLECTION) ("MDS" . SPARSER::PROTEIN)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("the dual phosphoinostitide 3- kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor BEZ-235"
     . SPARSER::DRUG)
    ("/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("AKT-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK2-TYK2" . SPARSER::COLLECTION) ("JAK2-JAK1" . SPARSER::COLLECTION)
    ("AKT and RAS" . SPARSER::COLLECTION) ("INCB" . SPARSER::DRUG)
    ("myr" . SPARSER::MOLECULE) ("transgene" . SPARSER::PROTEIN)
    ("INCB018424 (INCB)" . SPARSER::DRUG)
    ("JAK1 or non-receptor" . SPARSER::COLLECTION)
    ("JAK/-STAT" . SPARSER::COLLECTION) ("CYT" . SPARSER::MOLECULE)
    ("Ruxolitinib" . SPARSER::DRUG) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("the pro-apoptotic protein BAD" . SPARSER::PROTEIN)
    ("BAD" . SPARSER::PROTEIN) ("AKT or ERK" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION) ("triphosphatase" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE)
    ("JAK and its downstream substrate" . SPARSER::COLLECTION)
    ("JAK" . SPARSER::PROTEIN) ("β-Actin" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("STAT5" . SPARSER::PROTEIN)
    ("de-" . SPARSER::MOLECULE) ("SGI-1776" . SPARSER::DRUG)
    ("ABT-737" . SPARSER::DRUG) ("ABT-199" . SPARSER::DRUG)
    ("MCL-1" . SPARSER::PROTEIN) ("leukemia 1" . SPARSER::PROTEIN)
    ("BCL-w" . SPARSER::PROTEIN) ("2SA" . SPARSER::PROTEIN)
    ("JAK–STAT" . SPARSER::PROTEIN) ("PIM1" . SPARSER::PROTEIN)
    ("BCL-2-binding component 3" . SPARSER::PROTEIN)
    ("BH3-interacting domain death agonist" . SPARSER::PROTEIN)
    ("AZD-6244" . SPARSER::DRUG) ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK 2" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase 2" . SPARSER::PROTEIN)
    ("BEZ-235" . SPARSER::DRUG) ("MK-2206" . SPARSER::MOLECULE)
    ("Set2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TYK2" . SPARSER::PROTEIN)
    ("JAK1" . SPARSER::PROTEIN) ("INCB018424" . SPARSER::DRUG)
    ("SAR302503" . SPARSER::DRUG) ("TG101348" . SPARSER::DRUG)
    ("BCL-X" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN)
    ("BRD4 and MYC" . SPARSER::COLLECTION)
    ("other relevant proteins" . SPARSER::PROTEIN)
    ("4EBP1 and ER" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("ribosomal RNAs" . SPARSER::RNA)
    ("neither MCF7 nor ZR75" . SPARSER::COLLECTION)
    ("bromodomain" . SPARSER::PROTEIN) ("tet" . SPARSER::PROTEIN)
    ("two sequence-specific siRNAs" . SPARSER::PROTEIN)
    ("MYC and mTOR" . SPARSER::COLLECTION)
    ("MCF7 and ZR75" . SPARSER::COLLECTION)
    ("pS6 and p4EBP1" . SPARSER::COLLECTION) ("Serine" . SPARSER::AMINO-ACID)
    ("exemestane and everolimus" . SPARSER::COLLECTION)
    ("Everolimus" . SPARSER::MOLECULE)
    ("estrogen and mimic" . SPARSER::COLLECTION)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION)
    ("letrozole, anastrazole and exemestane" . SPARSER::COLLECTION)
    ("exemestane" . SPARSER::DRUG) ("anastrazole" . SPARSER::DRUG)
    ("letrozole" . SPARSER::DRUG) ("everolimus" . SPARSER::DRUG)
    ("PI3K/mTOR/Akt" . SPARSER::COLLECTION) ("chr8" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("Phenol-red" . SPARSER::DRUG)
    ("phenol red" . SPARSER::DRUG) ("L-glutamine" . SPARSER::MOLECULE)
    ("OTX015" . SPARSER::DRUG)
    ("bromodomain-containing protein 4" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("EBP1" . SPARSER::PROTEIN) ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pS6" . SPARSER::PROTEIN) ("Rad001" . SPARSER::DRUG)
    ("Estrogen receptor" . SPARSER::PROTEIN) ("BRD4" . SPARSER::PROTEIN)
    ("anti-estrogens" . SPARSER::DRUG) ("lncRNAs" . SPARSER::RNA)
    ("the miRNA-related low-risk group and the miRNA-related high-risk group (miRNA-DEGs)"
     . SPARSER::COLLECTION)
    ("the BRCA1/2 alteration carrier group and the miRNA-related high-risk group (BRCA-DEGs)"
     . SPARSER::COLLECTION)
    ("first detected differentially expressed genes" . SPARSER::GENE)
    ("MiRNAs and BRCA1/2" . SPARSER::COLLECTION)
    ("the miRNA-related high-risk group and the miRNA-related low-risk group"
     . SPARSER::COLLECTION)
    ("the BRCA1/2 alteration carriers group, the miRNA-related high-risk group and the miRNA-related low-risk group"
     . SPARSER::COLLECTION)
    ("a complete response (CR) group and a non-CR group" . SPARSER::COLLECTION)
    ("CR" . SPARSER::PROTEIN) ("the entire cohort" . SPARSER::MOLECULE)
    ("a high-risk group (n=54) and a low-risk group (n=54)"
     . SPARSER::COLLECTION)
    ("a miRNA-related high-risk group and a miRNA-related low-risk group"
     . SPARSER::COLLECTION)
    ("prognostic miRNAs" . SPARSER::PROTEIN) ("KL" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("MiRNAs" . SPARSER::PROTEIN) ("hsa" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("an aggressive tumor type" . TYPE)
    ("appropriate cohorts" . SPARSER::MOLECULE)
    ("acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("APL" . SPARSER::PROTEIN) ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("gold" . SPARSER::MOLECULE) ("ER and PR" . SPARSER::COLLECTION)
    ("Luminal" . SPARSER::DRUG) ("P5 and P8" . SPARSER::COLLECTION)
    ("Cytokeratin 5 and myoepithelial Cytokeratin" . SPARSER::COLLECTION)
    ("myoepithelial Cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("Cytokeratin" . SPARSER::PROTEIN-FAMILY)
    ("CD44, CD10 and CD49f" . SPARSER::COLLECTION)
    ("CD24 and EpCAM" . SPARSER::COLLECTION) ("EpCAM" . SPARSER::PROTEIN)
    ("IF" . SPARSER::PROTEIN) ("SMARCA5 and SMARCD1" . SPARSER::COLLECTION)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN) ("LEF-1/TCF" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("the proliferation marker Ki67 and the stem cell marker Aldehyde Dehydrogenase"
     . SPARSER::COLLECTION)
    ("NOD" . SPARSER::PROTEIN) ("PKH" . SPARSER::PROTEIN)
    ("CD49f and CD24" . SPARSER::COLLECTION) ("a global gene" . SPARSER::GENE)
    ("Nanog, Oct4 and Sox2" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN)
    ("tamoxifen and fulvestrant" . SPARSER::COLLECTION)
    ("fulvestrant" . SPARSER::DRUG) ("miRNA" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("MicroRNAs" . SPARSER::RNA)
    ("apex" . SPARSER::PROTEIN)
    ("a functional estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("β-Estradiol" . SPARSER::MOLECULE) ("Toto-3" . SPARSER::MOLECULE)
    ("F11" . SPARSER::PROTEIN) ("MUC1" . SPARSER::PROTEIN)
    ("CK8" . SPARSER::PROTEIN) ("CK14" . SPARSER::PROTEIN)
    ("MIB-1" . SPARSER::PROTEIN) ("RPL13A" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("delta-" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("GSK-3α" . SPARSER::PROTEIN)
    ("Glo 3" . SPARSER::PROTEIN) ("5-2" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("F-12" . SPARSER::PROTEIN)
    ("miR-221" . SPARSER::PROTEIN) ("β-estradiol" . SPARSER::MOLECULE)
    ("retinoic acid" . SPARSER::MOLECULE) ("Cytokeratin 5" . SPARSER::PROTEIN)
    ("SMARCD1" . SPARSER::PROTEIN) ("SMARCA5" . SPARSER::PROTEIN)
    ("BI2536" . SPARSER::DRUG) ("Wnt3a" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("BMP4" . SPARSER::PROTEIN)
    ("SFRP2" . SPARSER::PROTEIN) ("TCF4" . SPARSER::PROTEIN)
    ("DLK1" . SPARSER::PROTEIN) ("WISP1" . SPARSER::PROTEIN)
    ("LEF-1" . SPARSER::PROTEIN) ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALDH1" . SPARSER::PROTEIN) ("Aldehyde Dehydrogenase" . SPARSER::PROTEIN)
    ("caspase3" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Sox2" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("tumor suppressor gene" . SPARSER::PROTEIN)
    ("Dicer-1" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN)
    ("AR and EZH2" . SPARSER::COLLECTION) ("abl" . SPARSER::PROTEIN)
    ("EZH2 or PRC2" . SPARSER::COLLECTION) ("Lys" . SPARSER::AMINO-ACID)
    ("p19 [ xref ] or p21 [ xref ]" . SPARSER::COLLECTION)
    ("RUNX1 and EZH2" . SPARSER::COLLECTION) ("AcH" . SPARSER::PROTEIN)
    ("androgen-mediated gene and AR transcriptional activity in prostate cancer cells (Fig. xref , xref )"
     . SPARSER::COLLECTION)
    ("RUNX1 or control RNA (siControl)" . SPARSER::COLLECTION)
    ("FOXA1 and AR" . SPARSER::COLLECTION) ("HOMER" . SPARSER::PROTEIN-FAMILY)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and RUNX1" . SPARSER::COLLECTION)
    ("Flag-tagged AR and Myc-tagged RUNX1 and its deletion mutants (Fig. xref , upper)"
     . SPARSER::COLLECTION)
    ("AR and Myc-tagged" . SPARSER::COLLECTION) ("DHT" . SPARSER::PROTEIN)
    ("LNCaP" . SPARSER::PROTEIN) ("androgens" . SPARSER::DRUG)
    ("both oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("RUNX-CBFβ" . SPARSER::PROTEIN-PAIR) ("TGT" . SPARSER::PROTEIN)
    ("RUNX" . SPARSER::PROTEIN)
    ("the common core-binding factor (CBF) β subunit" . SPARSER::FRAGMENT)
    ("CBF" . SPARSER::PROTEIN)
    ("RUNX1, RUNX2, and RUNX3" . SPARSER::COLLECTION)
    ("testosterone" . SPARSER::MOLECULE)
    ("Androgen and its cognate receptor" . SPARSER::COLLECTION)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("Androgen" . SPARSER::PROTEIN) ("androgen" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mM 3" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("TACC2" . SPARSER::PROTEIN) ("pGL3" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG) ("DAB2IP" . SPARSER::PROTEIN)
    ("p19" . SPARSER::PROTEIN) ("DU145" . SPARSER::PROTEIN)
    ("SLIT2" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("histoneH3" . SPARSER::PROTEIN) ("E −5" . SPARSER::PROTEIN)
    ("E-5" . SPARSER::PROTEIN)
    ("Enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("CBFβ" . SPARSER::PROTEIN) ("RUNX3" . SPARSER::PROTEIN)
    ("RUNX2" . SPARSER::PROTEIN) ("OCT1" . SPARSER::PROTEIN)
    ("GATA2" . SPARSER::PROTEIN) ("NKX3-1" . SPARSER::PROTEIN)
    ("androgen receptor" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("Androgen receptor" . SPARSER::PROTEIN)
    ("Inhibitor" . SPARSER::INHIBITOR) ("tobacco" . SPARSER::DRUG)
    ("SOX2, PIK3CA, CCND1, FGFR1, MYC, GATA4 , and GATA6"
     . SPARSER::COLLECTION)
    ("cigarette" . SPARSER::DRUG) ("FGFR2 or FGFR3" . SPARSER::COLLECTION)
    ("NR" . SPARSER::PROTEIN) ("Adjuvant" . SPARSER::DRUG)
    ("male and 37 female" . SPARSER::COLLECTION) ("FGFR" . SPARSER::PROTEIN)
    ("SOX2, PIK3CA, CCND1 , and FGFR1" . SPARSER::COLLECTION)
    ("a dual tyrosine kinase inhibitor" . SPARSER::INHIBITOR)
    ("ERBB1 and HER2" . SPARSER::COLLECTION) ("Trastuzumab" . SPARSER::DRUG)
    ("lapatinib" . SPARSER::DRUG) ("alcohol" . SPARSER::DRUG)
    ("Both histologic subtypes" . SPARSER::PROTEIN) ("EAC" . SPARSER::PROTEIN)
    ("AHR" . SPARSER::PROTEIN) ("FGFR2 and FGFR3" . SPARSER::COLLECTION)
    ("AZD4547" . SPARSER::DRUG) ("GATA6" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("Of 45" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("ERBB1" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("FGFR1" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 1" . SPARSER::PROTEIN)
    ("that rapamycin and other rapalogs" . SPARSER::COLLECTION)
    ("TACE and SBRT" . SPARSER::COLLECTION) ("TACE" . SPARSER::PROTEIN)
    ("EGFR and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("HIF-1α or HIF-2α" . SPARSER::COLLECTION)
    ("HIF-1α, EGFR and COX2" . SPARSER::COLLECTION)
    ("HIF1α/EGFR" . SPARSER::COLLECTION) ("COX2/EGFR" . SPARSER::COLLECTION)
    ("EGFR and COX2" . SPARSER::COLLECTION) ("EGFR/COX2" . SPARSER::COLLECTION)
    ("EGFR-HIF-1α-VEGF" . SPARSER::COLLECTION)
    ("EGFR, HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("EGFR and EGFR-p845" . SPARSER::COLLECTION)
    ("γ-H2AX and γ-H2AX" . SPARSER::COLLECTION)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("γ-H2AX and HIF-1α" . SPARSER::COLLECTION)
    ("γ-H2AX and CD34" . SPARSER::COLLECTION)
    ("γ-H2AX, and CD34" . SPARSER::COLLECTION)
    ("Scr-siRNA/GFP" . SPARSER::COLLECTION) ("NC" . SPARSER::PROTEIN)
    ("γ-H2AX and VEGF" . SPARSER::COLLECTION)
    ("the high-expression group (n = 36) and low-expression group (n = 21)"
     . SPARSER::COLLECTION)
    ("post-LT" . SPARSER::PROTEIN)
    ("γ-H2AX/EGFR/HIF-1α/VEGF" . SPARSER::COLLECTION)
    ("hypoxia-inducible factor(HIF)" . SPARSER::PROTEIN)
    ("HIF" . SPARSER::PROTEIN-FAMILY) ("H2AX or H2AFX" . SPARSER::COLLECTION)
    ("Sre" . SPARSER::PROTEIN)
    ("LT and a potential therapeutic target" . SPARSER::COLLECTION)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("HCC and γ-H2AX" . SPARSER::COLLECTION)
    ("γ-H2AX/EGFR/HIF-1α" . SPARSER::COLLECTION)
    ("γ-H2AX, HIF-1α and EGFR" . SPARSER::COLLECTION)
    ("EGFR/HIF-1α/VEGF" . SPARSER::COLLECTION) ("LT" . SPARSER::PROTEIN)
    ("HCC" . SPARSER::PROTEIN) ("MgCl2" . SPARSER::MOLECULE)
    ("IgG 1" . SPARSER::BIO-COMPLEX) ("VEGF-A" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("COX2" . SPARSER::PROTEIN)
    ("COX-2" . SPARSER::PROTEIN) ("HIF-a" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("H2AFX" . SPARSER::PROTEIN)
    ("H2A histone family member X" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("oncoproteins, phosphatases and kinases" . SPARSER::COLLECTION)
    ("oncoproteins" . SPARSER::PROTEIN)
    ("Elk-1/CIP2A/PP2A/p-AKT" . SPARSER::COLLECTION)
    ("afatinib and cetuximab" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("docetaxel or pemetrexed" . SPARSER::COLLECTION)
    ("pemetrexed" . SPARSER::DRUG) ("docetaxel" . SPARSER::DRUG)
    ("the phase 3 Sequential Tarceva" . SPARSER::DRUG)
    ("Tarceva" . SPARSER::DRUG) ("IIIB" . SPARSER::DRUG)
    ("afatinib and EGFR" . SPARSER::COLLECTION)
    ("afatinib or EGFR" . SPARSER::COLLECTION)
    ("siRNA, or EGFR" . SPARSER::COLLECTION) ("Erb" . SPARSER::PROTEIN)
    ("family or KRAS" . SPARSER::COLLECTION)
    ("Raf-1/MEK/ERK" . SPARSER::COLLECTION)
    ("the proximal CIP2A promoter" . SPARSER::PROMOTER)
    ("Ets-1 and Elk-1" . SPARSER::COLLECTION)
    ("response element (SRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("SRE" . SPARSER::PROTEIN) ("Promoter" . SPARSER::PROMOTER)
    ("a potential drug target" . SPARSER::TARGET-PROTEIN)
    ("log-rank" . SPARSER::PROTEIN) ("CIP2A and Elk-1" . SPARSER::COLLECTION)
    ("blot and PP2A" . SPARSER::COLLECTION) ("forskolin" . SPARSER::PROTEIN)
    ("PP2A and AKT" . SPARSER::COLLECTION)
    ("CIP2A/PP2A/p-AKT" . SPARSER::COLLECTION) ("p" . SPARSER::PROTEIN)
    ("CIP2A-PP2A-AKT" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("iodide (PI)" . SPARSER::PROTEIN) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("FDA and Taiwan" . SPARSER::COLLECTION)
    ("HER2 and ErbB4" . SPARSER::COLLECTION)
    ("cysteines" . SPARSER::AMINO-ACID)
    ("EGFR, HER2 and ErbB4" . SPARSER::COLLECTION) ("ErbB4" . SPARSER::PROTEIN)
    ("Platinum" . SPARSER::MOLECULE)
    ("Elk-1/CIP2A/PP2A/AKT" . SPARSER::COLLECTION)
    ("Elk-1 and CIP2A" . SPARSER::COLLECTION) ("afatinib" . SPARSER::DRUG)
    ("Afatinib" . SPARSER::DRUG) ("pGL4" . SPARSER::PROTEIN)
    ("dual-luciferase" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("1-2" . SPARSER::PROTEIN)
    ("Protein phosphatase 2" . SPARSER::PROTEIN)
    ("KIAA1524" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("PIK3CA" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("Raf-1" . SPARSER::PROTEIN)
    ("proto-oncogene c-fos" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN) ("and -1" . SPARSER::PROTEIN)
    ("PP2Ac" . SPARSER::PROTEIN) ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("Elk-1" . SPARSER::PROTEIN)
    ("CIP2A" . SPARSER::PROTEIN)
    ("Antioxidant and dominant negative c-Jun" . SPARSER::COLLECTION)
    ("AP-1/CCN1" . SPARSER::COLLECTION)
    ("AP-1 and TGF-β" . SPARSER::COLLECTION)
    ("a ubiquitous transcription factor" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN) ("JNKs" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CCN4 and CCN5" . SPARSER::COLLECTION)
    ("CCN1 and CCN2" . SPARSER::COLLECTION)
    ("human skin dermal fibroblasts CCN1" . SPARSER::PROTEIN)
    ("receptors and ECM" . SPARSER::COLLECTION)
    ("CCN1 and ROS" . SPARSER::COLLECTION)
    ("ROS and CCN1" . SPARSER::COLLECTION) ("water" . SPARSER::MOLECULE)
    ("glutathione" . SPARSER::DRUG)
    ("c-Jun and its downstream effector CCN1" . SPARSER::COLLECTION)
    ("antioxidants" . SPARSER::DRUG) ("c-Jun and CCN1" . SPARSER::COLLECTION)
    ("c-Jun/AP-1" . SPARSER::COLLECTION)
    ("c-Jun mRNA ( xref ) and c-Jun total and phosphorylated proteins ( xref )"
     . SPARSER::COLLECTION)
    ("c-Jun total and phosphorylated proteins" . SPARSER::PROTEIN)
    ("oxidant" . SPARSER::PROTEIN) ("CCN1 or type I" . SPARSER::COLLECTION)
    ("N-acetyl-L-cysteine (NAC)" . SPARSER::MOLECULE)
    ("NAC" . SPARSER::PROTEIN) ("Antioxidant" . SPARSER::PROTEIN)
    ("type I procollagen mRNA ( xref ) and protein ( xref )"
     . SPARSER::COLLECTION)
    ("CCN1 mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("type I procollagen (COL-1) mRNA ( xref ) and protein ( xref )"
     . SPARSER::COLLECTION)
    ("the naturally occurring pro-oxidant hydrogen peroxide" . SPARSER::DRUG)
    ("Oxidant" . SPARSER::PROTEIN) ("chemotaxis" . SPARSER::PROTEIN)
    ("CCN" . SPARSER::PROTEIN-FAMILY)
    ("extracellular matrix-associated protein" . SPARSER::PROTEIN)
    ("collagen and other extra cellular matrix (ECM) proteins"
     . SPARSER::COLLECTION)
    ("c-Jun/CCN1" . SPARSER::COLLECTION)
    ("promoter and gene" . SPARSER::COLLECTION) ("AP-1" . SPARSER::PROTEIN)
    ("CC-1" . SPARSER::PROTEIN) ("β-galactosidase" . SPARSER::PROTEIN)
    ("ribosomal protein" . SPARSER::PROTEIN)
    ("housekeeping gene" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("32 P" . SPARSER::|32P|)
    ("pro-oxidants" . SPARSER::MOLECULE) ("TβRII" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("Smad7" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stress-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NH2" . SPARSER::MOLECULE)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("EGR-1" . SPARSER::PROTEIN) ("early growth response" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("αVβ3" . SPARSER::PROTEIN) ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("pro-oxidant" . SPARSER::MOLECULE) ("CCN6" . SPARSER::PROTEIN)
    ("protein-3" . SPARSER::PROTEIN) ("protein-2" . SPARSER::PROTEIN)
    ("CCN4" . SPARSER::PROTEIN) ("CCN3" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN) ("N-acetyl-L-cysteine" . SPARSER::MOLECULE)
    ("CCN1" . SPARSER::PROTEIN) ("cysteine-rich protein" . SPARSER::PROTEIN)
    ("both the β-catenin and the plakoglobin gene" . SPARSER::COLLECTION)
    ("plakoglobin and β-catenin" . SPARSER::COLLECTION)
    ("p120-catenin and α-catenin" . SPARSER::COLLECTION)
    ("hepatocytes" . SPARSER::PROTEIN) ("mESC" . SPARSER::PROTEIN)
    ("the key adherens junction proteins α-catenin (CTNNA1) and p120-catenin (CTNND1)"
     . SPARSER::COLLECTION)
    ("the here presented BxPC3ΔCTNNB1" . SPARSER::PROTEIN)
    ("PTC" . SPARSER::PROTEIN)
    ("potential toxic truncated proteins" . SPARSER::PROTEIN)
    ("functional β-catenin" . SPARSER::PROTEIN)
    ("p120 and α-catenin" . SPARSER::COLLECTION)
    ("α-catenin, p120-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("siRNA and plakoglobin" . SPARSER::COLLECTION)
    ("siRNA or plakoglobin" . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM)
    ("an additional longer isoform" . SPARSER::ISOFORM)
    ("E-cadherin and α-catenin" . SPARSER::COLLECTION)
    ("E-cadherin, α-catenin and p120-catenin" . SPARSER::COLLECTION)
    ("Abs" . SPARSER::PROTEIN)
    ("β-catenin or plakoglobin" . SPARSER::COLLECTION)
    ("BxPC3ΔCTNNB1" . SPARSER::PROTEIN)
    ("Notably another known target" . SPARSER::TARGET-PROTEIN)
    ("α-catenin (CTNNA1) and p120-catenin (CTNND1)" . SPARSER::COLLECTION)
    ("JUP" . SPARSER::PROTEIN) ("ITGA3, ITGAV and ITGB1" . SPARSER::COLLECTION)
    ("DSG2 and PKP1" . SPARSER::COLLECTION) ("LPXN" . SPARSER::PROTEIN)
    ("laminins" . SPARSER::PROTEIN-FAMILY) ("ITGAV" . SPARSER::PROTEIN)
    ("GO" . SPARSER::PROTEIN)
    ("the five β-catenin deficient" . SPARSER::PROTEIN)
    ("AnnexinV" . SPARSER::PROTEIN) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LiCl" . SPARSER::DRUG) ("PTCs" . SPARSER::PROTEIN)
    ("a band around 60 kDa" . SPARSER::PROTEIN)
    ("a predicted size around 75 kDa" . SPARSER::PROTEIN)
    ("ATG" . SPARSER::DRUG) ("distinct β-catenin" . SPARSER::PROTEIN)
    ("#79 weak β-catenin" . SPARSER::PROTEIN)
    ("#4 exhibited clear β-catenin" . SPARSER::PROTEIN)
    ("anti" . SPARSER::PROTEIN)
    ("#4 and #31 contained two sequence variants" . SPARSER::VARIANT)
    ("TCN" . SPARSER::DRUG) ("β-catenin and plakoglobin" . SPARSER::COLLECTION)
    ("α-catenin and p120-catenin" . SPARSER::COLLECTION)
    ("Plakoglobin" . SPARSER::PROTEIN) ("STF" . SPARSER::PROTEIN)
    ("ZFN" . SPARSER::PROTEIN) ("APC , AXIN1 and CTNNB1" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("TCF" . SPARSER::PROTEIN)
    ("PCP" . SPARSER::PROTEIN) ("calcium" . SPARSER::CALCIUM)
    ("KRAS , CDKN2A , TP53 and SMAD4" . SPARSER::COLLECTION)
    ("type and number" . SPARSER::COLLECTION)
    ("an aggressive cancer type" . TYPE) ("TFC/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN) ("cytoplasmatic puncta" . SPARSER::PROTEIN)
    ("puncta" . SPARSER::PROTEIN) ("plakoglobin" . SPARSER::PROTEIN)
    ("nuclease (ZFN)" . SPARSER::PROTEIN)
    ("WNT/β-catenin" . SPARSER::COLLECTION) ("p120" . SPARSER::PROTEIN)
    ("isoform 3" . SPARSER::PROTEIN) ("isoform 1" . SPARSER::PROTEIN)
    ("1-4" . SPARSER::PROTEIN) ("transmembrane protein" . SPARSER::PROTEIN)
    ("β catenin" . SPARSER::PROTEIN) ("HEF1" . SPARSER::PROTEIN)
    ("NEDD9" . SPARSER::PROTEIN) ("CTNND1" . SPARSER::PROTEIN)
    ("CTNNA1" . SPARSER::PROTEIN) ("PKP1" . SPARSER::PROTEIN)
    ("DSG2" . SPARSER::PROTEIN) ("F11R" . SPARSER::PROTEIN)
    ("PPFIBP1" . SPARSER::PROTEIN) ("LAMB1" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN) ("ITGA3" . SPARSER::PROTEIN)
    ("GSK3β" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("NP40" . SPARSER::MOLECULE)
    ("Ex2" . SPARSER::PROTEIN) ("3-F" . SPARSER::PROTEIN)
    ("α-Catenin" . SPARSER::PROTEIN) ("Zinc Finger" . SPARSER::PROTEIN)
    ("p120-catenin" . SPARSER::PROTEIN) ("γ-catenin" . SPARSER::PROTEIN)
    ("PANC-1" . SPARSER::PROTEIN) ("AXIN1" . SPARSER::PROTEIN)
    ("α-catenin" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("lobes" . SPARSER::PROTEIN) ("mut" . SPARSER::PROTEIN)
    ("serine proteases and urokinase plasminogen activator"
     . SPARSER::COLLECTION)
    ("Raf/Erk/Map" . SPARSER::COLLECTION) ("Map" . SPARSER::PROTEIN)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GTPase" . SPARSER::GTPASE)
    ("the most important established predictive biomarker" . SPARSER::MOLECULE)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("cetuximab" . SPARSER::DRUG)
    ("mCRC" . SPARSER::PROTEIN) ("plasminogen activator" . SPARSER::PROTEIN)
    ("its soluble form" . SPARSER::FORM)
    ("molecules or markers" . SPARSER::COLLECTION)
    ("an alternative diagnostic biomarker" . SPARSER::MOLECULE)
    ("CAE" . SPARSER::PROTEIN) ("TNM" . SPARSER::MOLECULE)
    ("intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)"
     . SPARSER::COLLECTION)
    ("recurrent GC" . SPARSER::PROTEIN) ("the only intestinal GC type" . TYPE)
    ("CEA" . SPARSER::PROTEIN) ("carcinoembryonic" . SPARSER::PROTEIN)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION)
    ("HER2, HER3, HER4, or E-cad" . SPARSER::COLLECTION)
    ("EGFR/HER1" . SPARSER::COLLECTION)
    ("HER-PI3K/Akt/mTOR-IAP" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HER" . SPARSER::PROTEIN)
    ("neu" . SPARSER::PROTEIN) ("growth factor (NGF)" . SPARSER::GROWTH-FACTOR)
    ("anti-HECD-1" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("a secondary labeled antibody" . SPARSER::ANTIBODY)
    ("42 selected serum soluble proteins" . SPARSER::PROTEIN)
    ("RPPA" . SPARSER::PROTEIN)
    ("120 kDa and the sE-cad" . SPARSER::COLLECTION)
    ("acrylamide" . SPARSER::MOLECULE)
    ("those monoclonal antibodies" . SPARSER::ANTIBODY)
    ("a coexistent Ca 2+" . SPARSER::CALCIUM-ION)
    ("peroxidase and substrate" . SPARSER::COLLECTION)
    ("solution" . SPARSER::MOLECULE)
    ("the two monoclonal antibodies" . SPARSER::ANTIBODY)
    ("peroxidase" . SPARSER::PROTEIN) ("HECD-1" . SPARSER::COLLECTION)
    ("matrix metalloproteinases (e.g., MMP-2, MMP-3, MMP-7, MMP-9, and MMP-14, stromelysin-1, and matrilysin) and cathepsins (B, L, S)"
     . SPARSER::COLLECTION)
    ("a soluble 80 kDa E-cad fragment" . SPARSER::FRAGMENT)
    ("bacterial proteases" . SPARSER::PROTEIN)
    ("MMP-2, MMP-3, MMP-7, MMP-9, and MMP-14, stromelysin-1, and matrilysin"
     . SPARSER::COLLECTION)
    ("MMP-14, stromelysin-1, and matrilysin" . SPARSER::COLLECTION)
    ("plasmin" . SPARSER::PROTEIN) ("AAM" . SPARSER::PROTEIN)
    ("matrilysin" . SPARSER::PROTEIN) ("calpain" . SPARSER::PROTEIN)
    ("colorectal CRC" . SPARSER::PROTEIN)
    ("nonepithelial cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Most epithelial tumors loose E-cad" . SPARSER::PROTEIN)
    ("Transcriptional E-cad" . SPARSER::PROTEIN)
    ("membrane-associated glycoproteins" . SPARSER::PROTEIN)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble E-cadherin" . SPARSER::PROTEIN) ("sera" . SPARSER::PROTEIN)
    ("sE" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Soluble E-cadherin" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("VCAM-1" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("HER4" . SPARSER::PROTEIN) ("HER3" . SPARSER::PROTEIN)
    ("HER1" . SPARSER::PROTEIN) ("stromelysin-1" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("E-cad" . SPARSER::PROTEIN) ("E-cadherins" . SPARSER::PROTEIN)
    ("epithelial cadherin" . SPARSER::PROTEIN) ("LCK—" . SPARSER::PROTEIN)
    ("thymocytes perceive incoming ligands" . SPARSER::LIGAND)
    ("customary ligands" . SPARSER::LIGAND)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("SHP and THEMIS" . SPARSER::COLLECTION)
    ("SHP1 and the adaptor protein CrkL" . SPARSER::COLLECTION)
    ("C-SH2 and PTPase" . SPARSER::COLLECTION) ("CrkL" . SPARSER::PROTEIN)
    ("PTPase" . SPARSER::PROTEIN)
    ("a pseudo-adaptor molecule" . SPARSER::MOLECULE)
    ("GRB" . SPARSER::PROTEIN) ("Bim" . SPARSER::PROTEIN)
    ("positively selecting weak agonist pMHC ligands" . SPARSER::LIGAND)
    ("LAT and PLCγ1" . SPARSER::COLLECTION)
    ("THEMIS or SHP1" . SPARSER::COLLECTION)
    ("LAT and THEMIS" . SPARSER::COLLECTION)
    ("SHP1 and/or SHP2" . SPARSER::COLLECTION)
    ("DOK-1/DOK-2" . SPARSER::COLLECTION) ("LAT:SLP-76" . SPARSER::BIO-COMPLEX)
    ("plate-bound NY-ESO-1 pMHC tetramers" . SPARSER::TETRAMER)
    ("the OVA agonist and the Q4 and T4 weak agonists" . SPARSER::COLLECTION)
    ("the Q4 and T4 weak agonists" . SPARSER::AGONIST)
    ("agonists" . SPARSER::AGONIST) ("ovalbumin" . SPARSER::PROTEIN)
    ("OT" . SPARSER::PROTEIN) ("IL-2 and IFN-γ" . SPARSER::COLLECTION)
    ("CD4, CD8, CD44, CD25, CD3 and CD5" . SPARSER::COLLECTION)
    ("lymphoid" . SPARSER::PROTEIN) ("Lck" . SPARSER::PROTEIN)
    ("Ala" . SPARSER::AMINO-ACID) ("weak agonist ligands" . SPARSER::LIGAND)
    ("strong agonist ligands" . SPARSER::LIGAND)
    ("Pao" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD95 and CD178" . SPARSER::COLLECTION)
    ("plate-bound NY-ESO-1 6V MHC tetramer" . SPARSER::TETRAMER)
    ("Fas (CD95) or its ligand FasL (CD178)" . SPARSER::COLLECTION)
    ("Fas-FasL" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("anti-CD3/CD28" . SPARSER::COLLECTION) ("CD3/CD28" . SPARSER::COLLECTION)
    ("CD69 and CD25" . SPARSER::COLLECTION) ("rIL" . SPARSER::PROTEIN)
    ("lentiviral THEMIS or control shRNA" . SPARSER::COLLECTION)
    ("lentiviral THEMIS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pERK" . SPARSER::PROTEIN) ("pErk" . SPARSER::PROTEIN)
    ("pY" . SPARSER::PROTEIN) ("Plas" . SPARSER::PROTEIN)
    ("THEMIS and SHP1" . SPARSER::COLLECTION)
    ("C-SH3-GST" . SPARSER::COLLECTION) ("GRB2-Myc" . SPARSER::COLLECTION)
    ("HA-SHP1" . SPARSER::COLLECTION)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("SHP1 and GRB2" . SPARSER::COLLECTION) ("tyrosines" . SPARSER::AMINO-ACID)
    ("THEMIS:GRB2:SHP" . SPARSER::BIO-COMPLEX)
    ("the potentially less disruptive THEMIS-R555A point mutant"
     . SPARSER::MUTANT)
    ("GRB2 and SHP1" . SPARSER::COLLECTION)
    ("THEMIS-dPRR1" . SPARSER::PROTEIN-PAIR)
    ("GRB2 and both SHP1 and SHP2 (Fig xref C)" . SPARSER::COLLECTION)
    ("Strep" . SPARSER::PROTEIN)
    ("Both wt THEMIS and a deletion mutant of the proline-rich region (dPRR1)"
     . SPARSER::COLLECTION)
    ("Both wt THEMIS and a deletion mutant" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("THEMIS-Strep" . SPARSER::COLLECTION)
    ("significant structural and functional homology" . SPARSER::PROTEIN)
    ("GRB2, SHP1 and SHP2" . SPARSER::COLLECTION)
    ("the protein tyrosine phosphatases (PTPs) SHP1 (PTPN6) and SHP2 (PTPN11)"
     . SPARSER::COLLECTION)
    ("PTPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mAb" . SPARSER::DRUG)
    ("Jurkat" . SPARSER::PROTEIN) ("THEMIS:GRB2:SHP1" . SPARSER::BIO-COMPLEX)
    ("LCK and SHP" . SPARSER::COLLECTION)
    ("CD3-ζ and Erk" . SPARSER::COLLECTION)
    ("the tyrosine phosphatase SHP1 (PTPN6) and SHP2 (PTPN11)"
     . SPARSER::COLLECTION)
    ("CD4 and CD8" . SPARSER::COLLECTION) ("CD4 or CD8" . SPARSER::COLLECTION)
    ("CD4/CD8" . SPARSER::COLLECTION) ("DP" . SPARSER::PROTEIN)
    ("pMHC" . SPARSER::BIO-COMPLEX) ("ligands" . SPARSER::LIGAND)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("THEMIS:SHP" . SPARSER::BIO-COMPLEX) ("LCK" . SPARSER::PROTEIN)
    ("signalosome" . SPARSER::PROTEIN)
    ("SHP1 and THEMIS" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("SHP" . SPARSER::PROTEIN) ("SHP1 and SHP2" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("THEMIS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cd3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IgG2b" . SPARSER::BIO-COMPLEX)
    ("B20" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("TCRβ" . SPARSER::PROTEIN) ("serine residue" . SPARSER::MOLECULE)
    ("RP23" . SPARSER::PROTEIN) ("Na 3 VO 4" . SPARSER::MOLECULE)
    ("β2m" . SPARSER::PROTEIN) ("heavy chain" . SPARSER::PROTEIN)
    ("D11" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD3ε" . SPARSER::PROTEIN)
    ("6B" . SPARSER::PROTEIN) ("K25" . SPARSER::PROTEIN)
    ("CD247" . SPARSER::PROTEIN) ("pMD2" . SPARSER::MOLECULE)
    ("Myc-tagged" . SPARSER::PROTEIN) ("Q8N1K5" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("poly-proline" . SPARSER::MOLECULE)
    ("Th2" . SPARSER::PROTEIN) ("3D" . SPARSER::PROTEIN-FAMILY)
    ("adaptor protein" . SPARSER::PROTEIN) ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("PLCγ1" . SPARSER::PROTEIN) ("ZAP-70" . SPARSER::PROTEIN)
    ("HPK1" . SPARSER::PROTEIN) ("DOK-2" . SPARSER::PROTEIN)
    ("DOK-1" . SPARSER::PROTEIN) ("SLP-76" . SPARSER::PROTEIN)
    ("H-2K" . SPARSER::PROTEIN) ("Rag2" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("C-SH2" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("CD25" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("C–E" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY) ("PP2" . SPARSER::DRUG)
    ("PRR1" . SPARSER::PROTEIN) ("PTPN11" . SPARSER::PROTEIN)
    ("PTPN6" . SPARSER::PROTEIN) ("CD69" . SPARSER::PROTEIN)
    ("CD3-ζ" . SPARSER::PROTEIN) ("C-SH3" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("SHP1" . SPARSER::PROTEIN)
    ("apt" . SPARSER::PROTEIN) ("RFP and Ecad" . SPARSER::COLLECTION)
    ("Ecad" . SPARSER::PROTEIN) ("dsRED" . SPARSER::PROTEIN)
    ("derivatives" . SPARSER::DERIVATIVE)
    ("a partially atorvastatin resistant state" . SPARSER::BIO-STATE)
    ("cell membrane and cytoplasmic E-cadherin" . SPARSER::COLLECTION)
    ("dependable biomarker" . SPARSER::MOLECULE)
    ("mesenchymal marker vimentin" . SPARSER::PROTEIN)
    ("vimentin and E-cadherin" . SPARSER::COLLECTION)
    ("HOP" . SPARSER::PROTEIN) ("PC-3" . SPARSER::PROTEIN)
    ("macrolide" . SPARSER::MOLECULE) ("Atorvastatin" . SPARSER::DRUG)
    ("atorvastatin" . SPARSER::DRUG)
    ("the isoprenoid intermediates geranyl-geranyl pyrophosphate and farnesyl pyrophosphate ( xref )"
     . SPARSER::COLLECTION)
    ("pyrophosphate" . SPARSER::MOLECULE) ("isoprenoid" . SPARSER::MOLECULE)
    ("ubiquinone" . SPARSER::DRUG) ("dolichol" . SPARSER::MOLECULE)
    ("Statin" . SPARSER::MOLECULE) ("HMGCR" . SPARSER::PROTEIN)
    ("metabolite" . SPARSER::MOLECULE) ("Neu" . SPARSER::PROTEIN)
    ("simvastatin" . SPARSER::DRUG)
    ("potent synergistic cytotoxic" . SPARSER::PROTEIN)
    ("ErbB2" . SPARSER::PROTEIN) ("Statins" . SPARSER::MOLECULE)
    ("statin-" . SPARSER::MOLECULE) ("statin" . SPARSER::MOLECULE)
    ("statins" . SPARSER::DRUG) ("Filipin III" . SPARSER::MOLECULE)
    ("HMG-CoA" . SPARSER::DRUG) ("protein or organelle" . SPARSER::COLLECTION)
    ("too much ASPP2" . SPARSER::PROTEIN) ("diamine" . SPARSER::MOLECULE)
    ("CDDP" . SPARSER::DRUG) ("ray" . SPARSER::PROTEIN)
    ("normal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Abnormal p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mutant" . SPARSER::MUTANT) ("ASPP2 and p53" . SPARSER::COLLECTION)
    ("anti-ASPP2 and anti-LC3" . SPARSER::COLLECTION)
    ("control RNAi-treated group and ASPP2 RNAi/3-MA-treated group"
     . SPARSER::MOLECULE)
    ("group and ASPP2" . SPARSER::COLLECTION)
    ("LC3-II/LC3-1" . SPARSER::COLLECTION) ("inducer" . SPARSER::PROTEIN)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("Annexin V/PI" . SPARSER::COLLECTION)
    ("ATG5 and ATG7" . SPARSER::COLLECTION)
    ("ATG5, ATG7 and Beclin-1" . SPARSER::COLLECTION)
    ("ATG16/ATG5/ATG12" . SPARSER::COLLECTION)
    ("ATG5/ATG12" . SPARSER::COLLECTION) ("p53/ASPP2" . SPARSER::COLLECTION)
    ("Bax and Bcl-2" . SPARSER::COLLECTION) ("Bax" . SPARSER::PROTEIN)
    ("pro-apoptotic genes" . SPARSER::GENE) ("/GFP" . SPARSER::COLLECTION)
    ("p53 or ASPP2" . SPARSER::COLLECTION)
    ("p53 and ASPP2" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("OHP" . SPARSER::PROTEIN)
    ("caspases-3" . SPARSER::PROTEIN) ("Atg-5" . SPARSER::PROTEIN)
    ("Beclin-1" . SPARSER::PROTEIN) ("ATG7" . SPARSER::PROTEIN)
    ("ATG12" . SPARSER::PROTEIN) ("ATG5" . SPARSER::PROTEIN)
    ("ATG16" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("GFP-LC3" . SPARSER::PROTEIN)
    ("ASPP2 " . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("p53-2" . SPARSER::PROTEIN) ("ASPP2" . SPARSER::PROTEIN)
    ("the UCP3 and the RPTOR [ xref – xref ]" . SPARSER::COLLECTION)
    ("skeletal muscle" . SPARSER::PROTEIN)
    ("the UCP3 and the RPTOR" . SPARSER::COLLECTION)
    ("BAT and VFA" . SPARSER::COLLECTION)
    ("FPG, HbA 1c , TG, TC, HDL-c and LDL-c" . SPARSER::COLLECTION)
    ("FPG" . SPARSER::PROTEIN-FAMILY)
    ("obesity-related quantitative traits" . SPARSER::PROTEIN)
    ("UCP3 and RPTOR" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the regulatory associated protein" . SPARSER::PROTEIN)
    ("BAT" . SPARSER::PROTEIN) ("thermogenic adipocytes" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("traits" . SPARSER::PROTEIN)
    ("the uncoupling protein 3 gene ( UCP3 ) and the regulatory associated protein of mTOR complex 1 gene ( RPTOR )"
     . SPARSER::COLLECTION)
    ("gene ( RPTOR )" . SPARSER::GENE) ("RPTOR" . SPARSER::PROTEIN)
    ("HbA 1" . SPARSER::PROTEIN) ("HbA1" . SPARSER::PROTEIN)
    ("LDL-c" . SPARSER::PROTEIN) ("Low density lipoprotein" . SPARSER::PROTEIN)
    ("HDL-c" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN) ("UCP1" . SPARSER::PROTEIN)
    ("uncoupling protein 1" . SPARSER::PROTEIN)
    ("regulatory associated protein of mTOR" . SPARSER::PROTEIN)
    ("UCP3" . SPARSER::PROTEIN) ("uncoupling protein 3" . SPARSER::PROTEIN)
    ("p38 and PI3K/AKT signaling components" . SPARSER::COLLECTION)
    ("p38 or AKT" . SPARSER::COLLECTION) ("p38 and AKT" . SPARSER::COLLECTION)
    ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("inhibitors, and therapies" . SPARSER::COLLECTION)
    ("herceptin" . SPARSER::DRUG) ("aromatase" . SPARSER::PROTEIN)
    ("the radiation-induced EMT" . SPARSER::PROTEIN)
    ("cisplatin, etoposide, or paclitaxel" . SPARSER::COLLECTION)
    ("radiation-induced SRC" . SPARSER::PROTEIN)
    ("radiation-activated SRC promoted EMT" . SPARSER::PROTEIN)
    ("CD44, SOX2, and Notch-2" . SPARSER::COLLECTION)
    ("SOX2, Notch-1, and Notch-2" . SPARSER::COLLECTION)
    ("PI3K and p38" . SPARSER::COLLECTION)
    ("N-cadherin and vimentin, and EMT" . SPARSER::COLLECTION)
    ("vimentin, and EMT" . SPARSER::COLLECTION)
    ("Radiation-activated SRC" . SPARSER::PROTEIN)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("SRC or mutant" . SPARSER::COLLECTION)
    ("Tyr" . SPARSER::AMINO-ACID)
    ("radiation-activated SRC" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin, and vimentin" . SPARSER::COLLECTION)
    ("vimentin" . SPARSER::PROTEIN) ("MCF7" . SPARSER::PROTEIN)
    ("cisplatin, etoposide, and paclitaxel" . SPARSER::COLLECTION)
    ("/CD24" . SPARSER::COLLECTION)
    ("PI3K, p38, and AKT" . SPARSER::COLLECTION)
    ("radiation-induced EMT" . SPARSER::PROTEIN) ("adjuvant" . SPARSER::DRUG)
    ("cisplatin, etoposide, paclitaxel, and IR" . SPARSER::COLLECTION)
    ("paclitaxel" . SPARSER::DRUG) ("etoposide" . SPARSER::DRUG)
    ("cisplatin" . SPARSER::DRUG)
    ("MAPK or protein kinase B" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/protein kinase B" . SPARSER::COLLECTION)
    ("SLUG" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN)
    ("Notch-2" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("IgG1" . SPARSER::BIO-COMPLEX)
    ("c-Src" . SPARSER::PROTEIN) ("LY294002" . SPARSER::MOLECULE)
    ("β-actin" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("ZEB1" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("p-p38" . SPARSER::PROTEIN) ("P38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD24" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("additional clinically relevant biomarkers" . SPARSER::MOLECULE)
    ("P53-MDM2" . SPARSER::COLLECTION) ("therapeutics" . SPARSER::THERAPEUTICS)
    ("alongside other MYC/MYCN" . SPARSER::COLLECTION)
    ("MYC/MYCN" . SPARSER::COLLECTION) ("MYCN and Ki-67" . SPARSER::COLLECTION)
    ("measurement revealed both MLN8237 and GDC-0449" . SPARSER::COLLECTION)
    ("MLN8237 and GDC-0449" . SPARSER::COLLECTION) ("MRI" . SPARSER::PROTEIN)
    ("Vismodegib" . SPARSER::DRUG) ("antagonist" . SPARSER::MOLECULE)
    ("Aurora-A/MYCN" . SPARSER::COLLECTION) ("Alisertib" . SPARSER::DRUG)
    ("protein and gatekeeper" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("Inhibitors" . SPARSER::INHIBITOR)
    ("Kinase" . SPARSER::KINASE) ("Cdkn1a" . SPARSER::PROTEIN)
    ("p53, or Dox" . SPARSER::COLLECTION) ("Tam" . SPARSER::PROTEIN)
    ("a 4-hydroxytamoxifen (4-OHT)-regulatable p53ER TAM fusion protein"
     . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and MYCN" . SPARSER::COLLECTION) ("TAM" . SPARSER::PROTEIN)
    ("tTA/TRE" . SPARSER::COLLECTION) ("Glt1" . SPARSER::PROTEIN)
    ("TRE" . SPARSER::PROTEIN) ("exogenous Myc or Mycn" . SPARSER::COLLECTION)
    ("MYC or MYCN" . SPARSER::COLLECTION) ("Myc or Mycn" . SPARSER::COLLECTION)
    ("p53 or Rb" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("-P53" . SPARSER::COLLECTION) ("rank" . SPARSER::PROTEIN)
    ("TTD" . SPARSER::PROTEIN)
    ("relapsed MB WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MYC and P53" . SPARSER::COLLECTION) ("LCA" . SPARSER::PROTEIN)
    ("large historic cohorts" . SPARSER::MOLECULE)
    ("our relapsed study cohort" . SPARSER::MOLECULE)
    ("MYC and MYCN" . SPARSER::COLLECTION)
    ("the only other published cohort" . SPARSER::MOLECULE)
    ("chromosome 17 and P53" . SPARSER::COLLECTION)
    ("Group (CCLG)" . SPARSER::MOLECULE) ("Leukemia" . SPARSER::PROTEIN)
    ("a clinical-trials-based cohort" . SPARSER::MOLECULE)
    ("MYC-p53" . SPARSER::COLLECTION) ("P53-MYC" . SPARSER::COLLECTION)
    ("Trp" . SPARSER::AMINO-ACID) ("Gli-1" . SPARSER::PROTEIN)
    ("Caspase 3" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("F12" . SPARSER::PROTEIN)
    ("a 3 " . SPARSER::HUMAN-PROTEIN-FAMILY) ("B2M" . SPARSER::PROTEIN)
    ("GDC-0449" . SPARSER::DRUG) ("Gli1" . SPARSER::PROTEIN)
    ("sonic hedgehog" . SPARSER::PROTEIN) ("MLN8237" . SPARSER::DRUG)
    ("Aurora-A" . SPARSER::PROTEIN) ("F–3H" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("–2" . SPARSER::PROTEIN) ("A–S1" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("MDM2" . SPARSER::PROTEIN)
    ("p14  ARF" . SPARSER::PROTEIN) ("chromosome 17" . SPARSER::PROTEIN)
    ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("directing multifunctional proteins" . SPARSER::PROTEIN)
    ("many multifunctional proteins" . SPARSER::PROTEIN)
    ("PCNA" . SPARSER::PROTEIN) ("SLX4 and TRF2" . SPARSER::COLLECTION)
    ("UBC9 and the SIMs" . SPARSER::COLLECTION)
    ("RNF168, HERC2, RAP80, BRCA1, and 53BP1" . SPARSER::COLLECTION)
    ("SLX4 and BLM" . SPARSER::COLLECTION)
    ("SUMO or ubiquitin" . SPARSER::COLLECTION)
    ("structure-specific endonucleases" . SPARSER::PROTEIN)
    ("RPA70 and MRN" . SPARSER::COLLECTION)
    ("RPA and MRN" . SPARSER::COLLECTION)
    ("SLX4 and MDC1" . SPARSER::COLLECTION)
    ("RPA and MDC1" . SPARSER::COLLECTION) ("myc-TRF2" . SPARSER::COLLECTION)
    ("myc" . SPARSER::PROTEIN) ("SLX4-TRF2" . SPARSER::COLLECTION)
    ("DDR and telomere-binding proteins" . SPARSER::COLLECTION)
    ("RPA, MRN and TRF2" . SPARSER::COLLECTION)
    ("CtIP and MDC1" . SPARSER::COLLECTION) ("nuclease" . SPARSER::PROTEIN)
    ("Mirin" . SPARSER::DRUG) ("CtIP" . SPARSER::PROTEIN)
    ("SLX4 L1022A and TRF2" . SPARSER::COLLECTION) ("HA" . SPARSER::PROTEIN)
    ("-complemented" . SPARSER::COLLECTION) ("complemented" . SPARSER::PROTEIN)
    ("RPA32 and H2AX" . SPARSER::COLLECTION)
    ("SAP and SLX4" . SPARSER::COLLECTION)
    ("MUS81 and SLX1" . SPARSER::COLLECTION)
    ("MUS81 and ERCC1" . SPARSER::COLLECTION) ("RA" . SPARSER::PROTEIN)
    ("MMC" . SPARSER::PROTEIN) ("SUMO-ubiquitin" . SPARSER::COLLECTION)
    ("alanines" . SPARSER::AMINO-ACID) ("His" . SPARSER::AMINO-ACID)
    ("XPF, MUS81, and SLX1" . SPARSER::COLLECTION) ("SBD" . SPARSER::PROTEIN)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("Acinus" . SPARSER::PROTEIN)
    ("SAP" . SPARSER::PROTEIN) ("MEI" . SPARSER::MOLECULE)
    ("SFB-SLX4" . SPARSER::COLLECTION) ("SFB-GFP" . SPARSER::COLLECTION)
    ("Streptavidin" . SPARSER::PROTEIN) ("SFB" . SPARSER::PROTEIN)
    ("Flag-1xSUMO-2" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("SLX4 and MUS81" . SPARSER::COLLECTION)
    ("purified linear SUMO-2 tetramers (GST-4xSUMO-2) and SUMO-2 monomers (GST-SUMO-2)"
     . SPARSER::COLLECTION)
    ("GST-4xSUMO-2" . SPARSER::COLLECTION) ("monomers" . SPARSER::MONOMER)
    ("tetramers" . SPARSER::TETRAMER) ("polymer" . SPARSER::MOLECULE)
    ("The basic residues K33" . SPARSER::PROTEIN)
    ("GST-SUMO-1" . SPARSER::COLLECTION) ("HA-SLX4" . SPARSER::COLLECTION)
    ("MSH2, and C20orf94" . SPARSER::COLLECTION)
    ("XPF/ERCC4" . SPARSER::COLLECTION)
    ("a nonconjugatable form" . SPARSER::FORM)
    ("GST-SUMO-2" . SPARSER::COLLECTION)
    ("multifunctional proteins" . SPARSER::PROTEIN)
    ("camptothecin (CPT)" . SPARSER::DRUG) ("camptothecin" . SPARSER::DRUG)
    ("ubiquitin and SUMO" . SPARSER::COLLECTION)
    ("ubiquitin or SUMO" . SPARSER::COLLECTION)
    ("BRCA1, 53BP1, MDC1, RPA, and BLM" . SPARSER::COLLECTION)
    ("BLM" . SPARSER::PROTEIN)
    ("the mono-ubiquitylated FANCD2 or other poly-ubiquitylated proteins"
     . SPARSER::COLLECTION)
    ("FANCP" . SPARSER::PROTEIN) ("MSH2-MSH3" . SPARSER::COLLECTION)
    ("several DNA structure-specific endonucleases" . SPARSER::PROTEIN)
    ("MUS81-EME1" . SPARSER::COLLECTION) ("XPF-ERCC1" . SPARSER::COLLECTION)
    ("XPF" . SPARSER::PROTEIN)
    ("multifunctional DNA repair proteins" . SPARSER::PROTEIN)
    ("PRR" . SPARSER::PROTEIN) ("SUMO and ubiquitin" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("UBC9 and MDC1" . SPARSER::COLLECTION) ("DNA-end" . SPARSER::DNA)
    ("CPT" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("SUMO" . SPARSER::PROTEIN) ("DNA-interstrand" . SPARSER::DNA)
    ("ICLs" . SPARSER::PROTEIN) ("ubiquitin" . SPARSER::PROTEIN)
    ("multiple DNA structure-specific endonucleases" . SPARSER::PROTEIN)
    ("endonucleases" . SPARSER::PROTEIN) ("HERC2" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("RPA70" . SPARSER::PROTEIN)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("Cyclin A" . SPARSER::PROTEIN)
    ("H2AX" . SPARSER::PROTEIN) ("RPA32" . SPARSER::PROTEIN)
    ("E7" . SPARSER::PROTEIN-FAMILY) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIM2" . SPARSER::PROTEIN) ("SIM1" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN) ("SAF-A" . SPARSER::PROTEIN)
    ("RNF4" . SPARSER::PROTEIN) ("GST-4" . SPARSER::PROTEIN)
    ("K33" . SPARSER::PROTEIN) ("SUMO-1" . SPARSER::PROTEIN)
    ("C20orf94" . SPARSER::PROTEIN) ("ERCC4" . SPARSER::PROTEIN)
    ("MUS312" . SPARSER::PROTEIN) ("BTBD12" . SPARSER::PROTEIN)
    ("DNA repair protein" . SPARSER::PROTEIN) ("RAP80" . SPARSER::PROTEIN)
    ("53BP1" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN)
    ("Fanconi Anemia" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("SLX1" . SPARSER::PROTEIN-FAMILY)
    ("EME1" . SPARSER::PROTEIN) ("MUS81" . SPARSER::PROTEIN)
    ("TRF2" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("MDC1" . SPARSER::PROTEIN) ("UBC9" . SPARSER::PROTEIN)
    ("SUMO-2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SLX4" . SPARSER::PROTEIN)
    ("HER2 or EGFR" . SPARSER::COLLECTION)
    ("miR-7 or EGFR" . SPARSER::COLLECTION) ("agonist" . SPARSER::AGONIST)
    ("integrins" . SPARSER::PROTEIN) ("gene or pathway" . SPARSER::COLLECTION)
    ("directly target Src kinase" . SPARSER::PROTEIN)
    ("Src" . SPARSER::PROTEIN) ("dasatinib" . SPARSER::DRUG)
    ("CHO" . SPARSER::PROTEIN) ("miR-7 and EGFR" . SPARSER::COLLECTION)
    ("KD" . SPARSER::PROTEIN) ("Jumonji/ARID1 B" . SPARSER::COLLECTION)
    ("Jumonji" . SPARSER::PROTEIN) ("837 unique human miRs" . SPARSER::PROTEIN)
    ("a relatively weak breast oncogene" . SPARSER::ONCOGENE)
    ("EGFR and independently inactivating Src kinase" . SPARSER::COLLECTION)
    ("FAK" . SPARSER::PROTEIN) ("miRs" . SPARSER::PROTEIN)
    ("MiRs" . SPARSER::PROTEIN) ("miR" . SPARSER::PROTEIN)
    ("EGFR and Src kinase" . SPARSER::COLLECTION) ("microRNA" . SPARSER::RNA)
    ("microRNAs" . SPARSER::RNA)
    ("tamoxifen and trastuzumab" . SPARSER::COLLECTION)
    ("trastuzumab" . SPARSER::DRUG) ("isoform" . SPARSER::ISOFORM)
    ("G-protein coupled" . SPARSER::PROTEIN)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IGF1R" . SPARSER::PROTEIN)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("in Chinese hamster" . SPARSER::PROTEIN) ("JARID1B" . SPARSER::PROTEIN)
    ("ARID1 B" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("Reducing Agent" . SPARSER::MOLECULE) ("P40)" . SPARSER::PROTEIN)
    ("a 20 µ" . SPARSER::PROTEIN) ("M1" . SPARSER::MOLECULE)
    ("KLF4" . SPARSER::PROTEIN) ("factor 4" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21-activated kinase 1" . SPARSER::PROTEIN)
    ("single-stranded RNAs" . SPARSER::RNA) ("Src kinase" . SPARSER::PROTEIN)
    ("MiR-7" . SPARSER::PROTEIN) ("miR-7" . SPARSER::PROTEIN)
    ("an EGFR-TKI and T790M-targeted immunotherapy" . SPARSER::COLLECTION)
    ("EGFR-TKI and immunotherapy" . SPARSER::COLLECTION)
    ("EGFR-TKI or anti-EGFR" . SPARSER::COLLECTION) ("MHC" . SPARSER::PROTEIN)
    ("EGFR-TKI and EGFR" . SPARSER::COLLECTION)
    ("irrelevant peptides" . SPARSER::PEPTIDE)
    ("distinct CTL" . SPARSER::PROTEIN)
    ("valine and leucine" . SPARSER::COLLECTION)
    ("Leucine and methionine" . SPARSER::COLLECTION)
    ("Leucine" . SPARSER::AMINO-ACID) ("anchor" . SPARSER::ANCHOR)
    ("TAAs" . SPARSER::DRUG) ("Cai" . SPARSER::DRUG)
    ("imatinib" . SPARSER::DRUG) ("ABL" . SPARSER::PROTEIN)
    ("calcein" . SPARSER::MOLECULE) ("Target" . SPARSER::TARGET-PROTEIN)
    ("H1975" . SPARSER::PROTEIN) ("DCs" . SPARSER::MOLECULE)
    ("two mutated peptides" . SPARSER::PEPTIDE) ("TAP" . SPARSER::PROTEIN)
    ("Val (T790M-D) or Leu (T790M-E)" . SPARSER::COLLECTION)
    ("Leu" . SPARSER::AMINO-ACID) ("mer" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STAT" . SPARSER::PROTEIN) ("H1975-A2" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN) ("CTLs" . SPARSER::PROTEIN)
    ("TKI" . SPARSER::PROTEIN) ("EGFR-TKIs" . SPARSER::COLLECTION)
    ("Epidermal growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("STAT3" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("Amino acid" . SPARSER::AMINO-ACID) ("M-B" . SPARSER::PROTEIN)
    ("CD107a" . SPARSER::PROTEIN) ("IL-15" . SPARSER::PROTEIN)
    ("IL-2" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("prostaglandin E2" . SPARSER::MOLECULE) ("GM-CSF" . SPARSER::PROTEIN)
    ("granulocyte-macrophage colony-stimulating factor" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("CD14" . SPARSER::PROTEIN)
    ("H-2" . SPARSER::PROTEIN) ("CD83" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFN-γ" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("M-A" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("trans-vivo" . SPARSER::PROTEIN-PAIR)
    ("pro-apoptotic induction immunosuppressants" . SPARSER::DRUG)
    ("a pro-apoptotic immunosuppressant" . SPARSER::DRUG)
    ("IL6, IL1β, or TNFα" . SPARSER::COLLECTION) ("SD" . SPARSER::PROTEIN)
    ("perforin" . SPARSER::PROTEIN)
    ("activated antigenic caspase-3" . SPARSER::PROTEIN)
    ("PPV" . SPARSER::MOLECULE)
    ("anti-CD154-phycoerythrin" . SPARSER::COLLECTION)
    ("phycoerythrin" . SPARSER::PROTEIN-FAMILY) ("monensin" . SPARSER::DRUG)
    ("IL6, IL1β and TNFα" . SPARSER::COLLECTION) ("MLR" . SPARSER::PROTEIN)
    ("cytokines, IL-6, IL1β, and TNFα" . SPARSER::COLLECTION)
    ("the caspase-3 and -7 substrate" . SPARSER::COLLECTION)
    ("BrdU" . SPARSER::DRUG) ("APO" . SPARSER::PROTEIN)
    ("fluorochrome" . SPARSER::MOLECULE) ("cytokine" . SPARSER::PROTEIN)
    ("sirolimus and cellcept" . SPARSER::COLLECTION)
    ("sirolimus" . SPARSER::DRUG) ("NCT" . SPARSER::PROTEIN)
    ("recurrent ACR" . SPARSER::PROTEIN) ("ACR" . SPARSER::PROTEIN)
    ("complement" . SPARSER::PROTEIN) ("lysosomal" . SPARSER::PROTEIN)
    ("cathepsins" . SPARSER::PROTEIN)
    ("caspase and cathepsin" . SPARSER::COLLECTION)
    ("cathepsin" . SPARSER::PROTEIN)
    ("a potentially tolerogenic immunosuppressant" . SPARSER::DRUG)
    ("Examples" . SPARSER::EXAMPLE) ("reagents" . SPARSER::MOLECULE)
    ("proapoptotic immunosuppressants" . SPARSER::DRUG)
    ("immunosuppressants" . SPARSER::DRUG)
    ("immunosuppressant" . SPARSER::DRUG)
    ("caspase-3, phiphilux, and TUNEL" . SPARSER::COLLECTION)
    ("ITx" . SPARSER::PROTEIN) ("HLA" . SPARSER::PROTEIN)
    ("Texas Red" . SPARSER::DRUG) ("CD45RO" . SPARSER::PROTEIN)
    ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cathepsin-B" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("IL1β" . SPARSER::PROTEIN) ("MLC 1" . SPARSER::PROTEIN)
    ("T-cell receptor" . SPARSER::PROTEIN) ("Caspase-3" . SPARSER::PROTEIN)
    ("CD154" . SPARSER::PROTEIN) ("cathepsin-B" . SPARSER::PROTEIN)
    ("a dominant-negative ETS1 (DN-ETS1) protein" . SPARSER::PROTEIN)
    ("PAX3-ETS1" . SPARSER::COLLECTION)
    ("a pathway wherein transcription factors ETS1 and PAX3"
     . SPARSER::COLLECTION)
    ("MEL" . SPARSER::PROTEIN) ("SK" . SPARSER::PROTEIN)
    ("PAX3 or MITF" . SPARSER::COLLECTION)
    ("PAX3 and MITF" . SPARSER::COLLECTION)
    ("Our group and others" . SPARSER::COLLECTION)
    ("PAX3, MITF, and SOX10" . SPARSER::COLLECTION) ("MITF" . SPARSER::PROTEIN)
    ("a dominant-negative ETS1 protein" . SPARSER::PROTEIN)
    ("ETS1-HGF" . SPARSER::COLLECTION) ("ETS1-PAX3" . SPARSER::COLLECTION)
    ("PAX3 or HGF" . SPARSER::COLLECTION) ("enhancers" . SPARSER::PROTEIN)
    ("The proximal MET promoter" . SPARSER::PROMOTER)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("exogenous wild-type ETS1 protein" . SPARSER::PROTEIN)
    ("MET and ERK" . SPARSER::COLLECTION)
    ("MET, ERK, and ETS" . SPARSER::COLLECTION)
    ("ETS1 or a mutant form" . SPARSER::COLLECTION)
    ("HGF or PAX3" . SPARSER::COLLECTION) ("ETS1/PAX3" . SPARSER::COLLECTION)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAX3 or Hepatocyte Growth Factor (HGF)" . SPARSER::COLLECTION)
    ("PAX3 or Hepatocyte Growth Factor" . SPARSER::COLLECTION)
    ("PAX3 and ETS" . SPARSER::COLLECTION) ("E1 and E2" . SPARSER::COLLECTION)
    ("mel" . SPARSER::PROTEIN) ("oligonucleotide" . SPARSER::MOLECULE)
    ("PAX3 or ETS1" . SPARSER::COLLECTION)
    ("proximal promoter and 28" . SPARSER::COLLECTION)
    ("proximal promoter" . SPARSER::PROMOTER)
    ("pGL2-Luciferase" . SPARSER::COLLECTION) ("Luciferase" . SPARSER::PROTEIN)
    ("the proximal MET promoter" . SPARSER::PROMOTER) ("AC" . SPARSER::PROTEIN)
    ("GGA" . SPARSER::MOLECULE)
    ("The MET proximal promoter" . SPARSER::PROMOTER)
    ("PAX3 and MET, or ETS1 and MET" . SPARSER::COLLECTION)
    ("MET, or ETS1 and MET" . SPARSER::COLLECTION)
    ("ETS1 and MET" . SPARSER::COLLECTION)
    ("PAX3, ETS1, MET, pETS1 and phosphorylated-MET" . SPARSER::COLLECTION)
    ("CIP" . SPARSER::PROTEIN) ("PAX3, ETS1, and MET" . SPARSER::COLLECTION)
    ("PAX3-" . SPARSER::PROTEIN) ("ETS1 and PAX3" . SPARSER::COLLECTION)
    ("a weak transcription factor" . SPARSER::PROTEIN)
    ("our group and others" . SPARSER::COLLECTION)
    ("MET and ETS1" . SPARSER::COLLECTION)
    ("uPA, MMP1, MMP3, and integrin-β3" . SPARSER::COLLECTION)
    ("integrin" . SPARSER::PROTEIN) ("uPA" . SPARSER::PROTEIN)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID)
    ("a PAX3 response element and two ETS1 consensus motifs"
     . SPARSER::COLLECTION)
    ("proximal MET promoter" . SPARSER::PROMOTER)
    ("PAX3 and ETS1" . SPARSER::COLLECTION)
    ("DNA polymerase I" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("beta-tubulin" . SPARSER::PROTEIN)
    ("beta-galactosidase activity" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("N1" . SPARSER::PROTEIN)
    ("Pax3" . SPARSER::PROTEIN) ("Bis-Tris" . SPARSER::MOLECULE)
    ("TM5" . SPARSER::PROTEIN) ("SOX10" . SPARSER::PROTEIN)
    ("PD184352" . SPARSER::DRUG)
    ("Hepatocyte Growth Factor" . SPARSER::PROTEIN)
    ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("set 1" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("ETS family" . SPARSER::PROTEIN)
    ("TBX2" . SPARSER::PROTEIN) ("MMP3" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN) ("MCL1" . SPARSER::PROTEIN)
    ("ETS1" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("fractioned" . SPARSER::BIO-FRACTION)
    ("c-MYC and the risk haplotype" . SPARSER::COLLECTION)
    ("RAD9 and RAD10" . SPARSER::COLLECTION)
    ("SPO11 and SPO17" . SPARSER::COLLECTION) ("IGH" . SPARSER::PROTEIN)
    ("three c-MYC and two centromere 8 FISH" . SPARSER::COLLECTION)
    ("four c-MYC and two centromere" . SPARSER::COLLECTION)
    ("dup" . SPARSER::HUMAN-PROTEIN-FAMILY) ("t" . SPARSER::PROTEIN)
    ("derivative" . SPARSER::DERIVATIVE) ("p-arm" . SPARSER::COLLECTION)
    ("c-MYC, PVT1 and TMEM75" . SPARSER::COLLECTION)
    ("parental MCF-10A" . SPARSER::PROTEIN) ("fractions" . SPARSER::COMPONENT)
    ("HER2 or basal-like" . SPARSER::COLLECTION) ("rays" . SPARSER::PROTEIN)
    ("MCF-10A" . SPARSER::PROTEIN) ("hydrogen peroxide" . SPARSER::MOLECULE)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("g protein" . SPARSER::PROTEIN) ("chr1" . SPARSER::PROTEIN)
    ("CDKN2B" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("BLIMP1" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("RAD10" . SPARSER::PROTEIN)
    ("RAD9" . SPARSER::PROTEIN) ("SPO11" . SPARSER::PROTEIN)
    ("p23" . SPARSER::PROTEIN) ("PVT1" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p21" . SPARSER::PROTEIN)
    ("activator or repressor" . SPARSER::COLLECTION)
    ("p16INK4 and c-Myc" . SPARSER::COLLECTION) ("p16INK4" . SPARSER::PROTEIN)
    ("XRN" . SPARSER::PROTEIN) ("exonuclease" . SPARSER::PROTEIN)
    ("HuR" . SPARSER::PROTEIN) ("VEGF and MAPK" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("cis" . SPARSER::PROTEIN)
    ("RPS6 and 4E-BP1" . SPARSER::COLLECTION) ("Matrigel" . SPARSER::PROTEIN)
    ("LacZ" . SPARSER::PROTEIN) ("Proteins" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor (VEGFR) and GRB2-associated binding protein (GAB)"
     . SPARSER::COLLECTION)
    ("tafazzin (TAZ) and small body size/mothers" . SPARSER::COLLECTION)
    ("epithelial-mesenchymal transition EMT effectors" . SPARSER::EFFECTOR)
    ("GRB2-associated binding protein (GAB)" . SPARSER::PROTEIN)
    ("protein (GAB)" . SPARSER::PROTEIN)
    ("receptor (VEGFR)" . SPARSER::RECEPTOR)
    ("BCL2-associated X protein (BAX)" . SPARSER::PROTEIN)
    ("protein (BAX)" . SPARSER::PROTEIN) ("TAZ" . SPARSER::PROTEIN)
    ("tafazzin" . SPARSER::PROTEIN) ("effectors" . SPARSER::EFFECTOR)
    ("EMT" . SPARSER::PROTEIN) ("paxillin" . SPARSER::PROTEIN)
    ("VEGFR" . SPARSER::PROTEIN) ("BAX" . SPARSER::PROTEIN)
    ("kinases and regulatory proteins" . SPARSER::COLLECTION)
    ("total RPS6 or total 4E-BP1" . SPARSER::COLLECTION)
    ("siRNAs" . SPARSER::PROTEIN) ("RICTOR" . SPARSER::PROTEIN)
    ("TSC1/TSC2" . SPARSER::COLLECTION) ("Tuberin" . SPARSER::PROTEIN)
    ("proteins and phosphoproteins" . SPARSER::COLLECTION)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("RSK" . SPARSER::PROTEIN)
    ("pRPS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RAPTOR" . SPARSER::PROTEIN)
    ("interactome" . SPARSER::PROTEIN)
    ("138 proteins and 44 phosphoproteins" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("mTOR protein and other protein components" . SPARSER::COLLECTION)
    ("LARP1-interactome" . SPARSER::PROTEIN-PAIR)
    ("-renilla-luciferase" . SPARSER::COLLECTION)
    ("MAPK12 and TWIST1" . SPARSER::COLLECTION)
    ("AKT1, AKT2 and MAPK11" . SPARSER::COLLECTION)
    ("MAPK12, mTOR and Twist-1" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("LARP1-mRNA" . SPARSER::COLLECTION) ("UK" . SPARSER::PROTEIN)
    ("Bank" . SPARSER::PROTEIN) ("LARP1 and mTOR" . SPARSER::COLLECTION)
    ("poly-A-binding protein (PABP)" . SPARSER::PROTEIN)
    ("rapamycin" . SPARSER::DRUG) ("ribosome" . SPARSER::BIO-COMPLEX)
    ("PABP" . SPARSER::PROTEIN) ("Drosophila" . SPARSER::PROTEIN)
    ("LARP" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cues" . SPARSER::PROTEIN-FAMILY)
    ("RBP" . SPARSER::PROTEIN) ("RBPs" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide"
     . SPARSER::MOLECULE)
    ("HSP60" . SPARSER::PROTEIN) ("P37" . SPARSER::PROTEIN)
    ("4EBP" . SPARSER::PROTEIN) ("4EBP1" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("Dual-Luciferase" . SPARSER::PROTEIN)
    ("130 kD" . SPARSER::PROTEIN) ("siRNA2" . SPARSER::PROTEIN)
    ("Actinomycin-D" . SPARSER::MOLECULE) ("INK4" . SPARSER::PROTEIN)
    ("BP1" . SPARSER::PROTEIN) ("P-4" . SPARSER::PROTEIN)
    ("micro-RNA" . SPARSER::MICRO-RNA) ("messenger RNA" . SPARSER::RNA)
    ("CD31" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("4E-BP1" . SPARSER::PROTEIN) ("mTORC2" . SPARSER::PROTEIN)
    ("TSC1" . SPARSER::PROTEIN) ("TCS1" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("TSC2" . SPARSER::PROTEIN) ("p90" . SPARSER::PROTEIN)
    ("RPS6" . SPARSER::PROTEIN) ("TWIST1" . SPARSER::PROTEIN)
    ("actinomycin-D" . SPARSER::MOLECULE) ("MAPK14" . SPARSER::PROTEIN)
    ("Twist-1" . SPARSER::PROTEIN) ("MAPK12" . SPARSER::PROTEIN)
    ("MAPK11" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("LARP7" . SPARSER::PROTEIN) ("LARP family" . SPARSER::PROTEIN)
    ("LARP1" . SPARSER::PROTEIN) ("La-related protein 1" . SPARSER::PROTEIN)
    ("JNK, ERK, Ras, NF-kB, and NFAT" . SPARSER::COLLECTION)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("JNK" . SPARSER::PROTEIN)
    ("Rho/Rac" . SPARSER::COLLECTION) ("GDP/GTP" . SPARSER::PROTEIN-PAIR)
    ("GTPases" . SPARSER::GTPASE) ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTP" . SPARSER::NUCLEOTIDE) ("GDP" . SPARSER::NUCLEOTIDE)
    ("Vav" . SPARSER::PROTEIN) ("Vav1 and SHH" . SPARSER::COLLECTION)
    ("alternative cohorts" . SPARSER::MOLECULE)
    ("both a prognostic and predictive biomarker" . SPARSER::MOLECULE)
    ("important potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("Ptch1 and Vav1" . SPARSER::COLLECTION)
    ("PTCH1 (~45%) and TERT (~30%)" . SPARSER::COLLECTION)
    ("TERT" . SPARSER::PROTEIN) ("immature CGNs" . SPARSER::PROTEIN)
    ("mature CGNs" . SPARSER::PROTEIN) ("CGN" . SPARSER::PROTEIN)
    ("IGL" . SPARSER::PROTEIN) ("EGL" . SPARSER::PROTEIN)
    ("CGNs" . SPARSER::PROTEIN) ("dominant-negative Vav1" . SPARSER::PROTEIN)
    ("Mycn" . SPARSER::PROTEIN)
    ("a Vav1 dominant-negative mutant" . SPARSER::MUTANT)
    ("an isolated amino terminal fragment" . SPARSER::FRAGMENT)
    ("a dominant-negative form" . SPARSER::FORM)
    ("Vav1/GFP" . SPARSER::COLLECTION) ("Ptch1" . SPARSER::PROTEIN)
    ("GEF" . SPARSER::GEF) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("Ptch" . SPARSER::PROTEIN) ("Dominant-negative Vav1" . SPARSER::PROTEIN)
    ("Cdkn2c" . SPARSER::PROTEIN) ("fraction" . SPARSER::COMPONENT)
    ("Med" . SPARSER::PROTEIN) ("MEB" . SPARSER::PROTEIN)
    ("Aza" . SPARSER::DRUG)
    ("Tal1 , Dsc2 , Spdef and Rassf1a" . SPARSER::COLLECTION)
    ("Spdef" . SPARSER::PROTEIN) ("SHH and SHH" . SPARSER::COLLECTION)
    ("alongside regions surrounding RASSF1A and COL1A2" . SPARSER::COLLECTION)
    ("RASSF1A and COL1A2" . SPARSER::COLLECTION) ("-WNT" . SPARSER::COLLECTION)
    ("MLL2 (~16% of MB SHH ) and DDX3X (~26%)" . SPARSER::COLLECTION)
    ("GLI2 and MYCN" . SPARSER::COLLECTION)
    ("genes and pathways" . SPARSER::COLLECTION) ("MYCN" . SPARSER::PROTEIN)
    ("SMO" . SPARSER::PROTEIN) ("SUFU" . SPARSER::PROTEIN)
    ("Wnt/Wingless" . SPARSER::COLLECTION) ("Wingless" . SPARSER::PROTEIN)
    ("a validated therapeutic target and prognostic biomarker"
     . SPARSER::COLLECTION)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("a critical epigenetically-regulated oncogene" . SPARSER::ONCOGENE)
    ("Shh" . SPARSER::PROTEIN) ("Group" . SPARSER::MOLECULE)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("SHH" . SPARSER::PROTEIN) ("K19" . SPARSER::PROTEIN)
    ("HSC70" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("nucleotide exchange factor" . SPARSER::NUCLEOTIDE-EXCHANGE-FACTOR)
    ("Vav3" . SPARSER::PROTEIN) ("Vav-1" . SPARSER::PROTEIN)
    ("H2B" . SPARSER::PROTEIN) ("Rassf1a" . SPARSER::PROTEIN)
    ("Dsc2" . SPARSER::PROTEIN) ("Tal1" . SPARSER::PROTEIN)
    ("COL1A2" . SPARSER::PROTEIN) ("DDX3X" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("GLI2" . SPARSER::PROTEIN)
    ("PTCH1" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("VAV1" . SPARSER::PROTEIN) ("Sonic Hedgehog" . SPARSER::PROTEIN)
    ("CD58 , ANXA1 , JAG1 and SOX9" . SPARSER::COLLECTION)
    ("ERα, FOXA1 and GATA3" . SPARSER::COLLECTION)
    ("ESR1 and FOXA1" . SPARSER::COLLECTION)
    ("FOXA1, ERα and GATA3" . SPARSER::COLLECTION)
    ("EZH2/PRC2" . SPARSER::COLLECTION)
    ("H3K27me3-associated gene" . SPARSER::GENE)
    ("methyltransferase and gene" . SPARSER::COLLECTION)
    ("methyltransferase" . SPARSER::PROTEIN) ("bisulphite" . SPARSER::MOLECULE)
    ("endocrine" . SPARSER::PROTEIN)
    ("BRCA2, BRCAx and BRCA2/x" . SPARSER::COLLECTION)
    ("BRCA1 and EZH2" . SPARSER::COLLECTION)
    ("BRCA1 or EZH2" . SPARSER::COLLECTION)
    ("BRCA1, EZH2 and DNMT3b" . SPARSER::COLLECTION)
    ("the repressive H3K27me3 histone" . SPARSER::PROTEIN)
    ("BRCA1, EZH2, DNMT1, DNMT3a and DNMT3b" . SPARSER::COLLECTION)
    ("bisulfite" . SPARSER::MOLECULE)
    ("BRCA1, EZH2, DNMT3b and H3K27me3" . SPARSER::COLLECTION)
    ("methionine" . SPARSER::AMINO-ACID)
    ("both western blot and quantitative reverse transcription-PCR"
     . SPARSER::COLLECTION)
    ("both western blot" . SPARSER::PROTEIN)
    ("BRCA1, FOXA1 and EZH2" . SPARSER::COLLECTION) ("DNAs" . SPARSER::DNA)
    ("siRNA, and FOXA1" . SPARSER::COLLECTION)
    ("-deoxycytidine" . SPARSER::COLLECTION)
    ("deoxycytidine" . SPARSER::PROTEIN) ("Bisulphite" . SPARSER::MOLECULE)
    ("CpG" . SPARSER::PROTEIN)
    ("BRCA1-reconstituted KB1PR-3.12 E3 and KB1PR-3.12 F4 (K14cre;Brca1F/F;p53F/F BRCA1-reconstituted clones E3 and F4) MMECs"
     . SPARSER::COLLECTION)
    ("cre" . SPARSER::PROTEIN) ("versa" . SPARSER::PROTEIN)
    ("protein and mRNA" . SPARSER::COLLECTION) ("Polycomb" . SPARSER::PROTEIN)
    ("ERα and GATA3" . SPARSER::COLLECTION)
    ("BRCA1 and FOXA1" . SPARSER::COLLECTION)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("DNMTs" . SPARSER::PROTEIN)
    ("polycomb" . SPARSER::PROTEIN)
    ("repressive linker histones" . SPARSER::PROTEIN)
    ("FOXA1 and ERα" . SPARSER::COLLECTION) ("forkhead" . SPARSER::PROTEIN)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("holoenzyme" . SPARSER::PROTEIN)
    ("BRCA1 and DNMT3b" . SPARSER::COLLECTION) ("DNMT" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN) ("aza" . SPARSER::DRUG)
    ("RNA and protein" . SPARSER::COLLECTION) ("luminal" . SPARSER::DRUG)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SOX9" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("ANXA1" . SPARSER::PROTEIN)
    ("CD58" . SPARSER::PROTEIN) ("SUZ12" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("DNMT3a" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("Histone 3" . SPARSER::PROTEIN)
    ("MO2" . SPARSER::PROTEIN) ("PR-3" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("P-3" . SPARSER::PROTEIN)
    ("PRC1" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("PRC2" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("p27 Kip1" . SPARSER::PROTEIN) ("FOXC1" . SPARSER::PROTEIN)
    ("GATA3" . SPARSER::PROTEIN) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("DNMT3b" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("EZH2" . SPARSER::PROTEIN) ("GSK126" . SPARSER::DRUG)
    ("Foxa1" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("FOXA1" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("linker" . SPARSER::LINKER) ("radiation-induced foci" . SPARSER::PROTEIN)
    ("stable ionizing radiation-induced foci" . SPARSER::PROTEIN)
    ("foci" . SPARSER::PROTEIN)
    ("recombination proteins BRCA1 [ xref ] and XRCC1 [ xref ]"
     . SPARSER::COLLECTION)
    ("Mdm4 [ xref ] and p53 [ xref ]" . SPARSER::COLLECTION)
    ("regulators PML [ xref ] and histone 1 [ xref ]" . SPARSER::COLLECTION)
    ("PML" . SPARSER::PROTEIN) ("an apical DDR protein" . SPARSER::PROTEIN)
    ("the residual Chk2 kinase" . SPARSER::KINASE)
    ("doxycycline" . SPARSER::DRUG) ("tetracycline" . SPARSER::DRUG)
    ("the treated monolayers" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN)
    ("HSV-1-associated CPE" . SPARSER::PROTEIN)
    ("elongation" . SPARSER::PROTEIN) ("hpi" . SPARSER::PROTEIN)
    ("CPE" . SPARSER::PROTEIN) ("Thr" . SPARSER::AMINO-ACID)
    ("a multifunctional serine/threonine kinase" . SPARSER::KINASE)
    ("serine/threonine" . SPARSER::COLLECTION) ("aims" . SPARSER::PROTEIN)
    ("an apical kinase" . SPARSER::KINASE) ("ATM" . SPARSER::PROTEIN)
    ("the viral thymidine kinase (TK)" . SPARSER::PROTEIN)
    ("TK" . SPARSER::PROTEIN) ("prodrugs" . SPARSER::DRUG)
    ("multidrug" . SPARSER::PROTEIN) ("antiviral drugs" . SPARSER::DRUG)
    ("oral acyclovir and/or topical nucleoside analogs" . SPARSER::COLLECTION)
    ("topical nucleoside analogs" . SPARSER::ANALOG)
    ("ganciclovir" . SPARSER::DRUG) ("analogs" . SPARSER::ANALOG)
    ("nucleoside" . SPARSER::MOLECULE) ("acyclovir" . SPARSER::DRUG)
    ("retina" . SPARSER::DRUG) ("ophthalmic" . SPARSER::DRUG)
    ("potential new therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("light" . SPARSER::PROTEIN) ("effective antiviral drugs" . SPARSER::DRUG)
    ("Aims" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("histone 1" . SPARSER::PROTEIN)
    ("FoxM1" . SPARSER::PROTEIN) ("E2F1" . SPARSER::PROTEIN)
    ("Mdm4" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("XRCC1" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("UL30" . SPARSER::PROTEIN) ("L -glutamate" . SPARSER::MOLECULE)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("T antigen" . SPARSER::MOLECULE)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("DNA polymerase" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN)
    ("kinase activity" . SPARSER::PROTEIN) ("Chk2" . SPARSER::PROTEIN)
    ("checkpoint kinase 2" . SPARSER::PROTEIN) ("MMP-9-" . SPARSER::PROTEIN)
    ("spontaneous PTB" . SPARSER::PROTEIN)
    ("placental chorionic villus genes" . SPARSER::GENE)
    ("fetal and maternal parts" . SPARSER::COMPONENT)
    ("parts" . SPARSER::COMPONENT) ("MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("allele and PPROM" . SPARSER::COLLECTION)
    ("MMP-1 -1607 1G allele and MMP-9 -1562 T allele" . SPARSER::COLLECTION)
    ("repressor" . SPARSER::REPRESSOR)
    ("MMP-1 and MMP - 9" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-9" . SPARSER::COLLECTION)
    ("MMPs, MMP-1, and MMP-9" . SPARSER::COLLECTION)
    ("23 zinc-dependent endopeptidases" . SPARSER::PROTEIN)
    ("metalloproteinases (MMP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endopeptidases" . SPARSER::PROTEIN) ("ECM" . SPARSER::PROTEIN)
    ("perinatal" . SPARSER::PROTEIN) ("PTB" . SPARSER::PROTEIN)
    ("fragment" . SPARSER::FRAGMENT) ("SPTB" . SPARSER::PROTEIN)
    ("MMP - 9" . SPARSER::PROTEIN) ("of pregnancy" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("actin/tubulin" . SPARSER::COLLECTION)
    ("tubulin" . SPARSER::PROTEIN) ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("cytoskeletal proteins, α-tubulin and F-actin" . SPARSER::COLLECTION)
    ("proteins, α-tubulin and F-actin" . SPARSER::COLLECTION)
    ("tubulins" . SPARSER::PROTEIN)
    ("both cytoskeletal proteins" . SPARSER::PROTEIN)
    ("cycloheximide and hTNFα" . SPARSER::COLLECTION)
    ("annexin V, TUNEL, and PI" . SPARSER::COLLECTION)
    ("PI" . SPARSER::PROTEIN) ("GST-rhotekin" . SPARSER::COLLECTION)
    ("rhotekin" . SPARSER::PROTEIN) ("GST" . SPARSER::PROTEIN)
    ("cue" . SPARSER::PROTEIN-FAMILY)
    ("these cytoskeletal components" . SPARSER::COMPONENT)
    ("blebbistatin" . SPARSER::DRUG) ("Blebbistatin" . SPARSER::DRUG)
    ("myosin light chain kinase (MLCK)" . SPARSER::PROTEIN)
    ("myo" . SPARSER::PROTEIN) ("caspase-3 or RhoA" . SPARSER::COLLECTION)
    ("MLCK" . SPARSER::PROTEIN) ("F-actin and α-tubulin" . SPARSER::COLLECTION)
    ("the cytoskeletal proteins" . SPARSER::PROTEIN)
    ("TetR" . SPARSER::PROTEIN-FAMILY) ("neo" . SPARSER::PROTEIN)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("α-tubulin and F-actin" . SPARSER::COLLECTION)
    ("redox" . SPARSER::PROTEIN)
    ("all other eukaryotic selenoprotein mRNAs" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN) ("selenium" . SPARSER::MOLECULE)
    ("Rho-associated protein kinase (ROCK)" . SPARSER::KINASE)
    ("kinase (ROCK)" . SPARSER::KINASE) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("selenoprotein" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("DNase I" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("Y-27632" . SPARSER::MOLECULE)
    ("RNase A" . SPARSER::PROTEIN) ("tumor necrosis factor" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN) ("MYPT1" . SPARSER::PROTEIN)
    ("T-REx" . SPARSER::PROTEIN-FAMILY) ("protein-1" . SPARSER::PROTEIN)
    ("p31" . SPARSER::PROTEIN) ("SEP15" . SPARSER::PROTEIN)
    ("thiol-disulfide oxidoreductase" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX)
    ("myosin phosphatase target subunit 1" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("Sep15" . SPARSER::PROTEIN)
    ("Cofilin and Lim kinase" . SPARSER::COLLECTION)
    ("a potential biomarker" . SPARSER::MOLECULE) ("drugs" . SPARSER::DRUG)
    ("drug" . SPARSER::DRUG) ("proteins or genes" . SPARSER::COLLECTION)
    ("barrier" . SPARSER::PROTEIN) ("CFL1-siRNA" . SPARSER::COLLECTION)
    ("CFL1-siRNA2" . SPARSER::PROTEIN-PAIR)
    ("siRNA-CFL1" . SPARSER::COLLECTION) ("siRNA" . SPARSER::PROTEIN)
    ("CFL1 and radioresistance" . SPARSER::COLLECTION)
    ("cofilin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("filaments" . SPARSER::PROTEIN-FAMILY)
    ("actin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitous cytoskeletal protein" . SPARSER::PROTEIN)
    ("Cofilin" . SPARSER::PROTEIN) ("RR" . SPARSER::MOLECULE)
    ("RNA and pcDNA" . SPARSER::COLLECTION)
    ("cofilin-1 (CFL1) and radioresistance" . SPARSER::COLLECTION)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE)
    ("actin-depolymerizing factor" . SPARSER::PROTEIN)
    ("CFL1" . SPARSER::PROTEIN) ("cofilin-1" . SPARSER::PROTEIN)
    ("antibody and nanoparticle" . SPARSER::COLLECTION)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("the mitochondrial ETC" . SPARSER::PROTEIN) ("metformin" . SPARSER::DRUG)
    ("mitochondrial NAD+" . SPARSER::MOLECULE)
    ("mitochondrial glutaminase (GLS)" . SPARSER::PROTEIN)
    ("ASCT2 and SN2" . SPARSER::COLLECTION) ("GLS" . SPARSER::PROTEIN)
    ("regenerate NAD+" . SPARSER::MOLECULE)
    ("mitochondrial-encoded genes" . SPARSER::GENE)
    ("polypeptides" . SPARSER::PEPTIDE)
    ("NRF1, PGC-1β and TFAM" . SPARSER::COLLECTION) ("TFAM" . SPARSER::PROTEIN)
    ("Myc-shRNA" . SPARSER::COLLECTION) ("Myc-ShRNA" . SPARSER::COLLECTION)
    ("ShRNA" . SPARSER::PROTEIN) ("Akt and Erk" . SPARSER::COLLECTION)
    ("ras/MAPK" . SPARSER::COLLECTION) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("media" . SPARSER::PROTEIN)
    ("deoxyglucose" . SPARSER::MOLECULE) ("OHT" . SPARSER::MOLECULE)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p32/C1QBP" . SPARSER::COLLECTION)
    ("tamoxifen (OHT)" . SPARSER::DRUG)
    ("Cyclin D2 and glutaminase" . SPARSER::COLLECTION)
    ("tamoxifen" . SPARSER::MOLECULE) ("normal astrocytes" . SPARSER::PROTEIN)
    ("astrocytes" . SPARSER::PROTEIN) ("p32 and Myc" . SPARSER::COLLECTION)
    ("MYC" . SPARSER::PROTEIN)
    ("a potential transcriptional target" . SPARSER::TARGET-PROTEIN)
    ("Myc and p32" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("mitochondrial-encoded electron transport complex subunits"
     . SPARSER::FRAGMENT)
    ("transporters and glutaminase" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("glutaminase" . SPARSER::PROTEIN)
    ("the oxidizable substrate" . SPARSER::SUBSTRATE)
    ("‘Myc’" . SPARSER::PROTEIN)
    ("protein and nucleotide" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE)
    ("an essential nutrient" . SPARSER::MOLECULE)
    ("nutrient" . SPARSER::MOLECULE) ("lipids" . SPARSER::PROTEIN)
    ("macromolecule" . SPARSER::MOLECULE) ("ETC" . SPARSER::PROTEIN)
    ("electron" . SPARSER::MOLECULE) ("oxygen" . SPARSER::MOLECULE)
    ("lactate" . SPARSER::LACTATE) ("suppressors" . SPARSER::SUPPRESSOR)
    ("Myc" . SPARSER::PROTEIN) ("glucose and glutamine" . SPARSER::COLLECTION)
    ("RNAse A" . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("triton X-100" . SPARSER::MOLECULE) ("or 2" . SPARSER::MOLECULE)
    ("min-1" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("p44" . SPARSER::PROTEIN) ("N-term" . SPARSER::PROTEIN)
    ("ETC." . SPARSER::PROTEIN) ("SN2" . SPARSER::PROTEIN)
    ("ASCT2" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("PGC-1β" . SPARSER::PROTEIN) ("NRF1" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("PI3K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Myc protein" . SPARSER::PROTEIN)
    ("ex1" . SPARSER::PROTEIN) ("Cyclin D2" . SPARSER::PROTEIN)
    ("P32" . SPARSER::PROTEIN) ("C1QBP" . SPARSER::PROTEIN)
    ("q subcomponent binding protein" . SPARSER::PROTEIN)
    ("complement component 1" . SPARSER::PROTEIN)
    ("α-ketoglutarate" . SPARSER::MOLECULE) ("p32" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("basal-like triple-negative class" . CLASS)
    ("BRCA1, RAD51 and ID4" . SPARSER::COLLECTION)
    ("PARP1 and HER2" . SPARSER::COLLECTION)
    ("PARP1 and PIASγ" . SPARSER::COLLECTION)
    ("sporadic breast cancer namely triple-negative class" . CLASS)
    ("PARP1 and BRCA1" . SPARSER::COLLECTION) ("Wang" . SPARSER::PROTEIN)
    ("PARPs" . SPARSER::MOLECULE) ("NER" . SPARSER::PROTEIN)
    ("BRCA1-protein" . SPARSER::COLLECTION) ("KU70/KU80" . SPARSER::COLLECTION)
    ("PIASγ and DNA-PKcs" . SPARSER::COLLECTION)
    ("RAD51, PIASγ and DNA-PKcs" . SPARSER::COLLECTION)
    ("CHK1 and p53" . SPARSER::COLLECTION) ("cohorts" . SPARSER::MOLECULE)
    ("BRCA1, BRCA2, ID4, BARD1 and APE1" . SPARSER::COLLECTION)
    ("RAD51, Ku70/80, CHK1, CHK2, DNA-PKcs, and PIASγ" . SPARSER::COLLECTION)
    ("PIASγ ( p  = 0.002) and p53 ( p  = 0.022, Table  xref )"
     . SPARSER::COLLECTION)
    ("PIASγ, DNA-PKcs and p53" . SPARSER::COLLECTION)
    ("BRCA1, RAD51, CHK1 and CHK2" . SPARSER::COLLECTION)
    ("ER−" . SPARSER::PROTEIN) ("ER " . SPARSER::PROTEIN)
    ("/BRCA1" . SPARSER::COLLECTION) ("Ku70/Ku80" . SPARSER::COLLECTION)
    ("CHK1 and CHK2" . SPARSER::COLLECTION)
    ("PIASγ and DNA" . SPARSER::COLLECTION)
    ("Ki67 and p53" . SPARSER::COLLECTION) ("histological tumour type" . TYPE)
    ("key biomarkers" . SPARSER::MOLECULE) ("biomarkers" . SPARSER::MOLECULE)
    ("caspase" . SPARSER::PROTEIN) ("caspases" . SPARSER::PROTEIN)
    ("fragments" . SPARSER::FRAGMENT) ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("BRCA" . SPARSER::PROTEIN-FAMILY) ("HR" . SPARSER::PROTEIN)
    ("SSBs" . SPARSER::PROTEIN) ("ER/BRCA1" . SPARSER::COLLECTION)
    ("RAD51, BRCA1, CHK1 and PIASγ" . SPARSER::COLLECTION)
    ("DDR-proteins" . SPARSER::COLLECTION)
    ("BRCA1, RAD51, Ku70/80, PIASγ and CHK1" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA) ("DDR" . SPARSER::PROTEIN)
    ("BRCA 2" . SPARSER::PROTEIN) ("KU80" . SPARSER::PROTEIN)
    ("KU70" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("ki67" . SPARSER::PROTEIN) ("APE1" . SPARSER::PROTEIN)
    ("Ku80" . SPARSER::PROTEIN) ("BARD1" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CHK2" . SPARSER::PROTEIN)
    ("ID4" . SPARSER::PROTEIN) ("BRCA2" . SPARSER::PROTEIN)
    ("Poly[ADP-ribose] polymerase" . SPARSER::PROTEIN)
    ("Ki67" . SPARSER::PROTEIN) ("CHK1" . SPARSER::PROTEIN)
    ("PIASγ" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA 1" . SPARSER::PROTEIN) ("PAR1" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE)
    ("a potential regulator" . SPARSER::REGULATOR)
    ("another HGF and hypoxia-inducible transcription factor"
     . SPARSER::COLLECTION)
    ("Ets-1, another HGF and hypoxia-inducible transcription factor"
     . SPARSER::COLLECTION)
    ("hypoxia" . SPARSER::PROTEIN) ("HGF" . SPARSER::PROTEIN)
    ("TNF-α, IL-6, IL-1, and IL-8" . SPARSER::COLLECTION)
    ("activators" . SPARSER::ACTIVATOR) ("Macrophage" . SPARSER::PROTEIN)
    ("SDF-1α" . SPARSER::PROTEIN) ("macrophage" . SPARSER::PROTEIN)
    ("Inflammatory cytokines" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule 1, and endothelial-leukocyte adhesion molecule 1"
     . SPARSER::COLLECTION)
    ("cell adhesion molecule 1, and endothelial-leukocyte adhesion molecule 1"
     . SPARSER::COLLECTION)
    ("metallopeptidase" . SPARSER::PROTEIN) ("Hypoxia" . SPARSER::PROTEIN)
    ("CXCR4 and SDF-1α" . SPARSER::COLLECTION)
    ("SDF-1α-CXCR4" . SPARSER::PROTEIN-PAIR) ("pyrrolidine" . SPARSER::DRUG)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("kinase (IKK)" . SPARSER::KINASE)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("TNF-α and IL-1" . SPARSER::COLLECTION) ("IKK" . SPARSER::PROTEIN)
    ("pro" . SPARSER::AMINO-ACID) ("dimers" . SPARSER::DIMER)
    ("cytokines" . SPARSER::PROTEIN) ("chemokine" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::LIGAND) ("chemokines" . SPARSER::PROTEIN)
    ("Chemokines and their receptors" . SPARSER::COLLECTION)
    ("essential mediators" . SPARSER::PROTEIN) ("mediators" . SPARSER::PROTEIN)
    ("Chemokines" . SPARSER::PROTEIN) ("PDTC" . SPARSER::DRUG)
    ("NF-κB and CXCR4" . SPARSER::COLLECTION) ("Ets-1" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("leukocyte adhesion molecule 1" . SPARSER::PROTEIN)
    ("cell adhesion molecule 1" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("anti-β" . SPARSER::PROTEIN) ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("Nonidet P-40" . SPARSER::DRUG) ("serum albumin" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("P65" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("several relatively new ALK" . SPARSER::PROTEIN)
    ("the traditional antibodies" . SPARSER::ANTIBODY)
    ("Sq" . SPARSER::MOLECULE) ("EML4–ALK" . SPARSER::COLLECTION)
    ("the VENTANA anti-ALK" . SPARSER::ANTIBODY)
    ("transformation-related protein 63 (p63) and/or cytokeratin (CK5/6)"
     . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("NCCN" . SPARSER::MOLECULE)
    ("FDA" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("TPM4-ALK" . SPARSER::COLLECTION)
    ("TFG-ALK" . SPARSER::COLLECTION) ("ATIC-ALK" . SPARSER::COLLECTION)
    ("TPM3-ALK" . SPARSER::COLLECTION) ("TFG" . SPARSER::PROTEIN)
    ("ATIC" . SPARSER::PROTEIN) ("NPM-ALK" . SPARSER::COLLECTION)
    ("NPM" . SPARSER::PROTEIN) ("fused" . SPARSER::PROTEIN)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("TKIs" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK)"
     . SPARSER::COLLECTION)
    ("pharmacologically targetable tyrosine kinases" . SPARSER::PROTEIN)
    ("tyrosine" . SPARSER::AMINO-ACID) ("biologic" . SPARSER::DRUG)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("andanaplastic lymphoma kinase gene (ALK)" . SPARSER::GENE)
    ("gene (ALK)" . SPARSER::GENE) ("MET" . SPARSER::PROTEIN)
    ("KRAS" . SPARSER::PROTEIN) ("EGFR" . SPARSER::PROTEIN)
    ("platinum" . SPARSER::MOLECULE)
    ("distinct histologic subtypes" . SPARSER::PROTEIN)
    ("States" . SPARSER::BIO-STATE) ("crizotinib" . SPARSER::DRUG)
    ("EML4-ALK" . SPARSER::COLLECTION) ("FISH" . SPARSER::PROTEIN)
    ("a specific rabbit monoclonal Ig antibody" . SPARSER::ANTIBODY)
    ("Ig" . SPARSER::MOLECULE) ("ACA" . SPARSER::PROTEIN)
    ("ALK" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN)
    ("transformation-related protein 63" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("ALK 2" . SPARSER::PROTEIN)
    ("TPM4" . SPARSER::PROTEIN) ("TPM3" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("tyrosine kinase" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("lymphoma kinase" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("B-Raf" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN)
    ("echinoderm microtubule-associated protein-like 4" . SPARSER::PROTEIN)
    ("mTOR" . SPARSER::PROTEIN)
    ("the remaining WT PTEN protein and possibly other proteins"
     . SPARSER::COLLECTION)
    ("possibly other proteins" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase-AKT" . SPARSER::COLLECTION)
    ("A39P" . SPARSER::PROTEIN) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("western blot" . SPARSER::PROTEIN) ("RFP-Cre" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("recombinase" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("the autism-associated mutants" . SPARSER::MUTANT)
    ("autism-associated PTEN mutants" . SPARSER::MUTANT)
    ("weaker" . SPARSER::PROTEIN) ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("PTEN C124S and PTEN G129R" . SPARSER::COLLECTION)
    ("ASD" . SPARSER::PROTEIN) ("Pten" . SPARSER::PROTEIN)
    ("thyroid and endometrium" . SPARSER::COLLECTION)
    ("Phosphatase and tensin" . SPARSER::COLLECTION)
    ("phosphoinositide 3-kinase/AKT" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("tensin" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("soma" . SPARSER::DRUG)
    ("All seven autism-associated PTEN mutants" . SPARSER::MUTANT)
    ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mutants" . SPARSER::MUTANT)
    ("PTEN" . SPARSER::PROTEIN) ("NP-40" . SPARSER::DRUG)
    ("L-ornithine" . SPARSER::DRUG) ("B-27" . SPARSER::PROTEIN)
    ("synapsin-1" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("E–G" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("S3A" . SPARSER::PROTEIN) ("protein phosphatase" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("U87MG" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("Pit-1 and MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("Pit-1 and MMPs" . SPARSER::COLLECTION) ("sentinel" . SPARSER::DRUG)
    ("fibrillin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tenascin" . SPARSER::PROTEIN) ("fibronectin" . SPARSER::PROTEIN)
    ("IV" . SPARSER::PROTEIN) ("aggrecan" . SPARSER::PROTEIN)
    ("VIII" . SPARSER::PROTEIN) ("VII" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN) ("collagen" . SPARSER::PROTEIN)
    ("collagenases, MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("Pit-1 and MMP13" . SPARSER::COLLECTION)
    ("Pit-1 and MMP-1" . SPARSER::COLLECTION) ("MMP-1-" . SPARSER::PROTEIN)
    ("Pit-1 and both MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("MMP-1 (r sub B = 0.242, P  = 0.011) and MMP-13 (r sub B = 0.199, P  = 0.041)"
     . SPARSER::COLLECTION)
    ("MICs" . SPARSER::PROTEIN-FAMILY)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("Pit-1, MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("examples" . SPARSER::EXAMPLE)
    ("MMP-1, MMP-13 and Pit-1" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN)
    ("CK-7, and CK-19" . SPARSER::COLLECTION) ("MTT" . SPARSER::MOLECULE)
    ("MMP-1 or MMP-13" . SPARSER::COLLECTION) ("matrigel" . SPARSER::PROTEIN)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("the proximal Pit-1 response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the MMP-1 and the MMP-13 gene" . SPARSER::COLLECTION)
    ("A-B" . SPARSER::PROTEIN) ("PA" . SPARSER::PROTEIN)
    ("TESS" . SPARSER::PROTEIN)
    ("Pit-1, MMP-1, and MMP-13" . SPARSER::COLLECTION)
    ("growth hormone (GH) and prolactin (PRL) [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("prolactin (PRL)" . SPARSER::PROTEIN) ("MMP" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN) ("prolactin" . SPARSER::PROTEIN)
    ("GH" . SPARSER::PROTEIN) ("activator" . SPARSER::ACTIVATOR)
    ("macrophages" . SPARSER::PROTEIN) ("variety" . SPARSER::VARIETY)
    ("the interstitial collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagenase" . SPARSER::PROTEIN)
    ("Interstitial collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIMPs" . SPARSER::PROTEIN) ("metalloproteases" . SPARSER::PROTEIN)
    ("MMPs or serine" . SPARSER::COLLECTION) ("proteases" . SPARSER::PROTEIN)
    ("MMPs" . SPARSER::PROTEIN)
    ("cysteine, serine, and threonine" . SPARSER::COLLECTION)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("classes" . CLASS)
    ("their intercellular adhesion complexes" . SPARSER::BIO-COMPLEX)
    ("fat" . SPARSER::PROTEIN) ("Western blot" . SPARSER::PROTEIN)
    ("MMP-1 and MMP-13" . SPARSER::COLLECTION)
    ("luciferase" . SPARSER::PROTEIN) ("pRSV-hPit-1" . SPARSER::COLLECTION)
    ("Pit-1 and two collagenases" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-13 (MMP-13)"
     . SPARSER::COLLECTION)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-14" . SPARSER::PROTEIN) ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MMP13" . SPARSER::PROTEIN)
    ("S6E" . SPARSER::PROTEIN-FAMILY) ("C-D" . SPARSER::PROTEIN)
    ("CK-19" . SPARSER::PROTEIN) ("CK-7" . SPARSER::PROTEIN)
    ("Pit-1 " . SPARSER::PROTEIN) ("S1 B" . SPARSER::PROTEIN)
    ("pGL3B" . SPARSER::MOLECULE)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("CK19" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("cytokeratin 7" . SPARSER::PROTEIN) ("mitomycin C" . SPARSER::DRUG)
    ("beta-actin" . SPARSER::PROTEIN) ("pGL2" . SPARSER::PROTEIN)
    ("G418" . SPARSER::MOLECULE) ("CO 2" . SPARSER::PROTEIN)
    ("growth hormone" . SPARSER::PROTEIN) ("collagenase-3" . SPARSER::PROTEIN)
    ("collagenase 3" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-13" . SPARSER::PROTEIN)
    ("MMP-1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("Pit-1" . SPARSER::PROTEIN) ("POU1F1" . SPARSER::PROTEIN)
    ("POU class 1 homeobox 1" . SPARSER::PROTEIN)
    ("an essential component" . SPARSER::COMPONENT) ("hot" . SPARSER::PROTEIN)
    ("mapping" . SPARSER::PROTEIN) ("maps" . SPARSER::PROTEIN)
    ("V617F -postive MPNs" . SPARSER::PROTEIN)
    ("MPNs and rs12343867" . SPARSER::COLLECTION)
    ("missing any potential causal variant" . SPARSER::VARIANT)
    ("S12 and S13" . SPARSER::COLLECTION)
    ("the most probable MPN-predisposing variants or haplotypes (Additional file xref : Table S2)"
     . SPARSER::COLLECTION)
    ("the most probable MPN-predisposing variants" . SPARSER::VARIANT)
    ("S12, and S13" . SPARSER::COLLECTION) ("emp" . SPARSER::PROTEIN)
    ("emp  " . SPARSER::PROTEIN) ("V617F -negative MPNs" . SPARSER::PROTEIN)
    ("such casual variants" . SPARSER::VARIANT)
    ("families" . SPARSER::PROTEIN-FAMILY) ("Phe" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("PMF" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN) ("MPNs and JAK2" . SPARSER::COLLECTION)
    ("Allele and haplotype" . SPARSER::COLLECTION) ("Allele" . SPARSER::ALLELE)
    ("MPNs" . SPARSER::PROTEIN) ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("S1B" . SPARSER::PROTEIN) ("i.e. S" . SPARSER::MOLECULE)
    ("S12" . SPARSER::PROTEIN) ("S13" . SPARSER::PROTEIN)
    ("S18" . SPARSER::PROTEIN) ("S17" . SPARSER::PROTEIN)
    ("S15" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("S10" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("S16" . SPARSER::PROTEIN) ("S11" . SPARSER::PROTEIN)
    ("S5" . SPARSER::MOLECULE) ("dominant and recessive" . SPARSER::PROTEIN)
    ("S19" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("JAK-STAT" . SPARSER::PROTEIN) ("BCR-ABL" . SPARSER::PROTEIN)
    ("JAK2" . SPARSER::PROTEIN) ("gonadotropin" . SPARSER::PROTEIN)
    ("the mutated homozygous AA" . SPARSER::MOLECULE)
    ("the mutated G allele" . SPARSER::ALLELE)
    ("more exogenous gonadotrophins" . SPARSER::PROTEIN)
    ("wild and mutated alleles" . SPARSER::ALLELE)
    ("mutated alleles" . SPARSER::ALLELE) ("Asn/Asn" . SPARSER::COLLECTION)
    ("Asn" . SPARSER::AMINO-ACID) ("FSHR" . SPARSER::PROTEIN)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("progesterone" . SPARSER::PROTEIN)
    ("hCG and estradiol" . SPARSER::COLLECTION) ("hCG" . SPARSER::PROTEIN)
    ("gonadotrophins" . SPARSER::PROTEIN) ("male" . SPARSER::MOLECULE)
    ("AG " . SPARSER::PROTEIN)
    ("the homogeneous protocol group" . SPARSER::MOLECULE)
    ("the homogenous dose group" . SPARSER::MOLECULE)
    ("TC and CC" . SPARSER::COLLECTION) ("TC " . SPARSER::PROTEIN)
    ("TC" . SPARSER::PROTEIN)
    ("the homogenous protocol group" . SPARSER::MOLECULE)
    ("FSH and estradiol" . SPARSER::COLLECTION) ("pg" . SPARSER::MOLECULE)
    ("ESR1 ( PvuII and XbaI ) and ESR2 ( AluI and RsaI ) polymorphisms"
     . SPARSER::COLLECTION)
    ("a normal ovarian reserve group" . SPARSER::MOLECULE)
    ("ESR1 (6q25.1) and ESR2 (14q23.2) genes" . SPARSER::COLLECTION)
    ("ERα and ERβ" . SPARSER::COLLECTION) ("subtypes" . SPARSER::PROTEIN)
    ("ERs" . SPARSER::PROTEIN) ("estrogen" . SPARSER::MOLECULE)
    ("Estrogens" . SPARSER::MOLECULE) ("gonadotropins" . SPARSER::PROTEIN)
    ("AMH" . SPARSER::PROTEIN) ("hormone" . SPARSER::MOLECULE)
    ("Inhibin" . SPARSER::PROTEIN) ("Estradiol" . SPARSER::MOLECULE)
    ("ER" . SPARSER::PROTEIN) ("TG" . SPARSER::PROTEIN)
    ("AA" . SPARSER::MOLECULE) ("estradiol and FSH" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::PROTEIN)
    ("ESR1, and RsaI and AluI" . SPARSER::COLLECTION)
    ("exogenous FSH" . SPARSER::DRUG) ("estrogens" . SPARSER::MOLECULE)
    ("ESRs" . SPARSER::PROTEIN) ("FSH" . SPARSER::DRUG)
    ("ERS1" . SPARSER::PROTEIN) ("ERS2" . SPARSER::PROTEIN)
    ("CA 125" . SPARSER::DRUG) ("ERβ" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN)
    ("Follicle Stimulating Hormone" . SPARSER::PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN)
    ("PARP-1 and OGG1 and" . SPARSER::COLLECTION)
    ("Polymorphic OGG1 form" . SPARSER::FORM)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("only Cys variant" . SPARSER::VARIANT) ("Ser/Cys" . SPARSER::COLLECTION)
    ("Cys/Cys" . SPARSER::COLLECTION) ("antioxidant" . SPARSER::PROTEIN)
    ("dC" . SPARSER::MOLECULE) ("dA" . SPARSER::MOLECULE)
    ("Cyt" . SPARSER::MOLECULE) ("Ade" . SPARSER::PROTEIN)
    ("part" . SPARSER::COMPONENT) ("Protein and mRNA" . SPARSER::COLLECTION)
    ("SSB" . SPARSER::PROTEIN) ("OGG1and PARP-1" . SPARSER::COLLECTION)
    ("harmful ROS" . SPARSER::PROTEIN) ("ROS" . SPARSER::PROTEIN)
    ("cytochrome" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("PARP-1 or OGG1" . SPARSER::COLLECTION)
    ("peripheral leukocytes" . SPARSER::PROTEIN)
    ("intact PARP-1" . SPARSER::PROTEIN)
    ("purified bovine PARP-1" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("kDa" . SPARSER::PROTEIN) ("a standard Western blot" . SPARSER::PROTEIN)
    ("only PARP-1 mRNA" . SPARSER::PROTEIN) ("APC" . SPARSER::PROTEIN)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("targets" . SPARSER::TARGET-PROTEIN) ("mRNAs" . SPARSER::PROTEIN)
    ("mRNA/proteins" . SPARSER::COLLECTION)
    ("OGG1 and ERCC1" . SPARSER::COLLECTION) ("methylase" . SPARSER::PROTEIN)
    ("the human c-MYC gene's" . SPARSER::GENE)
    ("guanine-quadruplex" . SPARSER::PROTEIN-PAIR)
    ("nucleotides" . SPARSER::NUCLEOTIDE) ("lyase" . SPARSER::PROTEIN)
    ("a typical biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("polymorphic OGG1" . SPARSER::PROTEIN)
    ("PARP" . SPARSER::PROTEIN) ("Se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ser" . SPARSER::AMINO-ACID) ("Cys" . SPARSER::AMINO-ACID)
    ("PARP-1 and OGG1" . SPARSER::COLLECTION)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("OGG1 and PARP-1" . SPARSER::COLLECTION)
    ("CRC" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("KLF8" . SPARSER::PROTEIN) ("PARP1" . SPARSER::PROTEIN)
    ("MMP2" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("caspases 3" . SPARSER::PROTEIN) ("PMM1" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("Lamin A/C" . SPARSER::PROTEIN)
    ("F 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hOGG1" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("ERCC1" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("c-MYC" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("OGG1" . SPARSER::PROTEIN) ("colon cancer" . SPARSER::PROTEIN)
    ("epithelioid" . SPARSER::PROTEIN) ("RGP" . SPARSER::PROTEIN)
    ("type" . TYPE) ("subclones" . SPARSER::PROTEIN)
    ("vemurafenib" . SPARSER::DRUG) ("RASSF1A and p16" . SPARSER::COLLECTION)
    ("Protein" . SPARSER::PROTEIN) ("NRAS" . SPARSER::PROTEIN)
    ("valine" . SPARSER::AMINO-ACID) ("MAPK" . SPARSER::PROTEIN)
    ("threonine" . SPARSER::AMINO-ACID) ("serine" . SPARSER::AMINO-ACID)
    ("oncogene" . SPARSER::ONCOGENE) ("exon" . SPARSER::PROTEIN)
    ("radical" . SPARSER::MOLECULE) ("medicine" . SPARSER::DRUG)
    ("BRAF or MEK" . SPARSER::COLLECTION) ("-mutant" . SPARSER::MUTANT)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("inhibitors" . SPARSER::INHIBITOR)
    ("p16 INK4a" . SPARSER::PROTEIN) ("p16" . SPARSER::PROTEIN)
    ("RASSF1A" . SPARSER::PROTEIN) ("a 20" . SPARSER::PROTEIN)
    ("of 45" . SPARSER::PROTEIN) ("Monoclonal Antibody" . SPARSER::DRUG)
    ("Anti-" . SPARSER::ANTIBODY) ("Tween 20" . SPARSER::MOLECULE)
    ("monoclonal antibody" . SPARSER::DRUG)
    ("glutamic acid" . SPARSER::AMINO-ACID)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("NFKB1 and GC" . SPARSER::COLLECTION)
    ("chromatin" . SPARSER::PROTEIN) ("Maps" . SPARSER::PROTEIN)
    ("the homozygous G/G alleles" . SPARSER::ALLELE)
    ("histones" . SPARSER::PROTEIN) ("cohort" . SPARSER::MOLECULE)
    ("variants" . SPARSER::VARIANT) ("–1" . SPARSER::PROTEIN)
    ("ins" . SPARSER::PROTEIN) ("allele" . SPARSER::ALLELE)
    ("p65/p50" . SPARSER::COLLECTION) ("dimer" . SPARSER::DIMER)
    ("c-Rel, and RELB" . SPARSER::COLLECTION) ("RELB" . SPARSER::PROTEIN)
    ("REL" . SPARSER::PROTEIN) ("RELA" . SPARSER::PROTEIN)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("types" . TYPE)
    ("Han" . SPARSER::PROTEIN) ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("GC" . SPARSER::PROTEIN) ("H3K4" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("Rel-B" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("NFKB2" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("A-G" . SPARSER::PROTEIN) ("G-A-A" . SPARSER::PROTEIN)
    ("A-C" . SPARSER::PROTEIN) ("A-T" . SPARSER::PROTEIN)
    ("NFKB1" . SPARSER::PROTEIN) ("factor-κB" . SPARSER::PROTEIN)
    ("PMA and ionomycin" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("PMA" . SPARSER::PROTEIN)
    ("available full-length caspase-8" . SPARSER::PROTEIN)
    ("available caspase-8 molecules" . SPARSER::MOLECULE)
    ("heterodimers" . SPARSER::HETERODIMER) ("homodimers" . SPARSER::HOMODIMER)
    ("Erk and Jnk" . SPARSER::COLLECTION) ("-kynurenine" . SPARSER::MOLECULE)
    ("indoleamone-2" . SPARSER::COLLECTION) ("kynurenine" . SPARSER::MOLECULE)
    ("IDO" . SPARSER::PROTEIN) ("Jnk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a pathogenic state" . SPARSER::BIO-STATE) ("Ripk3" . SPARSER::PROTEIN)
    ("pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("caspase-3 and annexin V" . SPARSER::COLLECTION)
    ("molecule" . SPARSER::MOLECULE)
    ("poorly proliferative CPs" . SPARSER::PROTEIN)
    ("heterodimer" . SPARSER::HETERODIMER) ("alleles" . SPARSER::ALLELE)
    ("puromycin" . SPARSER::DRUG)
    ("RIPK3 and a control shRNA (pLKO Scramble)" . SPARSER::COLLECTION)
    ("shRNAs" . SPARSER::RNA) ("RNAs" . SPARSER::RNA)
    ("example" . SPARSER::EXAMPLE) ("DMSO" . SPARSER::MOLECULE)
    ("RIPK1-RIPK3" . SPARSER::COLLECTION) ("inhibitor" . SPARSER::INHIBITOR)
    ("EC or VC" . SPARSER::COLLECTION) ("cytometry" . SPARSER::PROTEIN)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION) ("FM" . SPARSER::PROTEIN)
    ("antibodies" . SPARSER::ANTIBODY) ("antibody" . SPARSER::ANTIBODY)
    ("CD45RA (P < 0.01) and CCR7 (P < 0.05)" . SPARSER::COLLECTION)
    ("CD45RA and CCR7" . SPARSER::COLLECTION) ("Casp8" . SPARSER::PROTEIN)
    ("CFSE" . SPARSER::DRUG) ("Tetramer" . SPARSER::TETRAMER)
    ("VCs" . SPARSER::MOLECULE) ("VC" . SPARSER::MOLECULE)
    ("fluorescently-labeled caspase-8" . SPARSER::PROTEIN)
    ("FAM-LETD-FMK" . SPARSER::COLLECTION) ("FMK" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN) ("SL" . SPARSER::PROTEIN)
    ("GAPDH" . SPARSER::PROTEIN) ("Casp" . SPARSER::PROTEIN)
    ("SPC25 , MLF1IP , BUB1B , RAD51 , RAD51AP1 , C1orf59 , BRCA1 , RPA3 , PRIM1 , THOC4 , MND1 , CKS2 , CKS1B , CCNB2 , LMNB1 and UBASH3A"
     . SPARSER::COLLECTION)
    ("APP , CASP8 , SRC , FYB , LYN , IL-7R , AKAP13 , THRA , CD44 , CD74 and HLA-DQA1"
     . SPARSER::COLLECTION)
    ("THRA" . SPARSER::PROTEIN) ("APP" . SPARSER::PROTEIN)
    ("Genes" . SPARSER::GENE) ("our EC and CP gene" . SPARSER::COLLECTION)
    ("Arm and Cl13" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("pathogenic states" . SPARSER::BIO-STATE)
    ("SRC , LYN and FYB" . SPARSER::COLLECTION) ("leukemia" . SPARSER::PROTEIN)
    ("FYB" . SPARSER::PROTEIN) ("LYN" . SPARSER::PROTEIN)
    ("SRC" . SPARSER::PROTEIN)
    ("regulators of T cell homeostasis ( CASP8, IL7R ) and transcription factors ( IKZF2 )"
     . SPARSER::COLLECTION)
    ("regulators" . SPARSER::REGULATOR) ("Arm" . SPARSER::PROTEIN)
    ("interferon" . SPARSER::PROTEIN) ("chemical" . SPARSER::MOLECULE)
    ("membrane-associated caspase-8" . SPARSER::PROTEIN)
    ("receptor" . SPARSER::RECEPTOR) ("Fas/CD95" . SPARSER::COLLECTION)
    ("Fas" . SPARSER::PROTEIN) ("protein-protein" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cysteine" . SPARSER::AMINO-ACID) ("aspartate" . SPARSER::PROTEIN)
    ("DAPPLE" . SPARSER::PROTEIN) ("Gene" . SPARSER::GENE)
    ("tetramer" . SPARSER::TETRAMER) ("CPs" . SPARSER::PROTEIN)
    ("basic leucine transcription factor" . SPARSER::PROTEIN)
    ("NFAT" . SPARSER::PROTEIN) ("BATF" . SPARSER::PROTEIN)
    ("ATF" . SPARSER::PROTEIN) ("leucine" . SPARSER::AMINO-ACID)
    ("inhibitory immunoregulatory receptors" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::PROTEIN) ("receptors" . SPARSER::RECEPTOR)
    ("molecules" . SPARSER::MOLECULE) ("effector" . SPARSER::EFFECTOR)
    ("cytotoxic" . SPARSER::PROTEIN) ("EC" . SPARSER::PROTEIN)
    ("-1" . SPARSER::PROTEIN) ("full-length" . SPARSER::PROTEIN)
    ("3-dioxygenase" . SPARSER::PROTEIN) ("-2" . SPARSER::PROTEIN)
    ("Necrostatin-1" . SPARSER::MOLECULE) ("annexin V" . SPARSER::PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("factor-κ B" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("CD3" . SPARSER::PROTEIN) ("CD27" . SPARSER::PROTEIN)
    ("CCR7" . SPARSER::PROTEIN) ("CD45RA" . SPARSER::PROTEIN)
    ("p17" . SPARSER::PROTEIN) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell membrane" . SPARSER::PROTEIN) ("HLA-DQA1" . SPARSER::PROTEIN)
    ("AKAP13" . SPARSER::PROTEIN) ("IL-7R" . SPARSER::PROTEIN)
    ("UBASH3A" . SPARSER::PROTEIN) ("LMNB1" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("CKS1B" . SPARSER::PROTEIN)
    ("CKS2" . SPARSER::PROTEIN) ("MND1" . SPARSER::PROTEIN)
    ("THOC4" . SPARSER::PROTEIN) ("PRIM1" . SPARSER::PROTEIN)
    ("RPA3" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("C1orf59" . SPARSER::PROTEIN) ("RAD51AP1" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("BUB1B" . SPARSER::PROTEIN)
    ("MLF1IP" . SPARSER::PROTEIN) ("SPC25" . SPARSER::PROTEIN)
    ("IKZF2" . SPARSER::PROTEIN) ("IL7R" . SPARSER::PROTEIN)
    ("CASP8" . SPARSER::PROTEIN) ("LAT2" . SPARSER::PROTEIN)
    ("CD74" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("GP33" . SPARSER::PROTEIN) ("zinc finger" . SPARSER::PROTEIN)
    ("RIPK1" . SPARSER::PROTEIN) ("protein kinase-1" . SPARSER::PROTEIN)
    ("c-FLIP" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("p24" . SPARSER::PROTEIN) ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tim-3" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("RIPK3" . SPARSER::PROTEIN) ("PD-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    (NIL . SPARSER::PROTEIN) ("Caspase-8" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("oncogenes" . SPARSER::ONCOGENE) ("mask" . SPARSER::PROTEIN)
    ("melting" . SPARSER::DRUG) ("conformations" . SPARSER::BIO-CONFORMATION)
    ("hydrated" . SPARSER::MOLECULE) ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polymerase" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("a human telomere hybrid quadruplex form and an 8 bp hairpin"
     . SPARSER::COLLECTION)
    ("c-myc and hTERT" . SPARSER::COLLECTION)
    ("RNA and DNA" . SPARSER::COLLECTION) ("RNA" . SPARSER::RNA)
    ("guanines" . SPARSER::NUCLEOBASE) ("form" . SPARSER::FORM)
    ("ETS" . SPARSER::PROTEIN) ("adenine" . SPARSER::NUCLEOBASE)
    ("guanine" . SPARSER::PROTEIN) ("thymine" . SPARSER::MOLECULE)
    ("cytosine" . SPARSER::NUCLEOBASE) ("BRAF and hTERT" . SPARSER::COLLECTION)
    ("thyroid" . SPARSER::PROTEIN) ("BRAF" . SPARSER::PROTEIN)
    ("promoters" . SPARSER::PROMOTER) ("DNA" . SPARSER::DNA)
    ("map" . SPARSER::PROTEIN) ("forms" . SPARSER::FORM)
    ("gene" . SPARSER::GENE) ("promoter" . SPARSER::PROMOTER)
    ("hTERT" . SPARSER::PROTEIN) ("–3" . SPARSER::PROTEIN)
    ("Beta 1" . SPARSER::PROTEIN) ("K2" . SPARSER::PROTEIN)
    ("P – 1" . SPARSER::PROTEIN) ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIP3" . SPARSER::PROTEIN) ("cm −1" . SPARSER::PROTEIN)
    ("mM −1" . SPARSER::PROTEIN) ("Etc." . SPARSER::PROTEIN)
    ("HIF1α" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("K-Ras" . SPARSER::PROTEIN) ("c-Myb" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("transcription factor" . SPARSER::PROTEIN)
    ("trigger" . SPARSER::PROTEIN) ("DLST-lipoyl" . SPARSER::COLLECTION)
    ("suppressor" . SPARSER::SUPPRESSOR) ("catabolic genes" . SPARSER::GENE)
    ("genes" . SPARSER::GENE) ("glucose" . SPARSER::PROTEIN)
    ("residual SIRT4" . SPARSER::PROTEIN) ("kinases" . SPARSER::KINASE)
    ("states" . SPARSER::BIO-STATE)
    ("all previously characterized SIRT substrates" . SPARSER::SUBSTRATE)
    ("lipoyl" . SPARSER::PROTEIN) ("DLAT-lipoyl" . SPARSER::COLLECTION)
    ("its previously reported substrate" . SPARSER::SUBSTRATE)
    ("Enzyme" . SPARSER::ENZYME) ("mixture" . SPARSER::MOLECULE)
    ("KDa" . SPARSER::PROTEIN)
    ("the accessory PDH E3-binding subunit (PDHX)" . SPARSER::FRAGMENT)
    ("subunit (PDHX)" . SPARSER::FRAGMENT)
    ("acetyl-CoA, and DLAT" . SPARSER::COLLECTION)
    ("Coenzyme" . SPARSER::MOLECULE) ("group" . SPARSER::MOLECULE)
    ("arm" . SPARSER::PROTEIN)
    ("DLAT, DLST, DBT, PDHX and GCSH—the" . SPARSER::COLLECTION)
    ("GCSH" . SPARSER::PROTEIN) ("DBT" . SPARSER::PROTEIN)
    ("DLST" . SPARSER::PROTEIN) ("class" . CLASS)
    ("biotinidase" . SPARSER::PROTEIN) ("partial" . SPARSER::PROTEIN)
    ("mRNA" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT) ("Glutamine" . SPARSER::AMINO-ACID)
    ("a biological substrate" . SPARSER::SUBSTRATE)
    ("mCherry (CTL)" . SPARSER::PROTEIN)
    ("SIRT4, or SIRT4" . SPARSER::COLLECTION) ("mCherry" . SPARSER::PROTEIN)
    ("ions" . SPARSER::MOLECULE) ("GluC" . SPARSER::PROTEIN)
    ("specific lipoylated lysines of endogenous cellular DLAT"
     . SPARSER::PROTEIN)
    ("endogenous cellular DLAT" . SPARSER::PROTEIN)
    ("lysines" . SPARSER::AMINO-ACID) ("SRM" . SPARSER::PROTEIN)
    ("blot" . SPARSER::PROTEIN) ("SIRT3 or SIRT5" . SPARSER::COLLECTION)
    ("GFP (CTL)" . SPARSER::PROTEIN) ("SIRT3, or SIRT5" . SPARSER::COLLECTION)
    ("CTL" . SPARSER::PROTEIN) ("GFP" . SPARSER::PROTEIN)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("the known biological substrate peptide" . SPARSER::PEPTIDE)
    ("state" . SPARSER::BIO-STATE)
    ("the putative biological substrates" . SPARSER::SUBSTRATE)
    ("DLAT and PDHX" . SPARSER::COLLECTION) ("inactive" . SPARSER::INACTIVE)
    ("NAD + and substrate binding ( xref ; xref )" . SPARSER::COLLECTION)
    ("histidine" . SPARSER::AMINO-ACID) ("ion" . SPARSER::MOLECULE)
    ("acyl" . SPARSER::PROTEIN)
    ("biotinyl- or lipoyl-lysine" . SPARSER::COLLECTION)
    ("acetyl-" . SPARSER::MOLECULE) ("differentially" . SPARSER::PROTEIN)
    ("cofactor" . SPARSER::MOLECULE) ("biotinyl-" . SPARSER::MOLECULE)
    ("E2 and E3" . SPARSER::COLLECTION)
    ("dehydrogenase (BCKDH)" . SPARSER::PROTEIN)
    ("the multimeric mammalian dehydrogenase complexes—pyruvate dehydrogenase (PDH)"
     . SPARSER::PROTEIN)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN) ("OGDH" . SPARSER::PROTEIN)
    ("catabolism, and biotin" . SPARSER::COLLECTION)
    ("GLUD1, IDE and MLYCD" . SPARSER::COLLECTION) ("MLYCD" . SPARSER::PROTEIN)
    ("IDE" . SPARSER::PROTEIN) ("Mitochondria" . SPARSER::PROTEIN)
    ("SIRT4-EGFP" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("potential cellular substrates" . SPARSER::SUBSTRATE)
    ("complexes" . SPARSER::BIO-COMPLEX) ("regulator" . SPARSER::REGULATOR)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("kinase" . SPARSER::KINASE)
    ("PDHX" . SPARSER::PROTEIN) ("subunit" . SPARSER::FRAGMENT)
    ("subunits" . SPARSER::FRAGMENT)
    ("SIRT4 and the components" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT)
    ("in vivo biological substrates" . SPARSER::SUBSTRATE)
    ("active" . SPARSER::ACTIVE) ("acyl-histone" . SPARSER::PROTEIN-PAIR)
    ("peptides" . SPARSER::PEPTIDE) ("histone" . SPARSER::PROTEIN)
    ("peptide" . SPARSER::PEPTIDE) ("substrate" . SPARSER::SUBSTRATE)
    ("decarboxylase (MCD)" . SPARSER::PROTEIN) ("MCD" . SPARSER::PROTEIN)
    ("decarboxylase" . SPARSER::PROTEIN) ("CoA" . SPARSER::MOLECULE)
    ("malonyl" . SPARSER::PROTEIN) ("catabolism" . SPARSER::PROTEIN)
    ("lipid" . SPARSER::LIPID) ("ADP" . SPARSER::PROTEIN)
    ("SIRT3 and SIRT5" . SPARSER::COLLECTION) ("enzyme" . SPARSER::ENZYME)
    ("carbamoyl" . SPARSER::MOLECULE) ("acylcarnitines" . SPARSER::DRUG)
    ("ketone" . SPARSER::MOLECULE) ("target" . SPARSER::TARGET-PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN) ("ATP" . SPARSER::ATP)
    ("proteins" . SPARSER::PROTEIN)
    ("SIRT5 preferentially desuccinylates and demalonylates protein substrates"
     . SPARSER::SUBSTRATE)
    ("substrates" . SPARSER::SUBSTRATE) ("protein" . SPARSER::PROTEIN)
    ("SIRTs1-3 display robust deacetylase activity" . SPARSER::PROTEIN)
    ("acetyl" . SPARSER::MOLECULE) ("acetyltransferases" . SPARSER::PROTEIN)
    ("deacetylases" . SPARSER::PROTEIN)
    ("SIRT1, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("seven" . SPARSER::PROTEIN) ("family" . SPARSER::PROTEIN-FAMILY)
    ("glutamine" . SPARSER::AMINO-ACID)
    ("acetyltransferase (DLAT)" . SPARSER::PROTEIN) ("DLAT" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN) ("cofactors" . SPARSER::PROTEIN)
    ("lipoamide" . SPARSER::DRUG) ("component" . SPARSER::COMPONENT)
    ("lysine" . SPARSER::AMINO-ACID) ("biotinyl" . SPARSER::MOLECULE)
    ("complex (PDH)" . SPARSER::BIO-COMPLEX) ("complex" . SPARSER::BIO-COMPLEX)
    ("dehydrogenase" . SPARSER::PROTEIN) ("pyruvate" . SPARSER::PROTEIN)
    ("mitochondrial SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("SIRT4 and SIRT5" . SPARSER::COLLECTION) ("enzymes" . SPARSER::ENZYME)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY) ("N-terminally" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("SP5" . SPARSER::PROTEIN)
    ("ADP-ribosyltransferase" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID) ("PDP1" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Lys9" . SPARSER::PROTEIN)
    ("alpha-" . SPARSER::PROTEIN)
    ("oxoglutarate dehydrogenase" . SPARSER::PROTEIN)
    ("COX IV" . SPARSER::PROTEIN)
    ("dihydrolipoyl dehydrogenase" . SPARSER::PROTEIN)
    ("E3" . SPARSER::MOLECULE) ("amino acid" . SPARSER::AMINO-ACID)
    ("GLUD1" . SPARSER::PROTEIN) ("PPAR-α" . SPARSER::PROTEIN)
    ("synthase 1" . SPARSER::PROTEIN) ("fatty acid" . SPARSER::MOLECULE)
    ("SIRT3" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("SIRT6" . SPARSER::PROTEIN) ("SIRT1" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("E2" . SPARSER::MOLECULE) ("E1" . SPARSER::MOLECULE)
    ("acetyl-CoA" . SPARSER::MOLECULE)
    ("deacetylase activity" . SPARSER::PROTEIN) ("SIRT5" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN)))